Citrus Sinensis ID: 042853

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610----
Protein Sequence
LLPGLCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLRELGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT
Secondary Structure (PSIPRED)
cccccccccccccccccccccccEEEccccEEEEEEEccccccccEEEEEEccccccccccccccccccccccccccccccccccccEEEccccccccccccccEEEEcccccEEEEcccccEEEEEcccccccccEEEEEEcccEEEEEcccccccccccccccccccccccccccEEEEEEccccEEEEEEcccccccccEEEEEccccccEEEEEEccEEEEEEEEEccccEEEEEccccccccccccEEEEEEEEEcccEEEEEEEEcccccEEEEEEEcccccEEEcccccccccccccEEccccccccccccccccccccccccccccccccHHHHHHHHcccEEcccccHHHccccccccccEEEEEEEEEHHHHHHHHHHHHHHHEEEEHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHccccccccEEEcccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccHHHccccccccccccccccEEEccccEEEEEEEcccccccEEEEEEEccccHHHEEEHEHHcccccccccccccccccccccEEEEEccccccccccccEEEEEccccEEEEEEccccEEEEccccccccccEEEEEccccEEEEEccccccccccEEEEEccccccccccccEccccccccccEEEEEcccccccccEEEEEccccccEEEEEcccEEEEEccccccccEEccccccccccccccccEEEEEEEEcccEEEEEEEEEccccEEEEEEEccccEEEEEEEcccccccccccccccccccccccccccccccccHHHHHHHHcccccEEEEccccccEEEEccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHccccccccEccccccccccccccccccccEcHHHHHHHHccccccccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHcccHcEEEEEEccccccccHHHcccHccccccHHHHHHHHHHHHHHHHHHHHccHcccEcccccHHHEEEcccccEEEccccccEEcccccEEccccEEccc
Coil and Loop (DISEMBL)
llpglcycqtdklqqgqvlKDGEELVSAYGnfrlgffspsgrrnRYLAIYykkprdriLDVAFnclmgyptgdvsmqsynqaikprpvwianrdtpvlrnesatliidstdgnlkilrngkspieisSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELwqsfdyptdtllpgmklginlqtghqwflrssrsAEVSyrlglgtdpnitnklviwkddKVVWTSTIWlngslksgipgsvddvYNFYHQFYnfsytsneqeryltysvnedvtsfpaltfdsdgrlkddigidisctllggcedqtnyyghgppsyyppsyytepeggkkkWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLRElghnvslptifgnrktqarsdqtVKRDLKIFDFQTIavatdnfspanrlgqggfgpvykgklqDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEylpnksldffifDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNilldeqmnpkisdfgmaRTFTMNELEantnrivgt
Flexible Loop (DISEMBL)
llpglcycqtdklqqgqvLKDGEELVSAYGNfrlgffspsgrrnRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNEsatliidstdgnlkilrngkspieissvrragnttratllkngnlvLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLglgtdpnitnklviwkdDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLrelghnvslptifgnrktqarsdqtVKRDLKIFDFQTIAVatdnfspanrlgQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVsnilldeqmnpkISDFGMARTFTmneleantnrivgt
Low Complexity Region (SEG)
LLPGLCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDISCTLLGGCEDQTNyyghgppsyyppsyytepeggKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMslvivigvvsvvpllsyvsflllkklkAKVESMVNRQKLLRELGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT
Disordered region (IsUnstruct)
***GLCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLRELGHNVSLPTIFGNR********TVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ***EIAIK*******QGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT**************
Disordered Region (DISOPRED)
LLPGLCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKV*************GHNVSL*******************DLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT
Disordered Region (DISEMBL)
LLPGLCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLRELGHNVSLPTIFGN*********TVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT
Disordered Region (DISPRO)
LLPGLCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMV*******************************VKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRI***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LLPGLCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLxxxxxxxxxxxxxxxxxxxxxGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	614	2.2.26 [Sep-21-2011]
O64793	818	G-type lectin S-receptor-	yes	no	0.910	0.683	0.386	1e-107
O64771	809	G-type lectin S-receptor-	no	no	0.879	0.667	0.330	3e-76
O64778	807	G-type lectin S-receptor-	no	no	0.869	0.661	0.330	1e-70
Q9LW83	850	G-type lectin S-receptor-	no	no	0.470	0.34	0.478	3e-68
Q9SXB4	820	G-type lectin S-receptor-	no	no	0.470	0.352	0.449	3e-65
O81906	849	G-type lectin S-receptor-	no	no	0.281	0.203	0.653	3e-64
O81905	850	Receptor-like serine/thre	no	no	0.395	0.285	0.528	9e-64
O81833	815	G-type lectin S-receptor-	no	no	0.281	0.212	0.648	1e-63
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.403	0.294	0.477	3e-63
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.418	0.308	0.467	4e-63

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  389 bits (998), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 265/686 (38%), Positives = 359/686 (52%), Gaps = 127/686 (18%)

Query: 9   QTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMG 68
           +TD L QGQ LKDG+ELVSA+  F+L FF+     N YL I+            FN L  
Sbjct: 23  ETDTLHQGQFLKDGQELVSAFKIFKLKFFNFKNSENLYLGIW------------FNNLY- 69

Query: 69  YPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISS 128
                      N   + RPVWIANR+ P+  + S +L +DS  G LKILR   + +E+SS
Sbjct: 70  ----------LNTDSQDRPVWIANRNNPI-SDRSGSLTVDSL-GRLKILRGASTMLELSS 117

Query: 129 VRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQ 188
           +    NTT   LL +GNL L EM++DG S++R LWQSFDYPTDTLLPGMKLG + +T  +
Sbjct: 118 IETTRNTT-LQLLDSGNLQLQEMDADG-SMKRVLWQSFDYPTDTLLPGMKLGFDGKTRKR 175

Query: 189 WFLRS--SRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDV 246
           W L S    +   S     G D NITN L I     + W+S +W  G             
Sbjct: 176 WELTSWLGDTLPASGSFVFGMDTNITNVLTILWRGNMYWSSGLWNKGRFSE--------- 226

Query: 247 YNFYHQFYNFSYTSNEQERYLTYSVNED--VTSFPALTFDSDGRLKDD---------IGI 295
                  + FS+ S +  +Y  YS ++D   T FP +  D  G L+ +            
Sbjct: 227 EELNECGFLFSFVSTKSGQYFMYSGDQDDARTFFPTIMIDEQGILRREQMHRQRNRQNYR 286

Query: 296 DISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVL--GMCLLL 353
           + +C   G       Y   G  S+      +   G      F  +  +A+ L    CL  
Sbjct: 287 NRNCLAAGYVVRDEPY---GFTSFRVTVSSSASNGFVLSGTFSSVDCSAICLQNSSCLAY 343

Query: 354 ---------------------SLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVV-PLLSYV 391
                                S  +  R  ++   E K+  +  IV+  + ++ P++ ++
Sbjct: 344 ASTEPDGTGCEIWNTYPTNKGSASHSPRTIYIRGNENKKVAAWHIVVATLFLMTPIIWFI 403

Query: 392 SFLLLKKLKAK------------VESMV----------------------NRQKLLRELG 417
            +L+L+K   K            + SMV                      +++ LLRELG
Sbjct: 404 IYLVLRKFNVKGRNCIRITHKTVLVSMVFLLTMIGFIRRRILSLRFGSTIDQEMLLRELG 463

Query: 418 HNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKL 477
            + S            R+++    +L+IF F+++  ATD+FS  N+LG+GGFGPVYKGKL
Sbjct: 464 IDRSC--------IHKRNERKSNNELQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKL 515

Query: 478 QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK 528
            + +E+AIKRLS +SGQG+VEFKNEA LIAKLQHTNL           E++L+YEY+ NK
Sbjct: 516 LNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNK 575

Query: 529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP 588
           SLD+F+FD  RK++LDW  RF I+EGI QGLLYLHKYSRL+VIHRD+K SNILLDE MNP
Sbjct: 576 SLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNP 635

Query: 589 KISDFGMARTFTMNELEANTNRIVGT 614
           KISDFG+AR F   E  ANT R+ GT
Sbjct: 636 KISDFGLARIFGAEETRANTKRVAGT 661

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O64771|Y1148_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480 OS=Arabidopsis thaliana GN=At1g61480 PE=2 SV=2

 Score =  286 bits (732), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 227/686 (33%), Positives = 323/686 (47%), Gaps = 146/686 (21%)

Query: 19  LKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQS 78
           L  G+ L S+ G + LGFFS +  +N+Y+ I++K    R++                   
Sbjct: 32  LSIGKTLSSSNGVYELGFFSFNNSQNQYVGIWFKGIIPRVV------------------- 72

Query: 79  YNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRA 138
                    VW+ANR+ PV   +SA  +  S++G+L +     S +       A N +RA
Sbjct: 73  ---------VWVANREKPV--TDSAANLTISSNGSLLLFNENHSVVWSIGETFASNGSRA 121

Query: 139 TLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRS--SRS 196
            L  NGNLV+ + NS      R LW+SF++  DT+LP   L  NL TG +  L S  S +
Sbjct: 122 ELTDNGNLVVIDNNSG-----RTLWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHT 176

Query: 197 AEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNF 256
                   +   P + ++    +  K  W S  W      +GIP  +DD    Y   ++ 
Sbjct: 177 DPSPGDFTVQITPQVPSQACTMRGSKTYWRSGPWAKTRF-TGIP-VMDDT---YTSPFSL 231

Query: 257 SYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDI---------SCTLLG---- 303
              +N    +  +  N  + S+  +T +   ++    G+D          SC + G    
Sbjct: 232 QQDTNGSGSFTYFERNFKL-SYIMITSEGSLKIFQHNGMDWELNFEAPENSCDIYGFCGP 290

Query: 304 ---------------------------------GCEDQTNYYGHG--------------- 315
                                            GC   T  +  G               
Sbjct: 291 FGICVMSVPPKCKCFKGFVPKSIEEWKRGNWTDGCVRHTELHCQGNTNGKTVNGFYHVAN 350

Query: 316 --PPSYYPPSYYTEPEGGKKKWWF-WLIIAAAVVLGM-CLL----------LSLGYIIRR 361
             PP +Y  + + + EG  +        +A A + G+ CL+           S G  I  
Sbjct: 351 IKPPDFYEFASFVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQDLMDAVQFSAGGEILS 410

Query: 362 KHLNAKE---EKRWMSLVIVIGVVSVVPLLSYVSFLLLK-KLKAKVESMVNRQKLLRELG 417
             L + E    KR   +V  I  +S+  +L++ +F  L+ K+K  V + +++        
Sbjct: 411 IRLASSELGGNKRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIASKEAWN 470

Query: 418 HNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKL 477
           +++    + G               LK F+  TI  ATDNFS +N+LGQGGFG VYKGKL
Sbjct: 471 NDLEPQDVSG---------------LKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKL 515

Query: 478 QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK 528
           QD +EIA+KRLS SSGQG  EF NE  LI+KLQH NL         G ERLLVYE+L NK
Sbjct: 516 QDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNK 575

Query: 529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP 588
           SLD F+FDS ++  +DW KRF+IIEGI +GL YLH+ S LRVIHRDLKVSNILLDE+MNP
Sbjct: 576 SLDTFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNP 635

Query: 589 KISDFGMARTFTMNELEANTNRIVGT 614
           KISDFG+AR +   E + NT R+ GT
Sbjct: 636 KISDFGLARMYQGTEYQDNTRRVAGT 661

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64778|Y1142_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61420 OS=Arabidopsis thaliana GN=At1g61420 PE=2 SV=2

 Score =  268 bits (684), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 226/684 (33%), Positives = 319/684 (46%), Gaps = 150/684 (21%)

Query: 22  GEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQ 81
           G+ L S+ G + LGFF+ +  +N+Y+ I++K    R++                      
Sbjct: 35  GQTLSSSNGFYELGFFNFNNSQNQYVGIWFKGIIPRVV---------------------- 72

Query: 82  AIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRR-AGNTTRATL 140
                 VW+ANR+ PV  + +A L I S +G+L +L NGK  +  SS      N +RA L
Sbjct: 73  ------VWVANREKPV-TDSTANLAI-SNNGSL-LLFNGKHGVAWSSGEALVSNGSRAEL 123

Query: 141 LKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVS 200
              GNL++ + N  G    R LWQSFD+  DT+LP   L  NL TG +  L SS  +   
Sbjct: 124 SDTGNLIVID-NFSG----RTLWQSFDHLGDTMLPSSTLKYNLATGEKQVL-SSWKSYTD 177

Query: 201 YRLG---LGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGI---------PGSVDDVYN 248
             +G   L   P +  ++++ K     + S  W      +GI         P SV    N
Sbjct: 178 PSVGDFVLQITPQVPTQVLVTKGSTPYYRSGPWAKTRF-TGIPLMDDTFTGPVSVQQDTN 236

Query: 249 FYHQFYNFSYTSNEQERYLTYSVNED---------VTSFPALTFDSD--------GRLKD 291
                   +     Q   LT    ++         V +F A     D        G    
Sbjct: 237 GSGSLTYLNRNDRLQRTMLTSKGTQELSWHNGTDWVLNFVAPEHSCDYYGVCGPFGLCVK 296

Query: 292 DIGIDISC---------------TLLGGCEDQTNYYGHG-----------------PPSY 319
            +    +C                  GGC  +T  Y  G                 PP +
Sbjct: 297 SVPPKCTCFKGFVPKLIEEWKRGNWTGGCVRRTELYCQGNSTGKYANVFHPVARIKPPDF 356

Query: 320 YPPSYYTEPEGGKKKWWF-WLIIAAAVVLGM-CLLLS---------------LGYIIRRK 362
           Y  + +   E  +K        +A A + G+ CL+ +               L   + R 
Sbjct: 357 YEFASFVNVEECQKSCLHNCSCLAFAYIDGIGCLMWNQDLMDAVQFSEGGELLSIRLARS 416

Query: 363 HLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLRELGHNVSL 422
            L   + K+ ++  IV   +S+V ++++V+F   +                  + HN  +
Sbjct: 417 ELGGNKRKKAITASIV--SLSLVVIIAFVAFCFWR----------------YRVKHNADI 458

Query: 423 PTIFGNRKTQARSD---QTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQD 479
            T     +   R+D   Q V   L  FD  TI  AT+NFS +N+LGQGGFGPVYKGKLQD
Sbjct: 459 TT--DASQVSWRNDLKPQDVP-GLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQD 515

Query: 480 EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL 530
            +EIA+KRLS SSGQG  EF NE  LI+KLQH NL         G E+LL+YE++ N SL
Sbjct: 516 GKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSL 575

Query: 531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI 590
           D F+FDS ++  +DW KR  II+GI +G+ YLH+ S L+VIHRDLKVSNILLDE+MNPKI
Sbjct: 576 DTFLFDSRKRLEIDWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKI 635

Query: 591 SDFGMARTFTMNELEANTNRIVGT 614
           SDFG+AR +   E + NT R+VGT
Sbjct: 636 SDFGLARMYQGTEYQDNTRRVVGT 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  259 bits (663), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 156/326 (47%), Positives = 205/326 (62%), Gaps = 37/326 (11%)

Query: 304 GCE----DQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYII 359
           GCE    D TN       S++P + Y   +G K     WL++ A++ L + +   + Y++
Sbjct: 389 GCEIWNTDPTN---ENSASHHPRTIYIRIKGSKLAA-TWLVVVASLFLIIPVTWLIIYLV 444

Query: 360 RRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKA--KVESMVNRQKLLRELG 417
            RK            +     V   + ++S  S  L  K  +  +V S ++++ LL ELG
Sbjct: 445 LRK----------FKIKGTNFVSESLKMISSQSCSLTNKRLSTLRVGSTIDQEMLLLELG 494

Query: 418 HNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKL 477
                      R+   RS +    +L+IF F+++A ATD FS AN+LG+GGFGPVYKG+L
Sbjct: 495 --------IERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRL 546

Query: 478 QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK 528
            D +E+AIKRLS +SGQG+VEFKNEA LIAKLQHTNL           E++L+YEY+PNK
Sbjct: 547 IDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNK 606

Query: 529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP 588
           SLD+F+FD  RK +LDWK RF I+EGI QGLLYLHKYSRL+VIHRD+K  NILLDE MNP
Sbjct: 607 SLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNP 666

Query: 589 KISDFGMARTFTMNELEANTNRIVGT 614
           KISDFGMAR F   E +ANT R+ GT
Sbjct: 667 KISDFGMARIFGAQESKANTKRVAGT 692

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1

 Score =  250 bits (638), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 143/318 (44%), Positives = 195/318 (61%), Gaps = 29/318 (9%)

Query: 317 PSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLV 376
           P +   S  +EPE  +        IAAA  LG   ++  G ++  + L+A     ++ L 
Sbjct: 366 PDFARRSEASEPECLRTCLQTCSCIAAAHGLGYGCMIWNGSLVDSQELSASGLDLYIRLA 425

Query: 377 -----------IVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLRELGHNVSLPTI 425
                      I+IG +    +    + +LL +        +  +K  ++ G +     I
Sbjct: 426 HSEIKTKDKRPILIGTILAGGIFVVAACVLLAR-------RIVMKKRAKKKGRDAE--QI 476

Query: 426 FGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAI 485
           F   +  A  ++   ++L +F+FQ +A AT+NFS  N+LGQGGFGPVYKGKLQ+ QEIA+
Sbjct: 477 FERVEALAGGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAV 536

Query: 486 KRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFD 536
           KRLS++SGQG+ E  NE  +I+KLQH NL         G ER+LVYE++P KSLD+++FD
Sbjct: 537 KRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFD 596

Query: 537 SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           S R  LLDWK RF+II GI +GLLYLH+ SRLR+IHRDLK SNILLDE + PKISDFG+A
Sbjct: 597 SRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLA 656

Query: 597 RTFTMNELEANTNRIVGT 614
           R F  NE EANT R+VGT
Sbjct: 657 RIFPGNEDEANTRRVVGT 674

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  246 bits (629), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 119/182 (65%), Positives = 145/182 (79%), Gaps = 9/182 (4%)

Query: 442 DLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN 501
           +L +F    IA+AT++F   N LG+GGFGPVYKG L+D +EIA+KRLS  SGQG+ EFKN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572

Query: 502 EAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
           E  LIAKLQH NL         G E++LVYEY+PNKSLDFF+FD ++++L+DWK RFSII
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           EGI +GLLYLH+ SRLR+IHRDLKVSN+LLD +MNPKISDFGMAR F  N+ EANT R+V
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692

Query: 613 GT 614
           GT
Sbjct: 693 GT 694

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  245 bits (625), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 139/263 (52%), Positives = 182/263 (69%), Gaps = 20/263 (7%)

Query: 368 EEKRWMSLVIV---IGVVSVVPLLSYVSFLLLKKLKAK---VES-MVNRQKLLRELGHNV 420
           E+KR  S  I+   IGV SV+ LLS++ F L K+ + +   +E+ +V+ Q   R+L  N 
Sbjct: 433 EDKRNRSAKIIGSSIGV-SVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMN- 490

Query: 421 SLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDE 480
               +  +R+  +R + T   +L + +F+ +A+AT+NFS AN+LGQGGFG VYKGKL D 
Sbjct: 491 --EVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDG 548

Query: 481 QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLD 531
           QE+A+KRLSK+S QG  EFKNE KLIA+LQH NL          GE++L+YEYL N SLD
Sbjct: 549 QEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLD 608

Query: 532 FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKIS 591
             +FD SR S L+W+ RF II GI +GLLYLH+ SR R+IHRDLK SNILLD+ M PKIS
Sbjct: 609 SHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKIS 668

Query: 592 DFGMARTFTMNELEANTNRIVGT 614
           DFGMAR F  +E EANT ++VGT
Sbjct: 669 DFGMARIFGRDETEANTRKVVGT 691

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  244 bits (624), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 118/182 (64%), Positives = 146/182 (80%), Gaps = 9/182 (4%)

Query: 442 DLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN 501
           DL IFD +TI++ATD+FS  N LG+GGFGPVYKGKL+D QEIA+KRLS +SGQG+ EFKN
Sbjct: 484 DLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKN 543

Query: 502 EAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
           E KLIAKLQH NL         G E +L+YEY+PNKSLDFFIFD  R + LDWKKR +II
Sbjct: 544 EVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNII 603

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
            G+ +G+LYLH+ SRLR+IHRDLK  N+LLD  MNPKISDFG+A++F  ++ E++TNR+V
Sbjct: 604 NGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVV 663

Query: 613 GT 614
           GT
Sbjct: 664 GT 665

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  243 bits (620), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 128/268 (47%), Positives = 175/268 (65%), Gaps = 20/268 (7%)

Query: 358 IIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQK--LLRE 415
            IR  H   K     ++++I   V+ V+ + +    L  +K K +     +R    + + 
Sbjct: 431 FIRVAHSELKTHSN-LAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKR 489

Query: 416 LGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKG 475
           +    S          ++ S+Q   ++L +F+FQ +A +TD+FS  N+LGQGGFGPVYKG
Sbjct: 490 MEALTS--------DNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKG 541

Query: 476 KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP 526
           KL + QEIA+KRLS+ SGQG+ E  NE  +I+KLQH NL         G ER+LVYEY+P
Sbjct: 542 KLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMP 601

Query: 527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM 586
            KSLD ++FD  ++ +LDWK RF+I+EGI +GLLYLH+ SRL++IHRDLK SNILLDE +
Sbjct: 602 KKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENL 661

Query: 587 NPKISDFGMARTFTMNELEANTNRIVGT 614
           NPKISDFG+AR F  NE EANT R+VGT
Sbjct: 662 NPKISDFGLARIFRANEDEANTRRVVGT 689

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  243 bits (619), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 137/293 (46%), Positives = 184/293 (62%), Gaps = 36/293 (12%)

Query: 350 CLLLSLGYIIRRKHLNA---------KEE-KRW---------MSLVIVIGVVSVVPLLSY 390
           CL    G +  R +LN+         KEE  RW           L+I+I +++ V LL+ 
Sbjct: 396 CLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRRVLLILISLIAAVMLLTV 455

Query: 391 VSFLLLKKLKAKVESMVNRQKLLRELGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQT 450
           + F ++++ +       NR +      +   +P  F +   +   D+   R+L +FD  T
Sbjct: 456 ILFCVVRERRKS-----NRHR--SSSANFAPVPFDF-DESFRFEQDKARNRELPLFDLNT 507

Query: 451 IAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 510
           I  AT+NFS  N+LG GGFGPVYKG LQ+  EIA+KRLS++SGQG+ EFKNE KLI+KLQ
Sbjct: 508 IVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQ 567

Query: 511 HTNLG---------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H NL           E++LVYEYLPNKSLD+FIF   +++ LDW KR  I+ GI +G+LY
Sbjct: 568 HRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILY 627

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH+ SRLR+IHRDLK SNILLD +M PKISDFGMAR F  N++E  T+R+VGT
Sbjct: 628 LHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGT 680

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	614
255550026	795	Serine/threonine-protein kinase PBS1, pu	0.918	0.709	0.438	1e-122
359482600	789	PREDICTED: G-type lectin S-receptor-like	0.929	0.723	0.429	1e-117
322510097	818	RecName: Full=G-type lectin S-receptor-l	0.910	0.683	0.386	1e-105
42563025	587	lectin protein kinase-like protein [Arab	0.882	0.923	0.404	1e-105
225457483	787	PREDICTED: G-type lectin S-receptor-like	0.907	0.707	0.393	1e-103
147801639	744	hypothetical protein VITISV_029622 [Viti	0.869	0.717	0.396	1e-100
147780889	906	hypothetical protein VITISV_034502 [Viti	0.908	0.615	0.401	1e-100
297841445	785	predicted protein [Arabidopsis lyrata su	0.915	0.715	0.385	2e-98
449436595	743	PREDICTED: G-type lectin S-receptor-like	0.899	0.742	0.381	7e-97
359480377	751	PREDICTED: G-type lectin S-receptor-like	0.876	0.716	0.397	2e-95

>gi|255550026|ref|XP_002516064.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223544969|gb|EEF46484.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  446 bits (1147), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 290/662 (43%), Positives = 370/662 (55%), Gaps = 98/662 (14%)

Query: 7   YCQTDKLQQGQVLKDGEELVSAYGNFRLGF--FSPSGRR-NRYLAIYYKKPRDRILDVAF 63
           + QT  + QG  LK  +ELVSA G F+L F     SG   + YL I+Y    ++      
Sbjct: 25  HSQTRTILQGGELKYDQELVSADGMFKLKFGTVGESGESSDSYLGIWYNYIEEKF----- 79

Query: 64  NCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSP 123
                                  PVW+ANRDTP+  N S  L +DS  GNLKILR+    
Sbjct: 80  -----------------------PVWVANRDTPIFGN-SGILTVDS-QGNLKILRDKGRS 114

Query: 124 IEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINL 183
           I + SV++A     ATL   GN +L E+NS+G SI++ LWQSFDYPTDT LPGMKLGINL
Sbjct: 115 IVLYSVQKAIYNAIATLEDTGNFILRELNSNG-SIKQVLWQSFDYPTDTFLPGMKLGINL 173

Query: 184 QTGHQWFLRSSRSAEVSYR--LGLGTDPNITNKLVIWKDDKVVWTSTIWLNG-SLKSGIP 240
           +TG QW + S RS E   R    LGTDP+  N+LVIW+   + W S  W+   SL  G+ 
Sbjct: 174 KTGQQWSVISWRSFESPARGTFVLGTDPDSKNQLVIWRQGHIYWASGSWVGQFSLLGGLS 233

Query: 241 GSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRL----KDDIGID 296
                    ++  YNFSY S+E E Y  YS+N+  + FP LT +++G L    K D   +
Sbjct: 234 ---------FNVLYNFSYFSDENESYFIYSINKANSIFPRLTINAEGVLIGFLKYDYHEE 284

Query: 297 ISC-------TLLGGCEDQTNYYGHGPPSYY---PPSYYTEPEGGK--KKWWFWLIIAAA 344
           + C       +   GC +Q       P   +   P + Y   +G K        +I    
Sbjct: 285 VKCITSYDYMSPTVGCLEQNLPNCRSPSDAFLFKPRTGYMYSDGFKYSDSENLTMIDCKL 344

Query: 345 VVLGMCLLLSL--------GYII---------------RRKHLNAKEEKRWMSLVIVIGV 381
             L  C  ++         G  I               R+ ++  +  K W+ + I +G 
Sbjct: 345 NCLKNCSCIAYASKNEDGTGCEIWRSARSFIGSSSDDSRKIYIFDEVNKWWLPVTITLGG 404

Query: 382 VSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLRELGHNVSLPTIFGNRKTQARSDQTVKR 441
           + ++P L    + + KK         N + L  EL  N    T +   +TQ    +    
Sbjct: 405 IFLIPALCAFLYAIWKKCSRTGNGKTNLKNLWNELEGNALSLTTYDTLRTQ----KNEWD 460

Query: 442 DLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN 501
           +L IF F+ IA+AT  F P N+LG+GGFGPVYKGKL D QEIAIKRLS+SSGQG+VEFKN
Sbjct: 461 ELHIFCFEIIAIATKYFKPENKLGEGGFGPVYKGKLLDGQEIAIKRLSRSSGQGLVEFKN 520

Query: 502 EAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
           EA LIAKLQHTNL         G ER+LVYEY+P KSLD ++FDS +KS LDWKKRF II
Sbjct: 521 EAILIAKLQHTNLVKLLGFCVDGEERILVYEYMPKKSLDIYLFDSHKKSELDWKKRFKII 580

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           +GITQGLLYLHKYSRL+VIHRDLK SNILLD++MNPKISDFGMAR F + E EANTNRIV
Sbjct: 581 DGITQGLLYLHKYSRLKVIHRDLKASNILLDDEMNPKISDFGMARIFGLKESEANTNRIV 640

Query: 613 GT 614
           GT
Sbjct: 641 GT 642

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482600|ref|XP_003632790.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera]

 Score =  430 bits (1106), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 284/661 (42%), Positives = 361/661 (54%), Gaps = 90/661 (13%)

Query: 1   LLPGLCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILD 60
           L    CY   D L QG+ L+D E LVSA   F LGFF+     NRYL I+Y         
Sbjct: 18  LFLSTCYSTRDTLLQGKPLRDWERLVSANYAFTLGFFTQGSSDNRYLGIWYT-------- 69

Query: 61  VAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNG 120
                                + + R VW+ANR+ PV  + S  L+ID     LKI  NG
Sbjct: 70  ---------------------SFEVRRVWVANRNDPV-PDTSGNLMIDHA-WKLKITYNG 106

Query: 121 KSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLG 180
              I +S+  +  + T A L  NGN +L E  SDG +  R LWQSFDYPTDTLLPGMKLG
Sbjct: 107 -GFIAVSNYSQIASNTSAILQDNGNFILREHMSDGTT--RVLWQSFDYPTDTLLPGMKLG 163

Query: 181 INLQTGHQWFLRSSRSAEVSYR--LGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSL--- 235
           INL+TGHQW L S  + ++        G D    ++L+ W   K+ WTS  W NG+L   
Sbjct: 164 INLRTGHQWSLTSWLTNQIPATGYFSFGADFRNNSQLITWWRGKIYWTSGFWHNGNLSFD 223

Query: 236 --KSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDI 293
             ++ +P       + ++  Y F Y SN++E Y ++  NE V  FP L     G LK  +
Sbjct: 224 NLRASLPQK-----DHWNDGYGFRYMSNKKEMYFSFHPNESVF-FPMLVLLPSGVLKSLL 277

Query: 294 GIDISCTLL---GGCEDQTNYYGHGPPSY---YPPSYYTEPEGGK------------KKW 335
              + C       GC          P S    Y    Y   EG              + W
Sbjct: 278 RTYVHCESHIERQGCVKPDLPKCRNPASQRFQYTDGGYVVSEGFMFDDNATSVDCHFRCW 337

Query: 336 WFWLIIAAAVVLGMCLLLSLGYIIRRKHL-------------NAKEEKRWMSLVIVIGVV 382
                +A ++ L     +    I  RK+               A  +  W+ LV   G  
Sbjct: 338 NNCSCVAFSLHLAETRCVIWSRIQPRKYFVGESQQIYVLQTDKAARKMWWIWLVTAAGGA 397

Query: 383 SVVPLLSYVSFLLLKKLKAKVESMVNRQKLLRELGHNVSLPTIFGNRKTQARSDQTVKRD 442
            ++ L S +  L  KKLK + E+   +Q+LL ELG      T   ++K +    +T   +
Sbjct: 398 VIILLASSLCCLGWKKLKLQEENK-RQQELLFELGAITKPFTKHNSKKHEKVGKKT--NE 454

Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNE 502
           L++F FQ++A AT+NFS  N+LG+GGFGPVYKGKL D QEIAIKRLSKSS QG+VEFKNE
Sbjct: 455 LQLFSFQSLAAATNNFSIENKLGEGGFGPVYKGKLLDGQEIAIKRLSKSSRQGLVEFKNE 514

Query: 503 AKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE 553
             LIAKLQH NL           E++L+YEYLPNKSLDFFIFD S+K+LL+WKKR++IIE
Sbjct: 515 IALIAKLQHDNLVKLLGCCIKEEEKILIYEYLPNKSLDFFIFDPSKKNLLNWKKRYNIIE 574

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVG 613
           GITQGLLYLHK+SRLRVIHRDLK SNILLD +MNPKISDFGMAR F  +E EANTNR+VG
Sbjct: 575 GITQGLLYLHKFSRLRVIHRDLKASNILLDNEMNPKISDFGMARIFGQDECEANTNRVVG 634

Query: 614 T 614
           T
Sbjct: 635 T 635

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|322510097|sp|O64793.3|Y1675_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520; Flags: Precursor

 Score =  389 bits (998), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 265/686 (38%), Positives = 359/686 (52%), Gaps = 127/686 (18%)

Query: 9   QTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMG 68
           +TD L QGQ LKDG+ELVSA+  F+L FF+     N YL I+            FN L  
Sbjct: 23  ETDTLHQGQFLKDGQELVSAFKIFKLKFFNFKNSENLYLGIW------------FNNLY- 69

Query: 69  YPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISS 128
                      N   + RPVWIANR+ P+  + S +L +DS  G LKILR   + +E+SS
Sbjct: 70  ----------LNTDSQDRPVWIANRNNPI-SDRSGSLTVDSL-GRLKILRGASTMLELSS 117

Query: 129 VRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQ 188
           +    NTT   LL +GNL L EM++DG S++R LWQSFDYPTDTLLPGMKLG + +T  +
Sbjct: 118 IETTRNTT-LQLLDSGNLQLQEMDADG-SMKRVLWQSFDYPTDTLLPGMKLGFDGKTRKR 175

Query: 189 WFLRS--SRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDV 246
           W L S    +   S     G D NITN L I     + W+S +W  G             
Sbjct: 176 WELTSWLGDTLPASGSFVFGMDTNITNVLTILWRGNMYWSSGLWNKGRFSE--------- 226

Query: 247 YNFYHQFYNFSYTSNEQERYLTYSVNED--VTSFPALTFDSDGRLKDD---------IGI 295
                  + FS+ S +  +Y  YS ++D   T FP +  D  G L+ +            
Sbjct: 227 EELNECGFLFSFVSTKSGQYFMYSGDQDDARTFFPTIMIDEQGILRREQMHRQRNRQNYR 286

Query: 296 DISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVL--GMCLLL 353
           + +C   G       Y   G  S+      +   G      F  +  +A+ L    CL  
Sbjct: 287 NRNCLAAGYVVRDEPY---GFTSFRVTVSSSASNGFVLSGTFSSVDCSAICLQNSSCLAY 343

Query: 354 ---------------------SLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVV-PLLSYV 391
                                S  +  R  ++   E K+  +  IV+  + ++ P++ ++
Sbjct: 344 ASTEPDGTGCEIWNTYPTNKGSASHSPRTIYIRGNENKKVAAWHIVVATLFLMTPIIWFI 403

Query: 392 SFLLLKKLKAK------------VESMV----------------------NRQKLLRELG 417
            +L+L+K   K            + SMV                      +++ LLRELG
Sbjct: 404 IYLVLRKFNVKGRNCIRITHKTVLVSMVFLLTMIGFIRRRILSLRFGSTIDQEMLLRELG 463

Query: 418 HNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKL 477
            + S            R+++    +L+IF F+++  ATD+FS  N+LG+GGFGPVYKGKL
Sbjct: 464 IDRSC--------IHKRNERKSNNELQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKL 515

Query: 478 QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK 528
            + +E+AIKRLS +SGQG+VEFKNEA LIAKLQHTNL           E++L+YEY+ NK
Sbjct: 516 LNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNK 575

Query: 529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP 588
           SLD+F+FD  RK++LDW  RF I+EGI QGLLYLHKYSRL+VIHRD+K SNILLDE MNP
Sbjct: 576 SLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNP 635

Query: 589 KISDFGMARTFTMNELEANTNRIVGT 614
           KISDFG+AR F   E  ANT R+ GT
Sbjct: 636 KISDFGLARIFGAEETRANTKRVAGT 661

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42563025|ref|NP_176919.2| lectin protein kinase-like protein [Arabidopsis thaliana] gi|332196537|gb|AEE34658.1| lectin protein kinase-like protein [Arabidopsis thaliana]

 Score =  388 bits (996), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 254/628 (40%), Positives = 334/628 (53%), Gaps = 86/628 (13%)

Query: 9   QTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMG 68
           +TD L QGQ LKDG+ELVSA+  F+L FF+     N YL I+            FN L  
Sbjct: 23  ETDTLHQGQFLKDGQELVSAFKIFKLKFFNFKNSENLYLGIW------------FNNLY- 69

Query: 69  YPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISS 128
                      N   + RPVWIANR+ P+  + S +L +DS  G LKILR   + +E+SS
Sbjct: 70  ----------LNTDSQDRPVWIANRNNPI-SDRSGSLTVDSL-GRLKILRGASTMLELSS 117

Query: 129 VRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQ 188
           +    NTT   LL +GNL L EM++DG S++R LWQSFDYPTDTLLPGMKLG + +T  +
Sbjct: 118 IETTRNTT-LQLLDSGNLQLQEMDADG-SMKRVLWQSFDYPTDTLLPGMKLGFDGKTRKR 175

Query: 189 WFLRS--SRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDV 246
           W L S    +   S     G D NITN L I     + W+S +W  G             
Sbjct: 176 WELTSWLGDTLPASGSFVFGMDTNITNVLTILWRGNMYWSSGLWNKGRFSE--------- 226

Query: 247 YNFYHQFYNFSYTSNEQERYLTYSVNED--VTSFPALTFDSDGRLKDD---------IGI 295
                  + FS+ S +  +Y  YS ++D   T FP +  D  G L+ +            
Sbjct: 227 EELNECGFLFSFVSTKSGQYFMYSGDQDDARTFFPTIMIDEQGILRREQMHRQRNRQNYR 286

Query: 296 DISCTLLGGCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSL 355
           + +C   G       Y     P  +     T        +      ++     +CL  S 
Sbjct: 287 NRNCLAAG-------YVVRDEPYGFTSFRVTVSSSASNGFVLSGTFSSVDCSAICLQNSS 339

Query: 356 GYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLRE 415
                    +    + W +     G  S  P   Y+        +   + M     LLRE
Sbjct: 340 CLAYASTEPDGTGCEIWNTYPTNKGSASHSPRTIYI--------RGNDQEM-----LLRE 386

Query: 416 LGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKG 475
           LG + S            R+++    +L+IF F+++  ATD+FS  N+LG+GGFGPVYKG
Sbjct: 387 LGIDRSC--------IHKRNERKSNNELQIFSFESVVSATDDFSDENKLGEGGFGPVYKG 438

Query: 476 KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP 526
           KL + +E+AIKRLS +SGQG+VEFKNEA LIAKLQHTNL           E++L+YEY+ 
Sbjct: 439 KLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQ 498

Query: 527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM 586
           NKSLD+F+FD  RK++LDW  RF I+EGI QGLLYLHKYSRL+VIHRD+K SNILLDE M
Sbjct: 499 NKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDM 558

Query: 587 NPKISDFGMARTFTMNELEANTNRIVGT 614
           NPKISDFG+AR F   E  ANT R+ GT
Sbjct: 559 NPKISDFGLARIFGAEETRANTKRVAGT 586

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225457483|ref|XP_002267352.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520-like [Vitis vinifera]

 Score =  383 bits (984), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 265/674 (39%), Positives = 352/674 (52%), Gaps = 117/674 (17%)

Query: 1   LLPGLCYCQ-TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRIL 59
           L+P   + Q T  +  GQ L D E +VSA G F LGFFSP   ++RYL ++Y K   +  
Sbjct: 19  LIPLSIHSQPTHTITSGQNLTDSERMVSANGVFTLGFFSPGKSKHRYLGMWYTKDEAQ-- 76

Query: 60  DVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRN 119
                                     R VW+ANR  P+  N S  L I   DG LKI ++
Sbjct: 77  --------------------------RVVWVANRLIPI-TNSSGVLTI-GDDGRLKIKQS 108

Query: 120 GKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRE-LWQSFDYPTDTLLPGMK 178
           G  PI +++ + A +   ATLL +GNLVL  M +D  + +RE +WQSFD+P+DTLLPGMK
Sbjct: 109 GGLPIVLNTDQAAKHNATATLLDSGNLVLTHMINDNGAFKRETVWQSFDHPSDTLLPGMK 168

Query: 179 LGINLQTGHQWFLRSSRSAEVSY--RLGLGTDPNITN--KLVIWKDDKVVWTSTIWLNGS 234
           L +NL+ G    L S  S EV       LG DP + +  ++VIW+   V+WTS IW + S
Sbjct: 169 LAVNLKVGSNRSLTSWLSHEVPAPGAFTLGLDPTVDDSCQVVIWRRGIVLWTSGIWEDNS 228

Query: 235 LKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIG 294
                    +D +N Y+  +     S + E+Y  Y+   D +    L   +  ++K +  
Sbjct: 229 TH------FEDWWNTYNVSFACVVVS-KYEKYFNYTY-ADHSHLSRLVMGAWRQVKFNSF 280

Query: 295 IDISCTLL--------GGCEDQTNYYG--HGPPSYYPPSY-------------------- 324
            + + TL          GC ++ +  G  H     +   Y                    
Sbjct: 281 SEFAITLCEGRNPILSSGCVEEESKCGRHHRTAFRFKNKYMKRRAEYSDDDPNLGIADCD 340

Query: 325 -----------YTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWM 373
                      Y           FWL  +  V      +L L   +  + LN      W+
Sbjct: 341 AKCKENCSCIAYASAHKNGTGCHFWLQNSPPVEGA---ILGLDAYVSDQELNKGSNCNWI 397

Query: 374 SLVIVIGVVSVVPLLSYVSFLLLKKLKAKVE--SMVNRQKLLRELGHNVSLPTIFGNRKT 431
           S  IVI    +VP + Y S +     K+K+   + +     + EL  + S          
Sbjct: 398 SYAIVI---ILVPTMLY-SVICCSYTKSKIAPGNEIFHDDFVHELDTDGS---------- 443

Query: 432 QARSDQTVKR--DLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS 489
              S+ T K+  +L+ F F  I VAT NFS  N+LG+GGFGPVYKGKL + QEIA+KRLS
Sbjct: 444 --TSENTSKKCAELQRFSFSDITVATKNFSSKNKLGEGGFGPVYKGKLSEGQEIAVKRLS 501

Query: 490 KSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRK 540
           + S QG++EFKNE  LI+KLQHTNL           E++L+YEY+PNKSLDFFIFD +RK
Sbjct: 502 RGSVQGLLEFKNEIALISKLQHTNLVKLLGYCIDREEKMLIYEYMPNKSLDFFIFDPTRK 561

Query: 541 SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            LLDWKKRFSIIEGI QGLLYLHKYSRLRVIHRDLK SNILLD  MNPKISDFGMA+ F 
Sbjct: 562 ELLDWKKRFSIIEGIAQGLLYLHKYSRLRVIHRDLKTSNILLDNDMNPKISDFGMAKMFR 621

Query: 601 MNELEANTNRIVGT 614
            ++  ANTNR+VGT
Sbjct: 622 QDQSRANTNRVVGT 635

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147801639|emb|CAN74543.1| hypothetical protein VITISV_029622 [Vitis vinifera]

 Score =  374 bits (959), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 257/648 (39%), Positives = 344/648 (53%), Gaps = 114/648 (17%)

Query: 25  LVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIK 84
           +VSA G F LGFFSP   ++RYL ++Y K   +                           
Sbjct: 1   MVSANGVFTLGFFSPGKSKHRYLGMWYTKDEAQ--------------------------- 33

Query: 85  PRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNG 144
            R VW+ANR  P+  N S  L I   DG LKI ++G  PI +++ + A +   ATLL +G
Sbjct: 34  -RVVWVANRLIPI-TNSSGVLTI-GDDGRLKIKQSGGLPIVLNTDQAAKHNATATLLDSG 90

Query: 145 NLVLYEMNSDGLSIRRE-LWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEV---- 199
           NLVL  M +D  + +RE +WQSFD+P+DTLLPGMKLG+NL+ G    L S  S EV    
Sbjct: 91  NLVLTHMINDNGAFKRETVWQSFDHPSDTLLPGMKLGVNLKVGSNRSLTSWLSHEVPAPG 150

Query: 200 SYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYT 259
           ++ LGL    N + ++VIW+   V+W S IW + S         +D +N Y+   +F+  
Sbjct: 151 AFTLGLDPTVNDSCQVVIWRRGIVLWRSGIWEDKSTH------FEDWWNTYN--VSFTCA 202

Query: 260 SNEQERYLTYSVNEDVTSFPALTFDSDGRLKDDIGIDISCTLL---------GGCEDQTN 310
            ++ E+Y  Y+   D +    L   S  ++K +   +   TL           GC ++ +
Sbjct: 203 VSKYEKYFMYTY-ADHSHLSRLVMGSWRQVKFNSFPEFEITLCEGNRNPILSSGCVEEES 261

Query: 311 YYG-HGPPSYYPPSYYT---------EPEGGKKKW-----------------------WF 337
             G H   ++   + Y          +P  GK                           F
Sbjct: 262 KCGRHHRTAFRFMNKYMKRRAEYSDDDPNLGKAGCDAKCKENCSCIAYASAHNNGTGCHF 321

Query: 338 WLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLK 397
           WL  +  V      +L L   +  + LN      W  +   IG++ V  +L  V      
Sbjct: 322 WLQNSPPVEGA---ILGLDAFVSDQELNKGSNYNW--IWYAIGIILVPTMLYSVICCSYT 376

Query: 398 KLKAKVESMVNRQKLLRELGHNVSLPTIFGNRKTQARSDQTVKR--DLKIFDFQTIAVAT 455
           K K    + +    L+ EL  + S             S++T K+  +L+ F F  I VAT
Sbjct: 377 KSKIAPGNEIFHDDLVHELDTDGS------------TSEKTSKKCAELQRFSFSDITVAT 424

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
            NFS  N+LG+GGFGPVYKGKL + QEIA+KRLS+ S QG++EFKNE  LI+KLQHTNL 
Sbjct: 425 KNFSSKNKLGEGGFGPVYKGKLSEGQEIAVKRLSRGSVQGLLEFKNEIALISKLQHTNLV 484

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                     E++L+YEY+PNKSLDFFIFD +RK LLDWKKRFSIIEGI QGLLYLHKYS
Sbjct: 485 KILGYCIDREEKMLIYEYMPNKSLDFFIFDPTRKELLDWKKRFSIIEGIAQGLLYLHKYS 544

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RLRVIHRDLK SNILLD  MNPKISDFGMA+ F  ++  ANTNR+VGT
Sbjct: 545 RLRVIHRDLKTSNILLDNDMNPKISDFGMAKMFRQDQSRANTNRVVGT 592

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147780889|emb|CAN61711.1| hypothetical protein VITISV_034502 [Vitis vinifera]

 Score =  372 bits (955), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 255/635 (40%), Positives = 345/635 (54%), Gaps = 77/635 (12%)

Query: 1   LLPGLCYCQTDKLQQGQVLKDGEEL-VSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRIL 59
           ++P +   Q D ++ G+ L+  E+L VSA G F LGFFS       YL I++       +
Sbjct: 108 VVPYISSAQIDTIKPGEELQFSEKLLVSAKGTFTLGFFSL--ESGSYLGIWFT------I 159

Query: 60  DVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRN 119
           D                       +   VW+ANRD P+     A L +D+ DG L I+ +
Sbjct: 160 DA----------------------QKEKVWVANRDKPI-SGTDANLTLDA-DGKLMIMHS 195

Query: 120 GKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKL 179
           G  PI ++S + A N+T ATLL +GN VL E NSD  S++ +LW+SFD PTDTLLPGMKL
Sbjct: 196 GGDPIVLNSNQAARNST-ATLLDSGNFVLEEFNSD-RSVKEKLWESFDNPTDTLLPGMKL 253

Query: 180 GINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGI 239
           GINL+TG  W L S  + +V        + N T + V+ +     W+S    N S +  I
Sbjct: 254 GINLKTGQNWSLASWINEQVPAPGTFTLEWNGT-QFVMKRRGGTYWSSGTLKNRSFEF-I 311

Query: 240 PGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLKD-DIGIDIS 298
           P    D  N     Y F+  +NE E Y +YSV + V S  AL  +S G L D +  + ++
Sbjct: 312 PWLSFDTCN---NIYCFNSVANENEIYFSYSVPDGVVSEWAL--NSRGGLSDTNRPLFVT 366

Query: 299 CTLLGGCEDQTNYYGHGPPS-------YYPPSYYT--EPEGGKKKWWFWLIIAAAVVLGM 349
             +  G E+        PP+       +   S +    P   K+          A+    
Sbjct: 367 DDVCDGLEEYPGCAVQNPPTCRTRKDGFMKQSVHISESPSSIKEDSSLGPSDCQAICWNN 426

Query: 350 CLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNR 409
           C   +   I    + N    + W +              +Y      + L     S V  
Sbjct: 427 CSCTACNTI----YTNGTGCRFWGTKFT----------QAYAGDANQEALYVLSSSRVTG 472

Query: 410 QKLLRE-LGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGG 468
           ++ + E + H ++    F + K     D     DLK+F F +I  A++NFS  N+LG+GG
Sbjct: 473 ERKMEEAMLHELATSNSFSDSK-DVDHDGKRAHDLKLFSFDSIVAASNNFSSENKLGEGG 531

Query: 469 FGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERL 519
           FGPVYKGKL + QEIA+KRLS+ SGQG+VEFKNE +LIA+LQH NL         G E++
Sbjct: 532 FGPVYKGKLPEGQEIAVKRLSRGSGQGLVEFKNEIRLIARLQHMNLVRLLGCCIXGEEKM 591

Query: 520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN 579
           L+YE++PNKSLDFF+FD +R+ +LDWK+R +IIEGI QGLLYLHKYSRLR+IHRDLK SN
Sbjct: 592 LIYEFMPNKSLDFFLFDPARRKILDWKRRHNIIEGIAQGLLYLHKYSRLRIIHRDLKASN 651

Query: 580 ILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           ILLD  +NPKISDFGMARTF  N  EANTNRIVGT
Sbjct: 652 ILLDHDLNPKISDFGMARTFGRNASEANTNRIVGT 686

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297841445|ref|XP_002888604.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297334445|gb|EFH64863.1| predicted protein [Arabidopsis lyrata subsp. lyrata]

 Score =  366 bits (939), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 267/693 (38%), Positives = 357/693 (51%), Gaps = 131/693 (18%)

Query: 1   LLPGLCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILD 60
           LL G    +TD L QGQ LKDG+ELVSA+  F+L FF+    RN YL I+          
Sbjct: 15  LLLGQSCSETDTLHQGQFLKDGQELVSAFKIFKLKFFNFKNSRNWYLGIW---------- 64

Query: 61  VAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNG 120
             FN L             N  I+ R VWIANR+ P+    S +L +DS  G L+ILR  
Sbjct: 65  --FNNLY-----------LNTDIQDRAVWIANRNNPI-SERSGSLTVDSL-GRLRILRGA 109

Query: 121 KSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLG 180
            + +E+SS     NTT   LL +GNL L EM+SDG S++R LWQSFDYPTDTLLPGMKLG
Sbjct: 110 STMLELSSTETRRNTT-LKLLDSGNLQLQEMDSDG-SMKRVLWQSFDYPTDTLLPGMKLG 167

Query: 181 INLQTGHQWFLRS--SRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLK-- 236
            +++TG +W L S    +   S     G D NITN+L I     + WTS +W  G     
Sbjct: 168 FDVKTGKRWELTSWLGDTLPASGSFVFGMDANITNRLTILWRGNMYWTSGLWYKGRFSEE 227

Query: 237 ----SGIPGSVDDVYNFY----------------HQFYNF-SYTSNEQERYLTY------ 269
                G+  S +D   F+                HQ  N+ SY  N + +          
Sbjct: 228 ELNDCGLLFSFNDAITFFPTIMIDQQGILHRAKIHQTRNYDSYWQNSRNQNCLAAGYKGN 287

Query: 270 -----SVNEDVTSFPALTFDSDG------------RLKDDIGIDI---SCTLLG------ 303
                S +   TSF      S              RL D   I +   SC          
Sbjct: 288 NVADESYSNGFTSFRVTVSSSSSNGFVLNETSGRFRLVDCNAICVQNSSCLAYASTELDG 347

Query: 304 -GCEDQTNY-YGHGPPSYYPPSYYTEPEGG----KKKWWFWLIIAAAVVLGMCLLLSLGY 357
            GCE    Y   +G  S+ P + Y   +      KKK   W I+ A++ L + ++  + Y
Sbjct: 348 TGCEIWNTYPTNNGSSSHRPRTIYIRNDYSVGQEKKKVAAWQIVLASMCLMIPMIWFIIY 407

Query: 358 IIRRK-HLNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVNRQKLLREL 416
           ++ RK  +  ++ K ++S  I++               + +    +  S ++++ LLREL
Sbjct: 408 LVLRKFKVKGRKFKCFISWNILLS--------------MERNHSTRFGSTIDQEMLLREL 453

Query: 417 GHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK 476
           G +         RK+          +L IF F+++ +ATD+FS  N+LG+GGFGPVYKGK
Sbjct: 454 GIDRRRRHKRSERKSN--------NELLIFSFESVVLATDDFSDENKLGEGGFGPVYKGK 505

Query: 477 LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPN 527
           L D +E+AIKRLS +SGQG+VEFKNEA LIAKLQHTNL           E++L+YEY+ N
Sbjct: 506 LIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVQVLGCCVEKDEKMLIYEYMQN 565

Query: 528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQG------LLYLHKYSRLRVIHRDLKVSNIL 581
           KSLD+F+F   + S L+ +KRF +   +           YLHKYSRL+VIHRD+K SNIL
Sbjct: 566 KSLDYFLF--GKVSSLE-EKRFGLDVAVQDHGRNNSRAFYLHKYSRLKVIHRDIKASNIL 622

Query: 582 LDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LDE MNPKISDFGMAR F   E  ANT R+ GT
Sbjct: 623 LDEDMNPKISDFGMARIFGAEETRANTKRVAGT 655

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449436595|ref|XP_004136078.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like, partial [Cucumis sativus]

 Score =  361 bits (926), Expect = 7e-97,   Method: Compositional matrix adjust.
 Identities = 250/656 (38%), Positives = 339/656 (51%), Gaps = 104/656 (15%)

Query: 13  LQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTG 72
           + QGQ +  G  L+S   NF LGF+SPS   N Y+AI+Y                     
Sbjct: 1   MAQGQEITPGSTLISTMANFSLGFYSPSLLNNSYIAIWY--------------------- 39

Query: 73  DVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKIL------RNGKSPIEI 126
                    +    PVWIANR+    R+     +   ++G+LKI+      RNG +   +
Sbjct: 40  --------HSDSQNPVWIANRNFAFPRDFGTPCLTIDSNGSLKIVPKEGKGRNGYN-FYL 90

Query: 127 SSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTG 186
             V    N++ A LL NGN VL  +N DG SI+R+LWQSFD+PTDTLLPGMKLGIN +TG
Sbjct: 91  FEVEEPTNSS-AILLDNGNFVLCVLNLDG-SIKRQLWQSFDHPTDTLLPGMKLGINHKTG 148

Query: 187 HQWFLRSSRS--AEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSGIPGSVD 244
             W + S R   + +S    L  +PN TN+L+I     V WTS  W +G  +       +
Sbjct: 149 SIWSITSRRGDYSVLSGSFTLTVNPNNTNQLLILHRGSVFWTSGNWKDGRFEFS-----E 203

Query: 245 DVYNFYHQFYNFSYTSNEQERYLTYSVNE------------DVTSFPALTFDSDGRL-KD 291
           ++ N  +Q + FS  SNE E +  YS++             +V +F  L   +DG+L   
Sbjct: 204 ELSNINNQEFVFSRFSNENETFFNYSISNLFQLPNHNKGLIEVQTF--LRLGNDGKLVGR 261

Query: 292 DIGIDISCTLLG------------GCEDQTNYYGHGPPSYYPPSYYTEPE--GGKKKWWF 337
           +    + C                GC  +  +    P    PP  Y+  +  G  ++   
Sbjct: 262 NWDSKVECPYFENELFEPKHVSEVGCVGKMQH--KVPECRNPPKQYSTSQRFGNMERNGL 319

Query: 338 WLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEE----KRW---MSLVIVIGVVSVVPLLSY 390
               +  + +  C    +         +  EE    + W    + + V G   ++  L  
Sbjct: 320 RFRESENLTIYDCEKNCISSCDCIAFSSTNEEGTGCEMWNVGATFIPVEGGKRIIWSLEI 379

Query: 391 VSFLLLKKLKAKVESMVNRQKLLRELG---HNVSLPTIFGNRKTQARSDQTVKRDLKIFD 447
           V    ++K++   E     Q  L+ELG    +  +PTI   ++   R+ +     L+ F 
Sbjct: 380 VEGKAIRKIRRDSE----HQNFLQELGAKTKSFDIPTIMNKQRRDVRNSE-----LQFFS 430

Query: 448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIA 507
           F+++   T+NF+   +LG+GGFGPVYKG L D QE+AIKRLS  SGQGI EFKNE  LIA
Sbjct: 431 FRSVVSTTNNFADNCKLGEGGFGPVYKGTLADGQEVAIKRLSNKSGQGIEEFKNEVILIA 490

Query: 508 KLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
           KLQHTNL           ERLLVYE +PNKSLD F+FD  RK  L W KR  II+GI QG
Sbjct: 491 KLQHTNLVRLIGCCIHKEERLLVYECMPNKSLDSFLFDPVRKLTLTWDKRQHIIQGIIQG 550

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LLYLH YSRLR++HRDLK+SNILLD QMN KISDFGMAR F + + EANTN IVGT
Sbjct: 551 LLYLHNYSRLRIVHRDLKISNILLDAQMNAKISDFGMARIFDLTKEEANTNHIVGT 606

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359480377|ref|XP_003632441.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera]

 Score =  356 bits (914), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 259/651 (39%), Positives = 338/651 (51%), Gaps = 113/651 (17%)

Query: 1   LLPGLCYCQTDKLQQGQVLKDGEEL-VSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRIL 59
           ++P +   QTD ++  + L+  E+L VSA G F LGFFS   +   YL I+         
Sbjct: 23  VVPYISGAQTDTIKPREELQFSEKLLVSAKGTFTLGFFSL--QSGSYLGIW--------- 71

Query: 60  DVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRN 119
                      T D S          + VW+ANRD  +     A L +D+ DG L I  +
Sbjct: 72  ----------NTTDHS---------NKKVWVANRDKAI-SGTDANLTLDA-DGKLMITHS 110

Query: 120 GKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKL 179
              PI ++S + A N+T ATLL +GN VL E NSDG S++ +LW+SFD PTDTLLPGMKL
Sbjct: 111 EGDPIVLNSNQVARNST-ATLLDSGNFVLKEFNSDG-SVKEKLWESFDNPTDTLLPGMKL 168

Query: 180 GINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWT---STIWLNGSLK 236
           GINL+TG  W L S  S +V         P      + W   ++V      T W +G+LK
Sbjct: 169 GINLKTGRNWSLASWISEQV---------PAPGTFTLEWNGTQLVMKRRGGTYWSSGTLK 219

Query: 237 SGIPGSVDDVYNF---YHQFYNFSYTSNEQERYLTYSVNEDVTSFPALT-----FDSDGR 288
                  D  + F    +  Y+F+  SN  E Y +YSV E V S   LT     FD++  
Sbjct: 220 -------DRSFEFIPLLNNIYSFNSVSNANEIYFSYSVPEGVGSDWVLTSEGGLFDTNRS 272

Query: 289 --LKDDIGIDISCTLLGGCEDQTNYYGHGPPSYYPPSYYT--------------EPEGGK 332
             ++DD            C+    Y G    +  PP+  T               P   K
Sbjct: 273 VFMQDD-----------QCDRDKEYPGCAVQN--PPTCRTRKDGFVKESVLISGSPSSIK 319

Query: 333 KKWWFWLIIAAAVVLGMCLLLSLGYIIRRKHLNAKEEKRWMSLVIVIGVVSVVPLLSYVS 392
           +     L    A+    C   +   I    H N    + W +               YV 
Sbjct: 320 ENSSLGLGDCQAICWNNCSCTAYNSI----HTNGTGCRFWSTKFAQAYKDDGNQEERYV- 374

Query: 393 FLLLKKLKAKVESMVNRQKLLRELGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIA 452
            L   ++  + E     + +L EL  + S    F + K           DLK+F F +I 
Sbjct: 375 -LSSSRVTGEREM---EEAMLPELATSNS----FSDSKDVEHDGTRGAHDLKLFSFDSIV 426

Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
            AT+ FS  N+LG+GGFGPVYKGKL +  EIA+KRLS+ S QG+VEFKNE +LIAKLQH 
Sbjct: 427 AATNYFSSENKLGEGGFGPVYKGKLLEGHEIAVKRLSRGSSQGLVEFKNEIRLIAKLQHM 486

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           NL         G E++L+YE++PNKSLDFF+FD  R+ +LDWK+R +IIEG+ QGLLYLH
Sbjct: 487 NLVRLLGCCIQGEEKMLIYEFMPNKSLDFFLFDPDRRKILDWKRRHNIIEGVAQGLLYLH 546

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           KYSRLR+IHRDLKVSNILLD  +NPKISDFGMAR F  N  EANTNRIVGT
Sbjct: 547 KYSRLRIIHRDLKVSNILLDHDLNPKISDFGMARIFGRNASEANTNRIVGT 597

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	614
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.333	0.241	0.603	2.2e-115
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.301	0.236	0.587	8.5e-87
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.291	0.212	0.595	1.6e-85
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.281	0.203	0.653	1.2e-81
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.335	0.242	0.559	5.8e-80
TAIR|locus:2197729	805	SD1-29 "S-domain-1 29" [Arabid	0.280	0.213	0.635	3.9e-77
TAIR|locus:2197744	807	AT1G61420 [Arabidopsis thalian	0.280	0.213	0.618	1.7e-76
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.281	0.204	0.615	2e-76
TAIR|locus:2197704	831	AT1G61390 [Arabidopsis thalian	0.280	0.206	0.640	8.9e-76
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.281	0.212	0.648	1.2e-75

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 651 (234.2 bits), Expect = 2.2e-115, Sum P(3) = 2.2e-115
 Identities = 134/222 (60%), Positives = 165/222 (74%)

Query:   402 KVESMVNRQKLLRELGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPA 461
             +V S ++++ LL ELG           R+   RS +    +L+IF F+++A ATD FS A
Sbjct:   479 RVGSTIDQEMLLLELG--------IERRRRGKRSARNNNNELQIFSFESVAFATDYFSDA 530

Query:   462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----G-- 515
             N+LG+GGFGPVYKG+L D +E+AIKRLS +SGQG+VEFKNEA LIAKLQHTNL    G  
Sbjct:   531 NKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCC 590

Query:   516 ---GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
                 E++L+YEY+PNKSLD+F+FD  RK +LDWK RF I+EGI QGLLYLHKYSRL+VIH
Sbjct:   591 VEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIH 650

Query:   573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             RD+K  NILLDE MNPKISDFGMAR F   E +ANT R+ GT
Sbjct:   651 RDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAGT 692

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 563 (203.2 bits), Expect = 8.5e-87, Sum P(3) = 8.5e-87
 Identities = 114/194 (58%), Positives = 138/194 (71%)

Query:   430 KTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS 489
             +  +R  +    +L   D  T++ AT  FS  N+LGQGGFGPVYKG L   QE+A+KRLS
Sbjct:   437 RVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLS 496

Query:   490 KSSGQGIVEFKNEAKLIAKLQHTNL----G-----GERLLVYEYLPNKSLDFFIFDSSRK 540
             ++S QG+ EFKNE KLIAKLQH NL    G      ER+L+YEY PNKSLD FIFD  R+
Sbjct:   497 RTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERR 556

Query:   541 SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
               LDW KR  II+GI +G+LYLH+ SRLR+IHRDLK SN+LLD  MN KISDFG+ART  
Sbjct:   557 RELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLG 616

Query:   601 MNELEANTNRIVGT 614
              +E EANT R+VGT
Sbjct:   617 GDETEANTTRVVGT 630

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 555 (200.4 bits), Expect = 1.6e-85, Sum P(3) = 1.6e-85
 Identities = 112/188 (59%), Positives = 138/188 (73%)

Query:   436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQG 495
             DQ    DL IF F ++A AT +F+  N+LGQGGFG VYKG   + +EIA+KRLS  S QG
Sbjct:   503 DQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQG 562

Query:   496 IVEFKNEAKLIAKLQHTNL----G-----GERLLVYEYLPNKSLDFFIFDSSRKSLLDWK 546
             + EFKNE  LIAKLQH NL    G      E++L+YEY+PNKSLD F+FD S++  LDW+
Sbjct:   563 LEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWR 622

Query:   547 KRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
             KR+ +I GI +GLLYLH+ SRL++IHRDLK SNILLD +MNPKISDFGMAR F   +  A
Sbjct:   623 KRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHA 682

Query:   607 NTNRIVGT 614
             NT R+VGT
Sbjct:   683 NTIRVVGT 690

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 607 (218.7 bits), Expect = 1.2e-81, Sum P(2) = 1.2e-81
 Identities = 119/182 (65%), Positives = 145/182 (79%)

Query:   442 DLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN 501
             +L +F    IA+AT++F   N LG+GGFGPVYKG L+D +EIA+KRLS  SGQG+ EFKN
Sbjct:   513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572

Query:   502 EAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
             E  LIAKLQH NL         G E++LVYEY+PNKSLDFF+FD ++++L+DWK RFSII
Sbjct:   573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632

Query:   553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
             EGI +GLLYLH+ SRLR+IHRDLKVSN+LLD +MNPKISDFGMAR F  N+ EANT R+V
Sbjct:   633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692

Query:   613 GT 614
             GT
Sbjct:   693 GT 694

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 582 (209.9 bits), Expect = 5.8e-80, Sum P(2) = 5.8e-80
 Identities = 122/218 (55%), Positives = 155/218 (71%)

Query:   406 MVNRQKLLRELGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLG 465
             +V+ Q   R+L  N     +  +R+  +R + T   +L + +F+ +A+AT+NFS AN+LG
Sbjct:   477 IVDHQLRSRDLLMN---EVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLG 533

Query:   466 QGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GG 516
             QGGFG VYKGKL D QE+A+KRLSK+S QG  EFKNE KLIA+LQH NL          G
Sbjct:   534 QGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAG 593

Query:   517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLK 576
             E++L+YEYL N SLD  +FD SR S L+W+ RF II GI +GLLYLH+ SR R+IHRDLK
Sbjct:   594 EKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLK 653

Query:   577 VSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
              SNILLD+ M PKISDFGMAR F  +E EANT ++VGT
Sbjct:   654 ASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGT 691

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 577 (208.2 bits), Expect = 3.9e-77, Sum P(3) = 3.9e-77
 Identities = 115/181 (63%), Positives = 138/181 (76%)

Query:   443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNE 502
             +  F+  TI  AT+NFSP+N+LGQGGFGPVYKGKL D +EI +KRL+ SSGQG  EF NE
Sbjct:   473 VNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMNE 532

Query:   503 AKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE 553
               LI+KLQH NL         G E+LL+YE++ NKSLD FIFD   K  LDW KRF+II+
Sbjct:   533 ITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQ 592

Query:   554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVG 613
             GI +GLLYLH+ SRLRVIHRDLKVSNILLD++MNPKISDFG+AR F   + + NT R+VG
Sbjct:   593 GIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVG 652

Query:   614 T 614
             T
Sbjct:   653 T 653

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)]

 Score = 557 (201.1 bits), Expect = 1.7e-76, Sum P(3) = 1.7e-76
 Identities = 112/181 (61%), Positives = 136/181 (75%)

Query:   443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNE 502
             L  FD  TI  AT+NFS +N+LGQGGFGPVYKGKLQD +EIA+KRLS SSGQG  EF NE
Sbjct:   479 LDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 538

Query:   503 AKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE 553
               LI+KLQH NL         G E+LL+YE++ N SLD F+FDS ++  +DW KR  II+
Sbjct:   539 IVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLDIIQ 598

Query:   554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVG 613
             GI +G+ YLH+ S L+VIHRDLKVSNILLDE+MNPKISDFG+AR +   E + NT R+VG
Sbjct:   599 GIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 658

Query:   614 T 614
             T
Sbjct:   659 T 659

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 566 (204.3 bits), Expect = 2.0e-76, Sum P(3) = 2.0e-76
 Identities = 112/182 (61%), Positives = 138/182 (75%)

Query:   442 DLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN 501
             +LK++    I  AT NFS +N+LG+GGFGPVY G L   +E+A+KRL ++SGQG+ EFKN
Sbjct:   514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573

Query:   502 EAKLIAKLQHTNL----G-----GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
             E  LIAKLQH NL    G      E++LVYEY+PNKSLD F+F+  ++ LLDWKKRF II
Sbjct:   574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633

Query:   553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
             EGI +GLLYLH+ SRLRV+HRDLK SNILLD  M PKISDFGMAR F  ++ + NTNR+V
Sbjct:   634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693

Query:   613 GT 614
             GT
Sbjct:   694 GT 695

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)]

 Score = 579 (208.9 bits), Expect = 8.9e-76, Sum P(3) = 8.9e-76
 Identities = 116/181 (64%), Positives = 141/181 (77%)

Query:   443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNE 502
             + +FD  TI  AT+NFS +N+LGQGGFGPVYKGKL D +EIA+KRLS SSGQG  EF NE
Sbjct:   505 VNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLSSSSGQGTDEFMNE 564

Query:   503 AKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE 553
              +LI+KLQH NL         G E+LL+YEYL NKSLD F+FDS+ K  +DW+KRF+II+
Sbjct:   565 IRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLKFEIDWQKRFNIIQ 624

Query:   554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVG 613
             G+ +GLLYLH+ SRLRVIHRDLKVSNILLDE+M PKISDFG+AR     + + NT R+VG
Sbjct:   625 GVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQGTQYQDNTRRVVG 684

Query:   614 T 614
             T
Sbjct:   685 T 685

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 611 (220.1 bits), Expect = 1.2e-75, Sum P(2) = 1.2e-75
 Identities = 118/182 (64%), Positives = 146/182 (80%)

Query:   442 DLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN 501
             DL IFD +TI++ATD+FS  N LG+GGFGPVYKGKL+D QEIA+KRLS +SGQG+ EFKN
Sbjct:   484 DLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKN 543

Query:   502 EAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
             E KLIAKLQH NL         G E +L+YEY+PNKSLDFFIFD  R + LDWKKR +II
Sbjct:   544 EVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNII 603

Query:   553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
              G+ +G+LYLH+ SRLR+IHRDLK  N+LLD  MNPKISDFG+A++F  ++ E++TNR+V
Sbjct:   604 NGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVV 663

Query:   613 GT 614
             GT
Sbjct:   664 GT 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	614
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-30
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-27
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-26
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	6e-26
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	3e-22
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-21
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-19
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	3e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-17
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-13
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-09
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-09
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-08
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-07
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-06
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-05
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-05
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-05
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.001
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	0.001
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.002
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	0.002
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.002
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.002
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.003
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	0.003
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	0.003
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.004
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.004
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.004
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.004
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  117 bits (295), Expect = 4e-30
 Identities = 54/163 (33%), Positives = 81/163 (49%), Gaps = 19/163 (11%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+GGFG VY  +  +  +++AIK + K     ++E    E +++ KL H N+       
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
                  LV EY    SL   + ++  K  L   +   I+  I +GL YLH      +IH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 573 RDLKVSNILLDE-QMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RDLK  NILLD      K++DFG+++  T ++    T  IVGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  115 bits (291), Expect = 4e-29
 Identities = 56/164 (34%), Positives = 76/164 (46%), Gaps = 20/164 (12%)

Query: 463 RLGQGGFGPVYKGKLQDEQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL----- 514
           +LG G FG VYK K +   +I A+K L K S   +     + E +++ +L H N+     
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                    LV EY     L  ++   SR   L   +   I   I +GL YLH      +
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           IHRDLK  NILLDE    KI+DFG+A+    +     T   VGT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGT 161

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  112 bits (283), Expect = 6e-28
 Identities = 51/149 (34%), Positives = 73/149 (48%), Gaps = 20/149 (13%)

Query: 464 LGQGGFGPVYKGKLQD-----EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG VYKGKL+      + E+A+K L + +S Q I EF  EA+++ KL H N+   
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                      +V EY+    L  ++     +  L      S    I +G+ YL      
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---SK 121

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             IHRDL   N L+ E +  KISDFG++R
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  111 bits (280), Expect = 2e-27
 Identities = 53/149 (35%), Positives = 74/149 (49%), Gaps = 19/149 (12%)

Query: 464 LGQGGFGPVYKGKLQD-----EQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG VYKG L+      E E+A+K L +  S Q I EF  EA+++ KL H N+   
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                     ++V EY+P   L  ++  + R   L      S    I +G+ YL      
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE---SK 122

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             IHRDL   N L+ E +  KISDFG++R
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 3e-27
 Identities = 53/156 (33%), Positives = 77/156 (49%), Gaps = 23/156 (14%)

Query: 462 NRLGQGGFGPVYKGKLQDEQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL-- 514
            +LG+G FG VYKGKL+ +     E+A+K L +  S +   +F  EA+++ KL H N+  
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 515 -------GGERLLVYEYLPNKSLDFFI------FDSSRKSLLDWKKRFSIIEGITQGLLY 561
                       LV EY+    L  ++      F S  KS L  K   S    I +G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L      + +HRDL   N L+ E +  KISDFG++R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  109 bits (276), Expect = 4e-27
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 20/162 (12%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G FG VY  +  +  + +AIK + K   +   E    E K++ KL+H N+       
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  LV EY     L   +    R  L + + RF  +  I   L YLH      ++H
Sbjct: 67  EDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS---KGIVH 120

Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RDLK  NILLDE  + K++DFG+AR     E        VGT
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  107 bits (269), Expect = 5e-26
 Identities = 49/150 (32%), Positives = 70/150 (46%), Gaps = 20/150 (13%)

Query: 464 LGQGGFGPVYKGKL-----QDEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG VYKG L       E ++A+K L + +  +   EF  EA ++ KL H N+   
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                 G    +V EY+P   L  F+        L  K    +   I +G+ YL      
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---SK 121

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMART 598
             +HRDL   N L+ E +  KISDFG++R 
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRD 151

Length = 258

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  102 bits (255), Expect = 6e-26
 Identities = 45/111 (40%), Positives = 60/111 (54%), Gaps = 9/111 (8%)

Query: 87  PVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNL 146
            VW+ANR  P+  + S TLI+  +DGNL +       +  S+    G+   A L  +GNL
Sbjct: 4   VVWVANRLNPLT-DSSYTLIL-QSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNL 61

Query: 147 VLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSA 197
           VLY    +   +   LWQSFD+PTDTLLPG K G N+  G    L S +S 
Sbjct: 62  VLY---DNSGKV---LWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSN 105

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score = 92.0 bits (229), Expect = 3e-22
 Identities = 48/153 (31%), Positives = 59/153 (38%), Gaps = 38/153 (24%)

Query: 17  QVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSM 76
             L  G+ LVS+   F LGFF    +   Y  I YK                        
Sbjct: 2   NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKG----------------------- 38

Query: 77  QSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTT 136
                      VW+ANRD P     S TL + S DGNL I     + +  S+  R     
Sbjct: 39  ------SSRTVVWVANRDNPS--GSSCTLTLQS-DGNLVIYDGSGTVVWSSNTTRVNGNY 89

Query: 137 RATLLKNGNLVLYEMNSDGLSIRRELWQSFDYP 169
              LL +GNLVLY+ +         LWQSFDYP
Sbjct: 90  VLVLLDDGNLVLYDSDG------NFLWQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 32/174 (18%)

Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
           F    ++G+GGFG VYK +  +  +E+AIK +   S +   +  NE +++ K +H N+  
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD-WKKRFS------IIEGITQGLL 560
                    E  +V E+    SL         K LL    +  +      + + + +GL 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLE 112

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           YLH      +IHRD+K +NILL      K+ DFG++   +        N +VGT
Sbjct: 113 YLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGT 160

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 52/173 (30%), Positives = 78/173 (45%), Gaps = 32/173 (18%)

Query: 462 NRLGQGGFGPVYKGKLQDE-QEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN----L 514
             LG+G FG VY    +D  + +A+K   LS  S + +   + E ++++ LQH N     
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 515 GGER------LLVY-EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GITQGLLY 561
           G ER      L ++ EY+   SL          SLL    +            I +GL Y
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLS---------SLLKKFGKLPEPVIRKYTRQILEGLAY 116

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      ++HRD+K +NIL+D     K++DFG A+     E    T  + GT
Sbjct: 117 LH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 87.6 bits (218), Expect = 2e-19
 Identities = 50/169 (29%), Positives = 75/169 (44%), Gaps = 28/169 (16%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKR--LSKSSGQGIVEFKNEAKLIAKLQHTN------- 513
           +G+G FG VY  + + + ++  +K   LS  S +   +  NE K++ KL H N       
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 514 -LGGERLL-VYEYLPNKSLDFFIFDSSRKSLLDWKKRFS---IIEGITQ---GLLYLHKY 565
                +L  V EY     L   I     K      K F    I++   Q    L YLH  
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKI-----KKQKKEGKPFPEEQILDWFVQLCLALKYLH-- 120

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           SR +++HRD+K  NI L      K+ DFG+++  +     A T  +VGT
Sbjct: 121 SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score = 83.1 bits (206), Expect = 3e-19
 Identities = 47/152 (30%), Positives = 62/152 (40%), Gaps = 39/152 (25%)

Query: 17  QVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSM 76
             L  G+ LVS    F LGFF+   + N Y  I YK                        
Sbjct: 2   NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKS----------------------- 37

Query: 77  QSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTT 136
                      VW+ANRD PV  ++S TL + S DGNL +       +  S+   A    
Sbjct: 38  ------SSRTVVWVANRDNPV--SDSCTLTLQS-DGNLVLYDGDGRVVWSSNTTGANGNY 88

Query: 137 RATLLKNGNLVLYEMNSDGLSIRRELWQSFDY 168
              LL +GNLV+Y+ + +       LWQSFDY
Sbjct: 89  VLVLLDDGNLVIYDSDGN------FLWQSFDY 114

Length = 114

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 6e-19
 Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 34/172 (19%)

Query: 462 NRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSG-QGI-VEFKNEAKLIAKLQHTNL---- 514
            ++G+G +G VYK +  +  + +A+K++   +  +G  +    E KL+ KL+H N+    
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK-RFSI--IEGITQ----GLL 560
                   G   +V+EY+ +   D          LLD  + +F+   I+   +    GL 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH---DL-------TGLLDSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           YLH      ++HRD+K SNIL++     K++DFG+AR +T       TNR++
Sbjct: 115 YLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 24/172 (13%)

Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+   + +G+G FG VYKG  L+    +AIK++S      + +     E  L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 514 L---------GGERLLVYEYLPNKSLDFFI--FDSSRKSLLDWKKRFSIIEGITQGLLYL 562
           +              ++ EY  N SL   I  F    +SL+     +  +  + QGL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV---AVY--VYQVLQGLAYL 115

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           H+     VIHRD+K +NIL  +    K++DFG+A    +N++  +   +VGT
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 22/153 (14%)

Query: 462 NRLGQGGFGPVYKGK---LQDEQ--EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL- 514
            +LG+G FG V   +   L D    ++A+K L+ S   Q   +F+ E +++  L H N+ 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 515 ----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                     G    L+ EYLP+ SL  ++     +  ++ K+       I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
               R IHRDL   NIL++ +   KISDFG+A+
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 27/167 (16%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFK------NEAKLIAKLQHTNLGG 516
           LG+G FG V   + +D  ++ A+K L K     I++ K       E  +++++ H  +  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK---IIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 517 --------ERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
                   E+L LV EY P   L   +  S      + + RF   E I   L YLH    
Sbjct: 58  LHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAE-IVLALEYLH---S 111

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           L +I+RDLK  NILLD   + K++DFG+A+  +      NT    GT
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 84.0 bits (206), Expect = 2e-17
 Identities = 53/169 (31%), Positives = 77/169 (45%), Gaps = 23/169 (13%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL------ 514
           LG+G FG VY  +  D + +A+K L+K   S  + +  F  E +++A L H         
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                G   LV EY+   SL+  +    RK  L   +   I+  I   L YLH      +
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122

Query: 571 IHRDLKVSNILLDEQMN-PKISDFGMARTFT----MNELEANTNRIVGT 614
           IHRD+K  NILLD      K+ DFG+A+        + + A  +  VGT
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Length = 384

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 55/165 (33%), Positives = 76/165 (46%), Gaps = 19/165 (11%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      +LG G FG V+ G      ++AIK L K        F  EA L+ +LQH 
Sbjct: 3   VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHP 61

Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF       K  L   K   +   I +G+ +
Sbjct: 62  RL--VRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAF 117

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           +    R   IHRDL+ +NIL+ E +  KI+DFG+AR    NE  A
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 16/154 (10%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           +LG G FG V+ G      ++A+K L K        F  EA+++ KL+H  L        
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 515 GGERL-LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             E + +V EY+   SL DF      +K  L   +   +   I +G+ YL        IH
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE---SRNYIH 126

Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           RDL   NIL+ E +  KI+DFG+AR    +E  A
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 4e-16
 Identities = 52/170 (30%), Positives = 82/170 (48%), Gaps = 25/170 (14%)

Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIK--RLSKSSGQGIVEFKN---EAKLIAKLQH 511
           +    +LG+G +G VYK +  +  + +A+K  RL     +GI        E  L+ +L+H
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGI--PSTALREISLLKELKH 57

Query: 512 TN--------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL 562
            N            +L LV+EY     +D   +   R   L      SI+  + +GL Y 
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           H  S  R++HRDLK  NIL++     K++DFG+AR F +  L   T+ +V
Sbjct: 115 H--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVV 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 55/163 (33%), Positives = 77/163 (47%), Gaps = 32/163 (19%)

Query: 464 LGQGGFGPVYKGKL------QDEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN--- 513
           LG+G FG VYKG+L           +AIK L ++   +   EF+ EA+L++ LQH N   
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 514 -LG-----GERLLVYEYLPNKSLDFFIF-------------DSSRKSLLDWKKRFSIIEG 554
            LG         +++EYL +  L  F+              D + KS LD      I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           I  G+ YL   S    +HRDL   N L+ E +  KISDFG++R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 78.0 bits (193), Expect = 5e-16
 Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 40/185 (21%)

Query: 447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRL-SKSSGQGIVEFKNEAK 504
           D + + V          LGQG  G VYK + +   +I A+K++      +   +   E K
Sbjct: 2   DLERVKV----------LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK 51

Query: 505 LIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS--IIE 553
            +   +   +          GE  +V EY+   SL           LL    +    ++ 
Sbjct: 52  TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLA---------DLLKKVGKIPEPVLA 102

Query: 554 GIT----QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
            I     +GL YLH   +  +IHRD+K SN+L++ +   KI+DFG+++       + NT 
Sbjct: 103 YIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160

Query: 610 RIVGT 614
             VGT
Sbjct: 161 --VGT 163

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 78.0 bits (193), Expect = 7e-16
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 38/198 (19%)

Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIK--RLSKSS 492
           ++ +K  LK  D  +     + +    ++G+G  G VYK       +E+AIK  RL K +
Sbjct: 1   EEELKAALK--DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN 58

Query: 493 GQGIVEFKNEAKLIAKLQHTN---------LGGERLLVYEYLPNKSLDFFIFDSSRKSLL 543
            + I+   NE  ++   +H N         +G E  +V EY+   SL           ++
Sbjct: 59  KELII---NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL---------TDII 106

Query: 544 DWKKRF-------SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
                         +   + QGL YLH      VIHRD+K  NILL +  + K++DFG A
Sbjct: 107 TQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFA 163

Query: 597 RTFTMNELEANTNRIVGT 614
              T  + + N+  +VGT
Sbjct: 164 AQLTKEKSKRNS--VVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 18/149 (12%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQHTNL----- 514
           ++G+G +G VYK +     + +AIK++        +      E KL+ +L H N+     
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                G+  LV+E++ +  L   I D  R   L      S +  + QGL + H +    +
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTF 599
           +HRDLK  N+L++ +   K++DFG+AR+F
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF 148

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 75.7 bits (187), Expect = 4e-15
 Identities = 59/170 (34%), Positives = 74/170 (43%), Gaps = 24/170 (14%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDE-QEIAIKRLSKSSGQGIVEFK-----NE----AKL 505
           D+F     +G+G F  V   K ++  +E AIK L K   Q I E K      E     +L
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58

Query: 506 -----IAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                I KL +T    E L  V EY PN  L  +I             RF   E I   L
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC--TRFYAAE-ILLAL 115

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
            YLH      +IHRDLK  NILLD+ M+ KI+DFG A+    N    +  
Sbjct: 116 EYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 74.1 bits (182), Expect = 9e-15
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 18/170 (10%)

Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEI-AIKR--LSKSSGQGIVEFKNEAKLIAKLQHTN 513
           +F   N++G+G FG V+K   + ++ + A+K+  LSK + +   E  +EA+++AKL  + 
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +          G+  +V EY  N  L   +    R   L   + +     I  GL +LH 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
               +++HRD+K  N+ LD   N KI D G+A+  + N   ANT  IVGT
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 19/160 (11%)

Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G FG V +G+L+     E ++AIK L + SS +  ++F  EA ++ +  H N+    
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                    +++ EY+ N SLD F+ ++  K      +   ++ GI  G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
            +HRDL   NIL++  +  K+SDFG++R    +E    T 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 54/166 (32%), Positives = 80/166 (48%), Gaps = 20/166 (12%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           +  ++     +LG G FG V+ G   +  ++A+K L K     +  F  EA L+  LQH 
Sbjct: 3   IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHD 61

Query: 513 NLGGERL-----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLL 560
            L   RL           ++ EY+   SL DF   D   K LL     FS    I +G+ 
Sbjct: 62  KL--VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMA 117

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           Y+ + +    IHRDL+ +N+L+ E +  KI+DFG+AR    NE  A
Sbjct: 118 YIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 51/151 (33%), Positives = 76/151 (50%), Gaps = 23/151 (15%)

Query: 464 LGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
           LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+    
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 515 -----GGER--LLVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                 G R   LV EYLP  SL D+      R   LD +K       I +G+ YL    
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             R +HRDL   NIL++ +   KI DFG+ +
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTK 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 27/152 (17%)

Query: 464 LGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTN---- 513
           LG G FG VYKG    E E     +AIK L + +  +   E  +EA ++A + H +    
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 514 ----LGGERLLVYEYLPNKSLDFFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLHKY 565
               L  +  L+ + +P   L  ++ +       + LL+W  +      I +G+ YL + 
Sbjct: 75  LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEK 128

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 48/152 (31%), Positives = 64/152 (42%), Gaps = 25/152 (16%)

Query: 462 NRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN--- 513
             LG G FG V KG        E E+A+K L +     G  EF  EA ++A+L H     
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 514 -----LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ---GLLYLHKY 565
                 G   +LV E  P   L  ++       + D      + E   Q   G+ YL   
Sbjct: 61  LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSD------LKELAHQVAMGMAYLES- 113

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                +HRDL   N+LL  +   KISDFGM+R
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 71.5 bits (176), Expect = 8e-14
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 21/162 (12%)

Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           LG+G +G VYK    +  Q +AIK +     + + E   E  ++ +     +        
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 515 -GGERLLVYEYLPNKS-LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
              +  +V EY    S  D  I   + K+L   ++  +I+    +GL YLH     + IH
Sbjct: 69  KNTDLWIVMEYCGAGSVSD--IMKITNKTL-TEEEIAAILYQTLKGLEYLHS---NKKIH 122

Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  NILL+E+   K++DFG++    + +  A  N ++GT
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGT 162

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 54/158 (34%), Positives = 79/158 (50%), Gaps = 22/158 (13%)

Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEI-AIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN 513
            F   NR+G+G +G VY+ +     EI A+K  R+        +    E  L+  L+H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 514 LGGERLLVYEYLPNKSLD--FFIFDSSRK---SLLDWKKR-FSI--IEGITQ----GLLY 561
           +    L   E +  K LD  F + +   +   SLLD     FS   ++ +      GL Y
Sbjct: 68  I--VELK--EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           LH      +IHRDLKVSN+LL ++   KI+DFG+ART+
Sbjct: 124 LH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.1 bits (174), Expect = 9e-14
 Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 15/143 (10%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------- 514
           +G G FG V+ G   +++++AIK + +       +F  EA+++ KL H  L         
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 515 GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
                LV+E++ +  L  ++   +++     +    +   + +G+ YL   +   VIHRD
Sbjct: 71  RSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125

Query: 575 LKVSNILLDEQMNPKISDFGMAR 597
           L   N L+ E    K+SDFGM R
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 71.8 bits (177), Expect = 1e-13
 Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 19/150 (12%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRL---SKSSGQGIVEFK--NEAKLIAKLQHTNLGGE 517
           LG+G +  VYK +  +  + +AIK++    +   +  + F    E KL+ +L+H N+ G 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG- 66

Query: 518 RLL-VYEYLPNKSLDFFIFDSSRKSLLDWKKRF-------SIIEGITQGLLYLHKYSRLR 569
            LL V+ +  N +L F   ++  + ++  K          S +    +GL YLH      
Sbjct: 67  -LLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--- 122

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           ++HRDLK +N+L+      K++DFG+AR+F
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSF 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.0 bits (175), Expect = 2e-13
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 35/156 (22%)

Query: 463 RLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKN--------EAKLIAKLQ-HT 512
           +LG G FG VY  + ++  E+ AIK++ K       +F +        E K + KL  H 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHP 58

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           E   V+EY+   +L + +    +          SII  I QGL ++H
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 564 K--YSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           K  +      HRDLK  N+L+      KI+DFG+AR
Sbjct: 117 KHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 43/144 (29%), Positives = 71/144 (49%), Gaps = 17/144 (11%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------- 514
           +G+G FG V  G  +  Q++A+K L K        F  EA ++  L+H NL         
Sbjct: 14  IGKGEFGDVMLGDYRG-QKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 515 GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
           G    +V EY+   SL  ++    R  + L  +  F++   + +G+ YL +      +HR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYLEEK---NFVHR 126

Query: 574 DLKVSNILLDEQMNPKISDFGMAR 597
           DL   N+L+ E +  K+SDFG+A+
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 22/169 (13%)

Query: 458 FSPANRLGQGGFGPVYKG-KLQDEQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTN- 513
           F+    +G+G FG VYK    +  Q +AIK   L ++  + I + + E + +++ +    
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61

Query: 514 -------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                  L G +L ++ EY    S      D  +   LD      I+  +  GL YLH+ 
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                IHRD+K +NILL E+ + K++DFG++   T    + NT   VGT
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGT 161

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 16/156 (10%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           +LG G FG V++G   +   +A+K L K       +F  EA+++ KL+H  L        
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 515 -GGERLLVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
                 +V E +   SL ++    + R   L   +   +   +  G+ YL   +    IH
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---YIH 126

Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           RDL   N+L+ E    K++DFG+AR    +  EA  
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 30/161 (18%)

Query: 464 LGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL-- 514
           LG+G FG V+ G+        D++ +A+K L +++     + F+ EA+L+   QH N+  
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 515 -------GGERLLVYEYLPNKSLD-----------FFIFDSSRKSLLDWKKRFSIIEGIT 556
                  G   ++V+EY+ +  L+           F     S    L   +   I   I 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            G++YL   +    +HRDL   N L+   +  KI DFGM+R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 25/151 (16%)

Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLS-----KSSGQGIVEFKNEAKLIAKLQHTN---- 513
           LG G FG VY+G  L D    A+K +S     ++  + + + + E  L++KLQH N    
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 514 LG----GERLLVY-EYLPNKSLDFFI--FDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           LG     + L ++ E +P  SL   +  + S  + ++    R      I  GL YLH   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH--D 120

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           R   +HRD+K +NIL+D     K++DFGMA+
Sbjct: 121 R-NTVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 45/143 (31%), Positives = 68/143 (47%), Gaps = 15/143 (10%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------- 514
           LG G FG V+ GK + + ++AIK + + +     +F  EAK++ KL H NL         
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 515 GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
                +V EY+ N  L  ++    RK  L  +    +   + + + YL        IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 575 LKVSNILLDEQMNPKISDFGMAR 597
           L   N L+ E    K+SDFG+AR
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 31/166 (18%)

Query: 464 LGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLGGE 517
           LG G FG VYKG    E E     +AIK L++++G +  VEF +EA ++A + H +L   
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL--V 72

Query: 518 RLL----------VYEYLPNKSLDFFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLH 563
           RLL          V + +P+  L  ++ +       + LL+W  +      I +G++YL 
Sbjct: 73  RLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           +    R++HRDL   N+L+    + KI+DFG+AR    +E E N +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 13/149 (8%)

Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           F+   +LG G FG V++G  ++   +AIK L         +F+ E + + +L+H +L   
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 515 -----GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                 GE + ++ E +   SL  F+     + L        +   + +G+ YL +    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL-PVASLIDMACQVAEGMAYLEEQ--- 123

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             IHRDL   NIL+ E +  K++DFG+AR
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLAR 152

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 22/165 (13%)

Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQE-IAIKRL---SKSSGQGIVEFKNEAKLIAKL 509
              ++    +LG+G FG VYK +       +A+K++   ++  G  I   + E K++ KL
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 510 QHTNLGGERLLVYEYLPNKSLD-------FFIFDSSRKSLLDWKK-RFS------IIEGI 555
           +H N+     +  E                   D     LL+    + +       +  +
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124

Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            +G+ YLH+     ++HRD+K +NIL+D Q   KI+DFG+AR + 
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 52/157 (33%), Positives = 88/157 (56%), Gaps = 20/157 (12%)

Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTN 513
           +++   ++G+G +G VYKG+  +  Q +A+K++  +S  +G+      E  L+ +LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 514 LGG--------ERL-LVYEYLPNKSLDFFIF-DSSRKS-LLDWKKRFSIIEGITQGLLYL 562
           +           RL L++E+L   S+D   + DS  K   +D +   S +  I QG+L+ 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           H     RV+HRDLK  N+L+D +   K++DFG+AR F
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 15/144 (10%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNL------GG 516
           LG+G FG V+KG L+D+  +A+K   +   Q + ++F +EA+++ +  H N+        
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 517 ERLLVY---EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
           +R  +Y   E +P    DF  F   +K  L  K+          G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 574 DLKVSNILLDEQMNPKISDFGMAR 597
           DL   N L+ E    KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 23/150 (15%)

Query: 464 LGQGGFGPVYKGKLQDEQ------EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG- 516
           +G+G FG V+  + + +Q      +I +++++K         +NE +++  L H N+   
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSHPNIIEY 64

Query: 517 --------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                     ++V EY P  +L  +I      SLLD     +I+    Q LL LH     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDED---TILHFFVQILLALHHVHTK 120

Query: 569 RVIHRDLKVSNILLDE-QMNPKISDFGMAR 597
            ++HRDLK  NILLD+ +M  KI DFG+++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISK 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 54/163 (33%), Positives = 76/163 (46%), Gaps = 32/163 (19%)

Query: 464 LGQGGFGPVYKGKL-----QDEQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN---- 513
           LG+  FG +YKG L        Q +AIK L   ++ Q   EF+ EA L+A+L H N    
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 514 LGGER-----LLVYEYLPNKSLDFFIF--------------DSSRKSLLDWKKRFSIIEG 554
           LG         +++EYL    L  F+               D + KS LD      I   
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           I  G+ YL  +     +H+DL   NIL+ EQ++ KISD G++R
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 13/162 (8%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           +  ++     +LG G FG V+ G      ++A+K L K        F  EA+++ KL+H 
Sbjct: 3   IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHD 61

Query: 513 NLG------GER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
            L        E    +V EY+   SL  F+ D   ++L        +   +  G+ Y+  
Sbjct: 62  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE- 119

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
             R+  IHRDL+ +NIL+ + +  KI+DFG+AR    NE  A
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 19/156 (12%)

Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHT 512
           NF    ++G+G +G VYK +     + +A+K++   +++ G      + E  L+ +L H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59

Query: 513 NL--------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +L LV+E+L ++ L  F+ D+S  S +      S +  + QGL + H
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 54/170 (31%), Positives = 83/170 (48%), Gaps = 25/170 (14%)

Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 513
           F+    +G G FG VY  + ++  + +AIK++S S  Q   ++++   E + + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 514 LGGER---------LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
               +          LV EY    + D  I +  +K L +  +  +I  G  QGL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE-VEIAAICHGALQGLAYLHS 133

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           + R   IHRD+K  NILL E    K++DFG A       L +  N  VGT
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRL-SKSSGQGIVEFKNEAKL 505
           V  D+ +    LG G FG VY+G  +       E ++A+K L    S Q   +F  EA +
Sbjct: 3   VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62

Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           ++K  H N+            R ++ E +    L  F+ ++     R S L  K      
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             + +G  YL +      IHRD+   N LL         KI+DFGMAR
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 19/155 (12%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G      ++AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL----VPLY 67

Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKKR-----------FSIIEGITQGLLYLHKYSRLRVI 571
             +  + +        + SLLD+ K              +   I  G+ Y+    R+  I
Sbjct: 68  AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI 124

Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ + +  KI+DFG+AR    NE  A
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 18/149 (12%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRL-SKSSGQGI-VEFKNEAKLIAKLQHTNL----- 514
           R+G+G  G V+K K  +  + +A+K++  +    GI  +   E K +   QH  +     
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
               G   +LV EY+P+  L   + D  R       K +  +  + +G+ Y+H      +
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGI 120

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTF 599
           +HRDLK +N+L+      KI+DFG+AR F
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLF 149

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 20/168 (11%)

Query: 458 FSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE---------FKNEAKLIA 507
           F+   R+G+G FG V+KG   + +Q +AIK +     +  +E          + ++  + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 508 KLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           K   + L G +L ++ EYL   S      D  R    D  +  ++++ I +GL YLH   
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +   IHRD+K +N+LL EQ + K++DFG+A   T  +++ NT   VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 32/163 (19%)

Query: 464 LGQGGFGPVYKGKL------QDEQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNL-- 514
           LG+  FG VYKG L      +  Q +AIK L  K+ G    EFK+EA + ++LQH N+  
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 515 -------GGERLLVYEYLPNKSLDFFIF-------------DSSRKSLLDWKKRFSIIEG 554
                       +++ Y  +  L  F+              D + KS L+      I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           I  G+ +L   S   V+H+DL   N+L+ +++N KISD G+ R
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 31/154 (20%)

Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN---LG 515
           +G G FG V++G L+     E  +AIK L    + +   +F +EA ++ +  H N   L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 516 G------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GITQGLLYLH 563
           G        +++ EY+ N +LD +        L D    FS  +      GI  G+ YL 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKY--------LRDHDGEFSSYQLVGMLRGIAAGMKYL- 123

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             S +  +HRDL   NIL++  +  K+SDFG++R
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 50/152 (32%), Positives = 74/152 (48%), Gaps = 13/152 (8%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------G 515
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L        
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 516 GERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
            E + +V EY+   SL  F+     K  L   +   +   I  G+ Y+    R+  +HRD
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           L+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 51/183 (27%), Positives = 93/183 (50%), Gaps = 47/183 (25%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEI-AIKRL---SKSSGQGIVEFKNEAKLIAKLQHTN---- 513
            ++GQG FG V+K + +  ++I A+K++   ++  G  I   + E K++  L+H N    
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76

Query: 514 --------LGGER-----LLVYEY--------LPNKSLDFFIFDSSRKSLLDWKKRFSII 552
                       R      LV+E+        L NK++ F        +L + KK   ++
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF--------TLSEIKK---VM 125

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEAN---TN 609
           + +  GL Y+H   R +++HRD+K +NIL+ +    K++DFG+AR F++++       TN
Sbjct: 126 KMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 610 RIV 612
           R+V
Sbjct: 183 RVV 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 54/168 (32%), Positives = 85/168 (50%), Gaps = 20/168 (11%)

Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE---------FKNEAKLIA 507
           F+   R+G+G FG VYKG     +E+ AIK +     +  +E          + ++  I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 508 KLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           +   + L G +L ++ EYL   S      D  +   L+     +I+  I +GL YLH   
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             R IHRD+K +N+LL EQ + K++DFG+A   T  +++ NT   VGT
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 30/161 (18%)

Query: 464 LGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V+  +       QD+  +A+K L ++S     +F+ EA+L+  LQH ++   
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 515 ------GGERLLVYEYLPNKSLDFF---------IFDSSRKSL---LDWKKRFSIIEGIT 556
                 G   L+V+EY+ +  L+ F         I           L   +  +I   I 
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            G++YL   + L  +HRDL   N L+ + +  KI DFGM+R
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 65.7 bits (161), Expect = 9e-12
 Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 24/160 (15%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRL---SKSSGQGIVEFKNEAKLIAKLQH 511
           D +   NR+ +G +G VY+ + +   EI A+K+L    +  G  I   + E  ++ KLQH
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 512 TNLGGERLLVYEYLPNKSLD-FFI----FDSSRKSLLDWKK-RFSIIE--GITQGLL--- 560
            N+    + V E +   +LD  ++     +   KSL++  K  F   E   +   LL   
Sbjct: 64  PNI----VTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119

Query: 561 -YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +LH      ++HRDLK SN+LL+ +   KI DFG+AR +
Sbjct: 120 AHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 33/157 (21%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNL----- 514
           ++G+G +G VYK +     + +A+K++  ++  +G+      E  L+ +L H N+     
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 515 ---GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS----IIEG----ITQGLLYL 562
                 +L LV+E+L          D   K  +D          +I+     + QG+ Y 
Sbjct: 66  VVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           H  S  RV+HRDLK  N+L+D +   K++DFG+AR F
Sbjct: 116 H--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 27/160 (16%)

Query: 462 NRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN--------------EAKLI 506
             LG+G +G V K       + +AIK++        V                  E K++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 507 AKLQHTNLGGER-LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGITQGL 559
            +++H N+ G   + V     N  +D  I  S  K ++D K R +      I+  I  GL
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMD--IMASDLKKVVDRKIRLTESQVKCILLQILNGL 132

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
             LHK+     +HRDL  +NI ++ +   KI+DFG+AR +
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY 169

Length = 335

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 54/170 (31%), Positives = 80/170 (47%), Gaps = 25/170 (14%)

Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 513
           FS    +G G FG VY  + +++ + +AIK++S S  Q   ++++   E + + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 514 LGGER---------LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
               R          LV EY    + D        K  L   +  ++  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           ++   +IHRD+K  NILL E    K+ DFG A       + A  N  VGT
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 19/155 (12%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERL--- 519
           +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  L   +L   
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKL--VKLHAV 69

Query: 520 -------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                  ++ E++   SL DF   D   K  L     FS    I +G+ ++ + +    I
Sbjct: 70  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS--AQIAEGMAFIEQRN---YI 124

Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+   +  KI+DFG+AR    NE  A
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 38/160 (23%)

Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLS---------KSSGQGIVE-FKNEAKLIAKLQHT 512
           +G+G +G VY        E +A+K++           S  + +V+  ++E + +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 513 N----LGGERLLVY-----EYLPNKSLDFFIFDSSRKSLLDWKKRF------SIIEGITQ 557
           N    LG E    Y     EY+P  S+          S L    RF         E + +
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSI---------GSCLRTYGRFEEQLVRFFTEQVLE 119

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           GL YLH      ++HRDLK  N+L+D     KISDFG+++
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 28/159 (17%)

Query: 464 LGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V+  +       QD+  +A+K L  +S     +F  EA+L+  LQH ++   
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 515 ------GGERLLVYEYLPNKSLDFFI----------FDSSRKSLLDWKKRFSIIEGITQG 558
                 G   ++V+EY+ +  L+ F+           + +R + L   +   I + I  G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           ++YL   +    +HRDL   N L+ E +  KI DFGM+R
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 31/154 (20%)

Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTN---LG 515
           +G G FG V +G+L+     E  +AIK L S  + +   +F +EA ++ +  H N   L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 516 G------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GITQGLLYLH 563
           G        +++ E++ N +LD F+    R++      +F++I+      GI  G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL----RQN----DGQFTVIQLVGMLRGIAAGMKYL- 122

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             S +  +HRDL   NIL++  +  K+SDFG++R
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 29/162 (17%)

Query: 462 NRLGQGGFGPVYKGKLQD-------EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN 513
           N LG G FG VY+G   D          +A+K L K ++ Q   EF  EA L++   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 514 ---------LGGERLLVYEYLPNKSLDFFIFDSSRKS----LLDWKKRFSIIEGITQGLL 560
                    L   + ++ E +    L  ++ D+  +     LL  K+   I   + +G +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNP-----KISDFGMAR 597
           YL    ++  IHRDL   N L+ E+        KI DFG+AR
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 25/170 (14%)

Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 513
           F+    +G G FG VY  + ++  + +AIK++S S  Q   ++++   E K + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 514 ---LGGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                G  L      LV EY    + D        K  L   +  +I  G  QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           ++   +IHRD+K  NILL E    K++DFG A       + +  N  VGT
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGT 184

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 31/167 (18%)

Query: 464 LGQGGFGPVYKG--KLQDEQEI--AIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G FG V  G  KL  ++EI  AIK L    + +   +F +EA ++ +  H N+    
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GITQGLLYLH 563
                    ++V EY+ N SLD F+    RK       +F++I+      GI  G+ YL 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRGIASGMKYL- 122

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
             S +  +HRDL   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 34/182 (18%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRL---SKSSGQGIVEFKNEAKLIAKLQH 511
           D F    ++G+G +G VYK + +D  E+ A+K++   ++  G  I   + E K++ +L H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65

Query: 512 TNL-------------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRF--S 550
            N+                    G   LV+EY+     D  +       L+ + +    S
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKS 120

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            ++ + +GL Y HK + L   HRD+K SNILL+ +   K++DFG+AR +   E    TN+
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177

Query: 611 IV 612
           ++
Sbjct: 178 VI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 17/146 (11%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN---LGG- 516
           ++G+G FG VYKG L+   E+A+K  R +        +F  EA+++ +  H N   L G 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGV 60

Query: 517 --ER---LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             ++    +V E +P        F   +K+ L  KK   +      G+ YL   S+   I
Sbjct: 61  CVQKQPIYIVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE--SK-NCI 115

Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E    KISDFGM+R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 38/169 (22%)

Query: 464 LGQGGFGPVYK----GKLQDEQE--IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN--- 513
           +GQG FG V++    G L  E    +A+K L + +S     +F+ EA L+A+  H N   
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 514 ------LGGERLLVYEYLPNKSLDFFIFDSSRKSL-------------------LDWKKR 548
                 +G    L++EY+    L+ F+   S ++                    L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             I + +  G+ YL   S  + +HRDL   N L+ E M  KI+DFG++R
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.6 bits (152), Expect = 7e-11
 Identities = 45/143 (31%), Positives = 73/143 (51%), Gaps = 15/143 (10%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------GG 516
           LG G FG V  GK + + ++AIK + + S     EF  EAK++ KL H  L         
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 517 ER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
           +R   +V EY+ N  L  ++ +  ++      +   + + + +G+ YL      + IHRD
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHRD 125

Query: 575 LKVSNILLDEQMNPKISDFGMAR 597
           L   N L+D+Q   K+SDFG++R
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 15/145 (10%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEAKLIAKLQHTN------- 513
            R+G G +G VYK +     E+ AIK +    G      + E  ++ + +H N       
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 514 -LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
            L  ++L +V EY    SL   I+  +R  L + +  +   E + +GL YLH+      I
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETL-KGLAYLHE---TGKI 123

Query: 572 HRDLKVSNILLDEQMNPKISDFGMA 596
           HRD+K +NILL E  + K++DFG++
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 18/150 (12%)

Query: 463 RLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNL----- 514
            +G+G +G V K + +   EI AIK+  +S     V+     E K++ +L+H N+     
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                G   LV+EY+    L+  + ++S   L       S I  + Q + Y H      +
Sbjct: 68  AFRRKGRLYLVFEYVERTLLE--LLEASPGGL-PPDAVRSYIWQLLQAIAYCH---SHNI 121

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           IHRD+K  NIL+ E    K+ DFG AR   
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALR 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 51/179 (28%), Positives = 92/179 (51%), Gaps = 28/179 (15%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKR-LSKSSGQGI----------VEFKNEA 503
           D +    ++G+G +G VYK +     + +A+K+   +   +GI          ++  +E+
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 504 KLIAKL---QHT--NLGGERL-LVYEYLPNKSLDFFIFDSSRKSL---LDWKKRFSIIEG 554
             I +L   +H     G   L LV+EYL +  L  F+ DS+ +     L  K   S +  
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQ 118

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNELEANTNRIV 612
           + +G+ + HK+    V+HRDLK  N+L+D+Q    KI+D G+ R F++  +++ T+ IV
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV 173

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 53/165 (32%), Positives = 67/165 (40%), Gaps = 39/165 (23%)

Query: 463 RLGQGGFGPVYKGK----LQDEQEIAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLGGE 517
           +LG G FG V +G+          +A+K L       I+ +F  EA ++  L H NL   
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL--I 59

Query: 518 RL----------LVYEYLPNKSLDFFIFDSSRKS---------LLDWKKRFSIIEGITQG 558
           RL          +V E  P  SL     D  RK          L D+         I  G
Sbjct: 60  RLYGVVLTHPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYA------VQIANG 109

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           + YL   S+ R IHRDL   NILL      KI DFG+ R    NE
Sbjct: 110 MRYLE--SK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 46/149 (30%), Positives = 81/149 (54%), Gaps = 18/149 (12%)

Query: 463 RLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTN------ 513
           ++G+G +G V+K K ++  EI A+KR+      +G+      E  L+ +L+H N      
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 514 -LGGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
            L  ++   LV+EY  ++ L  + FDS    + D +   S +  + +GL + H +    V
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTF 599
           +HRDLK  N+L+++    K++DFG+AR F
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 46/183 (25%), Positives = 71/183 (38%), Gaps = 32/183 (17%)

Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHT 512
            T  F     +G+G +G VYK + +   ++   ++         E K E  ++ K   H 
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63

Query: 513 NL---------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------I 551
           N+                 +  LV E     S+   +     K L    KR        I
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAYI 118

Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRI 611
           +    +GL YLH+    +VIHRD+K  NILL +    K+ DFG++          NT   
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--F 173

Query: 612 VGT 614
           +GT
Sbjct: 174 IGT 176

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 28/162 (17%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQE-IAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           D +    ++G+G +G VYK + +   E IA+K++  +   +G+      E  L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 513 NL--------GGERL-LVYEYLPNKSLDFFIF-DSSRKSLLDWKKRFSIIEG----ITQG 558
           N+          +RL LV+EYL    LD     DSS     D+ K   +I+     I +G
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSP----DFAKNPRLIKTYLYQILRG 114

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNP-KISDFGMARTF 599
           + Y H +   RV+HRDLK  N+L+D + N  K++DFG+AR F
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153

Length = 294

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 25/165 (15%)

Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSG-QGIVEFK-NEAKLIAKLQ---H 511
           +     +G+G +G VYK + L   + +A+K++      +GI      E  L+ +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 512 TNL----------GGER----LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
            N+            +R     LV+E++ ++ L  ++     K  L  +    ++  + +
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
           G+ +LH +   R++HRDLK  NIL+      KI+DFG+AR ++  
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 28/174 (16%)

Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFK------NEAKLIAKL 509
           +F     +G+G FG V   + +D +++ A+K ++K   Q  VE        NE +++ +L
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK---QKCVEKGSVRNVLNERRILQEL 57

Query: 510 QH---TNL-----GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLL 560
            H    NL       E + LV + L    L + +  S +    + + +F I E I   L 
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALE 114

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           YLH      +IHRD+K  NILLDEQ +  I+DF +A   T +     T    GT
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 37/171 (21%)

Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQG---------IVEFKNEAKLIAKLQHTN 513
           +G G FG VY G      + +A+K++   S            +     E  L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 514 --------LGGERLLVY-EYLPNKSLDFFIFDSSRKSLLDWKKRF------SIIEGITQG 558
                   L  + L ++ EY+P  S+          +LL+    F      + +  I +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           L YLH  +R  +IHRD+K +NIL+D +   KISDFG+++    N L   TN
Sbjct: 119 LNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 50/167 (29%), Positives = 77/167 (46%), Gaps = 37/167 (22%)

Query: 447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNE--- 502
           DFQ +           ++GQGG+G V+  K +D  EI A+KR+ KS    ++   NE   
Sbjct: 2   DFQILT----------QVGQGGYGQVFLAKKKDTGEIVALKRMKKS----LLFKLNEVRH 47

Query: 503 ------------AKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRF 549
                       ++ + KL +     E L L  EY+P    DF    ++   L +   RF
Sbjct: 48  VLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARF 105

Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
            + E   + +  LH    L  IHRDLK  N L+D   + K++DFG++
Sbjct: 106 YMAEMF-EAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 16/159 (10%)

Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTN 513
           +F    +LG+G +G VYK K L D Q  A+K   L   S +   +  NE +++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 514 --------LGGERL-LVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSIIEGITQGLLYLH 563
                   L G +L +V EY P   L   I    + + L+  ++ + I   + +GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
           +    +++HRDLK +NILL      KI D G+++    N
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 15/143 (10%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------- 514
           LG G FG V+ GK + + ++AIK +++ +     +F  EAK++ KL H  L         
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 515 GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
                +V E++ N  L  ++    R+  L      S+ + + +G+ YL + S    IHRD
Sbjct: 71  QKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125

Query: 575 LKVSNILLDEQMNPKISDFGMAR 597
           L   N L+      K+SDFGM R
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 14/144 (9%)

Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEF-KNEAKLIAKLQHTNL------- 514
           +G G    VY        E +AIKR+     Q  V+  + E + +++  H N+       
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G E  LV  YL   SL   +  S  +  LD     ++++ + +GL YLH   +   IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IH 125

Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RD+K  NILL E  + KI+DFG++
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVS 149

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 46/154 (29%), Positives = 81/154 (52%), Gaps = 15/154 (9%)

Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNL 514
           NF    +LG+G +  VYKG+ +   EI A+K +   + +G       E  L+ +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                      + +LV+EY+ +K L  ++     +  LD     S    + +G+ + H+ 
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
              RV+HRDLK  N+L++++   K++DFG+AR F
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAF 150

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 61.4 bits (150), Expect = 4e-10
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 38/168 (22%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIAKLQHTN 513
           +G G +G V      +  +++AIK++S         F +         E KL+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 514 LGGERLLVYEYLPNKSLDF----FIFD----------SSRKSLLDWKKRFSIIEGITQGL 559
           + G   ++    P    DF     + +           S + L D   ++  +  I +GL
Sbjct: 61  IIGLLDILR---PPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY-FLYQILRGL 116

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEAN 607
            YLH      VIHRDLK SNIL++   + KI DFG+AR    +E E  
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 60.6 bits (148), Expect = 4e-10
 Identities = 53/165 (32%), Positives = 73/165 (44%), Gaps = 42/165 (25%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFK------NEAKLIAKLQH---TN 513
           LG G FG V   + +   +  A+K LSK     IV+ K      NE +++  ++H    N
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSK---AKIVKLKQVEHVLNEKRILQSIRHPFLVN 65

Query: 514 LGG-----ERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG------ITQGLLY 561
           L G       L LV EY+P    + F       S L    RF           +   L Y
Sbjct: 66  LYGSFQDDSNLYLVMEYVPGG--ELF-------SHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA-----RTFTM 601
           LH    L +++RDLK  N+LLD     KI+DFG A     RT+T+
Sbjct: 117 LH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 48/151 (31%), Positives = 67/151 (44%), Gaps = 24/151 (15%)

Query: 464 LGQGGFGPV----YKGKLQDEQE-IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL--- 514
           LG+G FG V    Y        E +A+K L +  GQ     +K E  ++  L H N+   
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G +   L+ EY+P  SL     D   K  L+  +     + I +G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
               IHRDL   N+LLD     KI DFG+A+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 25/151 (16%)

Query: 464 LGQGGFGPVY------KGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGE 517
           LGQG FG VY       G+    +++     S  + + +   + E +L+  LQH     E
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH-----E 64

Query: 518 RLLVYE--YLPNKSLDFFIFDSSRKSLLDWKKRF-SIIEGIT--------QGLLYLHKYS 566
           R++ Y      +++L  F+      S+ D  K + ++ E +T        +G+ YLH   
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH--- 121

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              ++HRD+K +NIL D   N K+ DFG ++
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 29/166 (17%)

Query: 457 NFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSGQGI-VEFKNEAKLIAKL 509
           N      LG+G FG V+  K +       E  + +K L K+  + +  EF+ E  +  KL
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 510 QHTNLGGERLL-----------VYEYLPNKSLDFFIFDSSRKSL------LDWKKRFSII 552
            H N+   RLL           + EY     L  F+  +  K        L  K++ ++ 
Sbjct: 66  SHKNV--VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             I  G+ +L   S  R +HRDL   N L+  Q   K+S   +++ 
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 19/148 (12%)

Query: 462 NRLGQGGFGPVYKGKLQ-DEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
           ++LG+G +  VYKG+ +  +  +A+K  RL    G      + E  L+  L+H N+    
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 515 ---GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                E+   LV+EYL +K L  ++ D      +   K F  +  + +GL Y H   R +
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMAR 597
           V+HRDLK  N+L++E+   K++DFG+AR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 20/149 (13%)

Query: 464 LGQGGFGPVYKGKL--QDEQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L   D Q+I  A+K L++ +    VE F  E  ++    H N    L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI   +    +  K        + +G+ YL   +  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYL---ASK 117

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + +HRDL   N +LDE    K++DFG+AR
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 19/148 (12%)

Query: 462 NRLGQGGFGPVYKGKLQ-DEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
            +LG+G +  V+KG+ +  E  +A+K  RL    G      + E  L+  L+H N+    
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                     LV+EYL +K L  ++ D      +   K F  +  I +GL Y H   R +
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRK 124

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMAR 597
           V+HRDLK  N+L++E+   K++DFG+AR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 54/170 (31%), Positives = 76/170 (44%), Gaps = 25/170 (14%)

Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 513
           F   + +G G FG VY        E+ A+K++S S  Q   ++++   E K + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 514 ---LGGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                G  L      LV EY    + D        K  L   +  +I  G  QGL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           ++    IHRD+K  NILL E    K++DFG A         +  N  VGT
Sbjct: 140 HNM---IHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGT 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 35/178 (19%)

Query: 462 NRLGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG 515
             +G+G FG V K      GK+   +EI    +++   Q +V   +E  ++ +L+H N+ 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV 62

Query: 516 G----------ERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS---IIEGITQGLLY 561
                      + L +V EY     L   I    +K   + +K      I   +TQ LL 
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI----QKCKKE-RKYIEEEFIWRILTQLLLA 117

Query: 562 LH-----KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           L+           V+HRDLK +NI LD   N K+ DFG+A+    +   A T   VGT
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 26/168 (15%)

Query: 448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKN---EA 503
            +T+    D +   + +G G +G V         +++AIK+LS+   Q  +  K    E 
Sbjct: 7   NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYREL 65

Query: 504 KLIAKLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSS------RKSLLDWKKRF 549
           +L+  + H N+ G   L+  + P  SL+ F        +  +        + L D   +F
Sbjct: 66  RLLKHMDHENVIG---LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF 122

Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            ++  I +GL Y+H      +IHRDLK SNI ++E    KI DFG+AR
Sbjct: 123 -LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 25/150 (16%)

Query: 464 LGQGGFGPVY------KGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ------- 510
           LG+GGFG V        GK+   +++  KRL K  G+ +    NE K++ K+        
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58

Query: 511 ----HTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                T    +  LV   +    L + I++       + +  F   + I  GL +LH   
Sbjct: 59  AYAFETK--DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH--- 112

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           + R+++RDLK  N+LLD+  N +ISD G+A
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 52/174 (29%), Positives = 72/174 (41%), Gaps = 33/174 (18%)

Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQG-------------IVEFKNE--AKLIA 507
           + +G +G V+   K       AIK + K+                 + + ++    KL  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 508 KLQHT-NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
             Q   NL     LV EYLP    D      +  SL +   R  I E I   L YLH   
Sbjct: 61  SFQGKKNL----YLVMEYLPGG--DLASLLENVGSLDEDVARIYIAE-IVLALEYLHSNG 113

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFG------MARTFTMNELEANTNRIVGT 614
              +IHRDLK  NIL+D   + K++DFG      + R   +N+ E    RIVGT
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 28/174 (16%)

Query: 464 LGQGGFGPVYKGKLQDEQE--IAIKRLS----------KSSGQGIVEFKNEAKLIAK-LQ 510
           LG G FG VYK + ++  +  +A+K ++          +   + I +  +E  +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 511 HTN--------LGGERL-LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLL 560
           H N        L  +RL +V + +    L + F     +K     ++ ++I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           YLHK  R  ++HRDL  +NI+L E     I+DFG+A+     + E+    +VGT
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGT 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 19/162 (11%)

Query: 463 RLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           ++GQG  G VY    +   QE+AIK+++           NE  ++ + +H N+       
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G E  +V EYL   SL     D   ++ +D  +  ++     Q L +LH     +VIH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138

Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  NILL    + K++DFG     T  + + +T  +VGT
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 56/162 (34%), Positives = 77/162 (47%), Gaps = 26/162 (16%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKN-EAKLIAK-----------LQ 510
           LG+G FG V   +L+   E  AIK L K     ++E  + E  ++ +           L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDV---VLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 511 H---TNLGGERLL-VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           H   T    E L  V EYL    L F I  S R      + RF   E I  GL +LHK  
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE--ARARFYAAE-IICGLQFLHKKG 116

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
              +I+RDLK+ N+LLD+  + KI+DFGM +     E +A+T
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 51/164 (31%), Positives = 75/164 (45%), Gaps = 30/164 (18%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSS------------GQGIVEFKNEAKLIAKLQ 510
           LG+G FG V   +L+   E+ AIK L K               + I+    +   +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 511 HTNLGGERLL-VYEYLPNKSLDFFI-----FDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                 +RL  V EY+    L F I     FD  R        RF   E +T  L++LH+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-------RFYAAE-VTLALMFLHR 114

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           +    VI+RDLK+ NILLD + + K++DFGM +   +N +   T
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 19/151 (12%)

Query: 462 NRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLL 520
           ++LG G +G VY+G  +     +A+K L K     + EF  EA ++ +++H NL   +LL
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL--VQLL 68

Query: 521 -----------VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                      + E++   +L  ++ + +R   ++      +   I+  + YL K +   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN--- 124

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            IHRDL   N L+ E    K++DFG++R  T
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 49/169 (28%)

Query: 465 GQGGFGPVYKGKLQ---DEQEIAIKRL--SKSSGQGIVEFK-NEAKLIAKLQHTNL---- 514
           G+G +G VYK K +   D +E AIK+    K    GI +    E  L+ +L+H N+    
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 515 -----GGERL--LVYEYLPNKSLDFF-------------IFDSSRKSLLDWKKRFSIIEG 554
                  ++   L+++Y  +   D +             I  S  KSLL W+        
Sbjct: 69  EVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLL-WQ-------- 116

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILL----DEQMNPKISDFGMARTF 599
           I  G+ YLH      V+HRDLK +NIL+     E+   KI D G+AR F
Sbjct: 117 ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 47/172 (27%), Positives = 72/172 (41%), Gaps = 35/172 (20%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIV-EFKNEAKLIAKLQHTN 513
           +     +RLG+G  G V K +L++   I A+K ++      +  +   E ++    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 514 L-----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGIT 556
           +                +  EY    SLD     S  K +     R        I E + 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG--------MARTFT 600
           +GL YLH  SR ++IHRD+K SNILL  +   K+ DFG        +A TFT
Sbjct: 116 KGLSYLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT 164

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 26/168 (15%)

Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 3   VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62

Query: 506 IAK---------LQHTNLGGERLLVYEYLPNKSLDFFIF-------DSSRKSLLDWKKRF 549
           + +         L   + G   L++ E +    L  ++        ++  ++    KK  
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 21/163 (12%)

Query: 448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKN--EAK 504
           F T+   T+ +     +G G FG V   + Q   Q +AIK++ K     ++  +   E K
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 505 LIAKLQHTNLGG----------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG 554
           L+  L+H N+            +   V E L     D     +SR     + + F  +  
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYF--LYQ 116

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           I +GL Y+H      V+HRDLK SNIL++E  + KI DFG+AR
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 20/151 (13%)

Query: 463 RLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFK---NEAKLIAKLQHTNLGG-- 516
           ++G+G +G V+K + ++  +I AIK+  +S    +++ K    E +++ +L+H NL    
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALREIRMLKQLKHPNLVNLI 66

Query: 517 ------ERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                  +L LV+EY  +  L+    + + + + +   +  II    Q + + HK++   
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLN--ELEKNPRGVPEHLIK-KIIWQTLQAVNFCHKHN--- 120

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            IHRD+K  NIL+ +Q   K+ DFG AR  T
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILT 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 48/174 (27%)

Query: 466 QGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER--LLVY 522
           +G FG VY  K +   +  AIK L KS             +IAK Q TN+  ER  +++ 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSD------------MIAKNQVTNVKAERAIMMIQ 53

Query: 523 EYLPNKSLDFFIFDSSR--------------KSLL--------DWKKRFSIIEGITQGLL 560
              P  +  ++ F S                 SL+        DW K++  I  +  G+ 
Sbjct: 54  GESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVE 111

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            LH+     +IHRD+K  N+L+D+  + K++DFG++R    N+      + VGT
Sbjct: 112 DLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGT 156

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 27/159 (16%)

Query: 464 LGQGGFGPVYKGKL-QDE---QEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V +G+L QD+    ++A+K  +L   +   I EF +EA  +    H N+   
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 515 ------GGER------LLVYEYLPNKSLDFFIFDSSRKSL---LDWKKRFSIIEGITQGL 559
                           +++  ++ +  L  F+  S    L   L  +     +  I  G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
            YL   S    IHRDL   N +L E M   ++DFG+++ 
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.4 bits (138), Expect = 6e-09
 Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 20/168 (11%)

Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE---------FKNEAKLIA 507
           F+   ++G+G FG V+KG     Q++ AIK +     +  +E          + ++  + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 508 KLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           K   + L   +L ++ EYL   S      D      LD  +  +I+  I +GL YLH   
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +   IHRD+K +N+LL E    K++DFG+A   T  +++   N  VGT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 24/150 (16%)

Query: 462 NRLGQGGFGPVYKG-KLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLGG-- 516
           N++G G FG VY    L   + +A+K  R+  +  + I E  +E K++  L+H NL    
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 517 ------ERLLVY-EYLPNKSLDFFIFDSSR-KSLLDWK--KRFSIIEGITQGLLYLHKYS 566
                 E++ ++ EY    +L     +      +LD    + +++   + +GL YLH + 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTL--QLLEGLAYLHSH- 118

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
              ++HRD+K +NI LD     K+ DFG A
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCA 146

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.0 bits (137), Expect = 9e-09
 Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 21/155 (13%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHT 512
           D++    +LG+G +  VYKGK + + + +A+K  RL +  G      + EA L+  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 513 NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS----------IIEGITQGLLYL 562
           N+    +L+++ +  K     +F+     L  +  +             +  + +GL Y+
Sbjct: 64  NI----VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           H+     ++HRDLK  N+L+ +    K++DFG+AR
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 20/148 (13%)

Query: 463 RLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLGGERLL 520
           R+G+G FG V+ G+L+ D   +A+K   ++    +  +F  EA+++ +  H N+   RL+
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI--VRLI 59

Query: 521 -----------VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                      V E +  +  DF  F  +    L  K+   ++E    G+ YL       
Sbjct: 60  GVCTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--- 114

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMAR 597
            IHRDL   N L+ E+   KISDFGM+R
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 15/105 (14%)

Query: 502 EAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
           EA L+  + H ++         G    +V   LP+ S D + + + R   L   +   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + I +GL YLH     R+IHRD+K  NI +++     I D G A+
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 36/162 (22%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE------FKNEAKLIAKLQHTNLGG 516
           LG GGFG V   K++ +    A+K + K     IVE        +E +++ +  H  +  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRH---IVETGQQEHIFSEKEILEECNHPFI-- 55

Query: 517 ERLLVYEYLPNKSLDFFIFD-----------SSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
             + +Y    +K   + + +             R    ++  RF  I  +     YLH  
Sbjct: 56  --VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLAFEYLH-- 110

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMA-------RTFT 600
               +I+RDLK  N+LLD     K+ DFG A       +T+T
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 22/157 (14%)

Query: 464 LGQGGFGPVYKGKLQDE-----QEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V   +   E     +++A+K L  +S G  I + K E +++  L H N+   
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 515 -------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  GG  + L+ E+LP+ SL  ++  +  K  L  + ++++   I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYLG--S 127

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           R + +HRDL   N+L++ +   KI DFG+ +    ++
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 30/156 (19%)

Query: 463 RLGQGGFGPVY-----KGKLQDE----QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 513
           RLG+G FG VY     K   ++     +EI +  L+ +     V+   EA+L++KL H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPA 63

Query: 514 LGG------ER---LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS---IIEGITQGLLY 561
           +        ER    ++ EY   + LD  +     + L    K  S   + E   Q LL 
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKL-----EELKHTGKTLSENQVCEWFIQLLLG 118

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +H   + R++HRDLK  NI L   +  KI DFG++R
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSR 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 31/162 (19%)

Query: 464 LGQGGFGPVYKGK------LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V+  +       +D+  +A+K L   +     +F+ EA+L+  LQH ++   
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSL-------------LDWKKRFSIIEGI 555
                 G   ++V+EY+ +  L+ F+      ++             L   +   I   I
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             G++YL   +    +HRDL   N L+   +  KI DFGM+R
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.4 bits (137), Expect = 2e-08
 Identities = 28/63 (44%), Positives = 41/63 (65%), Gaps = 5/63 (7%)

Query: 539 RKSLL-DWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           R ++L D  KR+ I+  + + L Y+H  S   VIHRDLK SNILL+     K++DFG+AR
Sbjct: 100 RANILEDVHKRY-IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Query: 598 TFT 600
           + +
Sbjct: 156 SLS 158

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 31/160 (19%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKS----SGQGIVEFKNE-------- 502
           D+F     +G+G FG V+  + +D  ++ A+K L KS      Q I   + E        
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59

Query: 503 AKLIAKLQHTNLGGERL-LVYEYLPNKSL-----DFFIFDSSRKSLLDWKKRFSIIEGIT 556
           +  I KL ++    E L LV EY+P   L        +F        +   RF I E + 
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETA-RFYIAE-LV 111

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
             L  +HK   L  IHRD+K  NIL+D   + K++DFG+ 
Sbjct: 112 LALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 15/143 (10%)

Query: 464 LGQGGFGPVYKGKLQDE-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG------ 516
           LG G FG VYK + ++     A K +   S + + +F  E  ++++ +H N+ G      
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 517 --ERLLVY-EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
              +L +  E+    +LD  I     + L + + R+ +   + + L +LH +   +VIHR
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHR 127

Query: 574 DLKVSNILLDEQMNPKISDFGMA 596
           DLK  NILL    + K++DFG++
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 17/146 (11%)

Query: 464 LGQGGFGPV------YKGKLQDEQEIAIKRLSKSSGQGIVEFKNE------AKLIAKLQH 511
           LG+GGFG V        GK+   +++  KRL K SG+ +   + E      +  I  L +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 512 TNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                  L LV   +    L + I++   + L + ++       IT G+L+LH    + +
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---MDI 116

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMA 596
           ++RD+K  N+LLD+Q N ++SD G+A
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 20/148 (13%)

Query: 464 LGQGGFGPVYKGKLQDE-QEIAIKRLSKSSGQGIVE--FKNEAKLIAKLQHTNLGG---- 516
           +G+G +G V K K ++  Q +AIK+  +S    +V+     E +++ +L+H NL      
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 517 ----ERL-LVYEYLPNKSLD-FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
               +RL LV+E++ +  LD    + +        K  F I+ GI     + H ++   +
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE----FCHSHN---I 121

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMART 598
           IHRD+K  NIL+ +    K+ DFG ART
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFART 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 28/152 (18%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 514
           +G+G FG V   K + + +  A+K L K +    +  K E K        L+  ++H  L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA----ILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 515 GG--------ERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
            G        ++L  V +Y+    L F +     +S  + + RF   E I   L YLH  
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS- 114

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             L +I+RDLK  NILLD Q +  ++DFG+ +
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 27/160 (16%)

Query: 457 NFSPANRLGQGGFGPVYKGKLQDE-QEIAIKRL-----SKSSGQGIVEFKNEAKLIAKLQ 510
           N+     LGQG FG VY     D  +E+A+K++     S  + + +   + E +L+  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 511 HTNLGGERLLVY----EYLPNKSLDFFIFDSSRKSLLDWKKRF-SIIEGIT--------Q 557
           H     ER++ Y         ++L  F+      S+ D  K + ++ E +T        +
Sbjct: 63  H-----ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE 117

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           G+ YLH      ++HRD+K +NIL D   N K+ DFG ++
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 23/165 (13%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTN-------- 513
           +G+G +G VY+GK +   + +A+K ++  +    V + + E  L+++L+ +         
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 514 ---LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
              L G RL ++ EY    S    +    +   +  K    II  +   L Y+HK     
Sbjct: 69  GSYLKGPRLWIIMEYAEGGS----VRTLMKAGPIAEKYISVIIREVLVALKYIHKVG--- 121

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           VIHRD+K +NIL+    N K+ DFG+A     N  + +T   VGT
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGT 164

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 23/147 (15%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLGGERLL- 520
            +G+G FG V +G+    Q++A+K +    + Q    F  E  ++ KL H NL   RLL 
Sbjct: 13  IIGEGEFGAVLQGEYTG-QKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNL--VRLLG 66

Query: 521 ---------VYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                    V E +   +L  F+    R  + +    +FS+   + +G+ YL      ++
Sbjct: 67  VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KL 121

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMAR 597
           +HRDL   NIL+ E    K+SDFG+AR
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 41/158 (25%)

Query: 463 RLGQGGFGPVYKGKLQ-DEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL----- 514
           +LG+G +  VYKG+ +   Q +A+K  RL    G      + EA L+  L+H N+     
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70

Query: 515 --GGERLL--VYEYLPNKSLDFFIFDSSRKSLLDWKKR-----------FSIIEGITQGL 559
               ++ L  V+EYL          D+  K  +D               F ++    +GL
Sbjct: 71  IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGL 116

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y H+    RV+HRDLK  N+L+ E+   K++DFG+AR
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 33/155 (21%)

Query: 462 NRLGQGGFGPVYKGKLQ-DEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
           ++LG+G +  V+KG+ +  E  +A+K  RL    G      + E  L+  L+H N+    
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69

Query: 515 ---GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGIT-------QGLLYL 562
                ER   LV+EYL          DS  K  LD       +  +        +GL Y 
Sbjct: 70  DIIHTERCLTLVFEYL----------DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           HK    +++HRDLK  N+L++E+   K++DFG+AR
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 29/185 (15%)

Query: 451 IAVATDNFSPANRLGQGGFGPVYKGKLQD-----EQEIAIKRLSKSSGQGIVE-FKNEAK 504
           IA++ D  + ++ L +G FG ++ G L D     E+E+ +K +   + +  V     E+ 
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 505 LIAKLQHTNL----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE- 553
           L+  L H N+          G    ++Y Y+   +L  F+    R    +  +  S  + 
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANNPQALSTQQL 119

Query: 554 -----GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR-TFTM--NELE 605
                 I  G+ YLHK     VIH+D+   N ++DE++  KI+D  ++R  F M  + L 
Sbjct: 120 VHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176

Query: 606 ANTNR 610
            N NR
Sbjct: 177 DNENR 181

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 53/184 (28%), Positives = 75/184 (40%), Gaps = 63/184 (34%)

Query: 462 NRLGQGGFGPVYK------GKL----------------QDEQEIAIKRLSKSSGQGIVEF 499
           NR+G G  G VYK      G+L                Q  +EI I R         V  
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR--------DVNH 131

Query: 500 KNEAKLIAKLQHTNLGGERLLVYEYLPNKSLD-------FFIFDSSRKSLLDWKKRFSII 552
            N  K      H    GE  ++ E++   SL+        F+ D +R+            
Sbjct: 132 PNVVKCHDMFDH---NGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ------------ 176

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF--TMNELEANTNR 610
             I  G+ YLH   R  ++HRD+K SN+L++   N KI+DFG++R    TM+      N 
Sbjct: 177 --ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP----CNS 227

Query: 611 IVGT 614
            VGT
Sbjct: 228 SVGT 231

Length = 353

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 37/183 (20%)

Query: 441 RDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK-SSGQ 494
           R LK  +F+ I V          LG G FG VYKG    E E     +AIK L + +S +
Sbjct: 2   RILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 51

Query: 495 GIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSL-DFFIFDSSR---KSL 542
              E  +EA ++A + + +        L     L+ + +P   L D+          + L
Sbjct: 52  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 111

Query: 543 LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
           L+W  +      I +G+ YL +    R++HRDL   N+L+    + KI+DFG+A+    +
Sbjct: 112 LNWCVQ------IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162

Query: 603 ELE 605
           E E
Sbjct: 163 EKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 28/160 (17%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           LG+G +G VY  + L  +  IAIK + +   + +     E  L + L+H N+        
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG--ITQGLLYLHKYSRLRVI 571
             G   +  E +P  SL   +   S+   L   ++  I     I +GL YLH     +++
Sbjct: 76  ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130

Query: 572 HRDLKVSNILLDEQMNP-KISDFG----------MARTFT 600
           HRD+K  N+L++      KISDFG             TFT
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 21/149 (14%)

Query: 463 RLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLGGERL 519
           +LG+G +  VYKG  + + Q +A+K +S  + +G V F    EA L+  L+H N+    +
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANI----V 66

Query: 520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS----------IIEGITQGLLYLHKYSRLR 569
           L+++ +  K    F+F+     L  +  +             +  + +GL Y+H      
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQH 123

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMART 598
           ++HRDLK  N+L+      K++DFG+AR 
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARA 152

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 19/157 (12%)

Query: 457 NFSPANRLGQGGFGPVY--KGKLQDEQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHT 512
            +    ++G+G FG +Y  K K   E  + IK   L+K   +     K E  L+AK++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+          G   +V EY     L   I +  R  L    +  S    I+ GL ++H
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 564 KYSRLRVIHRDLKVSNILLDEQ-MNPKISDFGMARTF 599
                +++HRD+K  NI L +  M  K+ DFG+AR  
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 27/160 (16%)

Query: 464 LGQGGFGPVYKGKLQDEQE-----IAIKRLSK-SSGQGIVEFKNEAKLIA--------KL 509
           LG G FG VYKG    + E     +AIK L + +S +   E  +EA ++A        +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 510 QHTNLGGERLLVYEYLPNKSL-DFFIFDSSR---KSLLDWKKRFSIIEGITQGLLYLHKY 565
               L     LV + +P   L D+   +  R   + LL+W  +      I +G+ YL + 
Sbjct: 75  LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE- 127

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
             +R++HRDL   N+L+    + KI+DFG+AR   ++E E
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 53.6 bits (128), Expect = 9e-08
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 19/175 (10%)

Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAK 508
           +I      ++   ++GQG  G V+    +   QE+AIK+++           NE  ++ +
Sbjct: 13  SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 509 LQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           L++ N+         G E  +V EYL   SL     D   ++ +D  +  ++     Q L
Sbjct: 73  LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            +LH     +VIHRD+K  N+LL    + K++DFG     T  + + +T  +VGT
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 30/161 (18%)

Query: 464 LGQGGFGPVYKGKLQDE---QEIAIKRLSKSSGQGI-VEFKNEAKLIAKL-QHTN----L 514
           +G+G FG V K +++ +    + AIKR+ + + +    +F  E +++ KL  H N    L
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 515 G-----GERLLVYEYLPNKSL-DF------------FIFDSSRKSLLDWKKRFSIIEGIT 556
           G     G   L  EY P+ +L DF            F   +S  S L  ++       + 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +G+ YL   S+ + IHRDL   NIL+ E    KI+DFG++R
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 47/153 (30%), Positives = 71/153 (46%), Gaps = 30/153 (19%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKS------------SGQGIVEFKNEAKLIAKLQ 510
           LG+G FG V   +L+   E+ A+K L K             + + ++    +   + +L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 511 HTNLGGERL-LVYEYLPNKSLDFFI-----FDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                 +RL  V EY+    L F I     FD  R        RF   E I  GL +LH+
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-------RFYAAE-IVLGLQFLHE 114

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                +I+RDLK+ N+LLD + + KI+DFGM +
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 22/58 (37%), Positives = 34/58 (58%), Gaps = 10/58 (17%)

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG--------MARTFT 600
           I   + +GL YLH   + ++IHRD+K SNIL++ +   K+ DFG        +A+TF 
Sbjct: 105 IAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV 160

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 40/164 (24%)

Query: 464 LGQGGFGPVYKG------KLQDEQEIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN--- 513
           LGQG FG VY+G      K + E  +AIK +++++     +EF NEA  + K  + +   
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS-VMKEFNCHHVV 72

Query: 514 --LG----GER-LLVYEYL-------------PNKSLDFFIFDSSRKSLLDWKKRFSIIE 553
             LG    G+  L+V E +             P    +  +   + +  +         E
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM-----AAE 127

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            I  G+ YL      + +HRDL   N ++ E +  KI DFGM R
Sbjct: 128 -IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 2/43 (4%)

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
            I + L YLH  S+L VIHRD+K SN+L++     K+ DFG++
Sbjct: 111 SIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 20/159 (12%)

Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSS------------GQGIVEFKNEAKLIAKLQ 510
           LG+G FG V   +L+ + E  A+K L K               + ++    E   +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 511 HTNLGGERLL-VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
            T    E L  V E+L    L F I D  R  L  ++  F   E I  GL +LH      
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAE-IVCGLQFLHSKG--- 116

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           +I+RDLK+ N++LD   + KI+DFGM +     +  A+T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 31/180 (17%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
             NF    ++G+G F  VYK   L D + +A+K++       I E  +         E  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEID 54

Query: 505 LIAKLQHTNL---------GGERLLVYEYLPNKSLDFFI-FDSSRKSLLDWKKRFSIIEG 554
           L+ +L H N+           E  +V E      L   I     +K L+  +  +     
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +   L ++H  S+ R++HRD+K +N+ +      K+ D G+ R F+     A++  +VGT
Sbjct: 115 LCSALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 49/148 (33%), Positives = 71/148 (47%), Gaps = 20/148 (13%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQH-----TNL- 514
           LG+G FG V   +L++   + A+K L K        VE     K I  L       T L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 515 ----GGERLL-VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                 +RL  V E++    L F I  S R    + + RF   E IT  L++LH      
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAE-ITSALMFLHDKG--- 116

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +I+RDLK+ N+LLD + + K++DFGM +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 31/158 (19%)

Query: 464 LGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           LG G  G V+     D ++ +A+K++  +  Q +     E K+I +L H N+    + VY
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI----VKVY 68

Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG--------ITQGLL-----YLHKYSRLR 569
           E L     D         SL +    + + E         + QG L      L  Y  LR
Sbjct: 69  EVLGPSGSD---LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125

Query: 570 ---------VIHRDLKVSNILLD-EQMNPKISDFGMAR 597
                    V+HRDLK +N+ ++ E +  KI DFG+AR
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 54/170 (31%), Positives = 73/170 (42%), Gaps = 32/170 (18%)

Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS------------GQGIVEFKNEAKLIAKLQ 510
           LG+G FG V+  +L+   Q  AIK L K               + ++    E   +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 511 HTNLGGERLL-VYEYLPNKSLDFFI-----FDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
            T    E L  V EYL    L F I     FD  R +       F   E I  GL +LH 
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRAT-------FYAAE-IICGLQFLHS 114

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                +++RDLK+ NILLD   + KI+DFGM +   +   +A T    GT
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGT 159

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 15/143 (10%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAI-KRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           LG G FG VYK K ++   +A  K +   S + + ++  E +++A   H  +        
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
             G+  ++ E+ P  ++D  + +  R   L   +   I   + + L YLH    +++IHR
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKIIHR 134

Query: 574 DLKVSNILLDEQMNPKISDFGMA 596
           DLK  N+LL    + K++DFG++
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 38/165 (23%)

Query: 458 FSPANRLGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           + P   +G+G +G V   K  +  E +AIK+++ +       F N         E KL+ 
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLR 59

Query: 508 KLQHTNLGGER--------------LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE 553
            L H N+   +               +VYE L +  L   I   S ++L D   ++ + +
Sbjct: 60  HLDHENVIAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQII--RSSQTLSDDHCQYFLYQ 116

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
            + +GL Y+H  +   V+HRDLK SN+LL+   + KI DFG+ART
Sbjct: 117 -LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + +GL Y+H  +   VIHRDLK SN+L++E    +I DFGMAR
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 24/174 (13%)

Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH------ 511
           F     +G G +G VYKG+     ++A  ++   +G    E K E  ++ K  H      
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 512 ----------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLD-WKKRFSIIEGITQGLL 560
                       +  +  LV E+    S+   I ++   +L + W     I   I +GL 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLS 125

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +LH++   +VIHRD+K  N+LL E    K+ DFG++    ++      N  +GT
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGT 174

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 49/188 (26%)

Query: 448 FQTIAVATDNFSPANR------LGQGGFGPV---YKGKLQDEQEIAIKRLSKSSGQGIVE 498
           F ++ V    F+   R      +G G  G V   Y       Q +AIK+LS+        
Sbjct: 2   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTG--QNVAIKKLSRP------- 52

Query: 499 FKN---------EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSR-- 539
           F+N         E  L+  + H N+ G   L+  + P KSL+ F        + D++   
Sbjct: 53  FQNVTHAKRAYRELVLMKLVNHKNIIG---LLNVFTPQKSLEEFQDVYLVMELMDANLCQ 109

Query: 540 --KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +  LD ++   ++  +  G+ +LH      +IHRDLK SNI++      KI DFG+AR
Sbjct: 110 VIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Query: 598 T----FTM 601
           T    F M
Sbjct: 167 TAGTSFMM 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 27/152 (17%)

Query: 464 LGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN--- 513
           LG G F   Y+      G L   +++   R + S  + +VE  + E +L+A+L H +   
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 514 -LGGERL-----LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSI--IEGITQGLLYLHKY 565
            LG         L  E++   S+   +          +K+   I   E + +GL YLH+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN 122

Query: 566 SRLRVIHRDLKVSNILLDEQ-MNPKISDFGMA 596
              ++IHRD+K +N+L+D      +I+DFG A
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 19/148 (12%)

Query: 464 LGQGGFGPVY------KGKLQDEQEIAIKRLSKSSG-QG-IVEFKNEAKL----IAKLQH 511
           LG+GGFG V        GKL   +++  KRL K  G +G +VE +  AK+    I  L +
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 512 T-NLGGERLLVYEYLPNKSLDFFIF--DSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                 +  LV   +    L + I+  D       + +  F   + I  GL +LH+    
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-IISGLEHLHQR--- 116

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMA 596
           R+I+RDLK  N+LLD   N +ISD G+A
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 20/116 (17%)

Query: 499 FKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
           F+ + KL   L + N GGE               F     R+   + + R  I E I   
Sbjct: 74  FQTDTKLHLILDYVN-GGE--------------LFTHLYQREHFTESEVRVYIAE-IVLA 117

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           L +LH+   L +I+RD+K+ NILLD + +  ++DFG+++ F   E E       GT
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGT 169

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 19/147 (12%)

Query: 464 LGQGGFGPV------YKGKLQDEQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQ 510
           LG+GGFG V        GK+   +++  KR+ K  G+        I+E K  ++ +  L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILE-KVNSRFVVSLA 66

Query: 511 HTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
           +     + L LV   +    L F I+        + +  F   E I  GL  LH   + R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLH---QER 122

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMA 596
           +++RDLK  NILLD+  + +ISD G+A
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 24/173 (13%)

Query: 457 NFSPANRLGQGGFGP--VYKGKLQDEQ----EIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 510
           ++ P   LG+G FG   +Y+    D      E+ + RLS+       +  NE  +++ LQ
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQ 57

Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+             L+  EY    +L +      +  L + +     +  I   + Y
Sbjct: 58  HPNIIAYYNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +HK     ++HRD+K  NI L +    K+ DFG+++        A T  +VGT
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 29/159 (18%)

Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 21  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 76

Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKK------RFSIIEGITQG 558
           N+ G   L+  + P +SL+ F        +  +   +++  +K      +F I + I +G
Sbjct: 77  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-ILRG 132

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 39/170 (22%)

Query: 463 RLGQGGFGPVYKGKLQDEQE---------------IAIKRL-SKSSGQGIVEFKNEAKLI 506
           +LG+G FG V+  + +   E               +A+K L +  +     +F  E K++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 507 AKLQHTNLGGERLL-----------VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGI 555
           ++L++ N+   RLL           + EY+ N  L+ F+  S R+    +    +I    
Sbjct: 72  SRLKNPNI--IRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANNIPSVS 127

Query: 556 TQGLLYLH-------KY-SRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              LLY+        KY + L  +HRDL   N L+      KI+DFGM+R
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 51.3 bits (122), Expect = 5e-07
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 19/162 (11%)

Query: 463 RLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           ++GQG  G VY    +   QE+AIK+++           NE  ++ + ++ N+       
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G E  +V EYL   SL     D   ++ +D  +  ++     Q L +LH     +VIH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  NILL    + K++DFG     T  + + +T  +VGT
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 21/148 (14%)

Query: 464 LGQGGFGPV------YKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH---TNL 514
           LG+GGFG V        GK+   +++  KR+ K  G+ +    NE +++ K+      +L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                      LV   +    L F I++       + +  F   E IT GL  LH   R 
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDLH---RE 121

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMA 596
           R+++RDLK  NILLD+  + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 47/155 (30%), Positives = 68/155 (43%), Gaps = 29/155 (18%)

Query: 464 LGQGGFGP--VYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL----- 514
           +G+G FG   + +    D Q+ A+K  RL KSS   + + + EA L+AK++H N+     
Sbjct: 8   VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRK-----SLLDWKKRFSIIEGITQGLLYLHKY 565
                G   +V EY     L   I     K     ++L W           Q  L +   
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---------FVQMCLGVQHI 116

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
              RV+HRD+K  NI L +    K+ DFG AR  T
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 19/147 (12%)

Query: 464 LGQGGFGPV------YKGKLQDEQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQ 510
           LG+GGFG V        GK+   +++  KR+ K  G+        I+E K  ++ +  L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILE-KVNSRFVVSLA 66

Query: 511 HTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
           +     + L LV   +    L F I++       + +  F   E +  GL  L    R R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RER 122

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMA 596
           +++RDLK  NILLD++ + +ISD G+A
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 55/189 (29%), Positives = 82/189 (43%), Gaps = 33/189 (17%)

Query: 448 FQTIAVATDNFSPANRLGQGGFGPVYK-GKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLI 506
            +++   TD +     +G+G +G VYK    +D    A+K L   S     E + E  ++
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72

Query: 507 AKL-QHTNL--------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS- 550
             L  H N+              GG+  LV E     S+   +     K LL   +R   
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127

Query: 551 -----IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
                I+ G   GL +LH     R+IHRD+K +NILL  +   K+ DFG++   T   L 
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 606 ANTNRIVGT 614
            NT+  VGT
Sbjct: 185 RNTS--VGT 191

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 26/168 (15%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKS-SGQGIVEFKNEAKL 505
           V+ +  +    LGQG FG VY+G  +D      E  +A+K +++S S +  +EF NEA +
Sbjct: 3   VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62

Query: 506 IAK---------LQHTNLGGERLLVYEYLPNKSLDFFIF-------DSSRKSLLDWKKRF 549
           +           L   + G   L+V E + +  L  ++        ++  +     ++  
Sbjct: 63  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122

Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HRDL   N ++      KI DFGM R
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 44/173 (25%)

Query: 464 LGQGGFGPVYKGK------LQDEQEIAIKRLSKSSGQGIVEFK---NEAKLIAKLQHTNL 514
           LG+G FG V K              +A+K L +++     E +   +E  L+ ++ H ++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHV 65

Query: 515 ---------GGERLLVYEYLPNKSLDFFI------------FDSSRKSLLDW-------- 545
                     G  LL+ EY    SL  F+             D +R S            
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 546 -KKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                S    I++G+ YL   + ++++HRDL   N+L+ E    KISDFG++R
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 17/146 (11%)

Query: 464 LGQGGFGPVYKG--KLQDEQ-EIAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNL----- 514
           LG G FG V KG  K++ +Q ++AIK L   + + +  E   EA+++ +L +  +     
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 515 --GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
               E L LV E      L+ F+  S +K  +       ++  ++ G+ YL   +    +
Sbjct: 63  VCEAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN---FV 117

Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N+LL  Q   KISDFG+++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 23/151 (15%)

Query: 464 LGQGGFGPVYKGKLQDEQE----IAIKRLSKS----SGQGIVEFKNEAKLIAKLQHT--- 512
           LG+GG+G V++ +     +     A+K L K+    + +     K E  ++  ++H    
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 513 ------NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                   GG+  L+ EYL    L  F+        ++    F + E I+  L +LH+  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSE-ISLALEHLHQ-- 118

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              +I+RDLK  NILLD Q + K++DFG+ +
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)

Query: 463 RLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           ++GQG  G VY    +   QE+AI++++           NE  ++ + ++ N+       
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G E  +V EYL   SL     D   ++ +D  +  ++     Q L +LH     +VIH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  NILL    + K++DFG     T    ++  + +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 26/159 (16%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLGGERLLV 521
           ++G+G +G VYK K +D ++     L +  G GI +    E  L+ +L+H N+   + + 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 522 YEYLPNKSLDFFIFDSSRKSLLDW------------KKRFSIIEGITQGLLY-----LHK 564
             +   K   + +FD +   L  W            KK   +  G+ + LLY     +H 
Sbjct: 68  LSHADRKV--WLLFDYAEHDL--WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 565 YSRLRVIHRDLKVSNILL----DEQMNPKISDFGMARTF 599
                V+HRDLK +NIL+     E+   KI+D G AR F
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 18/155 (11%)

Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-- 513
           ++    R+G G +G VYK   L   +  A+K +    G      + E  ++ + +H N  
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 514 ------LGGERLLV-YEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                 L  E+L +  EY    SL D +        L    +   +     QGL YLH  
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAYLHSK 125

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            ++   HRD+K +NILL +  + K++DFG+A   T
Sbjct: 126 GKM---HRDIKGANILLTDNGDVKLADFGVAAKIT 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           I +GL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 21/159 (13%)

Query: 456 DNFSPANRLGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           +N S    LG G FG V +       K     ++A+K L  ++     E   +E K+++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 509 L-QHTN---------LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
           L  H N         +GG  L++ EY     L  F+    R+S L  +   S    + +G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + +L   +    IHRDL   N+LL      KI DFG+AR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 21/146 (14%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           +G+G FG V  G  +  + +A+K + + ++ Q    F  EA ++ +L+H+NL        
Sbjct: 14  IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69

Query: 515 --GGERLLVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
              G   +V EY+   SL D+    S  +S+L           + + + YL   +    +
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124

Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N+L+ E    K+SDFG+ +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 30/154 (19%)

Query: 464 LGQGGFGPV---YKGKLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLGGE 517
           +G G +G V   Y  +L+  Q++A+K+LS+   Q ++  +    E +L+  ++H N+ G 
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIG- 78

Query: 518 RLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKK------RFSIIEGITQGLLYLH 563
             L+  + P  S++ F        +  +   +++  +K      +F I + + +GL Y+H
Sbjct: 79  --LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIH 135

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                 +IHRDLK SN+ ++E    +I DFG+AR
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 19/147 (12%)

Query: 464 LGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--- 514
           LG G FG V+KG    E +     +AIK +   SG Q   E  +    +  L H  +   
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                G    LV +  P  SL   +     +  LD ++  +    I +G+ YL ++   R
Sbjct: 75  LGICPGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH---R 129

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMA 596
           ++HR+L   NILL      +I+DFG+A
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 39/170 (22%)

Query: 458 FSPANRLGQGGFGPVYKGKLQDE----QEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 511
           F+    LG+G FG V + +L+ E    Q++A+K L     S   I EF  EA  + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 512 TNL-----------GGERL----LVYEYLPNKSLDFFI---------FDSSRKSLLDWKK 547
            N+              RL    ++  ++ +  L  F+         F    ++L+    
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116

Query: 548 RFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           RF I   I  G+ YL   S    IHRDL   N +L+E M   ++DFG+++
Sbjct: 117 RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 20/157 (12%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIA-IKRLSKSSGQGIVEFKNEAKLIAKLQHTN- 513
           ++F    R+G G +G VYK +  +  E+A IK +    G+     + E  ++   +H+N 
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 514 -------LGGERLLV-YEYLPNKSLD--FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
                  L  ++L +  E+    SL   + +     +S + +  R ++     QGL YLH
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
              +   +HRD+K +NILL +  + K++DFG++   T
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQIT 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 2/46 (4%)

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           I   + +GL YL  Y+  R++HRD+K SNIL++ +   K+ DFG++
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 52/170 (30%), Positives = 79/170 (46%), Gaps = 30/170 (17%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEAKLIAK---LQHTNLGGERL 519
           +G+G FG VY+ + +D + I A+K LSK     IV  K  A  I +   L  T L     
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE---IVAKKEVAHTIGERNILVRTLLDESPF 57

Query: 520 LV---YEYLPNKSLDFFIFDSSRKSLLDW-----------KKRFSIIEGITQGLLYLHKY 565
           +V   + +  +  L + + D      L W           + +F I E +   L +LHKY
Sbjct: 58  IVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKY 115

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMAR-TFTMNELEANTNRIVGT 614
               +++RDLK  NILLD   +  + DFG+++   T N+    TN   GT
Sbjct: 116 D---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGT 159

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 42/186 (22%)

Query: 440 KRDLKIFDFQ------TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG 493
           KRD   +  +      T+     N  P     QG     Y   L  E+ +AIK+LS+   
Sbjct: 5   KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-- 60

Query: 494 QGIVEFKN---------EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF--------IFD 536
                F+N         E  L+  + H N+ G   L+  + P KSL+ F        + D
Sbjct: 61  -----FQNQTHAKRAYRELVLMKCVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMD 112

Query: 537 SSRKSL----LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISD 592
           ++   +    LD ++   ++  +  G+ +LH      +IHRDLK SNI++      KI D
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 169

Query: 593 FGMART 598
           FG+ART
Sbjct: 170 FGLART 175

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 27/160 (16%)

Query: 457 NFSPANRLGQGGFGPVYKGKLQDE-QEIAIKRL-----SKSSGQGIVEFKNEAKLIAKLQ 510
           N+     LG+G FG VY     D  +E+A+K++     S+ + + +   + E +L+  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 511 HTNLGGERLLVY----EYLPNKSLDFFIFDSSRKSLLDWKKRF-SIIEGIT--------Q 557
           H     +R++ Y         K L  F+      S+ D  K + ++ E +T        Q
Sbjct: 63  H-----DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ 117

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           G+ YLH      ++HRD+K +NIL D   N K+ DFG ++
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           I  GL +LH      +I+RDLK+ N++LD + + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 26/157 (16%)

Query: 464 LGQGGFGPVYKGKL-QDEQ--EIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
           LG+G FG V +G+L QD+   ++A+K  +++  +   + +F +EA  + +  H N+    
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 515 -----GGER------LLVYEYLPNKSLDFFIFDS---SRKSLLDWKKRFSIIEGITQGLL 560
                  E       +++  ++ +  L  F+  S        L  +     +  I  G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           YL   S    IHRDL   N +L+E MN  ++DFG+++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 42/159 (26%), Positives = 67/159 (42%), Gaps = 29/159 (18%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLS-KSSGQGIVE-----FKNEAKLIAKLQHTNLG 515
             LG+G +G VY G     Q IA+K++   +S     E      + E  L+  L+H N  
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN-- 63

Query: 516 GERLLVYEY----LPNKSLDFFIFDSSRKSLLDWKKRFSII---------EGITQGLLYL 562
                + +Y    L + ++  F+      S+     RF  +         + I  G+ YL
Sbjct: 64  -----IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
           H      V+HRD+K +N++L      K+ DFG AR    
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 25/152 (16%)

Query: 464 LGQGGFGPVYKGKLQDE-QEIAIKRL-----SKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LGQG FG VY     D  +E+A K++     S  + + +   + E +L+  LQH  +   
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 515 ------GGERLLV--YEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                   E+ L    EY+P  S+ D      +    +  K    I+EG++    YLH  
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS----YLHSN 125

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
               ++HRD+K +NIL D   N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 19/145 (13%)

Query: 464 LGQGGFGPVYKG--KLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 514
           LG G FG + +G  KL  ++E  +AI  L    S +    F  EA  + +  H+N+    
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                G   ++V EY+ N +LD F+     +  L   +   ++ G+  G+ YL   S + 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127

Query: 570 VIHRDLKVSNILLDEQMNPKISDFG 594
            +H+ L    +L++  +  KIS F 
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 22/162 (13%)

Query: 451 IAVATDNFSPANRLGQGGFGPVYKG---KLQDEQ-EIAIKRLSKSSGQGIVE-FKNEAKL 505
             +  ++ +    +G+G FG VY+G     ++E+  +A+K     +   + E F  EA +
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60

Query: 506 IAKLQHTNLGGERL----------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGI 555
           + +  H ++   +L          +V E  P   L  ++     K  LD          +
Sbjct: 61  MRQFDHPHI--VKLIGVITENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQL 116

Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +  L YL      R +HRD+   N+L+      K+ DFG++R
Sbjct: 117 STALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 19/147 (12%)

Query: 464 LGQGGFGPV------YKGKLQDEQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQ 510
           LG+GGFG V        GK+   + +  KR+ K  G+        I+E K  ++ +  L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILE-KVNSQFVVNLA 66

Query: 511 HTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
           +     + L LV   +    L F I++       + +  F   E I  GL  LH   R  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLH---REN 122

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMA 596
            ++RDLK  NILLD+  + +ISD G+A
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 26/192 (13%)

Query: 441 RDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEF 499
           R L   D   +      F     +G G +G VYKG+ ++  Q  AIK +  +  +   E 
Sbjct: 1   RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEI 59

Query: 500 KNEAKLIAKLQH-----TNLGG-----------ERLLVYEYLPNKSLDFFIFDSSRKSLL 543
           K E  ++ K  H     T  G            +  LV E+    S+   + ++   +L 
Sbjct: 60  KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119

Query: 544 -DWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
            DW     I   I +GL +LH +   +VIHRD+K  N+LL E    K+ DFG++    ++
Sbjct: 120 EDWIA--YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLD 172

Query: 603 ELEANTNRIVGT 614
                 N  +GT
Sbjct: 173 RTVGRRNTFIGT 184

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 47.8 bits (113), Expect = 9e-06
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 32/162 (19%)

Query: 463 RLGQGGFGPVYKGKL---QDEQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLGGER 518
           ++G+G +G VYK K    +DE+E A+K++    G GI +    E  L+ +L+H N+   +
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQI---EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 519 LLVYEYLPNKSLDFFIFDSSRKSLLDW------------KKRFSIIEGITQGLLY----- 561
            +   +   K   + +FD +   L  W            KK   +   + + LLY     
Sbjct: 65  KVFLSHSDRKV--WLLFDYAEHDL--WHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 562 LHKYSRLRVIHRDLKVSNILL----DEQMNPKISDFGMARTF 599
           +H      V+HRDLK +NIL+     E+   KI+D G AR F
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 30/153 (19%)

Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAK-------LIAKLQHTNLG 515
           +G+G FG V   + + +E+  A+K L K   + I++ K E         L+  ++H  L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQK---KAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 516 GERLLVYEYLPNKSLDFFIFD-----------SSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           G   L + +     L +F+ D              +  L+ + RF   E I   L YLH 
Sbjct: 60  G---LHFSFQTADKL-YFVLDYINGGELFYHLQRERCFLEPRARFYAAE-IASALGYLHS 114

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              L +++RDLK  NILLD Q +  ++DFG+ +
Sbjct: 115 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 25/163 (15%)

Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQH--- 511
           + P   +G G +G VYK +       +A+K +   + +  +      E  L+ +L+    
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 512 --------------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
                         T+   +  LV+E++ ++ L  ++ D      L  +    ++    +
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLR 119

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           GL +LH      ++HRDLK  NIL+      K++DFG+AR ++
Sbjct: 120 GLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)

Query: 464 LGQGGFGPVYKGKLQ---DEQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTNL---- 514
           LG G FG V KG  +    E+ +A+K L   +    +  E   EA ++ +L +  +    
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                   +LV E      L+ F+     K + + K    ++  ++ G+ YL + +    
Sbjct: 63  GICEAESWMLVMELAELGPLNKFL--QKNKHVTE-KNITELVHQVSMGMKYLEETN---F 116

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +HRDL   N+LL  Q   KISDFG+++    +E
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 17/149 (11%)

Query: 462 NRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQ-HTNLGGE 517
            ++G+G F  V K +  +  +  AIK + K   + + +  N  E + + +L  H N+   
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 518 RLLVYEYLPNK-SLDFFIFDSS-------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
             ++++    + +L F + D +       RK  L  K+  S +  + + L ++H   R  
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNG 120

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMART 598
           + HRD+K  NIL+      K++DFG  R 
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRG 148

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 21/149 (14%)

Query: 464 LGQGGFGPVY---KGKLQDEQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHT----- 512
           LGQG FG V+   K    D  ++ A+K L K++   +  V  K E  ++A++ H      
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 513 ----NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                  G+  L+ ++L  +  D F   S      +   +F + E +   L +LH    L
Sbjct: 64  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLH---SL 117

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +I+RDLK  NILLDE+ + K++DFG+++
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 53/168 (31%), Positives = 80/168 (47%), Gaps = 28/168 (16%)

Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAK-------LQHTNLG 515
           +G+G FG V   K + D    A+K L K +   I++ K +  ++A+       L+H  L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKT---ILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 516 G--------ERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           G        E+L  V +Y+    L FF     R   L+ + RF   E +   + YLH   
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGEL-FFHLQRERC-FLEPRARFYAAE-VASAIGYLHS-- 114

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            L +I+RDLK  NILLD Q +  ++DFG+ +     E E  T+   GT
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 24/160 (15%)

Query: 464 LGQGGFGPVYKGK---LQDEQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQ-HTNLGG- 516
           LGQG +G V   +     +E+ +AIK+++    + I+  +   E KL+   + H N+   
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 517 -----------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                        L +YE L    L   I      +   ++   S I  I  GL Y+H  
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQ---SFIYQILCGLKYIHSA 124

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
           +   V+HRDLK  N+L++     KI DFG+AR F+ N  E
Sbjct: 125 N---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 30/175 (17%)

Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 513
             P   +G G FG V+     +D + +A+K++     Q +V  K    E K++   +H N
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDN 60

Query: 514 LGGERLLVYEYLPNKSLDFF----------------IFDSSRKSLLDWKKRFSIIEGITQ 557
           +    L   + L    +D F                I  S +    D  K F  +  I +
Sbjct: 61  V----LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVF--LYQILR 114

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           GL YLH      ++HRD+K  N+L++     KI DFG+AR    +E +  T  +V
Sbjct: 115 GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 21/46 (45%), Positives = 29/46 (63%), Gaps = 8/46 (17%)

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA-----RTFTM 601
           YLH      +I+RDLK  N+LLD + + K++DFG A     RTFT+
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL 175

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 24/164 (14%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           D+      +G G FG V+  + +  E   A+K ++       +      NE +++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 512 TNL-------GGERLL--VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL 562
             +         +R L  + EY+P   L  F +  +     +    F   E I   L YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYL 117

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA-----RTFTM 601
           H      +++RDLK  NILLD++ + K++DFG A     RT+T+
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)

Query: 464 LGQGGFGPVYKGKLQDE---QEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTNL---- 514
           +G+G FG V +  ++ +      AIK L + +S     +F  E +++ KL  H N+    
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 515 -----GGERLLVYEYLPNKSL-DF------------FIFDSSRKSLLDWKKRFSIIEGIT 556
                 G   +  EY P  +L DF            F  +    S L  ++       + 
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            G+ YL   S  + IHRDL   N+L+ E +  KI+DFG++R
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 20/149 (13%)

Query: 464 LGQGGFGPVYKGKLQ---DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL----- 514
           +G G FG V  G++       ++ +K L  S+  Q  ++F  EA+    LQH+NL     
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLL---DWKKRFSIIEGITQGLLYLHKYSR 567
                   LLV E+ P   L  ++  S RK+ L   D      +   I  GLL+LHK + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMA 596
              IH DL + N LL   +  KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 16/157 (10%)

Query: 468 GFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-LGGERLLVYE--- 523
           G     +GK + E+ IA KR+ K+  +  ++ +NE   + +L H N L  E +L  E   
Sbjct: 181 GVNSTNQGKPKCERLIA-KRV-KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANT 238

Query: 524 YLPNKSLDFFIFDSSRKSLLDWKKR------FSIIEGITQGLLYLHKYSRLRVIHRDLKV 577
           Y+  +  DF ++        DWK R       +I++ +   + Y+H     ++IHRD+K+
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295

Query: 578 SNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            NI L+      + DFG A  F   E EA     VGT
Sbjct: 296 ENIFLNCDGKIVLGDFGTAMPFE-KEREAFDYGWVGT 331

Length = 501

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 30/161 (18%)

Query: 464 LGQGGFGPVYKGKLQDE---QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQH----TNLG 515
           +G+G FG V K +++ +    + AIKR+ + +S     +F  E +++ KL H     NL 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 516 G---ERLLVY---EYLPNKSL-DF------------FIFDSSRKSLLDWKKRFSIIEGIT 556
           G    R  +Y   EY P+ +L DF            F   +S  S L  ++       + 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +G+ YL   S+ + IHRDL   NIL+ E    KI+DFG++R
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 25/77 (32%), Positives = 35/77 (45%), Gaps = 4/77 (5%)

Query: 525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE 584
           +P    D F +   R   L  ++  +I   + + L YLH      +IHRD+K  NI LDE
Sbjct: 165 MPKYKCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDE 220

Query: 585 QMNPKISDFGMARTFTM 601
             N  + DFG A     
Sbjct: 221 PENAVLGDFGAACKLDA 237

Length = 392

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 56/183 (30%)

Query: 463 RLGQGGFGPVYKGKLQDEQE-----------------IAIKRL-SKSSGQGIVEFKNEAK 504
           +LG+G FG V+  ++ + Q+                 +A+K L   ++     +F  E K
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 505 LIAKLQHTNLGGERLL-----------VYEYLPNKSLDFFIFDSSRKSLLD--------- 544
           ++++L+  N+   RLL           + EY+ N  L+ F+   S   L D         
Sbjct: 72  ILSRLKDPNI--IRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAV 126

Query: 545 ----------WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
                     +     +   I  G+ YL   S L  +HRDL   N L+ E +  KI+DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183

Query: 595 MAR 597
           M+R
Sbjct: 184 MSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 22/150 (14%)

Query: 463 RLGQGGFGP--VYKGKLQDEQ----EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
           ++G+G FG   + K K   +Q    EI I ++S    +   E + E  +++ ++H N+  
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
                   G   +V +Y     L +   ++ R  L    +       I   L ++H    
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-- 120

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +++HRD+K  NI L +    K+ DFG+AR
Sbjct: 121 -KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 39/168 (23%), Positives = 82/168 (48%), Gaps = 26/168 (15%)

Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQE-IAIKRLS-KSSGQGI----------------VE 498
           +     +G+G +G V+K + L++    +A+KR+  ++  +G+                 E
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 499 FKNEAKL--IAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGIT 556
             N  +L  +  +  T+   +  LV+E++ ++ L  ++ D   +  +  +    ++  + 
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLL 120

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
           +GL +LH +   RV+HRDLK  NIL+      K++DFG+AR ++    
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 165

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 32/154 (20%)

Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 514
           +G+G FG V   K + D +  A+K L K     IV  + E K        L+  ++H  L
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKK----IVLNRKEQKHIMAERNVLLKNVKHPFL 58

Query: 515 GGERLLVYEYLPNKSLDFFIFD-----------SSRKSLLDWKKRFSIIEGITQGLLYLH 563
            G   L Y +   + L +F+ D              +S  + + RF   E I   L YLH
Sbjct: 59  VG---LHYSFQTTEKL-YFVLDFVNGGELFFHLQRERSFPEPRARFYAAE-IASALGYLH 113

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
               + +++RDLK  NILLD Q +  ++DFG+ +
Sbjct: 114 S---INIVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 20/166 (12%)

Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSS------------GQGIVEFKNEA 503
           +F+    LG+G FG V   + +   E+ AIK L K               + ++  +++ 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 504 KLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL 562
             + +L       +RL  V EY+    L + I    +    + +  F   E I+ GL +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAE-ISVGLFFL 117

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           H+     +I+RDLK+ N++LD + + KI+DFGM +   ++ +   T
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 45/185 (24%)

Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKR------LSKSSGQGIVEFKNEAKLIAKL 509
           NF    ++G+G F  VY+   L D + +A+K+      +   + Q  V+   E  L+ +L
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59

Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLD-------------WKKRFSIIEGIT 556
            H N+             K LD FI D+    +L+             +KK+  +I   T
Sbjct: 60  NHPNV------------IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT 107

Query: 557 QGLLYL-------HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
               ++       H +SR RV+HRD+K +N+ +      K+ D G+ R F+     A++ 
Sbjct: 108 VWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS- 165

Query: 610 RIVGT 614
            +VGT
Sbjct: 166 -LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 22/165 (13%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLGGERL 519
           +G+GGFG VY  +  D  ++ A+K L K      QG     NE  +++ +   +      
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 520 LVYEYLPNKSLDFFI---------FDSSRKSLLDWKK-RFSIIEGITQGLLYLHKYSRLR 569
           + Y +     L F +         +  S+  +   K+ RF   E I  GL ++H  +R  
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE-IILGLEHMH--NRF- 117

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           V++RDLK +NILLDE  + +ISD G+A  F+  +  A+    VGT
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 23/150 (15%)

Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLGGERLL 520
           +G G +G V      +  +++AIK+LS+     I   +   E  L+  +QH N+ G   L
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIG---L 79

Query: 521 VYEYLPNKSL----DFFIF------DSSR---KSLLDWKKRFSIIEGITQGLLYLHKYSR 567
           +  +    S     DF++       D  +     L + K ++ + + +  GL Y+H    
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ-MLCGLKYIHSAG- 137

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +IHRDLK  N+ ++E    KI DFG+AR
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 15/143 (10%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAI-KRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           LG G FG VYK + ++   +A  K +   S + + ++  E  ++A   H N+   +LL  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI--VKLLDA 70

Query: 523 EYLPNKS---LDFFIFDSSRKSLLDWKKRFS------IIEGITQGLLYLHKYSRLRVIHR 573
            Y  N     ++F    +    +L+ ++  +      + +   + L YLH+    ++IHR
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127

Query: 574 DLKVSNILLDEQMNPKISDFGMA 596
           DLK  NIL     + K++DFG++
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 19/163 (11%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKN--EAKLIAKLQHTNL------ 514
           +G+G +G V K + ++ +EI AIK+   S     V+     E K++  L+  N+      
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
               G+  LV+EY+    L+  + +     +   K R S I  + + + + HK     ++
Sbjct: 69  FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKND---IV 122

Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+L+      K+ DFG AR  +     AN    V T
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVAT 164

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 22/165 (13%)

Query: 449 QTIAVATDNFSPANRLGQGGFGPV-YKGKLQDEQEIAIKRLSKSSGQGIVEFK--NEAKL 505
           +TI    D +    ++G G +G V      +   ++AIK+L +     +   +   E +L
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 506 IAKLQHTNLGGERLLVYEYLPNKSLDFFI-------FDSSRKSLLDWKKRFS------II 552
           +  ++H N+ G   L+  + P+ SLD F        F  +    L   ++ S      ++
Sbjct: 68  LKHMKHENVIG---LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + +GL Y+H      +IHRDLK  N+ ++E    KI DFG+AR
Sbjct: 125 YQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 41/172 (23%), Positives = 75/172 (43%), Gaps = 42/172 (24%)

Query: 463 RLGQGGFGPVYKGKLQDEQE-----------------IAIKRLSKSSGQGIV-EFKNEAK 504
           +LG+G FG V+  + +  ++                 +A+K L + + +    +F  E K
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 505 LIAKLQHTNLGGERLL-----------VYEYLPNKSLDFFI--------FDSSRKSLLDW 545
           ++++L+  N+   RLL           + EY+ N  L+ F+         + +    + +
Sbjct: 72  IMSRLKDPNI--IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 546 KKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                +   I  G+ YL   S L  +HRDL   N L+ +    KI+DFGM+R
Sbjct: 130 STLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 30/160 (18%)

Query: 464 LGQGGFGPVYKGKLQD--------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
           LGQG F  ++KG  ++        + E+ +K L KS       F   A ++++L H +L 
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                   G E ++V EY+   SLD ++  +     + WK     +E   Q    LH   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK-----LEVAKQLAWALHFLE 117

Query: 567 RLRVIHRDLKVSNILL-----DEQMNP---KISDFGMART 598
              + H ++   N+LL      +  NP   K+SD G++ T
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 42/142 (29%), Positives = 67/142 (47%), Gaps = 17/142 (11%)

Query: 463 RLGQGGFGPVYKGKLQDE-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-------- 513
           ++G+G  G V   + +   +++A+K +     Q      NE  ++   QH N        
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 514 LGGERLLV-YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
           L GE L V  E+L   +L     D   ++ L+ ++  ++ E + Q L YLH      VIH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 573 RDLKVSNILLDEQMNPKISDFG 594
           RD+K  +ILL      K+SDFG
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 39/172 (22%), Positives = 66/172 (38%), Gaps = 42/172 (24%)

Query: 463 RLGQGGFGPVYKGKLQDEQEI--AIKRLSKSSGQ----------------GIVEFKNEAK 504
           +LG+G FG V+  +    Q+        + ++                     +F  E K
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 505 LIAKLQHTNLGGERLL-----------VYEYLPNKSLDFFI--------FDSSRKSLLDW 545
           ++++L   N+   RLL           + EY+ N  L+ F+          +     L +
Sbjct: 72  ILSRLSDPNIA--RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 546 KKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                +   I  G+ YL     L  +HRDL   N L+ +    KI+DFGM+R
Sbjct: 130 STLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 8e-05
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 35/161 (21%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSS----GQGIVEFKNEAKLIA--- 507
           D+F     +G+G FG V   + +D   I A+K+L KS      Q +   + E  ++A   
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59

Query: 508 -----KLQHTNLGGERL-LVYEYLPNKSL-------DFFIFDSSRKSLLDWKKRFSIIEG 554
                KL ++      L L+ EYLP   +       D F  + +R         F I E 
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR---------FYIAET 110

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM 595
           I    L +    +L  IHRD+K  N+LLD + + K+SDFG+
Sbjct: 111 I----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 44.7 bits (106), Expect = 8e-05
 Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 4/43 (9%)

Query: 555 ITQGLLYL-HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           I + L YL  K+    VIHRD+K SNILLD   N K+ DFG++
Sbjct: 123 IVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 44.4 bits (105), Expect = 9e-05
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 20/149 (13%)

Query: 456 DNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 514
           DNF    ++G+G  G V         +++A+K++     Q      NE  ++   QH N+
Sbjct: 22  DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                    G E  +V E+L   +L     D    + ++ ++  ++   + + L +LH  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFG 594
               VIHRD+K  +ILL      K+SDFG
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 17/29 (58%), Positives = 23/29 (79%)

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           L++IHRD+K SNILLD   N K+ DFG++
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 55/196 (28%), Positives = 85/196 (43%), Gaps = 39/196 (19%)

Query: 428 NRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ--EIAI 485
           ++K  + S +  KR  K+          ++F+    LG G FG V     ++E    +AI
Sbjct: 10  HKKKDSDSTKEPKRKNKM--------KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAI 61

Query: 486 KRLSKSS---GQGIVEFKNEAKLIAKLQH---TNLGGE------RLLVYEYLPNKSLDFF 533
           KR  KS     + +    +E K++  + H    NL G         LV E++     +FF
Sbjct: 62  KRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG--EFF 119

Query: 534 IFDSSRKSLLDWKKRFSIIEGI---TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI 590
            F       L   KRF    G     Q +L       L +++RDLK  N+LLD+    K+
Sbjct: 120 TF-------LRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKM 172

Query: 591 SDFGMA-----RTFTM 601
           +DFG A     RT+T+
Sbjct: 173 TDFGFAKVVDTRTYTL 188

Length = 340

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 29/143 (20%), Positives = 50/143 (34%), Gaps = 24/143 (16%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
            L  G    VY    +DE +  +K     S +   + + E  ++  L    L        
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
               G   L+ E++  ++LD    +                  + + L  LH+   L + 
Sbjct: 62  GESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLVLC 111

Query: 572 HRDLKVSNILLDEQMNPKISDFG 594
           H DL   NIL+D+     I D+ 
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 35/180 (19%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKS---SGQGIVEFKNEAKLIA---- 507
            +F   + +G+G FG V   + +   +I A+K + KS   + + +  F+ E  +++    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 508 ----KLQHTNLGGERL-LVYEYLP--------NKSLDFFIFDSSRKSLLDWKKRFSIIEG 554
               +LQ+     + L LV EY P        N+  D   FD           +F + E 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMA-------QFYLAEL 111

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +    L +H   ++  +HRD+K  N+L+D   + K++DFG A   T N++  N+   VGT
Sbjct: 112 V----LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 43/173 (24%)

Query: 447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSS---GQGIVEFKNE 502
           DF T+ V          +G+G FG V   + +D  +I A+K L KS       +   K E
Sbjct: 2   DFHTVKV----------IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAE 51

Query: 503 AKLIA--------KLQHTNLGGERL-LVYEYLPNKSL-------DFFIFDSSRKSLLDWK 546
             ++A         L ++    + L L+ E+LP   L       D F  D +R       
Sbjct: 52  RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR------- 104

Query: 547 KRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
             F + E +    L +    +L  IHRD+K  NIL+D   + K+SDFG++  F
Sbjct: 105 --FYMAECV----LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 33/183 (18%)

Query: 426 FGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-A 484
           F +R  +A    T  R +K  DF  I V          +G+G FG V   + +  +++ A
Sbjct: 24  FLSRYEKAAEKITKLR-MKAEDFDVIKV----------IGRGAFGEVQLVRHKSSKQVYA 72

Query: 485 IKRLSKS------------SGQGIVEFKNEAKLIAKLQHTNLGGERL-LVYEYLPNKSLD 531
           +K LSK               + I+   N ++ I +L +     + L +V EY+P    D
Sbjct: 73  MKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYMVMEYMPGG--D 129

Query: 532 FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKIS 591
                S+      W  RF   E +   L  +H       IHRD+K  N+LLD+  + K++
Sbjct: 130 LVNLMSNYDIPEKWA-RFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 184

Query: 592 DFG 594
           DFG
Sbjct: 185 DFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 18/38 (47%), Positives = 28/38 (73%), Gaps = 3/38 (7%)

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM 595
           GL YLH+    ++++RDLK+ N+LLD +   KI+DFG+
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 33/138 (23%), Positives = 60/138 (43%), Gaps = 18/138 (13%)

Query: 462 NRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--------SGQGIVEFKNEAKLIAKLQHT 512
           N + +G  G  YKGK +++  +  +K ++          +  G ++  N  KLI   +  
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE 755

Query: 513 NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
                  L++EY+  K+L      S     L W++R  I  GI + L +LH      V+ 
Sbjct: 756 KGA---YLIHEYIEGKNL------SEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806

Query: 573 RDLKVSNILLDEQMNPKI 590
            +L    I++D +  P +
Sbjct: 807 GNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 18/148 (12%)

Query: 464 LGQGGFGPVYKGK---LQDEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL----- 514
           +G G FG V  G+      +  + +K L  S+     + F  E +   +L H N+     
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRF--SIIEGITQGLLYLHKYSRL 568
                   LLV E+ P   L  ++  +        +K     +   +  GLL+LH   + 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMA 596
             IH DL + N  L   ++ KI D+G+A
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 19/153 (12%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKS---SGQGIVEFKNEAKL------ 505
           D+F     +G+G FG V   + +D   I A+K L K+     + +   + E  +      
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 506 --IAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL 562
             + K+ ++      L L+ E+LP    D       + +L +   +F I E +    L +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAETV----LAI 114

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM 595
               +L  IHRD+K  N+LLD + + K+SDFG+
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 45/179 (25%)

Query: 456 DNFSPANRLGQGGFGPVYK----GKLQDEQE----IAIKRLSKSSGQGIVEFKNEAKLIA 507
           D       LG+G FG V +    G  +   +    +A+K L  ++       K+ A LI+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-----KDLADLIS 66

Query: 508 KLQ-------HTN----LG-----GERLLVYEYLPNKSLDFFI-----------FDSSR- 539
           +++       H N    LG     G   ++ EY    +L  F+           FD ++ 
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 540 -KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +  L +K   S    + +G+ YL   SR R IHRDL   N+L+ E    KI+DFG+AR
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           I  GL +LH      +I+RDLK+ N++LD + + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 38/132 (28%), Positives = 63/132 (47%), Gaps = 16/132 (12%)

Query: 483 IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF--------I 534
           +A+K+LS+   Q     K   + +  L+  N      L+  + P KSL+ F        +
Sbjct: 49  VAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107

Query: 535 FDSSRKSL----LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI 590
            D++   +    LD ++   ++  +  G+ +LH      +IHRDLK SNI++      KI
Sbjct: 108 MDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 164

Query: 591 SDFGMARTFTMN 602
            DFG+ART   N
Sbjct: 165 LDFGLARTACTN 176

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 26/167 (15%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLGGERL 519
           +G+GGFG VY  +  D  ++ A+K L K      QG     NE  +++ +   +      
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 520 LVYEY-LPNKSLDFFIFD-----------SSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
           + Y +  P+K    FI D           S      + + RF   E I  GL ++H  +R
Sbjct: 62  MSYAFHTPDKLS--FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE-IILGLEHMH--NR 116

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             V++RDLK +NILLDE  + +ISD G+A  F+  +  A+    VGT
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 18/161 (11%)

Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 509
           T+     N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  +
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLM 70

Query: 510 QHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQ 557
           +  N      L+  + P KSL+ F        + D++   +    LD ++   ++  +  
Sbjct: 71  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
           G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 21/51 (41%), Positives = 34/51 (66%), Gaps = 3/51 (5%)

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
           I   L +LHK   L +I+RD+K+ NILLD   +  ++DFG+++ F  +E+E
Sbjct: 114 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 30/160 (18%)

Query: 464 LGQGGFGPVYKGKLQDE---------QEIAIKR-LSKSSGQGIVEFKNEAKLIAKLQHTN 513
           LGQG F  +YKG L+ +         QE+++   +  S  +  + F   A L+++L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 514 L--------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
           L          E ++V EY+    LD F+        L WK    + + +   L YL   
Sbjct: 63  LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED- 119

Query: 566 SRLRVIHRDLKVSNILL-----DEQMNP--KISDFGMART 598
              +++H ++   NIL+     +E   P  K+SD G+  T
Sbjct: 120 --KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 45/176 (25%), Positives = 85/176 (48%), Gaps = 25/176 (14%)

Query: 457 NFSPANRLGQGGFGPVY---------KGKL---QDEQEIAIKRLSKS-----SGQGIVEF 499
           NF     LG G +G V+          GKL   +  Q+ A+ + +K+     + + ++E 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 500 KNEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
             ++  +  L +      +L L+ +Y+    +  F     R +  + + RF   E I   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEM--FTHLYQRDNFSEDEVRFYSGE-IILA 117

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           L +LHK   L +++RD+K+ NILLD + +  ++DFG+++ F ++E +  T    GT
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGT 169

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 19/147 (12%)

Query: 464 LGQGGFGPVY------KGK------LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 511
           LG+G FG V        GK      L+ E  IA   ++ +  +  V        +  L++
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 512 TNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
           +    +RL  V EY+    L F +  S  +   + + RF   E I   L YLH     ++
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAE-IVSALDYLHSG---KI 116

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMAR 597
           ++RDLK+ N++LD+  + KI+DFG+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 43/147 (29%), Positives = 70/147 (47%), Gaps = 18/147 (12%)

Query: 464 LGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 511
           LG+G FG V           Y  K L+ E  +A   ++ +  +  V   +    +  L++
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 512 TNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
           +    +RL  V EY     L F +  S  +   + + RF   E I   L YLH  S   V
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKNV 117

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMAR 597
           ++RDLK+ N++LD+  + KI+DFG+ +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 19/147 (12%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLGG--- 516
           LG+G FG V   + +   +  A+K L K    +   +     E++++   +H  L     
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 517 -----ERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                +RL  V EY     L F +  S  +   + + RF   E I   L YLH      V
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALGYLH---SCDV 116

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMAR 597
           ++RDLK+ N++LD+  + KI+DFG+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 19/158 (12%)

Query: 464 LGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 511
           LG+G FG V           Y  K L+ E  IA   ++ +  +  V        +  L++
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 512 TNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                +RL  V EY     L F +  S  +   + + RF   E I   L YLH      V
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD---V 116

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           ++RD+K+ N++LD+  + KI+DFG+ +    +     T
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.7 bits (98), Expect = 7e-04
 Identities = 25/78 (32%), Positives = 44/78 (56%), Gaps = 6/78 (7%)

Query: 520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN 579
            V E++    L F +    ++ L +   RF   E I+  L +LH+     +I+RDLK+ N
Sbjct: 73  FVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNFLHERG---IIYRDLKLDN 126

Query: 580 ILLDEQMNPKISDFGMAR 597
           +LLD + + K++D+GM +
Sbjct: 127 VLLDAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 41/174 (23%), Positives = 77/174 (44%), Gaps = 35/174 (20%)

Query: 456 DNFSPANRLGQGGFGPVY--------KGKLQDEQEIAIKRLS-KSSGQGIVEFKNEAKLI 506
           D  +    LG+G FG V         K K ++   +A+K L   ++ + + +  +E +++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 507 AKL-QHTNL---------GGERLLVYEYLPNKSLDFFI-----------FDSSR--KSLL 543
             + +H N+          G   ++ EY    +L  ++           +D +R     +
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 544 DWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +K   S    + +G+ YL   +  + IHRDL   N+L+ E    KI+DFG+AR
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 6/79 (7%)

Query: 519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVS 578
             V EY+    L F +    ++ L +   RF   E I+  L YLH+     +I+RDLK+ 
Sbjct: 72  FFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKLD 125

Query: 579 NILLDEQMNPKISDFGMAR 597
           N+LLD + + K++D+GM +
Sbjct: 126 NVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 39/168 (23%)

Query: 463 RLGQGGFGPVYKGKLQD------EQEIAIKRL-SKSSGQGIVEFKNEA---KLIAKLQHT 512
            LG+G FG V K +            +A+K L   ++ + + +  +E    K+I K  H 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HK 76

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSI--IEGITQ---- 557
           N+          G   +V EY  + +L  F+  + R               E +TQ    
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 558 --------GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                   G+ +L   +  + IHRDL   N+L+ E    KI+DFG+AR
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 45/175 (25%), Positives = 71/175 (40%), Gaps = 37/175 (21%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKR--LSKSSGQGIVE-FKNE------AKLI 506
           D+F    +LG+G FG VYK  L ++Q     +  L K++  G VE + NE          
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSC 191

Query: 507 AKLQHTNLGG-------ERLLVYEYLPNKSL-------DF------FIFDSSRKSLLDWK 546
           A   +  L         E  LV+ Y    +L       +F      ++    +      +
Sbjct: 192 ADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251

Query: 547 KRFSIIEGITQGLLY----LHKYSRLRVIHRDLKVSNILLDEQMNP-KISDFGMA 596
           +   II+ I + +L+    LH      ++HRD+K  NI+  E     KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 25/76 (32%), Positives = 41/76 (53%), Gaps = 6/76 (7%)

Query: 520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN 579
           L+ E+LP    D       + +L + + +F I E +    L +    +L  IHRD+K  N
Sbjct: 78  LIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETV----LAIDSIHQLGFIHRDIKPDN 131

Query: 580 ILLDEQMNPKISDFGM 595
           +LLD + + K+SDFG+
Sbjct: 132 LLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 19/164 (11%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           +G+G +G V   +   D ++  IK+L+   +S +     + EA+L+++L+H N+      
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 515 --GGERLL--VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
             G + LL  V  +     L +      +  LL   +       I   L YLH+     +
Sbjct: 68  WEGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HI 123

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +HRDLK  N+ L      K+ D G+AR        A+T  ++GT
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 41.3 bits (97), Expect = 0.002
 Identities = 48/169 (28%), Positives = 73/169 (43%), Gaps = 40/169 (23%)

Query: 464 LGQGGFGPVYKGKLQD---EQEIAIKRLSKS-SGQGIVE--FKNEAKLIAKLQHT----- 512
           +G+GG G VY     D    + +A+K++ +  S   +++  F  EAK+ A L H      
Sbjct: 10  IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 513 -NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLD--WKKR---------------FSIIEG 554
            ++  +   VY  +P      +I   + KSLL   W+K                 SI   
Sbjct: 68  YSICSDGDPVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           I   + Y+H  S+  V+HRDLK  NILL       I D+G A    + E
Sbjct: 122 ICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167

Length = 932

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.4 bits (97), Expect = 0.002
 Identities = 18/47 (38%), Positives = 30/47 (63%), Gaps = 3/47 (6%)

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
           L YLH++    +IHRDLK  N+L+  + + K++DFG+++     EL 
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN 160

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 19/41 (46%), Positives = 24/41 (58%), Gaps = 3/41 (7%)

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + L Y+H  +   V HRDLK  NIL +     KI DFG+AR
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 27/176 (15%)

Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLS---KSSGQGIVEFKNEAKLIAKLQHT 512
           NF    ++G+G F  VY+   L D   +A+K++        +   +   E  L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 513 NL---------GGERLLVYEYLPNKSLDFFI--FDSSRKSLLD---WKKRFSIIEGITQG 558
           N+           E  +V E      L   I  F   ++ + +   WK    +   +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
               H +SR RV+HRD+K +N+ +      K+ D G+ R F+     A++  +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 6/79 (7%)

Query: 519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVS 578
            LV EY+    L F +    ++ L +   RF   E I   L +LH+     +I+RDLK+ 
Sbjct: 72  FLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHERG---IIYRDLKLD 125

Query: 579 NILLDEQMNPKISDFGMAR 597
           N+LLD   + K++D+GM +
Sbjct: 126 NVLLDADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 24/172 (13%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRL------SKSSGQGIVEFK-----NEAK 504
           D+F   + LG G  G V K + +    I  ++L           Q I E +     N   
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSR--KSLLDWKKRFSIIEGITQGLLYL 562
           ++         GE  +  E++   SLD  + ++ R  + +L    + SI   + +GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSI--AVLRGLAYL 119

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 165

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 29/163 (17%)

Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSS-----------GQGIVEFKNEAKLIAKLQH 511
           +G+G FG V + + +D Q I A+K + K+             +  V  +     I  L+ 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 512 TNLGGERL-LVYEYLPNKSLDFFI-----FDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
           +    E+L LV  ++    L   +     FD SR        RF   E +   L  LHK+
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA-------RFYTAE-LLCALENLHKF 112

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           +   VI+RDLK  NILLD Q +  + DFG+ +    ++ + NT
Sbjct: 113 N---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 35/166 (21%)

Query: 464 LGQGGFGPVY--------KGKLQDEQEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTN 513
           LG+G FG V         K K      +A+K L   ++ + + +  +E +++  + +H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 514 L---------GGERLLVYEYLPNKSLDFFI-----------FDSSR--KSLLDWKKRFSI 551
           +          G   ++ EY    +L  ++           FD+ +  +  L +K   S 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              + +G+ YL   +  + IHRDL   N+L+ E    KI+DFG+AR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 36/142 (25%), Positives = 64/142 (45%), Gaps = 17/142 (11%)

Query: 463 RLGQGGFGPV-YKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           ++G+G  G V    +    +++A+K++     Q      NE  ++    H N+       
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G E  +V E+L   +L     D    + ++ ++  ++   + + L YLH      VIH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 573 RDLKVSNILLDEQMNPKISDFG 594
           RD+K  +ILL      K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 4/52 (7%)

Query: 548 RFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           RF I E +T  +  +HK   +  IHRD+K  NIL+D   + K++DFG+   F
Sbjct: 104 RFYIAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 25/64 (39%), Positives = 35/64 (54%), Gaps = 5/64 (7%)

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           I+     GL +LH     + IHRD+K +NILL  +   K+ DFG++   T   L  NT+ 
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184

Query: 611 IVGT 614
            VGT
Sbjct: 185 -VGT 187

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 17/29 (58%), Positives = 19/29 (65%)

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + IHRDL   NILL E    KI DFG+AR
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 39.3 bits (92), Expect = 0.004
 Identities = 19/53 (35%), Positives = 32/53 (60%), Gaps = 10/53 (18%)

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG--------MARTF 599
           + +GL YL +  + +++HRD+K SNIL++ +   K+ DFG        MA +F
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.5 bits (92), Expect = 0.004
 Identities = 27/105 (25%), Positives = 48/105 (45%), Gaps = 15/105 (14%)

Query: 501 NEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSI 551
           +EA+L+ +L H  +         GG   LV   LP    D + +  +R   L   +  ++
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAV 265

Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
              +   + Y+H      +IHRD+K  N+L++   +  + DFG A
Sbjct: 266 ARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAA 307

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	614
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.96
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.94
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.94
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.94
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.94
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.94
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.93
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.93
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.93
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.93
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.92
KOG3653	534	consensus Transforming growth factor beta/activin	99.92
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.92
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.92
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.91
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.91
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.91
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.91
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.91
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.91
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.91
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.9
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.9
KOG0198	313	consensus MEKK and related serine/threonine protei	99.9
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.9
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.9
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.9
KOG0605	550	consensus NDR and related serine/threonine kinases	99.89
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.89
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.89
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.89
KOG0578	550	consensus p21-activated serine/threonine protein k	99.89
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.88
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.88
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.88
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.88
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.88
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.88
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.88
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.87
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.87
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.87
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.87
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.87
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.87
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.87
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.87
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.87
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.87
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.87
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.87
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.87
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.87
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.87
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.87
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.87
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.87
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.87
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.86
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.86
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.86
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.86
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.86
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.86
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.86
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.86
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.86
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.86
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.86
PTZ00267	478	NIMA-related protein kinase; Provisional	99.86
PTZ00283	496	serine/threonine protein kinase; Provisional	99.86
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.86
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.86
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.86
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.85
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.85
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.85
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.85
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.85
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.85
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.85
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.85
KOG0589	426	consensus Serine/threonine protein kinase [General	99.85
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.85
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.85
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.85
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.85
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.85
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.85
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.85
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.85
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.85
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.85
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.85
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.85
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.85
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.85
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.85
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.85
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.85
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.84
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.84
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.84
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.84
PHA03212	391	serine/threonine kinase US3; Provisional	99.84
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.84
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.84
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.84
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.84
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.84
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.84
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.84
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.84
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.84
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.84
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.84
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.84
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.84
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.84
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.84
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.84
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.84
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.84
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.84
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.84
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.84
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.84
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.84
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.84
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.84
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.84
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.84
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.84
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.83
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.83
PHA03211	461	serine/threonine kinase US3; Provisional	99.83
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.83
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.83
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.83
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.83
PHA02988	283	hypothetical protein; Provisional	99.83
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.83
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.83
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.83
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.83
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.83
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.83
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.83
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.83
KOG0586	596	consensus Serine/threonine protein kinase [General	99.83
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.83
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.83
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.83
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.83
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.83
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.83
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.83
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.83
KOG0610	459	consensus Putative serine/threonine protein kinase	99.83
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.83
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.83
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.83
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.83
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.83
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.83
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.83
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.83
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.83
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.83
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.82
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.82
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.82
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.82
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.82
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.82
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.82
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.82
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.82
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.82
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.82
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.82
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.82
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.82
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.82
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.82
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.82
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.82
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.82
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.82
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.82
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.82
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.82
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.82
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.82
PTZ00036	440	glycogen synthase kinase; Provisional	99.82
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.82
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.82
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.82
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.82
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.82
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.82
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.82
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.82
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.82
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.82
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.82
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.82
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.82
KOG0584	632	consensus Serine/threonine protein kinase [General	99.82
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.82
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.82
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.82
PHA03207	392	serine/threonine kinase US3; Provisional	99.82
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.81
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.81
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.81
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.81
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.81
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.81
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.81
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.81
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.81
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.81
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.81
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.81
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.81
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.81
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.81
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.81
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.81
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.81
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.81
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.81
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.81
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.81
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.81
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.81
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.81
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.81
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.81
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.81
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.81
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.81
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.8
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.8
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.8
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.8
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.8
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.8
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.8
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.8
PHA03209	357	serine/threonine kinase US3; Provisional	99.8
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.8
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.8
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.8
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.8
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.8
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.8
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.8
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.8
PTZ00284	467	protein kinase; Provisional	99.8
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.8
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.8
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.8
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.8
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.8
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.8
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.8
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.8
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.8
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.8
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.8
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.8
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.8
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.8
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.8
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.79
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.79
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.79
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.79
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.79
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.79
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.79
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.79
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.79
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.79
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.79
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.79
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.79
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.79
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.79
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.79
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.79
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.79
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.79
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.79
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.78
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.78
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.78
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.78
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.78
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.78
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.78
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.78
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.78
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.78
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.78
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.78
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.78
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.78
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.78
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.78
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.78
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.78
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.77
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.77
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.77
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.77
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.77
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.77
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.77
PHA03210	501	serine/threonine kinase US3; Provisional	99.77
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.77
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.77
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.77
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.77
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.77
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.77
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.77
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.77
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.77
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.77
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.76
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.76
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.76
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.76
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.76
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.76
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.76
PLN00009	294	cyclin-dependent kinase A; Provisional	99.76
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.76
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.76
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.76
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.76
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.76
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.76
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.76
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.76
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.76
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.76
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.75
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.75
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.75
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.75
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.75
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.74
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.74
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.74
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.74
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.74
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.74
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.74
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.74
PHA02882	294	putative serine/threonine kinase; Provisional	99.74
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.74
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.73
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.73
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.73
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.73
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.73
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.73
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.73
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.73
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.73
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.72
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.72
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.72
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.72
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.71
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.71
smart00090	237	RIO RIO-like kinase.	99.71
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.71
KOG1152	772	consensus Signal transduction serine/threonine kin	99.7
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.69
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.69
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.69
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.69
PRK10345	210	hypothetical protein; Provisional	99.68
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.68
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.67
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.65
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.64
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.64
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.64
PRK12274	218	serine/threonine protein kinase; Provisional	99.63
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.63
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.61
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.6
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.58
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.56
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.54
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.52
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.52
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.51
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.51
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.5
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.49
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.49
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.48
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.38
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.24
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.14
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.05
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.03
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
PLN00181	793	protein SPA1-RELATED; Provisional	98.94
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.94
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	98.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.89
KOG3087	229	consensus Serine/threonine protein kinase [General	98.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.79
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.77
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.63
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.6
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	98.56
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	98.49
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.39
PRK09902	216	hypothetical protein; Provisional	98.31
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.28
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.26
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.26
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.25
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.14
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.12
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.11
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.11
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.08
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	97.99
PF01636	239	APH: Phosphotransferase enzyme family This family	97.83
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.81
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.73
KOG1243	690	consensus Protein kinase [General function predict	97.67
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	97.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	97.59
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.52
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.51
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.47
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.45
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.23
PLN02876	822	acyl-CoA dehydrogenase	97.17
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.15
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.12
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.08
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.97
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	96.95
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	96.89
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.88
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.64
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.58
PRK05231	319	homoserine kinase; Provisional	96.5
PRK10593	297	hypothetical protein; Provisional	96.41
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.23
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.19
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	96.05
PLN02236	344	choline kinase	95.97
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.86
KOG2270	520	consensus Serine/threonine protein kinase involved	95.32
COG2334	331	Putative homoserine kinase type II (protein kinase	95.05
KOG0606	1205	consensus Microtubule-associated serine/threonine	94.59
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.19
PRK06148	1013	hypothetical protein; Provisional	93.99
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	93.98
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.85
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	93.63
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	93.35
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	93.22
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	93.19
KOG0576	829	consensus Mitogen-activated protein kinase kinase	93.06
KOG1236	565	consensus Predicted unusual protein kinase [Genera	92.59
PRK11768	325	serine/threonine protein kinase; Provisional	91.93
PTZ00384	383	choline kinase; Provisional	91.67
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	90.65
PLN02756	418	S-methyl-5-thioribose kinase	90.09

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=308.69  Aligned_cols=159  Identities=50%  Similarity=0.839  Sum_probs=145.4

Q ss_pred             CcceechhhHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-------
Q 042853          442 DLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------  514 (614)
Q Consensus       442 ~~~~~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-------  514 (614)
                      ..+.|++.++..||++|+..+.||+|+||.||+|.++++..||||++.....+..++|.+|+.++.+++|+|+       
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            5778999999999999999999999999999999999999999999976543325679999999999999999       


Q ss_pred             --CC-eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEe
Q 042853          515 --GG-ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKIS  591 (614)
Q Consensus       515 --~~-~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~  591 (614)
                        .. +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence              34 599999999999999999875544 78999999999999999999999998999999999999999999999999


Q ss_pred             ecCcceeecC
Q 042853          592 DFGMARTFTM  601 (614)
Q Consensus       592 DFGla~~~~~  601 (614)
                      |||||+....
T Consensus       220 DFGLa~~~~~  229 (361)
T KOG1187|consen  220 DFGLAKLGPE  229 (361)
T ss_pred             CccCcccCCc
Confidence            9999987654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=248.20  Aligned_cols=142  Identities=31%  Similarity=0.484  Sum_probs=124.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .+|....+||+|+|++||+|++. ++.+||||.+.+.  ..+..+.+..|+.+|+.++|+||         .+..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            46777788999999999999986 5789999999765  34455668899999999999999         678999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC------CcEEEeecCcce
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ------MNPKISDFGMAR  597 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~------~~~kI~DFGla~  597 (614)
                      ||.+|+|..|+...   +.+++.....++.|+|.||++||+++   ||||||||+||||+..      -.+||+|||+||
T Consensus        90 yC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999644   35888999999999999999999997   9999999999999864      457999999999


Q ss_pred             eecCCc
Q 042853          598 TFTMNE  603 (614)
Q Consensus       598 ~~~~~~  603 (614)
                      .+....
T Consensus       164 ~L~~~~  169 (429)
T KOG0595|consen  164 FLQPGS  169 (429)
T ss_pred             hCCchh
Confidence            997544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.94  E-value=5.6e-27  Score=244.62  Aligned_cols=139  Identities=38%  Similarity=0.626  Sum_probs=121.5

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC--------CC--eeEEEEEecCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL--------GG--ERLLVYEYLPNK  528 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl--------~~--~~~lv~Ey~~~g  528 (614)
                      .+.||+|+||+||+|.+.+...||||++.....  ...++|.+|+.+|.+++|||+        ..  ..++|||||++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            566999999999999997666699999975432  225689999999999999999        22  589999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceeecCC
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTFTMN  602 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~~~~  602 (614)
                      +|..+++.. +...+++..++.++.|||+||.|||++.+  ||||||||+|||++.++ .+||+|||+++.....
T Consensus       126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999764 45679999999999999999999999863  99999999999999997 9999999999987643

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.94  E-value=1.6e-28  Score=214.43  Aligned_cols=108  Identities=44%  Similarity=0.620  Sum_probs=79.4

Q ss_pred             CcEEEcCCCCCCCCC-CCeEEEEEcCCCcEEEEeCCCCcEEEe-eeecCC-cccEEEeccCCCEEEEeecCCCCccccee
Q 042853           86 RPVWIANRDTPVLRN-ESATLIIDSTDGNLKILRNGKSPIEIS-SVRRAG-NTTRATLLKNGNLVLYEMNSDGLSIRREL  162 (614)
Q Consensus        86 t~VW~ANr~~Pv~~~-~~~~l~l~~~~G~L~l~~~~g~~vwss-~~~~~~-~~~~a~LldsGNlVl~~~~~~~~~~~~~l  162 (614)
                      ||||+|||+.|+... ...+|.|.. ||+|+|.|..++++|++ ++...+ ....|.|+|+|||||++.   ..   .+|
T Consensus         3 tvvW~an~~~p~~~~s~~~~L~l~~-dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~---~~---~~l   75 (114)
T PF01453_consen    3 TVVWVANRNSPLTSSSGNYTLILQS-DGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS---SG---NVL   75 (114)
T ss_dssp             -------TTEEEEECETTEEEEEET-TSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET---TS---EEE
T ss_pred             ccccccccccccccccccccceECC-CCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee---cc---eEE
Confidence            889999999999532 248999999 99999999999999999 444433 468999999999999984   22   799


Q ss_pred             ceecCCCCCCcCCCCeeeeeecCCceEEEEecCCCCCc
Q 042853          163 WQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVS  200 (614)
Q Consensus       163 WQSFD~PTDTlLpg~~l~~~~~tg~~~~L~S~~s~~~~  200 (614)
                      ||||||||||+||||+|+.+..+|.+..++||++.+||
T Consensus        76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dp  113 (114)
T PF01453_consen   76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDP  113 (114)
T ss_dssp             EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS---
T ss_pred             EeecCCCccEEEeccCcccCCCccccceEEeECCCCCC
Confidence            99999999999999999988777766779999988763

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.3e-26  Score=238.50  Aligned_cols=152  Identities=30%  Similarity=0.504  Sum_probs=127.0

Q ss_pred             cCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC-----------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL-----------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~l  520 (614)
                      .+.|+.+++||+|.||.|||++. .+++.||+|++....  .....-..+||.+|++|+||||           ....||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            35677789999999999999986 478999999996543  3334456899999999999999           357899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+|||++ +|.-++...  .-.++..+...++.|++.||+|||.++   |+|||||.+|||||.++.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999987 676666332  234788999999999999999999987   9999999999999999999999999999998


Q ss_pred             CCccccCCCcee
Q 042853          601 MNELEANTNRIV  612 (614)
Q Consensus       601 ~~~~~~~~~~~~  612 (614)
                      ......-|++++
T Consensus       270 ~~~~~~~T~rVv  281 (560)
T KOG0600|consen  270 PSGSAPYTSRVV  281 (560)
T ss_pred             CCCCcccccceE
Confidence            776555566543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.1e-26  Score=233.50  Aligned_cols=150  Identities=29%  Similarity=0.436  Sum_probs=122.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcch-------hHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~-------~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      +.|.+.+.||+|+||.|-+|... +++.||||.+++.....       .....+|+++|++|+||||         ....
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45666799999999999999865 78999999997653211       1224699999999999999         4567


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEeecCc
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGM  595 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~---~~~kI~DFGl  595 (614)
                      |+|||||++|+|.+++-...   .+.+..-..+..|++.|+.|||+++   |+||||||+||||..+   ..+||+||||
T Consensus       252 YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999886433   3555556678999999999999998   9999999999999755   7799999999


Q ss_pred             ceeecCCccccCCCceecC
Q 042853          596 ARTFTMNELEANTNRIVGT  614 (614)
Q Consensus       596 a~~~~~~~~~~~~~~~~GT  614 (614)
                      ||......   ...+.|||
T Consensus       326 AK~~g~~s---fm~TlCGT  341 (475)
T KOG0615|consen  326 AKVSGEGS---FMKTLCGT  341 (475)
T ss_pred             hhccccce---ehhhhcCC
Confidence            99987433   34457777

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-26  Score=230.90  Aligned_cols=152  Identities=29%  Similarity=0.441  Sum_probs=128.4

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      .+.|++.+.||+|+||+||.++.. +++.+|+|.+++..   ....+..++|..+|.+++||.|         ..+++||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            367888999999999999999876 57889999998753   2345667899999999999999         6789999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +||+++|.|..+|.+.   ..+++....-++..|+.||.|||+.+   ||||||||+|||||++|+++|+||||+|.-..
T Consensus       104 ld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999543   34677666667778999999999988   99999999999999999999999999997654


Q ss_pred             CccccCCCceecC
Q 042853          602 NELEANTNRIVGT  614 (614)
Q Consensus       602 ~~~~~~~~~~~GT  614 (614)
                      ..  ..|.+++||
T Consensus       178 ~~--~~t~tfcGT  188 (357)
T KOG0598|consen  178 DG--DATRTFCGT  188 (357)
T ss_pred             CC--CccccccCC
Confidence            43  345558887

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=8.2e-26  Score=238.08  Aligned_cols=151  Identities=30%  Similarity=0.496  Sum_probs=132.8

Q ss_pred             CCCCccceeccCCceeEEEEEe-CCccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ..|...+.||+|+|+.||+++. ..|..+|+|.+.+.   +....+...+||++.+.|+||||         ..+.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            3577789999999999999998 78999999999764   34455678999999999999999         57899999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |+|++++|..++.   ++..+++.+...+..||+.||.|||+.+   |||||||..|++|++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999884   4567899999999999999999999987   999999999999999999999999999999866


Q ss_pred             ccccCCCceecC
Q 042853          603 ELEANTNRIVGT  614 (614)
Q Consensus       603 ~~~~~~~~~~GT  614 (614)
                      +....|  ++||
T Consensus       172 ~Erk~T--lCGT  181 (592)
T KOG0575|consen  172 GERKKT--LCGT  181 (592)
T ss_pred             ccccce--ecCC
Confidence            433333  7887

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-26  Score=239.81  Aligned_cols=140  Identities=34%  Similarity=0.556  Sum_probs=123.3

Q ss_pred             ccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          460 PANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       460 ~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ..+.||+|.||.|+.|.+.....||||.++.. ....+.|.+|+++|++|+|+||         ...++||||||++|+|
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            36899999999999999988889999999763 3445789999999999999999         3458999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCcc
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL  604 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~  604 (614)
                      ..||... ....+...+.+.++.|||+||+||+++.   +|||||.++|||++++..+||+||||||.+..++.
T Consensus       289 l~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  289 LDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             HHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            9999762 3456788899999999999999999987   99999999999999999999999999996555443

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.93  E-value=2.9e-25  Score=195.43  Aligned_cols=115  Identities=42%  Similarity=0.622  Sum_probs=97.7

Q ss_pred             CccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEEEcCCCCC
Q 042853           17 QVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTP   96 (614)
Q Consensus        17 ~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW~ANr~~P   96 (614)
                      ++|++|++|+|+++.|++|||.+......+++|||.                        +     .+.++||.||++.|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~------------------------~-----~~~~~vW~snt~~~   52 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYK------------------------G-----SSRTVVWVANRDNP   52 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEe------------------------C-----CCCeEEEECCCCCC
Confidence            578899999999999999999987643499999998                        3     22378999999999


Q ss_pred             CCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCC
Q 042853           97 VLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYP  169 (614)
Q Consensus        97 v~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~P  169 (614)
                      .. . .+.|.|.+ +|+|+|.|.+|.++|+|++.......+|+|+|+|||||++.   ++   .++|||||||
T Consensus        53 ~~-~-~~~l~l~~-dGnLvl~~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~---~~---~~~W~Sf~~P  116 (116)
T cd00028          53 SG-S-SCTLTLQS-DGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDS---DG---NFLWQSFDYP  116 (116)
T ss_pred             CC-C-CEEEEEec-CCCeEEEcCCCcEEEEecccCCCCceEEEEeCCCCEEEECC---CC---CEEEcCCCCC
Confidence            54 3 58999998 99999999999999999987522356889999999999985   32   6899999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.93  E-value=8.8e-26  Score=225.60  Aligned_cols=148  Identities=28%  Similarity=0.381  Sum_probs=124.4

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CC-eeEEEEEec
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GG-ERLLVYEYL  525 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~-~~~lv~Ey~  525 (614)
                      ++..+.||+|..|+|||+.++ +++.+|+|.+... .....++..+|++++.+.+||+|         .. +..++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344689999999999999997 6778899999543 33456789999999999999999         34 589999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCccc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE  605 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~~  605 (614)
                      .+|||+.++...   +.+++...-+|+.+|++||.|||+.  .+||||||||+|||++..+++||||||.++.+...  .
T Consensus       161 DgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~  233 (364)
T KOG0581|consen  161 DGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I  233 (364)
T ss_pred             CCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence            999999998543   4478888899999999999999973  25999999999999999999999999999988654  2


Q ss_pred             cCCCceecC
Q 042853          606 ANTNRIVGT  614 (614)
Q Consensus       606 ~~~~~~~GT  614 (614)
                      +  ++.+||
T Consensus       234 a--~tfvGT  240 (364)
T KOG0581|consen  234 A--NTFVGT  240 (364)
T ss_pred             c--cccccc
Confidence            2  235665

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.92  E-value=5.4e-26  Score=243.47  Aligned_cols=142  Identities=30%  Similarity=0.542  Sum_probs=125.1

Q ss_pred             CCCccceeccCCceeEEEEEeC----CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ...+.+.||.|.||.|++|.++    ....||||.|+... +++..+|+.|+.+|++++||||         ....++|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4456789999999999999986    23579999998653 4566789999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |||+||+|+.||....  ..+.+.+...|.++||.||.||.+++   .|||||.++|||++.+..+||+||||+|.+..+
T Consensus       710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999997544  45889999999999999999999987   999999999999999999999999999988654


Q ss_pred             c
Q 042853          603 E  603 (614)
Q Consensus       603 ~  603 (614)
                      .
T Consensus       785 ~  785 (996)
T KOG0196|consen  785 P  785 (996)
T ss_pred             C
Confidence            4

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=3.5e-25  Score=226.17  Aligned_cols=148  Identities=30%  Similarity=0.506  Sum_probs=125.4

Q ss_pred             CccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHh--cCCCCC-------------CCeeEEEEE
Q 042853          459 SPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNL-------------GGERLLVYE  523 (614)
Q Consensus       459 ~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~nl-------------~~~~~lv~E  523 (614)
                      +..+.||+|.||.||||++.+ +.||||++..   +..+.|.+|-.+.+.  ++|+||             ..+++||+|
T Consensus       213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            446889999999999999964 8999999953   556778888887765  589999             238899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS------RLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      |.++|+|.+||.    ...++|....+|+..+++||+|||+.-      +++|+|||||.+|||+.+++.+.|+|||||.
T Consensus       289 fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  289 FHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            999999999994    346899999999999999999999743      4679999999999999999999999999999


Q ss_pred             eecCCccccCCCceecC
Q 042853          598 TFTMNELEANTNRIVGT  614 (614)
Q Consensus       598 ~~~~~~~~~~~~~~~GT  614 (614)
                      .+..+.....+...+||
T Consensus       365 ~~~p~~~~~d~~~qVGT  381 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGT  381 (534)
T ss_pred             EecCCCCCcchhhhhhh
Confidence            99876655444445666

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.92  E-value=4.3e-25  Score=213.91  Aligned_cols=138  Identities=27%  Similarity=0.408  Sum_probs=117.1

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chh-HhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGI-VEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~-~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .|+...++|+|+||+|||++.+ +|+.||||++..... +.+ +-.++|+++|+.++|+|+         ....+||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            4666789999999999999987 689999999965433 333 346899999999999999         5688999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++..-|+++-. .  ..-++.....+++.|+++|+.|+|.+.   ||||||||+||||..++.+||||||+||.+.
T Consensus        83 ~dhTvL~eLe~-~--p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   83 CDHTVLHELER-Y--PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             cchHHHHHHHh-c--cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc
Confidence            99876655432 1  223677888899999999999999987   9999999999999999999999999999987

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.92  E-value=2e-24  Score=206.13  Aligned_cols=141  Identities=33%  Similarity=0.541  Sum_probs=120.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-ch-hHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QG-IVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~-~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|...++||+|.||.||+|... +++.||||+++.... ++ .....+|+++|+.++|+|+         ....-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35666789999999999999874 789999999975422 22 3457899999999999999         567889999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+. +|...+.+.  ...+.-.+...++.++.+||+|||.+.   |+||||||.|+|+++++.+||+||||||.+...
T Consensus        82 fm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9975 888888653  346788888899999999999999886   999999999999999999999999999998643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-24  Score=225.71  Aligned_cols=143  Identities=31%  Similarity=0.426  Sum_probs=123.2

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~l  520 (614)
                      .++|...+.||+|+|++|++++.. .++++|||.+.+.   .....+....|-..|.+| .||-+         ...+|.
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            456777899999999999999875 6789999999764   223344567788899999 89998         567899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+||+++|+|..+|...   +.++......++.+|+.||+|||..+   ||||||||+|||||.+|++||+|||-||.+.
T Consensus       152 vLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            99999999999999654   45788888889999999999999988   9999999999999999999999999999996


Q ss_pred             CCc
Q 042853          601 MNE  603 (614)
Q Consensus       601 ~~~  603 (614)
                      ..+
T Consensus       226 ~~~  228 (604)
T KOG0592|consen  226 PSQ  228 (604)
T ss_pred             hhh
Confidence            543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.91  E-value=1.4e-24  Score=237.16  Aligned_cols=152  Identities=32%  Similarity=0.529  Sum_probs=130.1

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------  514 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------  514 (614)
                      .++.+.+....++||+|+||+||+|+..      +.+.||||.|+..... ...+|++|++++++++|+||         
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            3444556666899999999999999864      3467999999876544 77899999999999999999         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSS-------R----KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD  583 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld  583 (614)
                      ++..++|+|||.+|||.+||.-..       .    ..+|+..+.+.||.|||.||+||-++.   +|||||..+|+|+.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence            678899999999999999996321       1    234888999999999999999999876   99999999999999


Q ss_pred             CCCcEEEeecCcceeecCCccc
Q 042853          584 EQMNPKISDFGMARTFTMNELE  605 (614)
Q Consensus       584 ~~~~~kI~DFGla~~~~~~~~~  605 (614)
                      +++.|||+||||+|.+...+..
T Consensus       638 e~l~VKIsDfGLsRdiYssDYY  659 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYY  659 (774)
T ss_pred             cceEEEecccccchhhhhhhhh
Confidence            9999999999999988766644

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.91  E-value=2.4e-24  Score=208.44  Aligned_cols=148  Identities=30%  Similarity=0.418  Sum_probs=127.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|+....||.|+||.|...+.+ ++..+|+|.|++..   .++.+...+|..+|+.+.||.+         ..+.++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45677899999999999999886 56788999998653   2345567889999999999998         57899999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||.++|.|.++|...   ..++......+|.+|+.||+|||+..   ||+|||||+|||||.+|.+||+|||+||.+...
T Consensus       124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            999999999999644   34777888889999999999999987   999999999999999999999999999988632


Q ss_pred             ccccCCCceecC
Q 042853          603 ELEANTNRIVGT  614 (614)
Q Consensus       603 ~~~~~~~~~~GT  614 (614)
                           |-+++||
T Consensus       198 -----T~TlCGT  204 (355)
T KOG0616|consen  198 -----TWTLCGT  204 (355)
T ss_pred             -----EEEecCC
Confidence                 4457776

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=3.1e-25  Score=212.90  Aligned_cols=156  Identities=28%  Similarity=0.420  Sum_probs=129.4

Q ss_pred             CCCccceeccCCceeEEEEEe-CCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC----------CCe-eEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL----------GGE-RLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl----------~~~-~~lv~  522 (614)
                      .|++.++||+|+||.|||+.. .++..+|.|.+.-.  ..+..+....|+.+|+.|+||||          ..+ +.|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            466689999999999999975 58899999998632  23445678999999999999999          234 78999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYS-RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+..|+|...+...+ ....++++...++..|+++||..+|..- +.-|+||||||.||+|+.++.+||.||||+|.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            9999999999987643 3456899999999999999999999832 1239999999999999999999999999999998


Q ss_pred             CCccccCCCceecC
Q 042853          601 MNELEANTNRIVGT  614 (614)
Q Consensus       601 ~~~~~~~~~~~~GT  614 (614)
                      .+...+  ...|||
T Consensus       180 s~~tfA--~S~VGT  191 (375)
T KOG0591|consen  180 SKTTFA--HSLVGT  191 (375)
T ss_pred             chhHHH--HhhcCC
Confidence            665433  336777

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.91  E-value=1.7e-24  Score=212.36  Aligned_cols=141  Identities=29%  Similarity=0.468  Sum_probs=118.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcc-h-hHhHHHHHHHHHhcCCCCC-----------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQ-G-IVEFKNEAKLIAKLQHTNL-----------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-~-~~~f~~E~~~l~~l~H~nl-----------~~~~~lv  521 (614)
                      +.|+..+.|++|.||.||+|+.. ++..||.|+++..... + -..-.+|+.+|.+++||||           .+..++|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45777899999999999999986 5678999999754321 1 1235889999999999999           3578999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||||++ +|...+..-.  ..+...+...+..|+++|++|||.+.   |+||||||+|+|+.+.|.+||+||||||.+..
T Consensus       156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999987 7888875433  45677888889999999999999886   99999999999999999999999999998864


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus       230 p  230 (419)
T KOG0663|consen  230 P  230 (419)
T ss_pred             C
Confidence            3

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=1.1e-23  Score=184.82  Aligned_cols=113  Identities=41%  Similarity=0.629  Sum_probs=96.2

Q ss_pred             CccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEEEcCCCCC
Q 042853           17 QVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRDTP   96 (614)
Q Consensus        17 ~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW~ANr~~P   96 (614)
                      +.|+.+++|+|+++.|++|||.+.. ...+++|||.                        .     .+.++||+|||+.|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~-q~dgnlV~~~------------------------~-----~~~~~vW~snt~~~   51 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIM-QNDYNLILYK------------------------S-----SSRTVVWVANRDNP   51 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCC-CCCEEEEEEE------------------------C-----CCCcEEEECCCCCC
Confidence            5688999999999999999999875 5799999998                        2     22378999999999


Q ss_pred             CCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCC
Q 042853           97 VLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDY  168 (614)
Q Consensus        97 v~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~  168 (614)
                      +..+  ..|.+.+ +|+|+|.|.+|.++|+|++.......+|+|+|+|||||++.   .+   .++||||||
T Consensus        52 ~~~~--~~l~l~~-dGnLvl~~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~---~~---~~~W~Sf~~  114 (114)
T smart00108       52 VSDS--CTLTLQS-DGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDS---DG---NFLWQSFDY  114 (114)
T ss_pred             CCCC--EEEEEeC-CCCEEEEeCCCCEEEEecccCCCCceEEEEeCCCCEEEECC---CC---CEEeCCCCC
Confidence            8653  8899998 99999999999999999986323356899999999999984   22   699999997

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=1.4e-24  Score=216.99  Aligned_cols=142  Identities=30%  Similarity=0.513  Sum_probs=125.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .+|++.+.||+|.||+|-++.. ..+++||||.+++..   .+....+++|+++|..|+||||         .+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            3567779999999999999976 578999999997753   3455668999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||..+|.|.+|+.+.   ..|++.+...+..||..|+.|+|.+.   ++|||||.+|||||.++++||+||||+-.+..+
T Consensus       133 EYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            999999999999543   45899999999999999999999886   999999999999999999999999999887654


Q ss_pred             c
Q 042853          603 E  603 (614)
Q Consensus       603 ~  603 (614)
                      .
T Consensus       207 k  207 (668)
T KOG0611|consen  207 K  207 (668)
T ss_pred             c
Confidence            3

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.90  E-value=2.3e-24  Score=226.20  Aligned_cols=144  Identities=31%  Similarity=0.569  Sum_probs=125.6

Q ss_pred             hhhHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC--------CCe
Q 042853          448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL--------GGE  517 (614)
Q Consensus       448 ~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl--------~~~  517 (614)
                      .+++.+..+.+.+.+.||+|+||+||+|.+.+  .||||.|+..  ..+..++|++|+.++++.+|.||        ...
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            35566666677778999999999999999964  5999999754  34577899999999999999999        456


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      ..+|..+|++.+|..+|+...  ..++..+...||.|||+||.|||.+.   |||||||..||+|.+++.|||.|||||.
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             eeeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence            699999999999999997543  45788888999999999999999987   9999999999999999999999999986


Q ss_pred             e
Q 042853          598 T  598 (614)
Q Consensus       598 ~  598 (614)
                      .
T Consensus       537 v  537 (678)
T KOG0193|consen  537 V  537 (678)
T ss_pred             e
Confidence            4

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.1e-24  Score=226.38  Aligned_cols=141  Identities=32%  Similarity=0.493  Sum_probs=121.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeCC--c--cE-EEEEEccC---CCcchhHhHHHHHHHHHhcCCCCC---------CCe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQD--E--QE-IAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL---------GGE  517 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~--~--~~-vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nl---------~~~  517 (614)
                      -++....++||+|+||.||+|++..  +  .. ||||..+.   .......+|++|+++|++++|+|+         ...
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3444556899999999999999863  2  23 89999874   235678899999999999999999         567


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      ++||||+|++|+|+++|....  ..++..+++.++.+.|.||+|||+..   +|||||.++|+|++.+..+||+||||++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            899999999999999996543  25899999999999999999999987   9999999999999999999999999988


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      .-.
T Consensus       311 ~~~  313 (474)
T KOG0194|consen  311 AGS  313 (474)
T ss_pred             CCc
Confidence            653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-23  Score=211.08  Aligned_cols=140  Identities=31%  Similarity=0.491  Sum_probs=121.7

Q ss_pred             CCCccceeccCCceeEEEEEeCC-ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----C-----C--eeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----G-----G--ERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----~-----~--~~~lv~Ey  524 (614)
                      ++...+.||+|+||.||++...+ +...|||.+........+.+.+|+.+|.+++||||    +     .  .+++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            34557899999999999999864 78899999876533336678999999999999999    2     2  58999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-QMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-~~~~kI~DFGla~~~~~  601 (614)
                      +++|+|..++.....  .+++.....++.||++||.|||+++   ||||||||+||||+. ++.+||+|||+|+....
T Consensus        98 ~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999976543  5899999999999999999999887   999999999999999 79999999999998764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.6e-24  Score=220.08  Aligned_cols=141  Identities=33%  Similarity=0.477  Sum_probs=121.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhH--HHHHHHHHhcC-CCCC---------C-CeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEF--KNEAKLIAKLQ-HTNL---------G-GERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f--~~E~~~l~~l~-H~nl---------~-~~~~lv  521 (614)
                      ++|...++||.|.||.||+|+-. ++..||||++++.-.. .+|.  .+|+.-|++|+ ||||         . ..+++|
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            56777899999999999999864 7888999999764322 3333  67999999999 9999         2 378999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||||+. +|.+++.+.  ..++++.....|+.||.+||+|+|.++   +.||||||+|||+.....+||+||||||.+..
T Consensus        89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence            999965 788888654  567999999999999999999999998   99999999999999888999999999998865


Q ss_pred             Cc
Q 042853          602 NE  603 (614)
Q Consensus       602 ~~  603 (614)
                      ..
T Consensus       163 kp  164 (538)
T KOG0661|consen  163 KP  164 (538)
T ss_pred             CC
Confidence            44

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-23  Score=214.14  Aligned_cols=142  Identities=30%  Similarity=0.463  Sum_probs=120.5

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--------------chhHhHHHHHHHHHhcCCCCC--
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--------------QGIVEFKNEAKLIAKLQHTNL--  514 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--------------~~~~~f~~E~~~l~~l~H~nl--  514 (614)
                      .+..++|.+...||+|.||+|-++... +++.+|||.+.+...              ...+...+|+.+|++++|+|+  
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            344578999999999999999999875 688999999965411              012467899999999999999  


Q ss_pred             ---------CCeeEEEEEecCCCCHHHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 042853          515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE  584 (614)
Q Consensus       515 ---------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~  584 (614)
                               ....|||+|||..|.+...    ....+ +...+..++..++..||+|||.++   ||||||||+|+||++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence                     4688999999999986432    22333 889999999999999999999987   999999999999999


Q ss_pred             CCcEEEeecCcceeec
Q 042853          585 QMNPKISDFGMARTFT  600 (614)
Q Consensus       585 ~~~~kI~DFGla~~~~  600 (614)
                      ++.+||+|||.+-.+.
T Consensus       246 ~g~VKIsDFGVs~~~~  261 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFP  261 (576)
T ss_pred             CCcEEeeccceeeecc
Confidence            9999999999999874

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.90  E-value=1.1e-23  Score=218.57  Aligned_cols=150  Identities=31%  Similarity=0.511  Sum_probs=127.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+..  .+..+.+.+|++++++++||||         ..+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777899999999999999876 56889999997653  3345678999999999999999         578999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      |+.+ +|..+|.+.   ..+++.....++.++..||.|||+..   |+|||+||+||||+..+.+|+||||+||.+..+.
T Consensus        82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 999998543   35889999999999999999999986   9999999999999999999999999999987543


Q ss_pred             cccCCCceecC
Q 042853          604 LEANTNRIVGT  614 (614)
Q Consensus       604 ~~~~~~~~~GT  614 (614)
                      . . ..++.||
T Consensus       155 ~-v-ltsikGt  163 (808)
T KOG0597|consen  155 S-V-LTSIKGT  163 (808)
T ss_pred             e-e-eeeccCc
Confidence            2 2 2235565

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.89  E-value=3.3e-23  Score=215.29  Aligned_cols=144  Identities=26%  Similarity=0.405  Sum_probs=125.1

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCe
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGE  517 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~  517 (614)
                      .....++|+.+..||+|+||.||.++-+ +|..+|+|+|++..   ..+++..+.|-.+|...+++.+         ...
T Consensus       136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            3456688999999999999999999876 67889999998763   3345667889999999999998         678


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      +||||||+|+|++..+|-   +...|+......++.+.+.|++-||+.+   +|||||||+|+|||..|++||+||||++
T Consensus       216 LYLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             eEEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence            999999999999999984   4456888777778888999999999988   9999999999999999999999999997


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      -+.
T Consensus       290 gl~  292 (550)
T KOG0605|consen  290 GLD  292 (550)
T ss_pred             hhh
Confidence            553

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.89  E-value=4.3e-23  Score=216.79  Aligned_cols=146  Identities=27%  Similarity=0.425  Sum_probs=121.1

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC----------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL----------  514 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl----------  514 (614)
                      ++.++|.+.+.||+|+||.||+|...      .+..||||.+.... ......+.+|+.++.++ +|||+          
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            44567888999999999999999742      34679999997543 23346789999999999 89998          


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCC-------------------------------------------------------
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSR-------------------------------------------------------  539 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~-------------------------------------------------------  539 (614)
                      ....++||||+++|+|..++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            2357899999999999998864211                                                       


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          540 ----KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       540 ----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                          ...+++.+...++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~  226 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK  226 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence                134778888999999999999999886   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=6.8e-23  Score=215.73  Aligned_cols=141  Identities=28%  Similarity=0.435  Sum_probs=121.7

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC----Cc-chhHhHHHHHHHHHhcC-CCCC---------CCe
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS----SG-QGIVEFKNEAKLIAKLQ-HTNL---------GGE  517 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~----~~-~~~~~f~~E~~~l~~l~-H~nl---------~~~  517 (614)
                      ..++|...+.||+|+||+|+.|... ++..||||.+.+.    .. ...+.+.+|+.++++++ ||||         ...
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3467888899999999999999875 6789999977653    11 23445678999999999 9999         567


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEeecCcc
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-MNPKISDFGMA  596 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-~~~kI~DFGla  596 (614)
                      .++||||+.+|+|.+++.+   ...+.+.+...+..|++.|++|||..+   |+||||||+|||||.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999965   345777888899999999999999987   9999999999999999 99999999999


Q ss_pred             eeec
Q 042853          597 RTFT  600 (614)
Q Consensus       597 ~~~~  600 (614)
                      ....
T Consensus       169 ~~~~  172 (370)
T KOG0583|consen  169 AISP  172 (370)
T ss_pred             cccC
Confidence            9884

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-23  Score=217.63  Aligned_cols=149  Identities=26%  Similarity=0.470  Sum_probs=128.1

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .+.+.....++||+|.||.|..++...+..||||+++..... ...+|..|+++|.+++||||         .+.+++|+
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            445566678999999999999999988899999999865443 45889999999999999999         56788999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |||++|+|..|+..+.... ++-..-.+|+.|||.||+||.+..   +|||||.++|||+|.++++||+|||++|.+..+
T Consensus       615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999997553222 455667789999999999999865   999999999999999999999999999988766


Q ss_pred             ccc
Q 042853          603 ELE  605 (614)
Q Consensus       603 ~~~  605 (614)
                      +..
T Consensus       691 ~yy  693 (807)
T KOG1094|consen  691 DYY  693 (807)
T ss_pred             Cce
Confidence            644

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=6.5e-23  Score=214.61  Aligned_cols=150  Identities=32%  Similarity=0.492  Sum_probs=130.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ..|....+||+|+.|.||.+... ++++||||++........+-..+|+.+|+..+|+|+         .+++++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            44566689999999999999764 678999999987555555567899999999999999         67899999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCccc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE  605 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~~  605 (614)
                      ++|+|.+.+.    ...+++.+...|+.++++||+|||.++   |||||||.+||||+.++.+||+|||++..+...+..
T Consensus       353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            9999988873    334889999999999999999999987   999999999999999999999999999998876654


Q ss_pred             cCCCceecC
Q 042853          606 ANTNRIVGT  614 (614)
Q Consensus       606 ~~~~~~~GT  614 (614)
                      +.  +++||
T Consensus       426 R~--TmVGT  432 (550)
T KOG0578|consen  426 RS--TMVGT  432 (550)
T ss_pred             cc--cccCC
Confidence            33  37887

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.88  E-value=1.1e-22  Score=203.12  Aligned_cols=140  Identities=29%  Similarity=0.542  Sum_probs=115.5

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-ch-hHhHHHHHHHHHhcCCCC-C---------CC------e
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QG-IVEFKNEAKLIAKLQHTN-L---------GG------E  517 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~-~~~f~~E~~~l~~l~H~n-l---------~~------~  517 (614)
                      .|...++||+|.||+||+|+.. +++.||+|++.-... ++ -....+|+.++++++|+| +         ..      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            3455688999999999999876 778999999965433 22 234589999999999999 6         22      6


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRK-SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      .+||+||+. -+|..++...... ..++-.....++.||++||+|||+++   |+||||||+||||++.+.+||+|||+|
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence            789999995 4888888654421 34566778889999999999999987   999999999999999999999999999


Q ss_pred             eeec
Q 042853          597 RTFT  600 (614)
Q Consensus       597 ~~~~  600 (614)
                      +.+.
T Consensus       168 ra~~  171 (323)
T KOG0594|consen  168 RAFS  171 (323)
T ss_pred             HHhc
Confidence            9765

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2.8e-23  Score=195.65  Aligned_cols=142  Identities=31%  Similarity=0.443  Sum_probs=122.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      .++|++.+.||+|-||.||.|+.+ ++-.||+|.+.+.   ..+...++.+|+++-..|+||||         ....+|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            357888999999999999999876 5678999999764   23345679999999999999999         5678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +||.+.|+|...|.+.. ...++......++.|+|.||.|+|...   ||||||||+|+|++..+..||+|||-+..-.
T Consensus       101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            99999999999997543 334677778889999999999999876   9999999999999999999999999987654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=9.5e-23  Score=207.04  Aligned_cols=151  Identities=26%  Similarity=0.415  Sum_probs=126.7

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHh--cCCCCC-------------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNL-------------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~nl-------------~~~~~l  520 (614)
                      ......+.||+|.||.|++|.+. |..||||.+..   ..+..+.+|.++...  |+|+||             -.+++|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            45667899999999999999996 56799999964   344567788887755  699999             247899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK-----YSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      |.||.++|||.+||.    ...++-...++++..+|.||++||-     +++|.|.|||||.+|||+..++.+.|+|+||
T Consensus       287 vTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             eeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            999999999999994    3568889999999999999999994     6788999999999999999999999999999


Q ss_pred             ceeecCCc--cccCCCceecC
Q 042853          596 ARTFTMNE--LEANTNRIVGT  614 (614)
Q Consensus       596 a~~~~~~~--~~~~~~~~~GT  614 (614)
                      |.....+.  .....+..|||
T Consensus       363 Av~h~~~t~~idi~~N~rVGT  383 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGT  383 (513)
T ss_pred             eEEecccCCcccCCCCCccce
Confidence            99876543  22345556776

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.88  E-value=3.3e-22  Score=206.75  Aligned_cols=143  Identities=26%  Similarity=0.464  Sum_probs=119.6

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-----------------ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-----------------EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---  514 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-----------------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---  514 (614)
                      ++|...++||+|+||.||++...+                 +..||+|.+.... .....+|.+|++++.+++|+|+   
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467778999999999999997532                 2369999986542 2345679999999999999998   


Q ss_pred             ------CCeeEEEEEecCCCCHHHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 042853          515 ------GGERLLVYEYLPNKSLDFFIFDSS----------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH  572 (614)
Q Consensus       515 ------~~~~~lv~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH  572 (614)
                            ....++||||+++|+|..++....                ....++|.....++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence                  456799999999999999885421                1134688889999999999999999987   999


Q ss_pred             cCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          573 RDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       573 rDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||||+|||++.++.+||+|||+++.+..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~  190 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYA  190 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceeccc
Confidence            99999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.88  E-value=2.6e-22  Score=213.54  Aligned_cols=144  Identities=24%  Similarity=0.322  Sum_probs=123.0

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCe
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGE  517 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~  517 (614)
                      +....++|...+.||+|+||.||++... +++.+|+|.+.+.   .......+.+|+.+++.++|||+         ...
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3344577888999999999999999986 5778999998642   22234568899999999999999         567


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++||||+++|+|..++...    .+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+|+
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence            89999999999999988432    3678888899999999999999987   9999999999999999999999999999


Q ss_pred             eecC
Q 042853          598 TFTM  601 (614)
Q Consensus       598 ~~~~  601 (614)
                      .+..
T Consensus       191 ~~~~  194 (370)
T cd05621         191 KMDE  194 (370)
T ss_pred             eccc
Confidence            8753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.88  E-value=3.3e-22  Score=212.27  Aligned_cols=139  Identities=23%  Similarity=0.387  Sum_probs=120.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|+..+.||+|+||+||++... +++.+|||.+.+..   ......+..|+.++.+++|+|+         ....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46788899999999999999876 57899999996532   2334568889999999999999         45789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++|+|..++...   ..+++.....++.|++.||+|||+.+   ||||||||+|||++.++.+||+|||+|+.+.
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            999999999998542   45889999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-22  Score=229.60  Aligned_cols=148  Identities=34%  Similarity=0.563  Sum_probs=126.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeCC--c----cEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQD--E----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~--~----~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      ..+....+.||+|.||.||+|...+  +    ..||||.+++. +.+.+.+|.+|..+|++++|||+         ....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3445567899999999999998752  2    35899999875 45667789999999999999999         5678


Q ss_pred             EEEEEecCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          519 LLVYEYLPNKSLDFFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                      ++++|||++|+|..||.+..    ....|..+..+.++.|||+|+.||+++.   +|||||.++|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997652    1346888999999999999999999987   9999999999999999999999999


Q ss_pred             cceeecCCccc
Q 042853          595 MARTFTMNELE  605 (614)
Q Consensus       595 la~~~~~~~~~  605 (614)
                      |||.+.+.+..
T Consensus       848 lArDiy~~~yy  858 (1025)
T KOG1095|consen  848 LARDIYDKDYY  858 (1025)
T ss_pred             hhHhhhhchhe
Confidence            99977655543

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.87  E-value=1.9e-22  Score=215.68  Aligned_cols=148  Identities=32%  Similarity=0.487  Sum_probs=125.0

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------------CCeeEEEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------------GGERLLVYE  523 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------------~~~~~lv~E  523 (614)
                      .+.||+|+||.||+|+.+ +|..||||...+.. ....+....|+++|++++|+||               .....+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            578999999999999965 89999999987643 2334567899999999999999               245789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCc--EEEeecCcceee
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD--EQMN--PKISDFGMARTF  599 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld--~~~~--~kI~DFGla~~~  599 (614)
                      ||++|||...|.+..+..-|+..+.+.+..+++.||.|||+++   ||||||||.||++-  +++.  -||+|||.||.+
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            9999999999987777677999999999999999999999887   99999999999983  3333  599999999999


Q ss_pred             cCCccccCCCceecC
Q 042853          600 TMNELEANTNRIVGT  614 (614)
Q Consensus       600 ~~~~~~~~~~~~~GT  614 (614)
                      ..++.   -..++||
T Consensus       175 ~d~s~---~~S~vGT  186 (732)
T KOG4250|consen  175 DDNSL---FTSLVGT  186 (732)
T ss_pred             CCCCe---eeeecCc
Confidence            86652   2237777

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.87  E-value=4.5e-23  Score=205.77  Aligned_cols=139  Identities=32%  Similarity=0.486  Sum_probs=109.3

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CC---eeEEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GG---ERLLVY  522 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~---~~~lv~  522 (614)
                      |...+++|.|+||.||+|.+. +++.||||+.-....    .--.|+++|++++||||           ..   ...|||
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            444689999999999999986 568999999854322    22469999999999999           22   245799


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-MNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-~~~kI~DFGla~~~~  600 (614)
                      ||||. +|...+.+.. ....++.....-+.-||.+||.|||+.+   |+||||||+|||+|.+ +.+||||||-||.+.
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            99987 7777775421 1233454555557889999999999976   9999999999999966 889999999999997


Q ss_pred             CCcc
Q 042853          601 MNEL  604 (614)
Q Consensus       601 ~~~~  604 (614)
                      .++.
T Consensus       178 ~~ep  181 (364)
T KOG0658|consen  178 KGEP  181 (364)
T ss_pred             cCCC
Confidence            6653

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.8e-22  Score=212.07  Aligned_cols=154  Identities=28%  Similarity=0.428  Sum_probs=128.2

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcC-CCCC---------CCe
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQ-HTNL---------GGE  517 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~-H~nl---------~~~  517 (614)
                      ....++|....+||+|+||+|+.+.++ +++.+|||.+++..   ....+..+.|.+++.... ||.|         ..+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            445578888999999999999999987 56778999998863   445667888988887775 9988         678


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      ++.||||+.+|++..+.    ....++.....-++..|+.||.|||+++   ||+||||.+|||||.+|.+||+||||+|
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999943332    3345788888889999999999999998   9999999999999999999999999999


Q ss_pred             eecCCccccCCCceecC
Q 042853          598 TFTMNELEANTNRIVGT  614 (614)
Q Consensus       598 ~~~~~~~~~~~~~~~GT  614 (614)
                      .-....  ..|.+++||
T Consensus       517 e~m~~g--~~TsTfCGT  531 (694)
T KOG0694|consen  517 EGMGQG--DRTSTFCGT  531 (694)
T ss_pred             ccCCCC--CccccccCC
Confidence            765333  246679998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=6.8e-22  Score=203.28  Aligned_cols=139  Identities=26%  Similarity=0.395  Sum_probs=120.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|+..+.||+|+||.||++... +++.+|+|.+....   .+..+.+.+|+.++++++|||+         ....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36777899999999999999986 67889999986432   2345568899999999999998         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++|+|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            999999999988543   35788888999999999999999987   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=4.6e-22  Score=211.16  Aligned_cols=139  Identities=26%  Similarity=0.425  Sum_probs=121.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||+||++... +++.||||.+.+.   .......+.+|+.++..++|+|+         ....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888899999999999999986 6789999999653   12344568899999999999998         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++|+|..++...   ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            999999999988542   35788999999999999999999987   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.87  E-value=5.1e-22  Score=211.38  Aligned_cols=142  Identities=25%  Similarity=0.334  Sum_probs=121.1

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      ...++|+..+.||+|+||.||++... +++.+|+|.+.+.   .......+.+|+.+++.++|+|+         ....+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34567888999999999999999886 5788999998642   12334457899999999999999         45789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++|+|..++...    .++......++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999988532    3677778889999999999999986   999999999999999999999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       193 ~~  194 (370)
T cd05596         193 DA  194 (370)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.87  E-value=9.7e-22  Score=205.28  Aligned_cols=132  Identities=27%  Similarity=0.383  Sum_probs=114.6

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~g  528 (614)
                      +.||+|+||.||++... +++.+|+|.+++..   ......+..|+.++.+++|+|+         ....++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999875 67899999986532   2334567889999999999999         46789999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +|..++..   ...+++.+...++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            99888853   235788899999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.87  E-value=1.3e-21  Score=200.49  Aligned_cols=140  Identities=28%  Similarity=0.412  Sum_probs=119.8

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      |...+.||+|+||.||++... +++.+|||.+.+..   .+....+.+|+.++.+++|+|+         ....++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            566789999999999999875 78899999986432   2234467899999999999998         4578999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++|+|..++.... ...+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            99999988875432 235789999999999999999999986   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=7.5e-22  Score=210.68  Aligned_cols=138  Identities=26%  Similarity=0.392  Sum_probs=119.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.+|||.+.+.   ..+...++.+|++++.+++|+|+         ....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36778899999999999999875 6788999998643   22345678899999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||+++|+|..++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999988532   35788888889999999999999987   999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.87  E-value=7.6e-22  Score=210.95  Aligned_cols=137  Identities=26%  Similarity=0.384  Sum_probs=119.0

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .|...+.||+|+||+||++... +++.+|||.+.+.   .......+.+|+.++.+++|+|+         ....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5777899999999999999875 5788999999653   22345678999999999999999         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+++|+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999988543   34788888889999999999999886   999999999999999999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.87  E-value=9.7e-22  Score=209.28  Aligned_cols=146  Identities=23%  Similarity=0.312  Sum_probs=124.0

Q ss_pred             hhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------C
Q 042853          449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------G  515 (614)
Q Consensus       449 ~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~  515 (614)
                      .++....++|.+.+.||+|+||.||++... +++.+|+|.+.+.   .......+.+|+.++..++|||+         .
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555688999999999999999999986 5778999998642   12234557889999999999999         4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      ...++||||+++|+|..++...    .++......++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            6789999999999999988432    3677888889999999999999987   99999999999999999999999999


Q ss_pred             ceeecC
Q 042853          596 ARTFTM  601 (614)
Q Consensus       596 a~~~~~  601 (614)
                      |+.+..
T Consensus       189 a~~~~~  194 (371)
T cd05622         189 CMKMNK  194 (371)
T ss_pred             eeEcCc
Confidence            987754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.7e-21  Score=204.24  Aligned_cols=141  Identities=23%  Similarity=0.323  Sum_probs=121.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||.||++... +++.+|+|.+.+.   .....+.|.+|+.++..++|+|+         ....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46788899999999999999976 5789999998642   22234568899999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++|+|..++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999988542  234788888899999999999999987   99999999999999999999999999987653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.87  E-value=1.3e-21  Score=204.76  Aligned_cols=132  Identities=27%  Similarity=0.389  Sum_probs=115.0

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~g  528 (614)
                      +.||+|+||.||++... +++.+|||.+.+.   ......++.+|+.+++.++|||+         ....++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999875 6789999999653   22345678899999999999998         46789999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +|..++..   ...+++.+...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            99888753   235789999999999999999999886   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1e-21  Score=205.96  Aligned_cols=139  Identities=25%  Similarity=0.421  Sum_probs=121.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||.||++... +++.||||.+++..   ......+..|+.++..++|+|+         ....++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36788899999999999999986 57899999986532   2345578899999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++++|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            99999999999853   235788888999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.87  E-value=3.1e-22  Score=219.77  Aligned_cols=146  Identities=29%  Similarity=0.418  Sum_probs=127.7

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeCCc-cEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCC---------------
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQDE-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL---------------  514 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~-~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl---------------  514 (614)
                      .+...+..+.+.|-+|||+.||.+....+ .++|+|++-....+..+..++||++|++|+ |+||               
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34445667789999999999999998766 999999987667778888999999999998 9999               


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       515 -~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                       .-+.+|.||||++|+|-+++....... |++.+.++|+.++++|+.+||.. ++||||||||.+||||+.++..|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence             247899999999999999986543333 89999999999999999999987 588999999999999999999999999


Q ss_pred             Ccceee
Q 042853          594 GMARTF  599 (614)
Q Consensus       594 Gla~~~  599 (614)
                      |-|..-
T Consensus       191 GSatt~  196 (738)
T KOG1989|consen  191 GSATTK  196 (738)
T ss_pred             cccccc
Confidence            988643

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.87  E-value=1.6e-21  Score=204.31  Aligned_cols=142  Identities=23%  Similarity=0.325  Sum_probs=121.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||+++.. +++.+|+|.+.+.   .......+.+|+.++..++|+|+         ....++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46788899999999999999976 5678999998642   12234458889999999999998         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++...  ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999998642  235788888899999999999999886   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.87  E-value=1.2e-21  Score=205.29  Aligned_cols=140  Identities=25%  Similarity=0.359  Sum_probs=121.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.+|||.+.+.   ..+....+.+|+.++.+++|||+         ....++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46777899999999999999986 5788999998643   22344678999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++|+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999888543   34678888889999999999999987   99999999999999999999999999987643

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.87  E-value=1.7e-21  Score=203.98  Aligned_cols=142  Identities=24%  Similarity=0.355  Sum_probs=122.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.+|+|.+++..   .+..+.+..|+.++..++|+|+         ....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46788899999999999999876 67889999997532   2345568899999999999998         45789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998543  235888888999999999999999987   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.87  E-value=1.4e-21  Score=208.60  Aligned_cols=138  Identities=25%  Similarity=0.397  Sum_probs=119.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.+|||.+.+..   ......+.+|++++.+++|+|+         ....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36788899999999999999875 57889999986431   2234568899999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||+++|+|..++...   ..++......++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            999999999998542   35778888889999999999999987   999999999999999999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.86  E-value=1.1e-21  Score=209.70  Aligned_cols=137  Identities=26%  Similarity=0.410  Sum_probs=118.5

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .|...+.||+|+||.||++... +++.+|||.+.+..   ......+.+|+.++++++|+|+         ....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5777899999999999999875 57789999986532   2345578899999999999999         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+++|+|..++...   ..+++.....++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999999988543   34778888889999999999999987   999999999999999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.86  E-value=1.5e-21  Score=205.38  Aligned_cols=139  Identities=26%  Similarity=0.361  Sum_probs=119.9

Q ss_pred             CCCCccceeccCCceeEEEEEeCC--ccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD--EQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~--~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ++|...+.||+|+||.||++....  +..+|+|.+.+.   .......+.+|+.++..++|||+         ....++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            467778999999999999998653  358999998643   22345678899999999999999         4678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||+++|+|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999988543   35788889999999999999999987   9999999999999999999999999998764

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.86  E-value=1.5e-21  Score=203.84  Aligned_cols=132  Identities=27%  Similarity=0.384  Sum_probs=114.5

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~g  528 (614)
                      +.||+|+||.||++... +++.+|+|.+.+.   .......+.+|+.++..++|||+         ....++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999875 6789999998653   22344567889999999999999         45789999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            998887532   35789999999999999999999886   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=1.9e-21  Score=202.11  Aligned_cols=131  Identities=26%  Similarity=0.372  Sum_probs=114.3

Q ss_pred             eccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ||+|+||.||++... +++.+|+|.+.+.   .......+..|+.++.+++|||+         ....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999986 5778999998643   23345678899999999999999         4678999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ..++...   ..+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            9888542   35788999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.86  E-value=1.7e-21  Score=207.72  Aligned_cols=146  Identities=30%  Similarity=0.432  Sum_probs=121.5

Q ss_pred             hhcCCCCccceeccCCceeEEEEEe------CCccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------C
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------G  515 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------~  515 (614)
                      ...++|...+.||+|+||.||++..      .++..||||.++... ....+.+.+|+.++..+ +|||+         .
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3345678889999999999999974      245689999996533 23445788999999999 89999         4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCC--------------------------------------------------------
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSR--------------------------------------------------------  539 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~--------------------------------------------------------  539 (614)
                      ...++||||+++|+|..++.....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            678999999999999998854211                                                        


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          540 ----------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       540 ----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                                      ...++|.....++.||++||.|||+.+   |+||||||+|||++.+..+||+|||+++.+..
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                            124788899999999999999999876   99999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.86  E-value=3.3e-21  Score=201.40  Aligned_cols=133  Identities=28%  Similarity=0.378  Sum_probs=114.2

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~g  528 (614)
                      +.||+|+||.||++... +++.+|+|.+.+.   ......++..|++++..++|+|+         ....++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999875 6789999998653   22344567889999999999999         45789999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK-YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +|..++..   ...+++.....++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            99888743   2357899999999999999999997 44   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.86  E-value=2.3e-21  Score=201.75  Aligned_cols=141  Identities=27%  Similarity=0.461  Sum_probs=120.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-Ccc----EEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQ----EIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~----~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      .+|+..+.||+|+||.||+|.+. ++.    .||||.++... ....++|.+|+.+++.++|+|+        .....++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v   86 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   86 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence            45778899999999999999864 333    38999986543 3445679999999999999999        3456899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +||+++|+|.+++...  ...+++...+.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 ~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          87 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence            9999999999988643  235788999999999999999999886   99999999999999999999999999997754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.86  E-value=2.6e-21  Score=202.88  Aligned_cols=141  Identities=22%  Similarity=0.321  Sum_probs=120.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.+|+|.+.+.   .......|..|+.++..++|+|+         ....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36778899999999999999986 4678999998642   12233458889999999999998         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++|+|..++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999998642  235788888899999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.3e-21  Score=197.19  Aligned_cols=143  Identities=24%  Similarity=0.394  Sum_probs=124.7

Q ss_pred             cCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .+.|+..++||.|..++||+|.. +.+..||||++.-.. .....++.+|+..|..++||||         ..++++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            35788889999999999999985 467889999996432 2336789999999999999999         678999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||..||+.++++...... +++..+..|.+++++||.|||+++   .||||||+.|||||++|.+||+|||.+-.+..
T Consensus       105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999998655443 788888999999999999999998   99999999999999999999999998776643

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=3e-21  Score=203.70  Aligned_cols=141  Identities=28%  Similarity=0.433  Sum_probs=123.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||+||++... +++.+|||.+.+.   .......+..|+.++..++|+|+         ....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36788899999999999999986 6789999998653   12345678999999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++++|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998643   45788899999999999999999976   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.86  E-value=2.8e-21  Score=202.57  Aligned_cols=139  Identities=24%  Similarity=0.383  Sum_probs=117.4

Q ss_pred             CCCccceeccCCceeEEEEEeC----CccEEEEEEccCC----CcchhHhHHHHHHHHHhc-CCCCC---------CCee
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS----SGQGIVEFKNEAKLIAKL-QHTNL---------GGER  518 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~----~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~  518 (614)
                      +|++.+.||+|+||.||++...    +++.+|+|.+.+.    .....+.+..|+.++..+ +|+|+         ....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4677899999999999998763    5788999998643    122345678899999999 48988         4567


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||+++|+|..++...   ..+++.+...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            8999999999999888542   34788889999999999999999887   99999999999999999999999999987


Q ss_pred             ecC
Q 042853          599 FTM  601 (614)
Q Consensus       599 ~~~  601 (614)
                      +..
T Consensus       155 ~~~  157 (332)
T cd05614         155 FLS  157 (332)
T ss_pred             ccc
Confidence            643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.86  E-value=3.6e-21  Score=211.63  Aligned_cols=142  Identities=19%  Similarity=0.241  Sum_probs=121.2

Q ss_pred             CCccceeccCCceeEEEEEeC-C-ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-D-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      |...+.||+|+||.||++... + +..||+|.+..........+..|+.+++.++|||+         ....+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            677899999999999999765 3 56788887755444445678889999999999999         578899999999


Q ss_pred             CCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          527 NKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       527 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +|+|..++... .....+++.+...++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+...
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999888643 22345788899999999999999999876   999999999999999999999999999987543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.9e-21  Score=212.87  Aligned_cols=148  Identities=20%  Similarity=0.224  Sum_probs=124.6

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCCC-----------
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLGG-----------  516 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~~-----------  516 (614)
                      .....++|.+.+.||+|+||+||++... +++.||||.+...  ..+....+.+|+.++..++|+|+..           
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            3445578999999999999999999865 6889999998643  2344567889999999999999811           


Q ss_pred             ------eeEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          517 ------ERLLVYEYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       517 ------~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                            ..++||||+++|+|..++.... ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence                  2579999999999999886532 2346888899999999999999999876   99999999999999999999


Q ss_pred             EeecCcceeecC
Q 042853          590 ISDFGMARTFTM  601 (614)
Q Consensus       590 I~DFGla~~~~~  601 (614)
                      |+|||+++.+..
T Consensus       184 L~DFGls~~~~~  195 (496)
T PTZ00283        184 LGDFGFSKMYAA  195 (496)
T ss_pred             EEecccCeeccc
Confidence            999999987654

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.86  E-value=4.2e-21  Score=200.58  Aligned_cols=137  Identities=28%  Similarity=0.403  Sum_probs=116.7

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCC-C---------CCeeEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTN-L---------GGERLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~n-l---------~~~~~lv~  522 (614)
                      +|...+.||+|+||.||+|... +++.+|||.+.+.   .....+.+..|++++..++|++ +         ....++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            3667899999999999999876 5678999998653   2234566888999999998765 4         45789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||+++|+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            999999999888533   34788899999999999999999986   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.86  E-value=5.3e-21  Score=195.51  Aligned_cols=141  Identities=30%  Similarity=0.532  Sum_probs=122.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-----CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-----DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-----~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~  519 (614)
                      .+|.+.+.||+|+||.||++...     ++..+|+|.+........++|.+|++++.+++|+|+           ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46677899999999999999753     567899999976655566789999999999999998           23578


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +|+||+++++|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998543  235899999999999999999999886   999999999999999999999999999976


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       159 ~~  160 (284)
T cd05081         159 PQ  160 (284)
T ss_pred             cC
Confidence            53

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.86  E-value=6.6e-21  Score=195.13  Aligned_cols=140  Identities=26%  Similarity=0.438  Sum_probs=119.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|++.+.||+|+||.||++... +++.+|||++....  ....+.+.+|+.++..++|+|+         ....++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46788899999999999999986 57789999986532  2334568899999999999999         467899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |++++.+..+..   ....+++.....++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+|+.+..
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            999987765542   2235788889999999999999999876   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-21  Score=195.38  Aligned_cols=140  Identities=31%  Similarity=0.467  Sum_probs=118.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC--------------CCe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL--------------GGE  517 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl--------------~~~  517 (614)
                      ...|...+.||+|+||.|.++... ++..||||++...  ..-..++-.+|+++++.++|+|+              -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345555789999999999999876 6789999999743  33445678899999999999999              357


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++|+|+| ..+|...+..   ...|+......++.|+++||.|+|+.+   |+||||||+|+|++.+...||+||||||
T Consensus       101 vYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            89999999 5588888843   333777888888999999999999987   9999999999999999999999999999


Q ss_pred             eecC
Q 042853          598 TFTM  601 (614)
Q Consensus       598 ~~~~  601 (614)
                      ....
T Consensus       174 ~~~~  177 (359)
T KOG0660|consen  174 YLDK  177 (359)
T ss_pred             eccc
Confidence            9864

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.85  E-value=3.7e-21  Score=204.06  Aligned_cols=139  Identities=24%  Similarity=0.404  Sum_probs=120.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|+..+.||+|+||.||++... +++.+|||.+.+.   .......+..|+.++..++|+|+         ....++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            35777899999999999999876 5788999998643   22345568889999999999998         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++|+|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            999999999988532   35788888999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.85  E-value=2.7e-21  Score=199.04  Aligned_cols=146  Identities=30%  Similarity=0.469  Sum_probs=118.9

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK  528 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~g  528 (614)
                      .+.||.|-||+||-|+.+ +|+.||||.+.+.  ...+..++++|+.+|.+++||.+         .+..++|||-+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            578999999999999986 7899999999764  23456789999999999999998         567789999984 5


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEeecCcceeecCCccc
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTFTMNELE  605 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~---~~~kI~DFGla~~~~~~~~~  605 (614)
                      +..+.+... ....|+.+....++.||+.||.|||..+   ||||||||+||||.+.   -.+||||||+||++......
T Consensus       648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            555555433 3345787777778999999999999987   9999999999999754   35899999999999866543


Q ss_pred             cCCCceecC
Q 042853          606 ANTNRIVGT  614 (614)
Q Consensus       606 ~~~~~~~GT  614 (614)
                      +   .++||
T Consensus       724 r---sVVGT  729 (888)
T KOG4236|consen  724 R---SVVGT  729 (888)
T ss_pred             h---hhcCC
Confidence            2   25666

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.85  E-value=3.9e-21  Score=204.89  Aligned_cols=146  Identities=30%  Similarity=0.455  Sum_probs=120.8

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------C
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------G  515 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------~  515 (614)
                      ...++|+..+.||+|+||.||++...      +...||||+++... ......+.+|+++++.+ +|+|+         .
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34457888899999999999998742      33579999997543 23345688999999999 89998         4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcC---------------------------------------------------------
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSS---------------------------------------------------------  538 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~---------------------------------------------------------  538 (614)
                      ...++||||+++|+|..++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            57899999999999999885321                                                         


Q ss_pred             ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          539 ----------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       539 ----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                                ....+++.+..+++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence                      0124788888999999999999999886   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.85  E-value=6.3e-21  Score=195.75  Aligned_cols=139  Identities=29%  Similarity=0.525  Sum_probs=118.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+|+         ....++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46788899999999999999876 67889999986432 2234567899999999999998         4567899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++ +|..++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            984 888887533  234788888999999999999999886   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.85  E-value=7.4e-21  Score=194.39  Aligned_cols=135  Identities=29%  Similarity=0.421  Sum_probs=115.4

Q ss_pred             eccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ||+|+||+||++... +++.+|+|.+.+..   .+..+.+..|++++++++|+|+         ....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999876 67899999986532   2234567889999999999998         4568999999999999


Q ss_pred             HHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          531 DFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       531 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ..++.... ....+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            88875432 2345889999999999999999999986   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.85  E-value=6.9e-21  Score=204.27  Aligned_cols=147  Identities=26%  Similarity=0.397  Sum_probs=121.8

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCc-chhHhHHHHHHHHHhcC-CCCC---------
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQ-HTNL---------  514 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nl---------  514 (614)
                      ....++|.+.+.||+|+||.||+|...      ....||||++..... ...+.|.+|++++.++. |||+         
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            344567888899999999999999863      234699999965432 33457899999999996 9999         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCC-------------------------------------------------------
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSR-------------------------------------------------------  539 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~-------------------------------------------------------  539 (614)
                      ....+|||||+++|+|..++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            4678999999999999988864210                                                       


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 042853          540 --------------------------------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL  581 (614)
Q Consensus       540 --------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  581 (614)
                                                            ...+++..+..++.||++||.|||+.+   |+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence                                                  124778888999999999999999886   999999999999


Q ss_pred             EcCCCcEEEeecCcceeecC
Q 042853          582 LDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       582 ld~~~~~kI~DFGla~~~~~  601 (614)
                      ++.++.+||+|||+++.+..
T Consensus       270 l~~~~~~kL~DfGla~~~~~  289 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMH  289 (400)
T ss_pred             EeCCCEEEEEeCCcceeccc
Confidence            99999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=7.5e-21  Score=191.93  Aligned_cols=142  Identities=27%  Similarity=0.464  Sum_probs=124.4

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ..++|...+.||+|+||.||++...+++.+|+|.++... ...++|.+|+.++++++|+|+         ....+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            345678889999999999999998777889999986532 345679999999999999999         4568999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|.+++.... ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            99999999986433 345799999999999999999999886   9999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.85  E-value=1.5e-21  Score=203.18  Aligned_cols=153  Identities=28%  Similarity=0.468  Sum_probs=128.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCe-eEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGE-RLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~-~~lv~  522 (614)
                      ++|...+.+|+|+||.++..+.+ +.+.+++|.+.-.  .....+...+|+.++++++||||         .+. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46777899999999999888765 5678999988643  23334467899999999999999         334 89999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|...+.+.. ...+++++...+..|++.|+.|||++.   |+|||||++||++..+..+||.|||+||.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997654 456788999999999999999999776   999999999999999999999999999999877


Q ss_pred             ccccCCCceecC
Q 042853          603 ELEANTNRIVGT  614 (614)
Q Consensus       603 ~~~~~~~~~~GT  614 (614)
                      ...+  .+++||
T Consensus       160 ~~~a--~tvvGT  169 (426)
T KOG0589|consen  160 DSLA--STVVGT  169 (426)
T ss_pred             hhhh--heecCC
Confidence            6333  336776

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.85  E-value=7.7e-21  Score=198.50  Aligned_cols=133  Identities=29%  Similarity=0.471  Sum_probs=113.3

Q ss_pred             ceeccCCceeEEEEEeC----CccEEEEEEccCCC----cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          462 NRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +.||+|+||.||++...    .++.+|||.+++..    ......+.+|+.+++.++|||+         ....++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999863    56789999986431    2233467889999999999999         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++..   ...+.+.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            999999988853   234677888889999999999999987   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.85  E-value=7.1e-21  Score=198.80  Aligned_cols=137  Identities=28%  Similarity=0.417  Sum_probs=115.8

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCC-CCC---------CCeeEEEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH-TNL---------GGERLLVYE  523 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H-~nl---------~~~~~lv~E  523 (614)
                      |+..+.||+|+||.||++... +++.||+|.+.+.   .....+.+..|..++..+.| +++         ....++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            566789999999999999875 6788999998653   22344567889999988875 444         356899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+++|+|..++...   ..+++.+...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        82 y~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          82 YVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            99999999888532   35889999999999999999999886   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.85  E-value=7.8e-21  Score=198.45  Aligned_cols=138  Identities=28%  Similarity=0.381  Sum_probs=115.3

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcC-CCCC---------CCeeEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~  522 (614)
                      +|...+.||+|+||.||++... +++.+|||.+.+..   ....+.+..|..++..+. |+++         ....++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            3667899999999999999876 56789999987532   223445677888888774 6776         45688999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            999999998887533   34788999999999999999999886   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.85  E-value=4.7e-21  Score=202.67  Aligned_cols=135  Identities=28%  Similarity=0.454  Sum_probs=114.7

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +|+..++||+|+||.||++... +++.||||.+..... ....+|.+|++++++++|+|+         ....++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3455689999999999999876 678999999865432 334678999999999999999         45788999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|....       ...+.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999985432       3466777889999999999999987   99999999999999999999999999987653

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.85  E-value=1.1e-20  Score=197.94  Aligned_cols=141  Identities=23%  Similarity=0.313  Sum_probs=121.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .++|+..+.||+|+||.||++... ++..+|+|.+.... .....+|.+|++++.+++|+|+         ....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367888999999999999999986 57789999886542 2345679999999999999999         467899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+++++|..++...   ..+++.....++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999998543   34788889999999999999999853  49999999999999999999999999998664

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.85  E-value=7.7e-21  Score=199.34  Aligned_cols=137  Identities=26%  Similarity=0.407  Sum_probs=116.4

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCC--------------CeeE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLG--------------GERL  519 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~--------------~~~~  519 (614)
                      +|.+.+.||+|+||.||+|... +++.||||++...  ......++.+|+.++++++|||+.              ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4677899999999999999875 6789999998643  223345688999999999999981              2479


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||++ ++|..++..   ...+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 688887743   235889999999999999999999987   999999999999999999999999999865


Q ss_pred             c
Q 042853          600 T  600 (614)
Q Consensus       600 ~  600 (614)
                      .
T Consensus       154 ~  154 (338)
T cd07859         154 F  154 (338)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.85  E-value=6.8e-21  Score=193.06  Aligned_cols=139  Identities=26%  Similarity=0.458  Sum_probs=119.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC----CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ++|++.+.||+|+||.||+|.+.    .+..+|+|.++... ......|.+|+.++.+++|||+         ....++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46777899999999999999864    35689999987543 2334578999999999999998         5678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |||+++|+|+.++...  ...+++...+.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||++...
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999988543  235889999999999999999999886   999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.85  E-value=1e-20  Score=193.35  Aligned_cols=143  Identities=36%  Similarity=0.538  Sum_probs=120.2

Q ss_pred             CCCCccceeccCCceeEEEEEe-----CCccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKL-----QDEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      +.|+..+.||+|+||+||+|..     ..++.+|+|.+.... .+...+|.+|++++++++|+|+         ....++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3466678999999999999985     245789999997533 3445678999999999999998         467899


Q ss_pred             EEEecCCCCHHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC
Q 042853          521 VYEYLPNKSLDFFIFDSS--------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM  586 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~  586 (614)
                      +|||+++++|..++....              ....+++.+.+.++.|++.||.|||+.+   |+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999885321              1234788899999999999999999886   99999999999999999


Q ss_pred             cEEEeecCcceeecC
Q 042853          587 NPKISDFGMARTFTM  601 (614)
Q Consensus       587 ~~kI~DFGla~~~~~  601 (614)
                      .+||+|||+++.+..
T Consensus       162 ~~kl~dfg~~~~~~~  176 (283)
T cd05090         162 HVKISDLGLSREIYS  176 (283)
T ss_pred             cEEeccccccccccC
Confidence            999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=2e-21  Score=209.31  Aligned_cols=142  Identities=31%  Similarity=0.465  Sum_probs=122.8

Q ss_pred             cceeccCCceeEEEEEe-CCc----cEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecC
Q 042853          461 ANRLGQGGFGPVYKGKL-QDE----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~-~~~----~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~  526 (614)
                      .++||+|+||+||||.+ +.+    .+||+|.+... ..+..++|..|+-.|++++|+|+        ...+.||.+|||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP  780 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMP  780 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcc
Confidence            57899999999999986 333    36899988643 45567899999999999999999        456889999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCcccc
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA  606 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~~~  606 (614)
                      .|.|.+|+..+  +..+.-+..+.+..|||+||.|||++.   +|||||.++|+|+.+-..+||.|||+|+++..++.+.
T Consensus       781 ~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  781 LGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             cchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            99999998764  345777888999999999999999876   9999999999999999999999999999998877654


Q ss_pred             C
Q 042853          607 N  607 (614)
Q Consensus       607 ~  607 (614)
                      .
T Consensus       856 ~  856 (1177)
T KOG1025|consen  856 S  856 (1177)
T ss_pred             c
Confidence            3

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.85  E-value=1.1e-20  Score=195.24  Aligned_cols=140  Identities=29%  Similarity=0.480  Sum_probs=118.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .++|.+.+.||+|+||.||++... +++.+|||.+..... .....+.+|+.+++.++|+|+         ....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367888999999999999999986 678999999865432 233467889999999999999         457899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |++ ++|..++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+|+...
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            996 5777776432  234788888999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.85  E-value=9.6e-21  Score=197.59  Aligned_cols=133  Identities=33%  Similarity=0.465  Sum_probs=113.2

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||+|... +++.+|||.+.+.   .......+..|.+++..+ +|+|+         ....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999886 5678999998653   223445678899988876 79998         4578999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~  147 (321)
T cd05591          81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI  147 (321)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence            9998887533   34788889999999999999999987   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.85  E-value=9.1e-21  Score=193.15  Aligned_cols=145  Identities=30%  Similarity=0.525  Sum_probs=121.6

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CC
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GG  516 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~  516 (614)
                      ..+++|+..+.||+|+||.||+|...      .+..+|||.+.... .....+|.+|+.+++.++|+|+         ..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34577888999999999999998763      24579999986432 2345678999999999999999         45


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSR-------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                      ..++||||+++++|..++.....       ...+++.....++.|+++||.|||+.+   ++|+||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            78999999999999999864221       234678889999999999999999876   99999999999999999999


Q ss_pred             EeecCcceeec
Q 042853          590 ISDFGMARTFT  600 (614)
Q Consensus       590 I~DFGla~~~~  600 (614)
                      |+|||+++.+.
T Consensus       160 l~dfg~~~~~~  170 (277)
T cd05062         160 IGDFGMTRDIY  170 (277)
T ss_pred             ECCCCCccccC
Confidence            99999998654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=9.8e-21  Score=197.78  Aligned_cols=136  Identities=18%  Similarity=0.222  Sum_probs=110.4

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC--CccEEEEEEccCC-----CcchhHhHHHHHHHHHhcCCCCC------CCeeEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ--DEQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNL------GGERLL  520 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~--~~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nl------~~~~~l  520 (614)
                      ..++|...+.||+|+||+||+|...  +++.+|||++...     .......|.+|++++.+++|+|+      ..+.+|
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~L   95 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGL   95 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEE
Confidence            3467888999999999999999875  4677899987532     12234568999999999999998      346799


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCCEEEcCCCcEEEeecCcceee
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDL-KVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||||+++++|....    .   ..   ...++.++++||.|||+.+   |+|||| ||+|||++.++.+||+|||+|+.+
T Consensus        96 VmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         96 VRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             EEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            99999999996221    1   11   1357789999999999986   999999 999999999999999999999987


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      .+.
T Consensus       163 ~~~  165 (365)
T PRK09188        163 RRR  165 (365)
T ss_pred             ccC
Confidence            543

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.85  E-value=1.2e-20  Score=197.73  Aligned_cols=132  Identities=27%  Similarity=0.402  Sum_probs=113.1

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||++... +++.+|+|.+++.   ..+....+..|+.++.++ +|||+         ....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999976 5678999998753   223445678898888776 79999         4678999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            9998887432   35788999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.85  E-value=1e-20  Score=190.79  Aligned_cols=142  Identities=30%  Similarity=0.510  Sum_probs=123.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .++|+..++||+|+||.||+|...+++.+|+|.+... ....+.|.+|+.++++++|+|+         ....+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            3567788999999999999999888888999998653 2345689999999999999999         45678999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|..++.... ...+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence            9999999886432 335788899999999999999999876   99999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.3e-20  Score=192.99  Aligned_cols=140  Identities=30%  Similarity=0.428  Sum_probs=119.8

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      +|+..+.||+|+||+||++... +++.||||.+....   ......+.+|+.++++++|+|+         ....++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3667789999999999999875 67899999986532   2233457889999999999999         457899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+++|+|..++.... ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999998876432 235889999999999999999999987   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.85  E-value=9.8e-21  Score=197.20  Aligned_cols=134  Identities=29%  Similarity=0.400  Sum_probs=115.0

Q ss_pred             ceeccCCceeEEEEEe----CCccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          462 NRLGQGGFGPVYKGKL----QDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~----~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      +.||+|+||.||++..    .+++.+|+|.+.+..  ......+..|++++.+++|+|+         ....++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    357889999986532  2234457889999999999999         467899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +|+|..++..   ...+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            9999988843   335889999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.85  E-value=1.2e-20  Score=196.57  Aligned_cols=133  Identities=35%  Similarity=0.472  Sum_probs=111.1

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHh-cCCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAK-LQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~-l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||++... +++.||||.+++..   ....+.+..|..++.. .+|+|+         ....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999986 56789999986531   2334456667777765 489999         4678999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            9999888543   34788888899999999999999986   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.84  E-value=1.2e-20  Score=198.88  Aligned_cols=143  Identities=27%  Similarity=0.455  Sum_probs=118.8

Q ss_pred             cCCCCccceeccCCceeEEEEEe------CCccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC----------CC
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL----------GG  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl----------~~  516 (614)
                      .++|.+.+.||+|+||.||+|..      .+++.||||.++... ......+.+|+.++.++ +|+|+          ..
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45788899999999999999974      346789999996533 23455788999999999 68998          23


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCC---------------------------------------------------------
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSR---------------------------------------------------------  539 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  539 (614)
                      ..+++|||+++|+|..++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            56899999999999998853210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          540 -------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       540 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                             ...+++.....++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                   123678888999999999999999986   9999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.84  E-value=1.2e-20  Score=197.51  Aligned_cols=132  Identities=25%  Similarity=0.379  Sum_probs=113.9

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||++... +++.+|||.+++.   ..+....+..|..++..+ +|||+         ....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999876 6788999999753   223345688899999998 79999         4678999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|..++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            9998887432   35899999999999999999999887   999999999999999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.84  E-value=7.8e-21  Score=199.68  Aligned_cols=145  Identities=28%  Similarity=0.454  Sum_probs=120.1

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC----------C
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL----------G  515 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl----------~  515 (614)
                      +.++|++.+.||+|+||.||+|...      .++.||+|++.... ....+.+..|+.++.++ +|+|+          .
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            4457888899999999999999643      24689999986533 23345678899999999 89998          2


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCC--------------------------------------------------------
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSR--------------------------------------------------------  539 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~--------------------------------------------------------  539 (614)
                      ...+++|||+++++|..++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            457899999999999988853211                                                        


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          540 --KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       540 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                        ...++|..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~  225 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK  225 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence              125789999999999999999999886   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.84  E-value=1.1e-20  Score=197.53  Aligned_cols=135  Identities=28%  Similarity=0.418  Sum_probs=113.5

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHH---HhcCCCCC---------CCeeEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLI---AKLQHTNL---------GGERLLV  521 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l---~~l~H~nl---------~~~~~lv  521 (614)
                      |.+.+.||+|+||.||++... +++.+|||.+++..   ....+.+..|++++   ..++|+|+         ....++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            456789999999999999876 67899999996431   22344566676655   56789998         5678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |||+++++|..++.    ...+++.+...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            99999999988773    235899999999999999999999986   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.84  E-value=1.3e-20  Score=201.71  Aligned_cols=132  Identities=20%  Similarity=0.289  Sum_probs=114.4

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .++|++.+.||+|+||.||++... +++.||+|....      ..+.+|++++++++||||         ....++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            467999999999999999999875 678899997532      346889999999999999         4567899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +. ++|..++...   ..+++.....++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+..
T Consensus       165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            86 6888777432   34789999999999999999999986   999999999999999999999999999754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.84  E-value=1.4e-20  Score=189.27  Aligned_cols=138  Identities=31%  Similarity=0.474  Sum_probs=120.2

Q ss_pred             CCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      .|...+.||+|+||.||++...++..+|+|.+... .....+|.+|+.++++++|+|+         ....++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            46667899999999999999988788999988643 2334678999999999999998         4568999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+|..++....  ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        84 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          84 GCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            99999885432  35789999999999999999999887   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.84  E-value=2e-20  Score=189.81  Aligned_cols=140  Identities=26%  Similarity=0.500  Sum_probs=116.3

Q ss_pred             CccceeccCCceeEEEEEeCCcc---EEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCC---------------Cee
Q 042853          459 SPANRLGQGGFGPVYKGKLQDEQ---EIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLG---------------GER  518 (614)
Q Consensus       459 ~~~~~lG~G~fg~Vy~g~~~~~~---~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~---------------~~~  518 (614)
                      .+.+.||+|+||.||+|......   .+|+|.++..  .....++|..|++++..++|+|+.               ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            34688999999999999986432   5899988653  234456789999999999999981               135


Q ss_pred             EEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          519 LLVYEYLPNKSLDFFIFDSS---RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      +++|||+++|+|..++....   ....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            79999999999998874321   2345789999999999999999999876   99999999999999999999999999


Q ss_pred             ceeecC
Q 042853          596 ARTFTM  601 (614)
Q Consensus       596 a~~~~~  601 (614)
                      ++.+..
T Consensus       159 ~~~~~~  164 (272)
T cd05075         159 SKKIYN  164 (272)
T ss_pred             ccccCc
Confidence            997653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.84  E-value=2e-20  Score=189.35  Aligned_cols=140  Identities=31%  Similarity=0.586  Sum_probs=121.2

Q ss_pred             CCCCccceeccCCceeEEEEEeCC----ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ++|+..+.||+|+||+||+|.+..    ...+|||.++... .....+|..|+.++.+++|+|+         ....+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            567788999999999999998752    3578999986543 3345679999999999999998         4567899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||+++++|..++....  ..+++.+...++.|++.||.|||+.+   |+|+||||+|||+++++.+||+|||+++.+.
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999985432  35889999999999999999999876   9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.84  E-value=1.8e-20  Score=191.31  Aligned_cols=141  Identities=29%  Similarity=0.430  Sum_probs=117.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-Ccc----EEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQ----EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~----~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      .|...+.||+|+||+||+|... +++    .+++|.+..... ....++..|+..+++++|+|+        ....++++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~   87 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT   87 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEE
Confidence            4566789999999999999874 333    477888754322 334678888999999999998        45668999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++...  ...+++.....++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+...
T Consensus        88 e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          88 QLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            999999999998643  235899999999999999999999876   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.84  E-value=1.5e-20  Score=190.06  Aligned_cols=142  Identities=30%  Similarity=0.506  Sum_probs=122.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecC
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLP  526 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~  526 (614)
                      .++|.+.++||+|+||.||+|...+...||+|.++... ...++|.+|++++.+++|+|+        ....++||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence            35678889999999999999998777789999997532 234678999999999999998        445789999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +|+|..++.... ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            999999986432 235789999999999999999999886   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.84  E-value=1.7e-20  Score=196.82  Aligned_cols=141  Identities=23%  Similarity=0.327  Sum_probs=121.2

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .++|++.++||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++|+|+         ..+.++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367888999999999999999986 57788999886542 2344678999999999999999         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+++++|..++...   ..+++.....++.+++.||.|||+..  +|+||||||+|||+++++.+||+|||+++.+.
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999998542   34788888899999999999999742  49999999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.84  E-value=1.6e-20  Score=196.09  Aligned_cols=132  Identities=29%  Similarity=0.413  Sum_probs=110.3

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHH-HHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAK-LIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||+||++... +++.+|||.+.+..   .....++..|.. +++.++|||+         ....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999986 67899999986431   222344555544 5678999999         4578999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            999988853   235788888899999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.84  E-value=1.6e-20  Score=196.26  Aligned_cols=132  Identities=27%  Similarity=0.397  Sum_probs=110.7

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHH-HHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAK-LIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~-~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||+||++... +++.+|||.+.+.   ......++..|.. +++.++|+|+         ....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999875 6789999998643   1223345566655 5677999999         4678999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|..++..   ...+++.+...++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            999888743   335788899999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.84  E-value=1.6e-20  Score=195.91  Aligned_cols=132  Identities=30%  Similarity=0.456  Sum_probs=113.0

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||++... +++.+|||.+.+.   .......+..|..++..+ +|+|+         ....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999986 5788999998643   223455678888888876 69998         4578999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            9999887543   34788899999999999999999887   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=4.9e-21  Score=202.92  Aligned_cols=139  Identities=32%  Similarity=0.431  Sum_probs=120.3

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +...+.||.|+-|.|..|++. +|+.+|||.+.+...   .......+|+.+|+.|.|||+         ..++|||.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            455788999999999999875 899999999976521   122346789999999999998         6789999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +++|.|.+++..   ++.+..++..++..||..|+.|+|..+   |+||||||+|+|||...++||+|||||.+-..+
T Consensus        94 v~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   94 VPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             cCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            999999999854   456888999999999999999999887   999999999999999999999999999875443

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.84  E-value=2.3e-20  Score=191.50  Aligned_cols=143  Identities=32%  Similarity=0.564  Sum_probs=122.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      ++|.+.+.||+|+||+||++...      ++..+|+|.+..........|.+|++++.+++|+|+         ....++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46777899999999999999752      345689999876555566789999999999999999         467899


Q ss_pred             EEEecCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 042853          521 VYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI  590 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI  590 (614)
                      ||||+++++|..++....          ....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999986432          2234899999999999999999999886   999999999999999999999


Q ss_pred             eecCcceeecC
Q 042853          591 SDFGMARTFTM  601 (614)
Q Consensus       591 ~DFGla~~~~~  601 (614)
                      +|||+++.+..
T Consensus       162 ~dfg~~~~~~~  172 (288)
T cd05093         162 GDFGMSRDVYS  172 (288)
T ss_pred             ccCCccccccC
Confidence            99999986643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.84  E-value=1.1e-21  Score=187.74  Aligned_cols=150  Identities=30%  Similarity=0.466  Sum_probs=123.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC----c----chhHhHHHHHHHHHhc-CCCCC---------CC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS----G----QGIVEFKNEAKLIAKL-QHTNL---------GG  516 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~----~----~~~~~f~~E~~~l~~l-~H~nl---------~~  516 (614)
                      +.|...+.||+|..++|.++..+ ++++.|+|++....    .    +..++-..|+.+|+++ -||+|         ..
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            46777899999999999998775 77899999885321    1    1223457799999997 59999         45


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++|+|.|+.|.|.++|-.   .-.+++++..+|+.|+..|+.|||...   ||||||||+|||+|+++++||+|||+|
T Consensus        97 F~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence            67899999999999999843   345889999999999999999999987   999999999999999999999999999


Q ss_pred             eeecCCccccCCCceecC
Q 042853          597 RTFTMNELEANTNRIVGT  614 (614)
Q Consensus       597 ~~~~~~~~~~~~~~~~GT  614 (614)
                      ..+.+++.-.   ..+||
T Consensus       171 ~~l~~GekLr---elCGT  185 (411)
T KOG0599|consen  171 CQLEPGEKLR---ELCGT  185 (411)
T ss_pred             eccCCchhHH---HhcCC
Confidence            9998776432   25555

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.84  E-value=2.3e-20  Score=189.19  Aligned_cols=136  Identities=26%  Similarity=0.420  Sum_probs=112.7

Q ss_pred             ceeccCCceeEEEEEeCC---ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQD---EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~---~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~g  528 (614)
                      ++||+|+||.||+|...+   ...+++|.+.... .+...+|.+|+++++.++|+|+         ....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997643   3468888876433 2345678999999999999999         45689999999999


Q ss_pred             CHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          529 SLDFFIFDSSR--KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       529 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +|..++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence            99999865432  223467778899999999999999886   9999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.84  E-value=2.7e-20  Score=198.35  Aligned_cols=138  Identities=28%  Similarity=0.415  Sum_probs=117.1

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CC-----eeE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GG-----ERL  519 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~-----~~~  519 (614)
                      +|++.+.||+|+||.||++... +++.||||++....  ....+++.+|+++++.++|+|+         ..     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            3677899999999999999975 68899999986532  2345678899999999999999         12     679


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +|+||++ ++|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 577776642   345889999999999999999999987   999999999999999999999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       154 ~~  155 (372)
T cd07853         154 EP  155 (372)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.84  E-value=1.8e-20  Score=192.27  Aligned_cols=145  Identities=28%  Similarity=0.503  Sum_probs=120.5

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CC
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GG  516 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~  516 (614)
                      +.+++|++.+.||+|+||.||+|...      .+..+|+|.+.... .....++.+|+.+++.++|+|+         ..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34567888999999999999999753      24579999886432 2334568899999999999999         45


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSR-------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                      ..++||||+++|+|..++.....       ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            67999999999999999864221       234577788899999999999999886   99999999999999999999


Q ss_pred             EeecCcceeec
Q 042853          590 ISDFGMARTFT  600 (614)
Q Consensus       590 I~DFGla~~~~  600 (614)
                      |+|||+++.+.
T Consensus       160 L~Dfg~~~~~~  170 (288)
T cd05061         160 IGDFGMTRDIY  170 (288)
T ss_pred             ECcCCcccccc
Confidence            99999998654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.84  E-value=2e-20  Score=189.00  Aligned_cols=137  Identities=39%  Similarity=0.616  Sum_probs=117.4

Q ss_pred             ccceeccCCceeEEEEEeC-----CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          460 PANRLGQGGFGPVYKGKLQ-----DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       460 ~~~~lG~G~fg~Vy~g~~~-----~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ..+.||.|.||.||+|.+.     .+..|+||.++... .+..++|.+|++.+++++|+|+         ....++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999986     35689999996533 3346789999999999999999         4568999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++|+|..+|... ....+++..+..|+.||++||.|||+.+   |+|+||+++|||+++++.+||+|||+++...
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999999765 2345899999999999999999999986   9999999999999999999999999999873

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.84  E-value=1.9e-20  Score=195.94  Aligned_cols=132  Identities=27%  Similarity=0.380  Sum_probs=113.6

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||+||++... +++.+|+|.+++..   ......+..|+.++.++ +|+|+         ....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999876 56889999997532   23445688999999888 69998         4678999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|..++...   ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            9998887432   35899999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.84  E-value=2e-20  Score=195.18  Aligned_cols=132  Identities=28%  Similarity=0.400  Sum_probs=109.3

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHH-HHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAK-LIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||++... +++.+|+|.+.+..   .....++..|.. +++.++|+|+         ....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999986 57889999986432   222344555554 6788999999         4578999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ++|..++..   ...+.......++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            999887743   234677788889999999999999886   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.84  E-value=2.6e-20  Score=187.84  Aligned_cols=141  Identities=33%  Similarity=0.533  Sum_probs=124.1

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecC
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLP  526 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~  526 (614)
                      .+.|++.++||+|+||.||++...+++.+|+|.+.... ....+|.+|+.++++++|+|+        ....+++|||++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~   83 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME   83 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence            45677889999999999999998888999999987543 335678999999999999998        456899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++|..++.... ...+++.+...++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++...
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          84 NGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            999999886433 345789999999999999999999876   9999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.84  E-value=1.9e-20  Score=197.24  Aligned_cols=150  Identities=30%  Similarity=0.450  Sum_probs=126.4

Q ss_pred             cCCCCccceeccCCceeEEEEEeCC-ccEEEEEEccCCCcc---hhHhHHHHHHHHHhcC-CCCC---------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQ---GIVEFKNEAKLIAKLQ-HTNL---------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~-H~nl---------~~~~~l  520 (614)
                      ...|++.+.||+|.||.||++..+. ++.+|+|.+.+....   ....+.+|+.+|.++. |||+         ....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            3567778999999999999999874 899999999775443   3457899999999999 9999         568899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC----CcEEEeecCcc
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ----MNPKISDFGMA  596 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~----~~~kI~DFGla  596 (614)
                      |||++.+|.|.+.+...   . +++.....++.||+.|+.|||+.+   |+||||||+|+|+...    +.+|++|||+|
T Consensus       114 vmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999888654   2 888999999999999999999977   9999999999999633    47999999999


Q ss_pred             eeecCCccccCCCceecC
Q 042853          597 RTFTMNELEANTNRIVGT  614 (614)
Q Consensus       597 ~~~~~~~~~~~~~~~~GT  614 (614)
                      +....+.   ....++||
T Consensus       187 ~~~~~~~---~~~~~~Gt  201 (382)
T KOG0032|consen  187 KFIKPGE---RLHTIVGT  201 (382)
T ss_pred             eEccCCc---eEeeecCC
Confidence            9987622   22336665

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.84  E-value=2.2e-20  Score=200.38  Aligned_cols=147  Identities=26%  Similarity=0.440  Sum_probs=121.3

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCc-chhHhHHHHHHHHHhcC-CCCC--------
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQ-HTNL--------  514 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nl--------  514 (614)
                      +....++|.+.+.||+|+||.||+|.+.      .++.||||+++.... ...+.+.+|++++.++. |+|+        
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3344556777899999999999999863      345799999975432 23457899999999997 9999        


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhhcC-------------------------------------------------------
Q 042853          515 -GGERLLVYEYLPNKSLDFFIFDSS-------------------------------------------------------  538 (614)
Q Consensus       515 -~~~~~lv~Ey~~~gsL~~~l~~~~-------------------------------------------------------  538 (614)
                       ....++||||+++|+|.+++....                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence             457899999999999999986421                                                       


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 042853          539 ----------------------------------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVS  578 (614)
Q Consensus       539 ----------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~  578 (614)
                                                              ....+++.....++.|++.||.|||+.+   |+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                    1124677888899999999999999876   999999999


Q ss_pred             CEEEcCCCcEEEeecCcceeec
Q 042853          579 NILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       579 NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||+++++.+||+|||+++.+.
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~  290 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIM  290 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecc
Confidence            9999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.84  E-value=2.5e-20  Score=190.10  Aligned_cols=145  Identities=27%  Similarity=0.475  Sum_probs=124.1

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCC-----ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC----------CCe
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQD-----EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL----------GGE  517 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl----------~~~  517 (614)
                      ..++|...+.||+|+||.||+|....     +..|++|++.... ......+.+|+.++.+++|+|+          ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45678888999999999999999865     6789999987542 3345678999999999999998          356


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEee
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRK-----SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISD  592 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~D  592 (614)
                      .++++||+++++|..++......     ..+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            78999999999999998654322     45889999999999999999999876   99999999999999999999999


Q ss_pred             cCcceeecC
Q 042853          593 FGMARTFTM  601 (614)
Q Consensus       593 FGla~~~~~  601 (614)
                      ||+++.+..
T Consensus       161 ~g~~~~~~~  169 (280)
T cd05043         161 NALSRDLFP  169 (280)
T ss_pred             CCCcccccC
Confidence            999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.84  E-value=3.2e-20  Score=211.42  Aligned_cols=141  Identities=26%  Similarity=0.330  Sum_probs=120.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.++||+|+||.||+|... +++.||||++....   ....++|.+|++++++++|||+         ....+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888899999999999999876 57899999996532   2234579999999999999999         45789999


Q ss_pred             EecCCCCHHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          523 EYLPNKSLDFFIFDSS--------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                      ||+++++|..++....        ....+++...+.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1223567788899999999999999986   9999999999999999999999999


Q ss_pred             cceee
Q 042853          595 MARTF  599 (614)
Q Consensus       595 la~~~  599 (614)
                      +|+..
T Consensus       159 LAk~i  163 (932)
T PRK13184        159 AAIFK  163 (932)
T ss_pred             cceec
Confidence            99977

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.84  E-value=2.6e-20  Score=191.75  Aligned_cols=142  Identities=25%  Similarity=0.437  Sum_probs=119.0

Q ss_pred             CCCCccceeccCCceeEEEEEeCC---------------ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC-----
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD---------------EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL-----  514 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~---------------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl-----  514 (614)
                      ++|.+.+.||+|+||.||++....               ...+|+|.+.... ......|.+|++++.+++|+|+     
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            567888999999999999987642               1348999986542 3344579999999999999998     


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDSSR---------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL  581 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  581 (614)
                          ....++||||+++++|..++.....         ...+++..++.++.|++.||.|||+.+   ++||||||+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence                5678999999999999998854211         123688899999999999999999987   999999999999


Q ss_pred             EcCCCcEEEeecCcceeec
Q 042853          582 LDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       582 ld~~~~~kI~DFGla~~~~  600 (614)
                      +++++.+||+|||+++.+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             EcCCCcEEecccccccccc
Confidence            9999999999999998664

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.84  E-value=1.4e-20  Score=189.75  Aligned_cols=142  Identities=29%  Similarity=0.507  Sum_probs=125.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ..+|...+.||+|+||.||+|...++..+|+|.+.........++..|+.++..++|+|+         ....++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            345777899999999999999998888999999976555456789999999999999998         45678999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..++.... ...+++.+...++.||+.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+.
T Consensus        85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcC
Confidence            9999999986543 345799999999999999999999887   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.84  E-value=4.2e-21  Score=200.80  Aligned_cols=146  Identities=26%  Similarity=0.440  Sum_probs=125.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeCC-ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .....-.++||-|-||.||.|.++. .-.||||.|+.. .-..+||+.|+.+|+.++|||+         ....|+|.||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            3344446899999999999999974 457999999763 3457899999999999999999         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCcc
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL  604 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~  604 (614)
                      |.+|+|.+||.+..+. .++-...+.|+.||+.||+||....   +|||||.++|+|+.++..+||+||||+|+|..+..
T Consensus       345 M~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             ccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence            9999999999876543 4666778899999999999999876   99999999999999999999999999999986654


Q ss_pred             c
Q 042853          605 E  605 (614)
Q Consensus       605 ~  605 (614)
                      .
T Consensus       421 T  421 (1157)
T KOG4278|consen  421 T  421 (1157)
T ss_pred             e
Confidence            3

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.84  E-value=2.8e-20  Score=193.70  Aligned_cols=132  Identities=33%  Similarity=0.486  Sum_probs=111.8

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHh-cCCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAK-LQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~-l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||+|... +++.+|||.++...   ......+..|..++.. ++|||+         ....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999986 56789999986531   2334556778888876 489999         4578899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|..++...   ..+++.+...++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            9999888542   35788899999999999999999986   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.84  E-value=3.5e-20  Score=189.00  Aligned_cols=141  Identities=28%  Similarity=0.465  Sum_probs=119.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-Ccc----EEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQ----EIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~----~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      ++|+..+.||+|+||+||+|... +++    .||+|.++... .....++.+|+.++..++|+|+        ....+++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~   86 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV   86 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence            46777899999999999999853 443    47999986532 3345678999999999999999        3456799


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +||+++|+|..++...  ...+++...+.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 ~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          87 TQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            9999999999988643  235889999999999999999999886   99999999999999999999999999997753

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.83  E-value=3.4e-20  Score=188.93  Aligned_cols=142  Identities=30%  Similarity=0.562  Sum_probs=121.5

Q ss_pred             CCCCccceeccCCceeEEEEEeCC------ccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~------~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      ++|.+.+.||+|+||.||+|...+      ++.+|||.++..... ...+|.+|++++.+++|+|+         ....+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            456778999999999999998643      468999998764433 45789999999999999998         56789


Q ss_pred             EEEEecCCCCHHHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          520 LVYEYLPNKSLDFFIFDSS-----------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      +||||+++++|..++....           ....+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999986432           1234788899999999999999999886   9999999999999999999


Q ss_pred             EEeecCcceeec
Q 042853          589 KISDFGMARTFT  600 (614)
Q Consensus       589 kI~DFGla~~~~  600 (614)
                      ||+|||+++.+.
T Consensus       162 kl~d~g~~~~~~  173 (280)
T cd05049         162 KIGDFGMSRDVY  173 (280)
T ss_pred             EECCcccceecc
Confidence            999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.83  E-value=3.3e-20  Score=186.85  Aligned_cols=139  Identities=31%  Similarity=0.482  Sum_probs=120.4

Q ss_pred             CCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +|...+.||+|+||+||++...++..+|+|.+... .....+|.+|+.++.+++|||+         ....+++|||+++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            45667899999999999999877778999998653 2335679999999999999999         3456899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++|..++....  ..+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            99999885432  25899999999999999999999886   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.83  E-value=3.5e-20  Score=201.50  Aligned_cols=135  Identities=23%  Similarity=0.300  Sum_probs=116.0

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ..+|.+.+.||+|+||.||++... .++.||||...      ...+.+|++++++++|+||         ....++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457888999999999999999986 46789999542      2346789999999999999         4578899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +. ++|..++...  ...++|.++..++.||++||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            95 6888777432  235899999999999999999999887   99999999999999999999999999987654

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.83  E-value=3.1e-20  Score=186.97  Aligned_cols=138  Identities=31%  Similarity=0.471  Sum_probs=119.8

Q ss_pred             CCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +|...+.||+|+||.||++...++..+|+|.+.+.. ....+|.+|++++.+++|+|+         ....++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            356678999999999999998877789999886432 234578899999999999999         4567899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++|.+++....  ..+++.....++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence            99999885432  35789999999999999999999987   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.83  E-value=5.4e-20  Score=188.65  Aligned_cols=141  Identities=25%  Similarity=0.428  Sum_probs=114.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC--CccEEEEEEccCCC--cchhHhHHHHHHHHHhc---CCCCCC-------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ--DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL---QHTNLG-------------  515 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~--~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nl~-------------  515 (614)
                      ++|.+.+.||+|+||.||++...  +++.||||.++...  ......+.+|+.++..+   +|||+.             
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36778899999999999999873  46789999886432  22234567788777766   699981             


Q ss_pred             -CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          516 -GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       516 -~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                       ...++||||++ ++|..++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence             24789999997 68888875432 234789999999999999999999987   9999999999999999999999999


Q ss_pred             cceeecC
Q 042853          595 MARTFTM  601 (614)
Q Consensus       595 la~~~~~  601 (614)
                      +|+....
T Consensus       156 ~~~~~~~  162 (290)
T cd07862         156 LARIYSF  162 (290)
T ss_pred             ceEeccC
Confidence            9987653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.83  E-value=2.6e-20  Score=193.93  Aligned_cols=132  Identities=31%  Similarity=0.457  Sum_probs=111.5

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||++... +++.+|+|.+++..   ......+..|..++..+ +|+|+         ....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999986 57889999986531   23345567788887754 89999         4678999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|..++...   ..+++.+...++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            9999888542   34788888999999999999999987   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.83  E-value=8.5e-21  Score=171.18  Aligned_cols=138  Identities=28%  Similarity=0.476  Sum_probs=113.9

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cc-hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQ-GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|...++||+|.||+|||++.. ++..||+|++.-.. .+ .-....+|+.+++.++|.|+         .....||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3455689999999999999876 56778999886432 22 23457899999999999999         5678899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |.. +|..+....  ...++......++.|+++||.|+|++.   +.||||||+|.||+.+++.|++|||+||.+.
T Consensus        83 cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             hhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            954 676665322  335787888889999999999999987   9999999999999999999999999999775

>PHA02988 hypothetical protein; Provisional

Probab=99.83  E-value=4e-20  Score=189.43  Aligned_cols=134  Identities=21%  Similarity=0.315  Sum_probs=114.9

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcch---hHhHHHHHHHHHhcCCCCC--------C-----CeeEEEEEe
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHTNL--------G-----GERLLVYEY  524 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~---~~~f~~E~~~l~~l~H~nl--------~-----~~~~lv~Ey  524 (614)
                      ...|++|+++.||+|.+ +++.||||+++......   .+.|.+|+.++.+++|||+        .     ...++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 57899999997643222   4678899999999999999        1     256899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++|+|..++...   ..+++.....++.+++.||.|||+..  .++||||||+|||+++++.+||+|||+++.+.
T Consensus       104 ~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        104 CTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            9999999998543   35789999999999999999999742  37899999999999999999999999998654

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.83  E-value=4.3e-20  Score=186.95  Aligned_cols=139  Identities=27%  Similarity=0.418  Sum_probs=121.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.++.+++|+|+         ....++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46778899999999999999974 678899999875444455678899999999999998         45788999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            99999988753   235788999999999999999999876   9999999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.83  E-value=5.2e-20  Score=186.70  Aligned_cols=136  Identities=32%  Similarity=0.440  Sum_probs=113.4

Q ss_pred             ceeccCCceeEEEEEeCC---ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQD---EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~---~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~g  528 (614)
                      +.||+|+||.||+|...+   ...+|+|.++... ......|.+|+.++++++|+|+         ....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   3578999886543 2334578999999999999999         35678999999999


Q ss_pred             CHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          529 SLDFFIFDSSR--KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       529 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +|..++.....  ....++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999864322  234577788889999999999999886   9999999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.83  E-value=5e-20  Score=188.09  Aligned_cols=142  Identities=37%  Similarity=0.586  Sum_probs=119.6

Q ss_pred             CCCccceeccCCceeEEEEEeCC------ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      +|+..+.||+|+||.||+|....      ...+|+|.+.... .....+|.+|+.++.+++|+|+         ....++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            56678999999999999998643      2579999986543 2345678999999999999998         456789


Q ss_pred             EEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 042853          521 VYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN  587 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~  587 (614)
                      +|||+++++|..++.....             ...+++.....++.|++.||.|||+.+   |+|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence            9999999999999864321             145788899999999999999999987   999999999999999999


Q ss_pred             EEEeecCcceeecC
Q 042853          588 PKISDFGMARTFTM  601 (614)
Q Consensus       588 ~kI~DFGla~~~~~  601 (614)
                      +||+|||+++.+..
T Consensus       163 ~~L~dfg~~~~~~~  176 (283)
T cd05048         163 VKISDFGLSRDIYS  176 (283)
T ss_pred             EEECCCcceeeccc
Confidence            99999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.83  E-value=3.9e-20  Score=193.31  Aligned_cols=133  Identities=26%  Similarity=0.398  Sum_probs=108.6

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHH-HHHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEA-KLIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~-~~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||++... +++.+|+|.+.+..   .+...++..|. .++..++|+|+         ....++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999986 56789999986431   22233444444 45678999999         4678999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++|..++...   ..+.......++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~  147 (325)
T cd05602          81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  147 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence            9999888542   34667777789999999999999987   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.83  E-value=6.8e-20  Score=185.75  Aligned_cols=141  Identities=26%  Similarity=0.483  Sum_probs=118.1

Q ss_pred             CCccceeccCCceeEEEEEeCC----ccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CC------
Q 042853          458 FSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GG------  516 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~------  516 (614)
                      |.+.+.||+|+||.||+|.+..    +..+|+|+++...  .....++.+|+++++.++|+|+         ..      
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4557899999999999998742    3679999987532  2345679999999999999998         11      


Q ss_pred             eeEEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSS---RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                      ..++++||+++++|..++....   ....+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence            2689999999999999886432   2345889999999999999999999886   999999999999999999999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05035         158 GLSKKIYS  165 (273)
T ss_pred             cceeeccc
Confidence            99997653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.83  E-value=4.8e-20  Score=189.39  Aligned_cols=142  Identities=30%  Similarity=0.542  Sum_probs=121.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      .+|...+.||+|+||.||+++..      +...+++|.++.......+.|.+|++++.+++|+|+         ....++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            34666789999999999999753      345689999876555556789999999999999999         467899


Q ss_pred             EEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 042853          521 VYEYLPNKSLDFFIFDSS-------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN  587 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~  587 (614)
                      ||||+++++|.+++....             ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986432             1234789999999999999999999887   999999999999999999


Q ss_pred             EEEeecCcceeec
Q 042853          588 PKISDFGMARTFT  600 (614)
Q Consensus       588 ~kI~DFGla~~~~  600 (614)
                      +||+|||+++...
T Consensus       162 ~~l~dfg~a~~~~  174 (291)
T cd05094         162 VKIGDFGMSRDVY  174 (291)
T ss_pred             EEECCCCcccccC
Confidence            9999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.83  E-value=3.8e-20  Score=186.67  Aligned_cols=141  Identities=30%  Similarity=0.521  Sum_probs=122.8

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPN  527 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~  527 (614)
                      ++|++.++||+|+||.||++...++..+|+|.+..... ....|.+|+.++++++|+|+        ....+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~   84 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK   84 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence            46777899999999999999988888899999875332 34679999999999999998        4567899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++|..++.... ...+++..+..++.+++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          85 GSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            99999986432 234789999999999999999999987   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.83  E-value=4.8e-20  Score=191.15  Aligned_cols=139  Identities=29%  Similarity=0.540  Sum_probs=117.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|...++||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++++++|+|+         ....++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46777899999999999999876 567899999865432 233467889999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++ +|..++...  ...+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence            985 787777543  234788888899999999999999886   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.83  E-value=2.7e-20  Score=196.80  Aligned_cols=143  Identities=29%  Similarity=0.454  Sum_probs=122.9

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ....|.+...||+|.|++|..+... ++.+||||.+.+...  .....+.+|+++|..++||||         ...+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467888899999999999999876 688999999977532  223458899999999999999         5789999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+.+|.+..++....+   +.......+..|+..|++|||.++   |||||||++||||+.++++||+|||++-.+..
T Consensus       134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999976554   333666677889999999999987   99999999999999999999999999998864


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus       208 ~  208 (596)
T KOG0586|consen  208 G  208 (596)
T ss_pred             c
Confidence            3

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.83  E-value=6.5e-20  Score=187.91  Aligned_cols=139  Identities=29%  Similarity=0.419  Sum_probs=118.5

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      |...+.||+|+||+||++... +++.+|+|.+....   ......+.+|++++.+++|+|+         ....+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            455688999999999999875 67899999986532   2233457889999999999998         4578899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++.... ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999998886432 235899999999999999999999886   9999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.83  E-value=6.9e-20  Score=185.60  Aligned_cols=147  Identities=27%  Similarity=0.378  Sum_probs=123.3

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      ++.+++++.....||+|+||.||+|... ++..+|+|.+.....+..+.+.+|+.+++.++|+|+         ....++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3456677776789999999999999875 567899999876555566789999999999999998         467899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEeecCcceee
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-QMNPKISDFGMARTF  599 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-~~~~kI~DFGla~~~  599 (614)
                      |+||+++++|..++.........++.....++.||+.||+|||+.+   |+||||||+||+++. ++.+||+|||++..+
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999999864322111277888889999999999999876   999999999999986 678999999999866


Q ss_pred             c
Q 042853          600 T  600 (614)
Q Consensus       600 ~  600 (614)
                      .
T Consensus       160 ~  160 (268)
T cd06624         160 A  160 (268)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.83  E-value=4.1e-20  Score=210.62  Aligned_cols=140  Identities=25%  Similarity=0.427  Sum_probs=121.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.++||+|+||.||+|... +++.||||.+....   .....++..|+.++..++|+|+         ....++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56788899999999999999986 67899999986532   2234678899999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...   ..+++.....++.||+.||.|||..+   ||||||||+||||+.++.+||+|||+++....
T Consensus        84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~  156 (669)
T cd05610          84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN  156 (669)
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence            999999999988542   34788888999999999999999876   99999999999999999999999999997653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=3.9e-20  Score=193.72  Aligned_cols=131  Identities=26%  Similarity=0.427  Sum_probs=108.8

Q ss_pred             eccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhc---CCCCC---------CCeeEEEEEecCC
Q 042853          464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL---QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l---~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      ||+|+||+||++... +++.+|||.+.+..   ......+..|..++...   +|||+         ....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999876 57899999986431   12233455676776665   69998         4578999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+|..++..   ...+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~  147 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL  147 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence            999888753   335788999999999999999999987   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.83  E-value=4.8e-20  Score=189.34  Aligned_cols=147  Identities=27%  Similarity=0.470  Sum_probs=122.8

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeCC------ccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------  514 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------  514 (614)
                      ....++|+..+.||+|+||.||++....      ...+|+|.+.... .+...++.+|+.++.++ +|+|+         
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3444667778999999999999998642      3578999987532 33456789999999999 79998         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDS-------------SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL  581 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  581 (614)
                      ....+++|||+++|+|..++...             .....+++..++.++.|++.||.|||+.+   |+||||||+|||
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            45689999999999999998542             12345889999999999999999999876   999999999999


Q ss_pred             EcCCCcEEEeecCcceeecC
Q 042853          582 LDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       582 ld~~~~~kI~DFGla~~~~~  601 (614)
                      +++++.+||+|||+++.+..
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHH  184 (293)
T ss_pred             EcCCCeEEeCcccccccccc
Confidence            99999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.83  E-value=7.6e-20  Score=184.56  Aligned_cols=141  Identities=30%  Similarity=0.513  Sum_probs=121.5

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPN  527 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~  527 (614)
                      ++|.+.+.||+|+||.||++....+..+|+|.+.... ...+.|.+|+.++++++|+|+        ....+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence            4567788999999999999998877789999886532 334678999999999999998        4567899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++|.+++.... ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+..
T Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            99999986532 334789999999999999999999886   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.83  E-value=6.9e-20  Score=184.73  Aligned_cols=134  Identities=29%  Similarity=0.476  Sum_probs=114.8

Q ss_pred             eeccCCceeEEEEEeC---CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCCCCH
Q 042853          463 RLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~gsL  530 (614)
                      .||+|+||.||+|.+.   .+..||+|.+..... ...++|.+|+.++++++|+|+        ....++||||+++++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            4899999999999764   345699999865432 334679999999999999999        4567899999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ..++...  ...+++..+.+++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          82 NKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccC
Confidence            9988532  345899999999999999999999886   99999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.83  E-value=5.1e-20  Score=186.83  Aligned_cols=143  Identities=31%  Similarity=0.451  Sum_probs=121.9

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCCC---------------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLG---------------  515 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl~---------------  515 (614)
                      .+++.|+..+.||+|+||.||+|... +++.+|+|.+... .....++..|+.++.++ +|+|+.               
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677888899999999999999876 5678999998653 33456788999999998 799991               


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      ...+++|||+++++|..++... ....+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            2478999999999999988643 2345789999999999999999999986   99999999999999999999999999


Q ss_pred             ceeec
Q 042853          596 ARTFT  600 (614)
Q Consensus       596 a~~~~  600 (614)
                      ++.+.
T Consensus       158 ~~~~~  162 (272)
T cd06637         158 SAQLD  162 (272)
T ss_pred             ceecc
Confidence            98764

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.83  E-value=3.2e-20  Score=187.51  Aligned_cols=140  Identities=27%  Similarity=0.357  Sum_probs=118.7

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-ccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|...+.||+|.-|+||.+.+.+ +...|+|.+.+..   .+...+...|-+||+.++||-+         ....+|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            345567899999999999999975 4788999997653   2334567789999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |||++|+|..++..+. ...++......++..|+-||+|||-.+   ||.|||||+||||-++|++-|+||-|+...
T Consensus       157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999998876544 345677777778888999999999887   999999999999999999999999998755

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.83  E-value=8.2e-20  Score=186.37  Aligned_cols=134  Identities=28%  Similarity=0.440  Sum_probs=113.7

Q ss_pred             eccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ||+|+||.||++... +++.+|+|.+....   ......+..|++++.+++|||+         ....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999875 57899999986421   1223456679999999999999         4678999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ..++.... ...+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            88875433 234788999999999999999999886   99999999999999999999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.83  E-value=5.6e-20  Score=191.59  Aligned_cols=132  Identities=33%  Similarity=0.471  Sum_probs=113.4

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||+||++... +++.+|||.+.+.   .......+..|.+++..+ +|+|+         ....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999886 5678999998753   223445678899998888 69999         4578999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            9998887543   35889999999999999999999886   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=4.5e-21  Score=194.96  Aligned_cols=150  Identities=29%  Similarity=0.458  Sum_probs=126.4

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .|...+.||+|+||.||||... .++.||+|.+.-. ....+++..+|+.++..++++|+         +..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            3555689999999999999975 6788999999654 33456778999999999999999         56778999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCccc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE  605 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~~  605 (614)
                      .+|++...|.   ....+++.+..-|.+++..||.|||.++   .||||||+.|||+..++.+|++|||+|-.+......
T Consensus        94 ~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   94 GGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             cCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999988873   2334467777778899999999999987   999999999999999999999999999999876654


Q ss_pred             cCCCceecC
Q 042853          606 ANTNRIVGT  614 (614)
Q Consensus       606 ~~~~~~~GT  614 (614)
                      .  .+++||
T Consensus       168 r--~tfvGT  174 (467)
T KOG0201|consen  168 R--KTFVGT  174 (467)
T ss_pred             c--cccccc
Confidence            4  447887

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.83  E-value=6.5e-20  Score=185.81  Aligned_cols=141  Identities=30%  Similarity=0.541  Sum_probs=120.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC----CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ++|.+.+.||+|+||.||+|...    ....+|+|.++... ....+.|.+|+.++.+++|||+         ....++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45677899999999999999864    23468999986532 3345678999999999999999         4568999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++++|..++...  ...+++.+...++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998543  235789999999999999999999886   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.83  E-value=6.5e-20  Score=185.38  Aligned_cols=141  Identities=26%  Similarity=0.453  Sum_probs=121.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ..|...+.||+|+||.||+|... .++.+|+|.+... .....++.+|++++..++|+|+         ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            34666789999999999999876 4778999998653 3345679999999999999999         45678999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|..++.... ...+++..++.++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++.+..
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999999885432 345799999999999999999999876   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.83  E-value=5.4e-20  Score=187.16  Aligned_cols=145  Identities=28%  Similarity=0.492  Sum_probs=121.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeCC------ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      .++|.+.+.||+|+||.||+|....      +..+|+|.+.... .....+|.+|+.++..++|+|+         ....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3567778999999999999998742      3679999986542 2345678999999999999999         4578


Q ss_pred             EEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEe
Q 042853          519 LLVYEYLPNKSLDFFIFDSSR-------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKIS  591 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~  591 (614)
                      ++||||+++++|..++.....       ...++|.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999864321       234788999999999999999999876   9999999999999999999999


Q ss_pred             ecCcceeecCC
Q 042853          592 DFGMARTFTMN  602 (614)
Q Consensus       592 DFGla~~~~~~  602 (614)
                      |||+++.+...
T Consensus       162 dfg~~~~~~~~  172 (277)
T cd05032         162 DFGMTRDIYET  172 (277)
T ss_pred             CcccchhhccC
Confidence            99999876443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.83  E-value=7.1e-20  Score=183.69  Aligned_cols=134  Identities=31%  Similarity=0.508  Sum_probs=115.9

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      +.||+|+||.||++... +++.+|+|.+.... .+....|.+|++++++++|+|+         ....++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999885 67889999886433 3345679999999999999999         4567899999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ..++...  ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence            9988532  235789999999999999999999886   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.83  E-value=1.9e-21  Score=188.11  Aligned_cols=149  Identities=28%  Similarity=0.454  Sum_probs=127.5

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      -|.+.++||+|+||.|||+.++ .|+.+|||++..  ....+|...|+.+|...+.+.+         ...+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            4666799999999999999886 789999999864  3456789999999999998887         567899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCcccc
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA  606 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~~~  606 (614)
                      .|+..+++..  +.++|.+.+...+.+..++||+|||...   -||||||+.||||+.++.+||+|||.|-.+...-..+
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            9999999853  4567999999999999999999999875   8999999999999999999999999999886443333


Q ss_pred             CCCceecC
Q 042853          607 NTNRIVGT  614 (614)
Q Consensus       607 ~~~~~~GT  614 (614)
                        +++.||
T Consensus       187 --NTVIGT  192 (502)
T KOG0574|consen  187 --NTVIGT  192 (502)
T ss_pred             --CccccC
Confidence              335665

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.83  E-value=8e-20  Score=187.85  Aligned_cols=144  Identities=26%  Similarity=0.459  Sum_probs=121.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeCC-----------------ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQD-----------------EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--  514 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~-----------------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--  514 (614)
                      .++|.+.+.||+|+||.||++....                 +..+|+|.+.... .....+|.+|++++.+++|+|+  
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3567888999999999999987642                 2458999987543 3456679999999999999998  


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSS--------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN  579 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N  579 (614)
                             ....++++||+++++|..++....        ....+++.....++.|++.||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence                   467899999999999999986533        1225789999999999999999999886   9999999999


Q ss_pred             EEEcCCCcEEEeecCcceeecC
Q 042853          580 ILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       580 ILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+++.++.+||+|||+++.+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             eeecCCCceEEccccceeeccc
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.83  E-value=7.9e-20  Score=188.97  Aligned_cols=144  Identities=26%  Similarity=0.465  Sum_probs=120.2

Q ss_pred             cCCCCccceeccCCceeEEEEEeC--------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ--------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------G  515 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------~  515 (614)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+.... .....++.+|+.++..+ +|+|+         .
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            356677899999999999999742        23478999886532 34456789999999999 89999         4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL  582 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  582 (614)
                      ...+++|||+++|+|..++.....             ...+++..+..++.||++||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            567899999999999999865321             235788899999999999999999986   9999999999999


Q ss_pred             cCCCcEEEeecCcceeecC
Q 042853          583 DEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       583 d~~~~~kI~DFGla~~~~~  601 (614)
                      +.++.+||+|||+|+.+..
T Consensus       171 ~~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         171 TENNVMKIADFGLARDVNN  189 (304)
T ss_pred             cCCCcEEECCCccceeccc
Confidence            9999999999999987743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.82  E-value=8.1e-20  Score=188.15  Aligned_cols=143  Identities=25%  Similarity=0.459  Sum_probs=119.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-----------------CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-----------------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--  514 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-----------------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--  514 (614)
                      .++|++.+.||+|+||.||++...                 +...+|+|.+.... .....+|.+|+.++.+++|+|+  
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356888899999999999998532                 23468999987543 3345679999999999999998  


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSR--------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN  579 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N  579 (614)
                             ....+++|||+++++|..++.....        ...+++.....++.|++.||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence                   4668999999999999999865321        124678889999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEeecCcceeec
Q 042853          580 ILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       580 ILld~~~~~kI~DFGla~~~~  600 (614)
                      ||++.++.+||+|||+++.+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~  181 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLY  181 (296)
T ss_pred             EEEcCCCCEEeccCccccccc
Confidence            999999999999999998764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.82  E-value=7.3e-20  Score=187.26  Aligned_cols=140  Identities=29%  Similarity=0.538  Sum_probs=119.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-----CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC-----------CCeeE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-----DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL-----------GGERL  519 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-----~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~  519 (614)
                      .|++.+.||+|+||.||++...     ++..+|+|.++... .+....|.+|+++++.++|+|+           ....+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            4567889999999999999752     46789999986542 3445679999999999999998           14578


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++++|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        85 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            999999999999988543  235799999999999999999999887   999999999999999999999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       160 ~~  161 (284)
T cd05079         160 ET  161 (284)
T ss_pred             cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.82  E-value=8e-20  Score=186.64  Aligned_cols=142  Identities=31%  Similarity=0.551  Sum_probs=121.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      .++...++||+|+||.||++...      ++..+|+|.+..........|.+|++++..++|+|+         ....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35666789999999999999642      345789999876665666789999999999999999         456799


Q ss_pred             EEEecCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          521 VYEYLPNKSLDFFIFDSSR------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      +|||+++++|..++.....            ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            134789999999999999999999886   9999999999999999999


Q ss_pred             EEeecCcceeec
Q 042853          589 KISDFGMARTFT  600 (614)
Q Consensus       589 kI~DFGla~~~~  600 (614)
                      ||+|||+++.+.
T Consensus       162 kL~dfg~~~~~~  173 (280)
T cd05092         162 KIGDFGMSRDIY  173 (280)
T ss_pred             EECCCCceeEcC
Confidence            999999998664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.82  E-value=1.1e-19  Score=186.03  Aligned_cols=142  Identities=23%  Similarity=0.367  Sum_probs=121.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +|++.+.||+|+||.||++... .++.+|+|.+... ......++.+|+.++.+++|+|+         ....++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5677899999999999999986 6789999988653 22334678999999999999999         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..++........+++.....++.++++||.|||+..  +|+|+||||+||+++.++.+||+|||+++.+.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999988865333346899999999999999999999742  49999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.82  E-value=8.4e-20  Score=185.10  Aligned_cols=140  Identities=28%  Similarity=0.520  Sum_probs=119.7

Q ss_pred             CCCccceeccCCceeEEEEEeCC-c---cEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQD-E---QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~-~---~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .|...+.||+|+||.||+|.... +   ..+|||.++.. ......+|..|+.+++.++|||+         ....++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            35667899999999999998752 2   36999998754 23345689999999999999999         45679999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...  ...+++.++..++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||+++.+..
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999988543  235789999999999999999999886   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.82  E-value=9.2e-20  Score=187.08  Aligned_cols=141  Identities=30%  Similarity=0.492  Sum_probs=117.6

Q ss_pred             CCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      +|.+.+.||+|+||.||+|...      ....+++|.+..... ....++.+|+.+++.++|||+         ....++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3566789999999999999863      225688998865432 335678999999999999998         456789


Q ss_pred             EEEecCCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 042853          521 VYEYLPNKSLDFFIFDSS---------------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN  579 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N  579 (614)
                      ++||+++++|..++....                     ....+++...+.++.|++.||.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1134788999999999999999999876   9999999999


Q ss_pred             EEEcCCCcEEEeecCcceeec
Q 042853          580 ILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       580 ILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++++.+||+|||+++.+.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~  178 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVY  178 (290)
T ss_pred             EEEcCCCcEEecccccccccc
Confidence            999999999999999998664

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.82  E-value=5.7e-21  Score=198.41  Aligned_cols=128  Identities=29%  Similarity=0.458  Sum_probs=110.6

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCHH
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLD  531 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL~  531 (614)
                      ++.||.|+-|.||+|++. +..||||+++..+       ..+|+.|++|+|+||         ..-+|+|||||+.|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            689999999999999996 4679999885322       357889999999999         35678999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          532 FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       532 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ..|..   ...+.-.....+.++||.||.|||.+.   |||||||.-||||..+..+||+|||.++.+...
T Consensus       201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            99853   334666777889999999999999886   999999999999999999999999999977543

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.82  E-value=1.1e-19  Score=186.24  Aligned_cols=139  Identities=29%  Similarity=0.411  Sum_probs=118.4

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      |+..+.||+|+||.||++... +++.+|||.+....   .+....+.+|+.++.+++|+|+         ....++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            556789999999999999876 67899999986532   2223457889999999999998         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++.... ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            99999998885432 234788999999999999999999876   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.82  E-value=1.1e-19  Score=185.90  Aligned_cols=151  Identities=26%  Similarity=0.352  Sum_probs=126.4

Q ss_pred             chhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC----------
Q 042853          447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL----------  514 (614)
Q Consensus       447 ~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl----------  514 (614)
                      .+..+..+.++|++.+.||+|+||.||++... +++.+|+|.++.. .....++.+|+.++.++ +|+|+          
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34566678889999999999999999999875 5678999988643 22345688999999999 69999          


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                          ....++||||+++++|..++... .....+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence                13479999999999999887542 22345788888999999999999999876   99999999999999999999


Q ss_pred             EeecCcceeecC
Q 042853          590 ISDFGMARTFTM  601 (614)
Q Consensus       590 I~DFGla~~~~~  601 (614)
                      |+|||+++.+..
T Consensus       165 l~dfg~~~~~~~  176 (286)
T cd06638         165 LVDFGVSAQLTS  176 (286)
T ss_pred             EccCCceeeccc
Confidence            999999987643

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.82  E-value=5e-20  Score=187.70  Aligned_cols=132  Identities=27%  Similarity=0.424  Sum_probs=109.7

Q ss_pred             eeccCCceeEEEEEeCC-------------------------ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---
Q 042853          463 RLGQGGFGPVYKGKLQD-------------------------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---  514 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~~~-------------------------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---  514 (614)
                      .||+|+||.||+|.+..                         ...|++|.+.........+|.+|+.+++.++|+|+   
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997521                         13588998865444455678999999999999999   


Q ss_pred             ------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC--
Q 042853          515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM--  586 (614)
Q Consensus       515 ------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~--  586 (614)
                            ....++||||+++|+|+.++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence                  45778999999999999888542  335788999999999999999999876   99999999999997543  


Q ss_pred             -----cEEEeecCcceee
Q 042853          587 -----NPKISDFGMARTF  599 (614)
Q Consensus       587 -----~~kI~DFGla~~~  599 (614)
                           .+|++|||+++..
T Consensus       157 ~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             cCccceeeecCCcccccc
Confidence                 3799999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.82  E-value=9.4e-20  Score=198.38  Aligned_cols=144  Identities=25%  Similarity=0.406  Sum_probs=113.8

Q ss_pred             hcCCCCccceeccCCceeEEEEEe-----------------CCccEEEEEEccCCCcchhHh--------------HHHH
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKL-----------------QDEQEIAIKRLSKSSGQGIVE--------------FKNE  502 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~-----------------~~~~~vavK~l~~~~~~~~~~--------------f~~E  502 (614)
                      ..++|++.++||+|+||+||+|.+                 ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 234679999986533222222              3457


Q ss_pred             HHHHHhcCCCCC----------------------CCeeEEEEEecCCCCHHHHHhhcCC---------------------
Q 042853          503 AKLIAKLQHTNL----------------------GGERLLVYEYLPNKSLDFFIFDSSR---------------------  539 (614)
Q Consensus       503 ~~~l~~l~H~nl----------------------~~~~~lv~Ey~~~gsL~~~l~~~~~---------------------  539 (614)
                      +.++.+++|.++                      ....+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888877664                      2357999999999999998864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          540 KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       540 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ...++|..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  360 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC  360 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence            123467788889999999999999886   9999999999999999999999999998664

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.82  E-value=7.4e-20  Score=183.98  Aligned_cols=134  Identities=27%  Similarity=0.441  Sum_probs=112.9

Q ss_pred             ceeccCCceeEEEEEeCCcc-----------EEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          462 NRLGQGGFGPVYKGKLQDEQ-----------EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~-----------~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      +.||+|+||.||+|.+....           .+++|.+...... ...|.+|+.++++++|+|+        ....++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence            46999999999999986432           4777877543322 6789999999999999999        24678999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-------cEEEeecCc
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-------NPKISDFGM  595 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-------~~kI~DFGl  595 (614)
                      ||+++|+|..++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||+
T Consensus        80 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          80 EYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            9999999999986432  25789999999999999999999876   99999999999999887       799999999


Q ss_pred             ceeecC
Q 042853          596 ARTFTM  601 (614)
Q Consensus       596 a~~~~~  601 (614)
                      ++.+..
T Consensus       155 a~~~~~  160 (259)
T cd05037         155 PITVLS  160 (259)
T ss_pred             cccccc
Confidence            987543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.82  E-value=1e-19  Score=183.42  Aligned_cols=142  Identities=31%  Similarity=0.512  Sum_probs=124.5

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ..++|.+.+.||+|+||.||++...+++.+|||.+.... ....++.+|+.++++++|+|+         ....++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            346788889999999999999998888889999987532 345679999999999999999         3678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++.... ...+++.....++.+++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+.
T Consensus        83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence            99999999986532 235789999999999999999999887   9999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=4.3e-20  Score=177.35  Aligned_cols=133  Identities=19%  Similarity=0.204  Sum_probs=104.9

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcc--h-------hHhH-----------------HHHHHHHHhcCCCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ--G-------IVEF-----------------KNEAKLIAKLQHTNL  514 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~nl  514 (614)
                      ...||+|+||.||+|...+|+.||||.++.....  .       ...|                 ..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998653211  1       1122                 349999999987765


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCCEEEcCCC
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL-HKYSRLRVIHRDLKVSNILLDEQM  586 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NILld~~~  586 (614)
                             ....+|||||++++++...+..   ...++..+...++.|++.+|.|| |+.+   |+||||||+|||+++ +
T Consensus        82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~-~  154 (190)
T cd05147          82 PCPEPILLKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD-G  154 (190)
T ss_pred             CCCcEEEecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC-C
Confidence                   1234899999999877544322   23578888999999999999999 5665   999999999999984 6


Q ss_pred             cEEEeecCcceeec
Q 042853          587 NPKISDFGMARTFT  600 (614)
Q Consensus       587 ~~kI~DFGla~~~~  600 (614)
                      .++|+|||+|....
T Consensus       155 ~v~LiDFG~a~~~~  168 (190)
T cd05147         155 KLYIIDVSQSVEHD  168 (190)
T ss_pred             cEEEEEccccccCC
Confidence            89999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.82  E-value=1.5e-19  Score=184.61  Aligned_cols=134  Identities=23%  Similarity=0.360  Sum_probs=116.0

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +|+..+.||+|+||.||++... +++.+|+|.+... ......+|.+|+.++.+++|+|+         ....++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            4667789999999999999874 6788999998654 23345679999999999999999         45788999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..+.       .+++.....++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            999997553       3577888899999999999999987   9999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.82  E-value=1.2e-19  Score=182.55  Aligned_cols=139  Identities=29%  Similarity=0.551  Sum_probs=122.2

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      ++|+..+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++.+++|+|+         ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46777899999999999999875 68899999976433 56789999999999999998         467889999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++|..++..... ..+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            9999999864332 35899999999999999999999887   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.82  E-value=1e-19  Score=187.49  Aligned_cols=140  Identities=30%  Similarity=0.518  Sum_probs=117.2

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-c--cEEEEEEccCC-CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-E--QEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-~--~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv  521 (614)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.|.+|++++.++ +|||+         ....+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467778999999999999998753 3  24788888643 233456789999999999 79998         3457899


Q ss_pred             EEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          522 YEYLPNKSLDFFIFDSS-------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      +||+++++|.+++....             ....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999986432             1134788999999999999999999876   9999999999999999999


Q ss_pred             EEeecCccee
Q 042853          589 KISDFGMART  598 (614)
Q Consensus       589 kI~DFGla~~  598 (614)
                      ||+|||+++.
T Consensus       159 kl~dfg~~~~  168 (297)
T cd05089         159 KIADFGLSRG  168 (297)
T ss_pred             EECCcCCCcc
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.82  E-value=9.6e-20  Score=186.19  Aligned_cols=136  Identities=32%  Similarity=0.491  Sum_probs=116.7

Q ss_pred             CccceeccCCceeEEEEEe-----CCccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC-----------CCeeEEE
Q 042853          459 SPANRLGQGGFGPVYKGKL-----QDEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL-----------GGERLLV  521 (614)
Q Consensus       459 ~~~~~lG~G~fg~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv  521 (614)
                      ...+.||+|+||+||++..     .+++.+|+|.+.... .+....|.+|++++++++|+|+           ....+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6678999999999988653     356789999987543 2345678999999999999998           1247899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++++|..++..    ..+++.++..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            999999999998853    24899999999999999999999986   99999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=5e-21  Score=199.54  Aligned_cols=140  Identities=34%  Similarity=0.455  Sum_probs=116.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcc---hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQ---GIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      -|+....||.|+||.||-+... +...||||+++-...+   ....+..|+..|.+++|||.         ....+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3555788999999999999875 6678999999765443   34568899999999999998         234579999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||- ||-.+++.-.  ++++...++..|..|.++||.|||+..   .||||||+.||||.+.+.|||+|||-|.++.+-
T Consensus       107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            995 4666666322  356888899999999999999999987   899999999999999999999999999987643

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.82  E-value=8.4e-20  Score=186.55  Aligned_cols=141  Identities=33%  Similarity=0.500  Sum_probs=117.6

Q ss_pred             CCccceeccCCceeEEEEEeC------CccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      |.+.++||+|+||.||+|...      .++.||+|+++..... ...+|.+|+.++..++|+|+         ....+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            455789999999999999864      2468999999754332 34568999999999999998         3567899


Q ss_pred             EEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          522 YEYLPNKSLDFFIFDSS-------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      +||+++++|..++....             ....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence            99999999999985211             1234788889999999999999999886   9999999999999999999


Q ss_pred             EEeecCcceeecC
Q 042853          589 KISDFGMARTFTM  601 (614)
Q Consensus       589 kI~DFGla~~~~~  601 (614)
                      ||+|||+++.+..
T Consensus       164 kl~Dfg~~~~~~~  176 (283)
T cd05091         164 KISDLGLFREVYA  176 (283)
T ss_pred             Eeccccccccccc
Confidence            9999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.82  E-value=1.2e-19  Score=182.88  Aligned_cols=134  Identities=29%  Similarity=0.475  Sum_probs=115.2

Q ss_pred             eeccCCceeEEEEEeC---CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCCCC
Q 042853          463 RLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPNKS  529 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~gs  529 (614)
                      +||+|+||.||+|.+.   +++.+|+|.++...  ....++|.+|+.++++++|+|+        ....++||||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            6899999999999753   56789999986432  2345679999999999999998        456789999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          530 LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       530 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          82 LNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            99988532   35788999999999999999999886   999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.82  E-value=1.2e-19  Score=188.02  Aligned_cols=140  Identities=25%  Similarity=0.313  Sum_probs=119.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|++.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++.+++|+|+         ..+.++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36788899999999999999876 5678888988643 22334568899999999999999         5688999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++...   ..+++.....++.|+++||.|||+..  +++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            9999999998543   45788889999999999999999742  49999999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.82  E-value=7.6e-20  Score=189.45  Aligned_cols=143  Identities=27%  Similarity=0.464  Sum_probs=120.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC--------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ--------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------G  515 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------~  515 (614)
                      .++|.+.+.||+|+||.||++...        ....+|+|.+.... .....++..|+.++.++ +|+|+         .
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            356888899999999999999753        23469999987542 34456788999999999 79998         4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL  582 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  582 (614)
                      ...++||||+++|+|..++.....             ...+++.+++.++.|++.||+|||+.+   ++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            578999999999999999865321             235889999999999999999999876   9999999999999


Q ss_pred             cCCCcEEEeecCcceeec
Q 042853          583 DEQMNPKISDFGMARTFT  600 (614)
Q Consensus       583 d~~~~~kI~DFGla~~~~  600 (614)
                      +.++.+||+|||+|+.+.
T Consensus       174 ~~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         174 TEDNVMKIADFGLARDIH  191 (307)
T ss_pred             cCCCcEEECCCccccccc
Confidence            999999999999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.82  E-value=1.2e-19  Score=184.54  Aligned_cols=142  Identities=27%  Similarity=0.428  Sum_probs=121.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      ++|+....||+|+||.||++...      +.+.+++|.+.....+ ...+|.+|++++.+++|+|+         ....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46777899999999999999864      3467899988654433 45689999999999999998         35689


Q ss_pred             EEEEecCCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          520 LVYEYLPNKSLDFFIFDSSRK------SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                      +||||++.++|..++......      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998654321      25899999999999999999999887   999999999999999999999999


Q ss_pred             Ccceeec
Q 042853          594 GMARTFT  600 (614)
Q Consensus       594 Gla~~~~  600 (614)
                      |+++...
T Consensus       162 ~~~~~~~  168 (275)
T cd05046         162 SLSKDVY  168 (275)
T ss_pred             ccccccC
Confidence            9987543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.82  E-value=1.6e-19  Score=180.80  Aligned_cols=134  Identities=32%  Similarity=0.506  Sum_probs=116.6

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCHH
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLD  531 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL~  531 (614)
                      +.||+|+||.||+|...+++.+|+|.+..... +....|.+|++++.+++|+|+         ....++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988888999999875433 334568999999999999998         45688999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          532 FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       532 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      .++...  ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence            988543  235789999999999999999999886   9999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.82  E-value=9.7e-20  Score=184.78  Aligned_cols=133  Identities=23%  Similarity=0.394  Sum_probs=109.7

Q ss_pred             eeccCCceeEEEEEeCCc---cEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCC
Q 042853          463 RLGQGGFGPVYKGKLQDE---QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKS  529 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~~~~---~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gs  529 (614)
                      +||+|+||.||++...++   ..+++|.+.... .+..++|.+|+.+++.++|||+         ....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999976433   345677765432 3345689999999999999999         356799999999999


Q ss_pred             HHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          530 LDFFIFDSSR-KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       530 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      |..++..... ....++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence            9999865322 234566777889999999999999876   99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.82  E-value=1.1e-19  Score=187.47  Aligned_cols=139  Identities=30%  Similarity=0.430  Sum_probs=122.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .+|...+.||+|+||.||++... +++.+|+|.+........+.+.+|+.+++.++|+|+         ....++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            56778899999999999999864 788999999976544455678999999999999999         46789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|..++..    ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            99999998843    34788999999999999999999876   99999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.82  E-value=7.5e-20  Score=199.01  Aligned_cols=140  Identities=24%  Similarity=0.380  Sum_probs=114.0

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCC----------------
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG----------------  516 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~----------------  516 (614)
                      ...+|...+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++|+|+..                
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            4567999999999999999999875 57899999885422    23457999999999999821                


Q ss_pred             -eeEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeec
Q 042853          517 -ERLLVYEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDF  593 (614)
Q Consensus       517 -~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DF  593 (614)
                       ..++||||+++ +|..++... .....+++.....++.||++||.|||+.+   ||||||||+||||+.+. .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence             25689999985 666655432 23446888999999999999999999987   99999999999999654 6999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |+|+.+..
T Consensus       216 Gla~~~~~  223 (440)
T PTZ00036        216 GSAKNLLA  223 (440)
T ss_pred             ccchhccC
Confidence            99997653

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.82  E-value=1e-19  Score=188.17  Aligned_cols=140  Identities=32%  Similarity=0.546  Sum_probs=117.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-Ccc--EEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQ--EIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~--~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv  521 (614)
                      ++|++.+.||+|+||.||+|... ++.  .+|+|.++... .....+|.+|++++.++ +|+|+         ....++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46777899999999999999875 343  46888876432 33456789999999999 89998         4568999


Q ss_pred             EEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          522 YEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      |||+++++|..++.....             ...+++.+...++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            999999999999864321             235789999999999999999999886   9999999999999999999


Q ss_pred             EEeecCccee
Q 042853          589 KISDFGMART  598 (614)
Q Consensus       589 kI~DFGla~~  598 (614)
                      ||+|||+++.
T Consensus       164 kl~dfg~~~~  173 (303)
T cd05088         164 KIADFGLSRG  173 (303)
T ss_pred             EeCccccCcc
Confidence            9999999974

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.82  E-value=1.5e-19  Score=182.33  Aligned_cols=142  Identities=27%  Similarity=0.474  Sum_probs=122.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecC
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLP  526 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~  526 (614)
                      .++|.+.++||+|+||.||++....+..+|+|.+... ......|.+|++++++++|+|+        ....+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~   83 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA   83 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence            4567788999999999999999877788999988653 2345678999999999999999        445789999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++|..++.... ...+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            999999986532 335788999999999999999999876   99999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.82  E-value=1.1e-19  Score=184.04  Aligned_cols=142  Identities=28%  Similarity=0.543  Sum_probs=121.2

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-Cc---cEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DE---QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~---~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      .++|...+.||+|+||.||++... ++   ..+|+|.+.... ....++|.+|++++.+++|+|+         ....++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346777899999999999999875 23   368999986542 3345679999999999999998         457899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++++|..++...  ...+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999998543  245899999999999999999999886   9999999999999999999999999998764


Q ss_pred             C
Q 042853          601 M  601 (614)
Q Consensus       601 ~  601 (614)
                      .
T Consensus       159 ~  159 (268)
T cd05063         159 D  159 (268)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.82  E-value=9.3e-20  Score=183.22  Aligned_cols=136  Identities=35%  Similarity=0.557  Sum_probs=117.1

Q ss_pred             CCccceeccCCceeEEEEEeCC-ccEEEEEEccCCCcchh--HhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          458 FSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGI--VEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~--~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      |+..+.||+|+||+||++.... ++.+|+|.+........  .....|+.++..++|+|+         ....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            3457899999999999999874 56899999976543222  234569999999999999         56788999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +.++|..++.   ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.++|+|||.+..+
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999986   2345789999999999999999999987   999999999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.82  E-value=1.4e-19  Score=183.11  Aligned_cols=143  Identities=24%  Similarity=0.408  Sum_probs=121.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||.||+|... +++.+|||.+...   ..+....|.+|+++++.++|+|+         ....++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46788899999999999999875 6789999987542   22334568999999999999998         45789999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++.... ....++......++.|+++||.|||+.+   |+|+||||+|||++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998875422 2345788889999999999999999886   99999999999999999999999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.82  E-value=1.5e-19  Score=190.34  Aligned_cols=139  Identities=27%  Similarity=0.396  Sum_probs=117.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------------CC
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------------GG  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------------~~  516 (614)
                      .++|...+.||+|+||.||++... +++.||||.+....  ....+++.+|+.++++++|+|+               ..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            467888899999999999999875 67889999986532  2234567899999999999998               13


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++++|++ +++|..++.    ...+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence            468999987 678887763    234889999999999999999999987   999999999999999999999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +....
T Consensus       166 ~~~~~  170 (343)
T cd07878         166 RQADD  170 (343)
T ss_pred             eecCC
Confidence            87643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.82  E-value=1.4e-19  Score=184.56  Aligned_cols=141  Identities=27%  Similarity=0.454  Sum_probs=120.0

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-c----cEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-E----QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-~----~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      .+|...+.||+|+||.||+|.... +    ..+|+|.+.... .+...++.+|+.++++++|+|+        ....++|
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v   86 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI   86 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence            456667899999999999998752 2    258999886543 3345678999999999999998        4577899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++|+|..++...  ...+++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          87 TQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            9999999999998643  234889999999999999999999876   99999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.82  E-value=1.5e-19  Score=184.63  Aligned_cols=138  Identities=26%  Similarity=0.428  Sum_probs=120.0

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      |++.+.||+|+||.||++... ++..+++|.+.....+..+.|.+|+++++.++|+|+         ....++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            455688999999999999986 467789998876555566789999999999999999         5678999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence            9998887532  345899999999999999999999986   9999999999999999999999999997653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.82  E-value=2.4e-19  Score=181.13  Aligned_cols=143  Identities=24%  Similarity=0.404  Sum_probs=123.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++..   .....+.+.+|++++++++|+|+         ....++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999999999999987 7889999988632   22335678999999999999998         45788999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++.... ....+++.+...++.++++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886432 2345789999999999999999999886   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.82  E-value=2.4e-19  Score=179.92  Aligned_cols=141  Identities=31%  Similarity=0.459  Sum_probs=122.0

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|+||.||++... +++.+++|.+...  ......++.+|++++++++|+|+         ....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3666789999999999999886 6788999988643  23456679999999999999999         4578999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++++|..++... ....+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            9999999998653 2345889999999999999999999876   99999999999999999999999999997754

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=8.2e-20  Score=186.29  Aligned_cols=141  Identities=27%  Similarity=0.417  Sum_probs=123.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .++|++.+.||+|+||.||++... +++.+|+|.++.......+.|..|++++++++|+|+         ....++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888899999999999999985 578899999876555566789999999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++...  ...+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            9999999988543  235889999999999999999999987   9999999999999999999999999987553

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.82  E-value=1.8e-19  Score=185.18  Aligned_cols=139  Identities=27%  Similarity=0.461  Sum_probs=122.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +.|++.++||+|+||.||+|... +++.+++|.+.....+..+++.+|+.++++++|+|+         ....++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56777899999999999999986 478899999976655667789999999999999999         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ++++|..++...  ...+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            999998877543  235889999999999999999999876   999999999999999999999999998764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.82  E-value=5.3e-20  Score=174.37  Aligned_cols=148  Identities=28%  Similarity=0.283  Sum_probs=129.9

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------------CC
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------------GG  516 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------------~~  516 (614)
                      .+..++|.+.+.||+|||.-||.++. .+++.+|+|++.-...++.++.++|++..++++|||+              ..
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            34457888899999999999999984 4778899999987677788889999999999999998              34


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRK-SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      +.+|++.|...|+|.+.+.....+ ..+++.+.+.|..+|++||++||+.. ++.+||||||.|||+.+++.++|.|||-
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence            689999999999999988765443 47899999999999999999999985 5899999999999999999999999999


Q ss_pred             ceeec
Q 042853          596 ARTFT  600 (614)
Q Consensus       596 a~~~~  600 (614)
                      +....
T Consensus       176 ~~~a~  180 (302)
T KOG2345|consen  176 ATQAP  180 (302)
T ss_pred             ccccc
Confidence            87653

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.82  E-value=1.4e-20  Score=199.09  Aligned_cols=146  Identities=28%  Similarity=0.444  Sum_probs=119.2

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEcc--C--CCcchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEEEe
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLS--K--SSGQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVYEY  524 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~--~--~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~Ey  524 (614)
                      .++||+|+|-+||||.+. .|.+||--.++  +  ..++..+.|..|+++|+.|+|+||           .....+|.|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            478999999999999986 56777643332  1  134556789999999999999999           3346789999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEeecCcceeecCCc
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-~~~~~kI~DFGla~~~~~~~  603 (614)
                      |..|+|..|+....+   ++.+....+++||++||.|||.+. |||||||||..||+|+ ..|.|||.|+|||.++....
T Consensus       125 ~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999976543   677888899999999999999985 7899999999999998 55889999999999886543


Q ss_pred             cccCCCceecC
Q 042853          604 LEANTNRIVGT  614 (614)
Q Consensus       604 ~~~~~~~~~GT  614 (614)
                      .    ..+.||
T Consensus       201 a----ksvIGT  207 (632)
T KOG0584|consen  201 A----KSVIGT  207 (632)
T ss_pred             c----ceeccC
Confidence            2    125676

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.82  E-value=1.3e-19  Score=185.79  Aligned_cols=143  Identities=30%  Similarity=0.544  Sum_probs=121.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      .++|+..+.||+|+||.||++...      ++..+|+|.+.... .+...+|.+|+.++++++|+|+         ....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888899999999999999864      35789999987543 3345679999999999999999         4568


Q ss_pred             EEEEEecCCCCHHHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 042853          519 LLVYEYLPNKSLDFFIFDSS-------------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN  579 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N  579 (614)
                      +++|||+++++|..++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986421                   1124788889999999999999999886   9999999999


Q ss_pred             EEEcCCCcEEEeecCcceeec
Q 042853          580 ILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       580 ILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++++.+||+|||+++.+.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~  181 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIY  181 (288)
T ss_pred             eEecCCCceEECccccceecc
Confidence            999999999999999998654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.82  E-value=1.2e-19  Score=187.11  Aligned_cols=138  Identities=30%  Similarity=0.443  Sum_probs=121.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .+|...+.||+|+||.||++... +++.+|+|.+........+.+.+|+.+++.+.|+|+         ..+.++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            46777899999999999999864 678999999876555556778999999999999999         46789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..++..    ..+++.+...++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++...
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            99999998843    34788999999999999999999987   9999999999999999999999999988654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.82  E-value=2.9e-21  Score=182.25  Aligned_cols=141  Identities=28%  Similarity=0.422  Sum_probs=115.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccC--CCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++.|++.++||+|.|+.||++... +|+..|+|.+..  -.....+++.+|+.+..+|+||||         ....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            356777899999999999998764 788888887743  234467788999999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~---~~~kI~DFGla~~~  599 (614)
                      |+|.+++|..-+...   ...++...-..+.||++||.|+|.++   |||||+||+|+||.+.   --+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999986655322   23455666778999999999999987   9999999999999633   34899999999999


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       164 ~~  165 (355)
T KOG0033|consen  164 ND  165 (355)
T ss_pred             CC
Confidence            83

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.82  E-value=1.1e-19  Score=195.10  Aligned_cols=136  Identities=23%  Similarity=0.366  Sum_probs=115.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC---CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...     ..+.+|++++++++|+|+         ....+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457888999999999999999754   3467899988642     245689999999999999         35688999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+. ++|..++.   ....+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+...
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9986 67877773   2346899999999999999999999987   999999999999999999999999999876543

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.9e-20  Score=190.45  Aligned_cols=148  Identities=28%  Similarity=0.397  Sum_probs=127.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      -+.|..-+.||+|+||.||-+... +|+.+|.|++.+.   +.++....++|-.++.+++.+.+         .+.++||
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356777899999999999998876 6888999988543   23455567899999999999987         6789999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +..|.+|+|..+|..... .-+++.....++.+|+.||++||.+.   ||.|||||+|||||+.|+++|+|+|||..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999987655 35788888889999999999999876   99999999999999999999999999999987


Q ss_pred             Ccccc
Q 042853          602 NELEA  606 (614)
Q Consensus       602 ~~~~~  606 (614)
                      ++..+
T Consensus       340 g~~~~  344 (591)
T KOG0986|consen  340 GKPIR  344 (591)
T ss_pred             CCccc
Confidence            76543

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.81  E-value=1.6e-19  Score=187.67  Aligned_cols=143  Identities=28%  Similarity=0.482  Sum_probs=120.0

Q ss_pred             cCCCCccceeccCCceeEEEEEeC--------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ--------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------G  515 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------~  515 (614)
                      .++|.+.+.||+|+||.||++...        ....+|+|.++... .....++.+|+.++.++ +|+|+         .
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356777899999999999999752        23568999887532 34456789999999999 69998         4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSS-------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL  582 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  582 (614)
                      ...+++|||+++|+|..++....             ....+++.+...++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            56899999999999999986532             1235889999999999999999999886   9999999999999


Q ss_pred             cCCCcEEEeecCcceeec
Q 042853          583 DEQMNPKISDFGMARTFT  600 (614)
Q Consensus       583 d~~~~~kI~DFGla~~~~  600 (614)
                      +.++.+||+|||+++.+.
T Consensus       168 ~~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         168 TEDNVMKIADFGLARGVH  185 (314)
T ss_pred             cCCCcEEEcccccccccc
Confidence            999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.81  E-value=9.9e-20  Score=184.27  Aligned_cols=139  Identities=27%  Similarity=0.443  Sum_probs=121.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|...+.||+|+||.||++... +++.+|+|.++.........+.+|+.++..++|+|+         ....++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45666789999999999999875 578899999876544445668899999999999998         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..++...   ..+++.+...++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++..+.
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            999999988532   35789999999999999999999987   9999999999999999999999999998664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.81  E-value=1.6e-19  Score=186.71  Aligned_cols=143  Identities=30%  Similarity=0.464  Sum_probs=120.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------CCe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------GGE  517 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------~~~  517 (614)
                      .++|...+.||+|+||.||++...      .+..+|||.++... ....+.+.+|+.+++++ +|+|+         ...
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            356888899999999999999742      34579999987543 23345789999999999 79999         456


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .+++|||+++|+|..++.... ...+++.+...++.|++.||.|||+.+   |+|+||||+|||++.+..+||+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            899999999999999986432 234799999999999999999999886   9999999999999999999999999998


Q ss_pred             eecC
Q 042853          598 TFTM  601 (614)
Q Consensus       598 ~~~~  601 (614)
                      .+..
T Consensus       190 ~~~~  193 (302)
T cd05055         190 DIMN  193 (302)
T ss_pred             cccC
Confidence            7643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.9e-20  Score=208.50  Aligned_cols=160  Identities=24%  Similarity=0.309  Sum_probs=128.0

Q ss_pred             hhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------
Q 042853          448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------  514 (614)
Q Consensus       448 ~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------  514 (614)
                      ..++....++|.+.+.||+|+||.|...+.. +++.+|+|++++-   +......|+.|-.+|..-+.+-|         
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3455666678999999999999999999986 5778899999762   23344568888888877665544         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                      ..++|+||||||+|+|-.++-...   .++......++..|..||.-||+.+   .|||||||.|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            568899999999999999985433   4666666667778999999999987   9999999999999999999999999


Q ss_pred             cceeecCCccccCCCceecC
Q 042853          595 MARTFTMNELEANTNRIVGT  614 (614)
Q Consensus       595 la~~~~~~~~~~~~~~~~GT  614 (614)
                      -+-.+..+..-. ....|||
T Consensus       221 sClkm~~dG~V~-s~~aVGT  239 (1317)
T KOG0612|consen  221 SCLKMDADGTVR-SSVAVGT  239 (1317)
T ss_pred             hHHhcCCCCcEE-eccccCC
Confidence            998887555332 3336777

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.81  E-value=1.8e-19  Score=185.01  Aligned_cols=141  Identities=30%  Similarity=0.404  Sum_probs=121.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|...+.||+|+||.||++... +++.+|+|.+.+..   .+....+.+|++++++++|+|+         ....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36777899999999999999876 57899999986432   2345668899999999999998         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++++|..++...   ..+++..+..++.|+++||.|||+.+   |+|+||+|+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999988543   45788999999999999999999976   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.81  E-value=2.4e-19  Score=180.43  Aligned_cols=138  Identities=27%  Similarity=0.481  Sum_probs=119.1

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~Ey~  525 (614)
                      ++|...+.||+|+||.||++... +..+|+|.++..  ...+.|.+|+.++++++|+|+          ....+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            35677899999999999999875 677899988643  234678999999999999998          34578999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..++.... ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence            9999999986432 235789999999999999999999886   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.81  E-value=1.6e-19  Score=182.68  Aligned_cols=134  Identities=25%  Similarity=0.414  Sum_probs=111.7

Q ss_pred             ceeccCCceeEEEEEeCC-------------ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          462 NRLGQGGFGPVYKGKLQD-------------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~-------------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      +.||+|+||.||+|....             ...|++|.+..........|..|+.++..++|||+         ....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998632             22588898865544455678999999999999999         45678


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-------EEEee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN-------PKISD  592 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~-------~kI~D  592 (614)
                      +||||+++++|+.++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999998887532  345889999999999999999999886   999999999999986654       89999


Q ss_pred             cCcceeec
Q 042853          593 FGMARTFT  600 (614)
Q Consensus       593 FGla~~~~  600 (614)
                      ||++..+.
T Consensus       156 ~g~~~~~~  163 (262)
T cd05077         156 PGIPITVL  163 (262)
T ss_pred             CCCCcccc
Confidence            99997654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.81  E-value=2.6e-19  Score=186.21  Aligned_cols=135  Identities=32%  Similarity=0.491  Sum_probs=109.4

Q ss_pred             cceeccCCceeEEEEEeC---CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEEEecC
Q 042853          461 ANRLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~Ey~~  526 (614)
                      ..+||+|+||.||+|...   .++.+|+|.+....  ....+.+|+.++++++|||+           ....+++|||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865   45789999986532  23457889999999999999           235789999986


Q ss_pred             CCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEeecCcc
Q 042853          527 NKSLDFFIFDSS------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL----DEQMNPKISDFGMA  596 (614)
Q Consensus       527 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----d~~~~~kI~DFGla  596 (614)
                      + +|..++....      ....+++.....++.||+.||.|||+.+   |+||||||+|||+    +..+.+||+|||+|
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 7776664221      1224788888999999999999999987   9999999999999    45678999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +.+..
T Consensus       160 ~~~~~  164 (317)
T cd07868         160 RLFNS  164 (317)
T ss_pred             eccCC
Confidence            87653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.81  E-value=1.9e-19  Score=183.47  Aligned_cols=144  Identities=32%  Similarity=0.505  Sum_probs=120.5

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCC------ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCe
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGE  517 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~  517 (614)
                      .+++|.+.+.||+|+||.||++....      +..+|+|.+.... ......|..|+.++++++|+|+         ...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34678888999999999999998853      4678999886443 2334579999999999999999         456


Q ss_pred             eEEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEE
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSR----KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM---NPKI  590 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~---~~kI  590 (614)
                      .++||||+++++|..++.....    ...+++..++.++.||+.||.|||+.+   ++||||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            7899999999999999865321    235899999999999999999999986   99999999999998654   5899


Q ss_pred             eecCcceeec
Q 042853          591 SDFGMARTFT  600 (614)
Q Consensus       591 ~DFGla~~~~  600 (614)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (277)
T cd05036         161 ADFGMARDIY  170 (277)
T ss_pred             ccCccccccC
Confidence            9999998764

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=2.1e-20  Score=182.64  Aligned_cols=151  Identities=28%  Similarity=0.368  Sum_probs=122.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchh---HhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGI---VEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~---~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|...+.||+|.||+|-.++-+ .++.+|+|.|++..--..   ..-..|-++|...+||.+         ...+|.||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            56777899999999999999876 678899999987633222   334668889999999998         67899999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||..+|.|..+|.   +...+++.....+-..|..||.|||+..   ||.||||.+|.|||.++++||+||||+|.-...
T Consensus       248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence            9999999988874   3344666555557778999999999987   999999999999999999999999999964432


Q ss_pred             ccccCCCceecC
Q 042853          603 ELEANTNRIVGT  614 (614)
Q Consensus       603 ~~~~~~~~~~GT  614 (614)
                      .  +.+.+++||
T Consensus       322 g--~t~kTFCGT  331 (516)
T KOG0690|consen  322 G--DTTKTFCGT  331 (516)
T ss_pred             c--ceeccccCC
Confidence            2  345557886

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.81  E-value=1.9e-19  Score=182.62  Aligned_cols=141  Identities=23%  Similarity=0.400  Sum_probs=120.2

Q ss_pred             CCCCccceeccCCceeEEEEEeCC----ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      ++|...+.||+|+||.||+|...+    ...+|||...... .+..+.|.+|+.++++++|+|+        ....++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~   85 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM   85 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence            456678999999999999998743    2468999886543 3455679999999999999999        45678999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...  ...+++..+..++.+++.||.|||+.+   ++|+||||+|||++.++.+||+|||+++.+..
T Consensus        86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          86 ELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            999999999998543  234799999999999999999999876   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.81  E-value=1.9e-19  Score=188.77  Aligned_cols=143  Identities=26%  Similarity=0.452  Sum_probs=119.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC--------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------CC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ--------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------GG  516 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------~~  516 (614)
                      .+|.+.+.||+|+||.||++...        ....+|+|.+.... .....++.+|++++.++ +|+|+         ..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            45777899999999999999742        12368999886432 33456899999999999 79999         45


Q ss_pred             eeEEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSS-------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD  583 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld  583 (614)
                      ..+++|||+++|+|..++....             ....++|..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            6889999999999999986421             1235789999999999999999999986   99999999999999


Q ss_pred             CCCcEEEeecCcceeecC
Q 042853          584 EQMNPKISDFGMARTFTM  601 (614)
Q Consensus       584 ~~~~~kI~DFGla~~~~~  601 (614)
                      .++.+||+|||+++.+..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~  186 (334)
T cd05100         169 EDNVMKIADFGLARDVHN  186 (334)
T ss_pred             CCCcEEECCcccceeccc
Confidence            999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.81  E-value=1.6e-19  Score=186.75  Aligned_cols=141  Identities=31%  Similarity=0.545  Sum_probs=117.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-Ccc----EEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQ----EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~----~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      +.|...+.||+|+||.||++... ++.    .+|+|.+..... ....+|.+|+.+++.++|+|+        ....+++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v   86 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV   86 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence            45666789999999999999864 333    478898865432 334578999999999999998        3456789


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +||+++|+|..++...  ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 ~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          87 TQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             ehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence            9999999999988543  234788899999999999999999886   99999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.81  E-value=2.3e-19  Score=183.24  Aligned_cols=140  Identities=31%  Similarity=0.539  Sum_probs=119.3

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|+||.||+|... +++.+|||.+....  .....++.+|+.++..++|+|+         ....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            3667789999999999999986 67899999986432  2234578899999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++ ++|..++........+++.....++.|+++||.|||+.+   |+|+||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            97 688888754444456899999999999999999999886   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.81  E-value=2.4e-19  Score=183.14  Aligned_cols=141  Identities=29%  Similarity=0.396  Sum_probs=120.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|+....||+|+||.||++... +++.+|+|++....  ....+.+.+|+.+++.++|+|+         ....++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36777899999999999999986 57899999886432  2234568899999999999998         457889999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |++++.|..++..   ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999988877632   234899999999999999999999976   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.81  E-value=2.3e-19  Score=180.41  Aligned_cols=136  Identities=30%  Similarity=0.412  Sum_probs=118.0

Q ss_pred             ceeccCCceeEEEEEeCC--c--cEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQD--E--QEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~--~--~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~g  528 (614)
                      +.||+|++|.||++.+..  +  ..+|+|.+..... ...++|.+|+.++++++|+|+        ....++||||++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG   80 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence            468999999999998753  2  3689999977554 566789999999999999999        34678999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +|..++..... ..+++.....++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          81 SLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             cHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            99999865432 46899999999999999999999886   99999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.3e-19  Score=172.64  Aligned_cols=135  Identities=19%  Similarity=0.228  Sum_probs=107.7

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcch--------------------------hHhHHHHHHHHHhcCCCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQG--------------------------IVEFKNEAKLIAKLQHTNL  514 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~--------------------------~~~f~~E~~~l~~l~H~nl  514 (614)
                      ...||+|+||.||+|...+|+.||||.+.......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999998889999999987542110                          1123578999999999987


Q ss_pred             C-------CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCC
Q 042853          515 G-------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK-YSRLRVIHRDLKVSNILLDEQM  586 (614)
Q Consensus       515 ~-------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILld~~~  586 (614)
                      .       .+.+|||||++++++......   ...++..+...++.+++.+|.|||+ .+   |+||||||+|||++ ++
T Consensus        82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~  154 (190)
T cd05145          82 PVPEPILLKKNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCceEEEecCCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence            2       234799999998865433221   2346677888999999999999999 76   99999999999999 78


Q ss_pred             cEEEeecCcceeecCC
Q 042853          587 NPKISDFGMARTFTMN  602 (614)
Q Consensus       587 ~~kI~DFGla~~~~~~  602 (614)
                      .++|+|||+|+.+...
T Consensus       155 ~~~liDFG~a~~~~~~  170 (190)
T cd05145         155 KPYIIDVSQAVELDHP  170 (190)
T ss_pred             CEEEEEcccceecCCC
Confidence            9999999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.81  E-value=1.8e-19  Score=182.21  Aligned_cols=143  Identities=25%  Similarity=0.412  Sum_probs=121.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|+..+.||+|+||.||++... +++.+|||.+....   .....+|.+|+.+++.++|+|+         ....+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            45777899999999999999964 78899999886432   2334678999999999999998         45789999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++.... ....+++.....++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 2346899999999999999999999887   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.81  E-value=3.1e-19  Score=183.73  Aligned_cols=139  Identities=31%  Similarity=0.480  Sum_probs=119.3

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcc-----hhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQ-----GIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      +|+..+.||+|+||.||+|... +++.+|||.+......     ....+..|++++++++|+|+         ....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3666789999999999999975 6789999999654322     23457789999999999999         4678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+ .++|..++....  ..+++.....++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999885432  35899999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.81  E-value=3.7e-19  Score=178.63  Aligned_cols=138  Identities=37%  Similarity=0.585  Sum_probs=120.0

Q ss_pred             ceeccCCceeEEEEEeCC----ccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||++....    +..+++|.+...... ..+++.+|++++..++|+|+         ....+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999864    778999999765333 36789999999999999999         4578999999999


Q ss_pred             CCHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          528 KSLDFFIFDSSR------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       528 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++|..++.....      ...+++.++..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999865421      356899999999999999999999976   99999999999999999999999999998764


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus       158 ~  158 (262)
T cd00192         158 D  158 (262)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.81  E-value=4.1e-20  Score=179.96  Aligned_cols=142  Identities=32%  Similarity=0.475  Sum_probs=114.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC---C--ccEEEEEEccCCCcc-h-hHhHHHHHHHHHhcCCCCC----------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ---D--EQEIAIKRLSKSSGQ-G-IVEFKNEAKLIAKLQHTNL----------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~---~--~~~vavK~l~~~~~~-~-~~~f~~E~~~l~~l~H~nl----------~~~~  518 (614)
                      ..|+...+||+|.||.|||+.-.   +  .+.+|+|+++..+.. + .....+|+.+++.++|+|+          ....
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            35677889999999999999643   2  247899999764321 2 3456899999999999999          4578


Q ss_pred             EEEEEecCCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC----CcEEEee
Q 042853          519 LLVYEYLPNKSLDFFIFDS--SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ----MNPKISD  592 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~----~~~kI~D  592 (614)
                      +|++||.++ +|...+..+  .....++-.....|.-||+.|+.|||++-   |+||||||.|||+-.+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 566665432  22345777778889999999999999985   9999999999999766    8999999


Q ss_pred             cCcceeecC
Q 042853          593 FGMARTFTM  601 (614)
Q Consensus       593 FGla~~~~~  601 (614)
                      ||+||++..
T Consensus       180 lGlaR~~~~  188 (438)
T KOG0666|consen  180 LGLARLFNN  188 (438)
T ss_pred             ccHHHHhhc
Confidence            999998853

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.81  E-value=2.5e-19  Score=183.93  Aligned_cols=151  Identities=30%  Similarity=0.410  Sum_probs=127.2

Q ss_pred             echhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------
Q 042853          446 FDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------  514 (614)
Q Consensus       446 ~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------  514 (614)
                      +.+.++..++++|+..+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|+|+         
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            445666777899999999999999999999885 67889999986532 2345678899999998 89998         


Q ss_pred             -----CCeeEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          515 -----GGERLLVYEYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       515 -----~~~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                           ....++||||+++++|..++.... ....+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence                 135789999999999998875422 2345789999999999999999999876   9999999999999999999


Q ss_pred             EEeecCcceeec
Q 042853          589 KISDFGMARTFT  600 (614)
Q Consensus       589 kI~DFGla~~~~  600 (614)
                      ||+|||+++.+.
T Consensus       168 kl~dfg~~~~~~  179 (291)
T cd06639         168 KLVDFGVSAQLT  179 (291)
T ss_pred             EEeecccchhcc
Confidence            999999998654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.81  E-value=1.9e-19  Score=185.19  Aligned_cols=133  Identities=26%  Similarity=0.419  Sum_probs=117.0

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ...||+|+||.||++... ++..+|||.+........+.+.+|+.++.+++|+|+         ....++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            467999999999999875 578899999876555556678999999999999998         5678999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ..++..    ..+++.+...++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++..+.
T Consensus       107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658         107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            988732    24788999999999999999999986   9999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.81  E-value=2.3e-19  Score=181.45  Aligned_cols=139  Identities=27%  Similarity=0.410  Sum_probs=117.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-----cchhHhHHHHHHHHHhcCCCCC-----------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNL-----------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nl-----------~~~~  518 (614)
                      .+|...+.||+|+||.||++... ++..||||.+....     .+..+.+.+|+.++.+++|+|+           ....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46778899999999999999875 57899999875321     1234578899999999999998           1246


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      +++|||+++++|..++...   ..+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            7899999999999988533   34788888999999999999999887   99999999999999999999999999986


Q ss_pred             ec
Q 042853          599 FT  600 (614)
Q Consensus       599 ~~  600 (614)
                      +.
T Consensus       156 ~~  157 (265)
T cd06652         156 LQ  157 (265)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.81  E-value=1.8e-19  Score=191.04  Aligned_cols=137  Identities=28%  Similarity=0.358  Sum_probs=115.0

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCC---------------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLG---------------G  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~---------------~  516 (614)
                      .++|...+.||+|+||.||++... +++.+|||.+...  ......++.+|+.++..++|+|+.               .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            467888999999999999999875 5789999998653  223456788999999999999981               2


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++||||+++ +|...+.     ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence            46899999976 4555542     23678888889999999999999987   999999999999999999999999999


Q ss_pred             eeec
Q 042853          597 RTFT  600 (614)
Q Consensus       597 ~~~~  600 (614)
                      +...
T Consensus       171 ~~~~  174 (359)
T cd07876         171 RTAC  174 (359)
T ss_pred             cccc
Confidence            8654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.81  E-value=3.1e-19  Score=179.23  Aligned_cols=138  Identities=31%  Similarity=0.469  Sum_probs=119.9

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-----cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      |...+.||+|+||+||+|... +++.+++|.+....     .+..+++.+|+++++.++|+|+         ....++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            556789999999999999986 78899999886432     2345679999999999999998         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...   ..+++.....++.|+++||.|||+.+   |+|+||+|+||+++.++.+||+|||+++....
T Consensus        82 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          82 ELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999988533   34788999999999999999999886   99999999999999999999999999987643

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.81  E-value=2.5e-19  Score=190.23  Aligned_cols=138  Identities=29%  Similarity=0.355  Sum_probs=116.1

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC---------------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG---------------G  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~---------------~  516 (614)
                      .++|...+.||+|+||.||++... .++.+|||++....  .....++.+|+.+++.++|+|+.               .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467888999999999999999875 57889999997532  23456788999999999999991               2


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++||||+++ +|..++.     ..+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            46899999975 6666652     23788888899999999999999886   999999999999999999999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +....
T Consensus       174 ~~~~~  178 (364)
T cd07875         174 RTAGT  178 (364)
T ss_pred             cccCC
Confidence            87643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.81  E-value=3.1e-19  Score=182.02  Aligned_cols=139  Identities=31%  Similarity=0.526  Sum_probs=120.1

Q ss_pred             CCCccceeccCCceeEEEEEeC-----CccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC-----------CCeeE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-----DEQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL-----------GGERL  519 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-----~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl-----------~~~~~  519 (614)
                      .|...+.||+|+||.||++...     .++.+|||.+...... ...+|.+|+++++.++|+|+           ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4556789999999999999864     3578999999764432 46789999999999999999           23578


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ++|||+++++|..++....  ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+
T Consensus        85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            9999999999999985432  35899999999999999999999886   999999999999999999999999999877


Q ss_pred             c
Q 042853          600 T  600 (614)
Q Consensus       600 ~  600 (614)
                      .
T Consensus       160 ~  160 (284)
T cd05038         160 P  160 (284)
T ss_pred             c
Confidence            5

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=3.7e-19  Score=179.39  Aligned_cols=139  Identities=29%  Similarity=0.439  Sum_probs=119.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-----cchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      ++|...+.||+|+||.||++... +++.+|+|.+....     ......+.+|++++.+++|+|+         ....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56888899999999999999875 67899999885432     1234568899999999999999         467899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+||+++++|..++...   ..+++.....++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999999888543   34788888999999999999999987   9999999999999999999999999998664

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.81  E-value=3.4e-19  Score=182.15  Aligned_cols=140  Identities=29%  Similarity=0.423  Sum_probs=120.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|+..+.||+|+||.||++... +++.+|+|.+.+...  ...+.+.+|+++++.++|+|+         ....++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            35777899999999999999986 578999998865322  234568899999999999998         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+++++|..+...   ...+++.+...++.||++||.|||+.+   |+|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999877632   234799999999999999999999886   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.81  E-value=1.8e-19  Score=190.73  Aligned_cols=138  Identities=29%  Similarity=0.358  Sum_probs=115.5

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC---------------
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG---------------  515 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~---------------  515 (614)
                      ..++|...+.||+|+||.||++... .++.+|||.+....  ......+.+|+.+++.++|+|+.               
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468888999999999999999875 57889999997532  23346788999999999999981               


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      ...++||||+++ +|...+.     ..+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            246899999975 5655552     23788888899999999999999987   99999999999999999999999999


Q ss_pred             ceeec
Q 042853          596 ARTFT  600 (614)
Q Consensus       596 a~~~~  600 (614)
                      |+...
T Consensus       166 ~~~~~  170 (355)
T cd07874         166 ARTAG  170 (355)
T ss_pred             cccCC
Confidence            98754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.80  E-value=3.5e-19  Score=183.85  Aligned_cols=139  Identities=29%  Similarity=0.533  Sum_probs=117.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +.|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+|+         ....++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            45777899999999999999876 57889999986432 2234467889999999999999         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++ ++|..++...  ...+++.....++.||++||.|||+.+   |+|+||||+|||+++++.+||+|||+++...
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            97 5888887543  234788889999999999999999886   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.80  E-value=2.7e-19  Score=204.66  Aligned_cols=147  Identities=23%  Similarity=0.368  Sum_probs=120.4

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC-----------CCeeE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL-----------GGERL  519 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~  519 (614)
                      ..++|.+.+.||+|+||+||++... .+..+|+|.+...  .......|..|+.++..|+||||           ....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3467888999999999999999986 5667899988643  23345678999999999999998           23578


Q ss_pred             EEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecCCCCCCEEEcCC---------
Q 042853          520 LVYEYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSR----LRVIHRDLKVSNILLDEQ---------  585 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDlkp~NILld~~---------  585 (614)
                      |||||+++|+|..+|.... ....+++...+.|+.||+.||.|||+.+.    .+||||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999886432 23468999999999999999999998542    349999999999999642         


Q ss_pred             --------CcEEEeecCcceeec
Q 042853          586 --------MNPKISDFGMARTFT  600 (614)
Q Consensus       586 --------~~~kI~DFGla~~~~  600 (614)
                              ..+||+|||+++.+.
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~  193 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIG  193 (1021)
T ss_pred             cccccCCCCceEEccCCcccccc
Confidence                    348999999998764

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.80  E-value=4.9e-19  Score=178.25  Aligned_cols=134  Identities=34%  Similarity=0.513  Sum_probs=115.8

Q ss_pred             ceeccCCceeEEEEEeCC----ccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~g  528 (614)
                      ++||+|+||.||+|....    ...+|+|.+..... ...+++.+|+.+++++.|+|+        ....++||||++++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            469999999999997642    26899999875443 345679999999999999998        45679999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +|..++....   .+++..+..++.|++.||.|||..+   ++|+||||+|||++.++.+||+|||+++.+..
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence            9999986432   5789999999999999999999876   99999999999999999999999999987743

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.80  E-value=3.2e-19  Score=179.87  Aligned_cols=134  Identities=30%  Similarity=0.509  Sum_probs=112.6

Q ss_pred             ceeccCCceeEEEEEeC----CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEEecC
Q 042853          462 NRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYEYLP  526 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~Ey~~  526 (614)
                      +.||+|+||.||+|...    ....+|+|++.... .+..+.|.+|+.+++.++|+|+          ....++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999864    23578999986432 3345678999999999999998          234789999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++|..++...  ...+++...+.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999998543  234677888899999999999999876   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.80  E-value=4.9e-19  Score=177.90  Aligned_cols=142  Identities=25%  Similarity=0.384  Sum_probs=121.9

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|+||.||.++.. +++.+++|.+...  ......++.+|++++++++|+|+         ....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4677899999999999988865 5788999987543  33455678999999999999999         5678899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +++++|..++.... ...+++.....++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999886432 345789999999999999999999876   999999999999999999999999999876443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.80  E-value=3.1e-19  Score=183.99  Aligned_cols=139  Identities=29%  Similarity=0.449  Sum_probs=122.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .+|+..+.||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++|+|+         ....++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            45777899999999999999864 678999999876555556778999999999999999         46789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|..++..    ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            99999998843    34789999999999999999999986   99999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.80  E-value=3.2e-19  Score=184.56  Aligned_cols=137  Identities=23%  Similarity=0.406  Sum_probs=118.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|+..+.||+|+||.||++... .++.||+|.+....   .+....+.+|+.+++.++|+|+         ..+.++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36778899999999999999876 56789999886542   2334578899999999999999         45679999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ||+++++|..++...   ..+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            999999999998543   35788888899999999999999886   99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.80  E-value=4.9e-19  Score=177.34  Aligned_cols=134  Identities=34%  Similarity=0.512  Sum_probs=117.2

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCHH
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLD  531 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL~  531 (614)
                      ++||+|+||.||++...+++.+|+|.+...... ...+|.+|++++++++|+|+         ....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            369999999999999877899999998764333 55679999999999999998         45689999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          532 FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       532 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      .++...  ...+++.....++.++++||.|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            988543  235788899999999999999999887   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.80  E-value=2.9e-19  Score=189.28  Aligned_cols=135  Identities=25%  Similarity=0.353  Sum_probs=114.6

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ....+|.+.+.||+|+||.||+|... .++.||+|...+.      ....|+.++.+++|+|+         ....++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34467999999999999999999986 4578899875432      23569999999999999         45678999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||+. ++|..++...  ...+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+++..
T Consensus       137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            9995 6787777532  345899999999999999999999987   999999999999999999999999999854

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.80  E-value=3.2e-19  Score=181.78  Aligned_cols=137  Identities=32%  Similarity=0.504  Sum_probs=118.3

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      |+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+|+         ....++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            445688999999999999875 56789999886432 3445678999999999999999         567899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++|..++.    ...+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence            999998873    235788999999999999999999876   99999999999999999999999999987653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.80  E-value=3.3e-19  Score=179.17  Aligned_cols=138  Identities=28%  Similarity=0.492  Sum_probs=118.5

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPN  527 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~  527 (614)
                      ++|.+.+.||+|+||.||++.. .++.+|+|.++...  ....|.+|+.++.+++|+|+        ....+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence            3467789999999999999975 56779999886432  34578999999999999999        4567899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++|..++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          83 GNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            99999986543 235789999999999999999999876   9999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.80  E-value=4.6e-19  Score=179.49  Aligned_cols=139  Identities=29%  Similarity=0.430  Sum_probs=118.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-----cchhHhHHHHHHHHHhcCCCCC-----------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNL-----------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nl-----------~~~~  518 (614)
                      .+|...+.||+|+||.||++... +++.+|+|.+....     .+....+.+|+.+++.++|+|+           ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36778899999999999999875 57899999885431     1234568899999999999999           2456


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++++||+++++|..++...   ..+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            8899999999999988532   34788888999999999999999876   99999999999999999999999999986


Q ss_pred             ec
Q 042853          599 FT  600 (614)
Q Consensus       599 ~~  600 (614)
                      +.
T Consensus       156 ~~  157 (266)
T cd06651         156 LQ  157 (266)
T ss_pred             cc
Confidence            53

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.80  E-value=2.4e-19  Score=191.42  Aligned_cols=138  Identities=26%  Similarity=0.349  Sum_probs=115.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCC--------------CCeeEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL--------------GGERLL  520 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl--------------~~~~~l  520 (614)
                      +|++.+.||+|.||.|-||... +++.||||+++.. ..-..+-..|+.+|..|+ |.+-              .++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7888999999999999999876 6889999999763 344556678999999997 5432              578999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC--CcEEEeecCccee
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ--MNPKISDFGMART  598 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~--~~~kI~DFGla~~  598 (614)
                      |+|.+.. +|.++|.... ...++......|+.||+.||.+||+.+   ||||||||+||||.+.  ..+||+|||.|..
T Consensus       266 VfELL~~-NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhhh-hHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999854 8999987543 344888999999999999999999887   9999999999999744  3699999999987


Q ss_pred             ec
Q 042853          599 FT  600 (614)
Q Consensus       599 ~~  600 (614)
                      ..
T Consensus       341 ~~  342 (586)
T KOG0667|consen  341 ES  342 (586)
T ss_pred             cC
Confidence            64

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.80  E-value=4.9e-19  Score=178.22  Aligned_cols=139  Identities=29%  Similarity=0.416  Sum_probs=121.9

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      +|+..+.||+|+||.||++... +++.+|+|.+.+..   ....+.+.+|++++++++|||+         ....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777899999999999999986 57889999986532   2346789999999999999998         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+++++|..++...   ..+++.....++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            99999999988543   46788999999999999999999886   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.80  E-value=3.6e-19  Score=182.70  Aligned_cols=140  Identities=29%  Similarity=0.454  Sum_probs=117.3

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++++|...+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+.++..++|+|+         ....++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3567888999999999999999875 678999999865432 233467899999999999998         45789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||++ ++|..++...  ...+.+.+...++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            9996 6776666432  234678888889999999999999886   999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.80  E-value=6.6e-19  Score=178.73  Aligned_cols=141  Identities=28%  Similarity=0.481  Sum_probs=116.3

Q ss_pred             CCccceeccCCceeEEEEEeC----CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCC---------------C
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLG---------------G  516 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~---------------~  516 (614)
                      |.+.+.||+|+||.||+|.+.    .++.+|||.+...  .....+++.+|++++++++|||+.               .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            445688999999999999864    3578999998653  233456789999999999999981               1


Q ss_pred             eeEEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSS---RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                      ..++++||+++|+|..++....   ....+++.....++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2368899999999988875321   2234788889999999999999999886   999999999999999999999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05074         158 GLSKKIYS  165 (273)
T ss_pred             cccccccC
Confidence            99987643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.80  E-value=6.3e-19  Score=183.14  Aligned_cols=135  Identities=33%  Similarity=0.499  Sum_probs=109.2

Q ss_pred             cceeccCCceeEEEEEeC---CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEEEecC
Q 042853          461 ANRLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~Ey~~  526 (614)
                      ..+||+|+||.||+|...   .+..+|+|.+....  ....+.+|++++++++|+|+           ....++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999875   34689999986532  23467899999999999998           345689999987


Q ss_pred             CCCHHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEeecCcc
Q 042853          527 NKSLDFFIFDS------SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL----DEQMNPKISDFGMA  596 (614)
Q Consensus       527 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----d~~~~~kI~DFGla  596 (614)
                      + +|..++...      .....+++.....++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+|
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 666655321      12234788888999999999999999886   9999999999999    46678999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +.+..
T Consensus       160 ~~~~~  164 (317)
T cd07867         160 RLFNS  164 (317)
T ss_pred             eccCC
Confidence            87653

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PTZ00284 protein kinase; Provisional

Probab=99.80  E-value=2.9e-19  Score=196.15  Aligned_cols=145  Identities=24%  Similarity=0.298  Sum_probs=115.5

Q ss_pred             hhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC------------
Q 042853          448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------------  514 (614)
Q Consensus       448 ~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl------------  514 (614)
                      .+++...+++|.+.++||+|+||+||++... .++.||||+++.. .....++..|++++.+++|.++            
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3455566789999999999999999999875 5678999998642 2334566778888888877653            


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM----  586 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~----  586 (614)
                          ..+.++|||++ +++|..++...   ..+++.....|+.||+.||.|||++  .+||||||||+|||++.++    
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence                24678899988 66787777532   3588999999999999999999974  1399999999999998665    


Q ss_pred             ------------cEEEeecCcceee
Q 042853          587 ------------NPKISDFGMARTF  599 (614)
Q Consensus       587 ------------~~kI~DFGla~~~  599 (614)
                                  .+||+|||++...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~  298 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDE  298 (467)
T ss_pred             cccccccCCCCceEEECCCCccccC
Confidence                        4999999988643

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.80  E-value=5.9e-19  Score=179.10  Aligned_cols=138  Identities=25%  Similarity=0.424  Sum_probs=117.2

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc----------chhHhHHHHHHHHHhcCCCCC---------CC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG----------QGIVEFKNEAKLIAKLQHTNL---------GG  516 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~----------~~~~~f~~E~~~l~~l~H~nl---------~~  516 (614)
                      +|...+.||+|+||.||+|... +++.+|+|.++....          ...+.+..|+.++..++|+|+         ..
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3556789999999999999865 678999998753210          123468889999999999998         46


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++||||+++++|..++...   ..+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            788999999999999988543   45788899999999999999999876   999999999999999999999999999


Q ss_pred             eeec
Q 042853          597 RTFT  600 (614)
Q Consensus       597 ~~~~  600 (614)
                      +...
T Consensus       156 ~~~~  159 (272)
T cd06629         156 KKSD  159 (272)
T ss_pred             cccc
Confidence            8654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.80  E-value=4.1e-20  Score=196.16  Aligned_cols=144  Identities=31%  Similarity=0.418  Sum_probs=122.0

Q ss_pred             CCccceeccCCceeEEEEEeC--Cc--cEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEe
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ--DE--QEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEY  524 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~--~~--~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey  524 (614)
                      ....++||+|.||.|++|.+.  +|  ..||||.+..... .....|++|+.+|.+|+|+|+        +...++|+|.
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL  191 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL  191 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence            344689999999999999885  34  3689999976543 366789999999999999998        4677899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCcc
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL  604 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~  604 (614)
                      ++.|||.+.|.+ .....+-......++.|||.||.||..+.   +|||||.++|+||.....+||+||||.|-+..++.
T Consensus       192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999876 33445666677789999999999999876   99999999999999999999999999999876654


Q ss_pred             c
Q 042853          605 E  605 (614)
Q Consensus       605 ~  605 (614)
                      .
T Consensus       268 ~  268 (1039)
T KOG0199|consen  268 M  268 (1039)
T ss_pred             c
Confidence            3

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=5.3e-19  Score=178.05  Aligned_cols=141  Identities=28%  Similarity=0.455  Sum_probs=123.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++|+|+         ....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357788899999999999999875 567899999876555566789999999999999998         5678899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++...  ...++..+...++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++..+.
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence            9999999987543  235788999999999999999999876   9999999999999999999999999998664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.80  E-value=6.1e-19  Score=180.91  Aligned_cols=139  Identities=25%  Similarity=0.380  Sum_probs=117.2

Q ss_pred             CCCccceeccCCceeEEEEEe----CCccEEEEEEccCCC----cchhHhHHHHHHHHHhc-CCCCC---------CCee
Q 042853          457 NFSPANRLGQGGFGPVYKGKL----QDEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKL-QHTNL---------GGER  518 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nl---------~~~~  518 (614)
                      +|+..+.||+|+||.||++..    .++..+|+|.+....    ....+++.+|+.++.++ +|+|+         ....
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778999999999999986    367889999986532    22345688999999999 58998         3457


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||+++++|..++...   ..+++.....++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            8999999999999988542   34778888888999999999999876   99999999999999999999999999987


Q ss_pred             ecC
Q 042853          599 FTM  601 (614)
Q Consensus       599 ~~~  601 (614)
                      +..
T Consensus       155 ~~~  157 (290)
T cd05613         155 FHE  157 (290)
T ss_pred             ccc
Confidence            643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.80  E-value=7.1e-19  Score=178.59  Aligned_cols=134  Identities=33%  Similarity=0.561  Sum_probs=112.3

Q ss_pred             ceeccCCceeEEEEEeCC-cc--EEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQD-EQ--EIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~-~~--~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||+|.+.. +.  .+++|.++... ....+.|.+|++++.++ +|||+         ....+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999863 33  46888886532 33456789999999999 79998         3467899999999


Q ss_pred             CCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          528 KSLDFFIFDSS-------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       528 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                      |+|..++....             ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1234789999999999999999999876   9999999999999999999999999


Q ss_pred             ccee
Q 042853          595 MART  598 (614)
Q Consensus       595 la~~  598 (614)
                      +++.
T Consensus       158 l~~~  161 (270)
T cd05047         158 LSRG  161 (270)
T ss_pred             Cccc
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.80  E-value=5.9e-19  Score=177.30  Aligned_cols=139  Identities=28%  Similarity=0.505  Sum_probs=120.0

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      ..|...+.||+|+||.||++...++..+|+|.+.... ....+|.+|++++.+++|+|+         ....+++|||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            3466678999999999999988777889999886532 234679999999999999998         457889999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++|..++...  ...+++.....++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            99999888543  235788999999999999999999886   9999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.80  E-value=1e-18  Score=175.61  Aligned_cols=141  Identities=28%  Similarity=0.423  Sum_probs=120.5

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++|+|+         ....+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            3667899999999999999876 6788999988543 23345678899999999999998         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|..++... ....++......++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            999998887543 2335788889999999999999999886   99999999999999999999999999987753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.80  E-value=4.9e-19  Score=181.64  Aligned_cols=138  Identities=31%  Similarity=0.527  Sum_probs=117.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|+..+.||+|+||.||+|... +++.+|||.+..... .....+.+|++++++++|+|+         ....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56778899999999999999986 678899999864322 223457789999999999999         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +++ +|..++....  ..+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            985 8988875432  35788889999999999999999886   999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.80  E-value=6.5e-19  Score=180.33  Aligned_cols=140  Identities=26%  Similarity=0.464  Sum_probs=113.7

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhc---CCCCC--------------CC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKL---QHTNL--------------GG  516 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l---~H~nl--------------~~  516 (614)
                      +|++.+.||+|+||.||++... +++.+|+|.++....  .....+.+|+.++.++   +|+|+              ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4677899999999999999876 678899999865321  1233566777777665   69998              12


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..+++|||+++ +|..++.... ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            46899999984 8887775432 234789999999999999999999987   999999999999999999999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +.+..
T Consensus       156 ~~~~~  160 (288)
T cd07863         156 RIYSC  160 (288)
T ss_pred             ccccC
Confidence            87653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.80  E-value=6.2e-19  Score=180.04  Aligned_cols=140  Identities=29%  Similarity=0.531  Sum_probs=120.0

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +|+..+.||+|++|.||+|... +++.+|||.+..... .....+.+|+.++++++|+|+         .+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4677899999999999999986 678899999875432 234567889999999999998         45789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++ +|..++........+++.....++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+.
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            85 88888765444456899999999999999999999886   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.80  E-value=9.8e-19  Score=175.70  Aligned_cols=140  Identities=26%  Similarity=0.416  Sum_probs=119.9

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~E  523 (614)
                      +|++.+.||+|++|.||++... +++.+|+|++....  ....+.+.+|++++++++|+|+          ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4677899999999999999876 56789999986432  2345678999999999999999          124689999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+++++|..++.... ...+++.+...++.+++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+.
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEec
Confidence            999999998886532 345799999999999999999999987   9999999999999999999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.80  E-value=4.7e-19  Score=182.77  Aligned_cols=133  Identities=29%  Similarity=0.432  Sum_probs=116.6

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ...||+|+||.||++... +++.+|+|.+........+.+.+|+.++..++|+|+         ....++|+||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            357999999999999875 678999999865444455678899999999999998         5678999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ..++..    ..+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+.
T Consensus       106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659         106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            887732    34789999999999999999999887   9999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.80  E-value=7.4e-19  Score=177.20  Aligned_cols=139  Identities=29%  Similarity=0.461  Sum_probs=121.4

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|+||.||++... +++.+++|.+.....  ....++.+|+.++++++|+|+         ....++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4667899999999999999875 678899999875433  356789999999999999998         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++++|..++...   ..+++..+..++.+++.||.|||+.+   |+|+||||+||++++++.+||+|||++..+..
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            9999999988542   34788889999999999999999987   99999999999999999999999999987653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=7.4e-20  Score=205.29  Aligned_cols=140  Identities=34%  Similarity=0.515  Sum_probs=114.5

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC-----------------
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL-----------------  514 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl-----------------  514 (614)
                      -.+.|++.+.||+|+||.|||++.+ ||+.+|||+|.-. ..+......+|+.++++|+|||+                 
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3456777899999999999999987 8999999999643 23334557889999999999997                 


Q ss_pred             --------------------------------------------------------------------------------
Q 042853          515 --------------------------------------------------------------------------------  514 (614)
Q Consensus       515 --------------------------------------------------------------------------------  514 (614)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------C--------CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 042853          515 -----------------------G--------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH  563 (614)
Q Consensus       515 -----------------------~--------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH  563 (614)
                                             .        .-+|+=||||+.-.|..++.+.....  .-....++..+|+.||+|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence                                   0        12466799999988888875432211  23455678899999999999


Q ss_pred             hCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       564 ~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      +++   ||||||||.||+||++..+||.|||+|+.
T Consensus       715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             hCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence            998   99999999999999999999999999997

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.80  E-value=5.7e-19  Score=178.50  Aligned_cols=136  Identities=28%  Similarity=0.460  Sum_probs=117.6

Q ss_pred             CCccceeccCCceeEEEEEeCCccEEEEEEccCCC------cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~------~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      |...+.||+|+||.||+|...+++.+|||.+....      .+....+.+|++++++++|+|+         ....+++|
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            55678999999999999998888899999886431      1223468899999999999998         45789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||+++++|..++...   ..+++.....++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+
T Consensus        82 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          82 EFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            999999999998543   34788888899999999999999876   999999999999999999999999999865

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.79  E-value=9.3e-19  Score=178.81  Aligned_cols=140  Identities=29%  Similarity=0.460  Sum_probs=121.3

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|++.+.||+|+||.||++... +++.+|+|.+....  ......+.+|+.++++++|+|+         ....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            3667889999999999999975 67899999986543  2335678999999999999998         4578999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      + +++|..++....  ..+++.++..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 999999886433  45899999999999999999999886   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.79  E-value=8e-19  Score=180.62  Aligned_cols=139  Identities=31%  Similarity=0.445  Sum_probs=121.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|...+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++|||+         ....++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            56777899999999999999864 678899999865444455678999999999999998         45789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|..++..    ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            99999998843    24788899999999999999999887   99999999999999999999999999886643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.79  E-value=1.1e-18  Score=175.04  Aligned_cols=140  Identities=35%  Similarity=0.584  Sum_probs=120.1

Q ss_pred             CccceeccCCceeEEEEEeCC-----ccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          459 SPANRLGQGGFGPVYKGKLQD-----EQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       459 ~~~~~lG~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++.+.||+|+||.||++....     +..+|+|.+...... ..+.+..|+.++..++|+|+         ....+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456889999999999998863     378999999754433 56789999999999999999         457899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |+++++|..++..... ..+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999864322 11799999999999999999999886   999999999999999999999999999877543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.79  E-value=7.1e-19  Score=177.87  Aligned_cols=139  Identities=24%  Similarity=0.458  Sum_probs=118.5

Q ss_pred             CCCccceeccCCceeEEEEEe-CCccEEEEEEccCCC------cchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~------~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+....      .+..+++.+|+.++++++|+|+         .+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            466778999999999999986 467899999886432      1134678999999999999998         467899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceee
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTF  599 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~  599 (614)
                      ||||+++++|..++...   ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++ .+||+|||+++.+
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999988542   35788999999999999999999986   99999999999998775 5999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       155 ~~  156 (268)
T cd06630         155 AA  156 (268)
T ss_pred             cc
Confidence            53

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.79  E-value=7.1e-19  Score=179.50  Aligned_cols=142  Identities=25%  Similarity=0.365  Sum_probs=115.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHH-HHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKL-IAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~-l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|++.+.||+|+||.||++... +++.||+|+++... .+...++..|+.+ ++.++|+|+         ....+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36778899999999999999986 68899999987542 2233456666664 666789998         457899999


Q ss_pred             ecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |++ |+|..++... .....+++.....++.||+.||.|||++.  +++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            997 6887777542 23346899999999999999999999862  49999999999999999999999999998664

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.79  E-value=1.3e-18  Score=175.69  Aligned_cols=143  Identities=31%  Similarity=0.478  Sum_probs=123.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++|+|+         ....++++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46788899999999999999865 57789999986432 3356779999999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++++|..++........+++.....++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            999999999865433345889999999999999999999886   99999999999999999999999999987654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.79  E-value=8.1e-19  Score=177.44  Aligned_cols=139  Identities=28%  Similarity=0.437  Sum_probs=118.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-----CcchhHhHHHHHHHHHhcCCCCC-----------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNL-----------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~  518 (614)
                      .+|.+.+.||+|+||.||++... +++.+|+|.+...     ..+....|.+|++++++++|+|+           ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46778899999999999999875 5789999987432     12345678999999999999999           2347


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++++||+++++|..++...   ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999999888532   34788888999999999999999887   99999999999999999999999999986


Q ss_pred             ec
Q 042853          599 FT  600 (614)
Q Consensus       599 ~~  600 (614)
                      +.
T Consensus       156 ~~  157 (264)
T cd06653         156 IQ  157 (264)
T ss_pred             cc
Confidence            53

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.79  E-value=9.5e-19  Score=208.99  Aligned_cols=133  Identities=25%  Similarity=0.426  Sum_probs=113.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ..+...+.||+|+||.||+|... ++..||||++.....    ....|++++++++|||+         ....++|||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            45667789999999999999974 788999999865332    12356889999999999         45679999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ++|+|.+++.      .++|.++.+++.|||+||+|||+.+.++|+||||||+||+++.++.+++. ||++...
T Consensus       766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            9999999983      27999999999999999999998767789999999999999999998886 7776544

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.79  E-value=7.7e-19  Score=177.62  Aligned_cols=137  Identities=30%  Similarity=0.498  Sum_probs=117.2

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc---------chhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---------QGIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---------~~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      |.....||+|+||.||+|... +++.+|+|.+.....         +..+.+.+|+.++.+++|+|+         ....
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            455789999999999999875 578899998854321         123568899999999999998         4567


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      +++|||+++++|..++...   ..+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            8999999999999998532   35788888899999999999999886   99999999999999999999999999987


Q ss_pred             ec
Q 042853          599 FT  600 (614)
Q Consensus       599 ~~  600 (614)
                      +.
T Consensus       156 ~~  157 (267)
T cd06628         156 LE  157 (267)
T ss_pred             cc
Confidence            75

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.79  E-value=1.3e-18  Score=180.88  Aligned_cols=141  Identities=27%  Similarity=0.352  Sum_probs=121.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|+..+.||+|+||.||++... +++.+|+|.+.....   ...+.+..|++++..++|+|+         ....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            35777899999999999999986 478999999875432   245578999999999999999         45789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++++|..++... ....+++.....++.|+++||.|||..+   ++|+||||+||+++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            999999999988533 2345889999999999999999999886   9999999999999999999999999988653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.79  E-value=7.6e-19  Score=179.44  Aligned_cols=138  Identities=28%  Similarity=0.484  Sum_probs=116.9

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|+||.||++... +++.+|+|.+....  ......+.+|++++++++|+|+         ....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            3667789999999999999986 67889999986432  2234567889999999999998         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++ ++|..++...  ...+++.....++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            97 5777776432  235899999999999999999999986   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.79  E-value=8e-19  Score=176.14  Aligned_cols=139  Identities=29%  Similarity=0.456  Sum_probs=122.7

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|+..+.||+|+||.||++.... ++.+++|.+.....  .++|.+|++++++++|+|+         ....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578888999999999999999874 78899999865322  6789999999999999999         45788999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|..++...  ...+++.....++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++..+..
T Consensus        81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999988532  346899999999999999999999886   99999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.79  E-value=2.8e-19  Score=180.26  Aligned_cols=135  Identities=27%  Similarity=0.456  Sum_probs=112.8

Q ss_pred             ceeccCCceeEEEEEeCC--------ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          462 NRLGQGGFGPVYKGKLQD--------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +.||+|+||.||+|....        ...+|+|.+........++|.+|+.+++.++|+|+         ....++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998642        23488888765444556788999999999999999         4678899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--------EEEeecCcc
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN--------PKISDFGMA  596 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~--------~kI~DFGla  596 (614)
                      +++|+|..++....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.        +|++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999986432  35789999999999999999999886   999999999999987665        699999998


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      ..+..
T Consensus       156 ~~~~~  160 (258)
T cd05078         156 ITVLP  160 (258)
T ss_pred             cccCC
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.79  E-value=1.2e-18  Score=178.96  Aligned_cols=141  Identities=29%  Similarity=0.437  Sum_probs=116.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcC-CCCC---------CCe-----
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQ-HTNL---------GGE-----  517 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nl---------~~~-----  517 (614)
                      ++|+..+.||+|+||.||++... +++.||+|.+....  ......+.+|+.++++++ |+|+         ...     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46788899999999999999976 67899999876432  223457889999999995 6988         122     


Q ss_pred             eEEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEeecC
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSR--KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-QMNPKISDFG  594 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-~~~~kI~DFG  594 (614)
                      .++||||+++ +|..++.....  ...+++.....++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            6899999985 78887754322  245799999999999999999999886   999999999999998 8899999999


Q ss_pred             cceeec
Q 042853          595 MARTFT  600 (614)
Q Consensus       595 la~~~~  600 (614)
                      +++.+.
T Consensus       157 ~~~~~~  162 (295)
T cd07837         157 LGRAFS  162 (295)
T ss_pred             cceecC
Confidence            998653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.79  E-value=1e-18  Score=177.64  Aligned_cols=139  Identities=29%  Similarity=0.453  Sum_probs=121.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|+..+.||.|+||.||++... +++.+|+|.+.... .....++.+|+.+++.++|+|+         ....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35777889999999999999976 67889999986543 3445678999999999999998         5678899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++++|..++...    .+++.....++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            9999999988432    6899999999999999999999886   99999999999999999999999999988754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.79  E-value=7.1e-19  Score=179.94  Aligned_cols=139  Identities=23%  Similarity=0.316  Sum_probs=119.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|++.+.||+|+||+||++... +++.+|+|.+... .....++|.+|++++..++|+|+         ....++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45666789999999999999875 5788999987643 23445689999999999999998         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +++++|..++..   ...+++.....++.+++.||.|||+..  .|+||||||+||++++++.++|+|||+++.+
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            999999988743   235789999999999999999999742  3999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.79  E-value=1.7e-18  Score=174.39  Aligned_cols=141  Identities=28%  Similarity=0.399  Sum_probs=124.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|+..+.||+|++|.||++... +++.++||++..... ....++.+|+..+.+++|+|+         ....++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            35777899999999999999987 488999999876433 446789999999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK-YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +++++|..++...   ..+++.....++.|+++||.|||+ .+   ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999998643   457899999999999999999998 76   999999999999999999999999999977543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.79  E-value=1.5e-18  Score=179.96  Aligned_cols=141  Identities=30%  Similarity=0.412  Sum_probs=116.5

Q ss_pred             CCCccceeccCCceeEEEEEeCC---ccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------C--CeeE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQD---EQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------G--GERL  519 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~---~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~--~~~~  519 (614)
                      +|...+.||+|+||.||+|....   ++.+|+|.+....   ......+.+|+.++.+++|||+         .  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            36677899999999999999854   6889999997632   3334567889999999999998         3  6789


Q ss_pred             EEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC----CCcEEEeec
Q 042853          520 LVYEYLPNKSLDFFIFDSSR--KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE----QMNPKISDF  593 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~----~~~~kI~DF  593 (614)
                      +||||+++ +|..++.....  ...++......++.||+.||.|||+.+   |+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999986 56555543222  235788888999999999999999887   999999999999999    899999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |+++.+..
T Consensus       157 g~~~~~~~  164 (316)
T cd07842         157 GLARLFNA  164 (316)
T ss_pred             ccccccCC
Confidence            99987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.79  E-value=1.7e-18  Score=176.93  Aligned_cols=139  Identities=31%  Similarity=0.503  Sum_probs=118.5

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|+||.||++... +++.+|||.+....  ......+.+|++++++++|+|+         ....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4677899999999999999875 67889999886432  2234578899999999999998         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++ ++|..++.... ...+++.....++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||+++.+.
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            96 68888875432 345789999999999999999999886   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.79  E-value=1.6e-18  Score=176.69  Aligned_cols=137  Identities=30%  Similarity=0.481  Sum_probs=118.5

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      |+..+.||+|+||.||+|... ++..+|+|.+.... ......|.+|+.++.+++|+|+         ....++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            455788999999999999875 67889999886432 2345678999999999999998         467899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++|..++.    ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.+..
T Consensus        86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            999998874    235789999999999999999999876   99999999999999999999999999987653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.78  E-value=1.2e-18  Score=182.35  Aligned_cols=135  Identities=17%  Similarity=0.278  Sum_probs=114.4

Q ss_pred             cceeccC--CceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          461 ANRLGQG--GFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G--~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      .++||+|  +|++||++... +++.||+|++....  ......+.+|+++++.++|||+         ....++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            5789999  78999999875 67899999996532  2334567789999999999999         567899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +|+|..++..... ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|++||+.+..+
T Consensus        83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            9999998854322 34789999999999999999999887   999999999999999999999999875543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.78  E-value=1.3e-18  Score=175.17  Aligned_cols=147  Identities=25%  Similarity=0.431  Sum_probs=121.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~  522 (614)
                      +|+..+.||.|+||.||++... +++.+|+|.+...  .....+++.+|+.++++++|+|+           ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            3667789999999999999875 6788999988643  23345678899999999999999           23468999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYS--RLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||+++++|..++.... ....+++.....++.|++.||.|||..+  ..+|+|+||||+||++++++.+||+|||+++.+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999999986532 2356899999999999999999999332  345999999999999999999999999999987


Q ss_pred             cCCc
Q 042853          600 TMNE  603 (614)
Q Consensus       600 ~~~~  603 (614)
                      ....
T Consensus       161 ~~~~  164 (265)
T cd08217         161 GHDS  164 (265)
T ss_pred             cCCc
Confidence            5433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.78  E-value=1.4e-18  Score=177.74  Aligned_cols=141  Identities=29%  Similarity=0.443  Sum_probs=119.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|+..+.||+|+||.||++... +++.||||.++..  .......+.+|++++++++|+|+         ....+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            35778899999999999999886 5788999988643  23345678999999999999998         467899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |++++.+..++..   ...+++.....++.||+.||.|||+.+   |+|+||+|+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9998777665532   234789999999999999999999986   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.78  E-value=1.4e-18  Score=178.09  Aligned_cols=142  Identities=27%  Similarity=0.368  Sum_probs=120.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~  522 (614)
                      ++|...+.||+|++|.||++... +++.+|+|.+.... .....++.+|++++++++|+|+           ....++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35777899999999999999985 57889999886532 2345679999999999999998           23578999


Q ss_pred             EecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++++|.+++... .....++......++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++..+.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999998887532 22345788889999999999999999886   9999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.78  E-value=1.4e-18  Score=177.15  Aligned_cols=138  Identities=31%  Similarity=0.488  Sum_probs=119.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .|+..+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++|+|+         ....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3556788999999999999875 57889999886532 3445678999999999999999         46789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|.+++..    ..+++.+...++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus        85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            99999988842    34788888999999999999999876   99999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.78  E-value=2e-18  Score=173.42  Aligned_cols=141  Identities=26%  Similarity=0.415  Sum_probs=120.8

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|+||.||++... +++.+|+|.+...  ......++.+|+.++++++|+|+         ....++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4677899999999999999875 6788999998643  23345678999999999999998         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++++|..++.... ...+++.+...++.|++.||.|||+.+   ++|+||+|+|||++.++.+||+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            99999998885432 234788999999999999999999876   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.78  E-value=1.4e-18  Score=177.46  Aligned_cols=149  Identities=30%  Similarity=0.420  Sum_probs=123.7

Q ss_pred             chhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC----------
Q 042853          447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL----------  514 (614)
Q Consensus       447 ~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl----------  514 (614)
                      ++.++..+.+.|+..+.||+|+||.||+|... +++.+|+|.+.... ....++..|+.++.++ +|+|+          
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34445556678888899999999999999985 57889999886532 3345788999999998 69998          


Q ss_pred             -----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       515 -----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                           ....+++|||+++|+|..++.... ...+++.....++.||+.||.|||+.+   |+|+||||+||++++++.+|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 135689999999999999886432 234788888899999999999999986   99999999999999999999


Q ss_pred             EeecCcceeec
Q 042853          590 ISDFGMARTFT  600 (614)
Q Consensus       590 I~DFGla~~~~  600 (614)
                      |+|||+++.+.
T Consensus       162 l~dfg~~~~~~  172 (282)
T cd06636         162 LVDFGVSAQLD  172 (282)
T ss_pred             EeeCcchhhhh
Confidence            99999987653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.78  E-value=3.2e-19  Score=187.29  Aligned_cols=148  Identities=24%  Similarity=0.406  Sum_probs=125.0

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeCC---c--cEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC--------CCe
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQD---E--QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL--------GGE  517 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~~---~--~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl--------~~~  517 (614)
                      ....+.....+.||+|-||.||+|...+   +  -.||||.-+.. .....+.|+.|+.+|++++||||        ...
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P  464 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP  464 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc
Confidence            3444455667889999999999998642   2  35899988763 45567789999999999999999        567


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++|||.++.|.|..||...  +..|+......++.||+.||.|||+..   +|||||.++|||+.+.-.+||+||||+|
T Consensus       465 ~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence            89999999999999999643  345788888889999999999999876   9999999999999999999999999999


Q ss_pred             eecCCcc
Q 042853          598 TFTMNEL  604 (614)
Q Consensus       598 ~~~~~~~  604 (614)
                      -+..+..
T Consensus       540 ~~ed~~y  546 (974)
T KOG4257|consen  540 YLEDDAY  546 (974)
T ss_pred             hccccch
Confidence            8875543

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.78  E-value=1.2e-18  Score=179.08  Aligned_cols=140  Identities=28%  Similarity=0.450  Sum_probs=118.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------C--CeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------G--GERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~--~~~~lv  521 (614)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++....  .....+.+|+.++.+++|+|+         .  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            45777899999999999999986 578899999864322  223457789999999999998         2  678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||++ ++|..++....  ..+++.+...++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99998 48888775432  35899999999999999999999887   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.78  E-value=1.7e-18  Score=176.19  Aligned_cols=139  Identities=29%  Similarity=0.497  Sum_probs=119.8

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcC---CCCC---------CCeeEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQ---HTNL---------GGERLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~---H~nl---------~~~~~lv~  522 (614)
                      .|+..+.||+|+||.||+|... +++.+|+|.+... ......++.+|+.++++++   |+|+         ....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4666789999999999999974 6789999998653 2344567889999999997   9998         45678999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++++|..++..    ..+++.....++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||+++.+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999988743    25889999999999999999999887   999999999999999999999999999877543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.78  E-value=2.5e-18  Score=172.51  Aligned_cols=141  Identities=30%  Similarity=0.492  Sum_probs=119.7

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|+||.||++... +++.+|+|.+...  ..+...++.+|++++++++|+|+         ....++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4677899999999999999875 6788999998643  23345679999999999999998         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-MNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-~~~kI~DFGla~~~~~  601 (614)
                      +++++|.+++.... ...+++.....++.++++||.|||+++   |+|+||||+||+++++ ..+||+|||+++....
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            99999999986532 335789999999999999999999986   9999999999999855 4589999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.78  E-value=1.6e-18  Score=182.06  Aligned_cols=138  Identities=28%  Similarity=0.417  Sum_probs=117.4

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC--------------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL--------------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl--------------~~~~  518 (614)
                      +++|++.+.||+|+||.||+|... +++.||+|.++.. .......+.+|+.++.+++|+|+              ....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467888999999999999999875 6789999998643 23345668899999999999998              1247


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++++||+++ +|..++.    ...+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999975 7776663    235889999999999999999999987   99999999999999999999999999987


Q ss_pred             ec
Q 042853          599 FT  600 (614)
Q Consensus       599 ~~  600 (614)
                      ..
T Consensus       156 ~~  157 (336)
T cd07849         156 AD  157 (336)
T ss_pred             cc
Confidence            64

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.78  E-value=1.1e-18  Score=176.79  Aligned_cols=136  Identities=35%  Similarity=0.566  Sum_probs=114.3

Q ss_pred             ceeccCCceeEEEEEeCC-------ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          462 NRLGQGGFGPVYKGKLQD-------EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~-------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +.||+|+||.||+|+..+       ++.+|+|.+.+.. .....+|.+|+.+++.++|+|+         ....++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998742       2578999886533 2446679999999999999999         4568999999


Q ss_pred             cCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-----cEEEeecCc
Q 042853          525 LPNKSLDFFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-----NPKISDFGM  595 (614)
Q Consensus       525 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-----~~kI~DFGl  595 (614)
                      +++++|..++....    ....+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986532    2234788999999999999999999876   99999999999999877     899999999


Q ss_pred             ceeec
Q 042853          596 ARTFT  600 (614)
Q Consensus       596 a~~~~  600 (614)
                      ++.+.
T Consensus       158 ~~~~~  162 (269)
T cd05044         158 ARDIY  162 (269)
T ss_pred             ccccc
Confidence            98664

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.78  E-value=2.1e-18  Score=173.64  Aligned_cols=131  Identities=30%  Similarity=0.441  Sum_probs=114.9

Q ss_pred             eccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ||+|+||.||++... +++.+++|.+.....   .....+.+|++++.+++|+|+         ....+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 488999999865432   345678999999999999998         5678999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ..++....   .+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~  144 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL  144 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence            99886432   5789999999999999999999886   9999999999999999999999999988654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.78  E-value=1.9e-18  Score=181.25  Aligned_cols=139  Identities=27%  Similarity=0.462  Sum_probs=118.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC-------------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL-------------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl-------------~~~~~  519 (614)
                      ++|+..+.||+|+||.||++... +++.+|+|++....  ......+.+|+.++.+++|+|+             ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888899999999999999875 68899999987532  2345667889999999999998             13578


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||++ ++|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++.+
T Consensus        85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999996 688888742   334899999999999999999999886   999999999999999999999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       158 ~~  159 (334)
T cd07855         158 SS  159 (334)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.78  E-value=2e-18  Score=174.35  Aligned_cols=139  Identities=25%  Similarity=0.360  Sum_probs=120.5

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +|+..+.||+|+||.||++... +++.+|+|.+.... .+...++.+|++++++++|+|+         ....++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            4666789999999999999986 57889999987643 3445678999999999999998         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK-YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..++....  ..++......++.|++.||+|||+ .+   ++|+||||+||++++++.+||+|||+++.+.
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999886432  467888889999999999999998 65   9999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.78  E-value=1.8e-18  Score=181.59  Aligned_cols=139  Identities=29%  Similarity=0.511  Sum_probs=117.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhc-CCCCC-----------CCeeE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QHTNL-----------GGERL  519 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nl-----------~~~~~  519 (614)
                      .++|+..+.||+|+||.||+|... +++.+|||++.+.  .......+..|+.++.++ +|+|+           ....+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            356778899999999999999976 5788999988542  223445678899999999 99998           22579


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||++ ++|..++..    ..++|..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 588887743    25789999999999999999999876   999999999999999999999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       158 ~~  159 (337)
T cd07852         158 SE  159 (337)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.78  E-value=2.7e-18  Score=177.80  Aligned_cols=139  Identities=33%  Similarity=0.462  Sum_probs=117.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      +.|+..+.||+|+||.||++... +++.||+|.+....   .+...++.+|+++++.++|+|+         ....++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45777899999999999999875 67899999886432   2334578999999999999998         45778999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||++ |+|..++...  ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||+++...
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9997 5666665322  235899999999999999999999886   9999999999999999999999999998664

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.77  E-value=2e-18  Score=175.94  Aligned_cols=133  Identities=29%  Similarity=0.441  Sum_probs=113.9

Q ss_pred             eccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ||+|+||+||++... +++.+|+|.+.+..   ......+.+|++++..++|+|+         ....++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 67889999886432   2234457889999999999998         4678999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ..++..... ..+++.+...++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+.
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            998865432 35789999999999999999999886   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.2e-18  Score=184.61  Aligned_cols=146  Identities=29%  Similarity=0.441  Sum_probs=119.4

Q ss_pred             ceeccCCceeEEEEEeCC-ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCHH
Q 042853          462 NRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLD  531 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL~  531 (614)
                      -+||+|.||+||-|+..+ ...+|||.+.....+..+-+..|+.+-+.|+|.||         .+..-+.||.+|+|||.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            369999999999999864 45789999976666666778999999999999999         56778899999999999


Q ss_pred             HHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEeecCcceeecCCccccCC
Q 042853          532 FFIFDSSRKSLL--DWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTFTMNELEANT  608 (614)
Q Consensus       532 ~~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-~~~~~kI~DFGla~~~~~~~~~~~~  608 (614)
                      .+|..  .-+++  .+...-.+.+||++||.|||++.   |||||||-.|+|++ -.|.+||+|||.+|.+..-..  -|
T Consensus       661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~T  733 (1226)
T KOG4279|consen  661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CT  733 (1226)
T ss_pred             HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--cc
Confidence            99853  23344  56666778899999999999987   99999999999997 568899999999998764332  23


Q ss_pred             CceecC
Q 042853          609 NRIVGT  614 (614)
Q Consensus       609 ~~~~GT  614 (614)
                      .++.||
T Consensus       734 ETFTGT  739 (1226)
T KOG4279|consen  734 ETFTGT  739 (1226)
T ss_pred             cccccc
Confidence            334554

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.77  E-value=2.6e-18  Score=187.57  Aligned_cols=162  Identities=30%  Similarity=0.442  Sum_probs=134.9

Q ss_pred             echhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------
Q 042853          446 FDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------  514 (614)
Q Consensus       446 ~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------  514 (614)
                      .++..+...++-|++.+.||+|.+|.||+++.. +++.+|+|++... ....+|...|..+++.. +|||+         
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            345556667788899999999999999999865 6778888887653 33445677788888877 69998         


Q ss_pred             -----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       515 -----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                           +++++||||||.+||.-+++.... ...+.|.....|+..+++||.+||...   +||||||-.||||..++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence                 679999999999999999987655 556899999999999999999999876   99999999999999999999


Q ss_pred             EeecCcceeecCCccccCCCceecC
Q 042853          590 ISDFGMARTFTMNELEANTNRIVGT  614 (614)
Q Consensus       590 I~DFGla~~~~~~~~~~~~~~~~GT  614 (614)
                      +.|||++..+......++|  .+||
T Consensus       164 LvDFGvSaQldsT~grRnT--~iGt  186 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVGRRNT--FIGT  186 (953)
T ss_pred             EeeeeeeeeeecccccccC--cCCC
Confidence            9999999988765544433  5665

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.77  E-value=2.5e-18  Score=177.30  Aligned_cols=143  Identities=29%  Similarity=0.490  Sum_probs=119.1

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC--------------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG--------------  515 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~--------------  515 (614)
                      ...++|++.+.||+|+||.||+|... +++.+|+|.++...  ......+.+|+++++.++|||+.              
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34567888999999999999999986 57889999986432  22335678899999999999991              


Q ss_pred             -----CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 042853          516 -----GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI  590 (614)
Q Consensus       516 -----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI  590 (614)
                           ...++|+||+++ +|..++...  ...+++.....++.||+.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                 157899999986 666665432  335899999999999999999999986   999999999999999999999


Q ss_pred             eecCcceeecC
Q 042853          591 SDFGMARTFTM  601 (614)
Q Consensus       591 ~DFGla~~~~~  601 (614)
                      +|||+++.+..
T Consensus       158 ~dfg~~~~~~~  168 (302)
T cd07864         158 ADFGLARLYNS  168 (302)
T ss_pred             CcccccccccC
Confidence            99999987653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.77  E-value=4.9e-18  Score=169.91  Aligned_cols=140  Identities=31%  Similarity=0.459  Sum_probs=121.8

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|++|.||++... +++.+++|.+.....  ....++.+|++++.+++|+|+         ....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            3667899999999999999876 567899999876533  455679999999999999998         4567899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +++++|..++...   ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999988533   45899999999999999999999886   999999999999999999999999999977543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.77  E-value=2.9e-18  Score=175.71  Aligned_cols=138  Identities=24%  Similarity=0.386  Sum_probs=116.4

Q ss_pred             CCccceeccCCceeEEEEEeC----CccEEEEEEccCCC----cchhHhHHHHHHHHHhc-CCCCC---------CCeeE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKL-QHTNL---------GGERL  519 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~  519 (614)
                      |+..+.||+|+||.||++...    ++..+|||.+.+..    .+..+.+.+|+.++.++ +|+|+         ....+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            566789999999999998753    56789999886432    22345688999999999 59998         45678


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++++|..++..   ...+++.....++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+
T Consensus        82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            99999999999988753   235788888999999999999999876   999999999999999999999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       156 ~~  157 (288)
T cd05583         156 LA  157 (288)
T ss_pred             cc
Confidence            44

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.77  E-value=2.8e-18  Score=175.26  Aligned_cols=132  Identities=29%  Similarity=0.390  Sum_probs=107.0

Q ss_pred             eeccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHHHH---hcCCCCC---------CCeeEEEEEecC
Q 042853          463 RLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKLIA---KLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~l~---~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      .||+|+||.||++... +++.+|+|.+.+...   .....+.+|..++.   ..+|+|+         .+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 578999998865321   12233445544443   3478888         457789999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            99999888532   35899999999999999999999987   9999999999999999999999999997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.77  E-value=1e-18  Score=193.15  Aligned_cols=144  Identities=24%  Similarity=0.422  Sum_probs=108.0

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCC--ccEEEEE------------------EccCCCcchhHhHHHHHHHHHhcCCCC
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQD--EQEIAIK------------------RLSKSSGQGIVEFKNEAKLIAKLQHTN  513 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~--~~~vavK------------------~l~~~~~~~~~~f~~E~~~l~~l~H~n  513 (614)
                      ..++|.+.++||+|+||+||++....  +...++|                  .+. .......+|.+|+.++.+++|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            34689999999999999999987642  1112222                  111 11223456889999999999999


Q ss_pred             C---------CCeeEEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 042853          514 L---------GGERLLVYEYLPNKSLDFFIFDSSR--KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL  582 (614)
Q Consensus       514 l---------~~~~~lv~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  582 (614)
                      +         ....++|+|++. ++|..++.....  .......+...++.||+.||.|||+.+   ||||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9         456789999985 466666643221  112234556789999999999999986   9999999999999


Q ss_pred             cCCCcEEEeecCcceeecCC
Q 042853          583 DEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       583 d~~~~~kI~DFGla~~~~~~  602 (614)
                      +.++.+||+|||+|+.+...
T Consensus       301 ~~~~~vkL~DFGla~~~~~~  320 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKE  320 (501)
T ss_pred             CCCCCEEEEeCCCceecCcc
Confidence            99999999999999987543

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.77  E-value=3.4e-18  Score=177.16  Aligned_cols=141  Identities=31%  Similarity=0.510  Sum_probs=118.4

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC-----------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL-----------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~l  520 (614)
                      .++|+..+.||+|+||.||+|... +++.||+|.++...  ......+.+|+.++.+++|+|+           ....++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357888899999999999999986 57899999986432  2223456789999999999998           135789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++ +|..++...  ...+++.+...++.|+++||.|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 787777532  245899999999999999999999987   9999999999999999999999999998775


Q ss_pred             C
Q 042853          601 M  601 (614)
Q Consensus       601 ~  601 (614)
                      .
T Consensus       160 ~  160 (309)
T cd07845         160 L  160 (309)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.77  E-value=3.6e-18  Score=180.07  Aligned_cols=145  Identities=28%  Similarity=0.375  Sum_probs=120.9

Q ss_pred             hhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC---------
Q 042853          448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG---------  515 (614)
Q Consensus       448 ~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~---------  515 (614)
                      ..++...+++|...+.||+|+||.||++... +++.||+|++.+..  ....+.+.+|+.++.+++|+|+.         
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3556677899999999999999999999864 67899999987532  22345688899999999999981         


Q ss_pred             ------CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          516 ------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       516 ------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                            ...++++|++ +++|..++..    ..+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  2356777776 7788877632    24789999999999999999999987   99999999999999999999


Q ss_pred             EeecCcceeec
Q 042853          590 ISDFGMARTFT  600 (614)
Q Consensus       590 I~DFGla~~~~  600 (614)
                      |+|||+++...
T Consensus       161 l~dfg~~~~~~  171 (345)
T cd07877         161 ILDFGLARHTD  171 (345)
T ss_pred             Eeccccccccc
Confidence            99999998654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.77  E-value=3.9e-18  Score=172.79  Aligned_cols=144  Identities=27%  Similarity=0.480  Sum_probs=117.8

Q ss_pred             CCCccceeccCCceeEEEEEeCC--ccEEEEEEccCC----------CcchhHhHHHHHHHHHh-cCCCCC---------
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQD--EQEIAIKRLSKS----------SGQGIVEFKNEAKLIAK-LQHTNL---------  514 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~--~~~vavK~l~~~----------~~~~~~~f~~E~~~l~~-l~H~nl---------  514 (614)
                      +|++.+.||+|+||.||++....  ++.+|+|.+...          ......++..|+.++.+ ++|+|+         
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36678899999999999999865  578999987532          12234557788888875 799999         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                      ....+++|||+++++|..++... .....+++..+..++.|++.||.|||+..  +|+|+||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            56789999999999998887542 23345888999999999999999999632  4999999999999999999999999


Q ss_pred             CcceeecCC
Q 042853          594 GMARTFTMN  602 (614)
Q Consensus       594 Gla~~~~~~  602 (614)
                      |+++.....
T Consensus       159 g~~~~~~~~  167 (269)
T cd08528         159 GLAKQKQPE  167 (269)
T ss_pred             cceeecccc
Confidence            999876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.77  E-value=4.2e-18  Score=174.36  Aligned_cols=141  Identities=31%  Similarity=0.478  Sum_probs=123.8

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .+++|+..+.||+|+||.||++... +++.+++|.+..... ...++.+|+++++.++|+|+         ....++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4566777899999999999999987 678899999975433 56678999999999999998         467899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+++++|.+++....  ..+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            999999999986543  36899999999999999999999876   9999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.77  E-value=4.1e-18  Score=179.47  Aligned_cols=139  Identities=26%  Similarity=0.416  Sum_probs=117.5

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC---------------
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG---------------  515 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~---------------  515 (614)
                      ..++|+..+.||+|+||.||++... +++.||||++.+..  ......+.+|+.++++++|+|+.               
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3567888999999999999999865 67899999985432  22345688999999999999981               


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      ...++||||+ +++|..++..    ..+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence            2458999998 6788877632    35789999999999999999999886   99999999999999999999999999


Q ss_pred             ceeec
Q 042853          596 ARTFT  600 (614)
Q Consensus       596 a~~~~  600 (614)
                      ++...
T Consensus       165 ~~~~~  169 (343)
T cd07880         165 ARQTD  169 (343)
T ss_pred             ccccc
Confidence            98664

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.77  E-value=4.1e-18  Score=173.89  Aligned_cols=139  Identities=29%  Similarity=0.525  Sum_probs=118.7

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------C--CeeEEEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------G--GERLLVYE  523 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~--~~~~lv~E  523 (614)
                      |++.+.||+|+||.||++... +++.+|+|.+....  ......+.+|++++.+++|+|+         .  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456789999999999999886 57889999997642  3334568899999999999998         3  57899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |+++ +|..++...  ...+++.....++.||++||+|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9985 888877533  245889999999999999999999886   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.77  E-value=6.4e-18  Score=169.08  Aligned_cols=141  Identities=28%  Similarity=0.445  Sum_probs=123.2

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------C--CeeEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------G--GERLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~--~~~~lv~  522 (614)
                      +|...+.||+|++|.||+|... +++.+++|.+.....  ...+.+.+|+.++++++|+|+         .  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3566789999999999999987 688999999865432  456789999999999999999         3  5789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++++|..++....   .+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999986432   6899999999999999999999976   999999999999999999999999999987654


Q ss_pred             c
Q 042853          603 E  603 (614)
Q Consensus       603 ~  603 (614)
                      .
T Consensus       155 ~  155 (260)
T cd06606         155 E  155 (260)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.77  E-value=3.6e-18  Score=172.99  Aligned_cols=144  Identities=30%  Similarity=0.418  Sum_probs=122.5

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------C------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------G------  515 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~------  515 (614)
                      .++++|++.+.||+|+||.||++... +++.+++|.+.... ....+|.+|+.++.++ +|+|+         .      
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            45688999999999999999999986 56789999886543 3446789999999999 69998         1      


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                      ...++||||+++++|.+++.... ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence            13689999999999998875432 2346889999999999999999999886   9999999999999999999999999


Q ss_pred             cceeec
Q 042853          595 MARTFT  600 (614)
Q Consensus       595 la~~~~  600 (614)
                      ++....
T Consensus       159 ~~~~~~  164 (275)
T cd06608         159 VSAQLD  164 (275)
T ss_pred             cceecc
Confidence            997654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.77  E-value=6.9e-18  Score=168.14  Aligned_cols=140  Identities=31%  Similarity=0.516  Sum_probs=122.9

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      |...+.||+|++|.||++... +++.+++|++.....+...++.+|++++++++|+|+         ....++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            566789999999999999986 678899999976544466789999999999999998         4578899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ++|..++....  ..+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999885432  45899999999999999999999876   999999999999999999999999999877644

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.77  E-value=4.6e-18  Score=179.81  Aligned_cols=138  Identities=30%  Similarity=0.359  Sum_probs=116.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCC---------------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLG---------------G  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~---------------~  516 (614)
                      .++|+..+.||+|+||.||++... +++.+|+|.+.+.  ......++.+|+.++++++|+|+.               .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            467888999999999999999875 6789999998643  233445678899999999999981               2


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++||||++ ++|...+..     .++..+...++.|++.||.|||..+   |+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence            4689999996 477776632     2788888899999999999999986   999999999999999999999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +....
T Consensus       166 ~~~~~  170 (353)
T cd07850         166 RTAGT  170 (353)
T ss_pred             eeCCC
Confidence            87643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.76  E-value=4.3e-18  Score=173.03  Aligned_cols=140  Identities=36%  Similarity=0.491  Sum_probs=121.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcC-CCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv  521 (614)
                      ++|...+.||+|+||.||++... +++.+|+|.+.+.   ..+...++..|+.++.+++ |+|+         ....++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36777899999999999999986 6889999988653   2233467889999999999 9999         5678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++++|..++...   ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999988543   35899999999999999999999887   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.5e-18  Score=178.55  Aligned_cols=141  Identities=23%  Similarity=0.352  Sum_probs=120.1

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcc--hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      |...+.||+|.|.+|..+++- +|..||||.+.+.+-.  ....+.+|+++|+.+|||||         ...++||+|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            455688999999999988764 7889999999875432  34568899999999999999         56889999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE-cCCCcEEEeecCcceeecCCc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL-DEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-d~~~~~kI~DFGla~~~~~~~  603 (614)
                      .+|+|.+|+-.+.  .-+.+....++..||..|+.|+|+..   +|||||||+|+.. ..-|.+||.|||++-.+.+++
T Consensus       100 D~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen  100 DGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             CCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999986543  34778888899999999999999876   9999999999986 466789999999998887665

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2.6e-19  Score=187.88  Aligned_cols=138  Identities=25%  Similarity=0.433  Sum_probs=120.0

Q ss_pred             CCCccceeccCCceeEEEEEeCCcc-EEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~-~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      .+.++..||.|+||+|||+..+... ..|.|.|.....+..+.|+-|+++|+..+||++         .+.++++.|||+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3455788999999999999887544 346788876667778889999999999999998         678899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +|-.+..+.+..+  .|...++..++.|++.||.|||++.   |||||||+.|||+.-+|.++|+|||.+...
T Consensus       113 GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  113 GGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             CchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence            9999999876543  5888999999999999999999987   999999999999999999999999987543

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.76  E-value=6e-18  Score=172.68  Aligned_cols=132  Identities=28%  Similarity=0.383  Sum_probs=107.4

Q ss_pred             eeccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHH---HHhcCCCCC---------CCeeEEEEEecC
Q 042853          463 RLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKL---IAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~---l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      .||+|+||.||++... +++.||+|.+.+...   +....+..|..+   +...+|+|+         ....++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 578999999865321   222234455444   444578888         457889999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            9999988743   345899999999999999999999876   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.76  E-value=7.3e-18  Score=172.09  Aligned_cols=138  Identities=30%  Similarity=0.495  Sum_probs=117.5

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      |+..+.||+|++|.||+|... +++.+|+|++....  ......+.+|++++++++|+|+         ....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456789999999999999875 68899999986432  2234568899999999999998         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      + ++|..++..... ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.+.
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            5 689888754322 35799999999999999999999876   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.76  E-value=4.8e-18  Score=174.84  Aligned_cols=133  Identities=26%  Similarity=0.403  Sum_probs=116.5

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCHH
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLD  531 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL~  531 (614)
                      .+||+|+||.||++... +++.+|||.+..........+.+|+.+++.++|+|+         ....+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            67999999999999885 678999999865444455678999999999999998         56789999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          532 FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       532 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      .++..    ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus       106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            87732    24788999999999999999999986   99999999999999999999999999886643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.76  E-value=5.2e-18  Score=171.13  Aligned_cols=132  Identities=28%  Similarity=0.375  Sum_probs=115.0

Q ss_pred             eccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ||+|+||.||++... +++.+|+|.+.+..   ....+.+.+|+.+++.++|+|+         ....++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999986 47889999986532   2345679999999999999998         4568899999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ..++...   ..+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            9998542   34788899999999999999999876   99999999999999999999999999997754

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.76  E-value=7.9e-18  Score=173.01  Aligned_cols=140  Identities=30%  Similarity=0.487  Sum_probs=115.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|+..+.||+|++|.||+|... +++.+|+|.+....  ......+.+|++++++++|+|+         ....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46788899999999999999986 67889999886432  2334578899999999999999         568899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-QMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-~~~~kI~DFGla~~~~  600 (614)
                      |++ ++|..++.... ...+++.....++.||+.||+|||+.+   |+|+||||+||+++. +..+||+|||+++.+.
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            996 57777764322 223577777889999999999999886   999999999999985 5579999999998653

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.76  E-value=6.1e-18  Score=177.70  Aligned_cols=139  Identities=31%  Similarity=0.506  Sum_probs=118.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCC--------------Cee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLG--------------GER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~--------------~~~  518 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+...  ......++.+|+.++..++|+|+.              ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            56888899999999999999875 6789999998653  223345678899999999999991              247


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      +++|||+. ++|..++..   ...+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          85 YIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            99999996 688877743   245889999999999999999999886   99999999999999999999999999987


Q ss_pred             ecC
Q 042853          599 FTM  601 (614)
Q Consensus       599 ~~~  601 (614)
                      ...
T Consensus       158 ~~~  160 (337)
T cd07858         158 TSE  160 (337)
T ss_pred             cCC
Confidence            643

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.76  E-value=6.8e-18  Score=172.95  Aligned_cols=134  Identities=26%  Similarity=0.411  Sum_probs=117.3

Q ss_pred             ccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCC
Q 042853          460 PANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKS  529 (614)
Q Consensus       460 ~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gs  529 (614)
                      ..+.||+|++|.||++... +++.+++|.+........+.+.+|+.+++.++|+|+         ....++++||+++++
T Consensus        23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~  102 (285)
T cd06648          23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA  102 (285)
T ss_pred             cceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence            3478999999999999875 678899998865444455678999999999999998         467899999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          530 LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       530 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |..++..    ..+++.+...++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       103 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~  166 (285)
T cd06648         103 LTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS  166 (285)
T ss_pred             HHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence            9998854    34788999999999999999999987   9999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.76  E-value=6.2e-18  Score=174.81  Aligned_cols=140  Identities=27%  Similarity=0.523  Sum_probs=116.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC-----------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG-----------------  515 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~-----------------  515 (614)
                      ++|+..++||+|+||.||++... +++.+|||.+....  ......+.+|+.++++++|+|+.                 
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46888899999999999999876 67899999885432  22234567899999999999981                 


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      ...++||||+++ +|..++...  ...+++.+...++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence            234899999975 777766432  235789999999999999999999986   99999999999999999999999999


Q ss_pred             ceeecC
Q 042853          596 ARTFTM  601 (614)
Q Consensus       596 a~~~~~  601 (614)
                      ++.+..
T Consensus       166 ~~~~~~  171 (310)
T cd07865         166 ARAFSL  171 (310)
T ss_pred             cccccC
Confidence            987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.76  E-value=6.9e-18  Score=169.41  Aligned_cols=141  Identities=29%  Similarity=0.470  Sum_probs=119.3

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|+..+.||+|+||.||++... ++..+|+|.+...  .....+.+.+|+.+++.++|+|+         ....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677899999999999999986 5788999998643  12344578899999999999999         4578999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~~~  601 (614)
                      +++++|..++.... ...+++..+..++.|+++||.|||+.+   |+|+||||+||++++++ .+||+|||++..+..
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            99999999886432 235789999999999999999999886   99999999999999875 479999999987653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.76  E-value=8.7e-18  Score=174.95  Aligned_cols=137  Identities=34%  Similarity=0.484  Sum_probs=115.5

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      |...+.||+|+||.||++... ++..+|+|.+....   .+...++.+|++++++++|+|+         ....++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            556789999999999999875 67889999986432   2334578899999999999998         4567899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++ |+|..++...  ...+++.++..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++....
T Consensus       107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            97 5776666432  345899999999999999999999887   9999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.76  E-value=7.6e-18  Score=168.90  Aligned_cols=142  Identities=32%  Similarity=0.500  Sum_probs=121.5

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|++.+.||+|+||.||++... +++.+|+|.+....  .....++.+|++++++++|+|+         ....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677899999999999999865 67889999986532  2345678899999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++++|..++.... ....+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||+++....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            99999999886522 2345789999999999999999999887   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.76  E-value=3.1e-18  Score=167.38  Aligned_cols=133  Identities=26%  Similarity=0.389  Sum_probs=115.9

Q ss_pred             cceeccCCceeEEEEE-eCCccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCC---------CCeeEEEEEecCCCC
Q 042853          461 ANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVYEYLPNKS  529 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~-~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~Ey~~~gs  529 (614)
                      .+.||+|+|+.|--++ +.+++++|||.+.+..........+|++++...+ |+||         ....|||||-|.+|+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            5789999999998876 5689999999999876667778899999999986 9999         568899999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEeecCcceee
Q 042853          530 LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM---NPKISDFGMARTF  599 (614)
Q Consensus       530 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~---~~kI~DFGla~~~  599 (614)
                      |..++.+.   ..+++.+.-+++++||.||.|||..+   |.||||||+|||-.+..   -+||+||-|+.-+
T Consensus       163 lLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  163 LLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             HHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence            99998653   34788899999999999999999988   99999999999986443   3799999998654

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.76  E-value=1.3e-17  Score=166.88  Aligned_cols=143  Identities=26%  Similarity=0.422  Sum_probs=123.2

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +|...+.||+|+||.||++... +++.+++|++.....  +...++.+|+++++.++|+|+         ....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4667889999999999999986 578899999865432  455678999999999999998         4678899999


Q ss_pred             cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +++++|..++.... ....+++.+...++.++++||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999886532 1356899999999999999999999986   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=6.7e-19  Score=178.24  Aligned_cols=144  Identities=31%  Similarity=0.421  Sum_probs=117.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEcc--CCCcc-----hhHhHHHHHHHHHhcCCCCC----------CCe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLS--KSSGQ-----GIVEFKNEAKLIAKLQHTNL----------GGE  517 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~--~~~~~-----~~~~f~~E~~~l~~l~H~nl----------~~~  517 (614)
                      ++|-.++.||+|+|+.|||+..- ..+-||||+-.  +.-.+     -.+...+|-.+-+.|+||.|          ...
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            45666789999999999999865 45668888643  22111     12345678899999999998          356


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCcEEEeecC
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFG  594 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld---~~~~~kI~DFG  594 (614)
                      .|-|+|||++.+|+.||...   ..+++++...|+.||..||.||.+. .+||||-||||.||||.   ..+.+||+|||
T Consensus       543 FCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            78899999999999999643   4578999999999999999999987 47899999999999995   45789999999


Q ss_pred             cceeecCCc
Q 042853          595 MARTFTMNE  603 (614)
Q Consensus       595 la~~~~~~~  603 (614)
                      |+|+|..+.
T Consensus       619 LSKIMdddS  627 (775)
T KOG1151|consen  619 LSKIMDDDS  627 (775)
T ss_pred             hhhhccCCc
Confidence            999997654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.5e-19  Score=171.34  Aligned_cols=141  Identities=26%  Similarity=0.543  Sum_probs=112.4

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccC--CCcchhHhHHHHHHHHHhcCCCCC-----------------CC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNL-----------------GG  516 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nl-----------------~~  516 (614)
                      .|+...+||+|.||.||+++.. .++.||+|++--  .+..--....+|+.+|..++|+|+                 ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4555688999999999999876 467788886532  111122345789999999999998                 23


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..+||+++|++ +|.-+|-+  ....++..+..+++.++..||.|+|...   |+|||+||+|+||+.++.+||+|||+|
T Consensus        98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence            47899999987 67666633  2345778888999999999999999876   999999999999999999999999999


Q ss_pred             eeecCCc
Q 042853          597 RTFTMNE  603 (614)
Q Consensus       597 ~~~~~~~  603 (614)
                      |.+...+
T Consensus       172 r~fs~~~  178 (376)
T KOG0669|consen  172 RAFSTSK  178 (376)
T ss_pred             cceeccc
Confidence            9876443

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.75  E-value=4.8e-18  Score=189.31  Aligned_cols=142  Identities=27%  Similarity=0.365  Sum_probs=101.0

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-C----ccEEEEEEccCCCcchhHhHHHHH----------HHHHhcCCC---CCC
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-D----EQEIAIKRLSKSSGQGIVEFKNEA----------KLIAKLQHT---NLG  515 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~----~~~vavK~l~~~~~~~~~~f~~E~----------~~l~~l~H~---nl~  515 (614)
                      ..++|+..+.||+|+||.||+|.+. +    +..+|||++......  +.+..|.          ..+..+.++   .-.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNERVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHHHHHhhchhhHHHHHHhhhcccccccC
Confidence            4578888999999999999999986 3    578999988643211  1111110          011111111   114


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRK-----------------SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVS  578 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~  578 (614)
                      .+.+|||||+++++|..++......                 ..........++.||+.||.|||+.+   ||||||||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~  284 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ  284 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence            5789999999999999888543210                 00112234568899999999999886   999999999


Q ss_pred             CEEEcC-CCcEEEeecCcceeec
Q 042853          579 NILLDE-QMNPKISDFGMARTFT  600 (614)
Q Consensus       579 NILld~-~~~~kI~DFGla~~~~  600 (614)
                      |||++. ++.+||+|||+|+.+.
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~  307 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLR  307 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccc
Confidence            999985 5789999999998764

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.75  E-value=1.2e-17  Score=170.10  Aligned_cols=136  Identities=28%  Similarity=0.387  Sum_probs=112.8

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcC-CCCC---------C--CeeEEEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNL---------G--GERLLVYE  523 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nl---------~--~~~~lv~E  523 (614)
                      |...++||+|+||.||++... +++.+|+|.+++.. .........|+.++.++. |+|+         .  ...++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            455788999999999999875 67889999986532 222234567888898885 9998         3  67899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |++ ++|..++...  ...+++.+...++.|+++||.|||+.+   |+||||||+||+++. +.+||+|||+++.+.
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            997 5777776432  246899999999999999999999986   999999999999999 999999999998764

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.75  E-value=8.3e-18  Score=176.04  Aligned_cols=142  Identities=32%  Similarity=0.440  Sum_probs=119.1

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC----------CCe
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL----------GGE  517 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl----------~~~  517 (614)
                      +...+++|+..+.||+|+||.||++... +++.+|||++.+.  .....+.+..|++++..++|||+          ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3446788999999999999999999865 7889999988543  22334678899999999999999          345


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++++||+. ++|..++.    ...+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        85 ~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999984 68887773    234677888889999999999999986   9999999999999999999999999998


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      ...
T Consensus       157 ~~~  159 (328)
T cd07856         157 IQD  159 (328)
T ss_pred             ccC
Confidence            653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.75  E-value=2.1e-17  Score=168.66  Aligned_cols=139  Identities=33%  Similarity=0.449  Sum_probs=116.8

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcC-CCCC---------CCeeEEEEEec
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVYEYL  525 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~Ey~  525 (614)
                      |.+.+.||+|+||+||+|... +++.++||++..... .......+|+..+.+++ |+|+         ....++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            455789999999999999986 467899999865322 12234567999999999 9999         56889999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                       +|+|..++.... ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence             889988875432 235799999999999999999999986   99999999999999999999999999987653

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.75  E-value=1.9e-17  Score=168.73  Aligned_cols=139  Identities=30%  Similarity=0.473  Sum_probs=118.1

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      |+..+.||+|++|.||++... +++.+++|.+.....  .....+.+|++++++++|+|+         ....++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            445688999999999999876 678899999865432  245678899999999999998         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ++ +|..++....  ..+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||.+..+...
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            85 8877775422  45889999999999999999999987   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.74  E-value=1.7e-17  Score=174.63  Aligned_cols=136  Identities=29%  Similarity=0.443  Sum_probs=114.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC---------------Ce
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG---------------GE  517 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~---------------~~  517 (614)
                      ++|...+.||+|+||.||+|... +++.+|||++.+..  ......+.+|+.++++++|+|+.               .+
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            67888899999999999999875 68899999986532  22345688999999999999981               24


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++|+||++. +|..++     ...+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             EEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            6899999974 666554     124788899999999999999999886   9999999999999999999999999998


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      ...
T Consensus       166 ~~~  168 (342)
T cd07879         166 HAD  168 (342)
T ss_pred             CCC
Confidence            653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=2.4e-18  Score=180.90  Aligned_cols=141  Identities=24%  Similarity=0.403  Sum_probs=116.4

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      ....-|..++.||-|+||+|..+.-. +...+|+|.|.+..   ..+....+.|-.||+..+.+-+         .+.+|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            33456888899999999999988654 55678999997753   3344567889999999887776         57899


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++|++..+|-.   ...+++.....++..++.|+++.|..+   +|||||||.|||||.+|.+||+||||+.-+
T Consensus       706 FVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence            99999999999998843   345666666666777999999999987   999999999999999999999999998754

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.74  E-value=1.4e-17  Score=174.24  Aligned_cols=139  Identities=31%  Similarity=0.437  Sum_probs=119.0

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------C-----CeeE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------G-----GERL  519 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~-----~~~~  519 (614)
                      +|.+.+.||+|+||.||++... .++.+|||++....  ....+.+.+|+.+++.++|+|+         .     ...+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4677899999999999999986 47889999987543  3345678999999999999998         2     2679


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ++|||++ ++|..++..   ...+++.....++.|+++||.|||+.+   |+|+||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 478777743   236899999999999999999999987   999999999999999999999999999977


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       154 ~~~  156 (330)
T cd07834         154 DPD  156 (330)
T ss_pred             ccc
Confidence            543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.74  E-value=1.5e-17  Score=174.24  Aligned_cols=137  Identities=32%  Similarity=0.446  Sum_probs=113.5

Q ss_pred             CCCccceeccCCceeEEEEEeC-C--ccEEEEEEccCCC--cchhHhHHHHHHHHHhc-CCCCCC-------------Ce
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-D--EQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL-QHTNLG-------------GE  517 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~--~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l-~H~nl~-------------~~  517 (614)
                      +|...+.||+|+||.||++... .  ++.+|+|++....  ....+.+.+|+.++.++ +|+|+.             ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3667789999999999999976 3  6789999986432  22345688899999999 599981             23


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++++||++ ++|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+|+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            578888886 688888742   345889999999999999999999887   9999999999999999999999999998


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      .+.
T Consensus       154 ~~~  156 (332)
T cd07857         154 GFS  156 (332)
T ss_pred             ecc
Confidence            764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.74  E-value=1.6e-17  Score=167.41  Aligned_cols=133  Identities=29%  Similarity=0.379  Sum_probs=109.1

Q ss_pred             ceeccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHHH-HhcCCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKLI-AKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~l-~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      +.||+|+||.||++... +++.+|||.+.+...   .....+..|..++ ...+|+|+         ....++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999875 578999999865321   2223445555444 45589998         4578999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++|..++...   ..+++.....++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||+++...
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            9999988532   35788889999999999999999886   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.74  E-value=2.4e-17  Score=167.91  Aligned_cols=138  Identities=30%  Similarity=0.487  Sum_probs=118.4

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      |+..+.||+|.||.||+|+.. +++.+|+|.+....  ....+.+..|+.++++++|+|+         ....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            445678999999999999986 47899999987643  3334678899999999999999         46789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      + ++|..++....  ..+++..+..++.++++||.|||+.+   |+|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            8 58999886432  35889999999999999999999986   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.74  E-value=1.5e-17  Score=174.37  Aligned_cols=138  Identities=28%  Similarity=0.402  Sum_probs=114.5

Q ss_pred             CCCC-ccceeccCCceeEEEEEeC-CccEEEEEEccCCCcch--------------hHhHHHHHHHHHhcCCCCC-----
Q 042853          456 DNFS-PANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQG--------------IVEFKNEAKLIAKLQHTNL-----  514 (614)
Q Consensus       456 ~~f~-~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~--------------~~~f~~E~~~l~~l~H~nl-----  514 (614)
                      ++|. +.+.||+|+||.||++... +++.+|||.++......              ...+.+|++++..++|+|+     
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3443 3467999999999999875 67899999886432111              1247889999999999998     


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI  590 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI  590 (614)
                          ....++||||++ ++|..++..   ...+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence                467899999997 688888743   234788899999999999999999886   999999999999999999999


Q ss_pred             eecCcceeec
Q 042853          591 SDFGMARTFT  600 (614)
Q Consensus       591 ~DFGla~~~~  600 (614)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (335)
T PTZ00024        161 ADFGLARRYG  170 (335)
T ss_pred             CCccceeecc
Confidence            9999998765

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.74  E-value=1.5e-17  Score=175.16  Aligned_cols=137  Identities=28%  Similarity=0.456  Sum_probs=116.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCC-------------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG-------------------  515 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~-------------------  515 (614)
                      .+|...+.||+|+||.||+|... +++.||+|.+.....+..+.+.+|++++++++|+|+.                   
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888899999999999999875 6789999998765555667789999999999999981                   


Q ss_pred             ----CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEE
Q 042853          516 ----GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKI  590 (614)
Q Consensus       516 ----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-~~~~~kI  590 (614)
                          ...++||||++ ++|..++..    ..+++.....++.||+.||.|||+.+   |+||||||+||+++ ++..+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                24689999997 588877732    34788899999999999999999887   99999999999998 4557899


Q ss_pred             eecCcceeec
Q 042853          591 SDFGMARTFT  600 (614)
Q Consensus       591 ~DFGla~~~~  600 (614)
                      +|||+++.+.
T Consensus       157 ~dfg~~~~~~  166 (342)
T cd07854         157 GDFGLARIVD  166 (342)
T ss_pred             CCcccceecC
Confidence            9999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.74  E-value=2.3e-17  Score=169.86  Aligned_cols=138  Identities=22%  Similarity=0.306  Sum_probs=98.0

Q ss_pred             CCCCccceeccCCceeEEEEEeCCc----cEEEEEEccCCCcchhH-----------hHHHHHHHHHhcCCCCCCC----
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDE----QEIAIKRLSKSSGQGIV-----------EFKNEAKLIAKLQHTNLGG----  516 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~----~~vavK~l~~~~~~~~~-----------~f~~E~~~l~~l~H~nl~~----  516 (614)
                      ++|.+.+.||+|+||.||+|...+.    ..+|+|...........           ....+...+..++|+|+..    
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5788889999999999999997643    44566643322111111           1122333455668888721    


Q ss_pred             ---------eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 042853          517 ---------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN  587 (614)
Q Consensus       517 ---------~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~  587 (614)
                               ..++++|++.. ++...+..   ....++.....++.|+++||.|||+.+   |+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence                     23566776643 45444422   122467788899999999999999886   999999999999999999


Q ss_pred             EEEeecCcceeec
Q 042853          588 PKISDFGMARTFT  600 (614)
Q Consensus       588 ~kI~DFGla~~~~  600 (614)
                      +||+|||+|+.+.
T Consensus       165 ~~l~DFGla~~~~  177 (294)
T PHA02882        165 GYIIDYGIASHFI  177 (294)
T ss_pred             EEEEEcCCceeec
Confidence            9999999999774

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.74  E-value=2e-17  Score=171.12  Aligned_cols=140  Identities=29%  Similarity=0.493  Sum_probs=116.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC----------------
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG----------------  515 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~----------------  515 (614)
                      .++|.+.+.||+|+||.||++... +++.+|||++....  ......+.+|++++++++|+|+.                
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888999999999999999976 57889999885432  22234678899999999999991                


Q ss_pred             -CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          516 -GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       516 -~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                       ...++|+||++. +|...+...  ...+++.....++.|+++||.|||+.+   |+|+||||+|||+++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence             136899999975 566655432  335899999999999999999999987   9999999999999999999999999


Q ss_pred             cceeec
Q 042853          595 MARTFT  600 (614)
Q Consensus       595 la~~~~  600 (614)
                      +++...
T Consensus       161 ~~~~~~  166 (311)
T cd07866         161 LARPYD  166 (311)
T ss_pred             cchhcc
Confidence            998764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.73  E-value=2.5e-17  Score=170.95  Aligned_cols=135  Identities=20%  Similarity=0.201  Sum_probs=111.9

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKS  529 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gs  529 (614)
                      .+.+|.|+++.||++.. +++.+|||++...  ..+....+..|+++++.++|+|+         ....+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455566666666665 6889999998654  33455689999999999999998         467899999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          530 LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       530 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |..++..... ..+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||.+..+.
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence            9999865322 34788888899999999999999986   9999999999999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.73  E-value=2.9e-17  Score=169.13  Aligned_cols=140  Identities=24%  Similarity=0.392  Sum_probs=114.4

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-ccEEEEEEccCCC-cchhHhHHHHHHHHHhcC-CCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~E  523 (614)
                      ++|...+.||+|+||.||++.... ++.+|||.+++.. .....++..|+.++.+.+ |+|+         ....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            566778999999999999999874 8899999986542 233456677887777775 9998         457899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+++ +|..++...  ...+++..+..++.||++||.|||+..  +|+||||+|+||++++++.+||+|||+++.+.
T Consensus        95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            9864 676665432  236899999999999999999999742  49999999999999999999999999998664

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.73  E-value=4.5e-17  Score=162.78  Aligned_cols=132  Identities=29%  Similarity=0.417  Sum_probs=115.2

Q ss_pred             eccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      ||+|+||.||++... +++.+|+|.+.+...   ....++..|+.++++++|+|+         ....++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999986 478899999865422   245678999999999999999         5678999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ..++...   ..+++.....++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            9988543   25789999999999999999999876   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.73  E-value=5e-17  Score=168.97  Aligned_cols=136  Identities=34%  Similarity=0.479  Sum_probs=113.7

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      |...++||+|+||.||+|... +++.+++|.+....   .....++.+|+++++.++|+|+         ....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            444678999999999999875 67889999986432   2334568899999999999999         4568899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ++ ++|..++...  ...+++.++..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++...
T Consensus       103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            96 5676666432  345899999999999999999999886   999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.73  E-value=2.6e-17  Score=170.65  Aligned_cols=139  Identities=35%  Similarity=0.472  Sum_probs=115.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .|+..+.||+|+||.||+|... +++.+|+|.+...   ......++.+|+++++.++|+|+         ....++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3555688999999999999975 5678999988642   22334578899999999999998         456789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+. |+|..++...  ...+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            997 6777666432  235788999999999999999999876   99999999999999999999999999987653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=4.1e-19  Score=169.98  Aligned_cols=139  Identities=27%  Similarity=0.426  Sum_probs=111.7

Q ss_pred             CccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC--------------CCeeEEE
Q 042853          459 SPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--------------GGERLLV  521 (614)
Q Consensus       459 ~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl--------------~~~~~lv  521 (614)
                      +..+.||-|+||.||....+ +++.||.|++...-  -...+.+.+|++++..++|.|+              -.+.+++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            33578999999999999886 78999999886432  2245678899999999999998              1356778


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      .|.|. .+|..++..   ...|+-....-+..||++||.|||+.+   |.||||||.|.|++++...|||||||||.-..
T Consensus       136 TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            88885 367776643   334565666667899999999999987   99999999999999999999999999997765


Q ss_pred             Ccc
Q 042853          602 NEL  604 (614)
Q Consensus       602 ~~~  604 (614)
                      ++.
T Consensus       209 d~~  211 (449)
T KOG0664|consen  209 RDR  211 (449)
T ss_pred             hhh
Confidence            543

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.73  E-value=4e-17  Score=164.51  Aligned_cols=141  Identities=29%  Similarity=0.436  Sum_probs=113.2

Q ss_pred             CCCccceeccCCceeEEEEEeCC-ccEEEEEEccCC-----CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      +|.+.+.||+|+||.||++.... +..+++|.++..     ......++..|+.++++++|||+         ....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36677899999999999998753 334555544321     12234457789999999999998         4678999


Q ss_pred             EEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||+++++|..++... .....+++.+...++.|++.||.|||+.+   ++|+||||+||++++ ..+||+|||+++.+.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888642 22346899999999999999999999876   999999999999986 469999999998764


Q ss_pred             C
Q 042853          601 M  601 (614)
Q Consensus       601 ~  601 (614)
                      .
T Consensus       157 ~  157 (260)
T cd08222         157 G  157 (260)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.73  E-value=6.6e-17  Score=164.06  Aligned_cols=136  Identities=21%  Similarity=0.302  Sum_probs=108.0

Q ss_pred             cCCCCcccee--ccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEE
Q 042853          455 TDNFSPANRL--GQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~l--G~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv  521 (614)
                      .++|.+.+.+  |+|+||.||++... ++..+|+|.+......   +.  |+.....+ +|+|+         ....++|
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            3455555655  99999999999875 5678899988643211   11  22222222 69998         5678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~~  600 (614)
                      |||+++++|..++...   ..+++.+...++.|+++||.|||+.+   ++||||||+||+++.++ .+||+|||+++.+.
T Consensus        88 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         88 MDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            9999999999998543   26899999999999999999999987   99999999999999888 99999999998765


Q ss_pred             C
Q 042853          601 M  601 (614)
Q Consensus       601 ~  601 (614)
                      .
T Consensus       162 ~  162 (267)
T PHA03390        162 T  162 (267)
T ss_pred             C
Confidence            3

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.73  E-value=3.4e-17  Score=172.48  Aligned_cols=138  Identities=30%  Similarity=0.447  Sum_probs=117.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CC------
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GG------  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~------  516 (614)
                      .++|.....||+|+||.||+|... +++.+|||.+...  .......+.+|+.++++++|+|+         ..      
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            467888899999999999999986 5788999998643  22334567889999999999998         12      


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++|+||+ +++|..++..    ..+++.....++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence            379999998 5689888743    35899999999999999999999986   999999999999999999999999999


Q ss_pred             eeec
Q 042853          597 RTFT  600 (614)
Q Consensus       597 ~~~~  600 (614)
                      +.+.
T Consensus       166 ~~~~  169 (343)
T cd07851         166 RHTD  169 (343)
T ss_pred             cccc
Confidence            8764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.72  E-value=6.5e-17  Score=165.14  Aligned_cols=139  Identities=27%  Similarity=0.460  Sum_probs=113.4

Q ss_pred             CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhc---CCCCC---------CCe-----
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKL---QHTNL---------GGE-----  517 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l---~H~nl---------~~~-----  517 (614)
                      |++.+.||+|+||.||+++.. +++.+|+|.+.....  .....+.+|+.++.++   +|+|+         ...     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456789999999999999987 478999999864322  2234567788877666   59998         223     


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .+++|||+++ +|..++.... ...+++.....++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||+++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8899999974 7888775432 235899999999999999999999986   9999999999999999999999999998


Q ss_pred             eecC
Q 042853          598 TFTM  601 (614)
Q Consensus       598 ~~~~  601 (614)
                      .+..
T Consensus       156 ~~~~  159 (287)
T cd07838         156 IYSF  159 (287)
T ss_pred             eccC
Confidence            8753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.72  E-value=1.8e-17  Score=153.25  Aligned_cols=148  Identities=26%  Similarity=0.373  Sum_probs=115.2

Q ss_pred             hHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhc-CCCCC---------CCe
Q 042853          450 TIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNL---------GGE  517 (614)
Q Consensus       450 ~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nl---------~~~  517 (614)
                      .+.++.+.......||+|++|.|-+-++. +|+.+|||++... ..+..++..+|+.+..+- ..|..         ...
T Consensus        40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            34555666677889999999999877764 7899999999754 334455677888776554 44544         457


Q ss_pred             eEEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          518 RLLVYEYLPNKSLDFFIFD-SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      .++.||.|. -||+.|-.+ ......+++.-.-+|+..|..||.|||++  ..|||||+||+||||+.++++||||||++
T Consensus       120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccc
Confidence            889999995 477766433 22345577778889999999999999985  57999999999999999999999999998


Q ss_pred             eeec
Q 042853          597 RTFT  600 (614)
Q Consensus       597 ~~~~  600 (614)
                      -.+.
T Consensus       197 G~L~  200 (282)
T KOG0984|consen  197 GYLV  200 (282)
T ss_pred             eeeh
Confidence            8764

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.72  E-value=3.6e-17  Score=171.12  Aligned_cols=132  Identities=20%  Similarity=0.280  Sum_probs=111.4

Q ss_pred             ceeccC--CceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCC
Q 042853          462 NRLGQG--GFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       462 ~~lG~G--~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      ..||+|  +|++||++... +++.||||.+....  .+..+.+.+|+.+++.++|+|+         ....++|+||++.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            467777  89999999875 78999999986432  2334678899999999999999         4577899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      ++|..++..... ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+|++||+.+.
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            999988865322 34788888899999999999999876   9999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.72  E-value=3e-17  Score=184.63  Aligned_cols=153  Identities=27%  Similarity=0.424  Sum_probs=126.0

Q ss_pred             hHHhhcCCCCccceeccCCceeEEEEEeC----C----ccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC-----
Q 042853          450 TIAVATDNFSPANRLGQGGFGPVYKGKLQ----D----EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL-----  514 (614)
Q Consensus       450 ~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~----~----~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl-----  514 (614)
                      .++...+++.+.+.||+|.||.|++|.+.    .    ...||||+++... ....+.+..|+++|..+ +|+|+     
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34455556666779999999999999853    1    3579999997643 34567899999999998 59999     


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhcC---------C--C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDSS---------R--K--SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKV  577 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~~---------~--~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  577 (614)
                          ....++|+||+++|+|..+|....         .  .  ..+.....+.++.|||.||+||++..   +|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence                457899999999999999997654         0  0  23788899999999999999999875   99999999


Q ss_pred             CCEEEcCCCcEEEeecCcceeecCCccc
Q 042853          578 SNILLDEQMNPKISDFGMARTFTMNELE  605 (614)
Q Consensus       578 ~NILld~~~~~kI~DFGla~~~~~~~~~  605 (614)
                      +|||+..+..+||+||||||....++..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y  474 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYY  474 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCce
Confidence            9999999999999999999977655433

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=8.4e-18  Score=169.12  Aligned_cols=151  Identities=27%  Similarity=0.391  Sum_probs=116.5

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-ccEEEEEEccCCCc---chhHhHHHHHHHHHhcCCCCC----------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNL----------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv  521 (614)
                      .+|....+||+|+||+|..+.-++ ...+|||.|++..-   ...+--+.|-++|+....|-.          .+.++.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            456668999999999999998774 45689999987521   222333556666665543332          4678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+.+|+|..++....+   +.+.....+|..||-||-+||+.+   ||.||||..|||||.++.+||+|||++|.-.-
T Consensus       429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999999865433   445567778999999999999988   99999999999999999999999999996443


Q ss_pred             CccccCCCceecC
Q 042853          602 NELEANTNRIVGT  614 (614)
Q Consensus       602 ~~~~~~~~~~~GT  614 (614)
                      +.  ..|.+++||
T Consensus       503 ~~--~TTkTFCGT  513 (683)
T KOG0696|consen  503 DG--VTTKTFCGT  513 (683)
T ss_pred             CC--cceeeecCC
Confidence            33  235557787

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=6.5e-17  Score=156.63  Aligned_cols=134  Identities=20%  Similarity=0.188  Sum_probs=106.7

Q ss_pred             CCCccceeccCCceeEEEEEeCCccEEEEEEccCCCc----------------------chhHhHHHHHHHHHhcCCCCC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG----------------------QGIVEFKNEAKLIAKLQHTNL  514 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~----------------------~~~~~f~~E~~~l~~l~H~nl  514 (614)
                      .|...+.||+|+||.||++..++++.+|||.+.....                      .....+..|..++.++.|+++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            3666789999999999999988899999998653210                      011235778889999988754


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN  587 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~  587 (614)
                             ....++||||+++++|.....   .      .....++.+++.++.++|+.+   |+|+||||+||++++++.
T Consensus        96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~---~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          96 PVPKPIDWNRHAVVMEYIDGVELYRVRV---L------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCCceeecCCceEEEEEeCCcchhhccc---c------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence                   345689999999999876531   0      223568889999999999976   999999999999999999


Q ss_pred             EEEeecCcceeecCC
Q 042853          588 PKISDFGMARTFTMN  602 (614)
Q Consensus       588 ~kI~DFGla~~~~~~  602 (614)
                      ++|+|||+|..+..+
T Consensus       164 ~~liDfg~~~~~~~~  178 (198)
T cd05144         164 IYIIDWPQMVSTDHP  178 (198)
T ss_pred             EEEEECCccccCCCc
Confidence            999999999877543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.71  E-value=4.1e-17  Score=167.10  Aligned_cols=140  Identities=26%  Similarity=0.406  Sum_probs=112.3

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcC-CCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~Ey  524 (614)
                      +|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+|+         ....+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3445688999999999999876 57899999986532 234567899999999996 9999         4567899999


Q ss_pred             cCCCCHHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFI---FDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++. ++..+.   ... ....+++.....++.++++||+|||+..  .|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            874 444332   221 2245889999999999999999999752  39999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.71  E-value=2.7e-18  Score=164.17  Aligned_cols=142  Identities=30%  Similarity=0.396  Sum_probs=109.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHh-cCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAK-LQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~-l~H~nl---------~~~~~lv~E  523 (614)
                      ++.+....||.|+||+|+|-.++ .++.+|||+++.... ...++|+.|.+...+ -+.|||         .+..++.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            34455688999999999998875 789999999975433 455678888876544 468888         578899999


Q ss_pred             ecCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFD--SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      .|. -||+.+-..  ......+++...-.|...+..||.||.+.  ..|||||+||+|||||..|.+||||||++-.+.
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            995 466554321  11233467766677888889999999875  479999999999999999999999999987653

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=7e-17  Score=160.40  Aligned_cols=139  Identities=17%  Similarity=0.165  Sum_probs=107.9

Q ss_pred             CCCccceeccCCceeEEEEE--eCCccEEEEEEccCCCcc------------------------hhHhHHHHHHHHHhcC
Q 042853          457 NFSPANRLGQGGFGPVYKGK--LQDEQEIAIKRLSKSSGQ------------------------GIVEFKNEAKLIAKLQ  510 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~--~~~~~~vavK~l~~~~~~------------------------~~~~f~~E~~~l~~l~  510 (614)
                      .|.+.+.||+|+||.||+|.  ..+++.||||.+......                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46678899999999999998  568899999988643210                        0123568999999998


Q ss_pred             CCCC-------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 042853          511 HTNL-------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD  583 (614)
Q Consensus       511 H~nl-------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld  583 (614)
                      +..+       ....++||||+++.+|......   ...+...+...++.||+.+|.|||+.+  .|+||||||+||+++
T Consensus       109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeEecCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE
Confidence            6443       2245899999999888655422   123455556789999999999999875  399999999999999


Q ss_pred             CCCcEEEeecCcceeecC
Q 042853          584 EQMNPKISDFGMARTFTM  601 (614)
Q Consensus       584 ~~~~~kI~DFGla~~~~~  601 (614)
                       ++.++|+|||+|+....
T Consensus       184 -~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      184 -DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             -CCCEEEEEChhhhccCC
Confidence             78999999999987654

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.71  E-value=6.7e-18  Score=190.64  Aligned_cols=143  Identities=29%  Similarity=0.385  Sum_probs=117.9

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      -+-+.+....||.|.||.||-+... +|...|||-+.-.  .........+|+.++..|+|||+         .++.+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            3445566789999999999999765 6777899977533  34455678899999999999999         3456788


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||||++|+|.+.+...   ...++.....+..|++.|+.|||+++   ||||||||.||+||.++.+|+.|||.|+.+..
T Consensus      1313 MEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999988543   23455555567889999999999998   99999999999999999999999999998764


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus      1387 ~ 1387 (1509)
T KOG4645|consen 1387 N 1387 (1509)
T ss_pred             c
Confidence            4

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.70  E-value=5.8e-17  Score=169.44  Aligned_cols=140  Identities=26%  Similarity=0.358  Sum_probs=115.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--------cchhHhHHHHHHHHHhcC---CCCC---------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQ---HTNL---------  514 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~---H~nl---------  514 (614)
                      ..|...+.+|+|+||.|..+.++ +..+|+||.+.+..        .......-.|+++|+.++   |+||         
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35778899999999999999987 45789999997652        111223567999999998   9999         


Q ss_pred             CCeeEEEEEec-CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          515 GGERLLVYEYL-PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       515 ~~~~~lv~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                      .+..+|+||-. ++-+|..++.   ....+++.+...|.+||+.|+++||+++   |||||||-+|+.+|.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            56788999876 3456777773   3345788888899999999999999998   999999999999999999999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |-|.....
T Consensus       715 gsaa~~ks  722 (772)
T KOG1152|consen  715 GSAAYTKS  722 (772)
T ss_pred             cchhhhcC
Confidence            99876543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.69  E-value=1.9e-17  Score=160.78  Aligned_cols=138  Identities=27%  Similarity=0.351  Sum_probs=111.7

Q ss_pred             hcCCCCcc-ceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC-------------CCe
Q 042853          454 ATDNFSPA-NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL-------------GGE  517 (614)
Q Consensus       454 ~t~~f~~~-~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl-------------~~~  517 (614)
                      .+++|.+. ++||-|-.|+|-.+..+ +++..|+|.|...     ...++|+++--+. .|+||             ..-
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35566543 57999999999999876 6778899988542     2346788776555 59998             345


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCcEEEeecC
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFG  594 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld---~~~~~kI~DFG  594 (614)
                      +++|||.|++|.|...+.+.. ...+++++.-+|+.||+.|+.|||...   |.||||||+|+|..   .+..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            678999999999998887654 345899999999999999999999987   99999999999986   34568999999


Q ss_pred             cceeec
Q 042853          595 MARTFT  600 (614)
Q Consensus       595 la~~~~  600 (614)
                      +||.-.
T Consensus       210 FAK~t~  215 (400)
T KOG0604|consen  210 FAKETQ  215 (400)
T ss_pred             cccccC
Confidence            999765

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=7.7e-17  Score=168.03  Aligned_cols=154  Identities=25%  Similarity=0.362  Sum_probs=123.1

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCCccEEEEEEcc--CCCcchhHhHHHHHHHHHhcC-CCCC---------CCeeEEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLV  521 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~--~~~~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv  521 (614)
                      ....|++.++||.||.+.||++...+.+.+|+|++.  ....+....|++|+.+|.+|+ |.++         .+.+++|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            345577889999999999999999888889988874  335566788999999999996 7777         5688999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||= .-+|..+|..... ...+| .+..+..|+++|+.++|+++   |||.||||.|+|+-. |.+||+|||+|+.+..
T Consensus       439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            9985 4588888865433 33456 55668899999999999987   999999999999976 5899999999999876


Q ss_pred             CccccCCCceecC
Q 042853          602 NELEANTNRIVGT  614 (614)
Q Consensus       602 ~~~~~~~~~~~GT  614 (614)
                      +....--...+||
T Consensus       512 DTTsI~kdsQvGT  524 (677)
T KOG0596|consen  512 DTTSIVKDSQVGT  524 (677)
T ss_pred             cccceeeccccCc
Confidence            6544322334565

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.69  E-value=5.1e-16  Score=152.05  Aligned_cols=140  Identities=31%  Similarity=0.477  Sum_probs=121.2

Q ss_pred             CCccceeccCCceeEEEEEeCC-ccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          458 FSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      |...+.||+|++|.||++.... ++.+++|.+...... ..+.+.+|++.+.+++|+|+         ....++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            3456889999999999999875 788999999765444 56789999999999999998         357889999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +++|..++.....  .+++.....++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999998854322  1788999999999999999999886   999999999999999999999999999987654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.69  E-value=2.4e-16  Score=157.00  Aligned_cols=123  Identities=23%  Similarity=0.172  Sum_probs=104.2

Q ss_pred             CCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCHHHHHhh
Q 042853          467 GGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFD  536 (614)
Q Consensus       467 G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL~~~l~~  536 (614)
                      |.||.||++... +++.+|+|++....     ++..|...+....|||+         ....++||||+++|+|..++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999886 67889999996532     34455666666779998         4678999999999999988854


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          537 SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       537 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      .   ..+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+|++|||+++.+.
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~  136 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE  136 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence            3   24889999999999999999999876   9999999999999999999999999887654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PRK10345 hypothetical protein; Provisional

Probab=99.68  E-value=3.1e-16  Score=152.18  Aligned_cols=129  Identities=22%  Similarity=0.307  Sum_probs=95.7

Q ss_pred             ccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhc-----CCCCC--------C----Ce-eEEE
Q 042853          460 PANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNL--------G----GE-RLLV  521 (614)
Q Consensus       460 ~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-----~H~nl--------~----~~-~~lv  521 (614)
                      ..+.||+|+||.||.  .+.....+||++........+++.+|+.++..+     +||||        .    .. ..+|
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            357899999999996  443333478887654444567899999999999     57998        1    12 2378


Q ss_pred             EEe--cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecCCCCCCEEEcC----CCcEEEeecC
Q 042853          522 YEY--LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL-LYLHKYSRLRVIHRDLKVSNILLDE----QMNPKISDFG  594 (614)
Q Consensus       522 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDlkp~NILld~----~~~~kI~DFG  594 (614)
                      +||  ++.++|.+++.+.    .+++.  ..++.+++.++ .|||+++   ||||||||+|||++.    +..++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  6689999999532    24444  34567788777 8999987   999999999999973    3479999954


Q ss_pred             cceee
Q 042853          595 MARTF  599 (614)
Q Consensus       595 la~~~  599 (614)
                      -++.+
T Consensus       155 G~~~~  159 (210)
T PRK10345        155 GESTF  159 (210)
T ss_pred             CCcce
Confidence            44443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.68  E-value=1.2e-16  Score=160.25  Aligned_cols=155  Identities=23%  Similarity=0.345  Sum_probs=130.8

Q ss_pred             hhhHHhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC------
Q 042853          448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL------  514 (614)
Q Consensus       448 ~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl------  514 (614)
                      .+++.....++.....+-+|.||.||+|.+.      +.++|-||.++.. ++-+...|..|..++..+.|||+      
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4567777788988899999999999999664      4567888888654 33456678999999999999999      


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIF-----DSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ  585 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~  585 (614)
                          ....+++|.++.-|+|..||.     +......+.-.+...++.|++.||+|||.++   |||.||.++|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence                457789999999999999997     3334445677788899999999999999887   9999999999999999


Q ss_pred             CcEEEeecCcceeecCCccc
Q 042853          586 MNPKISDFGMARTFTMNELE  605 (614)
Q Consensus       586 ~~~kI~DFGla~~~~~~~~~  605 (614)
                      ..+||+|=.|+|.+.+.+.+
T Consensus       433 LqVkltDsaLSRDLFP~DYh  452 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYH  452 (563)
T ss_pred             eeEEeccchhccccCccccc
Confidence            99999999999988766544

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.67  E-value=5.4e-17  Score=152.10  Aligned_cols=147  Identities=22%  Similarity=0.452  Sum_probs=117.6

Q ss_pred             eechhhHHhh---cCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCC-----
Q 042853          445 IFDFQTIAVA---TDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL-----  514 (614)
Q Consensus       445 ~~~~~~~~~~---t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl-----  514 (614)
                      .++++...+.   .++|++.+++|+|-|+.||.|.. .+...++||.|+..   ..+...+|+.+|..|. ||||     
T Consensus        24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~D  100 (338)
T KOG0668|consen   24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLD  100 (338)
T ss_pred             hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhh
Confidence            4555544332   35788899999999999999975 46677899999653   3456789999999998 9999     


Q ss_pred             ------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-Cc
Q 042853          515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-MN  587 (614)
Q Consensus       515 ------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-~~  587 (614)
                            .....||+||+.|.+...+-      ..|.-.....++.+++.||.|+|+++   |+|||+||.|++||.. -.
T Consensus       101 iV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rk  171 (338)
T KOG0668|consen  101 IVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRK  171 (338)
T ss_pred             hhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhce
Confidence                  34567999999998876553      23455566678899999999999998   9999999999999955 56


Q ss_pred             EEEeecCcceeecCCc
Q 042853          588 PKISDFGMARTFTMNE  603 (614)
Q Consensus       588 ~kI~DFGla~~~~~~~  603 (614)
                      .+|+|.|||.+..+..
T Consensus       172 LrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  172 LRLIDWGLAEFYHPGK  187 (338)
T ss_pred             eeeeecchHhhcCCCc
Confidence            8999999999886654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=6.8e-16  Score=150.85  Aligned_cols=127  Identities=20%  Similarity=0.291  Sum_probs=103.6

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCc--c------hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG--Q------GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~--~------~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +.||+|++|.||+|.. .+..+++|.......  .      ....+.+|+.++..++|+++         ....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 566788887643211  1      12357889999999999887         3456799999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|+|||++ ++.++|+|||+++...
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            9999999887432      22 77889999999999999987   99999999999999 7789999999998643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=4e-16  Score=173.75  Aligned_cols=132  Identities=20%  Similarity=0.346  Sum_probs=104.2

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCc-------chhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG-------QGIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~-------~~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      ...|...+.||+|+||.||+|.+.....++.+++.+...       ...+++.+|++++.+++|+++         ....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            344566789999999999999886554333333322111       123568899999999999997         2467


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||+++++|..++.           .+..++.+++++|.|||+.+   |+||||||+|||+ +++.++|+|||+|+.
T Consensus       412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            89999999999988773           35678999999999999987   9999999999999 567899999999987


Q ss_pred             ecC
Q 042853          599 FTM  601 (614)
Q Consensus       599 ~~~  601 (614)
                      ...
T Consensus       477 ~~~  479 (535)
T PRK09605        477 SDL  479 (535)
T ss_pred             CCc
Confidence            643

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=1.6e-16  Score=156.11  Aligned_cols=153  Identities=25%  Similarity=0.359  Sum_probs=120.6

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhc-CCCCC---------CCeeE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNL---------GGERL  519 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~  519 (614)
                      ..++|....+||+|+|.+|..+++. +.+.+|+|.+++.   ..+.+.-...|-.+.... +||.+         ...++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3467888899999999999999886 5677899998764   233344455666666554 67776         45788


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      .|.||+++|+|..++..   ...|++.....+...|..||.|||+.+   ||.||||..|+|||.++.+|++|+|++|.-
T Consensus       328 fvieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            99999999999887743   334777777778888999999999998   999999999999999999999999999964


Q ss_pred             cCCccccCCCceecC
Q 042853          600 TMNELEANTNRIVGT  614 (614)
Q Consensus       600 ~~~~~~~~~~~~~GT  614 (614)
                      -+..  ..|.+++||
T Consensus       402 l~~g--d~tstfcgt  414 (593)
T KOG0695|consen  402 LGPG--DTTSTFCGT  414 (593)
T ss_pred             CCCC--cccccccCC
Confidence            4322  245567887

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=8.9e-16  Score=148.62  Aligned_cols=123  Identities=24%  Similarity=0.353  Sum_probs=99.5

Q ss_pred             eeccCCceeEEEEEeCCccEEEEEEccCCC---cc-----hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSS---GQ-----GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~---~~-----~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .||+|+||.||+|.+ ++..+++|......   .+     ...++.+|++++..++|+++         ....++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 56778888754321   11     13567889999999998876         34558999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..++....          ..++.+++++|.+||+.+   ++|+|++|+||+++ ++.+++.|||+++...
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            9999988763211          078899999999999887   99999999999999 7899999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.65  E-value=3.6e-16  Score=150.08  Aligned_cols=137  Identities=23%  Similarity=0.426  Sum_probs=109.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC----------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL----------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl----------~~~~~lv~E  523 (614)
                      +.|.+.+.||+|.||.+..++++ +.+.+++|.+.+. .....+|.+|..---.| .|.||          .+....++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            45777899999999999999987 5678899988653 23457888887654444 47777          457788999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE-c-CCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL-D-EQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-d-~~~~~kI~DFGla~~~~  600 (614)
                      |+|.|+|.+-+..    .-+.+....+++.|++.||.|+|+..   +||||||.+|||| + +...+||||||+.+..+
T Consensus       103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999887733    23566667789999999999999987   9999999999998 3 34579999999987543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.64  E-value=1.1e-15  Score=149.02  Aligned_cols=132  Identities=13%  Similarity=0.119  Sum_probs=105.9

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchh---Hh------HHHHHHHHHhcCCCCC---------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGI---VE------FKNEAKLIAKLQHTNL---------  514 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~---~~------f~~E~~~l~~l~H~nl---------  514 (614)
                      ...++|...+.||+|+||.||.... ++..+|||.+........   ..      |.+|+..+.+++|+++         
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3457899999999999999999655 566899999964422221   22      6789999999999998         


Q ss_pred             --------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC
Q 042853          515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM  586 (614)
Q Consensus       515 --------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~  586 (614)
                              ....+|+|||+++.+|.++..       ++.    ....+++++|..+|+.+   ++|||+||+||+++.++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence                    024789999999999977631       222    24568999999999987   99999999999999888


Q ss_pred             cEEEeecCcceeec
Q 042853          587 NPKISDFGMARTFT  600 (614)
Q Consensus       587 ~~kI~DFGla~~~~  600 (614)
                       ++|+|||..+...
T Consensus       173 -i~liDfg~~~~~~  185 (232)
T PRK10359        173 -LRIIDLSGKRCTA  185 (232)
T ss_pred             -EEEEECCCccccc
Confidence             9999999988764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.64  E-value=3.9e-15  Score=143.16  Aligned_cols=134  Identities=36%  Similarity=0.580  Sum_probs=115.5

Q ss_pred             eccCCceeEEEEEeCC-ccEEEEEEccCCCcc-hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCHHH
Q 042853          464 LGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDF  532 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL~~  532 (614)
                      ||+|.+|.||++.... ++.+++|.+.....+ ....+.+|++.+..++|+++         ....++++||+++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 788999998754332 35679999999999999998         346899999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEeecCcceeecCC
Q 042853          533 FIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-QMNPKISDFGMARTFTMN  602 (614)
Q Consensus       533 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-~~~~kI~DFGla~~~~~~  602 (614)
                      ++....  ..+++..+..++.+++++|.|||+.+   ++|+||+|.||+++. +..++|+|||.+......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            985432  35788999999999999999999986   999999999999998 899999999999877543

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.64  E-value=2.6e-16  Score=171.27  Aligned_cols=140  Identities=31%  Similarity=0.462  Sum_probs=106.9

Q ss_pred             CCccceeccCCcee-EEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecC
Q 042853          458 FSPANRLGQGGFGP-VYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       458 f~~~~~lG~G~fg~-Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~  526 (614)
                      |...+.+|.|+-|+ ||+|..+ +++||||++-.   +...-..+|+.++..- +|||+         ...+|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            45567899998876 7999995 67999999853   2233447899988876 59999         567899999996


Q ss_pred             CCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---C--CcEEEeecCcceeec
Q 042853          527 NKSLDFFIFDSSRK-SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE---Q--MNPKISDFGMARTFT  600 (614)
Q Consensus       527 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~---~--~~~kI~DFGla~~~~  600 (614)
                      . +|.+++...... ....-..-..+..|++.||++||..+   ||||||||+||||+.   +  ..++|+|||++|.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            4 899988653111 11111233567889999999999865   999999999999975   3  568999999999998


Q ss_pred             CCccc
Q 042853          601 MNELE  605 (614)
Q Consensus       601 ~~~~~  605 (614)
                      .+...
T Consensus       663 ~~~sS  667 (903)
T KOG1027|consen  663 GGKSS  667 (903)
T ss_pred             CCcch
Confidence            76544

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.63  E-value=3e-15  Score=143.07  Aligned_cols=127  Identities=22%  Similarity=0.220  Sum_probs=97.9

Q ss_pred             ccceeccCCceeEEEEEeCCccEEEEEEccCCCcchh-----HhHHHHHHHHHhcCC-CCC-----CCeeEEEEEecCCC
Q 042853          460 PANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGI-----VEFKNEAKLIAKLQH-TNL-----GGERLLVYEYLPNK  528 (614)
Q Consensus       460 ~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~-----~~f~~E~~~l~~l~H-~nl-----~~~~~lv~Ey~~~g  528 (614)
                      +...|++|+||+||...- ++..++.+.++... ...     ..|.+|+++|.+|+| +++     -...+++|||+++.
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~-~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~   83 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAP-WWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA   83 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccch-hhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence            357899999999997665 56667777775432 211     247899999999964 444     23568999999998


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCCEEEcCCCcEEEeecCcceeecC
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDL-KVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +|...+.    .      ....+..|++++|.++|..+   |||||| ||+|||++.++.++|+|||+|+....
T Consensus        84 ~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         84 AMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             cHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            8864331    0      11346788999999999987   999999 79999999999999999999986543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.63  E-value=4.1e-15  Score=146.91  Aligned_cols=129  Identities=33%  Similarity=0.434  Sum_probs=112.8

Q ss_pred             CceeEEEEEeC-CccEEEEEEccCCCcch-hHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCHHHHHhh
Q 042853          468 GFGPVYKGKLQ-DEQEIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFD  536 (614)
Q Consensus       468 ~fg~Vy~g~~~-~~~~vavK~l~~~~~~~-~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL~~~l~~  536 (614)
                      +||.||++... +++.+|+|.+....... .+.|.+|++.+++++|+|+         ....++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 47899999997654433 6789999999999999999         3678999999999999998854


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          537 SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       537 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ..   .+++.....++.+++++|.|||+.+   |+|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            32   2788999999999999999999986   999999999999999999999999999987653

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.63  E-value=2.8e-16  Score=150.88  Aligned_cols=137  Identities=25%  Similarity=0.377  Sum_probs=102.4

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcC-CCCC---------CCeeEEEEEecCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVYEYLPNK  528 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~Ey~~~g  528 (614)
                      ...||.|..|.|++.... .+..+|||.+.+.. .+..++.+..+.++.+-+ .|.|         .....+.||.|.- 
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence            578999999999999987 57889999997653 344566777777776654 6665         1222344555532 


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      .++.++..  ...++++...-++...+..||.||.+..  .|||||+||+|||+|+.|++|+||||++-.+...
T Consensus       176 C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  176 CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            23344432  2345777777788889999999999865  6999999999999999999999999999877543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=2.2e-15  Score=144.25  Aligned_cols=133  Identities=20%  Similarity=0.215  Sum_probs=96.5

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcc--hhHh----------------------HHHHHHHHHhcCCCCC--
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ--GIVE----------------------FKNEAKLIAKLQHTNL--  514 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~--~~~~----------------------f~~E~~~l~~l~H~nl--  514 (614)
                      .+.||+|+||.||++...+++.||||.+......  ...+                      ...|...+.++.+..+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888899999987643211  1111                      1356666666655433  


Q ss_pred             -----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCcE
Q 042853          515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK-YSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       515 -----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                           ....++||||++++.+.........   .. .+...++.+++.++.++|. .+   |+|+||||+||+++ ++.+
T Consensus        82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CceEecCCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcE
Confidence                 2356899999999654322111100   11 4566789999999999998 65   99999999999999 8899


Q ss_pred             EEeecCcceeecC
Q 042853          589 KISDFGMARTFTM  601 (614)
Q Consensus       589 kI~DFGla~~~~~  601 (614)
                      +|+|||.|..+..
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=2e-16  Score=163.15  Aligned_cols=149  Identities=25%  Similarity=0.324  Sum_probs=119.6

Q ss_pred             CCCccceeccCCceeEEEEEeCCcc-EEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~-~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      +++....||-|+||.|=........ ..|+|.+++.   ...+.+....|-.+|...+.+.|         ....|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4445678999999999888876443 3788888654   23445567889999998888877         457789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      -|-+|.|-..|.+..   .++......++..+.+|++|||..+   ||.|||||+|.|||.+|-+||.|||+||.+..++
T Consensus       501 aClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  501 ACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            999999988885433   3555555667888999999999887   9999999999999999999999999999987654


Q ss_pred             cccCCCceecC
Q 042853          604 LEANTNRIVGT  614 (614)
Q Consensus       604 ~~~~~~~~~GT  614 (614)
                         .|.+++||
T Consensus       575 ---KTwTFcGT  582 (732)
T KOG0614|consen  575 ---KTWTFCGT  582 (732)
T ss_pred             ---ceeeecCC
Confidence               35668887

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.60  E-value=3.6e-16  Score=166.16  Aligned_cols=141  Identities=28%  Similarity=0.439  Sum_probs=121.3

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ..++|+....+|.|.||.|||++.. .++..|||.++-.......-..+|+-+++.-+|+||         ....+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3457777899999999999999876 677889999876655566667789999999999999         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||.+|+|.+.-+-   -.++++.+...+++...+||+|||..+   -+|||||-.|||+.+.+.+|++|||.+-.+.
T Consensus        93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh
Confidence            9999999876532   346788888889999999999999987   7999999999999999999999999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.58  E-value=1.8e-14  Score=136.29  Aligned_cols=138  Identities=26%  Similarity=0.404  Sum_probs=108.5

Q ss_pred             cCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCCcchhHhHHHHHHHHHhcCC----CCC------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH----TNL------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H----~nl------~~~~~lv~E  523 (614)
                      ..+|.+.++||.|+||.+|.|.. .+|.+||||.-+...  ..-++..|..+.+.|+|    |.+      ...-.||||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            35788899999999999999985 578999999765432  23456788888888875    333      345679999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE---QMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~---~~~~kI~DFGla~~~~  600 (614)
                      .+ +-+|.++..-..+  .++.+..+-++.|+..-++|+|..+   +|||||||+|.|..-   ...+.++||||||.+.
T Consensus        92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            87 5578776543332  3677888899999999999999987   999999999999853   3458999999999774

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.56  E-value=5.3e-15  Score=157.72  Aligned_cols=137  Identities=28%  Similarity=0.364  Sum_probs=111.2

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~E  523 (614)
                      ++.|.....+|.|+|+.|.++... +.+..+||++.+...    +-.+|+.++.+. +|+|+         ..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567777888999999999999875 678899999976522    234566555544 79999         568899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE-cCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL-DEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-d~~~~~kI~DFGla~~~~~~  602 (614)
                      ++.++-|...++...    ....++..|+.+|+.|+.|||+++   ||||||||+|||+ ++.++++|+|||.++...++
T Consensus       397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999988766664322    222777789999999999999987   9999999999999 58899999999999988755

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.54  E-value=6.9e-14  Score=127.83  Aligned_cols=127  Identities=23%  Similarity=0.245  Sum_probs=104.2

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCC--CC---------CCeeEEEEEecCCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT--NL---------GGERLLVYEYLPNKS  529 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--nl---------~~~~~lv~Ey~~~gs  529 (614)
                      .+.||+|.++.||++...+ ..+++|.......  ..++..|+..+..++|.  .+         .+..+++|||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            5789999999999999865 7789998865432  45789999999999774  33         235899999999877


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          530 LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       530 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +..+          +......++.+++++|.+||......++|+|++|+|||++..+.+++.|||+++...
T Consensus        80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            6432          456667789999999999998755679999999999999998899999999998643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.52  E-value=8.9e-14  Score=145.13  Aligned_cols=136  Identities=27%  Similarity=0.380  Sum_probs=108.2

Q ss_pred             CCCccceeccCCceeEEEEEeCCc--cEEEEEEccCCCcchhHhHHHHHHHHHhcCC----CCC----------CCeeEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH----TNL----------GGERLL  520 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~--~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H----~nl----------~~~~~l  520 (614)
                      +|.+..+||+|+||.||.+.....  ..+|+|............+..|+.++..+++    +++          ....++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788899999999999999997653  4788887765433322368889999998873    122          235688


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-----CcEEEeecCc
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-----MNPKISDFGM  595 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-----~~~kI~DFGl  595 (614)
                      ||+.+ +.+|.++..... ...++-...+.|+.|++.+|.+||+.+   +|||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            98876 668888764443 456788899999999999999999987   9999999999999754     4689999999


Q ss_pred             ce
Q 042853          596 AR  597 (614)
Q Consensus       596 a~  597 (614)
                      |+
T Consensus       174 ar  175 (322)
T KOG1164|consen  174 AR  175 (322)
T ss_pred             Cc
Confidence            99

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.52  E-value=6.3e-14  Score=145.24  Aligned_cols=146  Identities=27%  Similarity=0.304  Sum_probs=116.1

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------------CC
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------------GG  516 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------------~~  516 (614)
                      .--++|.+....|+|-|++|-+|... .+++||||+|... .-..+.=+.|+++|++|+...-               .+
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            34468888889999999999999876 5779999999763 2223334567777777743221               56


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGM  595 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGl  595 (614)
                      ++|||+|-+ ..+|.+.|......--|..+....++.|+..||..|...+   |+|+||||.|||+++.- .+||||||-
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence            899999987 4588999887766666777888889999999999999766   99999999999998765 479999999


Q ss_pred             ceeecCCc
Q 042853          596 ARTFTMNE  603 (614)
Q Consensus       596 a~~~~~~~  603 (614)
                      |.....++
T Consensus       584 A~~~~ene  591 (752)
T KOG0670|consen  584 ASFASENE  591 (752)
T ss_pred             cccccccc
Confidence            99876655

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.51  E-value=3.3e-14  Score=144.77  Aligned_cols=138  Identities=24%  Similarity=0.450  Sum_probs=112.2

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeCC----ccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCC---------CC
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL---------GG  516 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl---------~~  516 (614)
                      +....+.|...++||+|.|++||++.+..    ...||+|.+....  ......+|+++|..+. |.|+         .+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            33445677888999999999999998753    4679999986532  3345789999999885 5555         67


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEeecCc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-MNPKISDFGM  595 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-~~~kI~DFGl  595 (614)
                      ...+|+||+++-...++..+      ++..+...+...+.+||.++|.++   ||||||||+|+|.+.. +.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            89999999999998888743      556777788999999999999998   9999999999999844 5578999999


Q ss_pred             ceee
Q 042853          596 ARTF  599 (614)
Q Consensus       596 a~~~  599 (614)
                      |...
T Consensus       180 A~~~  183 (418)
T KOG1167|consen  180 AQRY  183 (418)
T ss_pred             HHHH
Confidence            9853

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.51  E-value=5.8e-14  Score=141.20  Aligned_cols=143  Identities=22%  Similarity=0.275  Sum_probs=112.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCC--CC-------------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT--NL-------------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--nl-------------~~~~  518 (614)
                      +++|.+...+|+|.||.|-++... .+..||||.++.. ..-.+..+-|++++.+|.+.  +-             .++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            688999999999999999999876 4578999988653 23344567799999999532  21             5678


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--------------
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE--------------  584 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~--------------  584 (614)
                      ++|+|.| +-|+.++|... ...+++......|+.|++++++|||+..   ++|-||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            8899987 44778888543 2345777888999999999999999987   999999999999842              


Q ss_pred             ------CCcEEEeecCcceeecCCc
Q 042853          585 ------QMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       585 ------~~~~kI~DFGla~~~~~~~  603 (614)
                            +..+||+|||-|..-.+..
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h  266 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH  266 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc
Confidence                  2357999999998765544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.50  E-value=2.3e-13  Score=135.47  Aligned_cols=128  Identities=23%  Similarity=0.265  Sum_probs=98.8

Q ss_pred             cceec-cCCceeEEEEEeCCccEEEEEEccCCC-------------cchhHhHHHHHHHHHhcCCCCCC-----------
Q 042853          461 ANRLG-QGGFGPVYKGKLQDEQEIAIKRLSKSS-------------GQGIVEFKNEAKLIAKLQHTNLG-----------  515 (614)
Q Consensus       461 ~~~lG-~G~fg~Vy~g~~~~~~~vavK~l~~~~-------------~~~~~~f~~E~~~l~~l~H~nl~-----------  515 (614)
                      ...|| .|+.|+||+.... +..++||+.....             ......+.+|++++.+++|+++.           
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8899999998885 5678888775311             11234578899999999998861           


Q ss_pred             -C---eeEEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 042853          516 -G---ERLLVYEYLPN-KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI  590 (614)
Q Consensus       516 -~---~~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI  590 (614)
                       .   ..++|+||+++ .+|..++..    ..++..    .+.+|+++|.+||+.+   |+||||||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence             1   22599999997 688887743    223432    3568999999999987   999999999999998889999


Q ss_pred             eecCcceeec
Q 042853          591 SDFGMARTFT  600 (614)
Q Consensus       591 ~DFGla~~~~  600 (614)
                      +|||.++...
T Consensus       184 IDfg~~~~~~  193 (239)
T PRK01723        184 IDFDRGELRT  193 (239)
T ss_pred             EECCCcccCC
Confidence            9999998754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.49  E-value=2.1e-14  Score=141.25  Aligned_cols=136  Identities=32%  Similarity=0.371  Sum_probs=105.3

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------------CCee
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------------GGER  518 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------------~~~~  518 (614)
                      +|.....+|.|.- .|-.+... .++.||+|++...  ..+..+...+|..++..++|+|+               -.+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4444566777766 34333332 5788999988543  23445667889999999999998               2367


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++|||||. .+|...+.     ..++......|..|++.|+.|||..+   |+||||||+||++..+..+||.|||+|+.
T Consensus        97 y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence            89999995 47776664     23677777889999999999999987   99999999999999999999999999986


Q ss_pred             ecCC
Q 042853          599 FTMN  602 (614)
Q Consensus       599 ~~~~  602 (614)
                      -..+
T Consensus       168 e~~~  171 (369)
T KOG0665|consen  168 EDTD  171 (369)
T ss_pred             cCcc
Confidence            5433

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=1.4e-13  Score=141.97  Aligned_cols=126  Identities=25%  Similarity=0.325  Sum_probs=99.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC-----CCCC--------------
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----HTNL--------------  514 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----H~nl--------------  514 (614)
                      ..+|.+.++||-|.|++||.+... +.+.||+|..+.+ ..-.+..+.||++|..++     |++-              
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            367888999999999999999875 5678999988643 334456788999998873     3332              


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 042853          515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ  585 (614)
Q Consensus       515 --~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~  585 (614)
                        +.+.++|+|++-. +|..+|....-+ -++.....+|+.||+.||.|||.+|  +|||-||||+||||...
T Consensus       156 pNG~HVCMVfEvLGd-nLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  156 PNGQHVCMVFEVLGD-NLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCCcEEEEEehhhhh-HHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence              5789999999854 566666543332 3677888899999999999999977  79999999999999644

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.48  E-value=1.9e-13  Score=135.03  Aligned_cols=136  Identities=25%  Similarity=0.415  Sum_probs=106.4

Q ss_pred             CCCccceeccCCceeEEEEEe-CCccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCC---------CCeeEEEEEec
Q 042853          457 NFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVYEYL  525 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~Ey~  525 (614)
                      +|.+.++||+|+||.++.|+. -+++.||||.-...  ...-++..|-+..+.|. .+.|         +.+-.||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            677889999999999999974 47899999976432  12335667777776664 3444         44567899987


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----CCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-----QMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-----~~~~kI~DFGla~~~~  600 (614)
                       +-||.++..-+.+  .++.+....+|+|+..-++|+|++.   .|.|||||+|+||..     ...+.|.||||||...
T Consensus       107 -GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             -CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence             5588776544443  3788899999999999999999987   999999999999963     3458999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.44  E-value=1.9e-12  Score=132.61  Aligned_cols=140  Identities=34%  Similarity=0.536  Sum_probs=115.0

Q ss_pred             CCccceeccCCceeEEEEEeCCccEEEEEEccCCCcc---hhHhHHHHHHHHHhcCCC-CC---------CCeeEEEEEe
Q 042853          458 FSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ---GIVEFKNEAKLIAKLQHT-NL---------GGERLLVYEY  524 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~-nl---------~~~~~lv~Ey  524 (614)
                      |.....||.|+|+.||++...  ..+++|.+......   ....|.+|+.++..+.|+ ++         ....++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            455688999999999999987  77899988654322   367799999999999988 56         2336899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~~~~  602 (614)
                      +.++++..++........+.......++.|++.++.|+|..+   ++|||+||+|||++... .+|++|||+++.+...
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999966543221125778888999999999999999987   99999999999999888 7999999999966544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=9.3e-13  Score=142.33  Aligned_cols=134  Identities=21%  Similarity=0.281  Sum_probs=98.1

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcch----------------------------------------hHhHH
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQG----------------------------------------IVEFK  500 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~----------------------------------------~~~f~  500 (614)
                      .+.||.|++|.||+|++.+|+.||||.......+.                                        +..|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999875431110                                        01255


Q ss_pred             HHHHHHHhcC-----CCCC---------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 042853          501 NEAKLIAKLQ-----HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ-GLLYLHKY  565 (614)
Q Consensus       501 ~E~~~l~~l~-----H~nl---------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~  565 (614)
                      +|+..+.++.     ++++         ....+|||||+++++|.++......  ..   .+..++..+++ .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            5666555553     3333         3456899999999999876532111  11   23456666666 46788877


Q ss_pred             CCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       566 ~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +   ++|+|+||.||+++.++.+++.|||+++.+...
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            6   999999999999999999999999999988643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=1.4e-12  Score=148.50  Aligned_cols=141  Identities=23%  Similarity=0.339  Sum_probs=107.8

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcC----C-------CCC-CCee
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ----H-------TNL-GGER  518 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~----H-------~nl-~~~~  518 (614)
                      +......|.+..+||+|+||+||+|...+++.||+|.=+....   =||.--.+++.+|+    |       .++ .+.-
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            3445567888899999999999999998899999997654321   12222222233332    1       111 4567


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-------CCCcEEEe
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-------EQMNPKIS  591 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-------~~~~~kI~  591 (614)
                      +||+||.+.|+|.+++.   ..+.++|...+.++.|+++-++.||..+   |||+||||+|.||-       +...++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            89999999999999985   4456899999999999999999999987   99999999999993       23458999


Q ss_pred             ecCcceeec
Q 042853          592 DFGMARTFT  600 (614)
Q Consensus       592 DFGla~~~~  600 (614)
                      |||.|-.|.
T Consensus       844 DfG~siDm~  852 (974)
T KOG1166|consen  844 DFGRSIDMK  852 (974)
T ss_pred             ecccceeee
Confidence            999986553

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.24  E-value=3.9e-11  Score=112.72  Aligned_cols=125  Identities=19%  Similarity=0.186  Sum_probs=94.3

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCCCCHHH
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPNKSLDF  532 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~gsL~~  532 (614)
                      .+.|+.|.++.||+.... ++.+++|....... ....+..|+.++..+.+.++        ....++||||+++.++..
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT   80 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence            467899999999999875 66799998754321 23456789999988866554        234689999999987753


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          533 FIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS--RLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       533 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      .       . .   ....++.+++++|..||...  ...++|+|++|.||+++ ++.+++.|||.|..-
T Consensus        81 ~-------~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          81 E-------D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             c-------c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            2       0 0   11235678999999999876  33479999999999999 568999999998854

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.14  E-value=1.6e-10  Score=126.55  Aligned_cols=139  Identities=19%  Similarity=0.230  Sum_probs=90.1

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-ccEEEEEEccCCCcc------------------------------h---------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQ------------------------------G---------  495 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~------------------------------~---------  495 (614)
                      ..|+. +.||.|++|.||++.+++ |+.||||.+.....+                              .         
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 789999999999999987 999999998643110                              0         


Q ss_pred             -hHhHHHHHHHHHhcC----CCC-C---------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHH-H
Q 042853          496 -IVEFKNEAKLIAKLQ----HTN-L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG-L  559 (614)
Q Consensus       496 -~~~f~~E~~~l~~l~----H~n-l---------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L  559 (614)
                       +.+|..|+.-+.+++    +.+ +         ....+|||||++++.+.++..-...  ..+..   .++...++. +
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~~---~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDMK---LLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCHH---HHHHHHHHHHH
Confidence             012455555555543    221 2         3456799999999999764211111  11111   122222221 1


Q ss_pred             HHHHhCCCCceEecCCCCCCEEEcCCC----cEEEeecCcceeecCCc
Q 042853          560 LYLHKYSRLRVIHRDLKVSNILLDEQM----NPKISDFGMARTFTMNE  603 (614)
Q Consensus       560 ~yLH~~~~~~iiHrDlkp~NILld~~~----~~kI~DFGla~~~~~~~  603 (614)
                      .-++..+   ++|+|+||.||+++.++    .+++.|||++..+.+..
T Consensus       274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~~  318 (537)
T PRK04750        274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKED  318 (537)
T ss_pred             HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHHH
Confidence            2233344   99999999999999887    89999999999886543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=2.7e-10  Score=127.20  Aligned_cols=135  Identities=27%  Similarity=0.385  Sum_probs=98.4

Q ss_pred             ccceeccCCceeEEEEEeCC-ccEEEEEEcc----CCC-c-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          460 PANRLGQGGFGPVYKGKLQD-EQEIAIKRLS----KSS-G-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       460 ~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~----~~~-~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ..+.+|.|++|.|+...... ....+.|...    ... . +....+..|..+-..+.|+|+         .....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            35789999999777665432 2222222221    111 1 111125567777788899997         223334499


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |++. +|..++...   ..+...++..+.+|+..|+.|+|..+   |.|||||++|+|+...+.+||+|||.+..+..
T Consensus       402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence            9999 998888432   35677888899999999999999998   99999999999999999999999999987753

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.03  E-value=3e-09  Score=101.71  Aligned_cols=132  Identities=14%  Similarity=0.144  Sum_probs=93.2

Q ss_pred             ceeccCCceeEEEEEeCC-------ccEEEEEEccCCC------------c----------chhHhHH----HHHHHHHh
Q 042853          462 NRLGQGGFGPVYKGKLQD-------EQEIAIKRLSKSS------------G----------QGIVEFK----NEAKLIAK  508 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~-------~~~vavK~l~~~~------------~----------~~~~~f~----~E~~~l~~  508 (614)
                      ..||.|--+.||.|.-.+       +..+|||..+...            .          .....+.    .|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999998653       4689999654220            0          0011223    78888888


Q ss_pred             cCCCCC-------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCCE
Q 042853          509 LQHTNL-------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL-HKYSRLRVIHRDLKVSNI  580 (614)
Q Consensus       509 l~H~nl-------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NI  580 (614)
                      +....+       ....+|||||+.+..+.....   ....++..+...+..+++.+|.+| |..+   |||+||++.||
T Consensus        83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence            876554       345689999998754422211   111234445566788999999999 6665   99999999999


Q ss_pred             EEcCCCcEEEeecCcceeec
Q 042853          581 LLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       581 Lld~~~~~kI~DFGla~~~~  600 (614)
                      |+++ +.+.|+|||.|....
T Consensus       157 L~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEC-CcEEEEECCCceeCC
Confidence            9974 579999999998765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=6.8e-09  Score=96.17  Aligned_cols=125  Identities=22%  Similarity=0.322  Sum_probs=92.6

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCc-c------hhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG-Q------GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~------~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ..+.+|+-+.+|.+.+.+...|.-.++++.-. .      ....-.+|+.+|.+++---+         .....++|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            35789999999999775544333334444311 1      12345789999999865444         45678999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++-.|.+.+...          +..++..|-.-+.-||..+   |||+||.++||++..+. +.++||||++.-.
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            999888887432          3456777888888999987   99999999999998764 9999999998543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=98.94  E-value=1e-09  Score=128.34  Aligned_cols=76  Identities=14%  Similarity=0.210  Sum_probs=61.2

Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC------------
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE------------  584 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~------------  584 (614)
                      ..++++||+ .++|..+|...  ...+++.+.+.++.||++||.|||+++   ||||||||+||||+.            
T Consensus        54 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~  127 (793)
T PLN00181         54 SIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASC  127 (793)
T ss_pred             hhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeecccc
Confidence            457778887 55999998532  345899999999999999999999887   999999999999954            


Q ss_pred             -------CCcEEEeecCccee
Q 042853          585 -------QMNPKISDFGMART  598 (614)
Q Consensus       585 -------~~~~kI~DFGla~~  598 (614)
                             ++.+||+|||+++.
T Consensus       128 ~~~~~~~~~~~ki~DfG~a~~  148 (793)
T PLN00181        128 SDSGSDEDATTKSREIGSSRR  148 (793)
T ss_pred             CcccccccCcccccccccccc
Confidence                   44566666666654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.94  E-value=9.7e-09  Score=100.65  Aligned_cols=134  Identities=17%  Similarity=0.246  Sum_probs=101.4

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC----------C----CeeEEEEEecC
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL----------G----GERLLVYEYLP  526 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl----------~----~~~~lv~Ey~~  526 (614)
                      +.|+.|..+.||+....++..+++|....... ....++..|++++..+.+..+          .    +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999987767899998754322 235578999999999876333          1    24589999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS----------------------------------------  566 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  566 (614)
                      +.++...+..    ..++..++..++.+++++|.+||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9887654311    23566777778888888888888421                                        


Q ss_pred             -------------CCceEecCCCCCCEEEcC--CCcEEEeecCcceee
Q 042853          567 -------------RLRVIHRDLKVSNILLDE--QMNPKISDFGMARTF  599 (614)
Q Consensus       567 -------------~~~iiHrDlkp~NILld~--~~~~kI~DFGla~~~  599 (614)
                                   +..++|+|+.|.|||++.  +..+.|+||+.+..-
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                         245899999999999998  566899999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=98.93  E-value=3.3e-09  Score=92.27  Aligned_cols=58  Identities=40%  Similarity=0.785  Sum_probs=52.8

Q ss_pred             EEeCCCCCCcceeccCCcccccccccceeeEEEEEecCCeEEEEEEecCCCCeeeEEEEecCCcEE
Q 042853          225 WTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLK  290 (614)
Q Consensus       225 w~~g~w~~~~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~  290 (614)
                      ||+|+|+|..| +|+|++..      ...+.+.|+.+++|.+++|.+.+ .+.++|++|+.+|+++
T Consensus         1 wrsG~WnG~~f-~g~p~~~~------~~~~~~~fv~~~~e~~~t~~~~~-~s~~~r~~ld~~G~l~   58 (110)
T PF00954_consen    1 WRSGPWNGQRF-SGIPEMSS------NSLYNYSFVSNNEEVYYTYSLSN-SSVLSRLVLDSDGQLQ   58 (110)
T ss_pred             CCccccCCeEE-CCcccccc------cceeEEEEEECCCeEEEEEecCC-CceEEEEEEeeeeEEE
Confidence            89999999998 99999875      56788999999999999999987 6889999999999998

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.89  E-value=6.4e-09  Score=104.82  Aligned_cols=136  Identities=24%  Similarity=0.348  Sum_probs=92.3

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCC-CC---------C------------
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH-TN---------L------------  514 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H-~n---------l------------  514 (614)
                      .+.||.|+++.||.+.+. +++++|||...-.   .....+++++|.-.+..+.+ .|         +            
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            578999999999999997 5789999976422   23345667777655555433 11         1            


Q ss_pred             ------C--------CeeEEEEEecCCCCHHHHHh---hcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 042853          515 ------G--------GERLLVYEYLPNKSLDFFIF---DSSR-KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLK  576 (614)
Q Consensus       515 ------~--------~~~~lv~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk  576 (614)
                            .        .+.+++|.-+ .++|..++.   .... ...+....++.+..|+.+.+++||..+   +||+|||
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccc
Confidence                  0        1335666666 467776643   2221 123445667778899999999999998   9999999


Q ss_pred             CCCEEEcCCCcEEEeecCcceeec
Q 042853          577 VSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       577 p~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |+|++++.+|.++|+||+-.....
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g  196 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAG  196 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETT
T ss_pred             eeeEEEcCCCCEEEcChHHHeecC
Confidence            999999999999999999877554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.89  E-value=1.8e-08  Score=92.92  Aligned_cols=135  Identities=26%  Similarity=0.316  Sum_probs=97.1

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCc-------chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG-------QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~-------~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ...|-||+-+.|+++.+.....+.-++..+.-.       -.....++|++.+.+++---|         ...-.|+|||
T Consensus        12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            578899999999999997554444445544311       123456889999998765444         2344689999


Q ss_pred             cCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEeecCcceee
Q 042853          525 LPN-KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM---NPKISDFGMARTF  599 (614)
Q Consensus       525 ~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~---~~kI~DFGla~~~  599 (614)
                      +++ .++..++.........+. ....++..|-+.+.-||...   |||+||..+||+|..++   .+-++||||+..-
T Consensus        92 ~~g~~~vk~~i~~~~~~~~~d~-~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDESEDE-GLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ccchhHHHHHHHHHccCcccch-hHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            977 467888876544333222 22578888999999999987   99999999999997554   3589999998654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.79  E-value=7.5e-10  Score=118.79  Aligned_cols=135  Identities=24%  Similarity=0.332  Sum_probs=100.9

Q ss_pred             eeccCCceeEEEEE----eCCccEEEEEEccCCCc--chhHhHHHHHHHHHhcC-CCCC---------CCeeEEEEEecC
Q 042853          463 RLGQGGFGPVYKGK----LQDEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~----~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~Ey~~  526 (614)
                      .+|+|.||.|+...    .+.++..|+|.+++...  ........|..++...+ |+.+         ....+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999998653    23466788888865421  11124566888888887 7766         456788899999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      +|.|...+.+   ....+......+...++-|++++|+.+   |||||+|++||+++.+|.+|+.|||++|.+-..+
T Consensus        81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            9888766532   223444444445667889999999987   9999999999999999999999999999876544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.77  E-value=2.5e-09  Score=103.26  Aligned_cols=128  Identities=20%  Similarity=0.382  Sum_probs=103.4

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKS  529 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gs  529 (614)
                      ..+|.+...|..|+|+++.+. +++|.+...  .....+.|..|.--++.+.|||+         ..++.++..|||.|+
T Consensus       195 ~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            467888899999999997654 555666432  33445679999999999999999         568899999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEe
Q 042853          530 LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKIS  591 (614)
Q Consensus       530 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~  591 (614)
                      |...|++... -..+-.+..+++.+||+|++|||+.. +-|..--|..+.+++|++..+||+
T Consensus       274 lynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  274 LYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence            9999976543 34677889999999999999999975 334455699999999999999885

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.63  E-value=5.9e-07  Score=90.69  Aligned_cols=132  Identities=15%  Similarity=0.152  Sum_probs=93.8

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCc-----------chhHhHHHHHHHHHhcCCCCC----------------
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG-----------QGIVEFKNEAKLIAKLQHTNL----------------  514 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~-----------~~~~~f~~E~~~l~~l~H~nl----------------  514 (614)
                      +.+-+-....|.+..+ +|+.+.||+......           .....+.+|...+.++...++                
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3343333344667666 456788997643211           111247889998888866565                


Q ss_pred             CCeeEEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-------CC
Q 042853          515 GGERLLVYEYLPNK-SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-------QM  586 (614)
Q Consensus       515 ~~~~~lv~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-------~~  586 (614)
                      ....+||+|++++- +|.+++.+.. ....+...+..++.++++.+.-||..+   |+|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence            11367999999986 7888874321 123455667789999999999999988   999999999999975       46


Q ss_pred             cEEEeecCccee
Q 042853          587 NPKISDFGMART  598 (614)
Q Consensus       587 ~~kI~DFGla~~  598 (614)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            789999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=1.8e-07  Score=89.08  Aligned_cols=121  Identities=26%  Similarity=0.326  Sum_probs=77.7

Q ss_pred             eEEEEEeCCccEEEEEEccCCC-------------cc-------------hhHhHHHHHHHHHhcCCCCC-------CCe
Q 042853          471 PVYKGKLQDEQEIAIKRLSKSS-------------GQ-------------GIVEFKNEAKLIAKLQHTNL-------GGE  517 (614)
Q Consensus       471 ~Vy~g~~~~~~~vavK~l~~~~-------------~~-------------~~~~f~~E~~~l~~l~H~nl-------~~~  517 (614)
                      .||.|...++..+|||.-....             ..             ......+|.+.|.++....+       ...
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~   80 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR   80 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence            3899999889999999664320             00             01235679999999987755       234


Q ss_pred             eEEEEEecC--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          518 RLLVYEYLP--NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL-HKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       518 ~~lv~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                      ..|||||++  +..+..+. +..    ++......+..+++..+..+ |..+   |||+||.+.|||++++ .+.|+|||
T Consensus        81 ~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             TEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GT
T ss_pred             CEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecC
Confidence            579999999  54444332 211    11123345667777766664 5655   9999999999999988 99999999


Q ss_pred             cceeec
Q 042853          595 MARTFT  600 (614)
Q Consensus       595 la~~~~  600 (614)
                      .|....
T Consensus       152 qav~~~  157 (188)
T PF01163_consen  152 QAVDSS  157 (188)
T ss_dssp             TEEETT
T ss_pred             cceecC
Confidence            998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=98.56  E-value=2.2e-08  Score=113.10  Aligned_cols=134  Identities=22%  Similarity=0.251  Sum_probs=100.8

Q ss_pred             CCCccceeccCCceeEEEEEeCCccEEEEEEccCCCc-chhHhHHHHHHH--HHhcCCCCC---------CCeeEEEEEe
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG-QGIVEFKNEAKL--IAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~--l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .+...+.||.+.|=+|.+++.+.|. |+||.+-+..+ -..+.|.++++-  ...++|||.         ..-.+||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            3444688999999999999998776 88898865442 334555554443  445689997         2334566666


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ..+ +|.+.|   ..+..|...+..-|+.|++.||.-+|..+   |.|+|||.+||||..=.-+.|+||.--|.
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence            654 455444   34556777778889999999999999887   99999999999999888899999987664

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=2.5e-07  Score=94.24  Aligned_cols=75  Identities=28%  Similarity=0.414  Sum_probs=58.8

Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE--cCCCc--EEE
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL--DEQMN--PKI  590 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl--d~~~~--~kI  590 (614)
                      ...++|||.-++. +|..+++...    .+...+.-|+.|+++|+.|||.++   |.|||||..||||  |++..  ..|
T Consensus       315 ~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVv  386 (598)
T KOG4158|consen  315 PKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVV  386 (598)
T ss_pred             CceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEE
Confidence            3467888877755 7888886432    455566678899999999999987   9999999999998  44444  578


Q ss_pred             eecCcce
Q 042853          591 SDFGMAR  597 (614)
Q Consensus       591 ~DFGla~  597 (614)
                      +|||.+-
T Consensus       387 aDFGCcL  393 (598)
T KOG4158|consen  387 ADFGCCL  393 (598)
T ss_pred             cccceee
Confidence            9999764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.39  E-value=4e-07  Score=97.80  Aligned_cols=90  Identities=34%  Similarity=0.509  Sum_probs=78.0

Q ss_pred             HhcCCCCC---------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 042853          507 AKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKV  577 (614)
Q Consensus       507 ~~l~H~nl---------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  577 (614)
                      +.+.|.|+         +.+.+.|.+|++.|+|.+.+...  ...++|.-...++++|+.||.|||.-.  -..|..|++
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s   77 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS   77 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence            45778887         56788999999999999999753  345899999999999999999999753  239999999


Q ss_pred             CCEEEcCCCcEEEeecCcceeec
Q 042853          578 SNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       578 ~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +|+++|..+.+||+|||+..+..
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             ccceeeeeEEEEechhhhccccc
Confidence            99999999999999999988774

>PRK09902 hypothetical protein; Provisional

Probab=98.31  E-value=1.3e-05  Score=77.06  Aligned_cols=131  Identities=16%  Similarity=0.173  Sum_probs=99.7

Q ss_pred             eccCCceeEEEEEeCCccEEEEEEccCCC------cchhHhHHHHHHHHHhcCCCCC---------------CCeeEEEE
Q 042853          464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNL---------------GGERLLVY  522 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~~~~~vavK~l~~~~------~~~~~~f~~E~~~l~~l~H~nl---------------~~~~~lv~  522 (614)
                      -|+||-+.|++-.+.+. .+-+|+-....      +-+...|.+|...|.++...++               .-..+||+
T Consensus        26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            45688888998777544 57888765221      3356689999999999987666               12367999


Q ss_pred             EecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--EEEeecCcceee
Q 042853          523 EYLPN-KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN--PKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~--~kI~DFGla~~~  599 (614)
                      |-+++ -+|..++.+.. ....+...+..++.+|++.+.-||+.+   +.|+|+-++|||++.++.  ++++||--++..
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            97764 67888874432 224566777889999999999999987   999999999999986666  899999877643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.28  E-value=5.4e-06  Score=80.68  Aligned_cols=98  Identities=24%  Similarity=0.320  Sum_probs=78.2

Q ss_pred             HhHHHHHHHHHhcCCCCC---------------CCeeEEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 042853          497 VEFKNEAKLIAKLQHTNL---------------GGERLLVYEYLPN-KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLL  560 (614)
Q Consensus       497 ~~f~~E~~~l~~l~H~nl---------------~~~~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~  560 (614)
                      ....+|...+..+....|               ....+||+|++++ -+|..++.....   ++...+..++.++++.+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            457788888888876666               1234899999998 478888754222   445667789999999999


Q ss_pred             HHHhCCCCceEecCCCCCCEEEcCCC---cEEEeecCcceeec
Q 042853          561 YLHKYSRLRVIHRDLKVSNILLDEQM---NPKISDFGMARTFT  600 (614)
Q Consensus       561 yLH~~~~~~iiHrDlkp~NILld~~~---~~kI~DFGla~~~~  600 (614)
                      -||+.+   |+|+|+++.|||++.+.   .+.++||+-++...
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999998   99999999999999876   78999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.26  E-value=1.1e-05  Score=85.32  Aligned_cols=131  Identities=24%  Similarity=0.313  Sum_probs=101.6

Q ss_pred             eeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-------------CCeeEEEEEecCC-CCHHHHH
Q 042853          470 GPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------------GGERLLVYEYLPN-KSLDFFI  534 (614)
Q Consensus       470 g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-------------~~~~~lv~Ey~~~-gsL~~~l  534 (614)
                      .+.||+... +|..++.|++.....+....-..-++..+++.|+|+             ...++|||+|.|+ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            566888765 888999999954433333333456788999999998             3567899999997 5676665


Q ss_pred             hhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          535 FDSSR------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       535 ~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |....            ....++.....++.|++.||.++|+.+   ...+-|.+++||++.+.+++|+-.|.-..+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            53211            223566778889999999999999988   888999999999999999999999988777655


Q ss_pred             c
Q 042853          603 E  603 (614)
Q Consensus       603 ~  603 (614)
                      .
T Consensus       447 ~  447 (655)
T KOG3741|consen  447 P  447 (655)
T ss_pred             C
Confidence            4

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.26  E-value=1.7e-07  Score=104.96  Aligned_cols=141  Identities=28%  Similarity=0.367  Sum_probs=102.5

Q ss_pred             CCCccceeccCCceeEEEEEeC--CccEEEEEEccCCC--cchhHhHHHHHHHHHhcC-CCCC---------CCeeEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ--DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVY  522 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~--~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~  522 (614)
                      .|.....||+|+|+.|-.....  ....+|+|.+....  ....+....|..+-..+. |.|+         ....+++.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4455677999999999877654  33456777775432  222233344666666666 9988         46778999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH-KYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~~  600 (614)
                      ||..++++...+....... .+-...-.+..|+..++.|+| +.+   +.|||+||+|.+++..+ ..|++|||+|..+.
T Consensus       101 ~~s~g~~~f~~i~~~~~~~-~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTG-TSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             CcccccccccccccCCccC-CCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999877763222111 222334457789999999999 766   99999999999999998 99999999999887


Q ss_pred             C
Q 042853          601 M  601 (614)
Q Consensus       601 ~  601 (614)
                      .
T Consensus       177 ~  177 (601)
T KOG0590|consen  177 N  177 (601)
T ss_pred             c
Confidence            6

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.25  E-value=2.1e-06  Score=80.95  Aligned_cols=61  Identities=23%  Similarity=0.087  Sum_probs=52.9

Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+|.+++...  ...+++.++..++.||+.||.|||+.+         ||+|||++.++.+|+  ||+++....
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~   61 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP   61 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence            6888888542  345899999999999999999999864         999999999999999  999987654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.14  E-value=1.6e-06  Score=98.24  Aligned_cols=111  Identities=24%  Similarity=0.485  Sum_probs=74.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCCeeEEEEEecCCCCHHHH
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF  533 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~~~~lv~Ey~~~gsL~~~  533 (614)
                      .++|..++.|..|+||.||..++. ..+..|+ ++.+...    -.++   ++..      .++.+.|      |+-...
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l----ilRn---ilt~------a~npfvv------gDc~tl  141 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL----ILRN---ILTF------AGNPFVV------GDCATL  141 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccch----hhhc---cccc------cCCccee------chhhhh
Confidence            357888899999999999999886 4567787 4433211    0111   1111      2233344      443333


Q ss_pred             HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          534 IFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       534 l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +.   ....++-        +.+.+++|||..+   |+|||+||+|.||..-+.+|+.||||.+..
T Consensus       142 lk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  142 LK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             cc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence            32   1122221        2267999999887   999999999999999999999999998853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.12  E-value=2.7e-05  Score=76.84  Aligned_cols=130  Identities=17%  Similarity=0.200  Sum_probs=87.6

Q ss_pred             CccceeccCCceeEEEEEeCCccEEEEEEccCC----------C------c------chhHhHHHHHHHHHhcCCC--CC
Q 042853          459 SPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS----------S------G------QGIVEFKNEAKLIAKLQHT--NL  514 (614)
Q Consensus       459 ~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~----------~------~------~~~~~f~~E~~~l~~l~H~--nl  514 (614)
                      .+.+.||.|--+.||.|..+.+.++|||.=...          .      .      .......+|.+.|.+|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            446899999999999999999999999943211          0      0      0112356788888888654  33


Q ss_pred             -----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       515 -----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                           .+...+||||+++-.|...-.     ..-+..+.+   ..|++-+.-+-..+   |||+|+.+=|||+++++.+.
T Consensus       174 P~P~~~nRHaVvMe~ieG~eL~~~r~-----~~en~~~il---~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         174 PKPIAWNRHAVVMEYIEGVELYRLRL-----DVENPDEIL---DKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCccccccceeeeehcccceeecccC-----cccCHHHHH---HHHHHHHHHHHHcC---ccccCCchheEEEecCCCEE
Confidence                 345689999999866643211     112223333   33333333333334   99999999999999999999


Q ss_pred             EeecCcceee
Q 042853          590 ISDFGMARTF  599 (614)
Q Consensus       590 I~DFGla~~~  599 (614)
                      ++||--+...
T Consensus       243 vIDwPQ~v~~  252 (304)
T COG0478         243 VIDWPQAVPI  252 (304)
T ss_pred             EEeCcccccC
Confidence            9999766544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.11  E-value=1.6e-05  Score=87.05  Aligned_cols=133  Identities=17%  Similarity=0.273  Sum_probs=88.2

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCcch------------------------------hH----------hHHH
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQG------------------------------IV----------EFKN  501 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~------------------------------~~----------~f~~  501 (614)
                      +.|+.++-|.||+|++++|+.||||.....-.+.                              .+          .|..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6788999999999999999999999876541100                              01          1333


Q ss_pred             HHHHHHhcC-----CCCC---------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCC
Q 042853          502 EAKLIAKLQ-----HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL-LYLHKYS  566 (614)
Q Consensus       502 E~~~l~~l~-----H~nl---------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~  566 (614)
                      |+.-+.++.     .+++         .....|+|||+++-.+.+......  ...+-+   .++..++++. .-+-..+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence            433333331     2222         367789999999988877743222  123422   3333333332 1222233


Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       567 ~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                         +.|.|..|.||+++.++..-+.|||+...+.++
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence               999999999999999999999999999887644

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.11  E-value=1.9e-06  Score=92.81  Aligned_cols=140  Identities=23%  Similarity=0.273  Sum_probs=102.8

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC--CccEEEEEEccCCCcch------hHhHHHHHHHHHhcCCCCC------CCee
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ--DEQEIAIKRLSKSSGQG------IVEFKNEAKLIAKLQHTNL------GGER  518 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~--~~~~vavK~l~~~~~~~------~~~f~~E~~~l~~l~H~nl------~~~~  518 (614)
                      ..+..|.....||.+.|+.|++...+  ++..+++|.+.+.....      ..+...|+.+...+.+.+.      ..+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34457888899999999999987654  56778999886543221      2223334444433333332      3466


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEeecCcce
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-MNPKISDFGMAR  597 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-~~~kI~DFGla~  597 (614)
                      ++=.||++++++...+   .....++...++.+..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||++.
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            7888999999887655   22345677788889999999999999876   9999999999999876 788999999986


Q ss_pred             e
Q 042853          598 T  598 (614)
Q Consensus       598 ~  598 (614)
                      .
T Consensus       416 ~  416 (524)
T KOG0601|consen  416 R  416 (524)
T ss_pred             c
Confidence            4

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.08  E-value=1.1e-05  Score=70.62  Aligned_cols=84  Identities=23%  Similarity=0.300  Sum_probs=57.8

Q ss_pred             EEcCCCcEEEEeCC-CCcEEEeeeecCCc-ccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeeeeec
Q 042853          107 IDSTDGNLKILRNG-KSPIEISSVRRAGN-TTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQ  184 (614)
Q Consensus       107 l~~~~G~L~l~~~~-g~~vwss~~~~~~~-~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~~~~  184 (614)
                      ... +|+||+.+.. +.++|++++..+.. ...+.|.++|||||++.   ++   .++|+|     +|- ++        
T Consensus        26 ~q~-dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~---~g---~~vW~S-----~t~-~~--------   84 (114)
T smart00108       26 MQN-DYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG---DG---RVVWSS-----NTT-GA--------   84 (114)
T ss_pred             CCC-CEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC---CC---CEEEEe-----ccc-CC--------
Confidence            334 8999998765 68999999864322 36789999999999984   22   689997     111 11        


Q ss_pred             CCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEe
Q 042853          185 TGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTS  227 (614)
Q Consensus       185 tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~  227 (614)
                                     .+.+.+.++.+|...++-- ..++.|.+
T Consensus        85 ---------------~~~~~~~L~ddGnlvl~~~-~~~~~W~S  111 (114)
T smart00108       85 ---------------NGNYVLVLLDDGNLVIYDS-DGNFLWQS  111 (114)
T ss_pred             ---------------CCceEEEEeCCCCEEEECC-CCCEEeCC
Confidence                           3567788888887555422 24577875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=97.99  E-value=1.6e-06  Score=91.86  Aligned_cols=81  Identities=23%  Similarity=0.343  Sum_probs=70.9

Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++.|++|...+|.++|.........++.....++.|++.|+.|   ++   .+|||+||.||....+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468899999999999999766666667888999999999999999   44   899999999999998889999999998


Q ss_pred             eeecCCc
Q 042853          597 RTFTMNE  603 (614)
Q Consensus       597 ~~~~~~~  603 (614)
                      ..+....
T Consensus       404 ts~~~~~  410 (516)
T KOG1033|consen  404 TSQDKDE  410 (516)
T ss_pred             eecccCC
Confidence            8776544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.83  E-value=0.00022  Score=70.03  Aligned_cols=136  Identities=24%  Similarity=0.238  Sum_probs=82.0

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------------CCeeEEEEEecC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------------GGERLLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------------~~~~~lv~Ey~~  526 (614)
                      .+.|+.|..+.||+....+ ..+++|.....  ....++..|..++..+....+              ....+++||+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999999877 58888987543  345667888888888754333              224688999999


Q ss_pred             CCCHHH----------------HHh---hc-CCCCCCCHHHH--HH-------H------------HHHHHH-HHHHHHh
Q 042853          527 NKSLDF----------------FIF---DS-SRKSLLDWKKR--FS-------I------------IEGITQ-GLLYLHK  564 (614)
Q Consensus       527 ~gsL~~----------------~l~---~~-~~~~~l~~~~~--~~-------i------------~~~ia~-gL~yLH~  564 (614)
                      +..+..                .+.   .. .......+...  ..       .            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987776                111   11 01111111110  00       0            111222 2333332


Q ss_pred             ----CCCCceEecCCCCCCEEEc-CCCcEEEeecCcceee
Q 042853          565 ----YSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTF  599 (614)
Q Consensus       565 ----~~~~~iiHrDlkp~NILld-~~~~~kI~DFGla~~~  599 (614)
                          ..+..++|+|+.|.|||++ +++.+.|.||+.+..-
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence                2345699999999999999 6666689999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.81  E-value=0.00015  Score=79.32  Aligned_cols=134  Identities=17%  Similarity=0.286  Sum_probs=84.8

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcc-------------------------------------hhHhHHHHH
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ-------------------------------------GIVEFKNEA  503 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~-------------------------------------~~~~f~~E~  503 (614)
                      .+.|+.-+.|.||++++++|+.||||.-+..-.+                                     .+-.|..|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            3678999999999999999999999975443110                                     011244444


Q ss_pred             H----HHHhcCCCCC-------------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 042853          504 K----LIAKLQHTNL-------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS  566 (614)
Q Consensus       504 ~----~l~~l~H~nl-------------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  566 (614)
                      +    +...+.|-++             ...+.|+||||++..+.+...-...  .++-..   ++.-+.++.  ++.--
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~---i~~~l~~~~--~~qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHD---ILNKLVEAY--LEQIF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHH---HHHHHHHHH--HHHHH
Confidence            3    2333344442             4578999999999877554322111  133333   333333322  22111


Q ss_pred             CCceEecCCCCCCEEEcC----CCcEEEeecCcceeecC
Q 042853          567 RLRVIHRDLKVSNILLDE----QMNPKISDFGMARTFTM  601 (614)
Q Consensus       567 ~~~iiHrDlkp~NILld~----~~~~kI~DFGla~~~~~  601 (614)
                      ..+++|+|-.|.||++..    +..+.+-|||+.+.+..
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            123999999999999983    67899999999887653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.78  E-value=0.0004  Score=68.56  Aligned_cols=131  Identities=19%  Similarity=0.302  Sum_probs=75.4

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEEEecCCCC-
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVYEYLPNKS-  529 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~Ey~~~gs-  529 (614)
                      ..|++|..+.||+..   +...++|......  ......+|.+++..+....+           .....+|||++++.. 
T Consensus         7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            678999999999842   3456677765422  23446789888888765444           234578999998863 


Q ss_pred             HHHHH---------------------hhcC-CCCCCC-HHHHHH--HH------HHHHH-HHHHHHh-CCCCceEecCCC
Q 042853          530 LDFFI---------------------FDSS-RKSLLD-WKKRFS--II------EGITQ-GLLYLHK-YSRLRVIHRDLK  576 (614)
Q Consensus       530 L~~~l---------------------~~~~-~~~~l~-~~~~~~--i~------~~ia~-gL~yLH~-~~~~~iiHrDlk  576 (614)
                      +...+                     +... ....+. ...++.  +.      ..+.+ ...+|.. ..+..++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            21111                     1000 000111 001110  00      00111 1223321 123457899999


Q ss_pred             CCCEEEcCCCcEEEeecCccee
Q 042853          577 VSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       577 p~NILld~~~~~kI~DFGla~~  598 (614)
                      |.||++++++ +.|.||+.|..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999887 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.73  E-value=0.00043  Score=66.99  Aligned_cols=130  Identities=18%  Similarity=0.191  Sum_probs=82.8

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhH---------HHHHHHHHhcCCCCC----------
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEF---------KNEAKLIAKLQHTNL----------  514 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f---------~~E~~~l~~l~H~nl----------  514 (614)
                      ..++|...+.+-......|.+-.. +++...+|..........+.|         .+++..+.+++...+          
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            345676667776666666666555 356677776644322211211         223333333322111          


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN  587 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~  587 (614)
                             ....+|+|||+++..|.++.       .++.    .++..+.+++.-||+.+   +.|+|..|.|+++.++ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence                   34567899999998775442       1221    24566778899999987   9999999999999865 4


Q ss_pred             EEEeecCcceee
Q 042853          588 PKISDFGMARTF  599 (614)
Q Consensus       588 ~kI~DFGla~~~  599 (614)
                      +++.||+..+..
T Consensus       173 i~iID~~~k~~~  184 (229)
T PF06176_consen  173 IRIIDTQGKRMS  184 (229)
T ss_pred             EEEEECcccccc
Confidence            999999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=97.67  E-value=0.00031  Score=77.05  Aligned_cols=112  Identities=17%  Similarity=0.220  Sum_probs=84.8

Q ss_pred             CCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHH
Q 042853          478 QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKR  548 (614)
Q Consensus       478 ~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~  548 (614)
                      .++.+|.|...+...........+-++.|+.++||||         ....|||.|-+.-  |..++.+.      .....
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l------~~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL------GKEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh------HHHHH
Confidence            3677888888766555344456777889999999999         4578999998753  44444322      12223


Q ss_pred             HHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       549 ~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      --.+.||++||.|||+.+  .++|.+|.-..|.+++.|+-||.+|-++...
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence            335689999999999876  6999999999999999999999999887544

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=97.63  E-value=0.00022  Score=62.53  Aligned_cols=82  Identities=23%  Similarity=0.280  Sum_probs=57.1

Q ss_pred             CCcEEEEeCC-CCcEEEeeeecC-CcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeeeeecCCce
Q 042853          111 DGNLKILRNG-KSPIEISSVRRA-GNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQ  188 (614)
Q Consensus       111 ~G~L~l~~~~-g~~vwss~~~~~-~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~~~~tg~~  188 (614)
                      +|+|++.+.. ++++|++|+..+ .....+.|.++|||||.+.   ++   .++|||=-..                   
T Consensus        30 dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~---~g---~~vW~S~~~~-------------------   84 (116)
T cd00028          30 DYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG---SG---TVVWSSNTTR-------------------   84 (116)
T ss_pred             eEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC---CC---cEEEEecccC-------------------
Confidence            7899998764 589999998643 2345789999999999984   22   5899864210                   


Q ss_pred             EEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeC
Q 042853          189 WFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTST  228 (614)
Q Consensus       189 ~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g  228 (614)
                                ..+.+.+.++.+|...++-. ...+.|.+.
T Consensus        85 ----------~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf  113 (116)
T cd00028          85 ----------VNGNYVLVLLDDGNLVLYDS-DGNFLWQSF  113 (116)
T ss_pred             ----------CCCceEEEEeCCCCEEEECC-CCCEEEcCC
Confidence                      03457778888887555432 245788764

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.59  E-value=0.00011  Score=73.81  Aligned_cols=75  Identities=24%  Similarity=0.317  Sum_probs=61.5

Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEe
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKIS  591 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~  591 (614)
                      .+..++.|||+.|+|..+|.+-.. ...+..+.-.+++.||..||.|||+. .++|+|.++..+-|.+..++.+||.
T Consensus       145 ~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  145 PRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEec
Confidence            466889999999999999975332 23344455557899999999999996 5889999999999999999888884

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.52  E-value=0.00094  Score=66.62  Aligned_cols=133  Identities=18%  Similarity=0.206  Sum_probs=76.6

Q ss_pred             eeccCCc-eeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCC----CC------CCeeEEEEEecCCCCHH
Q 042853          463 RLGQGGF-GPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT----NL------GGERLLVYEYLPNKSLD  531 (614)
Q Consensus       463 ~lG~G~f-g~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~----nl------~~~~~lv~Ey~~~gsL~  531 (614)
                      .|-.|.. ..||+....+ ..+.||......   ..++..|++++..+...    .+      .+..++|||++++.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4555555 7889987654 567778765432   34567788888887432    22      22468999999987775


Q ss_pred             HHH-------------------hhcCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 042853          532 FFI-------------------FDSSR-KSLLD--WKKRFSIIE--------------------GITQGLLYLHK----Y  565 (614)
Q Consensus       532 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~  565 (614)
                      ...                   +.... .....  ...++.-..                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            431                   00000 00111  001110000                    01111222211    1


Q ss_pred             CCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       566 ~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ..+.++|+|+.|.|||++++..+.|+||+.|..-
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence            2355999999999999999877899999988643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.51  E-value=0.00092  Score=65.50  Aligned_cols=131  Identities=22%  Similarity=0.274  Sum_probs=84.8

Q ss_pred             eeccCCceeEEEEEeCCccEEEEEEccCCCcc---------hhHh---------------HHHHHHHHHhcCCCCC----
Q 042853          463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ---------GIVE---------------FKNEAKLIAKLQHTNL----  514 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~---------~~~~---------------f~~E~~~l~~l~H~nl----  514 (614)
                      .|++|--+.||+|.-.++..+|||+.......         +...               ...|..-|.++....+    
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            46677888999999888899999987543110         0001               1334445555433322    


Q ss_pred             ---CCeeEEEEEecCCCCH-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 042853          515 ---GGERLLVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI  590 (614)
Q Consensus       515 ---~~~~~lv~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI  590 (614)
                         ..+-.|||||+....+ .-.|.+    -.+...+...+..++.+.+.-|-..+  .+||.||..=|||+. ++.+.|
T Consensus       135 Pi~~~~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         135 PIAFRNNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             ceeecCCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCeEEE
Confidence               3355799999976522 111211    11222245556677777777776532  499999999999999 779999


Q ss_pred             eecCcceeec
Q 042853          591 SDFGMARTFT  600 (614)
Q Consensus       591 ~DFGla~~~~  600 (614)
                      +|||-|....
T Consensus       208 ID~~QaV~~~  217 (268)
T COG1718         208 IDVSQAVTID  217 (268)
T ss_pred             EECccccccC
Confidence            9999988664

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.47  E-value=0.00051  Score=65.68  Aligned_cols=101  Identities=21%  Similarity=0.120  Sum_probs=75.2

Q ss_pred             HHHHHHHHhcCCCC-C-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 042853          500 KNEAKLIAKLQHTN-L-----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR  573 (614)
Q Consensus       500 ~~E~~~l~~l~H~n-l-----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr  573 (614)
                      .+|.-++..+++.. +     .-..+++.||.+.+++...-.....-...+|..|.+||.++++.+.+|++.....+.-+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc   86 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC   86 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence            45788888888743 3     11347899999987653210000011235899999999999999999998655568889


Q ss_pred             CCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          574 DLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       574 Dlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |++++|+-+++++.+|+.|...+-...
T Consensus        87 Dv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   87 DVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             ecchHHeEEeCCCcEEEEechhcchhH
Confidence            999999999999999999998776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.45  E-value=0.00013  Score=78.99  Aligned_cols=141  Identities=23%  Similarity=0.320  Sum_probs=96.0

Q ss_pred             CCCccceecc--CCceeEEEEEe--C-CccEEEEEEccC--CCcchhHhHHHHHHHHHhcC-CCCC---------CCeeE
Q 042853          457 NFSPANRLGQ--GGFGPVYKGKL--Q-DEQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQ-HTNL---------GGERL  519 (614)
Q Consensus       457 ~f~~~~~lG~--G~fg~Vy~g~~--~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~  519 (614)
                      .|.....+|.  |.+|.||.+..  . ++..+|+|+=+.  ..++....=.+|+....+++ |+|.         .+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4555678999  99999999887  3 567788887322  11222222244554444443 5555         34556


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEeecC
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ----GLLYLHKYSRLRVIHRDLKVSNILLDEQ-MNPKISDFG  594 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDlkp~NILld~~-~~~kI~DFG  594 (614)
                      +-.|++. .+|..+......  .++-.....+..+..+    ||..+|...   |+|-|+||.||.+..+ ...++.|||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            6666664 677777654322  2344445556666666    999999876   9999999999999988 889999999


Q ss_pred             cceeecCCc
Q 042853          595 MARTFTMNE  603 (614)
Q Consensus       595 la~~~~~~~  603 (614)
                      +.+.+....
T Consensus       269 ~v~~i~~~~  277 (524)
T KOG0601|consen  269 LVSKISDGN  277 (524)
T ss_pred             eeEEccCCc
Confidence            998886544

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.23  E-value=0.0051  Score=58.95  Aligned_cols=131  Identities=23%  Similarity=0.285  Sum_probs=78.9

Q ss_pred             CCCCccceeccCCc-eeEEEEEeCCccEEEEEEccC---C---------Cc---------chhHhHHHHHHHHHhcCCCC
Q 042853          456 DNFSPANRLGQGGF-GPVYKGKLQDEQEIAIKRLSK---S---------SG---------QGIVEFKNEAKLIAKLQHTN  513 (614)
Q Consensus       456 ~~f~~~~~lG~G~f-g~Vy~g~~~~~~~vavK~l~~---~---------~~---------~~~~~f~~E~~~l~~l~H~n  513 (614)
                      ..++..+.||.|.- |.|||.++. |+.+|+|....   .         ..         ....-|..|.+..++|++.+
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67778899999999 999999995 66899998221   0         00         11235888999888887554


Q ss_pred             CCCe-eEEEEEecCCCCHHHHHh------hcCCCC--------CCC--HHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 042853          514 LGGE-RLLVYEYLPNKSLDFFIF------DSSRKS--------LLD--WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLK  576 (614)
Q Consensus       514 l~~~-~~lv~Ey~~~gsL~~~l~------~~~~~~--------~l~--~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk  576 (614)
                      -.+. ..-++-|+--- .+.-+.      ......        ..+  .....+-+.+|.+-|.-+|..+   |+-+|+|
T Consensus       116 ~e~~~Avkc~Gyl~L~-~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~g---I~~~Dv~  191 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLT-EDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLG---IVPRDVK  191 (207)
T ss_pred             ccCceEEEeeEEEEEc-hHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCC---eeeccCc
Confidence            3111 11122222000 000000      000000        000  0112334567888888999876   9999999


Q ss_pred             CCCEEEcCCCcEEEeecCcc
Q 042853          577 VSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       577 p~NILld~~~~~kI~DFGla  596 (614)
                      +.|..     .-||+|||.+
T Consensus       192 ~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  192 PRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ccccc-----CCEEEecccC
Confidence            99986     5699999965

>PLN02876 acyl-CoA dehydrogenase

Probab=97.17  E-value=0.0061  Score=71.84  Aligned_cols=69  Identities=17%  Similarity=0.363  Sum_probs=49.0

Q ss_pred             cceeccCCceeEEEEEeCCc---cEEEEEEccCCC-cchhHhHHHHHHHHHhcC-CCCC--------------CCeeEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQDE---QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNL--------------GGERLLV  521 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~---~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nl--------------~~~~~lv  521 (614)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|.+++..+. |.++              .+..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999877653   356777654322 123346889999999996 6666              1357899


Q ss_pred             EEecCCCC
Q 042853          522 YEYLPNKS  529 (614)
Q Consensus       522 ~Ey~~~gs  529 (614)
                      |||+++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.15  E-value=0.0036  Score=61.99  Aligned_cols=138  Identities=18%  Similarity=0.274  Sum_probs=79.1

Q ss_pred             cceeccCCceeEEEEEeCC--ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCC------CeeEEEEEecCCCCHHH
Q 042853          461 ANRLGQGGFGPVYKGKLQD--EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG------GERLLVYEYLPNKSLDF  532 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~--~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~------~~~~lv~Ey~~~gsL~~  532 (614)
                      .+.|..|-...+|+....+  ++.+++|...... .....-.+|+.++..+....+.      ..-.++|||+++..+..
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~~~l~e~i~G~~l~~   81 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQNGLIYEFIPGRTLEP   81 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeCCcEEEEeeCCCcCCH
Confidence            3567778888999988764  5678888664322 2222335788888887654441      12357999999876531


Q ss_pred             H--------------H---hhcCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHHH--
Q 042853          533 F--------------I---FDSSRK--------SLL-DWKKRFSIIE----------------------GITQGLLYL--  562 (614)
Q Consensus       533 ~--------------l---~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~gL~yL--  562 (614)
                      .              +   +.....        ... .|.....+..                      .+.+.+..|  
T Consensus        82 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  161 (235)
T cd05157          82 EDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLKE  161 (235)
T ss_pred             HHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHHH
Confidence            1              1   111100        011 1221111110                      111111222  


Q ss_pred             --HhC-CCCceEecCCCCCCEEEcC-CCcEEEeecCcceee
Q 042853          563 --HKY-SRLRVIHRDLKVSNILLDE-QMNPKISDFGMARTF  599 (614)
Q Consensus       563 --H~~-~~~~iiHrDlkp~NILld~-~~~~kI~DFGla~~~  599 (614)
                        ... .+..++|+|+.+.|||++. +..+.|.||-.|..-
T Consensus       162 ~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~  202 (235)
T cd05157         162 LLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN  202 (235)
T ss_pred             HhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence              111 2346999999999999997 578999999987643

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.12  E-value=0.0051  Score=61.02  Aligned_cols=33  Identities=24%  Similarity=0.271  Sum_probs=27.3

Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       567 ~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ++.++|+|+.+.|||++++....|.||+.|..-
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            345999999999999997766689999987643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.08  E-value=0.0029  Score=63.61  Aligned_cols=133  Identities=17%  Similarity=0.127  Sum_probs=75.4

Q ss_pred             eccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC------CCeeEEEEEecCCCCHHHH----
Q 042853          464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------GGERLLVYEYLPNKSLDFF----  533 (614)
Q Consensus       464 lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl------~~~~~lv~Ey~~~gsL~~~----  533 (614)
                      +..|-...+|+... +++.+++|..............+|..++..+....+      ...-.+||||+++..+...    
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~~~~v~e~i~G~~~~~~~~~~   82 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNEHWLLVEWLEGEVITLDQFVA   82 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeCCEEEEEeccCcccccccccC
Confidence            45677788998874 456677887544322211245778888888865444      2234689999998665321    


Q ss_pred             ----------H---hhcC-CCCCCCHHHHH-HHHHH---------HHHHHHHHHhC-----CCCceEecCCCCCCEEEcC
Q 042853          534 ----------I---FDSS-RKSLLDWKKRF-SIIEG---------ITQGLLYLHKY-----SRLRVIHRDLKVSNILLDE  584 (614)
Q Consensus       534 ----------l---~~~~-~~~~l~~~~~~-~i~~~---------ia~gL~yLH~~-----~~~~iiHrDlkp~NILld~  584 (614)
                                +   +... ....++...++ .+..+         +.+-+..+...     .+..++|+|+.|.|||+++
T Consensus        83 ~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~  162 (256)
T TIGR02721        83 LDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTP  162 (256)
T ss_pred             chhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeC
Confidence                      1   1111 01112222211 11111         11112222111     1345899999999999998


Q ss_pred             CCcEEEeecCccee
Q 042853          585 QMNPKISDFGMART  598 (614)
Q Consensus       585 ~~~~kI~DFGla~~  598 (614)
                      ++ ++|.||..|..
T Consensus       163 ~~-~~lIDwE~a~~  175 (256)
T TIGR02721       163 QG-LKLIDWEYASD  175 (256)
T ss_pred             CC-CEEEeccccCc
Confidence            76 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.97  E-value=0.0043  Score=57.69  Aligned_cols=122  Identities=21%  Similarity=0.265  Sum_probs=79.9

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCCee------EEEEEecCCCCHHHHH
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER------LLVYEYLPNKSLDFFI  534 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~~~------~lv~Ey~~~gsL~~~l  534 (614)
                      ...|++|.+|.||+|.+.+ .++|+|.=...  .....+..|++++..++-.++.++.      .+.|||..+-.|...-
T Consensus        27 ~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~  103 (201)
T COG2112          27 EKELAKGTTSVVYLGEWRG-GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLE  103 (201)
T ss_pred             hhhhhcccccEEEEeeccC-ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhh
Confidence            5789999999999999964 47888865432  2346788999999999888874443      3569999887776543


Q ss_pred             hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC-CCCEEEcCCCcEEEeecCccee
Q 042853          535 FDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLK-VSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       535 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk-p~NILld~~~~~kI~DFGla~~  598 (614)
                      ..      .+-++.    ..++++---|-..   .|-|..|. |..++|-.+..+-|+||--|+.
T Consensus       104 ~~------~~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         104 IG------GDRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hc------ccHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            11      122222    2333332222222   36666664 4555555555999999999884

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=96.95  E-value=0.00032  Score=54.73  Aligned_cols=30  Identities=27%  Similarity=0.026  Sum_probs=26.4

Q ss_pred             CCCccccccccccceEEEEEee----ccchhhhh
Q 042853          325 YTEPEGGKKKWWFWLIIAAAVV----LGMCLLLS  354 (614)
Q Consensus       325 ~s~~~C~~~Cl~~CsC~a~a~~----~~~C~l~~  354 (614)
                      .+.++|+..|+++|+|+||++.    +++|++|.
T Consensus        27 ~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~   60 (66)
T PF08276_consen   27 VSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWY   60 (66)
T ss_pred             CCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEc
Confidence            6678999999999999999997    35799986

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=96.89  E-value=0.013  Score=51.17  Aligned_cols=73  Identities=21%  Similarity=0.231  Sum_probs=46.9

Q ss_pred             CcEEEc-CCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEecc--CCCEEEEeecCCCCccccee
Q 042853           86 RPVWIA-NRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLK--NGNLVLYEMNSDGLSIRREL  162 (614)
Q Consensus        86 t~VW~A-Nr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~Lld--sGNlVl~~~~~~~~~~~~~l  162 (614)
                      ++||.. +...... . ...+.|.+ +|||||.|..+.++|+|..-  ...+...+++  .||++ ...   ..   .+.
T Consensus        39 ~~iWss~~t~~~~~-~-~~~~~L~~-~GNlvl~d~~~~~lW~Sf~~--ptdt~L~~q~l~~~~~~-~~~---~~---~~s  106 (114)
T PF01453_consen   39 SVIWSSNNTSGRGN-S-GCYLVLQD-DGNLVLYDSSGNVLWQSFDY--PTDTLLPGQKLGDGNVT-GKN---DS---LTS  106 (114)
T ss_dssp             EEEEE--S-TTSS--S-SEEEEEET-TSEEEEEETTSEEEEESTTS--SS-EEEEEET--TSEEE-EES---TS---SEE
T ss_pred             CEEEEecccCCccc-c-CeEEEEeC-CCCEEEEeecceEEEeecCC--CccEEEeccCcccCCCc-ccc---ce---EEe
Confidence            569999 4333332 2 57899998 99999999999999998422  2345566666  88888 542   21   578


Q ss_pred             ceecCCCC
Q 042853          163 WQSFDYPT  170 (614)
Q Consensus       163 WQSFD~PT  170 (614)
                      |.|=+.|+
T Consensus       107 w~s~~dps  114 (114)
T PF01453_consen  107 WSSNTDPS  114 (114)
T ss_dssp             EESS----
T ss_pred             ECCCCCCC
Confidence            88877663

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.88  E-value=0.015  Score=59.73  Aligned_cols=134  Identities=19%  Similarity=0.175  Sum_probs=82.2

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------------CCeeEEEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------------GGERLLVYE  523 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------------~~~~~lv~E  523 (614)
                      .+.|..|....+|+....++ .+++|....   ....+...|++++..+.+..+                 .+..++|+|
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            46677787789999876544 577787653   223456678888887755444                 123468999


Q ss_pred             ecCCCCHHH----HH----------hhcC--------CCCCCCHHHHHH----------HHHHHHHHHHHHHh----CCC
Q 042853          524 YLPNKSLDF----FI----------FDSS--------RKSLLDWKKRFS----------IIEGITQGLLYLHK----YSR  567 (614)
Q Consensus       524 y~~~gsL~~----~l----------~~~~--------~~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~  567 (614)
                      |+++..+..    ..          +...        ......|.....          ....+..++.++..    .-+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999866532    10          1100        011223433211          11223445555553    123


Q ss_pred             CceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          568 LRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       568 ~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ..++|+|+.|.|||++++..+.|.||+.|..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4599999999999999987779999988763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.64  E-value=0.026  Score=60.31  Aligned_cols=69  Identities=14%  Similarity=0.185  Sum_probs=47.5

Q ss_pred             cceeccCCceeEEEEEeCCc-cEEEEEEccCC-----C--cchhHhHHHHHHHHHhcC-C-----CCC----CCeeEEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQDE-QEIAIKRLSKS-----S--GQGIVEFKNEAKLIAKLQ-H-----TNL----GGERLLVY  522 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~-~~vavK~l~~~-----~--~~~~~~f~~E~~~l~~l~-H-----~nl----~~~~~lv~  522 (614)
                      .+.||.|.+..||+....++ +.+.||.-...     .  +.....+..|.+.|..+. +     |.+    ....++||
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVM  110 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVM  110 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEE
Confidence            36799999999999999876 48999974311     0  123456677888877752 1     222    34468999


Q ss_pred             EecCCCC
Q 042853          523 EYLPNKS  529 (614)
Q Consensus       523 Ey~~~gs  529 (614)
                      ||+++..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9998743

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.58  E-value=0.029  Score=54.03  Aligned_cols=125  Identities=18%  Similarity=0.253  Sum_probs=76.0

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCC----------------cchhHhHHHHHHHHHhcC-CCCC---------
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS----------------GQGIVEFKNEAKLIAKLQ-HTNL---------  514 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~----------------~~~~~~f~~E~~~l~~l~-H~nl---------  514 (614)
                      ...||+|+.-.||.  +++.....||.+....                .....++.+|+.-...+. +.+.         
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            56899999999996  4444556777775443                122456777777666665 4443         


Q ss_pred             -----CCeeEEEEEecCC--C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 042853          515 -----GGERLLVYEYLPN--K----SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD  583 (614)
Q Consensus       515 -----~~~~~lv~Ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld  583 (614)
                           ....-+|+|.+.+  |    +|.+++.+    ..++. +.   ...+-+-..||-+..   |+.+||+|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-EL---RQALDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HH---HHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence                 2345677777643  3    46666632    22443 22   222333345666655   99999999999995


Q ss_pred             CC--C--cEEEee-cCccee
Q 042853          584 EQ--M--NPKISD-FGMART  598 (614)
Q Consensus       584 ~~--~--~~kI~D-FGla~~  598 (614)
                      ..  +  .+.|.| ||-...
T Consensus       153 ~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             ecCCCceEEEEEeCCCCccc
Confidence            32  2  467777 555444

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK05231 homoserine kinase; Provisional

Probab=96.50  E-value=0.024  Score=59.00  Aligned_cols=132  Identities=17%  Similarity=0.194  Sum_probs=73.0

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------------CCeeEEEEEe
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------------GGERLLVYEY  524 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------------~~~~~lv~Ey  524 (614)
                      +.|..|....+|+....++ .+++|.....   ...+...|+.++..|....+                 .+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            5566777788999876655 5777876521   12333445555655543333                 2346899999


Q ss_pred             cCCCCHHH-----------HH---hhcCC--------CCCCCH-HHHHHH------------H-HHHHHHHHHHHhC---
Q 042853          525 LPNKSLDF-----------FI---FDSSR--------KSLLDW-KKRFSI------------I-EGITQGLLYLHKY---  565 (614)
Q Consensus       525 ~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~i------------~-~~ia~gL~yLH~~---  565 (614)
                      +++..+..           .+   +....        ...+.| .....-            . ..+...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99864311           11   11000        011222 221111            1 1111122233211   


Q ss_pred             -CCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          566 -SRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       566 -~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                       -+..+||+|+.|.|||++.+...-|.||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             23469999999999999976556899999875

>PRK10593 hypothetical protein; Provisional

Probab=96.41  E-value=0.049  Score=56.15  Aligned_cols=67  Identities=12%  Similarity=0.045  Sum_probs=46.5

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCC-CC--------------CCeeEEEEEec
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT-NL--------------GGERLLVYEYL  525 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~-nl--------------~~~~~lv~Ey~  525 (614)
                      .+.||.|..+.||+-...+++ +.+|..+.  ......|..|.+.++.|... .+              .+..+||||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            467999999999998766554 55565322  11235788999988887532 23              13479999999


Q ss_pred             CCCCH
Q 042853          526 PNKSL  530 (614)
Q Consensus       526 ~~gsL  530 (614)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.23  E-value=0.063  Score=55.52  Aligned_cols=134  Identities=22%  Similarity=0.215  Sum_probs=77.9

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------------CCeeEEEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------------GGERLLVYE  523 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------------~~~~~lv~E  523 (614)
                      ...++.|.-..+|+....++ ...+|......  ...+...|++++..|....+                 .+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777788998876555 46677654321  12344556677766643332                 234678999


Q ss_pred             ecCCCCHH----HH----------HhhcCC------C---CCCCHHHHHH------------HHHHHHHHHHHHHh----
Q 042853          524 YLPNKSLD----FF----------IFDSSR------K---SLLDWKKRFS------------IIEGITQGLLYLHK----  564 (614)
Q Consensus       524 y~~~gsL~----~~----------l~~~~~------~---~~l~~~~~~~------------i~~~ia~gL~yLH~----  564 (614)
                      |+++..+.    ..          ++....      .   ..-.|.....            ....+.+.+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99885432    00          111000      0   0112322111            11223445555543    


Q ss_pred             CCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       565 ~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      ..+..++|+|+.+.||+++.+..+.|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            224569999999999999988767899999884

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.19  E-value=0.043  Score=55.90  Aligned_cols=32  Identities=28%  Similarity=0.422  Sum_probs=26.7

Q ss_pred             CceEecCCCCCCEEEcCCCc-EEEeecCcceee
Q 042853          568 LRVIHRDLKVSNILLDEQMN-PKISDFGMARTF  599 (614)
Q Consensus       568 ~~iiHrDlkp~NILld~~~~-~kI~DFGla~~~  599 (614)
                      +.++|+|+.|.|||+++++. .-|.||+.|..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997555 579999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=96.05  E-value=0.0018  Score=52.46  Aligned_cols=37  Identities=14%  Similarity=-0.022  Sum_probs=31.4

Q ss_pred             CCCCCCC-CCCccccccccc---cceEEEEEee--ccchhhhh
Q 042853          318 SYYPPSY-YTEPEGGKKKWW---FWLIIAAAVV--LGMCLLLS  354 (614)
Q Consensus       318 ~~~p~~~-~s~~~C~~~Cl~---~CsC~a~a~~--~~~C~l~~  354 (614)
                      +++|+.. .+.++|++.|+.   +|+|.||++.  +.+|.+|.
T Consensus        17 ~klpd~~~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~   59 (80)
T cd00129          17 LKIKTTKANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFP   59 (80)
T ss_pred             ccCCcccccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEec
Confidence            6777765 578999999999   9999999986  45899996

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PLN02236 choline kinase

Probab=95.97  E-value=0.048  Score=57.46  Aligned_cols=137  Identities=16%  Similarity=0.230  Sum_probs=77.7

Q ss_pred             ceeccCCceeEEEEEeCC-----ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCCe------eEEEEEecCCCCH
Q 042853          462 NRLGQGGFGPVYKGKLQD-----EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGE------RLLVYEYLPNKSL  530 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~~------~~lv~Ey~~~gsL  530 (614)
                      ..|-.|-...+|+....+     ++.+.+|........ ...-.+|..++..+...++...      -..|+||+++.+|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g~v~efi~g~~l  120 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNGRVEEFIHARTL  120 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCceEEEeeCCCCC
Confidence            455557778889887542     256788876543322 2233678888888866555221      1268999987666


Q ss_pred             HHH-----------------HhhcC-C--CCCCCHHHHHHHHH-----------------HHHHHHHHH----Hh-CCCC
Q 042853          531 DFF-----------------IFDSS-R--KSLLDWKKRFSIIE-----------------GITQGLLYL----HK-YSRL  568 (614)
Q Consensus       531 ~~~-----------------l~~~~-~--~~~l~~~~~~~i~~-----------------~ia~gL~yL----H~-~~~~  568 (614)
                      ...                 ++... .  .....|.+..++..                 .+...+..|    .. ..+.
T Consensus       121 ~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~  200 (344)
T PLN02236        121 SAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEI  200 (344)
T ss_pred             CHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCc
Confidence            421                 01110 0  11112222222211                 111122222    21 2234


Q ss_pred             ceEecCCCCCCEEEcC-CCcEEEeecCcceee
Q 042853          569 RVIHRDLKVSNILLDE-QMNPKISDFGMARTF  599 (614)
Q Consensus       569 ~iiHrDlkp~NILld~-~~~~kI~DFGla~~~  599 (614)
                      .++|+|+++.|||+++ +..++++||..|..-
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            6899999999999986 467999999988754

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.86  E-value=0.063  Score=55.34  Aligned_cols=137  Identities=24%  Similarity=0.313  Sum_probs=78.8

Q ss_pred             ceeccCCceeEEEEEeCC-------ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCC------eeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQD-------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG------ERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~-------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~------~~~lv~Ey~~~g  528 (614)
                      +.|..|-...+|+....+       ++.+++|...... ....+..+|.+++..+....+..      .-.+|+||+++.
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~~~v~e~i~G~   82 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPNGRIEEFIPSR   82 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCCCchhheeCCC
Confidence            456666677889887654       4678888764432 23345577888887775444411      123578998886


Q ss_pred             CHHHH-----------------HhhcCCCC------CC--CHHHHHH--------------------------HHHHHHH
Q 042853          529 SLDFF-----------------IFDSSRKS------LL--DWKKRFS--------------------------IIEGITQ  557 (614)
Q Consensus       529 sL~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~~ia~  557 (614)
                      .+...                 ++......      ..  -|.....                          +...+..
T Consensus        83 ~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (302)
T cd05156          83 TLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEAK  162 (302)
T ss_pred             cCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHHH
Confidence            65321                 01111000      01  1111100                          0112222


Q ss_pred             HHHHHHh------CCCCceEecCCCCCCEEEcCC----CcEEEeecCcceee
Q 042853          558 GLLYLHK------YSRLRVIHRDLKVSNILLDEQ----MNPKISDFGMARTF  599 (614)
Q Consensus       558 gL~yLH~------~~~~~iiHrDlkp~NILld~~----~~~kI~DFGla~~~  599 (614)
                      -+.+|..      ..+..++|+|+.+.|||++++    ..++++||..|..-
T Consensus       163 ~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         163 YLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            3334432      245679999999999999874    78999999988743

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.32  E-value=0.082  Score=54.86  Aligned_cols=133  Identities=20%  Similarity=0.220  Sum_probs=91.9

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCC---------cchhHh-----------------HHHHHHHHHhcCCCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS---------GQGIVE-----------------FKNEAKLIAKLQHTNL  514 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~---------~~~~~~-----------------f~~E~~~l~~l~H~nl  514 (614)
                      ...|..|--+-||.+.-.+|..+|||+.+.+-         ..+...                 ...|++-|.+|+..-|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            45788899999999999999999999765320         001111                 2346667777766555


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN  587 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~  587 (614)
                             .....|||+|+.......-.   -....++..+...+-.++++-|.-|.+.|  +.||.||.-=|+|+-+ +.
T Consensus       229 P~PePIlLk~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G~  302 (520)
T KOG2270|consen  229 PCPEPILLKNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-GK  302 (520)
T ss_pred             CCCCceeeecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-CE
Confidence                   33457899999643321111   11223555667777788888888888876  6999999999999865 57


Q ss_pred             EEEeecCcceee
Q 042853          588 PKISDFGMARTF  599 (614)
Q Consensus       588 ~kI~DFGla~~~  599 (614)
                      +.|+|-+-+...
T Consensus       303 lyiIDVSQSVE~  314 (520)
T KOG2270|consen  303 LYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEccccccC
Confidence            899998877654

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.05  E-value=0.33  Score=50.64  Aligned_cols=127  Identities=21%  Similarity=0.312  Sum_probs=76.3

Q ss_pred             CceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------------CC--eeEEEEEecCCC
Q 042853          468 GFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------------GG--ERLLVYEYLPNK  528 (614)
Q Consensus       468 ~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------------~~--~~~lv~Ey~~~g  528 (614)
                      .-..+|+....+++. ++|.....  ....+...|...+..|.-..+                 ..  ..+-++||+++.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            456788888877776 66766543  334455666666666643333                 34  678899999998


Q ss_pred             CHHH-----HH----------h----hc-----CCCCCCCHHH---H----------HHHHHHHHHHHHHHHhC----CC
Q 042853          529 SLDF-----FI----------F----DS-----SRKSLLDWKK---R----------FSIIEGITQGLLYLHKY----SR  567 (614)
Q Consensus       529 sL~~-----~l----------~----~~-----~~~~~l~~~~---~----------~~i~~~ia~gL~yLH~~----~~  567 (614)
                      .+..     .+          +    +.     .......|..   +          .....++...+..+.+.    -+
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            7762     11          0    00     0111344541   0          01223344444444421    11


Q ss_pred             ---CceEecCCCCCCEEEcCCCc-EEEeecCcce
Q 042853          568 ---LRVIHRDLKVSNILLDEQMN-PKISDFGMAR  597 (614)
Q Consensus       568 ---~~iiHrDlkp~NILld~~~~-~kI~DFGla~  597 (614)
                         ..+||+|+-|.|||++.+.. +.+.||+-|.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               23999999999999998875 8999999876

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=94.59  E-value=0.0065  Score=69.98  Aligned_cols=139  Identities=19%  Similarity=0.190  Sum_probs=86.9

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      ..+.|.+.+-+-.+.++.++...-. .+...++|.....   .....+....+-.++-..+||-.         .....|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3456666777888999988866533 2222233322111   11112222222222222222322         456789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      +++|..+++|...|+...   .++..-....+..+.++++|||...   ++|||++|.|+|+..++..+++|||+.+.
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence            999999999988876433   2222222334555888999999864   89999999999999999999999995543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.19  E-value=0.072  Score=54.38  Aligned_cols=128  Identities=16%  Similarity=0.195  Sum_probs=83.2

Q ss_pred             CCCccceeccCCceeEEEEEeCCccEEEEEEcc--CC-------C-------cc------hhHhHHHHHHHHHhcCCCCC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS--KS-------S-------GQ------GIVEFKNEAKLIAKLQHTNL  514 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~--~~-------~-------~~------~~~~f~~E~~~l~~l~H~nl  514 (614)
                      -++..+.||-|--+-||.+....|++.++|.-.  ..       .       .+      .......|...|+.|.....
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            356689999999999999999888888877211  00       0       00      11234567888888764332


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN  587 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~  587 (614)
                             ....++|||++.+-.|...-      ...+....+.-+.+   -+.-|..++   +||+|..-=||+++++..
T Consensus       173 pVPkpiD~~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm~---~Iv~la~~G---lIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  173 PVPKPIDHNRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLMG---LIVRLANHG---LIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCCcccccceeeHHHhhcccceeeee------ecCChHHHHHHHHH---HHHHHHHcC---ceecccchheeEEecCCC
Confidence                   34568899998876654322      11222332222222   223344444   999999999999999999


Q ss_pred             EEEeecCcc
Q 042853          588 PKISDFGMA  596 (614)
Q Consensus       588 ~kI~DFGla  596 (614)
                      ++++||--.
T Consensus       241 i~vIDFPQm  249 (465)
T KOG2268|consen  241 IVVIDFPQM  249 (465)
T ss_pred             EEEeechHh
Confidence            999999643

>PRK06148 hypothetical protein; Provisional

Probab=93.99  E-value=0.62  Score=56.21  Aligned_cols=31  Identities=39%  Similarity=0.454  Sum_probs=25.7

Q ss_pred             CCceEecCCCCCCEEEcCCC--cE-EEeecCcce
Q 042853          567 RLRVIHRDLKVSNILLDEQM--NP-KISDFGMAR  597 (614)
Q Consensus       567 ~~~iiHrDlkp~NILld~~~--~~-kI~DFGla~  597 (614)
                      +..+||.|+.+.|||++.+.  .+ -|+|||-+.
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            44699999999999999775  44 499999765

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=93.98  E-value=0.82  Score=47.29  Aligned_cols=43  Identities=16%  Similarity=0.257  Sum_probs=34.4

Q ss_pred             HHHHHHhC-----CCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          558 GLLYLHKY-----SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       558 gL~yLH~~-----~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      -..||+++     .++.++|+|+.+.||+++.+..+-|.||+++..-.
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            34566654     33579999999999999988889999999987543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.85  E-value=0.83  Score=47.07  Aligned_cols=30  Identities=27%  Similarity=0.345  Sum_probs=25.7

Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          567 RLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       567 ~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      +..++|+|+.+.|||++. ..+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            346899999999999987 578999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=93.63  E-value=0.63  Score=48.71  Aligned_cols=136  Identities=16%  Similarity=0.287  Sum_probs=74.0

Q ss_pred             ceeccCCceeEEEEEeCC----ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCCee------EEEEEecCCCCHH
Q 042853          462 NRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER------LLVYEYLPNKSLD  531 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~~~------~lv~Ey~~~gsL~  531 (614)
                      +.|..|-...+|+....+    +..+.+|....... ....-.+|..++..+...++....      -+|.||+++..|.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G~i~~fi~g~~l~   98 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNGMIQSFINARTLT   98 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCcEeehhhcCCCCC
Confidence            455556667788876543    23677887654332 223346788888888766662221      2478888765542


Q ss_pred             H-------HH----------hhcC-C--CCCCCHHHHHHHHHH----------------------HHHHHHHHH----h-
Q 042853          532 F-------FI----------FDSS-R--KSLLDWKKRFSIIEG----------------------ITQGLLYLH----K-  564 (614)
Q Consensus       532 ~-------~l----------~~~~-~--~~~l~~~~~~~i~~~----------------------ia~gL~yLH----~-  564 (614)
                      .       .+          +... .  ..+--|....++..+                      +.+-+..+.    . 
T Consensus        99 ~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~  178 (330)
T PLN02421         99 PSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDSL  178 (330)
T ss_pred             hHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhccC
Confidence            1       01          1111 0  011123222222111                      111121111    1 


Q ss_pred             CCCCceEecCCCCCCEEEcC-CCcEEEeecCccee
Q 042853          565 YSRLRVIHRDLKVSNILLDE-QMNPKISDFGMART  598 (614)
Q Consensus       565 ~~~~~iiHrDlkp~NILld~-~~~~kI~DFGla~~  598 (614)
                      ..+....|.|+-+.|||+++ ++.++++||..|-.
T Consensus       179 ~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        179 KAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             CCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            12235899999999999974 56899999988764

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=93.35  E-value=0.018  Score=46.92  Aligned_cols=31  Identities=23%  Similarity=0.000  Sum_probs=26.4

Q ss_pred             CCCccccccccccceEEEEEee--ccchhhhhh
Q 042853          325 YTEPEGGKKKWWFWLIIAAAVV--LGMCLLLSL  355 (614)
Q Consensus       325 ~s~~~C~~~Cl~~CsC~a~a~~--~~~C~l~~~  355 (614)
                      .+.++|++.|+.||+|.|+++.  ++.|.+|..
T Consensus        32 ~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~   64 (84)
T cd01098          32 ISLEECREACLSNCSCTAYAYNNGSGGCLLWNG   64 (84)
T ss_pred             CCHHHHHHHHhcCCCcceeeecCCCCeEEEEec
Confidence            5678999999999999999987  467988753

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=93.22  E-value=0.49  Score=48.39  Aligned_cols=64  Identities=22%  Similarity=0.318  Sum_probs=40.0

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCC-C-----------CCeeEEEEEecCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-L-----------GGERLLVYEYLPNK  528 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-l-----------~~~~~lv~Ey~~~g  528 (614)
                      .+.++-|....+|+.. .+++.+.||.-.   ......|..|.+-|+.|...+ +           ....+||+||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4678888889999877 567788889765   233456888998888884222 1           34568999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=93.19  E-value=0.7  Score=48.58  Aligned_cols=66  Identities=15%  Similarity=0.146  Sum_probs=41.5

Q ss_pred             eeccCCceeEEEEEeCCc-cEEEEEEccCC-------CcchhHhHHHHHHHHHhcC--CCCC--------CCeeEEEEEe
Q 042853          463 RLGQGGFGPVYKGKLQDE-QEIAIKRLSKS-------SGQGIVEFKNEAKLIAKLQ--HTNL--------GGERLLVYEY  524 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~~~~-~~vavK~l~~~-------~~~~~~~f~~E~~~l~~l~--H~nl--------~~~~~lv~Ey  524 (614)
                      +||.|...-||++..+++ +.|.||.-...       -+-...+-.-|.+.|....  -|..        .....+|||+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd   81 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED   81 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence            589999999999998754 57899864311       1222334456666665542  1222        3445689999


Q ss_pred             cCCC
Q 042853          525 LPNK  528 (614)
Q Consensus       525 ~~~g  528 (614)
                      ++..
T Consensus        82 L~~~   85 (370)
T TIGR01767        82 LSHH   85 (370)
T ss_pred             Cccc
Confidence            9653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=93.06  E-value=0.023  Score=62.51  Aligned_cols=126  Identities=19%  Similarity=0.146  Sum_probs=83.7

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEEecCCC--
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYEYLPNK--  528 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~Ey~~~g--  528 (614)
                      .+.++++++++++|.+-...+.+.++.+...     .+..-++++|.+++|||.          ....+++++++..+  
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            4567899999999977655555555555332     455678999999999994          34566788888766  


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +.....   .....+...+...+...-+++|+|||+..   -+|||    |||..+ ...|..||+.+..+.+.
T Consensus       322 ~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  322 SALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             ccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            111100   00111222333345556678999999753   48998    888776 57899999998877654

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=92.59  E-value=0.37  Score=50.81  Aligned_cols=61  Identities=21%  Similarity=0.143  Sum_probs=39.8

Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD  583 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld  583 (614)
                      ...|+-+|+++-++..++....    .++..+.+++.--++||.-+-.-.  .++|.|+.|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence            3456777888888888875432    233444556655566664332211  399999999999995

>PRK11768 serine/threonine protein kinase; Provisional

Probab=91.93  E-value=2.6  Score=43.99  Aligned_cols=61  Identities=13%  Similarity=0.123  Sum_probs=38.8

Q ss_pred             CceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------------CCeeEEEEEecCCCC
Q 042853          468 GFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------------GGERLLVYEYLPNKS  529 (614)
Q Consensus       468 ~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------------~~~~~lv~Ey~~~gs  529 (614)
                      .-..||+....++..+++|..... .....+...|++.+..|....+                .+..+.+++++++..
T Consensus        37 ~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            446789988777778888876432 2234456667777666632222                345677889988754

>PTZ00384 choline kinase; Provisional

Probab=91.67  E-value=1.4  Score=47.13  Aligned_cols=69  Identities=17%  Similarity=0.339  Sum_probs=42.3

Q ss_pred             ceeccCCceeEEEEEeCCcc--E-----EEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCC------eeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQDEQ--E-----IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG------ERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~--~-----vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~------~~~lv~Ey~~~g  528 (614)
                      +.|..|-...+|++...++.  .     |.++.... ..+....-..|.+++..+.+.+++.      .-.+++||+++.
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~g~l~efIeGr  134 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGDFTIQEWVEGN  134 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCCEEEEEEeccc
Confidence            45656777889998765331  2     33333211 1122223367888999887777732      336899999987


Q ss_pred             CHH
Q 042853          529 SLD  531 (614)
Q Consensus       529 sL~  531 (614)
                      .|.
T Consensus       135 ~l~  137 (383)
T PTZ00384        135 TMG  137 (383)
T ss_pred             cCC
Confidence            664

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=90.65  E-value=0.71  Score=48.12  Aligned_cols=56  Identities=27%  Similarity=0.308  Sum_probs=45.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          542 LLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       542 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ...|.+.+.+..+.+.-+.-+..  ..+.=|||+.-.||||| +|++-|+||-++|.-.
T Consensus       317 ~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence            45788888888776655555544  35789999999999999 8999999999999543

>PLN02756 S-methyl-5-thioribose kinase

Probab=90.09  E-value=5.2  Score=42.94  Aligned_cols=66  Identities=17%  Similarity=0.129  Sum_probs=41.0

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCC----Cc---chhHhHHHHHHHHHhc------CCCCC----CCeeEEEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS----SG---QGIVEFKNEAKLIAKL------QHTNL----GGERLLVYE  523 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~----~~---~~~~~f~~E~~~l~~l------~H~nl----~~~~~lv~E  523 (614)
                      .+.||.|....||+.... ++.+.||+-...    ..   .....-..|.+.|..+      ..|.+    ....+++||
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME  115 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMR  115 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEe
Confidence            468999999999998764 456888875411    11   1222333445555443      33444    445688999


Q ss_pred             ecCC
Q 042853          524 YLPN  527 (614)
Q Consensus       524 y~~~  527 (614)
                      |++.
T Consensus       116 ~L~~  119 (418)
T PLN02756        116 YLEP  119 (418)
T ss_pred             ecCC
Confidence            9976

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	614
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-28
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-28
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-21
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-21
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-20
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-06
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-06
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-06
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-06
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-06
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-05
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-05
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-05
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-05
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		8e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 70/166 (42%), Positives = 99/166 (59%), Gaps = 11/166 (6%)
Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQG-IVEFKN 501
           LK F  + + VA+DNFS  N LG+GGFG VYKG+L D   +A+KRL +   QG  ++F+ 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 502 EAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSI 551
           E ++I+   H NL           ERLLVY Y+ N S+   + +    +  LDW KR  I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             G  +GL YLH +   ++IHRD+K +NILLDE+    + DFG+A+
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 190

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 69/166 (41%), Positives = 98/166 (59%), Gaps = 11/166 (6%)
Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQG-IVEFKN 501
           LK F  + + VA+DNF   N LG+GGFG VYKG+L D   +A+KRL +   QG  ++F+ 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 502 EAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSI 551
           E ++I+   H NL           ERLLVY Y+ N S+   + +    +  LDW KR  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             G  +GL YLH +   ++IHRD+K +NILLDE+    + DFG+A+
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/194 (36%), Positives = 98/194 (50%), Gaps = 35/194 (18%)
Query: 446 FDFQTIAVATDNFSP------ANRLGQGGFGPVYKGKLQDEQEIAIKRLSK----SSGQG 495
           F F  +   T+NF         N++G+GGFG VYKG + +   +A+K+L+     ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEEL 73
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD-- 544
             +F  E K++AK QH NL         G +  LVY Y+PN SL        R S LD  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL------LDRLSCLDGT 127
Query: 545 ----WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
               W  R  I +G   G+ +LH+      IHRD+K +NILLDE    KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 601 MNELEANTNRIVGT 614
                   +RIVGT
Sbjct: 185 KFAQTVMXSRIVGT 198

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/194 (36%), Positives = 97/194 (50%), Gaps = 35/194 (18%)
Query: 446 FDFQTIAVATDNFSP------ANRLGQGGFGPVYKGKLQDEQEIAIKRLSK----SSGQG 495
           F F  +   T+NF         N++G+GGFG VYKG + +   +A+K+L+     ++ + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEEL 67
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD-- 544
             +F  E K++AK QH NL         G +  LVY Y+PN SL        R S LD  
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL------LDRLSCLDGT 121
Query: 545 ----WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
               W  R  I +G   G+ +LH+      IHRD+K +NILLDE    KISDFG+AR   
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 601 MNELEANTNRIVGT 614
                    RIVGT
Sbjct: 179 KFAQXVMXXRIVGT 192

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/194 (36%), Positives = 97/194 (50%), Gaps = 35/194 (18%)
Query: 446 FDFQTIAVATDNFSP------ANRLGQGGFGPVYKGKLQDEQEIAIKRLSK----SSGQG 495
           F F  +   T+NF         N++G+GGFG VYKG + +   +A+K+L+     ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEEL 73
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD-- 544
             +F  E K++AK QH NL         G +  LVY Y+PN SL        R S LD  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL------LDRLSCLDGT 127
Query: 545 ----WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
               W  R  I +G   G+ +LH+      IHRD+K +NILLDE    KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 601 MNELEANTNRIVGT 614
                    RIVGT
Sbjct: 185 KFAQTVMXXRIVGT 198

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/194 (36%), Positives = 95/194 (48%), Gaps = 35/194 (18%)
Query: 446 FDFQTIAVATDNFSP------ANRLGQGGFGPVYKGKLQDEQEIAIKRLSK----SSGQG 495
           F F  +   T+NF         N+ G+GGFG VYKG + +   +A+K+L+     ++ + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEEL 64
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD-- 544
             +F  E K+ AK QH NL         G +  LVY Y PN SL        R S LD  
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL------LDRLSCLDGT 118
Query: 545 ----WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
               W  R  I +G   G+ +LH+      IHRD+K +NILLDE    KISDFG+AR   
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 601 MNELEANTNRIVGT 614
                   +RIVGT
Sbjct: 176 KFAQXVXXSRIVGT 189

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 88/157 (56%), Gaps = 13/157 (8%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQG---------IVEFKNEAK 504
           AT+NF     +G G FG VYKG L+D  ++A+KR +  S QG          + F     
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLH 563
           L++ +   +   E +L+Y+Y+ N +L   ++ S   ++ + W++R  I  G  +GL YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
             +   +IHRD+K  NILLDE   PKI+DFG+++  T
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISKKGT 190

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 88/157 (56%), Gaps = 13/157 (8%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQG---------IVEFKNEAK 504
           AT+NF     +G G FG VYKG L+D  ++A+KR +  S QG          + F     
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLH 563
           L++ +   +   E +L+Y+Y+ N +L   ++ S   ++ + W++R  I  G  +GL YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
             +   +IHRD+K  NILLDE   PKI+DFG+++  T
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISKKGT 190

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 81/175 (46%), Gaps = 20/175 (11%)
Query: 444 KIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEA 503
           K +D     +  ++     RLG G FG V+ G   +  ++A+K L K     +  F  EA
Sbjct: 1   KPWDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEA 59
Query: 504 KLIAKLQHTNLGGERL-----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSI 551
            L+  LQH  L   RL           ++ EY+   SL DF   D   K LL   K    
Sbjct: 60  NLMKTLQHDKLV--RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDF 115
Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
              I +G+ Y+    R   IHRDL+ +N+L+ E +  KI+DFG+AR    NE  A
Sbjct: 116 SAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 167

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +  S  K   + KK   I     +G+ YLH  S   +IH
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E    KI DFG+A
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +  S  K   + KK   I     +G+ YLH  S   +IH
Sbjct: 77  STKPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIH 131
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E    KI DFG+A
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLA 155

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 85/167 (50%), Gaps = 22/167 (13%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSS--GQGIVE-FKNEAKL 505
            I    ++F   N LG+G F  VY+ + +    E+AIK + K +    G+V+  +NE K+
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 506 IAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSR-----KSLLDWKKRFS------IIEG 554
             +L+H ++    L +Y Y  + +  + + +        + L +  K FS       +  
Sbjct: 65  HCQLKHPSI----LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
           I  G+LYLH +    ++HRDL +SN+LL   MN KI+DFG+A    M
Sbjct: 121 IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +  S  K   + KK   I     +G+ YLH  S   +IH
Sbjct: 89  STKPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E    KI DFG+A
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 82/169 (48%), Gaps = 26/169 (15%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
           DN      +G+G +G VYKG L DE+ +A+K  S ++ Q  +  KN  + +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYR-VPLMEHDNIA 70
Query: 515 ----GGER---------LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
               G ER         LLV EY PN SL  ++  S   S  DW     +   +T+GL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTS--DWVSSCRLAHSVTRGLAY 126
Query: 562 LHK------YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
           LH       + +  + HRDL   N+L+       ISDFG++   T N L
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 31/166 (18%)
Query: 464 LGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLGGE 517
           LG G FG VYKG    E E     +AIK L++++G +  VEF +EA ++A + H +L   
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL--V 103
Query: 518 RLL----------VYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSIIEGITQGLLYLH 563
           RLL          V + +P+  L  ++ +       + LL+W  +      I +G++YL 
Sbjct: 104 RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 157
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           +    R++HRDL   N+L+    + KI+DFG+AR    +E E N +
Sbjct: 158 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 200

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 76/156 (48%), Gaps = 20/156 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERL--- 519
           +LG G FG V+ G   +  ++A+K L K     +  F  EA L+  LQH  L   RL   
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKL--VRLYAV 75
Query: 520 --------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                   ++ E++   SL DF   D   K LL     FS    I +G+ Y+    R   
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIE---RKNY 130
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           IHRDL+ +N+L+ E +  KI+DFG+AR    NE  A
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 166

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 40  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 100 STKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 154
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLA 178

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 31/166 (18%)
Query: 464 LGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLGGE 517
           LG G FG VYKG    E E     +AIK L++++G +  VEF +EA ++A + H +L   
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL--V 80
Query: 518 RLL----------VYEYLPNKSLDFFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLH 563
           RLL          V + +P+  L  ++ +       + LL+W  +      I +G++YL 
Sbjct: 81  RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 134
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           +    R++HRDL   N+L+    + KI+DFG+AR    +E E N +
Sbjct: 135 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 177

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 147
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 129
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLA 153

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+      
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
               +  +V ++    SL   +     K   +  K   I     QG+ YLH  S   +IH
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK +NI L E +  KI DFG+A
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 13/146 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL------ 514
           ++G G FG V++ +     ++A+K L +     + + EF  E  ++ +L+H N+      
Sbjct: 44  KIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   +V EYL   SL   +  S  +  LD ++R S+   + +G+ YLH  +   ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDLK  N+L+D++   K+ DFG++R
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSR 187

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 68
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 69  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 124
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 12  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 70
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 71  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 126
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 127 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 168

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 80/165 (48%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 5   VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 63
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  L   K   +   I +G+ +
Sbjct: 64  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAF 119
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 120 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 161

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 11  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 69
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 70  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 125
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 126 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 167

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 68
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 69  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 124
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 15  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 73
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 74  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 129
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 130 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 171

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 74
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 75  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 130
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 131 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 172

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 79
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +   I   S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTA 171

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 79
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +   I   S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 18  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 76
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 77  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 132
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 133 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 174

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 19  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 77
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 78  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 133
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 134 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 175

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 74
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 75  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 130
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 131 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 172

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 68
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 69  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 124
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 20  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 78
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 79  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 134
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 135 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 176

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 77/146 (52%), Gaps = 13/146 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL------ 514
           ++G G FG V++ +     ++A+K L +     + + EF  E  ++ +L+H N+      
Sbjct: 44  KIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   +V EYL   SL   +  S  +  LD ++R S+   + +G+ YLH  +   ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HR+LK  N+L+D++   K+ DFG++R
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSR 187

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLL 520
           + R+G G FG VYKGK   +  + I ++   + +    F+NE  ++ K +H N+    LL
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI----LL 96
Query: 521 VYEYLPNKSLDFFI----FDSSRKSLLDWKKRFSIIEGI------TQGLLYLHKYSRLRV 570
              Y+   +L          S  K L   + +F + + I       QG+ YLH  +   +
Sbjct: 97  FMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---I 153
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMA 596
           IHRD+K +NI L E +  KI DFG+A
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLA 179

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------G 515
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L        
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 516 GERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
            E + +V EY+   SL  F+   + K  L   +   +   I  G+ Y+    R+  +HRD
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           L+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTA 420

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------G 515
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L        
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 516 GERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
            E + +V EY+   SL  F+   + K  L   +   +   I  G+ Y+    R+  +HRD
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           L+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------G 515
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L        
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 516 GERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
            E + +V EY+   SL  F+   + K  L   +   +   I  G+ Y+    R+  +HRD
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           L+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 69
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +       S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 70  AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTA 161

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------G 515
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L        
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 516 GERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
            E + +V EY+   SL  F+   + K  L   +   +   I  G+ Y+    R+  +HRD
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           L+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 79
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +       S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 80  AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------G 515
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L        
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 516 GERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
            E + +V EY+   SL  F+   + K  L   +   +   I  G+ Y+    R+  +HRD
Sbjct: 77  EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           L+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTA 164

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 70
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +       S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 71  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 162

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 6   VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQ 64
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  L   K   +   I +G+ +
Sbjct: 65  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAF 120
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHR+L+ +NIL+ + ++ KI+DFG+AR    NE  A
Sbjct: 121 IEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTA 162

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 68
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +       S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 69  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 160

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 79
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +       S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 28/170 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVEFKNEAKLI 506
           +   N      LG+G FG V+  +       QD+  +A+K L  +S     +F  EA+L+
Sbjct: 10  IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 69
Query: 507 AKLQHTNL---------GGERLLVYEYLPNKSLDFFI----------FDSSRKSLLDWKK 547
             LQH ++         G   ++V+EY+ +  L+ F+           + +  + L   +
Sbjct: 70  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQ 129
Query: 548 RFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              I + I  G++YL   +    +HRDL   N L+ E +  KI DFGM+R
Sbjct: 130 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 130
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 167

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 173

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 79
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +   +   S+  LLD+ K              +   I  G+ Y+    R+  +
Sbjct: 80  AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 135
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 172

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 129
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 166

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 137
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 174

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 186

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 513
           FS    +G G FG VY  + +++ + +AIK++S S  Q   ++++   E + + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 514 LGGER---------LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
               R          LV EY    + D        K  L   +  ++  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           ++   +IHRD+K  NILL E    K+ DFG A         A  N  VGT
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGT 174

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 186

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 458 FSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 513
           FS    +G G FG VY  + +++ + +AIK++S S  Q   ++++   E + + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 514 LGGER---------LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
               R          LV EY    + D        K  L   +  ++  G  QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           ++   +IHRD+K  NILL E    K+ DFG A         A  N  VGT
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGT 213

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 175

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKL----VQLY 246
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKKR-----------FSIIEGITQGLLYLHKYSRLRVI 571
             +  + +       S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 247 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 303
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+ R    NE  A
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTA 338

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 162
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 79
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +       S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL  +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ K++H  L    + +Y
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKL----VQLY 79
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +       S+ SLLD+ K              +   I  G+ Y+    R+  +
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 32/165 (19%)
Query: 462 NRLGQGGFGPVYKGKL------QDEQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNL 514
             LG+  FG VYKG L      +  Q +AIK L  K+ G    EF++EA L A+LQH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 515 ---------GGERLLVYEYLPNKSLDFFIF-------------DSSRKSLLDWKKRFSII 552
                         +++ Y  +  L  F+              D + KS L+      ++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             I  G+ YL   S   V+H+DL   N+L+ +++N KISD G+ R
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------G 515
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L        
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 516 GERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
            E + +V EY+   SL  F+   + K  L   +   +   I  G+ Y+    R+  +HRD
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           L+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTA 168

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 82/174 (47%), Gaps = 31/174 (17%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQH 511
           N S    +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GIT 556
            N+             ++V EY+ N SLD F+    RK       +F++I+      GI 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            G+ YL   S +  +HRDL   NIL++  +  K+SDFG+AR    +   A T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------G 515
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L        
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 516 GERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
            E + +V EY+   SL  F+   + K  L   +   +   I  G+ Y+    R+  +HRD
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           L+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTA 168

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 32/165 (19%)
Query: 462 NRLGQGGFGPVYKGKL------QDEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL 514
             LG+  FG VYKG L      +  Q +AIK L  K+ G    EF++EA L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 515 ---------GGERLLVYEYLPNKSLDFFIF-------------DSSRKSLLDWKKRFSII 552
                         +++ Y  +  L  F+              D + KS L+      ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             I  G+ YL   S   V+H+DL   N+L+ +++N KISD G+ R
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 82/167 (49%), Gaps = 31/167 (18%)
Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G FG V  G+L+     E  +AIK L    + +   +F +EA ++ +  H N+    
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GITQGLLYLH 563
                    +++ EY+ N SLD F+    RK+      RF++I+      GI  G+ YL 
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFL----RKN----DGRFTVIQLVGMLRGIGSGMKYL- 147
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
             S +  +HRDL   NIL++  +  K+SDFGM+R    +   A T R
Sbjct: 148 --SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L    + +Y
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL----VQLY 79
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKK-----------RFSIIEGITQGLLYLHKYSRLRVI 571
             +  + +       S+  LLD+ K              +   I  G+ Y+    R+  +
Sbjct: 80  AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           HRDL+ +NIL+ E +  K++DFG+AR    NE  A
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 451 IAVATDNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLS---------KSSGQGIVEFK 500
           IA   + F+   R+G+G FG V+KG   + +Q +AIK +              +  V  +
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
            ++  + K   + L G +L ++ EYL   S      D  R    D  +  ++++ I +GL
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGL 133
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            YLH   +   IHRD+K +N+LL EQ + K++DFG+A   T  +++ NT   VGT
Sbjct: 134 DYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 183

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 38/196 (19%)
Query: 435 SDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSK 490
           S QTV    K  D         N S    +G G FG V  G+L+     E  +AIK L  
Sbjct: 2   STQTVHEFAKELD-------ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 54
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRK 540
             + +   +F  EA ++ +  H N+             ++V EY+ N SLD F+    RK
Sbjct: 55  GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RK 110
Query: 541 SLLDWKKRFSIIE------GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
                  +F++I+      GI  G+ YL   S +  +HRDL   NIL++  +  K+SDFG
Sbjct: 111 H----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 163
Query: 595 MARTFTMNELEANTNR 610
           ++R    +   A T R
Sbjct: 164 LSRVLEDDPEAAYTTR 179

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 23/158 (14%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 515 ------GGER--LLVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                  G R   L+ EYLP  SL D+    + R   +D  K       I +G+ YL   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER---IDHIKLLQYTSQICKGMEYL--- 133
Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
              R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 41/216 (18%)
Query: 417 GHNVSLPTI--FGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYK 474
           GH + LP +  F +  T     QTV    K  D         N S    +G G FG V  
Sbjct: 12  GH-LKLPGLRTFVDPHTYEDPTQTVHEFAKELD-------ATNISIDKVVGAGEFGEVCS 63
Query: 475 GKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLL 520
           G+L+     E  +AIK L    + +   +F  EA ++ +  H N+             ++
Sbjct: 64  GRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123
Query: 521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GITQGLLYLHKYSRLRVIHRD 574
           V EY+ N SLD F+    RK       +F++I+      GI  G+ YL   S +  +HRD
Sbjct: 124 VTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRD 172
Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           L   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 38/196 (19%)
Query: 435 SDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSK 490
           S QTV    K  D         N S    +G G FG V  G+L+     E  +AIK L  
Sbjct: 19  STQTVHEFAKELD-------ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 71
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRK 540
             + +   +F  EA ++ +  H N+             ++V EY+ N SLD F+    RK
Sbjct: 72  GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RK 127
Query: 541 SLLDWKKRFSIIE------GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
                  +F++I+      GI  G+ YL   S +  +HRDL   NIL++  +  K+SDFG
Sbjct: 128 H----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 180
Query: 595 MARTFTMNELEANTNR 610
           ++R    +   A T R
Sbjct: 181 LSRVLEDDPEAAYTTR 196

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 22/152 (14%)
Query: 464 LGQGGFGPVYKGKLQ-----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN---L 514
           +G G FG VYKG L+      E  +AIK L    + +  V+F  EA ++ +  H N   L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 515 GG------ERLLVYEYLPNKSLDFFIFDSSRK-SLLDWKKRFSIIEGITQGLLYLHKYSR 567
            G        +++ EY+ N +LD F+ +   + S+L   +   ++ GI  G+ YL   + 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL---QLVGMLRGIAAGMKYL---AN 165
Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           +  +HRDL   NIL++  +  K+SDFG++R  
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ E+LP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 82/167 (49%), Gaps = 31/167 (18%)
Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G FG V  G+L+     E  +AIK L    + +   +F +EA ++ +  H N+    
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GITQGLLYLH 563
                    +++ EY+ N SLD F+    RK+      RF++I+      GI  G+ YL 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFL----RKN----DGRFTVIQLVGMLRGIGSGMKYL- 126
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
             S +  +HRDL   NIL++  +  K+SDFGM+R    +   A T R
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 82/167 (49%), Gaps = 31/167 (18%)
Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G FG V  G+L+     E  +AIK L    + +   +F +EA ++ +  H N+    
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GITQGLLYLH 563
                    +++ EY+ N SLD F+    RK+      RF++I+      GI  G+ YL 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFL----RKN----DGRFTVIQLVGMLRGIGSGMKYL- 132
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
             S +  +HRDL   NIL++  +  K+SDFGM+R    +   A T R
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 31/174 (17%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQH 511
           N S    +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GIT 556
            N+             ++V EY+ N SLD F+    RK       +F++I+      GI 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            G+ YL   S +  +HRDL   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 158 SGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 31/174 (17%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQH 511
           N S    +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GIT 556
            N+             ++V EY+ N SLD F+    RK       +F++I+      GI 
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 155
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            G+ YL   S +  +HRDL   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 156 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 31/174 (17%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQH 511
           N S    +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GIT 556
            N+             ++V EY+ N SLD F+    RK       +F++I+      GI 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            G+ YL   S +  +HRDL   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 84/156 (53%), Gaps = 25/156 (16%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHTNLGGERLL 520
           LG+G FG V K K +  +QE A+K ++K+S +         E +L+ KL H N+    + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI----MK 85
Query: 521 VYEYLPNKSLDFFIFDS--SRKSLLDW---KKRFS------IIEGITQGLLYLHKYSRLR 569
           ++E L + S  F+I     +   L D    +KRFS      II+ +  G+ Y+HK++   
Sbjct: 86  LFEILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 570 VIHRDLKVSNILLDEQ---MNPKISDFGMARTFTMN 602
           ++HRDLK  NILL+ +    + KI DFG++  F  N
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 31/174 (17%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQH 511
           N S    +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GIT 556
            N+             ++V EY+ N SLD F+    RK       +F++I+      GI 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            G+ YL   S +  +HRDL   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 30/161 (18%)
Query: 464 LGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V+  +       QD+  +A+K L ++S     +F+ EA+L+  LQH ++   
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 515 ------GGERLLVYEYLPNKSLDFFI------------FDSSRKSLLDWKKRFSIIEGIT 556
                 G   L+V+EY+ +  L+ F+             +      L   +  ++   + 
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            G++YL   + L  +HRDL   N L+ + +  KI DFGM+R
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------G 515
           RLG G FG V+ G      ++AIK L K        F  EA+++ KL+H  L        
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 516 GERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
            E + +V EY+   SL  F+ D   ++L        +   +  G+ Y+    R+  IHRD
Sbjct: 75  EEPIYIVTEYMNKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 575 LKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           L+ +NIL+   +  KI+DFG+AR    NE  A
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTA 162

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 30/161 (18%)
Query: 464 LGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V+  +       QD+  +A+K L ++S     +F+ EA+L+  LQH ++   
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 515 ------GGERLLVYEYLPNKSLDFFIF------------DSSRKSLLDWKKRFSIIEGIT 556
                 G   L+V+EY+ +  L+ F+             +      L   +  ++   + 
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            G++YL   + L  +HRDL   N L+ + +  KI DFGM+R
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 84/156 (53%), Gaps = 25/156 (16%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHTNLGGERLL 520
           LG+G FG V K K +  +QE A+K ++K+S +         E +L+ KL H N+    + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI----MK 85
Query: 521 VYEYLPNKSLDFFIFDS--SRKSLLDW---KKRFS------IIEGITQGLLYLHKYSRLR 569
           ++E L + S  F+I     +   L D    +KRFS      II+ +  G+ Y+HK++   
Sbjct: 86  LFEILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 570 VIHRDLKVSNILLDEQ---MNPKISDFGMARTFTMN 602
           ++HRDLK  NILL+ +    + KI DFG++  F  N
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 31/174 (17%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQH 511
           N S    +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GIT 556
            N+             ++V EY+ N SLD F+    RK       +F++I+      GI 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            G+ YL   S +  +HRDL   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 30/161 (18%)
Query: 464 LGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V+  +       QD+  +A+K L ++S     +F+ EA+L+  LQH ++   
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 515 ------GGERLLVYEYLPNKSLDFFI------------FDSSRKSLLDWKKRFSIIEGIT 556
                 G   L+V+EY+ +  L+ F+             +      L   +  ++   + 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            G++YL   + L  +HRDL   N L+ + +  KI DFGM+R
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 84/156 (53%), Gaps = 25/156 (16%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHTNLGGERLL 520
           LG+G FG V K K +  +QE A+K ++K+S +         E +L+ KL H N+    + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI----MK 85
Query: 521 VYEYLPNKSLDFFIFDS--SRKSLLDW---KKRFS------IIEGITQGLLYLHKYSRLR 569
           ++E L + S  F+I     +   L D    +KRFS      II+ +  G+ Y+HK++   
Sbjct: 86  LFEILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 570 VIHRDLKVSNILLDEQ---MNPKISDFGMARTFTMN 602
           ++HRDLK  NILL+ +    + KI DFG++  F  N
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 463 RLGQGGFGPVYKGK---LQDE--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +LG+G FG V   +   LQD   + +A+K+L  S+ + + +F+ E +++  LQH N+   
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G R   L+ EYLP  SL  ++     K  +D  K       I +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             R IHR+L   NIL++ +   KI DFG+ +    ++
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK 169

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 31/174 (17%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQH 511
           N S    +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GIT 556
            N+             ++V EY+ N SLD F+    RK       +F++I+      GI 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            G+ YL   S +  +HRDL   NIL++  +  K+SDFG+ R    +   A T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 79/165 (47%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
           V  +      RLG G  G V+ G      ++A+K L + S      F  EA L+ +LQH 
Sbjct: 10  VPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 68
Query: 513 NLGGERL----------LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            L   RL          ++ EY+ N SL DF    S  K  ++  K   +   I +G+ +
Sbjct: 69  RLV--RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 124
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           + + +    IHRDL+ +NIL+ + ++ KI+DFG+AR     E  A
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTA 166

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L     DF   D+S  + +      S +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 153

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L     DF   D+S  + +      S +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L     DF   D+S  + +      S +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 155

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H N+    
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                    ++V EY+ N SLD F+  +  +  +   +   ++ GI+ G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL---SDMG 144
Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            +HRDL   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 24/159 (15%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQ 510
           N+     LG+G FG V         Q++A+K      L+KS  QG +E   E   +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H ++           E ++V EY  N+  D+ +    R  + + + R    + I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIISAVEY 122
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            H++   +++HRDLK  N+LLDE +N KI+DFG++   T
Sbjct: 123 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 158

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 24/159 (15%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQ 510
           N+     LG+G FG V         Q++A+K      L+KS  QG +E   E   +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H ++           E ++V EY  N+  D+ +    R  + + + R    + I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIISAVEY 127
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            H++   +++HRDLK  N+LLDE +N KI+DFG++   T
Sbjct: 128 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 24/159 (15%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQ 510
           N+     LG+G FG V         Q++A+K      L+KS  QG +E   E   +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H ++           E ++V EY  N+  D+ +    R  + + + R    + I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIISAVEY 128
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            H++   +++HRDLK  N+LLDE +N KI+DFG++   T
Sbjct: 129 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 164

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 24/159 (15%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQ 510
           N+     LG+G FG V         Q++A+K      L+KS  QG +E   E   +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H ++           E ++V EY  N+  D+ +    R  + + + R    + I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIISAVEY 118
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            H++   +++HRDLK  N+LLDE +N KI+DFG++   T
Sbjct: 119 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 154

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 31/174 (17%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQH 511
           N S    +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GIT 556
            N+             ++V E + N SLD F+    RK       +F++I+      GI 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            G+ YL   S +  +HRDL   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 158 SGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 38/196 (19%)
Query: 435 SDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSK 490
           S QTV    K  D         N S    +G G FG V  G+L+     E  +AIK L  
Sbjct: 2   STQTVHEFAKELD-------ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 54
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRK 540
             + +   +F  EA ++ +  H N+             ++V E + N SLD F+    RK
Sbjct: 55  GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RK 110
Query: 541 SLLDWKKRFSIIE------GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
                  +F++I+      GI  G+ YL   S +  +HRDL   NIL++  +  K+SDFG
Sbjct: 111 H----DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 163
Query: 595 MARTFTMNELEANTNR 610
           ++R    +   A T R
Sbjct: 164 LSRVLEDDPEAAYTTR 179

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLGGER 518
           +G G FG V +G+L+     E  +AIK L    + +   EF +EA ++ + +H N+    
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKK-RFSIIE------GITQGLLYLHKYSRLRVI 571
            +V   +P   L  F+ + +  S L     +F++I+      GI  G+ YL + S    +
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS---YV 140
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVG 613
           HRDL   NIL++  +  K+SDFG++R    N  +      +G
Sbjct: 141 HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLGGER 518
           +G G FG V +G+L+     E  +AIK L    + +   EF +EA ++ + +H N+    
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKK-RFSIIE------GITQGLLYLHKYSRLRVI 571
            +V   +P   L  F+ + +  S L     +F++I+      GI  G+ YL + S    +
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS---YV 138
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
           HRDL   NIL++  +  K+SDFG++R    N
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGLSRFLEEN 169

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 31/174 (17%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQH 511
           N S    +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GIT 556
            N+             ++V E + N SLD F+    RK       +F++I+      GI 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            G+ YL   S +  +HRDL   NIL++  +  K+SDFG++R    +   A T R
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 19/159 (11%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIF-DSSRKSLLDWKKRFSIIEGITQGLL 560
           H N+           +  LV+E+L   S+D   F D+S  + +      S +  + QGL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 156

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 85/159 (53%), Gaps = 17/159 (10%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKL 509
           V  +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 510 QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLL 560
            H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 157

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 464 LGQGGFGPVYKGKL----QDEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G  G V  G+L    Q +  +AIK L    + +   +F +EA ++ +  H N+    
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                G   ++V EY+ N SLD F+   +        +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
            +HRDL   N+L+D  +  K+SDFG++R    +   A T 
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT 211

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 19/159 (11%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIF-DSSRKSLLDWKKRFSIIEGITQGLL 560
           H N+           +  LV+E+L   S+D   F D+S  + +      S +  + QGL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 154

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 154

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 155

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 15/153 (9%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  L     +V 
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 523 --------EYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
                   E++   SL DF   D   K  L   K       I +G+ ++ + +    IHR
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHR 308
Query: 574 DLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           DL+ +NIL+   +  KI+DFG+AR    NE  A
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTA 341

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 19/150 (12%)
Query: 464 LGQGGFGPVYKGKL----QDEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G  G V  G+L    Q +  +AIK L    + +   +F +EA ++ +  H N+    
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                G   ++V EY+ N SLD F+   +        +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +HRDL   N+L+D  +  K+SDFG++R  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 71/153 (46%), Gaps = 15/153 (9%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  L     +V 
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 523 --------EYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
                   E++   SL DF   D   K  L     FS    I +G+ ++ + +    IHR
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA--QIAEGMAFIEQRN---YIHR 135
Query: 574 DLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           DL+ +NIL+   +  KI+DFG+AR    NE  A
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTA 168

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 155

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 155

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF 154

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 157

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 154

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 154

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 160

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 160

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
              +G G FG V+ G   ++ ++AIK + +       +F  EA+++ KL H  L      
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   LV+E++ +  L  ++   +++ L   +    +   + +G+ YL + S   VI
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VI 125
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E    K+SDFGM R
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTR 151

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAI-KRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           LG+G FG   K   ++  E+ + K L +   +    F  E K++  L+H N+        
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 515 GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
             +RL  + EY+   +L   I   S  S   W +R S  + I  G+ YLH    + +IHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 574 DLKVSNILLDEQMNPKISDFGMAR 597
           DL   N L+ E  N  ++DFG+AR
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLAR 156

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 89/173 (51%), Gaps = 26/173 (15%)
Query: 445 IFDFQTIAVATDNFSPANRLGQGGFGPVY--KGKLQDEQEIAIKRLSKSSGQGIVEFKN- 501
           +F   + A+ +D +     LG+G FG V   K K+   QE A+K +SK   +   + ++ 
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESL 96
Query: 502 --EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDS-SRKSLLDW---KKRFS----- 550
             E +L+ +L H N+    + +YE+  +K   + + +  +   L D    +KRFS     
Sbjct: 97  LREVQLLKQLDHPNI----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 152
Query: 551 -IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTF 599
            II  +  G+ Y+HK    +++HRDLK  N+LL+ +    N +I DFG++  F
Sbjct: 153 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 202

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 89/173 (51%), Gaps = 26/173 (15%)
Query: 445 IFDFQTIAVATDNFSPANRLGQGGFGPVY--KGKLQDEQEIAIKRLSKSSGQGIVEFKN- 501
           +F   + A+ +D +     LG+G FG V   K K+   QE A+K +SK   +   + ++ 
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESL 97
Query: 502 --EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDS-SRKSLLDW---KKRFS----- 550
             E +L+ +L H N+    + +YE+  +K   + + +  +   L D    +KRFS     
Sbjct: 98  LREVQLLKQLDHPNI----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 153
Query: 551 -IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTF 599
            II  +  G+ Y+HK    +++HRDLK  N+LL+ +    N +I DFG++  F
Sbjct: 154 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 203

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 89/173 (51%), Gaps = 26/173 (15%)
Query: 445 IFDFQTIAVATDNFSPANRLGQGGFGPVY--KGKLQDEQEIAIKRLSKSSGQGIVEFKN- 501
           +F   + A+ +D +     LG+G FG V   K K+   QE A+K +SK   +   + ++ 
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESL 73
Query: 502 --EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDS-SRKSLLDW---KKRFS----- 550
             E +L+ +L H N+    + +YE+  +K   + + +  +   L D    +KRFS     
Sbjct: 74  LREVQLLKQLDHPNI----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129
Query: 551 -IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTF 599
            II  +  G+ Y+HK    +++HRDLK  N+LL+ +    N +I DFG++  F
Sbjct: 130 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 211
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E ++  N+
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 157
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E ++  N+
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 199

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 90/168 (53%), Gaps = 18/168 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTN 513
           + +    ++G+G +G VYK K    + +A+KR+   +  +GI      E  L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 514 L-------GGERLL--VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +         ER L  V+E++  K L   + D ++  L D + +  + + + +G+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           +   R++HRDLK  N+L++     K++DFG+AR F +  + + T+ +V
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV 181

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E ++  N+
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNK 195

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 90/168 (53%), Gaps = 18/168 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTN 513
           + +    ++G+G +G VYK K    + +A+KR+   +  +GI      E  L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 514 L-------GGERLL--VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +         ER L  V+E++  K L   + D ++  L D + +  + + + +G+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           +   R++HRDLK  N+L++     K++DFG+AR F +  + + T+ +V
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV 181

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 150
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E ++  N+
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 192

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E ++  N+
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 195

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E ++  N+
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 194

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E++ ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 19/149 (12%)
Query: 462 NRLGQGGFGPVYKGKLQ-DEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
           ++LG+G +  VYKGK +  +  +A+K  RL    G      + E  L+  L+H N+    
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 66
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                     LV+EYL +K L  ++ D    ++++       +  + +GL Y H   R +
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMART 598
           V+HRDLK  N+L++E+   K++DFG+AR 
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARA 149

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E ++  N+
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 194

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKG--KLQDEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK   KL  E     K    +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 17/156 (10%)
Query: 456 DNFSPANRLGQGGFGPVYKG--KLQDEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHT 512
           +NF    ++G+G +G VYK   KL  E     K    +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L ++ L  F+ D+S  + +      S +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 89/173 (51%), Gaps = 26/173 (15%)
Query: 445 IFDFQTIAVATDNFSPANRLGQGGFGPVY--KGKLQDEQEIAIKRLSKSSGQGIVEFKN- 501
           +F   + A+ +D +     LG+G FG V   K K+   QE A+K +SK   +   + ++ 
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESL 79
Query: 502 --EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDS-SRKSLLDW---KKRFS----- 550
             E +L+ +L H N+    + +YE+  +K   + + +  +   L D    +KRFS     
Sbjct: 80  LREVQLLKQLDHPNI----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 135
Query: 551 -IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTF 599
            II  +  G+ Y+HK    +++HRDLK  N+LL+ +    N +I DFG++  F
Sbjct: 136 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 185

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNK 193

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
              +G G FG V+ G   ++ ++AIK + + S     +F  EA+++ KL H  L      
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +     VI
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E    K+SDFGM R
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTR 171

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 19/157 (12%)
Query: 461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-------GQGIVEFKN-----EAKLIA 507
            + LG G FG V  GK +    ++A+K L++         G+   E +N        +I 
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
             Q  +   +  +V EY+    L  +I  + R   LD K+   + + I  G+ Y H++  
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM- 136
Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
             V+HRDLK  N+LLD  MN KI+DFG++   +  E 
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 22/157 (14%)
Query: 464 LGQGGFGPVYKGKLQDE-----QEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V   +   E     +++A+K L  +S G  I + K E +++  L H N+   
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 515 -------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  GG  + L+ E+LP+ SL  ++     K+ ++ K++      I +G+ YL    
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL---G 143
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             + +HRDL   N+L++ +   KI DFG+ +    ++
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 15/146 (10%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
              +G G FG V+ G   ++ ++AIK + +       +F  EA+++ KL H  L      
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +     VI
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E    K+SDFGM R
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTR 149

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 31/162 (19%)
Query: 464 LGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V+  +       +D+  +A+K L   +     +F+ EA+L+  LQH ++   
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKS--LLDWKKR-----------FSIIEGI 555
                 G   ++V+EY+ +  L+ F+      +  L+D + R             I   I
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             G++YL   +    +HRDL   N L+   +  KI DFGM+R
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 22/157 (14%)
Query: 464 LGQGGFGPVYKGKLQDE-----QEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V   +   E     +++A+K L  +S G  I + K E +++  L H N+   
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 515 -------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  GG  + L+ E+LP+ SL  ++     K+ ++ K++      I +G+ YL    
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL---G 131
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             + +HRDL   N+L++ +   KI DFG+ +    ++
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 168

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 510
           + +NF    ++G+G +G VYK + +   E+ A+K++   +  +G+      E  L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N+           +  LV+E++ ++ L  F+ D+S  + +      S +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            H +   RV+HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 156

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 170
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 212

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNL---- 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N+    
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                  G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 193

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 194

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 15/146 (10%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
              +G G FG V+ G   ++ ++AIK + +       +F  EA+++ KL H  L      
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +     VI
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E    K+SDFGM R
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTR 151

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 144
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 186

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 147
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNL---- 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N+    
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                  G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 194

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 15/146 (10%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
              +G G FG V+ G   ++ ++AIK + +       +F  EA+++ KL H  L      
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +     VI
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E    K+SDFGM R
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTR 154

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 21/151 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLS----KSSGQGIVEFK-NEAKLIAKLQHTNLGG- 516
           LG+G F  VYK + ++  +I AIK++       +  GI      E KL+ +L H N+ G 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 517 --------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                      LV++++    L+  I D+S        K + ++    QGL YLH++   
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW-- 132
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            ++HRDLK +N+LLDE    K++DFG+A++F
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 28/158 (17%)
Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLGGER-- 518
           +G GGFG VY+   + DE  +   R        Q I   + EAKL A L+H N+   R  
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 519 -------LLVYEYLPNKSLDFFIFDSSRKS--LLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                   LV E+     L+  +         L++W  +      I +G+ YLH  + + 
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIVP 128
Query: 570 VIHRDLKVSNILLDEQMNP--------KISDFGMARTF 599
           +IHRDLK SNIL+ +++          KI+DFG+AR +
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 171
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 213

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 149
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 191

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTN----L 514
           +G+G FG VY G L D        A+K L++ +  G + +F  E  ++    H N    L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 515 G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
           G      G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 150
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           + +HRDL   N +LDE+   K++DFG+AR     E  +  N+
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 192

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 20/168 (11%)
Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS---------KSSGQGIVEFKNEAKLIA 507
           F+  +R+G+G FG VYKG     +E+ AIK +              +  V  + ++  I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 508 KLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           +   + L   +L ++ EYL   S      D  +   L+     +I+  I +GL YLH   
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 135
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             R IHRD+K +N+LL EQ + K++DFG+A   T  +++ N    VGT
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGT 179

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 23/166 (13%)
Query: 452 AVATDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQG-------IVEFKNEA 503
            +A +      ++G+GGFG V+KG+L +D+  +AIK L     +G         EF+ E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 504 KLIAKLQHTN-------LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGIT 556
            +++ L H N       +     +V E++P   L   + D +    + W  +  ++  I 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNIL---LDEQ--MNPKISDFGMAR 597
            G+ Y+   +   ++HRDL+  NI    LDE   +  K++DFG+++
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 25/159 (15%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTN 513
           + +    ++G+G +G VYK +    +  A+K++  +   +GI      E  ++ +L+H+N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 514 LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG-------------ITQGLL 560
           +    + +Y+ +  K     +F+   +   D KK   + EG             +  G+ 
Sbjct: 62  I----VKLYDVIHTKKRLVLVFEHLDQ---DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           Y H     RV+HRDLK  N+L++ +   KI+DFG+AR F
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 25/159 (15%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTN 513
           + +    ++G+G +G VYK +    +  A+K++  +   +GI      E  ++ +L+H+N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 514 LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG-------------ITQGLL 560
           +    + +Y+ +  K     +F+   +   D KK   + EG             +  G+ 
Sbjct: 62  I----VKLYDVIHTKKRLVLVFEHLDQ---DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           Y H     RV+HRDLK  N+L++ +   KI+DFG+AR F
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 25/159 (15%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTN 513
           + +    ++G+G +G VYK +    +  A+K++  +   +GI      E  ++ +L+H+N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 514 LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG-------------ITQGLL 560
           +    + +Y+ +  K     +F+   +   D KK   + EG             +  G+ 
Sbjct: 62  I----VKLYDVIHTKKRLVLVFEHLDQ---DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           Y H     RV+HRDLK  N+L++ +   KI+DFG+AR F
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 26/195 (13%)
Query: 417 GHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKG- 475
           GH      IF +  T    ++ V+   K  D   + +          +G G FG V  G 
Sbjct: 1   GHMTPGMKIFIDPFTFEDPNEAVREFAKEIDISCVKIE-------QVIGAGEFGEVCSGH 53
Query: 476 -KLQDEQEI--AIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY 522
            KL  ++EI  AIK L S  + +   +F +EA ++ +  H N+             +++ 
Sbjct: 54  LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 113
Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL 582
           E++ N SLD F+  +  +  +   +   ++ GI  G+ YL   + +  +HRDL   NIL+
Sbjct: 114 EFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILV 168
Query: 583 DEQMNPKISDFGMAR 597
           +  +  K+SDFG++R
Sbjct: 169 NSNLVCKVSDFGLSR 183

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 20/186 (10%)
Query: 440 KRDLKIFDFQTIAVATDN-FSPANRLGQGGFGPVYKGKLQDE-QEIAIKRLSKSSGQGIV 497
           +R LK  D  ++    +  F    +LG+G +G VYK   ++  Q +AIK++   S   + 
Sbjct: 12  RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQ 69
Query: 498 EFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKR 548
           E   E  ++ +    ++           +  +V EY    S+   I    R   L   + 
Sbjct: 70  EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEI 127
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
            +I++   +GL YLH    +R IHRD+K  NILL+ + + K++DFG+A   T  +  A  
Sbjct: 128 ATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKR 182
Query: 609 NRIVGT 614
           N ++GT
Sbjct: 183 NXVIGT 188

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 15/146 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLV 521
            +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  L     +V
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 522 Y--------EYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
                    E++   SL DF   D   K  L   K       I +G+ ++ + +    IH
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 301
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDL+ +NIL+   +  KI+DFG+AR 
Sbjct: 302 RDLRAANILVSASLVCKIADFGLARV 327

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 31/180 (17%)
Query: 441 RDLKIFDFQTIAVATDNFSPANR--------LGQGGFGPVYKGKLQDEQE----IAIKRL 488
           RDL   D   +A   D   P  R        +G+G FG VY G+  D+ +     AIK L
Sbjct: 1   RDL---DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL 57
Query: 489 SK-SSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYEYLPNKSLDFFIFDS 537
           S+ +  Q +  F  E  L+  L H N+           G   ++  Y+ +  L  FI   
Sbjct: 58  SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP 117
Query: 538 SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            R   +  K   S    + +G+ YL   +  + +HRDL   N +LDE    K++DFG+AR
Sbjct: 118 QRNPTV--KDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 30/161 (18%)
Query: 464 LGQGGFGPVYKGKLQDE---QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN-----L 514
           +G+G FG V K +++ +    + AIKR+ + +S     +F  E +++ KL H       L
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 515 G-----GERLLVYEYLPNKSL-DF------------FIFDSSRKSLLDWKKRFSIIEGIT 556
           G     G   L  EY P+ +L DF            F   +S  S L  ++       + 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +G+ YL   S+ + IHRDL   NIL+ E    KI+DFG++R
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 30/161 (18%)
Query: 464 LGQGGFGPVYKGKLQDE---QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN-----L 514
           +G+G FG V K +++ +    + AIKR+ + +S     +F  E +++ KL H       L
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 515 G-----GERLLVYEYLPNKSL-DF------------FIFDSSRKSLLDWKKRFSIIEGIT 556
           G     G   L  EY P+ +L DF            F   +S  S L  ++       + 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +G+ YL   S+ + IHRDL   NIL+ E    KI+DFG++R
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 15/146 (10%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
              +G G FG V+ G   ++ ++AIK + +       +F  EA+++ KL H  L      
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   LV E++ +  L  ++   +++ L   +    +   + +G+ YL +     VI
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E    K+SDFGM R
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTR 152

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  + A L H N+       
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 127
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 26/159 (16%)
Query: 463 RLGQGGFGPVYKGKLQDE-QEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLGG-- 516
           ++GQG FG V+K + +   Q++A+K++   ++  G  I   + E K++  L+H N+    
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 517 --ERLLVYEYLPNKSLDFFIFDSSRKSL------------LDWKKRFSIIEGITQGLLYL 562
              R     Y   K+  + +FD     L            L   KR  +++ +  GL Y+
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
           H   R +++HRD+K +N+L+      K++DFG+AR F++
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 452 AVATDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQG-------IVEFKNEA 503
            +A +      ++G+GGFG V+KG+L +D+  +AIK L     +G         EF+ E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 504 KLIAKLQHTN-------LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGIT 556
            +++ L H N       +     +V E++P   L   + D +    + W  +  ++  I 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNIL---LDEQ--MNPKISDFGMAR 597
            G+ Y+   +   ++HRDL+  NI    LDE   +  K++DFG ++
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG----- 516
             LG G FG V  GK + + ++A+K + K       EF  EA+ + KL H  L       
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 517 ----ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
                  +V EY+ N  L  ++   S    L+  +   +   + +G+ +L  +   + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDL   N L+D  +  K+SDFGM R
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTR 152

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 26/173 (15%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVY--KGKLQDEQEIAIKRLSKSSGQGIVEFKN---EA 503
            + A+ +D +     LG+G FG V   K K+   QE A+K +SK   +   + ++   E 
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG-QECAVKVISKRQVKQKTDKESLLREV 77
Query: 504 KLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDS-SRKSLLDW---KKRFS------IIE 553
           +L+ +L H N+      +YE+  +K   + + +  +   L D    +KRFS      II 
Sbjct: 78  QLLKQLDHPNIXK----LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133
Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTFTMNE 603
            +  G+ Y HK    +++HRDLK  N+LL+ +    N +I DFG++  F  ++
Sbjct: 134 QVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 31/156 (19%)
Query: 464 LGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G FG V  G+L+     +  +AIK L    + +   +F  EA ++ +  H N+    
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIE------GITQGLLYLH 563
                G   ++V E++ N +LD F+    RK       +F++I+      GI  G+ YL 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL----RKH----DGQFTVIQLVGMLRGIAAGMRYL- 161
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
             + +  +HRDL   NIL++  +  K+SDFG++R  
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI 195

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 26/159 (16%)
Query: 463 RLGQGGFGPVYKGKLQDE-QEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLGG-- 516
           ++GQG FG V+K + +   Q++A+K++   ++  G  I   + E K++  L+H N+    
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 517 --ERLLVYEYLPNKSLDFFIFDSSRKSL------------LDWKKRFSIIEGITQGLLYL 562
              R     Y   K   + +FD     L            L   KR  +++ +  GL Y+
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
           H   R +++HRD+K +N+L+      K++DFG+AR F++
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS---------KSSGQGIVEFKNEAKLIA 507
           F+   ++G+G FG V+KG     Q++ AIK +              +  V  + ++  + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 508 KLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           K   + L   +L ++ EYL   S      D      LD  +  +I+  I +GL YLH   
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +   IHRD+K +N+LL E    K++DFG+A   T  +++ NT   VGT
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 187

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 40/197 (20%)
Query: 428 NRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDE---QEIA 484
           NRK +   D T+     + D+  I          + +G+G FG V K +++ +    + A
Sbjct: 4   NRKVKNNPDPTI---YPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAA 53
Query: 485 IKRLSK-SSGQGIVEFKNEAKLIAKLQHTN-----LG-----GERLLVYEYLPNKSL-DF 532
           IKR+ + +S     +F  E +++ KL H       LG     G   L  EY P+ +L DF
Sbjct: 54  IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 113
Query: 533 ------------FIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNI 580
                       F   +S  S L  ++       + +G+ YL   S+ + IHR+L   NI
Sbjct: 114 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNI 170
Query: 581 LLDEQMNPKISDFGMAR 597
           L+ E    KI+DFG++R
Sbjct: 171 LVGENYVAKIADFGLSR 187

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 26/159 (16%)
Query: 463 RLGQGGFGPVYKGKLQDE-QEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLGG-- 516
           ++GQG FG V+K + +   Q++A+K++   ++  G  I   + E K++  L+H N+    
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 82
Query: 517 --ERLLVYEYLPNKSLDFFIFDSSRKSL------------LDWKKRFSIIEGITQGLLYL 562
              R     Y   K   + +FD     L            L   KR  +++ +  GL Y+
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 140
Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
           H   R +++HRD+K +N+L+      K++DFG+AR F++
Sbjct: 141 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS---------KSSGQGIVEFKNEAKLIA 507
           F+   ++G+G FG V+KG     Q++ AIK +              +  V  + ++  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 508 KLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           K   + L   +L ++ EYL   S      D      LD  +  +I+  I +GL YLH   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +   IHRD+K +N+LL E    K++DFG+A   T  +++ NT   VGT
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 167

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 26/159 (16%)
Query: 463 RLGQGGFGPVYKGKLQDE-QEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLGG-- 516
           ++GQG FG V+K + +   Q++A+K++   ++  G  I   + E K++  L+H N+    
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 517 --ERLLVYEYLPNKSLDFFIFDSSRKSL------------LDWKKRFSIIEGITQGLLYL 562
              R     Y   K   + +FD     L            L   KR  +++ +  GL Y+
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
           H   R +++HRD+K +N+L+      K++DFG+AR F++
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 21/158 (13%)
Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSGQGIVEFKNEAKL--------IAK 508
           ++LG+G FG V   +     +     +A+K+L  S      +F+ E ++        I K
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 509 LQHTNLGGERL---LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
            +  + G  R    LV EYLP+  L  F+     ++ LD  +       I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG-- 128
Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           SR R +HRDL   NIL++ + + KI+DFG+A+   +++
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 165

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
           ++LG+G FG V   +     +     +A+K+L  S      +F+ E +++  L H++   
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 87
Query: 515 ---------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                    G + L LV EYLP+  L  F+     ++ LD  +       I +G+ YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL-- 143
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
               R +HRDL   NIL++ + + KI+DFG+A+   +++
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
           ++LG+G FG V   +     +     +A+K+L  S      +F+ E +++  L H++   
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 75
Query: 515 ---------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                    G + L LV EYLP+  L  F+     ++ LD  +       I +G+ YL  
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL-- 131
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
               R +HRDL   NIL++ + + KI+DFG+A+   +++
Sbjct: 132 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 169

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R ++ +          K 
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKM 130
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 40/171 (23%)
Query: 464 LGQGGFGPVYKGK------LQDEQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNL-- 514
           +G+G FG V++ +       +    +A+K L + +   +  +F+ EA L+A+  + N+  
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSL---------------------LDWK 546
                  G    L++EY+    L+ F+   S  ++                     L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 547 KRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           ++  I   +  G+ YL   S  + +HRDL   N L+ E M  KI+DFG++R
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
           ++LG+G FG V   +     +     +A+K+L  S      +F+ E +++  L H++   
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 74
Query: 515 ---------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                    G + L LV EYLP+  L  F+     ++ LD  +       I +G+ YL  
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL-- 130
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
               R +HRDL   NIL++ + + KI+DFG+A+   +++
Sbjct: 131 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 168

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R ++ +          K 
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKM 140
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 452 AVATDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQG-------IVEFKNEA 503
            +A +      ++G+GGFG V+KG+L +D+  +AIK L     +G         EF+ E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 504 KLIAKLQHTN-------LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGIT 556
            +++ L H N       +     +V E++P   L   + D +    + W  +  ++  I 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNIL---LDEQ--MNPKISDFGMAR 597
            G+ Y+   +   ++HRDL+  NI    LDE   +  K++DF +++
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 67  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 122
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 123 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 70  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 125
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 126 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 90  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 145
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 74  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 129
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 130 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 90  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 145
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 68  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 123
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 89  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 144
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 145 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 69  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 124
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 125 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 90  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 145
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 92  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 147
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 92  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 147
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 92  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 147
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 92  PFFVK---LYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE-IVSALEY 147
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 89  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 144
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 145 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 93  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 148
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAK 508
           V   ++   + LG G FG V  G+ Q    ++A+K L++    S   + + K E + +  
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 509 LQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
            +H ++           +  +V EY+    L  +I    R   ++ ++ F   + I   +
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAV 124
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
            Y H++    V+HRDLK  N+LLD  MN KI+DFG++   +  E 
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 93  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 148
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 95  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 150
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 151 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 92  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 147
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAK 508
           V   ++   + LG G FG V  G+ Q    ++A+K L++    S   + + K E + +  
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 509 LQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
            +H ++           +  +V EY+    L  +I    R   ++ ++ F   + I   +
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAV 124
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
            Y H++    V+HRDLK  N+LLD  MN KI+DFG++   +  E 
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 92  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 147
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDE-QEIAIKRLSKSSGQGIVE--FKNEAKLIAKLQHT 512
           + +    ++G+G +G V+K + +D  Q +AIK+  +S    +++     E +++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 513 NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGIT----QGLLYL 562
           NL      + E    K     +F+    ++L    R+       +++ IT    Q + + 
Sbjct: 63  NLVN----LLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           HK++    IHRD+K  NIL+ +    K+ DFG AR  T
Sbjct: 119 HKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 464 LGQGGFGPV-YKGKLQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLGGERL 519
           LG+G FG V      + +Q++A+K +S+         +  + E   +  L+H ++    +
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI----I 72
Query: 520 LVYEYLPNKSLDFFIFDSSRKSLLDW---KKRFSIIEG------ITQGLLYLHKYSRLRV 570
            +Y+ +   +    + + +   L D+   KKR +  EG      I   + Y H++   ++
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KI 129
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           +HRDLK  N+LLD+ +N KI+DFG++   T
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMT 159

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 127
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 73  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 125
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 127
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G  + L  EY     L   I         D ++ F     +  G++YLH    + + H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLMAGVVYLHG---IGITH 128
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G  + L  EY     L   I         D ++ F     +  G++YLH    + + H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLMAGVVYLHG---IGITH 128
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G  + L  EY     L   I         D ++ F     +  G++YLH    + + H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLMAGVVYLHG---IGITH 127
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G  + L  EY     L   I         D ++ F     +  G++YLH    + + H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLMAGVVYLHG---IGITH 128
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G  + L  EY     L   I         D ++ F     +  G++YLH    + + H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLMAGVVYLHG---IGITH 128
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGP-VYKGKLQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F   V   +L   +E AIK L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 90  PFFVK---LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 145
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 127
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK----------RFSIIEGITQGLLY 561
                   L + +  ++ L F +  +    LL + +          RF   E I   L Y
Sbjct: 97  PFFVK---LYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 152
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 153 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 37/195 (18%)
Query: 433 ARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKR 487
           A  +Q + R LK  + + + V          LG G FG VYKG    + E     +AIK 
Sbjct: 4   AAPNQALLRILKETELRKVKV----------LGSGAFGTVYKGIWIPDGENVKIPVAIKV 53
Query: 488 LSK-SSGQGIVEFKNEAKLIA--------KLQHTNLGGERLLVYEYLPNKSLDFFIFDS- 537
           L + +S +   E  +EA ++A        +L    L     LV + +P   L   + ++ 
Sbjct: 54  LRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENR 113
Query: 538 ---SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
                + LL+W  +      I +G+ YL     +R++HRDL   N+L+    + KI+DFG
Sbjct: 114 GRLGSQDLLNWCMQ------IAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFG 164
Query: 595 MARTFTMNELEANTN 609
           +AR   ++E E + +
Sbjct: 165 LARLLDIDETEYHAD 179

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 125
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 133
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 133
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 162
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 163 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 134
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 134
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 131
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 20/150 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE--FKNEAKLIAKLQHTNL------ 514
           +G+G +G V K + +D   I AIK+  +S    +V+     E KL+ +L+H NL      
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 515 ---GGERLLVYEYLPNKSLD-FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                   LV+E++ +  LD   +F +     +  K  F II GI  G  + H      +
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GFCHSHN-----I 145
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           IHRD+K  NIL+ +    K+ DFG ART  
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 127
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 22  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 78  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 133
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 140
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N ++ E    KI DFGM R
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+     +G+G F  V   + +   +E+AIK + K+  +   + +   E +++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 514 LGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---------KKRFSIIEGITQGLLYLH 563
           +    + ++E +  +   + I + +S   + D+         K+  S    I   + Y H
Sbjct: 76  I----VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
           +    R++HRDLK  N+LLD  MN KI+DFG +  FT+
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 22  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 78  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 135 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 43/176 (24%)
Query: 447 DFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKL 505
           DF+ IAV          LGQG FG V K +   D +  AIK++ + + + +    +E  L
Sbjct: 7   DFEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 506 IAKLQHTNL----------------------GGERLLVYEYLPNKSLDFFIFDSSRKSLL 543
           +A L H  +                           +  EY  N++L   I   +     
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 544 D--WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           D  W+    +   I + L Y+H      +IHRDLK  NI +DE  N KI DFG+A+
Sbjct: 116 DEYWR----LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 19/148 (12%)
Query: 464 LGQGGFGPVYKG--KLQDEQEI--AIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
           +G G FG V  G  KL  ++EI  AIK L S  + +   +F +EA ++ +  H N+    
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                    +++ E++ N SLD F+  +  +  +   +   ++ GI  G+ YL   + + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +HR L   NIL++  +  K+SDFG++R
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSR 157

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+       
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSL-LDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             G  + L  EY     L    FD     + +           +  G++YLH    + + 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 46  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 101
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 102 NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 159 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----GG 516
           ++LG G +G VY G  +     +A+K L + + + + EF  EA ++ +++H NL    G 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 517 ERL-----LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             L     +V EY+P  +L  ++ + +R+ +      +   + I+  + YL K +    I
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQ-ISSAMEYLEKKN---FI 152
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHA 189

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 38/60 (63%), Gaps = 3/60 (5%)
Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +  G++YLH    + + HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS---------KSSGQGIVEFKNEAKLIA 507
           F+   ++G+G FG V+KG     Q++ AIK +              +  V  + ++  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 508 KLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           K   + L   +L ++ EYL   S      D      LD  +  +I+  I +GL YLH   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +   IHRD+K +N+LL E    K++DFG+A   T  +++ N    VGT
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGT 167

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 46  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 101
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 102 NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 159 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 45  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 100
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 101 NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 158 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 32  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 88  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 143
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+     +G+G F  V   + +   +E+AIK + K+  +   + +   E +++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 514 LGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---------KKRFSIIEGITQGLLYLH 563
           +    + ++E +  +   + I + +S   + D+         K+  S    I   + Y H
Sbjct: 73  I----VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
           +    R++HRDLK  N+LLD  MN KI+DFG +  FT+
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 163

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 38/202 (18%)
Query: 426 FGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE--- 482
            G R  +A  +Q + R LK  +F+ I V          LG G FG VYKG    E E   
Sbjct: 3   MGIRSGEA-PNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVK 51
Query: 483 --IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLD 531
             +AIK L ++ S +   E  +EA ++A + + +        L     L+ + +P   L 
Sbjct: 52  IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLL 111
Query: 532 FFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN 587
            ++ +       + LL+W  +      I +G+ YL      R++HRDL   N+L+    +
Sbjct: 112 DYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 162
Query: 588 PKISDFGMARTFTMNELEANTN 609
            KI+DFG+A+     E E +  
Sbjct: 163 VKITDFGLAKLLGAEEKEYHAE 184

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LSK   Q I+  K    E +L+  ++H 
Sbjct: 38  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPF-QSIIHAKRTYRELRLLKHMKHE 93
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 94  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 151 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 33/161 (20%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 22  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 513 NLGGERLLVYEYLPNKSLDFF----------------IFDSSRKSLLDWKKRFSIIEGIT 556
           N+ G   L+  + P +SL+ F                I   ++  L D   +F +I  I 
Sbjct: 78  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK--LTDDHVQF-LIYQIL 131
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +GL Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 132 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 458 FSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLS---------KSSGQGIVEFKNEAKLIA 507
           F+   ++G+G FG V+KG     Q++ AIK +              +  V  + ++  + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 508 KLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           K   + L   +L ++ EYL   S      D      LD  +  +I+  I +GL YLH   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +   IHRD+K +N+LL E    K++DFG+A   T  +++   N  VGT
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNXFVGT 182

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 19/146 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLV 521
           LG+GGF   Y+    D +E+ A K + KS    +++   + K+  ++  H +L    ++ 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSM---LLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 522 YE-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRV 570
           +  +  +    + + +   R+SLL+  KR   +             QG+ YLH     RV
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMA 596
           IHRDLK+ N+ L++ M+ KI DFG+A
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 8   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI 117
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 118 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 169 LLGAEEKEYHAE 180

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 26/167 (15%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAK 504
           +TI    + +   + +G G +G V     ++   +IA+K+LS+   Q I+  K    E +
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRP-FQSIIHAKRTYRELR 102
Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFS 550
           L+  ++H N+ G   L+  + P  SL+ F  ++  +             + L D   +F 
Sbjct: 103 LLKHMKHENVIG---LLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF- 158
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +I  I +GL Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 19/146 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLV 521
           LG+GGF   Y+    D +E+ A K + KS    +++   + K+  ++  H +L    ++ 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSM---LLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 522 YE-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRV 570
           +  +  +    + + +   R+SLL+  KR   +             QG+ YLH     RV
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMA 596
           IHRDLK+ N+ L++ M+ KI DFG+A
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 5   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI 114
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 115 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 166 LLGAEEKEYHAE 177

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 19/146 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLV 521
           LG+GGF   Y+    D +E+ A K + KS    +++   + K+  ++  H +L    ++ 
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSM---LLKPHQKEKMSTEIAIHKSLDNPHVVG 90
Query: 522 YE-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRV 570
           +  +  +    + + +   R+SLL+  KR   +             QG+ YLH     RV
Sbjct: 91  FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 147
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMA 596
           IHRDLK+ N+ L++ M+ KI DFG+A
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 9   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 58
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 59  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI 118
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 119 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 169
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 170 LLGAEEKEYHAE 181

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 7   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI 116
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 117 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 167
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 168 LLGAEEKEYHAE 179

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 78/156 (50%), Gaps = 16/156 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             LG G FG V  GK + + ++AIK + + S     EF  EAK++  L H  L       
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 515 GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             +R   ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           RDL   N L+++Q   K+SDFG++R + +++ E ++
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSS 178

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 6   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 55
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 56  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI 115
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 116 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 166
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 167 LLGAEEKEYHAE 178

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 15/145 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             LG G FG V  GK + + ++AIK + + S     EF  EAK++  L H  L       
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 515 GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             +R   ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDL   N L+++Q   K+SDFG++R
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR 168

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 19/146 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLV 521
           LG+GGF   Y+    D +E+ A K + KS    +++   + K+  ++  H +L    ++ 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSM---LLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 522 YE-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRV 570
           +  +  +    + + +   R+SLL+  KR   +             QG+ YLH     RV
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMA 596
           IHRDLK+ N+ L++ M+ KI DFG+A
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 15/145 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             LG G FG V  GK + + ++AIK + K       EF  EAK++  L H  L       
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 515 GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             +R   ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDL   N L+++Q   K+SDFG++R
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSR 152

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 15/145 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             LG G FG V  GK + + ++AIK + K       EF  EAK++  L H  L       
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 515 GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             +R   ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDL   N L+++Q   K+SDFG++R
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSR 148

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 15/145 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             LG G FG V  GK + + ++AIK + K       EF  EAK++  L H  L       
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 515 GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             +R   ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDL   N L+++Q   K+SDFG++R
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 15/145 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             LG G FG V  GK + + ++AIK + K       EF  EAK++  L H  L       
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 515 GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             +R   ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDL   N L+++Q   K+SDFG++R
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 30/172 (17%)
Query: 465 GQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKL--IAKLQHTNL----GGER 518
            +G FG V+K +L +E  +A+K       Q    ++NE ++  +  ++H N+    G E+
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQS---WQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 519 ---------LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK----- 564
                     L+  +    SL  F+    + +++ W +   I E + +GL YLH+     
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 565 --YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
               +  + HRD+K  N+LL   +   I+DFG+A  F   +   +T+  VGT
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 15/145 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             LG G FG V  GK + + ++AIK + + S     EF  EAK++  L H  L       
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 515 GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             +R   ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDL   N L+++Q   K+SDFG++R
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSR 159

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 5   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 114
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 115 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 166 LLGAEEKEYHAE 177

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 8   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 117
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 118 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 169 LLGAEEKEYHAE 180

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 7   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 116
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 117 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 167
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 168 LLGAEEKEYHAE 179

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 8   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 117
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 118 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 169 LLGAEEKEYHAE 180

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 11  NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 60
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 61  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 120
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 121 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 171
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 172 LLGAEEKEYHAE 183

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 5   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 114
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 115 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 166 LLGAEEKEYHAE 177

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 17/145 (11%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLVY 522
           LG+GGF   ++    D +E+   ++   S   +++     K+  ++  H +L  + ++ +
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 523 E-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRVI 571
             +  +    F + +   R+SLL+  KR   +           I  G  YLH   R RVI
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 139
Query: 572 HRDLKVSNILLDEQMNPKISDFGMA 596
           HRDLK+ N+ L+E +  KI DFG+A
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 8   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 117
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 118 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 169 LLGAEEKEYHAE 180

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 15  NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 64
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 65  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 124
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 125 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 175
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 176 LLGAEEKEYHAE 187

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 80/183 (43%), Gaps = 32/183 (17%)
Query: 451 IAVATDNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSS------------GQGIV 497
           I +  ++F     LG+G FG V+  + +   Q  AIK L K               + ++
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 498 EFKNEAKLIAKLQHTNLGGERLL-VYEYLPNKSLDFFI-----FDSSRKSLLDWKKRFSI 551
               E   +  +  T    E L  V EYL    L + I     FD SR +       F  
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT-------FYA 125
Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRI 611
            E I  GL +LH      +++RDLK+ NILLD+  + KI+DFGM +   +   +A TN  
Sbjct: 126 AE-IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNEF 179
Query: 612 VGT 614
            GT
Sbjct: 180 CGT 182

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 6   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 55
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 56  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNI 115
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 116 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 166
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 167 LLGAEEKEYHAE 178

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 30/166 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 33  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHE 88
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 89  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 144
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR  T +E+
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM 186

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 17/145 (11%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLVY 522
           LG+GGF   ++    D +E+   ++   S   +++     K+  ++  H +L  + ++ +
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 523 E-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRVI 571
             +  +    F + +   R+SLL+  KR   +           I  G  YLH   R RVI
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 143
Query: 572 HRDLKVSNILLDEQMNPKISDFGMA 596
           HRDLK+ N+ L+E +  KI DFG+A
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N +P   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 36  NLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 91
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 92  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 147
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 148 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNL---- 514
             ++G+G FG V+ G+L+ D   +A+K   ++    +  +F  EA+++ +  H N+    
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 515 --GGERLLVYEYLP-NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
               ++  +Y  +   +  DF  F  +  + L  K    ++     G+ YL        I
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E+   KISDFGM+R
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 30/166 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 33  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 89  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 144
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR  T +E+
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM 186

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 17/145 (11%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLVY 522
           LG+GGF   ++    D +E+   ++   S   +++     K+  ++  H +L  + ++ +
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 523 E-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRVI 571
             +  +    F + +   R+SLL+  KR   +           I  G  YLH   R RVI
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 137
Query: 572 HRDLKVSNILLDEQMNPKISDFGMA 596
           HRDLK+ N+ L+E +  KI DFG+A
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNL---- 514
             ++G+G FG V+ G+L+ D   +A+K   ++    +  +F  EA+++ +  H N+    
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 515 --GGERLLVYEYLP-NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
               ++  +Y  +   +  DF  F  +  + L  K    ++     G+ YL        I
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E+   KISDFGM+R
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 30/166 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 33  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 89  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 144
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR  T +E+
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM 186

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 30  NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 79
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 80  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 139
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 140 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 190
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 191 LLGAEEKEYHAE 202

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 17/145 (11%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLVY 522
           LG+GGF   ++    D +E+   ++   S   +++     K+  ++  H +L  + ++ +
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 523 E-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRVI 571
             +  +    F + +   R+SLL+  KR   +           I  G  YLH   R RVI
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 139
Query: 572 HRDLKVSNILLDEQMNPKISDFGMA 596
           HRDLK+ N+ L+E +  KI DFG+A
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 20/172 (11%)
Query: 441 RDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFK 500
           R L   D   +      F     +G G +G VYKG+     ++A  ++   +G    E K
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 501 NEAKLIAKLQH----------------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLD 544
            E  ++ K  H                  +  +  LV E+    S+   I ++   +L +
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
               + I   I +GL +LH++   +VIHRD+K  N+LL E    K+ DFG++
Sbjct: 129 EWIAY-ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 31  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 87  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 142
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 22  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 78  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 135 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 17/145 (11%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLVY 522
           LG+GGF   ++    D +E+   ++   S   +++     K+  ++  H +L  + ++ +
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 523 E-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRVI 571
             +  +    F + +   R+SLL+  KR   +           I  G  YLH   R RVI
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 161
Query: 572 HRDLKVSNILLDEQMNPKISDFGMA 596
           HRDLK+ N+ L+E +  KI DFG+A
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKS--SGQGIV-EFKNE 502
           D  T     D+F     LG+G FG VY  + +    I A+K L KS    +G+  + + E
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 503 AKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLL----------DWKKRFSII 552
            ++ A L H N+    L +Y Y  ++   + I + + +  L          D ++  +I+
Sbjct: 74  IEIQAHLHHPNI----LRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM 129
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
           E +   L+Y H     +VIHRD+K  N+LL  +   KI+DFG
Sbjct: 130 EELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 28/169 (16%)
Query: 453 VATDNFSPANRLGQGGFGPVY----KGKLQDEQE--IAIKRLSKS-SGQGIVEFKNEAKL 505
           VA +  + +  LGQG FG VY    KG ++DE E  +AIK ++++ S +  +EF NEA +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD--------WKKR 548
           + +    ++         G   L++ E +    L  ++  S R  + +          K 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKM 127
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   I  G+ YL+     + +HRDL   N  + E    KI DFGM R
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 38  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 93
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 94  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 149
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 81/149 (54%), Gaps = 18/149 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNL----- 514
           ++G+G +G V+K K ++  EI A+KR+      +G+      E  L+ +L+H N+     
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 515 ---GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                ++L LV+E+  ++ L  + FDS    L D +   S +  + +GL + H  +   V
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTF 599
           +HRDLK  N+L++     K++DFG+AR F
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAF 151

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 26/165 (15%)
Query: 455 TDNFSPANRLGQGGFGPVY--KGKLQDEQEIAIKRLSKSSGQGIV---EFKNEAKLIAKL 509
           +D +    +LG G +G V   K KL    E AIK + KSS           +E  ++ +L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTG-AERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSSRK-SLLD---WKKRFS------IIEGITQGL 559
            H N+    + +YE+  +K   + + +  R   L D    +++FS      I++ +  G 
Sbjct: 62  DHPNI----MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGT 117
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNP---KISDFGMARTFTM 601
            YLHK++   ++HRDLK  N+LL+ +      KI DFG++  F +
Sbjct: 118 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV 159

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 38  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 93
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 94  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 149
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 33  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 89  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 144
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 23  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 78
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 79  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 136 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 45  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 100
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 101 NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 158 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 23  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 78
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 79  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 136 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 32  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 88  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 145 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 17/145 (11%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLLVY 522
           LG+GGF   ++    D +E+   ++   S   +++     K+  ++  H +L  + ++ +
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 523 E-YLPNKSLDFFIFD-SSRKSLLDWKKRFSII---------EGITQGLLYLHKYSRLRVI 571
             +  +    F + +   R+SLL+  KR   +           I  G  YLH   R RVI
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 163
Query: 572 HRDLKVSNILLDEQMNPKISDFGMA 596
           HRDLK+ N+ L+E +  KI DFG+A
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 31  NLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 87  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 142
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 28  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 84  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 139
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 24  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 79
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 80  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 137 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 31  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 87  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 142
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 25  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 80
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 81  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 136
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 137 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 26/165 (15%)
Query: 455 TDNFSPANRLGQGGFGPVY--KGKLQDEQEIAIKRLSKSSGQGIV---EFKNEAKLIAKL 509
           +D +    +LG G +G V   K KL    E AIK + KSS           +E  ++ +L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTG-AERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSSRK-SLLD---WKKRFS------IIEGITQGL 559
            H N+    + +YE+  +K   + + +  R   L D    +++FS      I++ +  G 
Sbjct: 79  DHPNI----MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGT 134
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNP---KISDFGMARTFTM 601
            YLHK++   ++HRDLK  N+LL+ +      KI DFG++  F +
Sbjct: 135 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV 176

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 37  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 92
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 93  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 150 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 5   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNI 114
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 115 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 166 LLGAEEKEYHAE 177

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 49  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 104
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 105 NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 162 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 75/181 (41%), Gaps = 45/181 (24%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
           +F     +G GGFG V+K K + D +   I+R+  ++ +     + E K +AKL H N+ 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIV 68
Query: 515 ---------------GGERLLVYEYLPNKSLD--------FFI-------------FDSS 538
                            + L   +Y P  S +         FI              +  
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 539 RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
           R   LD      + E IT+G+ Y+H     ++IHRDLK SNI L +    KI DFG+  +
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 599 F 599
Sbjct: 186 L 186

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFK-NEAKLIAKLQH 511
           ++  F    +LG G +  VYKG  +     +A+K +   S +G       E  L+ +L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 512 TNLGGERLLVYEYLPNK-SLDFFIFDSSRKSLLDWKKRFSIIEGIT------------QG 558
            N+   RL    +  NK +L F   D+  K  +D +   +   G+             QG
Sbjct: 63  ENI--VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           L + H+    +++HRDLK  N+L++++   K+ DFG+AR F
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 81/173 (46%), Gaps = 26/173 (15%)
Query: 462 NRLGQGGFGPVYKGKLQDE-QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL----- 514
            RLG GGFG V +   QD  +++AIK+  +  S +    +  E +++ KL H N+     
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG--------ITQGLLYLHK 564
              G + L    LP  ++++      RK L  ++    + EG        I+  L YLH+
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 565 YSRLRVIHRDLKVSNILLD---EQMNPKISDFGMARTFTMNELEANTNRIVGT 614
               R+IHRDLK  NI+L    +++  KI D G A+     EL       VGT
Sbjct: 141 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGT 187

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 46  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 101
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 102 NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 159 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 28  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 84  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 139
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+KL H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 88  ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 28  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 84  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 141 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 81/173 (46%), Gaps = 26/173 (15%)
Query: 462 NRLGQGGFGPVYKGKLQDE-QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL----- 514
            RLG GGFG V +   QD  +++AIK+  +  S +    +  E +++ KL H N+     
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG--------ITQGLLYLHK 564
              G + L    LP  ++++      RK L  ++    + EG        I+  L YLH+
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 565 YSRLRVIHRDLKVSNILLD---EQMNPKISDFGMARTFTMNELEANTNRIVGT 614
               R+IHRDLK  NI+L    +++  KI D G A+     EL       VGT
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGT 186

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 26/178 (14%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRL---SKSSGQGIVEFKNEAKL 505
           +  + +   ++LG GG   VY   L ++     ++AIK +    +   + +  F+ E   
Sbjct: 8   IINERYKIVDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 506 IAKLQHTNLGGE---------RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGIT 556
            ++L H N+              LV EY+   +L  +I +S     +D    F+    I 
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFT--NQIL 121
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            G+ + H    +R++HRD+K  NIL+D     KI DFG+A+  +   L   TN ++GT
Sbjct: 122 DGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGT 175

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 32  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 88  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 143
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 37  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 92
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 93  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 150 KYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 49  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 104
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 105 NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 160
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 74/176 (42%), Gaps = 43/176 (24%)
Query: 447 DFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKL 505
           DF+ IAV          LGQG FG V K +   D +  AIK++ + + + +    +E  L
Sbjct: 7   DFEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXL 55
Query: 506 IAKLQHTNL----------------------GGERLLVYEYLPNKSLDFFIFDSSRKSLL 543
           +A L H  +                           +  EY  N++L   I   +     
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR 115
Query: 544 D--WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           D  W+    +   I + L Y+H      +IHR+LK  NI +DE  N KI DFG+A+
Sbjct: 116 DEYWR----LFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 31  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 87  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 142
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+KL H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 102 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 56/110 (50%), Gaps = 8/110 (7%)
Query: 490 KSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSL-----DFFIFDSSRKSLLD 544
           K+  Q I + KNE  L  +   TN   E  ++YEY+ N S+      FF+ D +    + 
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            +    II+ +     Y+H  +   + HRD+K SNIL+D+    K+SDFG
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFG 197

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKS------------SGQGIVEF 499
           +  DNF     LG+G FG V   ++++  ++ A+K L K             + + I+  
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 500 KNEAKLIAKLQHTNLGGERLL-VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
                 + +L       +RL  V E++    L F I  S R    + + RF   E I   
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAE-IISA 136
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           L++LH      +I+RDLK+ N+LLD + + K++DFGM +    N +   T
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 38/202 (18%)
Query: 426 FGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE--- 482
            G R  +A  +Q + R LK  +F+ I V          LG G FG VYKG    E E   
Sbjct: 3   MGIRSGEA-PNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVK 51
Query: 483 --IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLD 531
             +AIK L ++ S +   E  +EA ++A + + +        L     L+ + +P   L 
Sbjct: 52  IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLL 111
Query: 532 FFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN 587
            ++ +       + LL+W  +      I +G+ YL      R++HRDL   N+L+    +
Sbjct: 112 DYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 162
Query: 588 PKISDFGMARTFTMNELEANTN 609
            KI+DFG A+     E E +  
Sbjct: 163 VKITDFGRAKLLGAEEKEYHAE 184

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 82/175 (46%), Gaps = 24/175 (13%)
Query: 432 QARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAI-KRLSK 490
           ++R  + V+RDL   +   I            LG G FG VYK K ++   +A  K +  
Sbjct: 4   KSREYEHVRRDLDPNEVWEIV---------GELGDGAFGKVYKAKNKETGALAAAKVIET 54
Query: 491 SSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKS 541
            S + + ++  E +++A   H  +          G+  ++ E+ P  ++D  + +  R  
Sbjct: 55  KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG- 113
Query: 542 LLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
            L   +   +   + + L +LH     R+IHRDLK  N+L+  + + +++DFG++
Sbjct: 114 -LTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 73/176 (41%), Gaps = 43/176 (24%)
Query: 447 DFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKL 505
           DF+ IAV          LGQG FG V K +   D +  AIK++ + + + +    +E  L
Sbjct: 7   DFEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 506 IAKLQHTNL----------------------GGERLLVYEYLPNKSLDFFIFDSSRKSLL 543
           +A L H  +                           +  EY  N +L   I   +     
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 544 D--WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           D  W+    +   I + L Y+H      +IHRDLK  NI +DE  N KI DFG+A+
Sbjct: 116 DEYWR----LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 32  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 88  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 143
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 28  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 84  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 139
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DFG+AR
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 7   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI 116
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG A+
Sbjct: 117 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 168 LLGAEEKEYHAE 179

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 463 RLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           ++GQG  G VY    +   QE+AI++++           NE  ++ + ++ N+       
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G E  +V EYL   SL     D   ++ +D  +  ++     Q L +LH     +VIH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  NILL    + K++DFG     T  + + +T  +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 9   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 58
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 59  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI 118
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG A+
Sbjct: 119 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 169
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 170 LLGAEEKEYHAE 181

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 19/163 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+     +G+G F  V   + +   +E+A+K + K+  +   + +   E +++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +              LV EY     +  ++    R    + + +F  I    Q   Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM-NELEA 606
                ++HRDLK  N+LLD  MN KI+DFG +  FT  N+L+A
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA 171

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 80/183 (43%), Gaps = 32/183 (17%)
Query: 451 IAVATDNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSS------------GQGIV 497
           I +  ++F     LG+G FG V+  + +   Q  AIK L K               + ++
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 498 EFKNEAKLIAKLQHTNLGGERLL-VYEYLPNKSLDFFI-----FDSSRKSLLDWKKRFSI 551
               E   +  +  T    E L  V EYL    L + I     FD SR +       F  
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT-------FYA 124
Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRI 611
            E I  GL +LH      +++RDLK+ NILLD+  + KI+DFGM +   +   +A TN  
Sbjct: 125 AE-IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNXF 178
Query: 612 VGT 614
            GT
Sbjct: 179 CGT 181

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 24/165 (14%)
Query: 452 AVATDNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLS-KSSGQGIVEFK-NEAKLIAK 508
           A + D +    +LG+G +G VYK       + +AIKR+  +   +G+      E  L+ +
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 509 LQHTNL--------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           LQH N+           RL L++EY  N  L  ++  +   S+   K   S +  +  G+
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK---SFLYQLINGV 145
Query: 560 LYLHKYSRLRVIHRDLKVSNILL---DEQMNP--KISDFGMARTF 599
            + H  SR R +HRDLK  N+LL   D    P  KI DFG+AR F
Sbjct: 146 NFCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 7   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNI 116
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG A+
Sbjct: 117 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 168 LLGAEEKEYHAE 179

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 34/169 (20%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
           +F     +G GGFG V+K K + D +   IKR+  ++ +     + E K +AKL H N+ 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIV 67
Query: 515 ------------------GGER------LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS 550
                                R       +  E+    +L+ +I +  R   LD      
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           + E IT+G+ Y+H     ++I+RDLK SNI L +    KI DFG+  + 
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 38/202 (18%)
Query: 426 FGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE--- 482
            G R  +A  +Q + R LK  +F+ I V          L  G FG VYKG    E E   
Sbjct: 3   MGIRSGEA-PNQALLRILKETEFKKIKV----------LSSGAFGTVYKGLWIPEGEKVK 51
Query: 483 --IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLD 531
             +AIK L ++ S +   E  +EA ++A + + +        L     L+ + +P   L 
Sbjct: 52  IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLL 111
Query: 532 FFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN 587
            ++ +       + LL+W  +      I +G+ YL      R++HRDL   N+L+    +
Sbjct: 112 DYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 162
Query: 588 PKISDFGMARTFTMNELEANTN 609
            KI+DFG+A+     E E +  
Sbjct: 163 VKITDFGLAKLLGAEEKEYHAE 184

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAI-KRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
            LG G FG VYK K ++   +A  K +   S + + ++  E +++A   H  +       
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
              G+  ++ E+ P  ++D  + +  R   L   +   +   + + L +LH     R+IH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RDLK  N+L+  + + +++DFG++
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 27/171 (15%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQ 510
            F     LG G FG VYKG    E E     +AIK L ++ S +   E  +EA ++A + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 511 HTN--------LGGERLLVYEYLPNKSLDFFIFDSS----RKSLLDWKKRFSIIEGITQG 558
           + +        L     L+ + +P   L  ++ +       + LL+W  +      I +G
Sbjct: 73  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAEG 126
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           + YL      R++HRDL   N+L+    + KI+DFG+A+     E E +  
Sbjct: 127 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 21/153 (13%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKS--SGQGIV-EFKNEAKLIAKLQH 511
           D+F     LG+G FG VY  + +  + I A+K L KS    +G+  + + E ++ + L+H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLL----------DWKKRFSIIEGITQGLLY 561
            N+    L +Y Y  ++   + + + + +  L          D ++  + +E +   L Y
Sbjct: 75  PNI----LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY 130
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            H+    +VIHRD+K  N+L+  +   KI+DFG
Sbjct: 131 CHER---KVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 7   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 116
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG A+
Sbjct: 117 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 168 LLGAEEKEYHAE 179

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKN 501
           LK   F       D +     +G G +G V   + +   Q++AIK++  ++   +   K 
Sbjct: 41  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKR 99
Query: 502 ---EAKLIAKLQHTNL------------GGERLLVYEYLPNKSLDFF-IFDSSRKSLLDW 545
              E K++   +H N+             GE   VY  L     D   I  SS+   L+ 
Sbjct: 100 TLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 159
Query: 546 KKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
            + F  +  + +GL Y+H     +VIHRDLK SN+L++E    KI DFGMAR    +  E
Sbjct: 160 VRYF--LYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 214

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKN 501
           LK   F       D +     +G G +G V   + +   Q++AIK++  ++   +   K 
Sbjct: 42  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKR 100
Query: 502 ---EAKLIAKLQHTNL------------GGERLLVYEYLPNKSLDFF-IFDSSRKSLLDW 545
              E K++   +H N+             GE   VY  L     D   I  SS+   L+ 
Sbjct: 101 TLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 160
Query: 546 KKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
            + F  +  + +GL Y+H     +VIHRDLK SN+L++E    KI DFGMAR    +  E
Sbjct: 161 VRYF--LYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 463 RLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           ++GQG  G VY    +   QE+AI++++           NE  ++ + ++ N+       
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G E  +V EYL   SL     D   ++ +D  +  ++     Q L +LH     +VIH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  NILL    + K++DFG     T    ++  + +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSEMVGT 179

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 21/153 (13%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKS--SGQGIV-EFKNEAKLIAKLQH 511
           D+F     LG+G FG VY  + +  + I A+K L KS    +G+  + + E ++ + L+H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLL----------DWKKRFSIIEGITQGLLY 561
            N+    L +Y Y  ++   + + + + +  L          D ++  + +E +   L Y
Sbjct: 74  PNI----LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY 129
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            H+    +VIHRD+K  N+L+  +   KI+DFG
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 177 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AIK L +
Sbjct: 5   NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 114
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG A+
Sbjct: 115 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 165
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 166 LLGAEEKEYHAE 177

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 147
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 148 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 179 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 181 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 27/171 (15%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQ 510
            F     LG G FG VYKG    E E     +AIK L ++ S +   E  +EA ++A + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 511 HTN--------LGGERLLVYEYLPNKSLDFFIFDSS----RKSLLDWKKRFSIIEGITQG 558
           + +        L     L+ + +P   L  ++ +       + LL+W  +      I +G
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 123
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           + YL      R++HRDL   N+L+    + KI+DFG+A+     E E +  
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI D+G+AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 38/202 (18%)
Query: 426 FGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE--- 482
            G R  +A  +Q + R LK  +F+ I V          L  G FG VYKG    E E   
Sbjct: 3   MGIRSGEA-PNQALLRILKETEFKKIKV----------LSSGAFGTVYKGLWIPEGEKVK 51
Query: 483 --IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLD 531
             +AIK L ++ S +   E  +EA ++A + + +        L     L+ + +P   L 
Sbjct: 52  IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLL 111
Query: 532 FFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN 587
            ++ +       + LL+W  +      I +G+ YL      R++HRDL   N+L+    +
Sbjct: 112 DYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 162
Query: 588 PKISDFGMARTFTMNELEANTN 609
            KI+DFG+A+     E E +  
Sbjct: 163 VKITDFGLAKLLGAEEKEYHAE 184

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 170
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 171 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 77/180 (42%), Gaps = 23/180 (12%)
Query: 441 RDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRL----------- 488
           RD   F  QT+ +          L +GGF  VY+ + +   +E A+KRL           
Sbjct: 13  RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI 72
Query: 489 -------SKSSGQ-GIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRK 540
                   K SG   IV+F + A  I K +      E LL+ E    + ++F     SR 
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAAS-IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131
Query: 541 SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            L        I     + + ++H+  +  +IHRDLKV N+LL  Q   K+ DFG A T +
Sbjct: 132 PL-SCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSSRK----------SLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + + +          S  D ++  + I  +   L
Sbjct: 71  RHPNI----LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 177 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 155 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 19  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 78
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 79  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 138
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 139 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 150
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 151 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 185

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 463 RLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           ++GQG  G VY    +   QE+AI++++           NE  ++ + ++ N+       
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G E  +V EYL   SL     D   ++ +D  +  ++     Q L +LH     +VIH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  NILL    + K++DFG     T    ++  + +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSXMVGT 179

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 463 RLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           ++GQG  G VY    +   QE+AI++++           NE  ++ + ++ N+       
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
             G E  +V EYL   SL     D   ++ +D  +  ++     Q L +LH     +VIH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 573 RDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           RD+K  NILL    + K++DFG     T    ++  + +VGT
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSXMVGT 180

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 161
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 162 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 196

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 222 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 44  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 103
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 104 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 163
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 164 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 33/161 (20%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF----------------IFDSSRKSLLDWKKRFSIIEGIT 556
           N+ G   L+  + P +SL+ F                I  S +  L D   +F +I  I 
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK--LTDDHVQF-LIYQIL 135
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +GL Y+H      +IHRDLK SN+ ++E    KI DFG+ R
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 34/156 (21%)
Query: 464 LGQGGFGPV---YKGKLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLGGE 517
           +G G +G V   Y  +L+  Q++A+K+LS+   Q ++  +    E +L+  L+H N+ G 
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPF-QSLIHARRTYRELRLLKHLKHENVIG- 91
Query: 518 RLLVYEYLPNKSLDFF----------------IFDSSRKSLLDWKKRFSIIEGITQGLLY 561
             L+  + P  S++ F                I  S  ++L D   +F ++  + +GL Y
Sbjct: 92  --LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS--QALSDEHVQF-LVYQLLRGLKY 146
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +H      +IHRDLK SN+ ++E    +I DFG+AR
Sbjct: 147 IHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 21/190 (11%)
Query: 435 SDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSG 493
           SD+ +   L+I    ++      ++   ++GQG  G VY    +   QE+AI++++    
Sbjct: 2   SDEEILEKLRII--VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 59
Query: 494 QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD 544
                  NE  ++ + ++ N+         G E  +V EYL   SL     D   ++ +D
Sbjct: 60  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD 115
Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
             +  ++     Q L +LH     +VIHR++K  NILL    + K++DFG     T  + 
Sbjct: 116 EGQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQS 172
Query: 605 EANTNRIVGT 614
           + +T  +VGT
Sbjct: 173 KRST--MVGT 180

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 69  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 63  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 118
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 119 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 150

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 70  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 157

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 34  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 93
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 94  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 153
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 154 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 155 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 45  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 104
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 105 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 164
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 165 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 66  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 155
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 156 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 190

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 188 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 71  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 143
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 144 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 178

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 71  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 69  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 69  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 66  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 67  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL------- 514
           +G G FG VY+ KL D  E +AIK++ +        FKN E +++ KL H N+       
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 515 --GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
              GE+       LV +Y+P          S  K  L        +  + + L Y+H + 
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 146
Query: 567 RLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
              + HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 147 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 181

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 67  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 66  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 81/154 (52%), Gaps = 30/154 (19%)
Query: 464 LGQGGFGPV---YKGKLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLGGE 517
           +G G +G V   Y  +L+  Q++A+K+LS+   Q ++  +    E +L+  L+H N+ G 
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPF-QSLIHARRTYRELRLLKHLKHENVIG- 83
Query: 518 RLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQGLLYLH 563
             L+  + P  S++ F  ++  +             ++L D   +F ++  + +GL Y+H
Sbjct: 84  --LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 140
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                 +IHRDLK SN+ ++E    +I DFG+AR
Sbjct: 141 SAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 81/149 (54%), Gaps = 18/149 (12%)
Query: 463 RLGQGGFGPVYKGKLQDEQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNL----- 514
           ++G+G +G V+K K ++  EI A+KR+      +G+      E  L+ +L+H N+     
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 515 ---GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                ++L LV+E+  ++ L  + FDS    L D +   S +  + +GL + H  +   V
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTF 599
           +HRDLK  N+L++     K+++FG+AR F
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAF 151

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 54  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 113
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 114 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 173
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 174 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSSRK----------SLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + + +          S  D ++  + I  +   L
Sbjct: 71  RHPNI----LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 67  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 65  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 121 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 152

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 66  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNE 502
           L + D++ I V          +G+G FG V K K +  +++AIK++   S +    F  E
Sbjct: 3   LHMIDYKEIEVE-------EVVGRGAFGVVCKAKWR-AKDVAIKQIESESERK--AFIVE 52
Query: 503 AKLIAKLQHTN---LGGERL----LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGI 555
            + ++++ H N   L G  L    LV EY    SL   +  +            S     
Sbjct: 53  LRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 112
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP-KISDFGMA 596
           +QG+ YLH      +IHRDLK  N+LL       KI DFG A
Sbjct: 113 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 66  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 66  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          LG G FG VYKG    E E     +AI  L +
Sbjct: 39  NQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIMELRE 88
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 89  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 148
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 149 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 199
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 200 LLGAEEKEYHAE 211

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 66  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 71  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 26/171 (15%)
Query: 450 TIAVATD------NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFK 500
           +I  ATD      N+     +G+G F  V   + +   +E+A+K + K+  +   + +  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 501 NEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSI 551
            E +++  L H N+              LV EY     +  ++    R    + + +F  
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 552 IEGITQGLLYLH-KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
           I    Q   Y H KY    ++HRDLK  N+LLD  MN KI+DFG +  FT+
Sbjct: 123 IVSAVQ---YCHQKY----IVHRDLKAENLLLDGDMNIKIADFGFSNEFTV 166

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 69  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 68  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 69  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 83  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 139 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 170

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNE 502
           L + D++ I V          +G+G FG V K K +  +++AIK++   S +    F  E
Sbjct: 2   LHMIDYKEIEVE-------EVVGRGAFGVVCKAKWR-AKDVAIKQIESESERK--AFIVE 51
Query: 503 AKLIAKLQHTN---LGGERL----LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGI 555
            + ++++ H N   L G  L    LV EY    SL   +  +            S     
Sbjct: 52  LRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP-KISDFGMA 596
           +QG+ YLH      +IHRDLK  N+LL       KI DFG A
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 37/192 (19%)
Query: 436 DQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK 490
           +Q + R LK  +F+ I V          L  G FG VYKG    E E     +AIK L +
Sbjct: 5   NQALLRILKETEFKKIKV----------LSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 491 S-SGQGIVEFKNEAKLIAKLQHTN--------LGGERLLVYEYLPNKSLDFFIFDSS--- 538
           + S +   E  +EA ++A + + +        L     L+ + +P   L  ++ +     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI 114
Query: 539 -RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + LL+W  +      I +G+ YL      R++HRDL   N+L+    + KI+DFG+A+
Sbjct: 115 GSQYLLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 598 TFTMNELEANTN 609
                E E +  
Sbjct: 166 LLGAEEKEYHAE 177

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+     +G+G F  V   + +   +E+A+K + K+  +   + +   E +++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +              LV EY     +  ++    R    + + +F  I    Q   Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
                ++HRDLK  N+LLD  MN KI+DFG +  FT
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI DF +AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+     +G+G F  V   + +   +E+A+K + K+  +   + +   E +++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +              LV EY     +  ++    R    + + +F  I    Q   Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
                ++HRDLK  N+LLD  MN KI+DFG +  FT
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSG-QGIVEFKNEAKL 505
           V+ +  +    LGQG FG VY+G  +D      E  +A+K +++S+  +  +EF NEA +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFI-------FDSSRKSLLDWKKRF 549
           +      ++         G   L+V E + +  L  ++        ++  +     ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HRDL   N ++      KI DFGM R
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 92  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 148 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 23/163 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 510
           +D +     LG GG   V+  + L+D +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 511 H-------------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           H             T  G    +V EY+   +L   +     +  +  K+   +I    Q
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            L + H+     +IHRD+K +NIL+      K+ DFG+AR   
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIA 167

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 92  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 148 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 81/154 (52%), Gaps = 30/154 (19%)
Query: 464 LGQGGFGPV---YKGKLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLGGE 517
           +G G +G V   Y  +L+  Q++A+K+LS+   Q ++  +    E +L+  L+H N+ G 
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPF-QSLIHARRTYRELRLLKHLKHENVIG- 91
Query: 518 RLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQGLLYLH 563
             L+  + P  S++ F  ++  +             ++L D   +F ++  + +GL Y+H
Sbjct: 92  --LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                 +IHRDLK SN+ ++E    +I DFG+AR
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSG-QGIVEFKNEAKL 505
           V+ +  +    LGQG FG VY+G  +D      E  +A+K +++S+  +  +EF NEA +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFI-------FDSSRKSLLDWKKRF 549
           +      ++         G   L+V E + +  L  ++        ++  +     ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HRDL   N ++      KI DFGM R
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKS-SGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALI 101
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMAR
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSG-QGIVEFKNEAKL 505
           V+ +  +    LGQG FG VY+G  +D      E  +A+K +++S+  +  +EF NEA +
Sbjct: 13  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIF-------DSSRKSLLDWKKRF 549
           +      ++         G   L+V E + +  L  ++        ++  +     ++  
Sbjct: 73  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 132
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HRDL   N ++      KI DFGM R
Sbjct: 133 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSG-QGIVEFKNEAKL 505
           V+ +  +    LGQG FG VY+G  +D      E  +A+K +++S+  +  +EF NEA +
Sbjct: 11  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 70
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIF-------DSSRKSLLDWKKRF 549
           +      ++         G   L+V E + +  L  ++        ++  +     ++  
Sbjct: 71  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 130
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HRDL   N ++      KI DFGM R
Sbjct: 131 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSG-QGIVEFKNEAKL 505
           V+ +  +    LGQG FG VY+G  +D      E  +A+K +++S+  +  +EF NEA +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIF-------DSSRKSLLDWKKRF 549
           +      ++         G   L+V E + +  L  ++        ++  +     ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HRDL   N ++      KI DFGM R
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSG-QGIVEFKNEAKL 505
           V+ +  +    LGQG FG VY+G  +D      E  +A+K +++S+  +  +EF NEA +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFI-------FDSSRKSLLDWKKRF 549
           +      ++         G   L+V E + +  L  ++        ++  +     ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HRDL   N ++      KI DFGM R
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 79  CVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 79  VVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + ++ + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 66  RHPNI----LRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     +VIHRD+K  N+LL      KI+DFG
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 79  VVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN-------- 501
           T+     N  P     QG     Y   L  E+ +AIK+LS+        F+N        
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 502 -EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKR 548
            E  L+  + H N+ G   L+  + P KSL+ F        + D++   +    LD ++ 
Sbjct: 72  RELVLMKCVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             ++  +  G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 79  CVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN-------- 501
           T+     N  P     QG     Y   L  E+ +AIK+LS+        F+N        
Sbjct: 26  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 76
Query: 502 -EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKR 548
            E  L+  + H N+ G   L+  + P KSL+ F        + D++   +    LD ++ 
Sbjct: 77  RELVLMKCVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 133
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             ++  +  G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 134 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 180

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 79  VVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN-------- 501
           T+     N  P     QG     Y   L  E+ +AIK+LS+        F+N        
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 502 -EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKR 548
            E  L+  + H N+ G   L+  + P KSL+ F        + D++   +    LD ++ 
Sbjct: 72  RELVLMKCVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             ++  +  G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKLQH 511
           ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGLLY 561
            N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L Y
Sbjct: 72  PNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 75/157 (47%), Gaps = 20/157 (12%)
Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+     +G+G F  V   + +   +E+A+K + K+  +   + +   E +++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 514 LGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---------KKRFSIIEGITQGLLYLH 563
           +    + ++E +  +   + + + +S   + D+         K+  +    I   + Y H
Sbjct: 68  I----VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH 123
Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           +     ++HRDLK  N+LLD  MN KI+DFG +  FT
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 157

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 79  CVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 22  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 72
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 73  CVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 169

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 79  CVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKLQH 511
           ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGLLY 561
            N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L Y
Sbjct: 72  PNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            H     RVIHRD+K  N+LL      KI+DFG
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 29  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 79
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 80  CVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 30  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 80
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 81  CVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 137
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 138 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 177

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI  FG+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+     +G+G F  V   + +   +E+A++ + K+  +   + +   E +++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +              LV EY     +  ++    R    + + +F  I    Q   Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
                ++HRDLK  N+LLD  MN KI+DFG +  FT
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 23/163 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 510
           +D +     LG GG   V+  + L+D +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 511 H-------------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           H             T  G    +V EY+   +L   +     +  +  K+   +I    Q
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            L + H+     +IHRD+K +NI++      K+ DFG+AR   
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 79  CVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI D G+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  E+ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVVAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+ G   L+  + P KSL+ F        + D++   +    LD ++   ++  +
Sbjct: 79  VVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART 175

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSK-SSGQGIVEFKNEAKL 505
           V   N +    LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSII 552
           I+K  H N+            R ++ E +    L  F+ ++    S+ S L       + 
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
             I  G  YL +      IHRD+   N LL         KI DFGMA+
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 23/163 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 510
           +D +     LG GG   V+  + L+D +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 511 H-------------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           H             T  G    +V EY+   +L   +     +  +  K+   +I    Q
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            L + H+     +IHRD+K +NI++      K+ DFG+AR   
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 19/157 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTN 513
           D++     +G G    V       ++E +AIKR++    Q  + E   E + +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 514 L---------GGERLLVYEYLPNKS----LDFFIFDSSRKS-LLDWKKRFSIIEGITQGL 559
           +           E  LV + L   S    +   +     KS +LD     +I+  + +GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
            YLHK  +   IHRD+K  NILL E  + +I+DFG++
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 163

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+     +G+G F  V   + +   +E+A++ + K+  +   + +   E +++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +              LV EY     +  ++    R    + + +F  I    Q   Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
                ++HRDLK  N+LLD  MN KI+DFG +  FT
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 17/158 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLL 520
           ++LG G FG VY+G  +     +A+K L + + + + EF  EA ++ +++H NL   +LL
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV--QLL 73
Query: 521 VYEYLPNKSLDFFIFDS--SRKSLLDWKKRFSIIEGITQGLLY--------LHKYSRLRV 570
               +  +   F+I     +  +LLD+ +  +  E     LLY        +    +   
Sbjct: 74  G---VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           IHRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 168

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 70  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 124
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 125 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 70  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 124
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 125 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 19/157 (12%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTN 513
           D++     +G G    V       ++E +AIKR++    Q  + E   E + +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 514 L---------GGERLLVYEYLPNKS----LDFFIFDSSRKS-LLDWKKRFSIIEGITQGL 559
           +           E  LV + L   S    +   +     KS +LD     +I+  + +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
            YLHK  +   IHRD+K  NILL E  + +I+DFG++
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 168

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKL 505
           FQ+++V    +S   ++G GG   V++   + +Q  AIK   L ++  Q +  ++NE   
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 506 IAKLQHTNLGGERLLVYE--------YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           + KLQ  +    RL  YE         +   ++D   +   +KS+  W+++ S  + + +
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLE 138
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
            +  +H++    ++H DLK +N L+ + M  K+ DFG+A     N+++ +T  +V
Sbjct: 139 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 184

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 69  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI++FG
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFG 156

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 509
           A ++F     LG+G FG VY  + +  + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 510 QHTNLGGERLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGL 559
           +H N+    L +Y Y  + +  + I + +          + S  D ++  + I  +   L
Sbjct: 68  RHPNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
            Y H     RVIHRD+K  N+LL      KI++FG
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFG 155

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 29/159 (18%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--IFDSSR------------KSLLDWKKRFSIIEGITQG 558
           N+ G   L+  + P +SL+ F  ++  +             + L D   +F +I  I +G
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 137
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L Y+H      +IHRDLK SN+ ++E    KI D G+AR
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 17/158 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLL 520
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL   +LL
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV--QLL 73
Query: 521 VYEYLPNKSLDFFIFDS--SRKSLLDWKKRFSIIEGITQGLLYL--------HKYSRLRV 570
               +  +   F+I     +  +LLD+ +  +  E     LLY+            +   
Sbjct: 74  G---VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           IHRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHA 168

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 27/158 (17%)
Query: 457 NFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 512
           N SP   +G G +G V      +    +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 513 NLGGERLLVYEYLPNKSLDFF--------IFDSSRKSLLDWKKRFS-----IIEGITQGL 559
           N+ G   L+  + P +SL+ F        +  +   +++  +K        +I  I +GL
Sbjct: 82  NVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            Y+H      +IHRDLK SN+ ++E    KI D G+AR
Sbjct: 139 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 456 DNFSPANRLGQGGFGPVYKGK-----LQDEQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 508
           D +     LG G F  V K +     LQ   +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 509 LQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           +QH N+    + ++E   NK+            + F F + ++SL + ++    ++ I  
Sbjct: 71  IQHPNV----ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILN 125
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMAR 597
           G+ YLH    L++ H DLK  NI+L ++  P    KI DFG+A 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 80/172 (46%), Gaps = 34/172 (19%)
Query: 456 DNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSS---------GQGIVEFK----N 501
           +++    +LG G +G V   K ++   E AIK + KS           + I +F     N
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 502 EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSR----------KSLLDWKKRFSI 551
           E  L+  L H N+    + +++   +K   + + +             +   D     +I
Sbjct: 96  EISLLKSLDHPNI----IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTFT 600
           ++ I  G+ YLHK++   ++HRD+K  NILL+ +   +N KI DFG++  F+
Sbjct: 152 MKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 513
           N+     +G+G F  V   + +   +E+A+K + K+  +   + +   E ++   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +              LV EY     +  ++    R    + + +F  I    Q   Y H+
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM-NELEA 606
                ++HRDLK  N+LLD   N KI+DFG +  FT  N+L+A
Sbjct: 132 KF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA 171

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 175

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 17/158 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLL 520
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL   +LL
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV--QLL 75
Query: 521 VYEYLPNKSLDFFIFDS--SRKSLLDWKKRFSIIEGITQGLLYL--------HKYSRLRV 570
               +  +   F+I     +  +LLD+ +  +  E     LLY+            +   
Sbjct: 76  G---VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           IHRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 17/158 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLL 520
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL   +LL
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV--QLL 75
Query: 521 VYEYLPNKSLDFFIFDS--SRKSLLDWKKRFSIIEGITQGLLYL--------HKYSRLRV 570
               +  +   F+I     +  +LLD+ +  +  E     LLY+            +   
Sbjct: 76  G---VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           IHRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 17/158 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLL 520
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL   +LL
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV--QLL 80
Query: 521 VYEYLPNKSLDFFIFDS--SRKSLLDWKKRFSIIEGITQGLLYL--------HKYSRLRV 570
               +  +   F+I     +  +LLD+ +  +  E     LLY+            +   
Sbjct: 81  G---VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 137
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           IHRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 36/193 (18%)
Query: 438 TVKRDLKIFDFQTIA--VATDNFSPANRLGQGGFGPVY---------KGKLQDEQEIAIK 486
           TVK +L+  +    A  V  +NF     LG G +G V+          GKL      A+K
Sbjct: 34  TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL-----YAMK 88
Query: 487 RLSKSS-------------GQGIVEFKNEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDF 532
            L K++              + ++E   ++  +  L +      +L L+ +Y+    L  
Sbjct: 89  VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL-- 146
Query: 533 FIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISD 592
           F   S R+   + + +  + E I   L +LHK   L +I+RD+K+ NILLD   +  ++D
Sbjct: 147 FTHLSQRERFTEHEVQIYVGE-IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTD 202
Query: 593 FGMARTFTMNELE 605
           FG+++ F  +E E
Sbjct: 203 FGLSKEFVADETE 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 137
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSG-QGIVEFKNEAKL 505
           V+ +  +    LGQG FG VY+G  +D      E  +A+K +++S+  +  +EF NEA +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIF-------DSSRKSLLDWKKRF 549
           +      ++         G   L+V E + +  L  ++        ++  +     ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HR+L   N ++      KI DFGM R
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSG-QGIVEFKNEAKL 505
           V+ +  +    LGQG FG VY+G  +D      E  +A+K +++S+  +  +EF NEA +
Sbjct: 15  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 74
Query: 506 IAKLQHTNL---------GGERLLVYEYLPNKSLDFFIF-------DSSRKSLLDWKKRF 549
           +      ++         G   L+V E + +  L  ++        ++  +     ++  
Sbjct: 75  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 134
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +   I  G+ YL+     + +HR+L   N ++      KI DFGM R
Sbjct: 135 QMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 26/156 (16%)
Query: 459 SPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLG 515
           SP + +G G +G V      +  +++AIK+LS+     I   +   E  L+  +QH N+ 
Sbjct: 28  SPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 516 GERLLVYEYLPNKSL----DFFIFDSSRKSLLDWKK----RFS------IIEGITQGLLY 561
           G   L+  + P  SL    DF++     ++  D +K    +FS      ++  + +GL Y
Sbjct: 87  G---LLDVFTPASSLRNFYDFYLVMPFMQT--DLQKIMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +H      V+HRDLK  N+ ++E    KI DFG+AR
Sbjct: 142 IHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 24/179 (13%)
Query: 451 IAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSS---GQGIVEFKNEAKLI 506
           I +  ++FS    +G+GGFG VY  +  D  ++ A+K L K      QG     NE  ++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 507 AKLQHTNLGGERLLVYEYLPNKSLDFFIFD-----------SSRKSLLDWKKRFSIIEGI 555
           + +   +      + Y +     L F I D           S      +   RF   E I
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-I 301
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             GL ++H  +R  V++RDLK +NILLDE  + +ISD G+A  F+  +  A+    VGT
Sbjct: 302 ILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 24/179 (13%)
Query: 451 IAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSS---GQGIVEFKNEAKLI 506
           I +  ++FS    +G+GGFG VY  +  D  ++ A+K L K      QG     NE  ++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 507 AKLQHTNLGGERLLVYEYLPNKSLDFFIFD-----------SSRKSLLDWKKRFSIIEGI 555
           + +   +      + Y +     L F I D           S      +   RF   E I
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-I 301
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             GL ++H  +R  V++RDLK +NILLDE  + +ISD G+A  F+  +  A+    VGT
Sbjct: 302 ILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 24/170 (14%)
Query: 437 QTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAI-KRLSKSSGQG 495
           + V RDL   DF  I            LG G FG VYK + ++   +A  K +   S + 
Sbjct: 27  EHVTRDLNPEDFWEII---------GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWK 546
           + ++  E  ++A   H N+              ++ E+    ++D  + +  R   L   
Sbjct: 78  LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTES 135
Query: 547 KRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           +   + +     L YLH     ++IHRDLK  NIL     + K++DFG++
Sbjct: 136 QIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 24/170 (14%)
Query: 437 QTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAI-KRLSKSSGQG 495
           + V RDL   DF  I            LG G FG VYK + ++   +A  K +   S + 
Sbjct: 27  EHVTRDLNPEDFWEII---------GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWK 546
           + ++  E  ++A   H N+              ++ E+    ++D  + +  R   L   
Sbjct: 78  LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTES 135
Query: 547 KRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           +   + +     L YLH     ++IHRDLK  NIL     + K++DFG++
Sbjct: 136 QIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 24/179 (13%)
Query: 451 IAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSS---GQGIVEFKNEAKLI 506
           I +  ++FS    +G+GGFG VY  +  D  ++ A+K L K      QG     NE  ++
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 507 AKLQHTNLGGERLLVYEYLPNKSLDFFIFD-----------SSRKSLLDWKKRFSIIEGI 555
           + +   +      + Y +     L F I D           S      +   RF   E I
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-I 300
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             GL ++H  +R  V++RDLK +NILLDE  + +ISD G+A  F+  +  A+    VGT
Sbjct: 301 ILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 352

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 24/179 (13%)
Query: 451 IAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSS---GQGIVEFKNEAKLI 506
           I +  ++FS    +G+GGFG VY  +  D  ++ A+K L K      QG     NE  ++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 507 AKLQHTNLGGERLLVYEYLPNKSLDFFIFD-----------SSRKSLLDWKKRFSIIEGI 555
           + +   +      + Y +     L F I D           S      +   RF   E I
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-I 301
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             GL ++H  +R  V++RDLK +NILLDE  + +ISD G+A  F+  +  A+    VGT
Sbjct: 302 ILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 24/170 (14%)
Query: 437 QTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAI-KRLSKSSGQG 495
           + V RDL   DF  I            LG G FG VYK + ++   +A  K +   S + 
Sbjct: 27  EHVTRDLNPEDFWEII---------GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWK 546
           + ++  E  ++A   H N+              ++ E+    ++D  + +  R   L   
Sbjct: 78  LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTES 135
Query: 547 KRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           +   + +     L YLH     ++IHRDLK  NIL     + K++DFG++
Sbjct: 136 QIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 172

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 13/75 (17%)
Query: 532 FFIFDSSRK-SLLDW---------KKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL 581
           F +FD  +K  L D+         K+   I+  + + +  LHK   L ++HRDLK  NIL
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENIL 156
Query: 582 LDEQMNPKISDFGMA 596
           LD+ MN K++DFG +
Sbjct: 157 LDDDMNIKLTDFGFS 171

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 15/149 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFT 600
           HRDL   N L+ E    K++DFG++R  T
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMT 164

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 13/75 (17%)
Query: 532 FFIFDSSRK-SLLDW---------KKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL 581
           F +FD  +K  L D+         K+   I+  + + +  LHK   L ++HRDLK  NIL
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENIL 156
Query: 582 LDEQMNPKISDFGMA 596
           LD+ MN K++DFG +
Sbjct: 157 LDDDMNIKLTDFGFS 171

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 13/75 (17%)
Query: 532 FFIFDSSRK-SLLDW---------KKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL 581
           F +FD  +K  L D+         K+   I+  + + +  LHK   L ++HRDLK  NIL
Sbjct: 87  FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENIL 143
Query: 582 LDEQMNPKISDFGMA 596
           LD+ MN K++DFG +
Sbjct: 144 LDDDMNIKLTDFGFS 158

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ +      +   + I+  + YL K +    I
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 131
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 168

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 15/149 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFT 600
           HRDL   N L+ E    K++DFG++R  T
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMT 163

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 172

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ +      +   + I+  + YL K +    I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 175

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 25/171 (14%)
Query: 464 LGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +G G +G   K      GK+   +E+    ++++  Q +V   +E  L+ +L+H N+   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVRY 70
Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSIIEGITQGLLYLHKY 565
                        +V EY     L   I   ++ +  LD +    ++  +T  L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 566 SR--LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           S     V+HRDLK +N+ LD + N K+ DFG+AR   +N  E      VGT
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDEDFAKEFVGT 179

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 15/149 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFT 600
           HRDL   N L+ E    K++DFG++R  T
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMT 163

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ +      +   + I+  + YL K +    I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HRDL   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 75/149 (50%), Gaps = 15/149 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+ + +      +   I+  + YL K +    I
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN---FI 146
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFT 600
           HRDL   N L+ E    K++DFG++R  T
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMT 175

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 26/174 (14%)
Query: 461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG---- 516
             ++G+G +G V+ GK + E+ +A+K    +        + E      ++H N+ G    
Sbjct: 42  VKQIGKGRYGEVWMGKWRGEK-VAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFIAA 99
Query: 517 ---------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK--- 564
                    +  L+ +Y  N SL    +D  + + LD K    +      GL +LH    
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 565 --YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT--MNELEANTNRIVGT 614
               +  + HRDLK  NIL+ +     I+D G+A  F    NE++   N  VGT
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 15/177 (8%)
Query: 448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKL 505
           FQ+++V    +S   ++G GG   V++   + +Q  AIK   L ++  Q +  ++NE   
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 506 IAKLQHTNLGGERLLVYE--------YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           + KLQ  +    RL  YE         +   ++D   +   +KS+  W+++ S  + + +
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLE 138
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            +  +H++    ++H DLK +N L+ + M  K+ DFG+A     +      +  VGT
Sbjct: 139 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGT 191

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 26/172 (15%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT-- 512
           +F P   LG+GGFG V++ K + D+   AIKR+   + +   E    E K +AKL+H   
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 513 ----NLGGERLLVYEYLPNKSLDFFIFD---SSRKSLLDWKKRFSIIE------------ 553
               N   E+    +  P+    +         +++L DW      IE            
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
            I + + +LH      ++HRDLK SNI        K+ DFG+      +E E
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 35/155 (22%)
Query: 464 LGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--- 514
           LG G FG V+KG    E E     + IK +   SG Q      +    I  L H ++   
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKS--------LLDWKKRFSIIEGITQGLLY 561
                G    LV +YLP  SL     D  R+         LL+W  +      I +G+ Y
Sbjct: 81  LGLCPGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMYY 130
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           L ++    ++HR+L   N+LL      +++DFG+A
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 162

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 465 GQGGFGPVYKGKLQDEQEIAIKRLS---KSSGQGIVE------FKNEAKL---IAKLQHT 512
            +G FG V+K +L ++  +A+K      K S Q   E       K+E  L    A+ + +
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 513 NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK-------- 564
           NL  E  L+  +    SL  ++    + +++ W +   + E +++GL YLH+        
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             +  + HRD K  N+LL   +   ++DFG+A  F   +   +T+  VGT
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGT 188

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 35/155 (22%)
Query: 464 LGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--- 514
           LG G FG V+KG    E E     + IK +   SG Q      +    I  L H ++   
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKS--------LLDWKKRFSIIEGITQGLLY 561
                G    LV +YLP  SL     D  R+         LL+W  +      I +G+ Y
Sbjct: 99  LGLCPGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMYY 148
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           L ++    ++HR+L   N+LL      +++DFG+A
Sbjct: 149 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 180

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 26/156 (16%)
Query: 459 SPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLG 515
           SP + +G G +G V      +  +++AIK+LS+     I   +   E  L+  +QH N+ 
Sbjct: 46  SPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 104
Query: 516 GERLLVYEYLPNKSL----DFFIFDSSRKSLLDWKK----RFS------IIEGITQGLLY 561
           G   L+  + P  SL    DF++     ++  D +K     FS      ++  + +GL Y
Sbjct: 105 G---LLDVFTPASSLRNFYDFYLVMPFMQT--DLQKIMGMEFSEEKIQYLVYQMLKGLKY 159
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +H      V+HRDLK  N+ ++E    KI DFG+AR
Sbjct: 160 IHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 25/171 (14%)
Query: 464 LGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +G G +G   K      GK+   +E+    ++++  Q +V   +E  L+ +L+H N+   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVRY 70
Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSIIEGITQGLLYLHKY 565
                        +V EY     L   I   ++ +  LD +    ++  +T  L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 566 SR--LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           S     V+HRDLK +N+ LD + N K+ DFG+AR    +   A T   VGT
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 13/80 (16%)
Query: 527 NKSLDFFIFDSSRK-SLLDW---------KKRFSIIEGITQGLLYLHKYSRLRVIHRDLK 576
           + S  F +FD  RK  L D+         K+  SI+  + + + +LH  +   ++HRDLK
Sbjct: 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLK 227
Query: 577 VSNILLDEQMNPKISDFGMA 596
             NILLD+ M  ++SDFG +
Sbjct: 228 PENILLDDNMQIRLSDFGFS 247

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 24/152 (15%)
Query: 464 LGQGGFGPV----YKGKLQDEQE-IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V    Y        E +A+K L   +G Q    +K E  ++  L H ++   
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 515 -------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G   L LV EY+P  SL  ++   S    +   +     + I +G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
               IHRDL   N+LLD     KI DFG+A+ 
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 29/170 (17%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQ-GI-VEFKNEAKLIAKL 509
           +AT  + P   +G G +G VYK +       +A+K +   +G+ G+ +    E  L+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 510 Q---HTNLGGERL----------------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS 550
           +   H N+   RL                LV+E++ ++ L  ++ D +    L  +    
Sbjct: 61  EAFEHPNV--VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 116
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           ++    +GL +LH      ++HRDLK  NIL+      K++DFG+AR ++
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 29/170 (17%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQ-GI-VEFKNEAKLIAKL 509
           +AT  + P   +G G +G VYK +       +A+K +   +G+ G+ +    E  L+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 510 Q---HTNLGGERL----------------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS 550
           +   H N+   RL                LV+E++ ++ L  ++ D +    L  +    
Sbjct: 61  EAFEHPNV--VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 116
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           ++    +GL +LH      ++HRDLK  NIL+      K++DFG+AR ++
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 37/60 (61%), Gaps = 5/60 (8%)
Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           I+ GL +LHK     +I+RDLK+ N++LD + + KI+DFGM +   M+ +   T    GT
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGT 183

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 26/171 (15%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG------- 516
           +G+G +G V++G  Q E  +A+K  S    +     + E      L+H N+ G       
Sbjct: 16  VGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 517 ------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH-----KY 565
                 +  L+  Y    SL    +D  + + LD      I+  I  GL +LH       
Sbjct: 74  SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMA--RTFTMNELEANTNRIVGT 614
            +  + HRDLK  NIL+ +     I+D G+A   + + N+L+   N  VGT
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 29/170 (17%)
Query: 453 VATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQ-GI-VEFKNEAKLIAKL 509
           +AT  + P   +G G +G VYK +       +A+K +   +G+ G+ +    E  L+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 510 Q---HTNLGGERL----------------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS 550
           +   H N+   RL                LV+E++ ++ L  ++ D +    L  +    
Sbjct: 61  EAFEHPNV--VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 116
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           ++    +GL +LH      ++HRDLK  NIL+      K++DFG+AR ++
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 26/171 (15%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG------- 516
           +G+G +G V++G  Q E  +A+K  S    +     + E      L+H N+ G       
Sbjct: 45  VGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 102
Query: 517 ------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH-----KY 565
                 +  L+  Y    SL    +D  + + LD      I+  I  GL +LH       
Sbjct: 103 SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMA--RTFTMNELEANTNRIVGT 614
            +  + HRDLK  NIL+ +     I+D G+A   + + N+L+   N  VGT
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 209

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 26/171 (15%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG------- 516
           +G+G +G V++G  Q E  +A+K  S    +     + E      L+H N+ G       
Sbjct: 16  VGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 517 ------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH-----KY 565
                 +  L+  Y    SL    +D  + + LD      I+  I  GL +LH       
Sbjct: 74  SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMA--RTFTMNELEANTNRIVGT 614
            +  + HRDLK  NIL+ +     I+D G+A   + + N+L+   N  VGT
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 33/161 (20%)
Query: 464 LGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           LG GG G V+     D ++ +AIK++  +  Q +     E K+I +L H N+        
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 515 -GGERL--------------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
             G +L              +V EY+     +       +  LL+   R  + + + +GL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARLFMYQ-LLRGL 133
Query: 560 LYLHKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTF 599
            Y+H  +   V+HRDLK +N+ ++ E +  KI DFG+AR  
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARV 193

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 155
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARV 181

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 35/172 (20%)
Query: 456 DNFSPANRLGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           +N      LG G FG V +      GK     ++A+K L  ++     E   +E K+++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 509 L-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG---- 554
           L QH N+         GG  L++ EY     L  F+   SR  +L+    F+I       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR--VLETDPAFAIANSTAST 163
Query: 555 ---------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                    + QG+ +L   +    IHRD+   N+LL      KI DFG+AR
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 153
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARV 179

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 144
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARV 170

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 17/158 (10%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLL 520
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL   +LL
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL--VQLL 282
Query: 521 VYEYLPNKSLDFFIFDS--SRKSLLDWKKRFSIIEGITQGLLY--------LHKYSRLRV 570
               +  +   F+I     +  +LLD+ +  +  E     LLY        +    +   
Sbjct: 283 G---VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           IHR+L   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 35/172 (20%)
Query: 456 DNFSPANRLGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           +N      LG G FG V +      GK     ++A+K L  ++     E   +E K+++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 509 L-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG---- 554
           L QH N+         GG  L++ EY     L  F+   SR  +L+    F+I       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR--VLETDPAFAIANSTLST 163
Query: 555 ---------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                    + QG+ +L   +    IHRD+   N+LL      KI DFG+AR
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 21/165 (12%)
Query: 457 NFSPANRLGQGGFGPVY---KGKLQDEQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQ 510
           +F     LGQG FG V+   K    D   + A+K L K++   +  V  K E  ++A + 
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN 88
Query: 511 HT---------NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H             G+  L+ ++L  +  D F   S      +   +F + E +  GL +
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALGLDH 145
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
           LH    L +I+RDLK  NILLDE+ + K++DFG+++    +E +A
Sbjct: 146 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKA 187

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 21/146 (14%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           +G+G FG V  G  +  + +A+K + + ++ Q    F  EA ++ +L+H+NL        
Sbjct: 201 IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLL-DWKKRFSIIEGITQGLLYLHKYSRLRVI 571
              G   +V EY+   SL  ++    R  L  D   +FS+   + + + YL   +    +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 311
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N+L+ E    K+SDFG+ +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 36/163 (22%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 507
           N  P     QG     Y   L  ++ +AIK+LS+        F+N         E  L+ 
Sbjct: 28  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 78
Query: 508 KLQHTNLGGERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGI 555
            + H N+     L+  + P K+L+ F        + D++   +    LD ++   ++  +
Sbjct: 79  XVNHKNIIS---LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             G+ +LH      +IHRDLK SNI++      KI DFG+ART
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART 175

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 70/166 (42%), Gaps = 27/166 (16%)
Query: 456 DNFSPANRLGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           +N      LG G FG V +      GK     ++A+K L  ++     E   +E K+++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 509 L-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSL-------LDWKKRFSI 551
           L QH N+         GG  L++ EY     L  F+   +   L       L+ +     
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              + QG+ +L   +    IHRD+   N+LL      KI DFG+AR
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 200

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 71/174 (40%), Gaps = 27/174 (15%)
Query: 448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRLSKS--SGQGIVEFKN 501
            + + +    F+    LG+G FG V + +L+ E     ++A+K L     +   I EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 502 EAKLIAKLQHTNLGGE---------------RLLVYEYLPNKSLDFFIFDS---SRKSLL 543
           EA  + +  H ++                   +++  ++ +  L  F+  S        L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 544 DWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +     +  I  G+ YL   S    IHRDL   N +L E M   ++DFG++R
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 522 YEYLPNKSLDFFIF-DSSRKSLLDWKKRFSI--------IEGITQGLLYLHKYSRLRVIH 572
                 +  D +I  D     L    K   +        +  I +GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 25/171 (14%)
Query: 464 LGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
           +G G +G   K      GK+   +E+    ++++  Q +V   +E  L+ +L+H N+   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVRY 70
Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSIIEGITQGLLYLHKY 565
                        +V EY     L   I   ++ +  LD +    ++  +T  L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 566 SR--LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           S     V+HRDLK +N+ LD + N K+ DFG+AR   +N   +     VGT
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKAFVGT 179

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 70/166 (42%), Gaps = 27/166 (16%)
Query: 456 DNFSPANRLGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           +N      LG G FG V +      GK     ++A+K L  ++     E   +E K+++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 509 L-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSL-------LDWKKRFSI 551
           L QH N+         GG  L++ EY     L  F+   +   L       L+ +     
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              + QG+ +L   +    IHRD+   N+LL      KI DFG+AR
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 208

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 21/146 (14%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           +G+G FG V  G  +  + +A+K + + ++ Q    F  EA ++ +L+H+NL        
Sbjct: 29  IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLL-DWKKRFSIIEGITQGLLYLHKYSRLRVI 571
              G   +V EY+   SL  ++    R  L  D   +FS+   + + + YL   +    +
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 139
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N+L+ E    K+SDFG+ +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 21/146 (14%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           +G+G FG V  G  +  + +A+K + + ++ Q    F  EA ++ +L+H+NL        
Sbjct: 20  IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLL-DWKKRFSIIEGITQGLLYLHKYSRLRVI 571
              G   +V EY+   SL  ++    R  L  D   +FS+   + + + YL   +    +
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 130
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N+L+ E    K+SDFG+ +
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 28  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 84
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS 144
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLART 175

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 77
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS 137
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 138 AG---IIHRDLKPSNIVVKSDXTLKILDFGLART 168

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 23/161 (14%)
Query: 455 TDNFSPANRLGQGGFGPVY--KGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 511
           ++ +    +LG G +G V   + K+   E+ I I R +  S     +   E  ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRK-SLLD---WKKRFS------IIEGITQGLLY 561
            N+    + +Y++  +K   + + +  +   L D    + +F+      II+ +  G+ Y
Sbjct: 96  PNI----MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNP---KISDFGMARTF 599
           LHK++   ++HRDLK  N+LL+ +      KI DFG++  F
Sbjct: 152 LHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 28  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKXVNHKN 84
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLART 175

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 28/168 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEAKLIAK-------LQHTNLG 515
           +G+G FG V   + + E+   A+K L K   + I++ K E  ++++       ++H  L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQK---KAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 516 GERL---------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
           G             V +Y+    L  F      +  L+ + RF   E I   L YLH   
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS-- 157
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            L +++RDLK  NILLD Q +  ++DFG+ +     E  + T+   GT
Sbjct: 158 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNSTTSTFCGT 202

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 21/146 (14%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           +G+G FG V  G  +  + +A+K + + ++ Q    F  EA ++ +L+H+NL        
Sbjct: 14  IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLL-DWKKRFSIIEGITQGLLYLHKYSRLRVI 571
              G   +V EY+   SL  ++    R  L  D   +FS+   + + + YL   +    +
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 124
Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N+L+ E    K+SDFG+ +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARV 173

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 522 YE---------YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
                      YL    +   ++   +   L        +  I +GL Y+H  +   V+H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARV 193

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 66  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 122
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 183 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNL------- 514
           LG G F  V   + +  Q+ +AIK ++K + +G     +NE  ++ K++H N+       
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 515 --GGERLLVYEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             GG   L+ + +    L    FD    K     +    +I  +   + YLH    L ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 572 HRDLKVSNIL---LDEQMNPKISDFGMAR 597
           HRDLK  N+L   LDE     ISDFG+++
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK 167

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 462 NRLGQGGFGPVYKGKLQDEQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL      
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++ + +R+  ++      +   I+  + YL K +    I
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 379
Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           HR+L   N L+ E    K++DFG++R  T +   A+ 
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 416

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNL------- 514
           LG G F  V   + +  Q+ +AIK ++K + +G     +NE  ++ K++H N+       
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 515 --GGERLLVYEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             GG   L+ + +    L    FD    K     +    +I  +   + YLH    L ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 572 HRDLKVSNIL---LDEQMNPKISDFGMAR 597
           HRDLK  N+L   LDE     ISDFG+++
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK 167

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++   +H N+ G   ++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLI 506
           + I+V    +S   ++G GG   V++   + +Q  AIK   L ++  Q +  ++NE   +
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 60
Query: 507 AKLQHTNLGGERLLVYE--------YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
            KLQ  +    RL  YE         +   ++D   +   +KS+  W+++ S  + + + 
Sbjct: 61  NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEA 119
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           +  +H++    ++H DLK +N L+ + M  K+ DFG+A     N+++ +T  +V
Sbjct: 120 VHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 164

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 28/173 (16%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRLSK---SSGQGIVEFKNE 502
           T  +   +     +LG G FG V +G+          +A+K L     S  + + +F  E
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 503 AKLIAKLQHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKS----LLDWKKRFS 550
              +  L H NL             +V E  P  SL     D  RK     LL    R++
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYA 121
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +   + +G+ YL      R IHRDL   N+LL  +   KI DFG+ R    N+
Sbjct: 122 V--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNL------- 514
           LG G F  V   + +  Q+ +AIK ++K + +G     +NE  ++ K++H N+       
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 515 --GGERLLVYEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             GG   L+ + +    L    FD    K     +    +I  +   + YLH    L ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 572 HRDLKVSNIL---LDEQMNPKISDFGMAR 597
           HRDLK  N+L   LDE     ISDFG+++
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK 167

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AI+++S    Q   +    E K++ + +H N+ G   ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLI 506
           + I+V    +S   ++G GG   V++   + +Q  AIK   L ++  Q +  ++NE   +
Sbjct: 5   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 64
Query: 507 AKLQHTNLGGERLLVYE--------YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
            KLQ  +    RL  YE         +   ++D   +   +KS+  W+++ S  + + + 
Sbjct: 65  NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEA 123
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           +  +H++    ++H DLK +N L+ + M  K+ DFG+A     N+++ +T  +V
Sbjct: 124 VHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 168

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 28  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKXVNHKN 84
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLART 175

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 28/173 (16%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRLSK---SSGQGIVEFKNE 502
           T  +   +     +LG G FG V +G+          +A+K L     S  + + +F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 503 AKLIAKLQHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKS----LLDWKKRFS 550
              +  L H NL             +V E  P  SL     D  RK     LL    R++
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYA 117
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +   + +G+ YL      R IHRDL   N+LL  +   KI DFG+ R    N+
Sbjct: 118 V--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 29  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 85
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 145
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 146 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 28/173 (16%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRLSK---SSGQGIVEFKNE 502
           T  +   +     +LG G FG V +G+          +A+K L     S  + + +F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 503 AKLIAKLQHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKS----LLDWKKRFS 550
              +  L H NL             +V E  P  SL     D  RK     LL    R++
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYA 117
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +   + +G+ YL      R IHRDL   N+LL  +   KI DFG+ R    N+
Sbjct: 118 V--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNL------- 514
           LG G F  V   + +  Q+ +AIK ++K + +G     +NE  ++ K++H N+       
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 515 --GGERLLVYEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
             GG   L+ + +    L    FD    K     +    +I  +   + YLH    L ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 572 HRDLKVSNIL---LDEQMNPKISDFGMAR 597
           HRDLK  N+L   LDE     ISDFG+++
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK 167

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 28  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 84
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 33/156 (21%)
Query: 464 LGQGGFGPVYK---------GKLQDEQEIAIKRLSKS----SGQGIVEFKNEAKLIAKLQ 510
           LG+GG+G V++         GK+      A+K L K+    + +     K E  ++ +++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKI-----FAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H  +         GG+  L+ EYL    L  F+        ++    F + E I+  L +
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGH 136
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           LH+     +I+RDLK  NI+L+ Q + K++DFG+ +
Sbjct: 137 LHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLI 506
           + I+V    +S   ++G GG   V++   + +Q  AIK   L ++  Q +  ++NE   +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 507 AKLQHTNLGGERLLVYE--------YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
            KLQ  +    RL  YE         +   ++D   +   +KS+  W+++ S  + + + 
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEA 120
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           +  +H++    ++H DLK +N L+ + M  K+ DFG+A     N+++ +T  +V
Sbjct: 121 VHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 165

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 28/173 (16%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRLSK---SSGQGIVEFKNE 502
           T  +   +     +LG G FG V +G+          +A+K L     S  + + +F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 503 AKLIAKLQHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKS----LLDWKKRFS 550
              +  L H NL             +V E  P  SL     D  RK     LL    R++
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYA 117
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +   + +G+ YL      R IHRDL   N+LL  +   KI DFG+ R    N+
Sbjct: 118 V--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 29  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 85
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 145
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 146 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLI 506
           + I+V    +S   ++G GG   V++   + +Q  AIK   L ++  Q +  ++NE   +
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 507 AKLQHTNLGGERLLVYE--------YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
            KLQ  +    RL  YE         +   ++D   +   +KS+  W+++ S  + + + 
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEA 167
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           +  +H++    ++H DLK +N L+ + M  K+ DFG+A     N+++ +T  +V
Sbjct: 168 VHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 212

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 25/168 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGKLQD---EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 511
           +DN+     LG+G F  V +   +    E    I    K S +   + + EA++  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 512 TNLGGERLLVYEYLPNKSLDFFIF----------DSSRKSLLDWKKRFSIIEGITQGLLY 561
            N+    + +++ +  +S  + +F          D   +           I+ I + + Y
Sbjct: 64  PNI----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGMARTFTMNELEA 606
            H      ++HR+LK  N+LL  +      K++DFG+A    +N+ EA
Sbjct: 120 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA 162

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 22  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 78
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 139 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 169

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 26/170 (15%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGK-LQDEQE-IAIKRLSKSSGQG---------------- 495
           A   +     +G+G +G V+K + L++    +A+KR+   +G+                 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 496 -IVEFKNEAKL--IAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
              E  N  +L  +  +  T+   +  LV+E++ ++ L  ++ D   +  +  +    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
             + +GL +LH +   RV+HRDLK  NIL+      K++DFG+AR ++  
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 25/168 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGKLQD---EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 511
           +DN+     LG+G F  V +   +    E    I    K S +   + + EA++  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 512 TNLGGERLLVYEYLPNKSLDFFIF----------DSSRKSLLDWKKRFSIIEGITQGLLY 561
            N+    + +++ +  +S  + +F          D   +           I+ I + + Y
Sbjct: 88  PNI----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNP---KISDFGMARTFTMNELEA 606
            H      ++HR+LK  N+LL  +      K++DFG+A    +N+ EA
Sbjct: 144 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA 186

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 25/168 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGKLQD---EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 511
           +DN+     LG+G F  V +   +    E    I    K S +   + + EA++  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 512 TNLGGERLLVYEYLPNKSLDFFIF----------DSSRKSLLDWKKRFSIIEGITQGLLY 561
            N+    + +++ +  +S  + +F          D   +           I+ I + + Y
Sbjct: 65  PNI----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGMARTFTMNELEA 606
            H      ++HR+LK  N+LL  +      K++DFG+A    +N+ EA
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA 163

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 28  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 84
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 77
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 22  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 78
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 139 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 169

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 26/170 (15%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGK-LQDEQE-IAIKRLSKSSGQG---------------- 495
           A   +     +G+G +G V+K + L++    +A+KR+   +G+                 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 496 -IVEFKNEAKL--IAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
              E  N  +L  +  +  T+   +  LV+E++ ++ L  ++ D   +  +  +    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
             + +GL +LH +   RV+HRDLK  NIL+      K++DFG+AR ++  
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 27  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 83
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 84  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 143
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 144 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 174

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 70/163 (42%), Gaps = 23/163 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 510
           +D +     LG GG   V+  + L+  +++A+K L     +     + F+ EA+  A L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 511 H-------------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           H             T  G    +V EY+   +L   +     +  +  K+   +I    Q
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 144
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            L + H+     +IHRD+K +NI++      K+ DFG+AR   
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 184

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 28/173 (16%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRLSK---SSGQGIVEFKNE 502
           T  +   +     +LG G FG V +G+          +A+K L     S  + + +F  E
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 503 AKLIAKLQHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKS----LLDWKKRFS 550
              +  L H NL             +V E  P  SL     D  RK     LL    R++
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYA 127
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +   + +G+ YL      R IHRDL   N+LL  +   KI DFG+ R    N+
Sbjct: 128 V--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 30/168 (17%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIA 507
           Q   V  D+  P   LG+G +G V K + +   Q +A+KR+     +  V  + + +L+ 
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-----RATVNSQEQKRLLM 98
Query: 508 KLQ-----------HTNLG-----GERLLVYEYLPNKSLDFF---IFDSSRKSLLDWKKR 548
            L             T  G     G+  +  E + + SLD F   + D  +    D   +
Sbjct: 99  DLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK 157
Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
            ++   I + L +LH  S+L VIHRD+K SN+L++     K+ DFG++
Sbjct: 158 IAV--SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 201

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
           N  P     QG     Y   L  ++ +AIK+LS+   Q     K   + +  ++  N   
Sbjct: 66  NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKN 122
Query: 517 ERLLVYEYLPNKSLDFF--------IFDSSRKSL----LDWKKRFSIIEGITQGLLYLHK 564
              L+  + P K+L+ F        + D++   +    LD ++   ++  +  G+ +LH 
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                +IHRDLK SNI++      KI DFG+ART
Sbjct: 183 AG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 28/173 (16%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRLSK---SSGQGIVEFKNE 502
           T  +   +     +LG G FG V +G+          +A+K L     S  + + +F  E
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 503 AKLIAKLQHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKS----LLDWKKRFS 550
              +  L H NL             +V E  P  SL     D  RK     LL    R++
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYA 121
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +   + +G+ YL      R IHRDL   N+LL  +   KI DFG+ R    N+
Sbjct: 122 V--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 33/156 (21%)
Query: 464 LGQGGFGPVYK---------GKLQDEQEIAIKRLSKS----SGQGIVEFKNEAKLIAKLQ 510
           LG+GG+G V++         GK+      A+K L K+    + +     K E  ++ +++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKI-----FAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 511 HT---------NLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H            GG+  L+ EYL    L  F+        ++    F + E I+  L +
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGH 136
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           LH+     +I+RDLK  NI+L+ Q + K++DFG+ +
Sbjct: 137 LHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 28/173 (16%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRLSK---SSGQGIVEFKNE 502
           T  +   +     +LG G FG V +G+          +A+K L     S  + + +F  E
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 503 AKLIAKLQHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKS----LLDWKKRFS 550
              +  L H NL             +V E  P  SL     D  RK     LL    R++
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYA 127
Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +   + +G+ YL      R IHRDL   N+LL  +   KI DFG+ R    N+
Sbjct: 128 V--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 26/170 (15%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGK-LQDEQE-IAIKRLSKSSGQG---------------- 495
           A   +     +G+G +G V+K + L++    +A+KR+   +G+                 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 496 -IVEFKNEAKL--IAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
              E  N  +L  +  +  T+   +  LV+E++ ++ L  ++ D   +  +  +    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
             + +GL +LH +   RV+HRDLK  NIL+      K++DFG+AR ++  
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 69/132 (52%), Gaps = 24/132 (18%)
Query: 496 IVEFKNEAKLIAKLQHTNLGGERLLVYEYL--PNKSLDFFIFD----------SSRKSLL 543
           I +   E  ++ KL H N+    + + E L  PN+   + +F+           + K L 
Sbjct: 80  IEQVYQEIAILKKLDHPNV----VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 544 DWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           + + RF   + + +G+ YLH     ++IHRD+K SN+L+ E  + KI+DFG++  F  ++
Sbjct: 136 EDQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 604 -LEANTNRIVGT 614
            L +NT   VGT
Sbjct: 192 ALLSNT---VGT 200

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 40/192 (20%)
Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSK-SSGQG 495
            KI +         N      LG+G FG V K              +A+K L + +S   
Sbjct: 10  FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE 69
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSR------- 539
           + +  +E  ++ ++ H ++          G  LL+ EY    SL  F+ +S +       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 540 ------KSLLDWKKRFSIIEG--------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ 585
                  S LD     ++  G        I+QG+ YL   + ++++HRDL   NIL+ E 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 586 MNPKISDFGMAR 597
              KISDFG++R
Sbjct: 187 RKMKISDFGLSR 198

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 70/163 (42%), Gaps = 23/163 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 510
           +D +     LG GG   V+  + L+  +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 511 H-------------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           H             T  G    +V EY+   +L   +     +  +  K+   +I    Q
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            L + H+     +IHRD+K +NI++      K+ DFG+AR   
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 30/179 (16%)
Query: 446 FDFQTIAVATDNFSPANRLGQGGFGPVYKG------KLQDEQEIAIKRLSKSSGQGIVE- 498
           +D        D  +    LG+G FG V +       K    + +A+K L + +       
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 499 FKNEAKLIAKLQH-----------TNLGGERLLVYE---------YLPNKSLDFFIFDSS 538
             +E K++  + H           T  GG  +++ E         YL +K  +F  +   
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 539 RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            K  L  +        + +G+ +L   +  + IHRDL   NILL E+   KI DFG+AR
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 40/192 (20%)
Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSK-SSGQG 495
            KI +         N      LG+G FG V K              +A+K L + +S   
Sbjct: 10  FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE 69
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSR------- 539
           + +  +E  ++ ++ H ++          G  LL+ EY    SL  F+ +S +       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 540 ------KSLLDWKKRFSIIEG--------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ 585
                  S LD     ++  G        I+QG+ YL   + ++++HRDL   NIL+ E 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 586 MNPKISDFGMAR 597
              KISDFG++R
Sbjct: 187 RKMKISDFGLSR 198

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 16/146 (10%)
Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           LG+G +G VY G+ L ++  IAIK + +   +       E  L   L+H N+        
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSI-IEGITQGLLYLHKYSRLRVIH 572
             G   +  E +P  SL   +  S    L D ++      + I +GL YLH     +++H
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 573 RDLKVSNILLDEQMNP-KISDFGMAR 597
           RD+K  N+L++      KISDFG ++
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSK 171

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLGGERLLVY 522
           +G G FG V++ KL +  E+AIK++ +        FKN E +++  ++H N+   +   Y
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 523 EYLPNKSLDF--FIFDSSRKSLLDWKKRFSIIEGITQGLLY-LHKYSRLR---------V 570
                K   F   + +   +++    + ++ ++     LL  L+ Y  LR         +
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI 162
Query: 571 IHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
            HRD+K  N+LLD      K+ DFG A+     E
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 14/145 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V        +  +AIK++S    Q   +    E +++ + +H N+ G R ++
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                    D +I     ++    LL  ++  +      +  I +GL Y+H  +   V+H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDLK SN+L++   + KI DFG+AR
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLAR 192

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 70/163 (42%), Gaps = 23/163 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 510
           +D +     LG GG   V+  + L+  +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 511 H-------------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           H             T  G    +V EY+   +L   +     +  +  K+   +I    Q
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            L + H+     +IHRD+K +NI++      K+ DFG+AR   
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 35/157 (22%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAI-------KRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
           +G+G F  VYKG L  E  + +       ++L+KS  Q    FK EA+ +  LQH N+  
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 515 ---------GGER--LLVYEYLPNKSLDFFI--FDSSR-KSLLDWKKRFSIIEGITQGLL 560
                     G++  +LV E   + +L  ++  F   + K L  W ++      I +GL 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQ 143
Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNP-KISDFGMA 596
           +LH  +   +IHRDLK  NI +       KI D G+A
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA 179

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 464 LGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLGGERLLV 521
           +G+G +G V       ++  +AIK++S    Q   +    E K++   +H N+ G   ++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 522 YEYLPNKSLDFFI----FDSSRKSLLDWKKRFS-----IIEGITQGLLYLHKYSRLRVIH 572
                 +  D +I     ++    LL  +   +      +  I +GL Y+H  +   V+H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 573 RDLKVSNILLDEQMNPKISDFGMART 598
           RDLK SN+LL+   + KI DFG+AR 
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARV 175

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 16/146 (10%)
Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           LG+G +G VY G+ L ++  IAIK + +   +       E  L   L+H N+        
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSI-IEGITQGLLYLHKYSRLRVIH 572
             G   +  E +P  SL   +  S    L D ++      + I +GL YLH     +++H
Sbjct: 76  ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 131
Query: 573 RDLKVSNILLDEQMNP-KISDFGMAR 597
           RD+K  N+L++      KISDFG ++
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSK 157

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLI 506
           + I+V    +S   ++G GG   V++   + +Q  AIK   L ++  Q +  ++NE   +
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 507 AKLQHTNLGGERLLVYE--------YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
            KLQ  +    RL  YE         +   ++D   +   +KS+  W+++ S  + + + 
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEA 167
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           +  +H++    ++H DLK +N L+ + M  K+ DFG+A     N+++ +T  +V
Sbjct: 168 VHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 212

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLI 506
           + I+V    +S   ++G GG   V++   + +Q  AIK   L ++  Q +  ++NE   +
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 507 AKLQHTNLGGERLLVYE--------YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQG 558
            KLQ  +    RL  YE         +   ++D   +   +KS+  W+++ S  + + + 
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEA 167
Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           +  +H++    ++H DLK +N L+ + M  K+ DFG+A     N+++ +T  +V
Sbjct: 168 VHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVV 212

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 17/144 (11%)
Query: 463 RLGQGGFGPVYKGKLQDE-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-------- 513
           ++G+G  G V   + +   +++A+K +     Q      NE  ++   QH N        
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 514 LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
           L GE L ++ E+L   +L     D   +  L+ ++  ++ E + Q L YLH      VIH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 573 RDLKVSNILLDEQMNPKISDFGMA 596
           RD+K  +ILL      K+SDFG  
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFC 188

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 24/163 (14%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKN---EAKLIAKL 509
             DN+   + +G+G +G VY    ++  + +AIK++++   + +++ K    E  ++ +L
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRM-FEDLIDCKRILREITILNRL 84
Query: 510 Q-------HTNLGGERLLVYEYLPNKSLDFFIFDSSRKSL------LDWKKRFSIIEGIT 556
           +       H  +  E LL ++ L    +   I DS  K L      L  +   +I+  + 
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDEL---YIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLL 141
Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
            G  ++H+     +IHRDLK +N LL++  + KI DFG+ART 
Sbjct: 142 LGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTI 181

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 24/152 (15%)
Query: 464 LGQGGFGPV--YKGKLQDE---QEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V  Y     ++   + +A+K L    G Q    +K E  ++  L H ++   
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  GE+   LV EY+P  SL  ++   S    +   +     + I +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
               IHR+L   N+LLD     KI DFG+A+ 
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKA 166

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 19/143 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN----LGG--- 516
           +G+G FG VY G+   E  I +  + + +   +  FK E     + +H N    +G    
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 517 --ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
                ++      ++L   + D+  K +LD  K   I + I +G+ YLH      ++H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 575 LKVSNILLDEQMNPK--ISDFGM 595
           LK  N+  D   N K  I+DFG+
Sbjct: 156 LKSKNVFYD---NGKVVITDFGL 175

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 25/168 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKGKLQD---EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 511
           +DN+     LG+G F  V +   +    E    I    K S +   + + EA++  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 512 TNLGGERLLVYEYLPNKSLDFFIF----------DSSRKSLLDWKKRFSIIEGITQGLLY 561
            N+    + +++ +  +S  + +F          D   +           I+ I + + Y
Sbjct: 65  PNI----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGMARTFTMNELEA 606
            H      ++HR+LK  N+LL  +      K++DFG+A    +N+ EA
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA 163

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 24/152 (15%)
Query: 464 LGQGGFGPV--YKGKLQDE---QEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--- 514
           LG+G FG V  Y     ++   + +A+K L    G Q    +K E  ++  L H ++   
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  GE+   LV EY+P  SL  ++   S    +   +     + I +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
               IHR+L   N+LLD     KI DFG+A+ 
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKA 166

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 26/157 (16%)
Query: 464 LGQGGFGPVYKGKLQDEQ----EIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN---- 513
           LG+G FG V +G L+ E     ++A+K  +L  SS + I EF +EA  +    H N    
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 514 LG----------GERLLVYEYLPNKSLDFFIFDSSRKS---LLDWKKRFSIIEGITQGLL 560
           LG           + +++  ++    L  ++  S  ++    +  +     +  I  G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           YL   S    +HRDL   N +L + M   ++DFG+++
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 30/167 (17%)
Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAK 508
           ++ V  D+  P   LG+G +G V K + +   Q +A+KR+     +  V  + + +L+  
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-----RATVNSQEQKRLLMD 55
Query: 509 LQ-----------HTNLG-----GERLLVYEYLPNKSLDFF---IFDSSRKSLLDWKKRF 549
           L             T  G     G+  +  E + + SLD F   + D  +    D   + 
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           ++   I + L +LH  S+L VIHRD+K SN+L++     K+ DFG++
Sbjct: 115 AV--SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 463 RLGQGGFGPVYKGKLQDEQEI-AIKRLS---KSSGQGIVEFKNEAKLIAKLQHTNLGGER 518
           +LG+G +G V+K   +   E+ A+K++    ++S      F+    L     H N+    
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN-- 73
Query: 519 LLVYEYLPNKSLDFFIFDSS--------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
           LL      N    + +FD          R ++L+   +  ++  + + + YLH      +
Sbjct: 74  LLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---L 130
Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           +HRD+K SNILL+ + + K++DFG++R+F 
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSRSFV 160

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 72/150 (48%), Gaps = 16/150 (10%)
Query: 462 NRLGQGGFG-PVYKGKLQDEQEIAIKRL--SKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
            ++G+G FG  +     +D ++  IK +  S+ S +   E + E  ++A ++H N+    
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                 G   +V +Y   +  D F   +++K +L  + +  I++   Q  L L      +
Sbjct: 90  ESFEENGSLYIVMDYC--EGGDLFKRINAQKGVLFQEDQ--ILDWFVQICLALKHVHDRK 145
Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           ++HRD+K  NI L +    ++ DFG+AR  
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 19/153 (12%)
Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           LG G FG V+K +      ++A K +     +   E KNE  ++ +L H NL        
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 515 -GGERLLVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
              + +LV EY+    L D  I +S   + LD       ++ I +G+ ++H   ++ ++H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMH---QMYILH 210
Query: 573 RDLKVSNILL--DEQMNPKISDFGMARTFTMNE 603
            DLK  NIL    +    KI DFG+AR +   E
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 454 ATDNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 512
             DN+   + +G+G +G VY    ++ E+ +AIK++++   + +++ K   + I  L   
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRL 82
Query: 513 NLGGERLLVYEYLPNKSLDF-------FIFDSSRKSLLDWKKRFSIIEGITQGLLY---- 561
                  L    +P+  L F        I DS  K L  +K    + E   + +LY    
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKL--FKTPIFLTEEHIKTILYNLLL 140
Query: 562 ----LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT-------MNELEAN 607
               +H+     +IHRDLK +N LL++  + K+ DFG+ART         +N+LE N
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  ++F     LG+G FG V           Y  K L+ E  IA   ++ +  +  V   
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                +  L++     +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSAL 118
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH      V++RD+K+ N++LD+  + KI+DFG+ +
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  ++F     LG+G FG V           Y  K L+ E  IA   ++ +  +  V   
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                +  L++     +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSAL 118
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH      V++RD+K+ N++LD+  + KI+DFG+ +
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  ++F     LG+G FG V           Y  K L+ E  IA   ++ +  +  V   
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                +  L++     +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSAL 118
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH      V++RD+K+ N++LD+  + KI+DFG+ +
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 453 VATDNFSPANRLGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGI------VEFK 500
           V  + F     LG+GGFG V        GK+   +++  KR+ K  G+ +      +  K
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
             ++ +  L +     + L LV   +    L F I+   +    + +  F   E I  GL
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGL 299
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
             LH   R R+++RDLK  NILLD+  + +ISD G+A
Sbjct: 300 EDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  ++F     LG+G FG V           Y  K L+ E  IA   ++ +  +  V   
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                +  L++     +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH      V++RD+K+ N++LD+  + KI+DFG+ +
Sbjct: 122 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  ++F     LG+G FG V           Y  K L+ E  IA   ++ +  +  V   
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                +  L++     +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSAL 118
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH      V++RD+K+ N++LD+  + KI+DFG+ +
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  + F     LG+G FG V           Y  K L+ E  +A   ++ +  +  V   
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           +    +  L+++    +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 121
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH  S   V++RDLK+ N++LD+  + KI+DFG+ +
Sbjct: 122 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  ++F     LG+G FG V           Y  K L+ E  IA   ++ +  +  V   
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                +  L++     +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSAL 118
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH      V++RD+K+ N++LD+  + KI+DFG+ +
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 30/179 (16%)
Query: 446 FDFQTIAVATDNFSPANRLGQGGFGPVYKG------KLQDEQEIAIKRLSKSSGQGIVE- 498
           +D        D  +    LG+G FG V +       K    + +A+K L + +       
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 499 FKNEAKLIAKLQH-----------TNLGGERLLVYE---------YLPNKSLDFFIFDSS 538
             +E K++  + H           T  GG  +++ E         YL +K  +F  +   
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 539 RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            K  L  +        + +G+ +L   +  + IHRDL   NILL E+   KI DFG+AR
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 453 VATDNFSPANRLGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGI------VEFK 500
           V  + F     LG+GGFG V        GK+   +++  KR+ K  G+ +      +  K
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
             ++ +  L +     + L LV   +    L F I+   +    + +  F   E I  GL
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGL 299
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
             LH   R R+++RDLK  NILLD+  + +ISD G+A
Sbjct: 300 EDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  ++F     LG+G FG V           Y  K L+ E  IA   ++ +  +  V   
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                +  L++     +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSAL 123
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH      V++RD+K+ N++LD+  + KI+DFG+ +
Sbjct: 124 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 158

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 79/192 (41%), Gaps = 40/192 (20%)
Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSK-SSGQG 495
            KI +         N      LG+G FG V K              +A+K L + +S   
Sbjct: 10  FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE 69
Query: 496 IVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSR------- 539
           + +  +E  ++ ++ H ++          G  LL+ EY    SL  F+ +S +       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 540 ------KSLLDWKKRFSIIEG--------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ 585
                  S LD     ++  G        I+QG+ YL + S   ++HRDL   NIL+ E 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEG 186
Query: 586 MNPKISDFGMAR 597
              KISDFG++R
Sbjct: 187 RKMKISDFGLSR 198

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  + F     LG+G FG V           Y  K L+ E  +A   ++ +  +  V   
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           +    +  L+++    +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 261
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH  S   V++RDLK+ N++LD+  + KI+DFG+ +
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  + F     LG+G FG V           Y  K L+ E  +A   ++ +  +  V   
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           +    +  L+++    +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 264
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH  S   V++RDLK+ N++LD+  + KI+DFG+ +
Sbjct: 265 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 24/152 (15%)
Query: 464 LGQGGFGPV--YKGKLQDE---QEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL--- 514
           LG+G FG V  Y     ++   + +A+K L +  G  +   ++ E +++  L H ++   
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  GE+   LV EY+P  SL     D   +  +   +     + I +G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
               IHR L   N+LLD     KI DFG+A+ 
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAKA 160

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  + F     LG+G FG V           Y  K L+ E  +A   ++ +  +  V   
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           +    +  L+++    +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 122
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH  S   V++RDLK+ N++LD+  + KI+DFG+ +
Sbjct: 123 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 24/152 (15%)
Query: 464 LGQGGFGPV--YKGKLQDE---QEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL--- 514
           LG+G FG V  Y     ++   + +A+K L +  G  +   ++ E +++  L H ++   
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 515 ------GGER--LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  GE+   LV EY+P  SL     D   +  +   +     + I +G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
               IHR L   N+LLD     KI DFG+A+ 
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAKA 161

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/176 (22%), Positives = 76/176 (43%), Gaps = 36/176 (20%)
Query: 452 AVATDNFSPANRLGQGGFGPVYKGK--------------------------LQDEQEIAI 485
           ++AT  + P   +G G +G VYK +                          +   +E+A+
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 486 -KRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLD 544
            +RL       +V   +    +     T+   +  LV+E++ ++ L  ++ D +    L 
Sbjct: 65  LRRLEAFEHPNVVRLMD----VCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLP 118
Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            +    ++    +GL +LH      ++HRDLK  NIL+      K++DFG+AR ++
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 453 VATDNFSPANRLGQGGFGPV-----------YKGK-LQDEQEIAIKRLSKSSGQGIVEFK 500
           V  + F     LG+G FG V           Y  K L+ E  +A   ++ +  +  V   
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 501 NEAKLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           +    +  L+++    +RL  V EY     L F +  S  +   + + RF   E I   L
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 123
Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            YLH  S   V++RDLK+ N++LD+  + KI+DFG+ +
Sbjct: 124 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 23/158 (14%)
Query: 455 TDNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 511
           TD +     +G+G F  V +  KL    E A K ++  K S +   + + EA++   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 512 TNLGGERLLVYEYLPNKSLDFFIFD--SSRKSLLDWKKR--------FSIIEGITQGLLY 561
           +N+    + +++ +  +   + +FD  +  +   D   R           I+ I + +L+
Sbjct: 63  SNI----VRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGMA 596
            H+   + V+HRDLK  N+LL  +      K++DFG+A
Sbjct: 119 CHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA 153

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 130
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNXG 130
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 149
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 150 ---VLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 130
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 75  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 133
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 134 ---VLHRDIKDENILIDLNRGELKLIDFG 159

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 163
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 164 ---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 162
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 163 ---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 150
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 151 ---VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 163
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 164 ---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 149
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 150 ---VLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 162
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 163 ---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 150
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 151 ---VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 163
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 164 ---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 162
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 163 ---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 79/168 (47%), Gaps = 26/168 (15%)
Query: 448 FQTIAVAT---DNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLS--KSSGQGIVEFKN 501
           FQ +A  T   D++     LG+G F  V +  K    QE A K ++  K S +   + + 
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 502 EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFD--SSRKSLLDWKKR--------FSI 551
           EA++   L+H N+    + +++ +  +   + +FD  +  +   D   R           
Sbjct: 80  EARICRLLKHPNI----VRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC 135
Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGMA 596
           I  I + + ++H++    ++HRDLK  N+LL  +      K++DFG+A
Sbjct: 136 IHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA 180

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 135
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 136 ---VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 150
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 151 ---VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 162
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 163 ---VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 134
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 135 ---VLHRDIKDENILIDLNRGELKLIDFG 160

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 163
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 164 ---VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 135
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 136 ---VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 76  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 134
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 135 ---VLHRDIKDENILIDLNRGELKLIDFG 160

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 169
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 170 ---VLHRDIKDENILIDLNRGELKLIDFG 195

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 124 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 182
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 183 ---VLHRDIKDENILIDLNRGELKLIDFG 208

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 177
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 178 ---VLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 177
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 178 ---VLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 135
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 136 ---VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 21/158 (13%)
Query: 464 LGQGGFGPVY---KGKLQDEQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--- 514
           LGQG FG V+   K    D +++ A+K L K++   +  V  K E  ++ ++ H  +   
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                  G+  L+ ++L  +  D F   S      +   +F + E +   L +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 145
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
            +I+RDLK  NILLDE+ + K++DFG+++    +E +A
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 34/173 (19%)
Query: 456 DNFSPANRLGQGGFGPVYKG------KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           D       LG+G FG V +       K    + +A+K L + +         +E K++  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 509 LQH-----------TNLGGERLLVYEYLPNKSLDFFI------FDSSRKSLLDWKKRFSI 551
           + H           T  GG  +++ E+    +L  ++      F   +++  D  K F  
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 552 IEG-------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +E        + +G+ +L   +  + IHRDL   NILL E+   KI DFG+AR
Sbjct: 149 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 35/173 (20%)
Query: 456 DNFSPANRLGQGGFGPVYKG------KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           D  +    LG+G FG V +       K    + +A+K L + +         +E K++  
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 509 LQH-----------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWK------KRFSI 551
           + H           T  GG  +++ E+    +L  ++  S R   + +K      K F  
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKTPEDLYKDFLT 146
Query: 552 IEG-------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +E        + +G+ +L   +  + IHRDL   NILL E+   KI DFG+AR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYE 523
           +G+G FG V++GK + E E+A+K  S    +     + E      L+H N+ G   +  +
Sbjct: 12  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILG--FIAAD 67
Query: 524 YLPNKSLD--FFIFD-SSRKSLLDWKKRFSI-IEGITQ-------GLLYLH-----KYSR 567
              N +    + + D     SL D+  R+++ +EG+ +       GL +LH        +
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 127
Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMA--RTFTMNELEANTNRIVGT 614
             + HRDLK  NIL+ +     I+D G+A       + ++   N  VGT
Sbjct: 128 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 176

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 21/158 (13%)
Query: 464 LGQGGFGPVY---KGKLQDEQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--- 514
           LGQG FG V+   K    D +++ A+K L K++   +  V  K E  ++ ++ H  +   
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                  G+  L+ ++L  +  D F   S      +   +F + E +   L +LH    L
Sbjct: 93  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 146
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
            +I+RDLK  NILLDE+ + K++DFG+++    +E +A
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 184

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 28/167 (16%)
Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIA 507
           +   V  D+  P   LG+G +G V K + +   Q  A+KR+     +  V  + + +L+ 
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI-----RATVNSQEQKRLLX 81
Query: 508 KLQHTNLGGERLLVYEY---------------LPNKSLDFF---IFDSSRKSLLDWKKRF 549
            L  +    +      +               L + SLD F   + D  +    D   + 
Sbjct: 82  DLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKI 141
Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           ++   I + L +LH  S+L VIHRD+K SN+L++     K  DFG++
Sbjct: 142 AV--SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS 184

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 21/158 (13%)
Query: 464 LGQGGFGPVY---KGKLQDEQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--- 514
           LGQG FG V+   K    D +++ A+K L K++   +  V  K E  ++ ++ H  +   
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                  G+  L+ ++L  +  D F   S      +   +F + E +   L +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 145
Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
            +I+RDLK  NILLDE+ + K++DFG+++    +E +A
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 24/151 (15%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLGGERLL 520
           +G G +G V      +   ++AIK+L +     +   +   E +L+  ++H N+ G   L
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG---L 89
Query: 521 VYEYLPNKSLDFF--------IFDSSRKSLLDWKK------RFSIIEGITQGLLYLHKYS 566
           +  + P+++LD F           +    L+  +K      +F + + + +GL Y+H   
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ-MLKGLRYIHAAG 148
Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              +IHRDLK  N+ ++E    KI DFG+AR
Sbjct: 149 ---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 27/155 (17%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVE----FKNEAKLIAKLQHTNLGGE 517
           N +G+G +G V   K+  ++   I+R +K   +  VE    FK E +++  L H N+   
Sbjct: 15  NTIGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI--- 68
Query: 518 RLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
            + +YE   + +  + + +             K +        I++ +   + Y HK   
Sbjct: 69  -IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK--- 124
Query: 568 LRVIHRDLKVSNILL--DEQMNP-KISDFGMARTF 599
           L V HRDLK  N L   D   +P K+ DFG+A  F
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 22/149 (14%)
Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 517 ERLLVYEYLPNKSL----------DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
            RLL +   P+  +          D F F + R +L +   R S    + + + + H   
Sbjct: 99  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNCG 157
Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFG 594
              V+HRD+K  NIL+D  +   K+ DFG
Sbjct: 158 ---VLHRDIKDENILIDLNRGELKLIDFG 183

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 32/168 (19%)
Query: 452 AVATDNFSPANRLGQGGFGPVYK------GKLQDEQEIAIKRLSKSSGQGIV--EFKNEA 503
           ++  D++     LG G F  V K      GK    + I  +RLS SS +G+   E + E 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREV 59
Query: 504 KLIAKLQHTNLGGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSII 552
            ++ +++H N+    + +++   NK+            + F F + ++SL +  +    +
Sbjct: 60  NILREIRHPNI----ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFL 114
Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNI-LLDEQM-NPKIS--DFGMA 596
           + I  G+ YLH     R+ H DLK  NI LLD+ + NP+I   DFG+A
Sbjct: 115 KQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYE 523
           +G+G FG V++GK + E E+A+K  S    +     + E      L+H N+ G   +  +
Sbjct: 37  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILG--FIAAD 92
Query: 524 YLPNKSLD--FFIFD-SSRKSLLDWKKRFSI-IEGITQ-------GLLYLH-----KYSR 567
              N +    + + D     SL D+  R+++ +EG+ +       GL +LH        +
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 152
Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMA--RTFTMNELEANTNRIVGT 614
             + HRDLK  NIL+ +     I+D G+A       + ++   N  VGT
Sbjct: 153 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 201

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYE 523
           +G+G FG V++GK + E E+A+K  S    +     + E      L+H N+ G   +  +
Sbjct: 17  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILG--FIAAD 72
Query: 524 YLPNKSLD--FFIFD-SSRKSLLDWKKRFSI-IEGITQ-------GLLYLH-----KYSR 567
              N +    + + D     SL D+  R+++ +EG+ +       GL +LH        +
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 132
Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMA--RTFTMNELEANTNRIVGT 614
             + HRDLK  NIL+ +     I+D G+A       + ++   N  VGT
Sbjct: 133 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 181

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 26/159 (16%)
Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLGGERLLV 521
           ++G+G +G VYK K +D ++     L +  G GI +    E  L+ +L+H N+   + + 
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 522 YEYLPNKSLDFFIFDSSRKSLLDW------------KKRFSIIEGITQGLLY-----LHK 564
             +   K   + +FD +   L  W            KK   +  G+ + LLY     +H 
Sbjct: 88  LSHADRKV--WLLFDYAEHDL--WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 565 YSRLRVIHRDLKVSNILL----DEQMNPKISDFGMARTF 599
                V+HRDLK +NIL+     E+   KI+D G AR F
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYE 523
           +G+G FG V++GK + E E+A+K  S    +     + E      L+H N+ G   +  +
Sbjct: 14  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILG--FIAAD 69
Query: 524 YLPNKSLD--FFIFD-SSRKSLLDWKKRFSI-IEGITQ-------GLLYLH-----KYSR 567
              N +    + + D     SL D+  R+++ +EG+ +       GL +LH        +
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 129
Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMA--RTFTMNELEANTNRIVGT 614
             + HRDLK  NIL+ +     I+D G+A       + ++   N  VGT
Sbjct: 130 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 178

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 75/182 (41%), Gaps = 34/182 (18%)
Query: 446 FDFQTIAVATDNFSPANRLGQGGFGPVYKG------KLQDEQEIAIKRLSKSSGQGIVE- 498
           +D        D       LG+G FG V +       K    + +A+K L + +       
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 499 FKNEAKLIAKLQH-----------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWK- 546
             +E K++  + H           T  GG  +++ E+    +L  ++  S R   + +K 
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKP 137
Query: 547 ----KRFSIIEG-------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM 595
               K F  +E        + +G+ +L   +  + IHRDL   NILL E+   KI DFG+
Sbjct: 138 EDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGL 194
Query: 596 AR 597
           AR
Sbjct: 195 AR 196

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 16/132 (12%)
Query: 483 IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF--------I 534
           +A+K+LS+   Q     K   + +  L+  N      L+  + P K+L+ F        +
Sbjct: 50  VAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 108
Query: 535 FDSSRKSL----LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI 590
            D++   +    LD ++   ++  +  G+ +LH      +IHRDLK SNI++      KI
Sbjct: 109 MDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 165
Query: 591 SDFGMARTFTMN 602
            DFG+ART + N
Sbjct: 166 LDFGLARTASTN 177

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 27/155 (17%)
Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVE----FKNEAKLIAKLQHTNLGGE 517
           N +G+G +G V   K+  ++   I+R +K   +  VE    FK E +++  L H N+   
Sbjct: 32  NTIGRGSWGEV---KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI--- 85
Query: 518 RLLVYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
            + +YE   + +  + + +             K +        I++ +   + Y HK   
Sbjct: 86  -IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK--- 141
Query: 568 LRVIHRDLKVSNILL--DEQMNP-KISDFGMARTF 599
           L V HRDLK  N L   D   +P K+ DFG+A  F
Sbjct: 142 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 176

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYE 523
           +G+G FG V++GK + E E+A+K  S    +     + E      L+H N+ G   +  +
Sbjct: 11  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILG--FIAAD 66
Query: 524 YLPNKSLD--FFIFD-SSRKSLLDWKKRFSI-IEGITQ-------GLLYLH-----KYSR 567
              N +    + + D     SL D+  R+++ +EG+ +       GL +LH        +
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMA--RTFTMNELEANTNRIVGT 614
             + HRDLK  NIL+ +     I+D G+A       + ++   N  VGT
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 87/190 (45%), Gaps = 29/190 (15%)
Query: 427 GNRKTQARSDQTVKRDLKIFDFQTIAV---ATDNFSPANRLGQGGFGPVYKGKLQDEQEI 483
           G+ K +  +D  V R  + +D++ + V     D++    ++G+G +  V++G   +  E 
Sbjct: 1   GSSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEK 60
Query: 484 AIKRLSKSSG-----------QGIVEFKNEAKL--IAKLQHTNLGGERLLVYEYLPNKSL 530
            I ++ K              Q +    N  KL  I + QH+       L++EY+ N   
Sbjct: 61  CIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS---LIFEYVNNTD- 116
Query: 531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP-K 589
               F     +L D+  R+ I E + + L Y H      ++HRD+K  N+++D ++   +
Sbjct: 117 ----FKVLYPTLTDYDIRYYIYE-LLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLR 168
Query: 590 ISDFGMARTF 599
           + D+G+A  +
Sbjct: 169 LIDWGLAEFY 178

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 86/191 (45%), Gaps = 37/191 (19%)
Query: 430 KTQARSDQTVKRDLKIFDFQTIAVA---TDNFSPANRLGQGGFGPVYKG-KLQDEQEIAI 485
           + +  +D    R  + +D+ +  V     D++    +LG+G +  V++   + + +++ +
Sbjct: 8   RARVYTDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67
Query: 486 KRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERL----------------LVYEYLPNKS 529
           K L       I   K E K++  L+    GG  +                LV+E++ N  
Sbjct: 68  KILKPVKKNKI---KREIKILENLR----GGPNIITLADIVKDPVSRTPALVFEHVNNTD 120
Query: 530 LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNP 588
                F    ++L D+  RF + E I + L Y H    + ++HRD+K  N+++D E    
Sbjct: 121 -----FKQLYQTLTDYDIRFYMYE-ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKL 171
Query: 589 KISDFGMARTF 599
           ++ D+G+A  +
Sbjct: 172 RLIDWGLAEFY 182

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 456 DNFSPANRLGQGGFGPV-----------YKGKLQDEQEIA-IKRLSKSSGQGIVEFKNEA 503
           D F     LG G FG V           Y  K+ D+Q++  +K++  +  +  ++     
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 504 KLIAKLQHTNLGGERL-LVYEYLPNKSLDFFIFDSSRK--SLLDWKKRFSIIEGITQGLL 560
             + KL+ +      L +V EY P   +    F   R+     +   RF   + I     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 156
Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           YLH    L +I+RDLK  N+L+D+Q   K++DFG A+
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK 190

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 36/174 (20%)
Query: 456 DNFSPANRLGQGGFGPVYKG------KLQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           D       LG+G FG V +       K    + +A+K L + +         +E K++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 509 LQH-----------TNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWK-------KRFS 550
           + H           T  GG  +++ E+    +L  ++  S R   + +K       K F 
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFL 136
Query: 551 IIEG-------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +E        + +G+ +L   +  + IHRDL   NILL E+   KI DFG+AR
Sbjct: 137 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYE 523
           +G+G FG V++GK + E E+A+K  S    +     + E      L+H N+ G   +  +
Sbjct: 50  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILG--FIAAD 105
Query: 524 YLPNKSLD--FFIFD-SSRKSLLDWKKRFSI-IEGITQ-------GLLYLH-----KYSR 567
              N +    + + D     SL D+  R+++ +EG+ +       GL +LH        +
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMA--RTFTMNELEANTNRIVGT 614
             + HRDLK  NIL+ +     I+D G+A       + ++   N  VGT
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 483 IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF--------I 534
           +A+K+LS+   Q     K   + +  L+  N      L+  + P K+L+ F        +
Sbjct: 52  VAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 535 FDSSRKSL----LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI 590
            D++   +    LD ++   ++  +  G+ +LH      +IHRDLK SNI++      KI
Sbjct: 111 MDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 167
Query: 591 SDFGMARTFTMN 602
            DFG+ART   N
Sbjct: 168 LDFGLARTACTN 179

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 30/160 (18%)
Query: 464 LGQGGFGPVYKGKLQD--------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
           LGQG F  ++KG  ++        E E+ +K L K+       F   A +++KL H +L 
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                   G E +LV E++   SLD ++  +     + WK     +E   Q    +H   
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVAKQLAAAMHFLE 130
Query: 567 RLRVIHRDLKVSNILLDEQM-----NP---KISDFGMART 598
              +IH ++   NILL  +      NP   K+SD G++ T
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	614
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-79
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-72
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-67
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-49
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-44
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-33
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-30
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-30
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-28
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-28
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-24
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-23
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-23
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-23
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-22
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-22
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-22
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-22
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-22
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-21
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-20
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-20
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-20
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-19
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-19
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-18
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-18
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-18
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-18
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-17
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-17
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-17
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-16
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-15
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-15
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-15
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-15
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-14
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-14
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-14
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-14
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-05
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-14
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-13
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-13
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-13
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-13
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-12
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-12
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-12
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-12
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-12
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-12
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-11
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-11
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-06
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	7e-06
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	8e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-05
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	1e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  252 bits (645), Expect = 3e-79
 Identities = 70/200 (35%), Positives = 100/200 (50%), Gaps = 23/200 (11%)

Query: 434 RSDQTVKRDLKIFDFQTIAVATDNFSP------ANRLGQGGFGPVYKGKLQDEQEIAIKR 487
           +S +        F F  +   T+NF         N++G+GGFG VYKG + +   +A+K+
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK 61

Query: 488 LSK----SSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFI 534
           L+     ++ +   +F  E K++AK QH NL         G +  LVY Y+PN SL   +
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121

Query: 535 FDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG 594
                   L W  R  I +G   G+ +LH+      IHRD+K +NILLDE    KISDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178

Query: 595 MARTFTMNELEANTNRIVGT 614
           +AR          T+RIVGT
Sbjct: 179 LARASEKFAQTVMTSRIVGT 198

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  233 bits (597), Expect = 6e-72
 Identities = 73/183 (39%), Positives = 104/183 (56%), Gaps = 12/183 (6%)

Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGI-VEFKN 501
           LK F  + + VA+DNFS  N LG+GGFG VYKG+L D   +A+KRL +   QG  ++F+ 
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 502 EAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSI 551
           E ++I+   H NL           ERLLVY Y+ N S+   + +    +  LDW KR  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRI 611
             G  +GL YLH +   ++IHRD+K +NILLDE+    + DFG+A+     +    T  +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AV 195

Query: 612 VGT 614
            GT
Sbjct: 196 RGT 198

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  220 bits (564), Expect = 4e-67
 Identities = 64/190 (33%), Positives = 102/190 (53%), Gaps = 13/190 (6%)

Query: 435 SDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ 494
           S   V  +        +  AT+NF     +G G FG VYKG L+D  ++A+KR +  S Q
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ 77

Query: 495 GIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSL-LD 544
           GI EF+ E + ++  +H +L           E +L+Y+Y+ N +L   ++ S   ++ + 
Sbjct: 78  GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137

Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
           W++R  I  G  +GL YLH  +   +IHRD+K  NILLDE   PKI+DFG+++  T  + 
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194

Query: 605 EANTNRIVGT 614
              +  + GT
Sbjct: 195 THLSTVVKGT 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  174 bits (442), Expect = 1e-49
 Identities = 41/189 (21%), Positives = 78/189 (41%), Gaps = 26/189 (13%)

Query: 446 FDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKL 505
              + +   +          +G FG V+K +L + + +A+K       Q   + + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 506 IAKLQHTNL-------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
           +  ++H N+               +  L+  +    SL  F+    + +++ W +   I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 553 EGITQGLLYLH-------KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
           E + +GL YLH          +  + HRD+K  N+LL   +   I+DFG+A  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 606 ANTNRIVGT 614
            +T+  VGT
Sbjct: 188 GDTHGQVGT 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  161 bits (409), Expect = 1e-44
 Identities = 56/197 (28%), Positives = 83/197 (42%), Gaps = 36/197 (18%)

Query: 446 FDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAK- 504
                 ++  DN      +G+G +G VYKG L DE+ +A+K  S ++ Q    F NE   
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 505 -LIAKLQHTNL--------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRF 549
             +  ++H N+                E LLV EY PN SL  ++         DW    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114

Query: 550 SIIEGITQGLLYLH------KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN- 602
            +   +T+GL YLH       + +  + HRDL   N+L+       ISDFG++   T N 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 603 -----ELEANTNRIVGT 614
                E +      VGT
Sbjct: 175 LVRPGEEDNAAISEVGT 191

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  133 bits (337), Expect = 5e-35
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 15/164 (9%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL----- 514
            ++G G FG V++ +     ++A+K L +     + + EF  E  ++ +L+H N+     
Sbjct: 43  EKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                    +V EYL   SL   +  S  +  LD ++R S+   + +G+ YLH      +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +HR+LK  N+L+D++   K+ DFG++R      L + +    GT
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGT 202

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  128 bits (323), Expect = 4e-33
 Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 16/161 (9%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----GG- 516
             +G+G FG V K K +  +++AIK++   S      F  E + ++++ H N+    G  
Sbjct: 14  EVVGRGAFGVVCKAKWRA-KDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 517 --ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD 574
                LV EY    SL   +  +            S     +QG+ YLH      +IHRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 575 LKVSNILLDEQMN-PKISDFGMARTFTMNELEANTNRIVGT 614
           LK  N+LL       KI DFG A      +++ +     G+
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGS 166

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  126 bits (319), Expect = 6e-33
 Identities = 29/153 (18%), Positives = 60/153 (39%), Gaps = 16/153 (10%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL----- 514
            +L +   G ++KG+ Q   +I +K L     S +   +F  E   +    H N+     
Sbjct: 16  TKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                      L+  ++P  SL   + + +   + D  +       + +G+ +LH    L
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTLEPL 133

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
            +    L   ++++DE M  +IS   +  +F  
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQS 165

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  126 bits (319), Expect = 2e-32
 Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 15/159 (9%)

Query: 462 NRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
             LG+G FG   K    +  + + +K L +   +    F  E K++  L+H N+      
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                    + EY+   +L   I     +    W +R S  + I  G+ YLH    + +I
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNII 130

Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           HRDL   N L+ E  N  ++DFG+AR     + +    R
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  120 bits (303), Expect = 1e-30
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 17/163 (10%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL----- 514
            R+G G FG VYKGK   +  +A+K L+ +  + Q +  FKNE  ++ K +H N+     
Sbjct: 30  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                +  +V ++    SL   +  S  K   + KK   I     +G+ YLH      +I
Sbjct: 88  YSTAPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLH---AKSII 142

Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           HRDLK +NI L E    KI DFG+A   +         ++ G+
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  119 bits (301), Expect = 2e-30
 Identities = 46/168 (27%), Positives = 71/168 (42%), Gaps = 26/168 (15%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKS----SGQGIVEFKNEAKLIAKLQHTNL--- 514
             +G GGFG VY+       E+A+K           Q I   + EAKL A L+H N+   
Sbjct: 13  EIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                      LV E+     L+  +        +      +    I +G+ YLH  + +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 569 RVIHRDLKVSNILLDEQMNP--------KISDFGMARTFTMNELEANT 608
            +IHRDLK SNIL+ +++          KI+DFG+AR +      +  
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  119 bits (301), Expect = 2e-30
 Identities = 42/173 (24%), Positives = 79/173 (45%), Gaps = 28/173 (16%)

Query: 462 NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTN 513
            ++G+GGFG V+KG+L  D+  +AIK L     +G         EF+ E  +++ L H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 514 ----LGG---ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                G       +V E++P   L   +    +   + W  +  ++  I  G+ Y+    
Sbjct: 85  IVKLYGLMHNPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQN-Q 141

Query: 567 RLRVIHRDLKVSNILLDEQ-----MNPKISDFGMARTFTMNELEANTNRIVGT 614
              ++HRDL+  NI L        +  K++DFG+++     +   + + ++G 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGN 189

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  115 bits (291), Expect = 1e-28
 Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 30/175 (17%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAK--LIAKLQHTNL----- 514
            ++G+G +G V+ GK +  +++A+K            +  E +      ++H N+     
Sbjct: 43  KQIGKGRYGEVWMGKWRG-EKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH--- 563
                     +  L+ +Y  N SL    +D  + + LD K    +      GL +LH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 564 --KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF--TMNELEANTNRIVGT 614
                +  + HRDLK  NIL+ +     I+D G+A  F    NE++   N  VGT
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  115 bits (290), Expect = 1e-28
 Identities = 37/160 (23%), Positives = 67/160 (41%), Gaps = 19/160 (11%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL----- 514
             +G+G FG VY G+     E+AI+ +     +   +  FK E     + +H N+     
Sbjct: 39  ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 515 ---GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                  L ++      ++L   +     K +LD  K   I + I +G+ YLH      +
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           +H+DLK  N+  D      I+DFG+     + +     ++
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDK 190

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  114 bits (288), Expect = 1e-28
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 30/175 (17%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKL--IAKLQHTNL----- 514
             +G+G +G V++G  Q  + +A+K  S    +    +  E +L     L+H N+     
Sbjct: 14  ECVGKGRYGEVWRGSWQG-ENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH--- 563
                     +  L+  Y    SL    +D  + + LD      I+  I  GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 564 --KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR--TFTMNELEANTNRIVGT 614
                +  + HRDLK  NIL+ +     I+D G+A   + + N+L+   N  VGT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  111 bits (279), Expect = 6e-27
 Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 30/175 (17%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAK--LIAKLQHTNL----- 514
             +G+G FG V++GK +  +E+A+K  S    +    +  EA+      L+H N+     
Sbjct: 48  ESIGKGRFGEVWRGKWRG-EEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH--- 563
                     +  LV +Y  + SL    FD   +  +  +    +      GL +LH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 564 --KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF--TMNELEANTNRIVGT 614
                +  + HRDLK  NIL+ +     I+D G+A       + ++   N  VGT
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  109 bits (275), Expect = 1e-26
 Identities = 40/174 (22%), Positives = 67/174 (38%), Gaps = 28/174 (16%)

Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIA 507
             + +   ++    +LG+GGF  V   + L D    A+KR+     Q   E + EA +  
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 508 KLQHTNL-------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS---- 550
              H N+               E  L+  +    +L   I     + L D     +    
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQI 136

Query: 551 --IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
             ++ GI +GL  +H        HRDLK +NILL ++  P + D G      ++
Sbjct: 137 LWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  104 bits (261), Expect = 2e-24
 Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 16/146 (10%)

Query: 463 RLGQGGFGPVYKGKLQ-DEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++G+G FG V+ G+L+ D   +A+K            +F  EA+++ +  H N+      
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   +V E +       F+   +  + L  K    ++     G+ YL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N L+ E+   KISDFGM+R
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR 261

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  101 bits (255), Expect = 3e-24
 Identities = 50/185 (27%), Positives = 79/185 (42%), Gaps = 37/185 (20%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN- 513
            +F     +G GGFG V+K K   D +   IKR+  ++     + + E K +AKL H N 
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 514 -----------------------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRF 549
                                     + L +  E+    +L+ +I +  R   LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
            + E IT+G+ Y+H     ++I+RDLK SNI L +    KI DFG+  +   N+ +    
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRTR- 180

Query: 610 RIVGT 614
              GT
Sbjct: 181 -SKGT 184

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  101 bits (254), Expect = 5e-24
 Identities = 41/176 (23%), Positives = 67/176 (38%), Gaps = 26/176 (14%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN 513
            +F P   LG+GGFG V++ K   D+   AIKR+          +   E K +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 514 ------------------LGGERLLVY---EYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
                                 ++ +Y   +    ++L  ++         +      I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
             I + + +LH      ++HRDLK SNI        K+ DFG+      +E E   
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  101 bits (254), Expect = 7e-24
 Identities = 40/178 (22%), Positives = 69/178 (38%), Gaps = 29/178 (16%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQH 511
            NF    ++G+G F  VY+   L D   +A+K++        +   +   E  L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 512 TN--------LGGERLLVY-EYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGIT 556
            N        +    L +  E      L   I     K     K+             + 
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLC 146

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             L ++H     RV+HRD+K +N+ +      K+ D G+ R F+     A++  +VGT
Sbjct: 147 SALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 15/145 (10%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             +G G FG V+ G   ++ ++AIK + +       +F  EA+++ KL H  L       
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
                  LV E++ +  L  ++   +++ L   +    +   + +G+ YL       VIH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDL   N L+ E    K+SDFGM R
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTR 152

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  100 bits (251), Expect = 2e-23
 Identities = 41/178 (23%), Positives = 78/178 (43%), Gaps = 17/178 (9%)

Query: 448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKL 505
           FQ+++V    +S   ++G GG   V++   + +Q  AIK ++      Q +  ++NE   
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 506 IAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDW---KKRFS------IIEGIT 556
           + KLQ  +    RL  Y+Y       + + +     L  W   KK           + + 
Sbjct: 80  LNKLQQHSDKIIRL--YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML 137

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           + +  +H++    ++H DLK +N L+ +    K+ DFG+A     +      +  VGT
Sbjct: 138 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  100 bits (252), Expect = 2e-23
 Identities = 39/171 (22%), Positives = 73/171 (42%), Gaps = 18/171 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHT 512
           + +    ++G+G FG     K  +D ++  IK   +S+ S +   E + E  ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+          G   +V +Y     L   I ++ +  L    +       I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                +++HRD+K  NI L +    ++ DFG+AR        A     +GT
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 98.8 bits (247), Expect = 3e-23
 Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 15/144 (10%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
            LG G FG V  GK + + ++A+K + K       EF  EA+ + KL H  L        
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
                 +V EY+ N  L  ++   S    L+  +   +   + +G+ +L      + IHR
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 574 DLKVSNILLDEQMNPKISDFGMAR 597
           DL   N L+D  +  K+SDFGM R
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTR 152

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.8 bits (247), Expect = 3e-23
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 15/145 (10%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             LG G FG V  GK + + ++AIK + K       EF  EAK++  L H  L       
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIH 572
                  ++ EY+ N  L  ++     +     ++   + + + + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 573 RDLKVSNILLDEQMNPKISDFGMAR 597
           RDL   N L+++Q   K+SDFG++R
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR 168

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 99.2 bits (248), Expect = 6e-23
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 27/166 (16%)

Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL- 514
             LG G FG VYKG    E E     +AIK L + +S +   E  +EA ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSIIEGITQGLLYLH 563
                       L+ + +P   L  ++ +       + LL+W         I +G+ YL 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL- 133

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
                R++HRDL   N+L+    + KI+DFG+A+     E E +  
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  100 bits (252), Expect = 6e-23
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 13/150 (8%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
            +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  L       
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
                 ++ E++   SL  F+  S   S     K       I +G+ ++    +   IHR
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHR 308

Query: 574 DLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           DL+ +NIL+   +  KI+DFG+AR    NE
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNE 338

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 98.1 bits (245), Expect = 7e-23
 Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 19/176 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 512
           +++     +G G +G   K +   D + +  K L     +        +E  L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 513 NL-----------GGERLLVYEYLPNKSLDFFIFDSSRK-SLLDWKKRFSIIEGITQGLL 560
           N+                +V EY     L   I   +++   LD +    ++  +T  L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 561 YLH--KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             H        V+HRDLK +N+ LD + N K+ DFG+AR    +   A T   VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 36/153 (23%), Positives = 67/153 (43%), Gaps = 17/153 (11%)

Query: 463 RLGQGGFGPVYKGKLQ---DEQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL---- 514
            LG G FG V +G  +    + ++AIK L + +      E   EA+++ +L +  +    
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                   +LV E      L  F+    ++  +       ++  ++ G+ YL        
Sbjct: 77  GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 131

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +HRDL   N+LL  +   KISDFG+++    ++
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 40/177 (22%), Positives = 76/177 (42%), Gaps = 17/177 (9%)

Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLI 506
           + I+V    +S   ++G GG   V++   + +Q  AIK ++      Q +  ++NE   +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 507 AKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDW---KKRFS------IIEGITQ 557
            KLQ  +    RL  Y+Y       + + +     L  W   KK           + + +
Sbjct: 62  NKLQQHSDKIIRL--YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 119

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            +  +H++    ++H DLK +N L+ +    K+ DFG+A     +      +  VGT
Sbjct: 120 AVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 45/167 (26%), Positives = 66/167 (39%), Gaps = 25/167 (14%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 513
             +F     LGQG FG V K +   D +  AIK++  +  + +    +E  L+A L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 514 --------LGGERLLVYEYLPNKSLDFFI----------FD--SSRKSLLDWKKRFSIIE 553
                   L     +       K    FI          +D   S        + + +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            I + L Y+H      +IHRDLK  NI +DE  N KI DFG+A+   
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 31/164 (18%)

Query: 462 NRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
             LG+G FG V+  +       +D+  +A+K L   +     +F+ EA+L+  LQH ++ 
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 515 --------GGERLLVYEYLPNKSLDFF-------------IFDSSRKSLLDWKKRFSIIE 553
                   G   ++V+EY+ +  L+ F                   K  L   +   I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            I  G++YL   +    +HRDL   N L+   +  KI DFGM+R
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 30/163 (18%)

Query: 462 NRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
             LG+G FG V+  +       QD+  +A+K L ++S     +F+ EA+L+  LQH ++ 
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 515 --------GGERLLVYEYLPNKSLDFF------------IFDSSRKSLLDWKKRFSIIEG 554
                   G   L+V+EY+ +  L+ F              +      L   +  ++   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +  G++YL   + L  +HRDL   N L+ + +  KI DFGM+R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 21/158 (13%)

Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
            +LG+G FG V   +    Q+     +A+K+L  S+ + + +F+ E +++  LQH N+  
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 515 --------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                   G   L L+ EYLP  SL  ++     K  +D  K       I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
              R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 19/150 (12%)

Query: 462 NRLGQGGFGPVYKGKLQ----DEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
             +G G  G V  G+L+     +  +AIK L +  + +   +F +EA ++ +  H N+  
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
                  G   ++V EY+ N SLD F+     +      +   ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           L  +HRDL   N+L+D  +  K+SDFG++R
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)

Query: 463 RLGQGGFGPVYKGKLQ---DEQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNL--- 514
            LG G FG V KG  Q     + +A+K L    +      E   EA ++ +L +  +   
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSR---KSLLDWKKRFSIIEGITQGLLYLHKYS 566
                    +LV E      L+ ++  +     K++++       +  ++ G+ YL    
Sbjct: 84  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYL---E 134

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
               +HRDL   N+LL  Q   KISDFG+++    +E
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 21/158 (13%)

Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
            +LG+G FG V   +    Q+     +A+K+L  S+ + + +F+ E +++  LQH N+  
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 515 --------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                   G   L L+ EYLP  SL  ++     K  +D  K       I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
              R IHRDL   NIL++ +   KI DFG+ +    ++
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 96.3 bits (240), Expect = 4e-22
 Identities = 44/159 (27%), Positives = 66/159 (41%), Gaps = 24/159 (15%)

Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL- 514
             LG+G FG V         +     +A+K L   +G Q    +K E  ++  L H ++ 
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 515 ---------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                    G   L LV EY+P  SL  ++     +  +   +     + I +G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH- 151

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
                 IHRDL   N+LLD     KI DFG+A+      
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 19/172 (11%)

Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIA 507
           QT+ +          L +GGF  VY+ + +   +E A+KRL  +  +       E   + 
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80

Query: 508 KLQ-HTNL----------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS 550
           KL  H N+                G    L+   L    L  F+     +  L       
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
           I     + + ++H   +  +IHRDLKV N+LL  Q   K+ DFG A T +  
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 47/146 (32%), Positives = 70/146 (47%), Gaps = 17/146 (11%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLL- 520
            RLG G FG V+ G      ++A+K L K        F  EA L+ +LQH  L   RL  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL--VRLYA 75

Query: 521 ---------VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                    + EY+ N SL  F+  +     L   K   +   I +G+ ++        I
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL+ +NIL+ + ++ KI+DFG+AR
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLAR 157

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 32/165 (19%)

Query: 462 NRLGQGGFGPVYKGKL------QDEQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 514
             LG+  FG VYKG L      +  Q +AIK L   + G    EF++EA L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 515 ---------GGERLLVYEYLPNKSLDFF-------------IFDSSRKSLLDWKKRFSII 552
                         +++ Y  +  L  F               D + KS L+      ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             I  G+ YL   S   V+H+DL   N+L+ +++N KISD G+ R
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 95.4 bits (238), Expect = 6e-22
 Identities = 44/162 (27%), Positives = 64/162 (39%), Gaps = 32/162 (19%)

Query: 463 RLGQGGFGPVYKGKLQ----DEQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLG 515
           +LG G FG V +G+          +A+K L     S  + + +F  E   +  L H NL 
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL- 83

Query: 516 GERL----------LVYEYLPNKSLDFFIFDSSRK----SLLDWKKRFSIIEGITQGLLY 561
             RL          +V E  P  SL   +          +L  +         + +G+ Y
Sbjct: 84  -IRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGY 136

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           L      R IHRDL   N+LL  +   KI DFG+ R    N+
Sbjct: 137 L---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 96.7 bits (241), Expect = 7e-22
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 19/150 (12%)

Query: 462 NRLGQGGFGPVYKGKLQ----DEQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL-- 514
             +G G FG V  G+L+     E  +AIK L    + +   +F  EA ++ +  H N+  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
                      ++V EY+ N SLD F+      +     +   ++ GI  G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SD 165

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +  +HRDL   NIL++  +  K+SDFG+ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGR 195

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 20/150 (13%)

Query: 463 RLGQGGFGPVYKGKLQD-----EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL-- 514
            +G G FG VYKG L+      E  +AIK L    + +  V+F  EA ++ +  H N+  
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
                      +++ EY+ N +LD F+    +       +   ++ GI  G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL---AN 165

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           +  +HRDL   NIL++  +  K+SDFG++R
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSR 195

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 30/166 (18%)

Query: 463 RLGQGGFGPVYKGKLQD--------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 514
            LGQG F  ++KG  ++        E E+ +K L K+       F   A +++KL H +L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                    G E +LV E++   SLD ++     K+ ++   +  + + +   + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 566 SRLRVIHRDLKVSNILLDEQMNP--------KISDFGMARTFTMNE 603
               +IH ++   NILL  + +         K+SD G++ T    +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 97.5 bits (243), Expect = 9e-22
 Identities = 48/156 (30%), Positives = 70/156 (44%), Gaps = 13/156 (8%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
            +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L       
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
                 +V EY+   SL  F         L   +   +   I  G+ Y+    R+  +HR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 304

Query: 574 DLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           DL+ +NIL+ E +  K++DFG+AR    NE  A   
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 96.8 bits (241), Expect = 9e-22
 Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 17/177 (9%)

Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLI 506
           + I+V    +S   ++G GG   V++   + +Q  AIK ++      Q +  ++NE   +
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108

Query: 507 AKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDW---KKRFSIIEG------ITQ 557
            KLQ  +    RL  Y+Y       + + +     L  W   KK     E       + +
Sbjct: 109 NKLQQHSDKIIRL--YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 166

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            +  +H++    ++H DLK +N L+ +    K+ DFG+A     +      +  VG 
Sbjct: 167 AVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 22/159 (13%)

Query: 462 NRLGQGGFGPVYKGKL-----QDEQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL- 514
             LG+G FG V   +         +++A+K L  +S G  I + K E +++  L H N+ 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 515 ---------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                    GG  + L+ E+LP+ SL  ++     K+ ++ K++      I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
               + +HRDL   N+L++ +   KI DFG+ +    ++
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 38/158 (24%), Positives = 71/158 (44%), Gaps = 15/158 (9%)

Query: 462 NRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L K     + EF  EA ++ +++H NL      
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++     +  +       +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           HRDL   N L+ E    K++DFG++R  T +   A+  
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 43/154 (27%), Positives = 63/154 (40%), Gaps = 27/154 (17%)

Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL- 514
             LG G FG V+KG    E E     + IK +   SG Q      +    I  L H ++ 
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSIIEGITQGLLYLH 563
                  G    LV +YLP  SL   +         + LL+W         I +G+ YL 
Sbjct: 79  RLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL- 131

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                 ++HR+L   N+LL      +++DFG+A 
Sbjct: 132 --EEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 20/151 (13%)

Query: 462 NRLGQGGFGPVYKGKLQD----EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL-- 514
             +G+G FG VY G L D    +   A+K L++ +    + +F  E  ++    H N+  
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                    G  L+V  Y+ +  L  FI + +       K        + +G+ YL   +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---A 145

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + +HRDL   N +LDE+   K++DFG+AR
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 27/166 (16%)

Query: 462 NRLGQGGFGPVYKGKLQDEQE-----IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL- 514
             LG G FG VYKG    E E     +AIK L   +S +   E  +EA ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDS----SRKSLLDWKKRFSIIEGITQGLLYLH 563
                       L+ + +P   L  ++ +       + LL+W         I +G+ YL 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL- 133

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
                R++HRDL   N+L+    + KI+DFG+A+     E E +  
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 97.6 bits (243), Expect = 1e-21
 Identities = 48/156 (30%), Positives = 70/156 (44%), Gaps = 13/156 (8%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
            +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  L       
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR 573
                 +V EY+   SL  F         L   +   +   I  G+ Y+    R+  +HR
Sbjct: 332 SEEPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 387

Query: 574 DLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           DL+ +NIL+ E +  K++DFG+AR    NE  A   
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 47/202 (23%), Positives = 83/202 (41%), Gaps = 28/202 (13%)

Query: 419 NVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANR--------LGQGGFG 470
           + SL    G+     +   TV  DL   + + +          +         +G+G FG
Sbjct: 44  STSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFG 103

Query: 471 PVYKGKLQD----EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL----------G 515
            VY G L D    +   A+K L++ +    + +F  E  ++    H N+           
Sbjct: 104 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163

Query: 516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDL 575
           G  L+V  Y+ +  L  FI + +       K        + +G+ +L   +  + +HRDL
Sbjct: 164 GSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDL 218

Query: 576 KVSNILLDEQMNPKISDFGMAR 597
              N +LDE+   K++DFG+AR
Sbjct: 219 AARNCMLDEKFTVKVADFGLAR 240

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 21/158 (13%)

Query: 462 NRLGQGGFGPVYKGKL-----QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-- 514
           ++LG+G FG V   +           +A+K+L  S      +F+ E +++  L    +  
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 515 --------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                   G + L LV EYLP+  L  F+     ++ LD  +       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
              R +HRDL   NIL++ + + KI+DFG+A+   +++
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 35/148 (23%), Positives = 58/148 (39%), Gaps = 18/148 (12%)

Query: 463 RLGQGGFGPVYKGKLQD----EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL--- 514
            +G+G FG V++G           +AIK     +S     +F  EA  + +  H ++   
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                     ++ E      L  F+    RK  LD          ++  L YL      R
Sbjct: 82  IGVITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ESKR 136

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +HRD+   N+L+      K+ DFG++R
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR 164

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 20/151 (13%)

Query: 462 NRLGQGGFGPVYKGKLQD----EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL-- 514
             +G+G FG VY G+  D      + AIK LS+ +  Q +  F  E  L+  L H N+  
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                    G   ++  Y+ +  L  FI    R      K   S    + +G+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---A 141

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             + +HRDL   N +LDE    K++DFG+AR
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 36/148 (24%), Positives = 63/148 (42%), Gaps = 18/148 (12%)

Query: 463 RLGQGGFGPVYKGKLQD----EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL--- 514
            LG+G FG VY+G   +    +  +A+K   K  +     +F +EA ++  L H ++   
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                     ++ E  P   L  ++     K+ L           I + + YL     + 
Sbjct: 79  IGIIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL---ESIN 133

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +HRD+ V NIL+      K+ DFG++R
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSR 161

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 17/146 (11%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             +G+G FG V  G  +   ++A+K +   +      F  EA ++ +L+H+NL       
Sbjct: 27  QTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 83

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
               G   +V EY+   SL  ++  S  +S+L           + + + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N+L+ E    K+SDFG+ +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK 165

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 96.2 bits (239), Expect = 5e-21
 Identities = 35/153 (22%), Positives = 66/153 (43%), Gaps = 17/153 (11%)

Query: 463 RLGQGGFGPVYKGKLQDEQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL---- 514
            LG G FG V +G  +  ++   +AIK L   +      E   EA+++ +L +  +    
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
                   +LV E      L  F+    ++  +       ++  ++ G+ YL        
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 457

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           +HR+L   N+LL  +   KISDFG+++    ++
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 26/159 (16%)

Query: 462 NRLGQGGFGPVYKGKLQD------EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 514
             LGQG FG VY+G  +       E  +AIK +++ +S +  +EF NEA ++ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 515 ---------GGERLLVYEYLPNKSLDFF-------IFDSSRKSLLDWKKRFSIIEGITQG 558
                    G   L++ E +    L  +       + ++   +     K   +   I  G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + YL   +  + +HRDL   N ++ E    KI DFGM R
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 95.2 bits (237), Expect = 7e-21
 Identities = 37/158 (23%), Positives = 71/158 (44%), Gaps = 15/158 (9%)

Query: 462 NRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------ 514
           ++LG G +G VY+G  +     +A+K L K     + EF  EA ++ +++H NL      
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
                   ++ E++   +L  ++     +  +       +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 572 HRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           HR+L   N L+ E    K++DFG++R  T +   A+  
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 92.4 bits (230), Expect = 8e-21
 Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 34/171 (19%)

Query: 464 LGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN----LG--- 515
           LG+G +G VY G+    Q  IAIK + +   +       E  L   L+H N    LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 516 -GERLLVY-EYLPNKSLDFFIFDSSRKSLLDWK-KRFSIIEG--------ITQGLLYLHK 564
               + ++ E +P  SL          +LL  K       E         I +GL YLH 
Sbjct: 90  ENGFIKIFMEQVPGGSL---------SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH- 139

Query: 565 YSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTFTMNELEANTNRIVGT 614
               +++HRD+K  N+L++      KISDFG ++   +  +   T    GT
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGT 186

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 27/150 (18%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTNLGGERL 519
           LG+GGF   ++      ++  A K + KS        E    E  +   L H ++     
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV--VGF 106

Query: 520 -----------LVYEYLPNKSLDFFIFD--SSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                      +V E    +SL     +    RK+L + + R+  +  I  G  YLH   
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLH--- 158

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           R RVIHRDLK+ N+ L+E +  KI DFG+A
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 27/150 (18%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTNLGGERL 519
           LG+GGF   ++      ++  A K + KS        E    E  +   L H ++     
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV--VGF 80

Query: 520 -----------LVYEYLPNKSLDFFIFD--SSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                      +V E    +SL     +    RK+L + + R+  +  I  G  YLH   
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLH--- 132

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           R RVIHRDLK+ N+ L+E +  KI DFG+A
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 36/159 (22%), Positives = 68/159 (42%), Gaps = 26/159 (16%)

Query: 462 NRLGQGGFGPVYKGKLQD----EQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNL- 514
             LG+G FG V +G L+       ++A+K +    SS + I EF +EA  +    H N+ 
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 515 -------------GGERLLVYEYLPNKSLDFFIFDS---SRKSLLDWKKRFSIIEGITQG 558
                          + +++  ++    L  ++  S   +    +  +     +  I  G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + YL   S    +HRDL   N +L + M   ++DFG+++
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 39/169 (23%), Positives = 74/169 (43%), Gaps = 20/169 (11%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQ 510
            +   +  ++ LGQG    V++G+  +     AIK  +  S    V+    E +++ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 511 HTNL-----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           H N+              ++L+ E+ P  SL   + + S    L   +   ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 560 LYLHKYSRLRVIHRDLKVSNILL----DEQMNPKISDFGMARTFTMNEL 604
            +L +     ++HR++K  NI+     D Q   K++DFG AR    +E 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 27/162 (16%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTNLGGERL 519
           LG+G F  VY+ + +    E+AIK + K +    G+V+  +NE K+  +L+H ++    L
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI--LEL 76

Query: 520 -----------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                      LV E   N  +      +  K   + + R   +  I  G+LYLH     
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARH-FMHQIITGMLYLH---SH 131

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            ++HRDL +SN+LL   MN KI+DFG+A      +L+    +
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEK 168

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 37/146 (25%), Positives = 63/146 (43%), Gaps = 17/146 (11%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
             +G+G FG V  G  +   ++A+K +   +      F  EA ++ +L+H+NL       
Sbjct: 199 QTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 255

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
               G   +V EY+   SL  ++    R  L            + + + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 572 HRDLKVSNILLDEQMNPKISDFGMAR 597
           HRDL   N+L+ E    K+SDFG+ +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK 337

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 37/170 (21%), Positives = 74/170 (43%), Gaps = 17/170 (10%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 513
            + +     LG G FG VYK K  +     A K +   S + + ++  E +++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 514 --------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                       +L ++ E+ P  ++D  +        L   +   +   + + L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
               R+IHRDLK  N+L+  + + +++DFG++        + ++   +GT
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 46/159 (28%), Positives = 65/159 (40%), Gaps = 26/159 (16%)

Query: 462 NRLGQGGFGPVYKGKLQD------EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 514
             LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 515 ---------GGERLLVYEYLPNKSLDFFI----FDSSRKSLLDWKKRFSIIEGITQGLLY 561
                       R ++ E +    L  F+       S+ S L       +   I  G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 562 LHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
           L        IHRD+   N LL         KI DFGMAR
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 39/169 (23%), Positives = 74/169 (43%), Gaps = 20/169 (11%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQ 510
            +   +  ++ LGQG    V++G+  +     AIK  +  S    V+    E +++ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 511 HTNL-----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           H N+              ++L+ E+ P  SL   + + S    L   +   ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 560 LYLHKYSRLRVIHRDLKVSNILL----DEQMNPKISDFGMARTFTMNEL 604
            +L +     ++HR++K  NI+     D Q   K++DFG AR    +E 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 20/165 (12%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIK--RLSKSSGQGIVE-FKNEAKLIAKLQHTNL---- 514
           +LG GG   VY  +      ++AIK   +     +  ++ F+ E    ++L H N+    
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                     LV EY+   +L  +I        L      +    I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           ++HRD+K  NIL+D     KI DFG+A+  +   L   TN ++GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGT 175

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 90.9 bits (226), Expect = 6e-20
 Identities = 46/159 (28%), Positives = 65/159 (40%), Gaps = 26/159 (16%)

Query: 462 NRLGQGGFGPVYKGKLQD------EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 514
             LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 515 ---------GGERLLVYEYLPNKSLDFFI----FDSSRKSLLDWKKRFSIIEGITQGLLY 561
                       R ++ E +    L  F+       S+ S L       +   I  G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 562 LHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMAR 597
           L        IHRD+   N LL         KI DFGMAR
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 19/170 (11%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 513
              ++   ++GQG  G VY    +   QE+AI++++           NE  ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 514 --------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                   L G+ L +V EYL   SL     D   ++ +D  +  ++     Q L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
               +VIHRD+K  NILL    + K++DFG     T  + + +T  +VGT
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 90.1 bits (224), Expect = 7e-20
 Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 27/160 (16%)

Query: 462 NRLGQGGFGPVYKGKLQD----EQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNL- 514
             LG+G FG V + +L+       ++A+K L     +   I EF  EA  + +  H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 515 --------------GGERLLVYEYLPNKSLDFFIFDSS---RKSLLDWKKRFSIIEGITQ 557
                             +++  ++ +  L  F+  S        L  +     +  I  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           G+ YL   S    IHRDL   N +L E M   ++DFG++R
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 20/171 (11%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHT 512
            + F+   ++G+G FG V+KG   + ++ +AIK +  + +   I + + E  ++++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 513 N--------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
                    L   +L ++ EYL   S      D      LD  +  +I+  I +GL YLH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                + IHRD+K +N+LL E    K++DFG+A   T  +++ NT   VGT
Sbjct: 137 S---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 89.1 bits (222), Expect = 9e-20
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 30/175 (17%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAK 508
           +NF    ++G+G +G VYK +     + +A+K++   +  +G+          E  L+ +
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV----PSTAIREISLLKE 58

Query: 509 LQHTNL--------GGERL-LVYEYLPN--KSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           L H N+           +L LV+E+L    K       D+S  + +      S +  + Q
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQLLQ 114

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           GL + H +   RV+HRDLK  N+L++ +   K++DFG+AR F    +   T+ +V
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV 165

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 40/179 (22%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAKL 509
           + +    ++G+G +G VYK K    + +A+KR+   +  +GI          E  L+ +L
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI----PSTAIREISLLKEL 76

Query: 510 QHTNL--------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRF-------SIIE 553
            H N+            L LV+E++          +   K +LD  K           + 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM----------EKDLKKVLDENKTGLQDSQIKIYLY 126

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
            + +G+ + H++   R++HRDLK  N+L++     K++DFG+AR F    + + T+ +V
Sbjct: 127 QLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV 181

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 19/170 (11%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 513
                   ++G+G  G V   +     +++A+K +     Q      NE  ++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 514 --------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                   L GE L ++ E+L   +L     D   +  L+ ++  ++ E + Q L YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                VIHRD+K  +ILL      K+SDFG     + +  +  +  +VGT
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 91.8 bits (228), Expect = 1e-19
 Identities = 35/148 (23%), Positives = 59/148 (39%), Gaps = 18/148 (12%)

Query: 463 RLGQGGFGPVYKGKLQD----EQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL--- 514
            +G+G FG V++G           +AIK   + +S     +F  EA  + +  H ++   
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                     ++ E      L  F+    RK  LD          ++  L YL      R
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKR 511

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMAR 597
            +HRD+   N+L+      K+ DFG++R
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR 539

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 30/163 (18%)

Query: 462 NRLGQGGFGPVYKGKLQD---EQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QHTNL-- 514
           + +G+G FG V K +++      + AIKR+   +S     +F  E +++ KL  H N+  
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 515 -------GGERLLVYEYLPNKSLDFF-------------IFDSSRKSLLDWKKRFSIIEG 554
                   G   L  EY P+ +L  F                +S  S L  ++       
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + +G+ YL   S+ + IHRDL   NIL+ E    KI+DFG++R
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 45/186 (24%)

Query: 454 ATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN-----EAKLIA 507
           ++  F    +LG G +  VYKG        +A+K +   S +G           E  L+ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLMK 58

Query: 508 KLQHTN--------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGIT-- 556
           +L+H N            +L LV+E++          D+  K  +D +   +   G+   
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFM----------DNDLKKYMDSRTVGNTPRGLELN 108

Query: 557 ----------QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEA 606
                     QGL + H+    +++HRDLK  N+L++++   K+ DFG+AR F    +  
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNT 164

Query: 607 NTNRIV 612
            ++ +V
Sbjct: 165 FSSEVV 170

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 32/175 (18%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGI-VEFKNEAKLIAKLQHTN 513
           + +   ++LG+G +  VYKGK +    + A+K +     +G       E  L+  L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 514 L--------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRF-------SIIEGITQ 557
           +          + L LV+EYL          D   K  LD              +  + +
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYL----------DKDLKQYLDDCGNIINMHNVKLFLFQLLR 111

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           GL Y H+    +V+HRDLK  N+L++E+   K++DFG+AR  +    +   N +V
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV 162

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 41/180 (22%), Positives = 76/180 (42%), Gaps = 41/180 (22%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAK 508
             +    ++G+G +G V+K K  +  + +A+KR+      +G+          E  L+ +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKE 57

Query: 509 LQHTN--------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRF-------SII 552
           L+H N           ++L LV+E+           D   K   D            S +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFC----------DQDLKKYFDSCNGDLDPEIVKSFL 107

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
             + +GL + H      V+HRDLK  N+L++     K+++FG+AR F    +   +  +V
Sbjct: 108 FQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV 163

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 90.7 bits (225), Expect = 3e-19
 Identities = 35/169 (20%), Positives = 64/169 (37%), Gaps = 32/169 (18%)

Query: 463 RLGQGGFGPVYKGK--LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL----- 514
            +  GG G +Y       + + + +K L  S           E + +A++ H ++     
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 515 -------GGERL--LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                   G+ +  +V EY+  +SL       S+   L   +  + +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH-- 199

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             + +++ DLK  NI+L E+   K+ D G                + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 45/189 (23%), Positives = 82/189 (43%), Gaps = 39/189 (20%)

Query: 447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKN-EAKL 505
           D +T       ++    +G G FG V++ KL +  E+AIK++ +        FKN E ++
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQI 85

Query: 506 IAKLQHTNL---------GGERL------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS 550
           +  ++H N+          G++       LV EY+P +++         +     K+   
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRAS-----RHYAKLKQTMP 139

Query: 551 IIEG------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNE 603
           ++        + + L Y+H    + + HRD+K  N+LLD      K+ DFG A+      
Sbjct: 140 MLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IA 194

Query: 604 LEANTNRIV 612
            E N + I 
Sbjct: 195 GEPNVSYIC 203

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 42/173 (24%), Positives = 71/173 (41%), Gaps = 40/173 (23%)

Query: 462 NRLGQGGFGPVYKGKLQD------EQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL 514
             +G+G FG V++ +            +A+K L  ++S     +F+ EA L+A+  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 515 ---------GGERLLVYEYLPNKSLDFF---------------------IFDSSRKSLLD 544
                    G    L++EY+    L+ F                        S     L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             ++  I   +  G+ YL   S  + +HRDL   N L+ E M  KI+DFG++R
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 86.5 bits (215), Expect = 6e-19
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 27/166 (16%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVE-FKNEAKLIAKLQH 511
           ++F     LG+G FG VY  +  Q +  +A+K L K+     G+    + E ++ + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 512 TNLGGERLLVYEYLPNKSLDFFIFDSSRK----SLLDWKKRFS------IIEGITQGLLY 561
            N+    L +Y Y  + +  + I + +        L    +F        I  +   L Y
Sbjct: 69  PNI----LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 124

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA------RTFTM 601
            H     RVIHRD+K  N+LL      KI+DFG +      R   +
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL 167

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.8 bits (216), Expect = 7e-19
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 19/169 (11%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKN--EAKLIAKLQHT 512
           + +    ++G+G +G V+K + +D  +I AIK+  +S    +++     E +++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 513 NL--------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           NL           RL LV+EY               +  +      SI     Q + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           K+     IHRD+K  NIL+ +    K+ DFG AR  T    +   + + 
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA 164

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 87.2 bits (217), Expect = 9e-19
 Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 42/182 (23%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN--------EAKLI 506
             +   + LG+G F  VYK +     Q +AIK++         E K+        E KL+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLL 66

Query: 507 AKLQHTN--------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRF-------S 550
            +L H N             + LV++++          ++  + ++             +
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFM----------ETDLEVIIKDNSLVLTPSHIKA 116

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            +    QGL YLH++    ++HRDLK +N+LLDE    K++DFG+A++F  +   A T++
Sbjct: 117 YMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQ 172

Query: 611 IV 612
           +V
Sbjct: 173 VV 174

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 87.1 bits (216), Expect = 9e-19
 Identities = 54/173 (31%), Positives = 76/173 (43%), Gaps = 25/173 (14%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLS---KSSGQGIVEFKNEAKLIAKLQ 510
              FS    +G G FG VY  + +++ + +AIK++S   K S +   +   E + + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 511 HTN--------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N        L      LV EY    + D        K  L   +  ++  G  QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRD+K  NILL E    K+ DFG A         AN+   VGT
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANS--FVGT 213

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 38/167 (22%), Positives = 66/167 (39%), Gaps = 34/167 (20%)

Query: 462 NRLGQGGFGPVYKGKLQD------EQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QHTN 513
             LG+G FG V +            + +A+K L   ++        +E K++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 514 L----------GGERLLVYEYLPNKSL-DF------------FIFDSSRKSLLDWKKRFS 550
           +          GG  +++ E+    +L  +               +   K  L  +    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
               + +G+ +L   +  + IHRDL   NILL E+   KI DFG+AR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.0 bits (214), Expect = 1e-18
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 40/179 (22%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAKL 509
           + +    ++G+G +G VYK +    +  A+K++  +   +GI          E  ++ +L
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKEL 57

Query: 510 QHTNL--------GGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRF-------SIIE 553
           +H+N+          +RL LV+E+L          D   K LLD  +         S + 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSFLL 107

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
            +  G+ Y H     RV+HRDLK  N+L++ +   KI+DFG+AR F    +   T+ IV
Sbjct: 108 QLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV 162

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 24/170 (14%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIK--RLSKSSGQGIVE-FKNEAKLIAKLQHTNL---- 514
            LG GG   V+  + L+D +++A+K  R   +        F+ EA+  A L H  +    
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 515 ------GGERLLVY---EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                      L Y   EY+   +L   +     +  +  K+   +I    Q L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE-ANTNRIVGT 614
            +  +IHRD+K +NI++      K+ DFG+AR    +      T  ++GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 58/209 (27%), Positives = 80/209 (38%), Gaps = 45/209 (21%)

Query: 427 GNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AI 485
           G    Q        R  +  DF+   +          LG+G F  V   +        AI
Sbjct: 11  GAGSLQHAQPPPQPRKKRPEDFKFGKI----------LGEGSFSTVVLARELATSREYAI 60

Query: 486 KRLSKSSGQGIVEFK------NEAKLIAKLQH---TNLGG-----ERL-LVYEYLPNKSL 530
           K L K     I++         E  ++++L H     L       E+L     Y  N  L
Sbjct: 61  KILEKRH---IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117

Query: 531 DFFI-----FDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ 585
             +I     FD +         RF   E I   L YLH      +IHRDLK  NILL+E 
Sbjct: 118 LKYIRKIGSFDETCT-------RFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNED 166

Query: 586 MNPKISDFGMARTFTMNELEANTNRIVGT 614
           M+ +I+DFG A+  +    +A  N  VGT
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGT 195

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 25/169 (14%)

Query: 463 RLGQGGFGPVYKGKLQDE-QEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL----- 514
            +G+G F  VYKG   +   E+A    +  K +      FK EA+++  LQH N+     
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 515 -------GGERLLVY-EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                  G + +++  E + + +L  ++    R  ++  K   S    I +GL +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148

Query: 567 RLRVIHRDLKVSNILLD-EQMNPKISDFGMARTFTMNELEANTNRIVGT 614
              +IHRDLK  NI +     + KI D G+A     +        ++GT
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 193

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 88.6 bits (219), Expect = 2e-18
 Identities = 45/162 (27%), Positives = 68/162 (41%), Gaps = 23/162 (14%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN------- 513
           RLG GGFG V +       +++AIK+  +       E +  E +++ KL H N       
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 514 --------LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                        LL  EY     L  ++        L      +++  I+  L YLH+ 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 566 SRLRVIHRDLKVSNILLD---EQMNPKISDFGMARTFTMNEL 604
              R+IHRDLK  NI+L    +++  KI D G A+     EL
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 19/170 (11%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 513
            + F    +LG+G +G VYK    +  Q +AIK++       + E   E  ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 514 --------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                        L +V EY    S+   I    R   L   +  +I++   +GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
              +R IHRD+K  NILL+ + + K++DFG+A   T    + NT  ++GT
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 40/173 (23%)

Query: 462 NRLGQGGFGPVYKGKLQD------EQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL 514
             LG+G FG V K              +A+K L   +S   + +  +E  ++ ++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 515 ---------GGERLLVYEYLPNKSL-DF--------------------FIFDSSRKSLLD 544
                     G  LL+ EY    SL  F                       D   +  L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                S    I+QG+ YL   + ++++HRDL   NIL+ E    KISDFG++R
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 26/198 (13%)

Query: 435 SDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSG 493
           +  +  R L   D   +      F     +G G +G VYKG+ ++  Q  AIK +   +G
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTG 61

Query: 494 QGIVEFKNEAKLIAKL-QHTNL--------------GGERL-LVYEYLPNKSL-DFFIFD 536
               E K E  ++ K   H N+                ++L LV E+    S+ D  +  
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIK 119

Query: 537 SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           +++ + L  +    I   I +GL +LH+    +VIHRD+K  N+LL E    K+ DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 597 RTFTMNELEANTNRIVGT 614
                     NT   +GT
Sbjct: 177 AQLDRTVGRRNT--FIGT 192

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 36/168 (21%), Positives = 71/168 (42%), Gaps = 35/168 (20%)

Query: 462 NRLGQGGFGPVYKGKLQD--------EQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QH 511
             LG+G FG V   +              +A+K L   ++ + + +  +E +++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 512 TNL---------GGERLLVYEYLPNKSL-DF------------FIFDSSRKSLLDWKKRF 549
            N+          G   ++ EY    +L ++            +  +   +  + +K   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           S    + +G+ YL   +  + IHRDL   N+L+ E    KI+DFG+AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 39/165 (23%), Positives = 65/165 (39%), Gaps = 20/165 (12%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSK--SSGQGIVE-FKNEAKLIAKLQHTNL---- 514
            +G+GG G VY+ +    E+ +A+K +S+  SS        + EA+   +LQ  ++    
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLR 569
                 G+  +    +    L   +        L   +  +I+  I   L   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             HRD+K  NIL+       + DFG+A   T  +L       VGT
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGT 198

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 45/184 (24%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAK 508
           D +    +LG+G +G VYK       + +AIKR+  +   +G+          E  L+ +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV----PGTAIREVSLLKE 89

Query: 509 LQHTN--------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRF------SIIE 553
           LQH N            RL L++EY           ++  K  +D           S + 
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSFLY 139

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP-----KISDFGMARTFTMNELEANT 608
            +  G+ + H     R +HRDLK  N+LL           KI DFG+AR F +  +   T
Sbjct: 140 QLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFT 195

Query: 609 NRIV 612
           + I+
Sbjct: 196 HEII 199

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 39/173 (22%), Positives = 61/173 (35%), Gaps = 37/173 (21%)

Query: 462 NRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN------- 513
            R+G+G FG V++ K  Q   + A+K++     +       E    A L           
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 514 -LGGERLLVY-EYLPNKSLDFFIFDSSRKSLLDWKKRF--SIIEGIT----QGLLYLHKY 565
              G  + ++ E L   SL           L+                   +GL YLH  
Sbjct: 119 VREGPWVNIFMELLEGGSL---------GQLIKQMGCLPEDRALYYLGQALEGLEYLH-- 167

Query: 566 SRLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNELEANTNR---IVGT 614
              R++H D+K  N+LL    +   + DFG A     + L  +      I GT
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 84.6 bits (210), Expect = 5e-18
 Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 25/172 (14%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKN--EAKLIAKLQHT 512
           + +     +G+G +G V K + +D   I AIK+  +S    +V+     E KL+ +L+H 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 513 NL--------GGERL-LVYEYLPN---KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLL 560
           NL          +R  LV+E++ +     L+         + LD++     +  I  G+ 
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDHTILDDLE------LFPNGLDYQVVQKYLFQIINGIG 138

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
           + H +    +IHRD+K  NIL+ +    K+ DFG ART      E   + + 
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA 186

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 36/168 (21%), Positives = 71/168 (42%), Gaps = 35/168 (20%)

Query: 462 NRLGQGGFGPVYKGKLQD--------EQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QH 511
             LG+G FG V   +              +A+K L   ++ + + +  +E +++  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 512 TNL---------GGERLLVYEYLPNKSL-DF------------FIFDSSRKSLLDWKKRF 549
            N+          G   ++ EY    +L ++            +  +   +  + +K   
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           S    + +G+ YL   +  + IHRDL   N+L+ E    KI+DFG+AR
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 84.2 bits (209), Expect = 6e-18
 Identities = 40/164 (24%), Positives = 62/164 (37%), Gaps = 31/164 (18%)

Query: 462 NRLGQGGFGPVYKGKLQD------EQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QHTN 513
             LG G FG V +             ++A+K L S +         +E K+++ L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 514 L---------GGERLLVYEYLPNKSL-----------DFFIFDSSRKSLLDWKKRFSIIE 553
           +         GG  L++ EY     L           +     +   S    +       
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            + QG+ +L   +    IHRD+   N+LL      KI DFG+AR
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 83.8 bits (208), Expect = 7e-18
 Identities = 45/169 (26%), Positives = 65/169 (38%), Gaps = 37/169 (21%)

Query: 462 NRLGQGGFGPVYKGKL------QDEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTN 513
             LG G FG V +              +A+K L  S          +E K+++ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG---------- 554
           +         GG  L++ EY     L  F+    R S +  K   +I+E           
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 555 ------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                 + +G+ +L   +    IHRDL   NILL      KI DFG+AR
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 37/176 (21%), Positives = 70/176 (39%), Gaps = 40/176 (22%)

Query: 464 LGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEF-----------------KNEAKLI 506
           L QG F  +   + +D +  A+K+  KS  +   +F                 KNE ++I
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 507 AKLQHTNLGGERL-----------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS----- 550
             +++                   ++YEY+ N S+     +       ++          
Sbjct: 98  TDIKNEYC--LTCEGIITNYDEVYIIYEYMENDSI-LKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 551 -IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE 605
            II+ +     Y+H  +   + HRD+K SNIL+D+    K+SDFG +      +++
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 37/172 (21%), Positives = 59/172 (34%), Gaps = 22/172 (12%)

Query: 456 DNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QH 511
            +F   +RLG G +G V+K    +D +  A+KR        +       E     K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 512 TN--------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL 562
                       G  L L  E     SL       +  + L   + +  +      L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           H      ++H D+K +NI L  +   K+ DFG+                 G 
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGD 219

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 38/169 (22%), Positives = 72/169 (42%), Gaps = 37/169 (21%)

Query: 462 NRLGQGGFGPVYKGKLQD--------EQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QH 511
             LG+G FG V   +             ++A+K L S ++ + + +  +E +++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG-------- 554
            N+          G   ++ EY    +L  ++  + R   L++    S            
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 555 ------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                 + +G+ YL   +  + IHRDL   N+L+ E    KI+DFG+AR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 27/158 (17%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVE-FKNEAKLIAKLQHTNLGGERL 519
           LG+G FG VY  +  Q++  +A+K L KS    +G+    + E ++ + L+H N+    L
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI----L 77

Query: 520 LVYEYLPNKSLDFFIFDSSRK----SLLDWKKRFS------IIEGITQGLLYLHKYSRLR 569
            +Y Y  ++   + + + + +      L    RF        +E +   L Y H     +
Sbjct: 78  RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERK 134

Query: 570 VIHRDLKVSNILLDEQMNPKISDFGMA------RTFTM 601
           VIHRD+K  N+L+  +   KI+DFG +      R  TM
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM 172

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 42/179 (23%), Positives = 70/179 (39%), Gaps = 24/179 (13%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 513
           D++     +G G    V        ++++AIKR++ +     + E   E + +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 514 --------LGGERL-LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGITQG 558
                   +  + L LV + L   S+   I                      I+  + +G
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT---NRIVGT 614
           L YLHK      IHRD+K  NILL E  + +I+DFG++                  VGT
Sbjct: 134 LEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 50/178 (28%)

Query: 456 DNFSPANRLGQGGFGPVYKG---------------KLQDEQ---------EIAI-KRLSK 490
             +     +G+G +G V+K                ++Q  +         E+A+ + L  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70

Query: 491 SSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS 550
                +V   +    +  +  T+   +  LV+E++          D    + LD      
Sbjct: 71  FEHPNVVRLFD----VCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPG 116

Query: 551 IIEG--------ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
           +           + +GL +LH +   RV+HRDLK  NIL+      K++DFG+AR ++
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.1 bits (208), Expect = 4e-17
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)

Query: 422 LPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ 481
           L +I+ NR  Q +  +  ++ +    F+   V          LG+GGFG V   +++   
Sbjct: 162 LDSIYFNRFLQWKWLE--RQPVTKNTFRQYRV----------LGKGGFGEVCACQVRATG 209

Query: 482 EI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQH---TNLG-----GERL-LVYEYLPNK 528
           ++ A K+L K      +G     NE +++ K+      +L       + L LV   +   
Sbjct: 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 269

Query: 529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP 588
            L F I+   +    + +  F   E I  GL  LH+    R+++RDLK  NILLD+  + 
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHGHI 325

Query: 589 KISDFGMARTFTMNELEANTNRIVGT 614
           +ISD G+A      +        VGT
Sbjct: 326 RISDLGLAVHVPEGQT---IKGRVGT 348

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 82.1 bits (203), Expect = 7e-17
 Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 40/214 (18%)

Query: 423 PTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE 482
                 + ++ +    V   +             +++    +G G FG VY+ KL D  E
Sbjct: 21  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80

Query: 483 I-AIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNL---------GGERL------LVYEYL 525
           + AIK++ +        FKN E +++ KL H N+          GE+       LV +Y+
Sbjct: 81  LVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135

Query: 526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEG------ITQGLLYLHKYSRLRVIHRDLKVSN 579
           P +++         +     K+   +I        + + L Y+H      + HRD+K  N
Sbjct: 136 P-ETVYRVA-----RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQN 186

Query: 580 ILLDEQMNP-KISDFGMARTFTMNELEANTNRIV 612
           +LLD      K+ DFG A+       E N + I 
Sbjct: 187 LLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYIC 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 40/196 (20%), Positives = 82/196 (41%), Gaps = 25/196 (12%)

Query: 435 SDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ 494
           S  ++++D    +   + V   +F P + LG G  G +    + D +++A+KR+      
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS 62

Query: 495 GIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD 544
                  E +L+ +  +H N+            + +  E     +L  ++    +     
Sbjct: 63  FA---DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHL 116

Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-----MNPKISDFGMARTF 599
             +  ++++  T GL +LH    L ++HRDLK  NIL+        +   ISDFG+ +  
Sbjct: 117 GLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173

Query: 600 TMNELE-ANTNRIVGT 614
            +     +  + + GT
Sbjct: 174 AVGRHSFSRRSGVPGT 189

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 38/176 (21%), Positives = 71/176 (40%), Gaps = 40/176 (22%)

Query: 454 ATDNFSPANRLGQGGFGPVYKG--------------KLQDEQ------------EIAI-K 486
           AT  + P   +G G +G VYK               ++ +              E+A+ +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 487 RLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPN--KSLDFFIFDSSRKSLLD 544
           RL       +V   +    +     T+   +  LV+E++    ++      D +    L 
Sbjct: 67  RLEAFEHPNVVRLMD----VCATSRTDREIKVTLVFEHVDQDLRTY----LDKAPPPGLP 118

Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
            +    ++    +GL +LH      ++HRDLK  NIL+      K++DFG+AR ++
Sbjct: 119 AETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 37/173 (21%), Positives = 59/173 (34%), Gaps = 40/173 (23%)

Query: 462 NRLGQGGFGPVYKGKLQD------EQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTN 513
             LG G FG V               ++A+K L +           +E K++ +L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 514 L---------GGERLLVYEYLPNKSL-DF-------FIFDSSRKSLLDWKKRFSIIEGIT 556
           +          G   L++EY     L ++       F  D          +    +  +T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 557 Q------------GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                        G+ +L        +HRDL   N+L+      KI DFG+AR
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 43/196 (21%), Positives = 81/196 (41%), Gaps = 61/196 (31%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEA----------- 503
             +    ++GQG FG V+K + +   +  A+K+         V  +NE            
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK---------VLMENEKEGFPITALREI 67

Query: 504 KLIAKLQHTN-----------------LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWK 546
           K++  L+H N                   G   LV+++           +     LL   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC----------EHDLAGLLSNV 117

Query: 547 K-RF------SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
             +F       +++ +  GL Y+H+    +++HRD+K +N+L+      K++DFG+AR F
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174

Query: 600 TMNELEAN---TNRIV 612
           ++ +       TNR+V
Sbjct: 175 SLAKNSQPNRYTNRVV 190

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 26/180 (14%), Positives = 59/180 (32%), Gaps = 25/180 (13%)

Query: 455 TDNFSPANRLGQG--GFGPVYKGK-LQDEQEIAIKR--LSKSSGQGIVEFKNEAKLIAKL 509
              +     +G+G      V   +     + + ++R  L   S + +   + E  +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 510 QHTN--------LGGERL-LVYEYLPNKSL-DFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
            H N        +    L +V  ++   S  D  +  +     ++      I++G+ + L
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLKAL 141

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT-----NRIVGT 614
            Y+H    +  +HR +K S+IL+       +S      +   +              V  
Sbjct: 142 DYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 80.6 bits (199), Expect = 4e-16
 Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 33/217 (15%)

Query: 413 LRELGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPV 472
           L +      L +++  R  Q +  +   + +    F    V          LG+GGFG V
Sbjct: 154 LGQAPFQEFLDSLYFLRFLQWKWLE--AQPMGEDWFLDFRV----------LGRGGFGEV 201

Query: 473 YKGKLQDEQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQH---TNLG-----GERL- 519
           +  +++   ++ A K+L+K      +G      E K++AK+      +L         L 
Sbjct: 202 FACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261

Query: 520 LVYEYLPNKSLDFFIFDSSRKS--LLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKV 577
           LV   +    + + I++    +    + +  F   + I  GL +LH+     +I+RDLK 
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQ---RNIIYRDLKP 317

Query: 578 SNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            N+LLD+  N +ISD G+A      + +       GT
Sbjct: 318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 40/187 (21%), Positives = 69/187 (36%), Gaps = 33/187 (17%)

Query: 440 KRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE 498
              LKI   Q      ++      +G+G +G V K       Q +A+KR+  +  +   +
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65

Query: 499 -FKNEAKLIAKL-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK 547
               +  ++ +      +          G+  +  E + + S D F     +        
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDD 120

Query: 548 RFS------IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG------- 594
                    I     + L +L     L++IHRD+K SNILLD   N K+ DFG       
Sbjct: 121 VIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178

Query: 595 -MARTFT 600
            +A+T  
Sbjct: 179 SIAKTRD 185

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 24/195 (12%), Positives = 50/195 (25%), Gaps = 47/195 (24%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLGGE- 517
            LGQ       +    +  +   +     +       I + K E   +  L+      + 
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 518 -----------------------------------RLLVYEYLPNKSLDFFIFDSSRKSL 542
                                              R  +Y  + +    F     S  S 
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 543 ---LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
              L    R  +   + + L  LH      ++H  L+  +I+LD++    ++ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 600 TMNELEANTNRIVGT 614
             + +     R    
Sbjct: 262 GASAVSP-IGRGFAP 275

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 39/201 (19%)

Query: 436 DQTVKRDLKIFDFQ---TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKS 491
           D+  ++ L+ F  Q      +  D+F   + LG G  G V+K   +    + A K +   
Sbjct: 10  DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69

Query: 492 SGQGIVEF-KNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKS 541
               I      E +++ +     +          GE  +  E++   SLD          
Sbjct: 70  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD---------Q 120

Query: 542 LLDWKKRFS------IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM 595
           +L    R        +   + +GL YL    + +++HRD+K SNIL++ +   K+ DFG+
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 596 AR--TFTMNELEANTNRIVGT 614
           +     +M    AN+   VGT
Sbjct: 179 SGQLIDSM----ANSF--VGT 193

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 78.6 bits (193), Expect = 9e-16
 Identities = 15/177 (8%), Positives = 35/177 (19%), Gaps = 45/177 (25%)

Query: 463 RLGQGGFGPVYKGKLQDE-QEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLG--- 515
            L  G    V+  +  +  ++ A+K  +     S   +          A+L   +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 516 --------------------------------GERLLVYEYLP---NKSLDFFIFDSSRK 540
                                              LL+                F    +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 541 SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                     +   + +    L       ++H      N+ +       + D     
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 78.6 bits (194), Expect = 9e-16
 Identities = 43/202 (21%), Positives = 80/202 (39%), Gaps = 35/202 (17%)

Query: 429 RKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKR 487
           +  +    +  +  L+  DF+ + V          +G+G F  V   K++   ++ A+K 
Sbjct: 44  QWAEPIVVRLKEVRLQRDDFEILKV----------IGRGAFSEVAVVKMKQTGQVYAMKI 93

Query: 488 LSKSSGQGIVE------FKNEAKLIAKLQH---TNL-----GGERL-LVYEYLPNKSLDF 532
           ++K     +++      F+ E  ++        T L         L LV EY     L  
Sbjct: 94  MNKWD---MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150

Query: 533 FIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISD 592
            +     +   +   RF + E I   +  +H+   L  +HRD+K  NILLD   + +++D
Sbjct: 151 LLSKFGERIPAEMA-RFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205

Query: 593 FGMARTFTMNELEANTNRIVGT 614
           FG       +     +   VGT
Sbjct: 206 FGSCLKLRADG-TVRSLVAVGT 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 44/182 (24%)

Query: 463 RLGQGGFGPVYKGKLQDEQ---EIAIKRLSK----SSGQGIVEFKNEAKLIAKLQHTNL- 514
           ++G+G +G VYK K +D +   + A+K++       S         E  L+ +L+H N+ 
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVI 81

Query: 515 ---------GGERL-LVYEYLPNKSLDFF-IFDSSRKSLLDWKKRF-------SIIEGIT 556
                       ++ L+++Y      D + I    R S  + K          S++  I 
Sbjct: 82  SLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 557 QGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMARTFT--MNELEANTNR 610
            G+ YLH      V+HRDLK +NIL+  +       KI+D G AR F   +  L      
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 611 IV 612
           +V
Sbjct: 196 VV 197

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 42/183 (22%), Positives = 79/183 (43%), Gaps = 29/183 (15%)

Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAK-LI 506
           ++ V  D+  P   LG+G +G V K + +   Q +A+KR+  +      +    +    +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 507 AKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------I 551
             +               G+  +  E + + SLD F      K ++D  +         I
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114

Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRI 611
              I + L +LH  S+L VIHRD+K SN+L++     K+ DFG++     +++  + +  
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDID-- 169

Query: 612 VGT 614
            G 
Sbjct: 170 AGC 172

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 25/151 (16%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLGGER 518
           LG+G +G V +    +     A+K L K        G    K E +L+ +L+H N+    
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV---- 68

Query: 519 LLVYEYLPNKSLD--FFIF---DSSRKSLLDW--KKRFSIIEG------ITQGLLYLHKY 565
           + + + L N+     + +        + +LD   +KRF + +       +  GL YLH  
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH-- 126

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
               ++H+D+K  N+LL      KIS  G+A
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 44/168 (26%), Positives = 71/168 (42%), Gaps = 29/168 (17%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLGGERLLV 521
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+   +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV--VKF-- 70

Query: 522 YEYLPNKSLDFFI---------FDSSRKSLLDWKKRFSIIEG------ITQGLLYLHKYS 566
           Y +    ++ +           FD      ++        +       +  G++YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQLMAGVVYLH--- 122

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            + + HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 38/184 (20%)

Query: 455 TDNFSPANRLGQGGFGPVYKGKLQDEQE-IAIKR-LSKSSGQGIVEFKN----EAKLIAK 508
            D F      GQG FG V  GK +     +AIK+ +          F+N      + +A 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75

Query: 509 LQHTNL---------GGER-------LLVYEYLP---NKSLDFFIFDSSRKSLLDWKKRF 549
           L H N+          GER        +V EY+P   ++    +         +  K   
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK--- 132

Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP-KISDFGMARTFTMNELEANT 608
             +  + + +  LH  S + V HRD+K  N+L++E     K+ DFG A+    +  E N 
Sbjct: 133 VFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNV 189

Query: 609 NRIV 612
             I 
Sbjct: 190 AYIC 193

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 44/202 (21%), Positives = 82/202 (40%), Gaps = 35/202 (17%)

Query: 429 RKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKR 487
              +  + +  +  L   DF+ + V          +G+G FG V   KL++  ++ A+K 
Sbjct: 57  EWAKPFTSKVKQMRLHREDFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKI 106

Query: 488 LSKSSGQGIVE------FKNEAKLIAKLQH---TNL-----GGERL-LVYEYLPNKSLDF 532
           L+K     +++      F+ E  ++        T L         L LV +Y     L  
Sbjct: 107 LNKWE---MLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL-L 162

Query: 533 FIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISD 592
            +       L +   RF + E +   +  +H+   L  +HRD+K  NIL+D   + +++D
Sbjct: 163 TLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD 218

Query: 593 FGMARTFTMNELEANTNRIVGT 614
           FG       +     ++  VGT
Sbjct: 219 FGSCLKLMEDG-TVQSSVAVGT 239

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 34/166 (20%), Positives = 61/166 (36%), Gaps = 37/166 (22%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKL------IAKLQHTNL 514
           LG G FG V+     +  +E+ +K + K        +E     K+      +++++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 515 GGERLLVYEYLPNKSLDFFI----------FDSSRKSLLDWKKRFSIIEG------ITQG 558
               + V +   N+     +          F       +D   R            +   
Sbjct: 92  ----IKVLDIFENQGFFQLVMEKHGSGLDLFA-----FIDRHPRLDEPLASYIFRQLVSA 142

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
           + YL       +IHRD+K  NI++ E    K+ DFG A      +L
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 45/197 (22%), Positives = 77/197 (39%), Gaps = 40/197 (20%)

Query: 434 RSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSS 492
           + +   +   ++  F  I            LG G FG V   K ++     A+K L K  
Sbjct: 29  KWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKILDKQK 78

Query: 493 GQGIVEFK------NEAKLIAKLQH---TNLGG-----ERL-LVYEYLPNKSLDFFIFDS 537
              +V+ K      NE +++  +       L         L +V EY+    + F     
Sbjct: 79  ---VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRR 134

Query: 538 SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
             +   +   RF   + I     YLH      +I+RDLK  N+L+D+Q   +++DFG A+
Sbjct: 135 IGR-FSEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189

Query: 598 TFTMNELEANTNRIVGT 614
                 ++  T  + GT
Sbjct: 190 -----RVKGRTWTLCGT 201

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 37/202 (18%)

Query: 429 RKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKR 487
            + +   ++     +K  D++ + V          +G+G FG V   + +  +++ A+K 
Sbjct: 52  SRYKDTINKIRDLRMKAEDYEVVKV----------IGRGAFGEVQLVRHKSTRKVYAMKL 101

Query: 488 LSKSSGQGIVE------FKNEAKLIAKLQH---TNLGG-----ERL-LVYEYLPNKSLDF 532
           LSK     +++      F  E  ++A         L         L +V EY+P   L  
Sbjct: 102 LSKFE---MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-V 157

Query: 533 FIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISD 592
            +   S   + +   RF   E +   L  +H    +  IHRD+K  N+LLD+  + K++D
Sbjct: 158 NLM--SNYDVPEKWARFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211

Query: 593 FGMARTFTMNELEANTNRIVGT 614
           FG         +    +  VGT
Sbjct: 212 FGTCMKMNKEGMV-RCDTAVGT 232

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 44/168 (26%), Positives = 71/168 (42%), Gaps = 29/168 (17%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLGGERLLV 521
           LG+G +G V        E+ +A+K +         E  K E  +   L H N+   +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV--VKF-- 70

Query: 522 YEYLPNKSLDFFI---------FDSSRKSLLDWKKRFSIIEG------ITQGLLYLHKYS 566
           Y +    ++ +           FD      ++        +       +  G++YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQLMAGVVYLH--- 122

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            + + HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 22/178 (12%), Positives = 47/178 (26%), Gaps = 46/178 (25%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLGGE- 517
            LGQ       +    +  +   +     +       I + K E   +  L+      + 
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 518 -----------------------------------RLLVYEYLPNKSLDFF--IFDSSRK 540
                                              R  +Y  + +    F   +   S  
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 541 S-LLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
              L    R  +   + + L  LH      ++H  L+  +I+LD++    ++ F    
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 74.5 bits (184), Expect = 5e-15
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 31/160 (19%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTNLGGERL 519
           LG G FG V  G+      ++A+K L++       +V   K E + +   +H ++    +
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI----I 74

Query: 520 LVYEYLPNKSLDFFI---------FDSSRKSLLDWKKRFSIIEG------ITQGLLYLHK 564
            +Y+ +   +  F +         FD      +    R   +E       I   + Y H 
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFD-----YICKHGRVEEMEARRLFQQILSAVDYCH- 128

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
             R  V+HRDLK  N+LLD  MN KI+DFG++   +  E 
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 30/205 (14%)

Query: 430 KTQARSDQTVKRDLKIFDFQTIAVATDNFS------PANRLGQGGFGPVYKGK-LQDEQE 482
           K  +     +      FD + +       +          LG G FG V+K +      +
Sbjct: 57  KRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLK 116

Query: 483 IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFF 533
           +A K +     +   E KNE  ++ +L H NL           + +LV EY+    L   
Sbjct: 117 LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL--- 173

Query: 534 IFDS--SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP--K 589
            FD        L        ++ I +G+ ++H+   + ++H DLK  NIL   +     K
Sbjct: 174 -FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIK 229

Query: 590 ISDFGMARTFTMNELEANTNRIVGT 614
           I DFG+AR +   E         GT
Sbjct: 230 IIDFGLARRYKPRE---KLKVNFGT 251

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 39/161 (24%), Positives = 59/161 (36%), Gaps = 24/161 (14%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLGG 516
           LG GGFG VY G  + D   +AIK + K       E  N      E  L+ K+     G 
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 517 ERLLVYEYLPNKSLDFFIFD--SSRKSLLDW---KKRFSIIEG------ITQGLLYLHKY 565
            RL   ++         I +     + L D+   +              + + + + H  
Sbjct: 111 IRL--LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-- 166

Query: 566 SRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTFTMNELE 605
               V+HRD+K  NIL+D  +   K+ DFG           
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 206

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 30/159 (18%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVE-FKNEAKLIAKLQHTNLGGERL 519
           LG+G FG V      + +Q++A+K +S+       +    + E   +  L+H ++   +L
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI--IKL 74

Query: 520 LVYEYLPNKSLDFFI--------FDSSRKSLLDWKKRFSIIEG------ITQGLLYLHKY 565
             Y+ +   +    +        FD      +  KKR +  EG      I   + Y H  
Sbjct: 75  --YDVITTPTDIVMVIEYAGGELFD-----YIVEKKRMTEDEGRRFFQQIICAIEYCH-- 125

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
            R +++HRDLK  N+LLD+ +N KI+DFG++   T    
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 75.5 bits (186), Expect = 9e-15
 Identities = 40/198 (20%), Positives = 74/198 (37%), Gaps = 28/198 (14%)

Query: 435 SDQTVKRDLKIFDFQTIAVATDNFSP----ANRLGQGGFGPVYKGK-LQDEQEIAIKRLS 489
            D+  +   K +  Q + V   +          LG G FG V++       +    K ++
Sbjct: 26  YDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN 85

Query: 490 KSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFD--SS 538
                     KNE  ++ +L H  L           E +L+ E+L    L    FD  ++
Sbjct: 86  TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAA 141

Query: 539 RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP--KISDFGMA 596
               +   +  + +    +GL ++H+     ++H D+K  NI+ + +     KI DFG+A
Sbjct: 142 EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLA 198

Query: 597 RTFTMNELEANTNRIVGT 614
                +E          T
Sbjct: 199 TKLNPDE---IVKVTTAT 213

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 43/193 (22%), Positives = 67/193 (34%), Gaps = 42/193 (21%)

Query: 455 TDNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKR--LSKSSGQGIVEFKNEAKLIAKL-Q 510
           T  F    ++G G FG V+K  K  D    AIKR     +          E    A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 511 HTN--------LGGERLLVY-EYLPNKSLDFFIFDSSRK-SLLDWKKRFSIIEGITQGLL 560
           H++           + +L+  EY    SL   I ++ R  S     +   ++  + +GL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNP-------------------KISDFGMARTFTM 601
           Y+H    + ++H D+K SNI +     P                   KI D G     + 
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185

Query: 602 NELEANTNRIVGT 614
                +     G 
Sbjct: 186 -----SPQVEEGD 193

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 38/206 (18%), Positives = 75/206 (36%), Gaps = 28/206 (13%)

Query: 427 GNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSP----ANRLGQGGFGPVYKGK-LQDEQ 481
           G     +  D  V    K +  Q + +  D+          LG G FG V++        
Sbjct: 124 GKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGN 183

Query: 482 EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDF 532
             A K +           + E + ++ L+H  L           E +++YE++    L  
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL-- 241

Query: 533 FIFD--SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP-- 588
             F+  +   + +   +    +  + +GL ++H+      +H DLK  NI+   + +   
Sbjct: 242 --FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNEL 296

Query: 589 KISDFGMARTFTMNELEANTNRIVGT 614
           K+ DFG+       +   +     GT
Sbjct: 297 KLIDFGLTAHLDPKQ---SVKVTTGT 319

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 46/197 (23%), Positives = 74/197 (37%), Gaps = 50/197 (25%)

Query: 440 KRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE 498
             D+    F+ +            +G+G FG V   +  D +++ A+K ++K      VE
Sbjct: 9   NEDVNFDHFEILRA----------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQK---CVE 55

Query: 499 FK------NEAKLIAKLQH---TNLGG-----ERL-LVYEYLPNKSLDFF------IFDS 537
                    E +++  L+H    NL       E + +V + L    L  +       F  
Sbjct: 56  RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKE 114

Query: 538 SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
                     +  I E +   L YL      R+IHRD+K  NILLDE  +  I+DF +A 
Sbjct: 115 ETV-------KLFICE-LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAA 163

Query: 598 TFTMNELEANTNRIVGT 614
                        + GT
Sbjct: 164 MLPRETQ---ITTMAGT 177

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 52/186 (27%)

Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFK- 500
             + DFQ +            LG G FG V+  + +      A+K L K     +V  K 
Sbjct: 3   YSLQDFQILRT----------LGTGSFGRVHLIRSRHNGRYYAMKVLKKEI---VVRLKQ 49

Query: 501 -----NEAKLIAKLQH---TNLGG-----ERL-LVYEYLPNKSLDFF------IFDSSRK 540
                +E  +++ + H     + G     +++ ++ +Y+    L F        F +   
Sbjct: 50  VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVA 108

Query: 541 SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA---- 596
                  +F   E +   L YLH      +I+RDLK  NILLD+  + KI+DFG A    
Sbjct: 109 -------KFYAAE-VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157

Query: 597 -RTFTM 601
             T+T+
Sbjct: 158 DVTYTL 163

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 52/176 (29%), Positives = 86/176 (48%), Gaps = 26/176 (14%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 511
            + ++    LG+G FG V K K    +QE A+K ++K+    +       E +L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 512 TNLGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---KKRFS------IIEGITQGLLY 561
            N+    + ++E L + S  + + +  +   L D    +KRFS      II+ +  G+ Y
Sbjct: 81  PNI----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 562 LHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +HK     ++HRDLK  NILL   ++  + KI DFG++  F  N         +GT
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 40/183 (21%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 511
           ++ +    +LG G +G V   +      E AIK + K+  S     +   E  ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 512 TNLGGERL-----------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEG 554
            N+   +L           LV E      L    FD         + +F+      II+ 
Sbjct: 96  PNIM--KLYDFFEDKRNYYLVMECYKGGEL----FDEIIH-----RMKFNEVDAAVIIKQ 144

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRI 611
           +  G+ YLHK     ++HRDLK  N+LL   ++    KI DFG++  F   +        
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKER 198

Query: 612 VGT 614
           +GT
Sbjct: 199 LGT 201

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 20/154 (12%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLGGERLL 520
           +G+G F  V   + +   +E+AIK + K+  +   + +   E +++  L H N+   +L 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI--VKL- 79

Query: 521 VYEYLPNKSLDFFIFD-SSRKSLLDW---KKRFSIIEG------ITQGLLYLHKYSRLRV 570
            +E +  +   + I + +S   + D+     R    E       I   + Y H   + R+
Sbjct: 80  -FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRI 135

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
           +HRDLK  N+LLD  MN KI+DFG +  FT+   
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 42/170 (24%), Positives = 64/170 (37%), Gaps = 34/170 (20%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
           +G+G +G V            A K++ K   + +  FK E +++  L H N+        
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGITQGLLYLHKYSR 567
              +  LV E      L    F+         K+ F       I++ +   + Y HK   
Sbjct: 77  DNTDIYLVMELCTGGEL----FERVVH-----KRVFRESDAARIMKDVLSAVAYCHK--- 124

Query: 568 LRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           L V HRDLK  N L          K+ DFG+A  F   ++       VGT
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGT 171

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 75.7 bits (186), Expect = 2e-14
 Identities = 53/193 (27%), Positives = 79/193 (40%), Gaps = 40/193 (20%)

Query: 440 KRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE 498
              L + DF    +          +G+GGFG VY  +  D  ++ A+K L K     I  
Sbjct: 183 NIHLTMNDFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKM 229

Query: 499 FKNEAKLIAK---LQHTNLGGERLLV---YEYLPNKSLDFFIFD-----------SSRKS 541
            + E   + +   L   + G    +V   Y +     L  FI D           S    
Sbjct: 230 KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL-SFILDLMNGGDLHYHLSQHGV 288

Query: 542 LLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM 601
             +   RF   E I  GL ++H      V++RDLK +NILLDE  + +ISD G+A  F+ 
Sbjct: 289 FSEADMRFYAAE-IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS- 343

Query: 602 NELEANTNRIVGT 614
              +   +  VGT
Sbjct: 344 ---KKKPHASVGT 353

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 52/176 (29%), Positives = 86/176 (48%), Gaps = 26/176 (14%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 511
            + ++    LG+G FG V K K    +QE A+K ++K+    +       E +L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 512 TNLGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---KKRFS------IIEGITQGLLY 561
            N+    + ++E L + S  + + +  +   L D    +KRFS      II+ +  G+ Y
Sbjct: 81  PNI----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 562 LHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +HK     ++HRDLK  NILL   ++  + KI DFG++  F  N         +GT
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGT 186

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 42/188 (22%), Positives = 64/188 (34%), Gaps = 36/188 (19%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL 514
           +       LG G  G V        + +A+KR+             E KL+ +   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNV 71

Query: 515 ---------GGERLLVYEYLPNKSLDFFI----FDSSRKSLLDWKKRFSIIEGITQGLLY 561
                         +  E   N +L   +           L       S++  I  G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 562 LHKYSRLRVIHRDLKVSNILLD-------------EQMNPKISDFGMARTFTMNE--LEA 606
           LH    L++IHRDLK  NIL+              E +   ISDFG+ +     +     
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 607 NTNRIVGT 614
           N N   GT
Sbjct: 188 NLNNPSGT 195

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 31/160 (19%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLGGERL 519
           LG G FG V  GK      ++A+K L++    S   + + + E + +   +H ++   +L
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI--IKL 81

Query: 520 LVYEYLPNKSLDFFI---------FDSSRKSLLDWKKRFSIIEG------ITQGLLYLHK 564
             Y+ +   S  F +         FD      +    R    E       I  G+ Y H 
Sbjct: 82  --YQVISTPSDIFMVMEYVSGGELFD-----YICKNGRLDEKESRRLFQQILSGVDYCH- 133

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
             R  V+HRDLK  N+LLD  MN KI+DFG++   +  E 
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 44/172 (25%), Positives = 65/172 (37%), Gaps = 33/172 (19%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL------- 514
           LG G FG V+  +      E  IK ++K   Q  +E  + E +++  L H N+       
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFS------IIEGITQGLLYLHKY 565
                  +V E      L     +  R  S     K  S      +++ +   L Y H  
Sbjct: 90  EDYHNMYIVMETCEGGEL----LE--RIVSAQARGKALSEGYVAELMKQMMNALAYFHS- 142

Query: 566 SRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
               V+H+DLK  NIL          KI DFG+A  F  +E    +    GT
Sbjct: 143 --QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGT 189

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 22/102 (21%), Positives = 36/102 (35%), Gaps = 13/102 (12%)

Query: 523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL 582
           +    ++L  ++         +      I   I + + +LH      ++HRDLK SNI  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197

Query: 583 DEQMNPKISDFGMARTFTMNELEANTN----------RIVGT 614
                 K+ DFG+      +E E                VGT
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 21/60 (35%), Positives = 32/60 (53%), Gaps = 2/60 (3%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 513
            +F P   +G+GGFG V++ K   D+   AIKR+   + +   E    E K +AKL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 27/177 (15%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ 510
           +D +     LG+G FG V   K     QE A+K +SK              E +L+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 511 HTNLGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---KKRFS------IIEGITQGLL 560
           H N+    + +YE+  +K   + + +  +   L D    +KRFS      II  +  G+ 
Sbjct: 85  HPNI----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT 140

Query: 561 YLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           Y+HK    +++HRDLK  N+LL    +  N +I DFG++  F  ++        +GT
Sbjct: 141 YMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGT 191

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 23/180 (12%), Positives = 54/180 (30%), Gaps = 31/180 (17%)

Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGK------LQDEQEIAIKRLSKSSGQGIVEFKNEA 503
              + +      + LG+G F  VY+         +++Q+  +K    ++           
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 504 KLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFI--FDSSRKSLLDWKKRFSII 552
           + +                     +LV E     +L   I  + ++ + ++      S  
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP-----------KISDFGMARTFTM 601
             +   +  +H      +IH D+K  N +L                  + D G +    +
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 39/216 (18%), Positives = 63/216 (29%), Gaps = 59/216 (27%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIK-----RLSKSSGQGIVEFKNEAKLIAK 508
              +     +GQG +G V      Q     AIK     ++ + + + +   K E +L+ K
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 509 LQHTNL---------------------GGE-------------------RLLVYEYLPNK 528
           L H N+                     GG                     +        +
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 529 SLDFFIFDSSRKSLLDWKKRFS------IIEGITQGLLYLHKYSRLRVIHRDLKVSNILL 582
             +  I  S                   I+  I   L YLH      + HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 583 --DEQMNPKISDFGMARTFTMNELEANT--NRIVGT 614
             ++    K+ DFG+++ F               GT
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 39/171 (22%), Positives = 68/171 (39%), Gaps = 37/171 (21%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLGGE 517
           +G+G +G V       D    A+K LSK      +G          +          G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 518 ----------RLL-------VYEYL--PNKSLDFFIFDSSRK-SLLD--WKKRFSIIEG- 554
                     + L       + E L  PN+   + +F+   +  +++    K  S  +  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 555 -----ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
                + +G+ YLH     ++IHRD+K SN+L+ E  + KI+DFG++  F 
Sbjct: 141 FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 42/206 (20%), Positives = 86/206 (41%), Gaps = 30/206 (14%)

Query: 429 RKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKR 487
           + T+    Q++  + ++ D+         + P + +G+G    V +        E A+K 
Sbjct: 67  KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126

Query: 488 LSKSSGQGIVE--------FKNEAKLIAKL-QHTNLGGERLLVYEYLPNKSLDFFIFD-S 537
           +  ++ +   E         + E  ++ ++  H ++    + + +   + S  F +FD  
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI----ITLIDSYESSSFMFLVFDLM 182

Query: 538 SRKSLLDW---KKRFS------IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP 588
            +  L D+   K   S      I+  + + + +LH      ++HRDLK  NILLD+ M  
Sbjct: 183 RKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQI 239

Query: 589 KISDFGMARTFTMNELEANTNRIVGT 614
           ++SDFG +      E       + GT
Sbjct: 240 RLSDFGFSCHLEPGEK---LRELCGT 262

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 45/181 (24%), Positives = 75/181 (41%), Gaps = 31/181 (17%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE---------FKNEAK 504
            +N+ P   LG+G    V +       +E A+K +  + G                 E  
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 505 LIAKL-QHTNLGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---KKRFS------IIE 553
           ++ K+  H N+    + + +     +  F +FD   +  L D+   K   S      I+ 
Sbjct: 76  ILRKVSGHPNI----IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVG 613
            + + +  LHK   L ++HRDLK  NILLD+ MN K++DFG +      E       + G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 185

Query: 614 T 614
           T
Sbjct: 186 T 186

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 37/160 (23%), Positives = 61/160 (38%), Gaps = 32/160 (20%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL------- 514
           LG+G    V     L   QE A+K + K  G        E +++ + Q H N+       
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGITQGLLYLHKYS 566
                  LV+E +   S+         K     ++ F+      +++ +   L +LH   
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LSHIHK-----RRHFNELEASVVVQDVASALDFLHN-- 129

Query: 567 RLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNE 603
              + HRDLK  NIL    ++    KI DF +     +N 
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 35/176 (19%), Positives = 61/176 (34%), Gaps = 35/176 (19%)

Query: 455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVE--FKN---------EA 503
              ++    +  G +G V  G   +   +AIKR+  +   G       +         E 
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 504 KLIAKLQHTNLGGERLLVYEYLPNKSLDFF----------------IFDSSRKSLLDWKK 547
           +L+    H N+    L + +   +                      +    R  +     
Sbjct: 81  RLLNHFHHPNI----LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136

Query: 548 RFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           ++  +  I  GL  LH+     V+HRDL   NILL +  +  I DF +AR  T + 
Sbjct: 137 QY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 35/180 (19%), Positives = 79/180 (43%), Gaps = 40/180 (22%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
            D +   + +G G +G V +     +++ +AIK++ +        F++         E  
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFF-----IFD----------SSRKSLLDWKKRF 549
           ++ +L H ++    + V + +  K ++ F     + +           +   L +   + 
Sbjct: 105 ILNRLNHDHV----VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT 160

Query: 550 SIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
            ++  +  G+ Y+H  S   ++HRDLK +N L+++  + K+ DFG+ART    E   +  
Sbjct: 161 -LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 42/184 (22%), Positives = 71/184 (38%), Gaps = 34/184 (18%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIK-----RLSKSSGQGIVEFKNEAKLIAK 508
            D +     +G+G F  V +    +  Q+ A+K     + + S G    + K EA +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 509 LQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIE 553
           L+H ++          G   +V+E++    L F I   +          +S       + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG-----FVYSEAVASHYMR 137

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNR 610
            I + L Y H      +IHRD+K   +LL   +     K+  FG+A     + L A    
Sbjct: 138 QILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-- 192

Query: 611 IVGT 614
            VGT
Sbjct: 193 RVGT 196

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 43/190 (22%)

Query: 440 KRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVY---KGKLQDEQEI-AIKRLSKSS--G 493
                   F+ + V          LGQG FG V+   K    D +++ A+K L K++   
Sbjct: 18  HEKADPSQFELLKV----------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV 67

Query: 494 QGIVEFKNEAKLIAKLQH---TNLG-----GERL-LVYEYLPNKSLDFF------IFDSS 538
           +  V  K E  ++ ++ H     L        +L L+ ++L    L F       +F   
Sbjct: 68  RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEE 126

Query: 539 RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
                    +F + E +   L +LH    L +I+RDLK  NILLDE+ + K++DFG+++ 
Sbjct: 127 DV-------KFYLAE-LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175

Query: 599 FTMNELEANT 608
              +E +A +
Sbjct: 176 SIDHEKKAYS 185

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 54/208 (25%), Positives = 82/208 (39%), Gaps = 46/208 (22%)

Query: 423 PTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQE 482
           P+     +    S    K  + + +F+ + +          LG+G FG V   K +    
Sbjct: 125 PSDNSGAEEMEVSLAKPKHRVTMNEFEYLKL----------LGKGTFGKVILVKEKATGR 174

Query: 483 I-AIKRLSKSSGQGIVE------FKNEAKLIAKLQH---TNLG-----GERL-LVYEYLP 526
             A+K L K     IV          E +++   +H   T L       +RL  V EY  
Sbjct: 175 YYAMKILKKEV---IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231

Query: 527 NKSLDFF------IFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNI 580
              L FF      +F   R        RF   E I   L YLH  S   V++RDLK+ N+
Sbjct: 232 GGEL-FFHLSRERVFSEDRA-------RFYGAE-IVSALDYLH--SEKNVVYRDLKLENL 280

Query: 581 LLDEQMNPKISDFGMARTFTMNELEANT 608
           +LD+  + KI+DFG+ +    +     T
Sbjct: 281 MLDKDGHIKITDFGLCKEGIKDGATMKT 308

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 26/176 (14%)

Query: 455 TDNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 511
           +DN+     LG+G F  V +        E A K ++    S +   + + EA++  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 512 TNLGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---KKRFS------IIEGITQGLLY 561
            N+    + +++ +  +S  + +FD  +   L +    ++ +S       I+ I + + Y
Sbjct: 65  PNI----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120

Query: 562 LHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            H      ++HR+LK  N+LL    +    K++DFG+A     +E     +   GT
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 37/154 (24%), Positives = 60/154 (38%), Gaps = 26/154 (16%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKL---IAKLQHTNLGGE-- 517
           LG+GGFG V+ G  L D  ++AIK + ++   G     +       +A L     GG   
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 518 ---RLLVYEYLPNKSLDFFI--FDSSRKSLLDW---KKRFSIIEG------ITQGLLYLH 563
              RL   ++   +     +       + L D+   K              +   + + H
Sbjct: 99  GVIRL--LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNP-KISDFGMA 596
                 V+HRD+K  NIL+D +    K+ DFG  
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 51/193 (26%), Positives = 79/193 (40%), Gaps = 50/193 (25%)

Query: 440 KRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE 498
               K  DF  + V          +G+G FG V   + + E+   A+K L K +   I++
Sbjct: 32  NPHAKPSDFHFLKV----------IGKGSFGKVLLARHKAEEVFYAVKVLQKKA---ILK 78

Query: 499 FKNEAK--------LIAKLQH---TNL-----GGERL-LVYEYLPNKSLDFF------IF 535
            K E K        L+  ++H     L       ++L  V +Y+    L F+       F
Sbjct: 79  -KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL-FYHLQRERCF 136

Query: 536 DSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM 595
              R        RF   E I   L YLH    L +++RDLK  NILLD Q +  ++DFG+
Sbjct: 137 LEPRA-------RFYAAE-IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL 185

Query: 596 ARTFTMNELEANT 608
            +    +    +T
Sbjct: 186 CKENIEHNSTTST 198

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 69.1 bits (170), Expect = 5e-13
 Identities = 37/175 (21%), Positives = 71/175 (40%), Gaps = 45/175 (25%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVY 522
           LG G F  V+  K     +  A+K + KS        +NE  ++ K++H N+    + + 
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI----VTLE 72

Query: 523 EYLPNKSLDFFIFDSSRK-----------SLLDW---KKRFS------IIEGITQGLLYL 562
           +          I++S+              L D    +  ++      +I+ +   + YL
Sbjct: 73  D----------IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 563 HKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           H+     ++HRDLK  N+L    +E     I+DFG+++      +    +   GT
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGT 170

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.5 bits (171), Expect = 5e-13
 Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 51/195 (26%)

Query: 440 KRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVY---KGKLQDEQEI-AIKRLSKSSGQG 495
              ++   F+ + V          LG+GG+G V+   K    +  +I A+K L K+    
Sbjct: 11  PEKIRPECFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM--- 57

Query: 496 IVEFKNEA-------KLIAKLQH---TNL-----GGERL-LVYEYLPNKSLDFF------ 533
           IV    +         ++ +++H    +L      G +L L+ EYL    L F       
Sbjct: 58  IVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL-FMQLEREG 116

Query: 534 IFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF 593
           IF             F + E I+  L +LH+     +I+RDLK  NI+L+ Q + K++DF
Sbjct: 117 IFMEDTA-------CFYLAE-ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDF 165

Query: 594 GMARTFTMNELEANT 608
           G+ +    +    +T
Sbjct: 166 GLCKESIHDGTVTHT 180

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 48/188 (25%), Positives = 76/188 (40%), Gaps = 47/188 (25%)

Query: 443 LKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE--- 498
           + + DF  + +          LG+G FG V   + +      A+K L K     I+    
Sbjct: 2   VTMNDFDYLKL----------LGKGTFGKVILVREKATGRYYAMKILRKEV---IIAKDE 48

Query: 499 ---FKNEAKLIAKLQH---TNLG-----GERL-LVYEYLPNKSLDFF------IFDSSRK 540
                 E++++   +H   T L       +RL  V EY     L FF      +F   R 
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERA 107

Query: 541 SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
                  RF   E I   L YLH      V++RD+K+ N++LD+  + KI+DFG+ +   
Sbjct: 108 -------RFYGAE-IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156

Query: 601 MNELEANT 608
            +     T
Sbjct: 157 SDGATMKT 164

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 26/176 (14%)

Query: 455 TDNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 511
           +DN+     LG+G F  V +        E A K ++    S +   + + EA++  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 512 TNLGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---KKRFS------IIEGITQGLLY 561
            N+    + +++ +  +S  + +FD  +   L +    ++ +S       I+ I + + Y
Sbjct: 88  PNI----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 143

Query: 562 LHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            H      ++HR+LK  N+LL    +    K++DFG+A     +E     +   GT
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 53/215 (24%)

Query: 427 GNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVY---KGKLQDEQEI 483
              + +  +       + I +F+ + V          LG G +G V+   K    D  ++
Sbjct: 35  VKHELRTANLTGHAEKVGIENFELLKV----------LGTGAYGKVFLVRKISGHDTGKL 84

Query: 484 -AIKRLSKSSGQGIVEF-------KNEAKLIAKLQH----TNL-----GGERL-LVYEYL 525
            A+K L K++   IV+        + E +++  ++       L        +L L+ +Y+
Sbjct: 85  YAMKVLKKAT---IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI 141

Query: 526 PNKSLDFF------IFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN 579
               L F        F            +  + E I   L +LHK   L +I+RD+K+ N
Sbjct: 142 NGGEL-FTHLSQRERFTEHEV-------QIYVGE-IVLALEHLHK---LGIIYRDIKLEN 189

Query: 580 ILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           ILLD   +  ++DFG+++ F + +         GT
Sbjct: 190 ILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGT 223

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 33/174 (18%), Positives = 71/174 (40%), Gaps = 25/174 (14%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 513
            + +  A  LG+G FG V++      ++    K +    G   V  K E  ++   +H N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRN 62

Query: 514 L---------GGERLLVYEYLPNKSLDFFIFD--SSRKSLLDWKKRFSIIEGITQGLLYL 562
           +           E ++++E++    +    F+  ++    L+ ++  S +  + + L +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNP--KISDFGMARTFTMNELEANTNRIVGT 614
           H      + H D++  NI+   + +   KI +FG AR     +   N   +   
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 46/186 (24%), Positives = 69/186 (37%), Gaps = 41/186 (22%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSS------GQGIVEFKNEAKLIA 507
            D +     LG G F  V K +      E A K + K        G    E + E  ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 508 KLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------II 552
           ++ H N+           + +L+ E +    L    FD      L  K+  S       I
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDF-----LAQKESLSEEEATSFI 121

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMARTFTMNELEANT 608
           + I  G+ YLH     ++ H DLK  NI+L ++  P    K+ DFG+A            
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175

Query: 609 NRIVGT 614
             I GT
Sbjct: 176 KNIFGT 181

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 51/194 (26%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIV-------------EFK 500
            +++    +LG G +G V   K      E AIK + KS                   E  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 501 NEAKLIAKLQHTNLGGERL-----------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRF 549
           NE  L+  L H N+   +L           LV E+     L    F+      +  + +F
Sbjct: 95  NEISLLKSLDHPNII--KLFDVFEDKKYFYLVTEFYEGGEL----FEQ-----IINRHKF 143

Query: 550 S------IIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFT 600
                  I++ I  G+ YLHK     ++HRD+K  NILL   +  +N KI DFG++  F+
Sbjct: 144 DECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

Query: 601 MNELEANTNRIVGT 614
            +         +GT
Sbjct: 201 KDY---KLRDRLGT 211

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 50/181 (27%)

Query: 440 KRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE 498
           +  +K+ DF  + V          LG+G FG V   + +   E+ A+K L K     +++
Sbjct: 14  RDRMKLTDFNFLMV----------LGKGSFGKVMLSERKGTDELYAVKILKKDV---VIQ 60

Query: 499 FKNEAK--------LIAKLQH---TNLG-----GERL-LVYEYLPNKSLDFF------IF 535
             ++ +        L    +    T L       +RL  V EY+    L  +       F
Sbjct: 61  -DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRF 118

Query: 536 DSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM 595
                        F   E I  GL +L       +I+RDLK+ N++LD + + KI+DFGM
Sbjct: 119 KEPHA-------VFYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 167

Query: 596 A 596
            
Sbjct: 168 C 168

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 33/166 (19%), Positives = 62/166 (37%), Gaps = 29/166 (17%)

Query: 449 QTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLI 506
           Q      ++      +G G  G V+K +  +    IA+K++ +S  +   +    +  ++
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 507 AKL-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------ 550
            K      +           +  +  E +     +              +          
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--------KRMQGPIPERILGK 128

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA 596
           +   I + L YL    +  VIHRD+K SNILLDE+   K+ DFG++
Sbjct: 129 MTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 69.3 bits (169), Expect = 2e-12
 Identities = 48/218 (22%), Positives = 82/218 (37%), Gaps = 50/218 (22%)

Query: 415 ELGHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYK 474
           ++G     P            +   +  +K+ DF  + V          LG+G FG V  
Sbjct: 310 KIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMV----------LGKGSFGKVML 359

Query: 475 GKLQDEQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQH---TNLGG-----E 517
            + +   E+ A+K L K     +++  ++ +        L    +    T L       +
Sbjct: 360 SERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415

Query: 518 RL-LVYEYLPNKSLDFF------IFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV 570
           RL  V EY+    L  +       F             F   E I  GL +L       +
Sbjct: 416 RLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-------VFYAAE-IAIGLFFLQS---KGI 463

Query: 571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           I+RDLK+ N++LD + + KI+DFGM +    + +   T
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 46/186 (24%), Positives = 69/186 (37%), Gaps = 41/186 (22%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS------SGQGIVEFKNEAKLIA 507
            D +     LG G F  V K +      E A K + K        G    E + E  ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 508 KLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------II 552
           ++ H N+           + +L+ E +    L    FD      L  K+  S       I
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDF-----LAQKESLSEEEATSFI 121

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMARTFTMNELEANT 608
           + I  G+ YLH     ++ H DLK  NI+L ++  P    K+ DFG+A            
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175

Query: 609 NRIVGT 614
             I GT
Sbjct: 176 KNIFGT 181

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 37/167 (22%), Positives = 75/167 (44%), Gaps = 30/167 (17%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HT 512
            D++    +LG+G +  V++   + + +++ +K L     +   + K E K++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 513 N-----------LGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           N           +     LV+E++ N            ++L D+  RF + E I + L Y
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDY 145

Query: 562 LHKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTF----TMNE 603
            H  S   ++HRD+K  N+++D E    ++ D+G+A  +      N 
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 50/205 (24%)

Query: 428 NRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIK 486
           + K            L I +F+ I V          LG+G FG V   ++++  ++ A+K
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRV----------LGKGSFGKVMLARVKETGDLYAVK 54

Query: 487 RLSKSSGQGIVEFKNEAK--------LIAKLQH---TNLG-----GERL-LVYEYLPNKS 529
            L K     I++  ++ +        L     H   T L       +RL  V E++    
Sbjct: 55  VLKKDV---ILQ-DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGD 110

Query: 530 LDFF------IFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD 583
           L  F       FD +R        RF   E I   L++LH      +I+RDLK+ N+LLD
Sbjct: 111 L-MFHIQKSRRFDEARA-------RFYAAE-IISALMFLHD---KGIIYRDLKLDNVLLD 158

Query: 584 EQMNPKISDFGMARTFTMNELEANT 608
            + + K++DFGM +    N +   T
Sbjct: 159 HEGHCKLADFGMCKEGICNGVTTAT 183

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 43/188 (22%), Positives = 68/188 (36%), Gaps = 45/188 (23%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE--------FKNEAKL 505
            D +  +  LG G  G V      +  +++AIK +SK                 + E ++
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 506 IAKLQHTNLGGERL----------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS----- 550
           + KL H  +   ++          +V E +    L    FD          KR       
Sbjct: 69  LKKLNHPCI--IKIKNFFDAEDYYIVLELMEGGEL----FDKVVG-----NKRLKEATCK 117

Query: 551 -IIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEA 606
                +   + YLH      +IHRDLK  N+LL   +E    KI+DFG ++      L  
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172

Query: 607 NTNRIVGT 614
               + GT
Sbjct: 173 -MRTLCGT 179

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 52/181 (28%), Positives = 76/181 (41%), Gaps = 50/181 (27%)

Query: 440 KRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE 498
           +  LKI DF    +          LG+G FG V+  + +   +  AIK L K     ++ 
Sbjct: 11  QIKLKIEDFILHKM----------LGKGSFGKVFLAEFKKTNQFFAIKALKKDV---VLM 57

Query: 499 FKNEAK--------LIAKLQH---TNLGG-----ERL-LVYEYLPNKSLDFF------IF 535
             ++ +        L    +H   T++       E L  V EYL    L  +       F
Sbjct: 58  -DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKF 115

Query: 536 DSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM 595
           D SR         F   E I  GL +LH      +++RDLK+ NILLD+  + KI+DFGM
Sbjct: 116 DLSRA-------TFYAAE-IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM 164

Query: 596 A 596
            
Sbjct: 165 C 165

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 37/168 (22%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
              +     +G G +G V      +  +++AIK+LS+        F++         E  
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFF-----IFDS--------SRKSLLDWKKRFSI 551
           L+  +QH N+ G   L+  + P  SL  F     +                 + K ++ +
Sbjct: 76  LLKHMQHENVIG---LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-L 131

Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           +  + +GL Y+H      V+HRDLK  N+ ++E    KI DFG+AR  
Sbjct: 132 VYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 40/204 (19%), Positives = 81/204 (39%), Gaps = 40/204 (19%)

Query: 432 QARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSK 490
                 +  R+   F         DN+   + +G+G +G VY       E+ +AIK++++
Sbjct: 2   HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR 61

Query: 491 SSGQGIVEFKN---------EAKLIAKLQHTNLGGERLLVYEYLPNKSLDFF-----IFD 536
                   F++         E  ++ +L+   +    + +Y+ +    L  F     + +
Sbjct: 62  M-------FEDLIDCKRILREITILNRLKSDYI----IRLYDLIIPDDLLKFDELYIVLE 110

Query: 537 ----------SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM 586
                      +   L +   +  I+  +  G  ++H      +IHRDLK +N LL++  
Sbjct: 111 IADSDLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDC 166

Query: 587 NPKISDFGMARTFTMNELEANTNR 610
           + K+ DFG+ART    +     N 
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVND 190

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 43/193 (22%), Positives = 69/193 (35%), Gaps = 50/193 (25%)

Query: 440 KRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVE 498
              L + DF  + V          +G+G +  V   +L+    I A+K + K     + +
Sbjct: 3   MDPLGLQDFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKEL---VND 49

Query: 499 FKNEAK--------LIAKLQH---TNL-----GGERL-LVYEYLPNKSLDFF------IF 535
              +                H     L        RL  V EY+    L  F        
Sbjct: 50  -DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKL 107

Query: 536 DSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM 595
                       RF   E I+  L YLH+     +I+RDLK+ N+LLD + + K++D+GM
Sbjct: 108 PEEHA-------RFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM 156

Query: 596 ARTFTMNELEANT 608
            +         +T
Sbjct: 157 CKEGLRPGDTTST 169

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 37/172 (21%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
              +     +G G  G V        ++ +AIK+LS+        F+N         E  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFF-----IFDS--------SRKSLLDWKKRFSI 551
           L+  + H N+     L+  + P K+L+ F     + +          +  L   +  + +
Sbjct: 114 LMKCVNHKNIIS---LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 170

Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
            + +  G+ +LH      +IHRDLK SNI++      KI DFG+ART   + 
Sbjct: 171 YQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 65.7 bits (161), Expect = 5e-12
 Identities = 45/186 (24%), Positives = 72/186 (38%), Gaps = 41/186 (22%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS------SGQGIVEFKNEAKLIA 507
            D++     LG G F  V K +     +E A K + K        G    E + E  ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 508 KLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------II 552
           +++H N+           + +L+ E +    L    FD      L  K+  +       +
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDF-----LAEKESLTEDEATQFL 114

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMARTFTMNELEANT 608
           + I  G+ YLH     R+ H DLK  NI+L ++  P    K+ DFG+A            
Sbjct: 115 KQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EF 168

Query: 609 NRIVGT 614
             I GT
Sbjct: 169 KNIFGT 174

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 43/205 (20%), Positives = 70/205 (34%), Gaps = 50/205 (24%)

Query: 428 NRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIK 486
                 R        L + DF  + V          +G+G +  V   +L+    I A++
Sbjct: 34  KEAMNTRESGKASSSLGLQDFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMR 83

Query: 487 RLSKSSGQGIVEFKNEAK--------LIAKLQH---TNL-----GGERL-LVYEYLPNKS 529
            + K     + +   +                H     L        RL  V EY+    
Sbjct: 84  VVKKEL---VND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD 139

Query: 530 LDFF------IFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD 583
           L  F                    RF   E I+  L YLH+     +I+RDLK+ N+LLD
Sbjct: 140 L-MFHMQRQRKLPEEHA-------RFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLD 187

Query: 584 EQMNPKISDFGMARTFTMNELEANT 608
            + + K++D+GM +         +T
Sbjct: 188 SEGHIKLTDYGMCKEGLRPGDTTST 212

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 65.7 bits (161), Expect = 8e-12
 Identities = 44/177 (24%), Positives = 69/177 (38%), Gaps = 41/177 (23%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKS------SGQGIVEFKNEAKLIAKLQHTNL-- 514
           LG G F  V K +      + A K + K        G    + + E  ++ ++QH N+  
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGITQGLLY 561
                    + +L+ E +    L    FD      L  K+  +       ++ I  G+ Y
Sbjct: 79  LHEVYENKTDVILILELVAGGEL----FDF-----LAEKESLTEEEATEFLKQILNGVYY 129

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMARTFTMNELEANTNRIVGT 614
           LH    L++ H DLK  NI+L ++  P    KI DFG+A              I GT
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 180

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 37/173 (21%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
              +     +G G  G V        E+ +AIK+LS+        F+N         E  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFF-----IFDS--------SRKSLLDWKKRFSI 551
           L+  + H N+ G   L+  + P KSL+ F     + +          +  L   +  + +
Sbjct: 77  LMKCVNHKNIIG---LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-L 132

Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
           +  +  G+ +LH      +IHRDLK SNI++      KI DFG+ART   + +
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 45/211 (21%), Positives = 73/211 (34%), Gaps = 60/211 (28%)

Query: 444 KIFDFQTIAVATDNFSPAN---------RLGQGGFGPVYKGK-LQDEQEIAIKRLSKS-- 491
           K+F F  + V   +  P            LG G  G V      +  +++AI+ +SK   
Sbjct: 114 KVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKF 173

Query: 492 ------SGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIFDSSRKS---- 541
                      +  + E +++ KL H  +    + +             FD+        
Sbjct: 174 AIGSAREADPALNVETEIEILKKLNHPCI----IKIKN----------FFDAEDYYIVLE 219

Query: 542 ------LLDW---KKRFS------IIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---D 583
                 L D     KR            +   + YLH+     +IHRDLK  N+LL   +
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQE 276

Query: 584 EQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           E    KI+DFG ++      L      + GT
Sbjct: 277 EDCLIKITDFGHSKILGETSL---MRTLCGT 304

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 35/173 (20%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT-NL----- 514
           LG+G F  V +       QE A K L K         E  +E  ++   +    +     
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGITQGLLYLHK 564
                 E +L+ EY     +    F      L +  +  S      +I+ I +G+ YLH+
Sbjct: 97  VYENTSEIILILEYAAGGEI----FS---LCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149

Query: 565 YSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                ++H DLK  NILL       + KI DFGM+R             I+GT
Sbjct: 150 ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGT 196

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 39/176 (22%), Positives = 79/176 (44%), Gaps = 25/176 (14%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 511
           T+ +     LG+G F  V +   +   QE A   ++    S +   + + EA++   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 512 TNLGGERLLVYEYLPNKSLDFFIFD-SSRKSLLDW---KKRFS------IIEGITQGLLY 561
            N+    + +++ +  +   + IFD  +   L +    ++ +S       I+ I + +L+
Sbjct: 70  PNI----VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 562 LHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            H+   + V+HR+LK  N+LL    +    K++DFG+A      +         GT
Sbjct: 126 CHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGT 176

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 47/181 (25%), Positives = 70/181 (38%), Gaps = 39/181 (21%)

Query: 455 TDNFSPANRLGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHT 512
           TD +     +G G +    +        E A+K + KS      +   E +++ +  QH 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHP 76

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGITQ 557
           N+         G    +V E +    L     D   +     +K FS      ++  IT+
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGEL----LDKILR-----QKFFSEREASAVLFTITK 127

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILL-DEQMNP---KISDFGMARTFTMNELEANTNRIVG 613
            + YLH      V+HRDLK SNIL  DE  NP   +I DFG A+          T     
Sbjct: 128 TVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCY 182

Query: 614 T 614
           T
Sbjct: 183 T 183

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 37/162 (22%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLGGERL-- 519
           +G G FG     +    ++ +A+K + +  G  I E  + E      L+H N+   R   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNI--VRFKE 83

Query: 520 ---------LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG------ITQGLLYLHK 564
                    ++ EY     L    ++      +    RFS  E       +  G+ Y H 
Sbjct: 84  VILTPTHLAIIMEYASGGEL----YE-----RICNAGRFSEDEARFFFQQLLSGVSYCH- 133

Query: 565 YSRLRVIHRDLKVSNILLDEQ--MNPKISDFGMARTFTMNEL 604
              +++ HRDLK+ N LLD       KI DFG +++  ++  
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 38/169 (22%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
              +     +G G +G V      +   ++AIK+L +        F++         E +
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFF-----IFD---------SSRKSLLDWKKRFS 550
           L+  ++H N+ G   L+  + P+++LD F     +              + L + + +F 
Sbjct: 77  LLKHMRHENVIG---LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF- 132

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           ++  + +GL Y+H      +IHRDLK  N+ ++E    KI DFG+AR  
Sbjct: 133 LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 27/212 (12%)

Query: 417 GHNVSLPTIFGNRKTQARSDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK 476
             N+   ++     + A    ++  D  I      A+ +D F   + LG+G    VY+ K
Sbjct: 15  TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL-SDFFEVESELGRGATSIVYRCK 73

Query: 477 -LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERLLVYEYLPNKSLDFFIF 535
               ++  A+K L K+  + IV  + E  ++ +L H N+    + + E     +    + 
Sbjct: 74  QKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNI----IKLKEIFETPTEISLVL 127

Query: 536 D-SSRKSLLDW---KKRFS------IIEGITQGLLYLHKYSRLRVIHRDLKVSNILL--- 582
           +  +   L D    K  +S       ++ I + + YLH+     ++HRDLK  N+L    
Sbjct: 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATP 184

Query: 583 DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                 KI+DFG+++      L      + GT
Sbjct: 185 APDAPLKIADFGLSKIVEHQVL---MKTVCGT 213

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 39/209 (18%), Positives = 68/209 (32%), Gaps = 58/209 (27%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQE-IAIKRLSKSSGQGIVEFKN-EAKLIAKLQ 510
            ++  +S    LG G FG V +    +  +  A+K++ +        +KN E  ++  L 
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58

Query: 511 HTNLGGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL-------LY-- 561
           H N+   +L+ Y Y                + L  K         +  +       L   
Sbjct: 59  HVNI--IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 562 -------LHKYSR---------------------LR---------VIHRDLKVSNILLDE 584
                  LHK  +                      R         + HRD+K  N+L++ 
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 585 QMNP-KISDFGMARTFTMNELEANTNRIV 612
           + N  K+ DFG A+       E +   I 
Sbjct: 177 KDNTLKLCDFGSAKKL--IPSEPSVAYIC 203

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 13/153 (8%), Positives = 38/153 (24%), Gaps = 25/153 (16%)

Query: 463 RLGQGGFGPVYKGKLQDEQ---EIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNL-- 514
             G       ++    D     ++A+  +          + E  +    ++++    +  
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
                      L+V E++   SL          +          ++ +       H   R
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMARTFT 600
             V       S + +    +  ++         
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMPDAN 180

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 43/171 (25%), Positives = 65/171 (38%), Gaps = 37/171 (21%)

Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL------- 514
           LG+G F    K    +  Q  A+K +SK         + E   +   + H N+       
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEVF 75

Query: 515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFS------IIEGITQGLLYLHKYS 566
                  LV E L    L    F+  +K     KK FS      I+  +   + ++H   
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKK-----KKHFSETEASYIMRKLVSAVSHMHD-- 124

Query: 567 RLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            + V+HRDLK  N+L    ++ +  KI DFG AR    +     T     T
Sbjct: 125 -VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 38/177 (21%), Positives = 76/177 (42%), Gaps = 40/177 (22%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
              ++  + +G+G +G V       ++  +AIK++S         F++         E K
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFF-----IFD---------SSRKSLLDWKKRFS 550
           ++ + +H N+    + + + +   +++       + D            + L +    + 
Sbjct: 78  ILLRFRHENI----IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY- 132

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEAN 607
            +  I +GL Y+H  S   V+HRDLK SN+LL+   + KI DFG+AR    +     
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.6 bits (153), Expect = 9e-11
 Identities = 39/178 (21%), Positives = 71/178 (39%), Gaps = 38/178 (21%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
           + +F   + LG+G +G V         + +AIK++          F           E K
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDF----FIFD---------SSRKSLLDWKKRFSI 551
           ++   +H N+     +     P+   +F     I +          S + L D   ++  
Sbjct: 62  ILKHFKHENIIT---IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-F 117

Query: 552 IEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
           I    + +  LH  +   VIHRDLK SN+L++   + K+ DFG+AR    +  + +  
Sbjct: 118 IYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 62.7 bits (153), Expect = 9e-11
 Identities = 38/175 (21%), Positives = 63/175 (36%), Gaps = 43/175 (24%)

Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLL- 520
           LG G  G V +    +  Q+ A+K L  S      + + E     +     ++    +L 
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHI--VCILD 89

Query: 521 VYEYLPNKSLDFFI----------FD--SSRKSLLDWKKRFS------IIEGITQGLLYL 562
           VYE + +      I          F     R       + F+      I+  I   + +L
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGD-----QAFTEREAAEIMRDIGTAIQFL 144

Query: 563 HKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           H      + HRD+K  N+L    ++    K++DFG A+  T N L         T
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYT 192

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 38/168 (22%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
            + +   + +G G +G V      +    +A+K+LS+        F++         E +
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFF-----IFD---------SSRKSLLDWKKRFS 550
           L+  ++H N+ G   L+  + P +SL+ F     +              + L D   +F 
Sbjct: 81  LLKHMKHENVIG---LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF- 136

Query: 551 IIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
           +I  I +GL Y+H      +IHRDLK SN+ ++E    KI DFG+AR 
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 181

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 36/164 (21%), Positives = 64/164 (39%), Gaps = 39/164 (23%)

Query: 464 LGQGGFGPVYKG-KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLGGERLL- 520
           LG G  G V +    + +++ A+K L         + + E +L  +     ++   R++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHI--VRIVD 122

Query: 521 VYEYLPNKSLDFFI----------FD--SSRKSLLDWKKRFS------IIEGITQGLLYL 562
           VYE L        I          F     R       + F+      I++ I + + YL
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYL 177

Query: 563 HKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMNE 603
           H    + + HRD+K  N+L          K++DFG A+  T + 
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 36/157 (22%), Positives = 62/157 (39%), Gaps = 39/157 (24%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLGGERLL- 520
           LG G  G V +    + +++ A+K L         + + E +L  +  Q  ++   R++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHI--VRIVD 78

Query: 521 VYEYLPNKSLDFFI----------FD--SSRKSLLDWKKRFS------IIEGITQGLLYL 562
           VYE L        I          F     R       + F+      I++ I + + YL
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYL 133

Query: 563 HKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMA 596
           H    + + HRD+K  N+L          K++DFG A
Sbjct: 134 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 41/183 (22%), Positives = 70/183 (38%), Gaps = 43/183 (23%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKN---------EAK 504
              +     LG GG G V+       ++ +AIK++            +         E K
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 505 LIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIF------DSSR----KSLLDW 545
           +I +L H N+          G +L        +    +I       D +       LL+ 
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120

Query: 546 KKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTFTMNEL 604
             R   +  + +GL Y+H  +   V+HRDLK +N+ ++ E +  KI DFG+AR    +  
Sbjct: 121 HARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 605 EAN 607
              
Sbjct: 177 HKG 179

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.6 bits (138), Expect = 4e-09
 Identities = 32/201 (15%), Positives = 58/201 (28%), Gaps = 55/201 (27%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRL--------SKSSGQGIVEFKNEAK 504
           + T+      ++G+G FG V++    D   +AIK +        + S  +   E   E  
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 505 LIAKLQHTNLGGER----------------------LLVYEYLPNKSLDFFIFDSSRK-- 540
           +  +L   +                           L  +++  +            K  
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 541 --------------------SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNI 580
                                L       SI+  +T  L        LR  HRDL   N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193

Query: 581 LLDEQMNPKISDFGMARTFTM 601
           LL +    K+      ++ T+
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTI 214

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 20/53 (37%), Positives = 32/53 (60%), Gaps = 3/53 (5%)

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
            + YLH  S   ++HRD+K SNILL+ + + K++DFG++R+F       N   
Sbjct: 121 VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 34/153 (22%), Positives = 63/153 (41%), Gaps = 24/153 (15%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERL-L 520
           ++G G FG +Y G  +   +E+AIK     +    +    E+K+   +Q    GG  +  
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQ----GGVGIPT 69

Query: 521 VYEYLPNKSLDFFIFDSSRKSLLDW----KKRFS------IIEGITQGLLYLHKYSRLRV 570
           +         +  + +    SL D      ++FS      + + +   + Y+H  +    
Sbjct: 70  IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 126

Query: 571 IHRDLKVSNILLDEQMNPK---ISDFGMARTFT 600
           IHRD+K  N L+          I DFG+A+ + 
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 37/168 (22%), Positives = 67/168 (39%), Gaps = 44/168 (26%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT-----NLGGE 517
           LG G F  V+  K + +   +A+K + +         ++E KL+ ++        +  G 
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 518 RLLVYEYLPNKSLDFFIFDSS------------RKSLLDWKKRF-----------SIIEG 554
             ++      K LD F                  ++LL   K++            I + 
Sbjct: 86  NHIL------KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP------KISDFGMA 596
           +  GL Y+H+  R  +IH D+K  N+L++   +P      KI+D G A
Sbjct: 140 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 28/163 (17%), Positives = 61/163 (37%), Gaps = 29/163 (17%)

Query: 463 RLGQGGFGPVYKGK----LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER 518
           ++G GGFG +Y        + +    +K   + +G    E K   ++  K         +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 519 LLVYEYLP-----------NKSLDFFIFD---SSRKSLLDWKKRFS------IIEGITQG 558
            L Y  +P            +S  F + +      + +      F       +   +   
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163

Query: 559 LLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI--SDFGMARTF 599
           L Y+H+      +H D+K +N+LL  +   ++  +D+G++  +
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 40/166 (24%), Positives = 65/166 (39%), Gaps = 32/166 (19%)

Query: 463 RLGQGGFGPVYKG------KLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG 516
            +GQGGFG +Y         +  +    +K     +G    E K   +     Q      
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 517 ERLLVYEYLPN-----------KSLDFFIFD---SSRKSLLDW-KKRFS------IIEGI 555
            R L Y  +P            KS  F I D   S  + + +   KRFS      +   I
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI--SDFGMARTF 599
              L Y+H++     +H D+K SN+LL+ +   ++   D+G+A  +
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 5e-07
 Identities = 65/486 (13%), Positives = 133/486 (27%), Gaps = 160/486 (32%)

Query: 189 WFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLK--SGIPGSVDDV 246
           W L S +   V   +      N                   +L   +K     P  +  +
Sbjct: 69  WTLLSKQEEMVQKFVEEVLRINYK-----------------FLMSPIKTEQRQPSMMTRM 111

Query: 247 YNFYHQFYNFSYTSNEQERYLTYSVN--EDVTSF-PALTFDSDGRLKDDIGIDISCTLLG 303
           Y             N+ + +  Y+V+  +       AL       L+    + I      
Sbjct: 112 YIEQR-----DRLYNDNQVFAKYNVSRLQPYLKLRQALL-----ELRPAKNVLI------ 155

Query: 304 GCEDQTNYYGHGPPSYYPPSYYTEPEGGKKKWWFWLIIAAAVVLGMCLLLSLGYIIRRKH 363
                      G               G  K W    +A  V L   +   + + I    
Sbjct: 156 ----------DGV-------------LGSGKTW----VALDVCLSYKVQCKMDFKIF--- 185

Query: 364 LNAKEEKRWMSLVIVIGVVSVVPLLSYVSFLLLKKLKAKVESMVN-----------RQKL 412
                   W++L       +V+ +L  + + +     ++ +   N            ++L
Sbjct: 186 --------WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 413 LRELGHNVSLPTIFGNRKTQARSDQTV--KRDLKIFDFQ-TIAVATDNFSPANRLGQGGF 469
           L+   +   L  +  N          V   +    F+    I + T      + L     
Sbjct: 238 LKSKPYENCL-LVLLN----------VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286

Query: 470 GPV----YKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNLGGE 517
             +    +   L  ++  ++  L K       +   E          +IA+     L   
Sbjct: 287 THISLDHHSMTLTPDEVKSL--LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGL--A 342

Query: 518 RLLVYEYLPNKSL---------------------DFFIFDSSRK------SLLDWKKRFS 550
               ++++    L                        +F  S        SL+ +    S
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402

Query: 551 IIEGITQGLLYLHKYS-----------RLRVIHRDLKVSNILLDEQMNPKISD-FGMART 598
            +  +      LHKYS            +  I+ +LKV  +  +  ++  I D + + +T
Sbjct: 403 DVMVVVNK---LHKYSLVEKQPKESTISIPSIYLELKV-KLENEYALHRSIVDHYNIPKT 458

Query: 599 FTMNEL 604
           F  ++L
Sbjct: 459 FDSDDL 464

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 3e-06
 Identities = 54/372 (14%), Positives = 116/372 (31%), Gaps = 89/372 (23%)

Query: 4   GLCYCQTDKLQQGQVL-----KDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDR- 57
             C      L+  Q L      +         N +L   S      R L     KP +  
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK---SKPYENC 246

Query: 58  --ILD-V-------AFN--C--LMGYPTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESA 103
             +L  V       AFN  C  L+   T    +  +  A     + + +    +  +E  
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKILL--TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304

Query: 104 TL---IIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVL--YE-MNSDGL- 156
           +L    +D    +L       +P  +S +        A  +++G      ++ +N D L 
Sbjct: 305 SLLLKYLDCRPQDLPREVLTTNPRRLSII--------AESIRDGLATWDNWKHVNCDKLT 356

Query: 157 -----SIR-------RELWQSFD-YPTDTLLPGMKLGI------------NLQTGHQWFL 191
                S+        R+++     +P    +P + L +             +   H++ L
Sbjct: 357 TIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416

Query: 192 RSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTI-----WLNGSLKSGIPGSVDDV 246
              +  E +  +     P+I  +L +  +++     +I              +     D 
Sbjct: 417 VEKQPKESTISI-----PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471

Query: 247 YNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFD---SDGRLK-DDIGIDISCTLL 302
           Y + H  ++     +           E +T F  +  D    + +++ D    + S ++L
Sbjct: 472 YFYSHIGHHLKNIEHP----------ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL 521

Query: 303 GGCEDQTNYYGH 314
              +    Y  +
Sbjct: 522 NTLQQLKFYKPY 533

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 36/153 (23%), Positives = 66/153 (43%), Gaps = 24/153 (15%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERL-L 520
           ++G G FG +Y G  +Q  +E+AIK  +  +    + +  E+K+   LQ    GG  +  
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQ----GGTGIPN 67

Query: 521 VYEYLPNKSLDFFIFDSSRKSLLDW----KKRFS------IIEGITQGLLYLHKYSRLRV 570
           V  +      +  + D    SL D      ++ S      + + +   + ++H  S    
Sbjct: 68  VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---F 124

Query: 571 IHRDLKVSNILLDEQMNPK---ISDFGMARTFT 600
           +HRD+K  N L+          I DFG+A+ + 
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.0 bits (120), Expect = 9e-07
 Identities = 34/154 (22%), Positives = 65/154 (42%), Gaps = 26/154 (16%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERL-L 520
           R+G+G FG +++G  L + Q++AIK   + S    +    E +    L     G   +  
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLA----GCTGIPN 70

Query: 521 VYEYLPNKSLDFFIFDSSRKSLLDW----KKRFS------IIEGITQGLLYLHKYSRLRV 570
           VY +      +  + D    SL D      ++FS        + +   +  +H+ S   +
Sbjct: 71  VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 127

Query: 571 IHRDLKVSNILLDEQMNPK-----ISDFGMARTF 599
           ++RD+K  N L+    +       + DFGM + +
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.1 bits (120), Expect = 9e-07
 Identities = 27/168 (16%), Positives = 55/168 (32%), Gaps = 34/168 (20%)

Query: 462 NRLGQGGFGPVYKGK---------LQDEQEIAIKRLSKSSGQGIVEFK--------NEAK 504
           +   +   G +Y+              +Q+ ++K L    G+   E           +  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 505 LIAKLQHTNLGGERLLVYEYLPNKSLDFFIFD---SSRKSLLDW--KKRFS------IIE 553
              KL  T L      +   +      F +      S +S LD   K   S      +  
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVAC 166

Query: 554 GITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI--SDFGMARTF 599
            +   L +LH+      +H ++   NI +D +   ++  + +G A  +
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
           + +G+ +L   +  + IHRDL   NILL E+   KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.2 bits (112), Expect = 9e-06
 Identities = 28/160 (17%), Positives = 56/160 (35%), Gaps = 28/160 (17%)

Query: 462 NRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQG-IVEFKNEAKLIAKL-QHTN 513
             LG+G FG V +            + +A+K L + +         +E K++  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 514 L----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           +          GG  +++ E+    +L  ++            KR   +   T+G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
               +  I  DLK     +    +   S F   ++ +  E
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 36/154 (23%), Positives = 62/154 (40%), Gaps = 26/154 (16%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERL-L 520
           ++G G FG +  GK L   + +AIK     S    +    E +   +L      G+ +  
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLG----SGDGIPQ 69

Query: 521 VYEYLPNKSLDFFIFDSSRKSLLDW----KKRFS------IIEGITQGLLYLHKYSRLRV 570
           VY + P    +  + +    SL D      + FS      I   +   + Y+H  +   +
Sbjct: 70  VYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---L 126

Query: 571 IHRDLKVSNILLDEQMNPK-----ISDFGMARTF 599
           I+RD+K  N L+    N       I DF +A+ +
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 36/158 (22%), Positives = 58/158 (36%), Gaps = 36/158 (22%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIK---RLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERL 519
           +G+G FG V K     +++ +AIK          Q     + E +L+  +   +   +  
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117

Query: 520 LVYEYLPNKSLDFFI--------FDSSRKSLLDWKKRF-------SIIEGITQ----GLL 560
           +V           F+        F+    +L D  +         ++     Q     LL
Sbjct: 118 IV------HLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNP--KISDFGMA 596
           +L     L +IH DLK  NILL        KI DFG +
Sbjct: 172 FLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 38/158 (24%), Positives = 63/158 (39%), Gaps = 38/158 (24%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLGGERL 519
           +G+G FG V K    +  Q +A+K +    +   Q   E     +++  L+  +      
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160

Query: 520 LVYEYLPNKSLDFFI--------FDSSRKSLLDWKKR-----FSI--IEGITQ----GLL 560
           ++        L+ F         F+    +L +  K+     FS+  +          L 
Sbjct: 161 VI------HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNP--KISDFGMA 596
            LHK    R+IH DLK  NILL +Q     K+ DFG +
Sbjct: 215 ALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 44.5 bits (105), Expect = 7e-06
 Identities = 24/158 (15%), Positives = 41/158 (25%), Gaps = 51/158 (32%)

Query: 11  DKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYP 70
           + L  G+ L  G+ L      +              L +Y                    
Sbjct: 2   NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYDHS----------------- 37

Query: 71  TGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVR 130
                            VW +N      +   A L    +DGN  +       +  S   
Sbjct: 38  ---------------TSVWASNTGILGKKGCKAVL---QSDGNFVVYDAEGRSLWASHSV 79

Query: 131 RAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDY 168
           R        L ++GN+V+Y           ++W +  Y
Sbjct: 80  RGNGNYVLVLQEDGNVVIY---------GSDIWSTGTY 108

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 44.1 bits (104), Expect = 8e-06
 Identities = 27/156 (17%), Positives = 50/156 (32%), Gaps = 50/156 (32%)

Query: 10  TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGY 69
           +D+L  G  L  G  L    G +     +     +  L +Y                   
Sbjct: 1   SDRLNSGHQLDTGGSLAE--GGYLFIIQN-----DCNLVLYDNN---------------- 37

Query: 70  PTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSV 129
                           R VW +  +    +     L + + DGNL ++ +G   I  S+ 
Sbjct: 38  ----------------RAVWASGTNG---KASGCVLKMQN-DGNL-VIYSGSRAIWASNT 76

Query: 130 RRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS 165
            R        L ++ N+V+Y  ++   +I    W +
Sbjct: 77  NRQNGNYYLILQRDRNVVIY--DNSNNAI----WAT 106

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 37/145 (25%), Positives = 65/145 (44%), Gaps = 35/145 (24%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG--GERLL 520
           LG G F  V+    +Q ++ +A+K + KS+        +E +L+  +++++       ++
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 521 VYEYLPNKSLDFF------------IFDSSRKSLLDWKKRF-----------SIIEGITQ 557
           V      + LD F            +F+     LL W  +             II+ + Q
Sbjct: 104 V------QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILL 582
           GL YLH  ++ R+IH D+K  NILL
Sbjct: 158 GLDYLH--TKCRIIHTDIKPENILL 180

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.2 bits (105), Expect = 7e-05
 Identities = 35/170 (20%), Positives = 60/170 (35%), Gaps = 37/170 (21%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIK---RLSKSSGQGIVEFKNEAKLIAKLQHTNLGGERL 519
           +G G FG V   + + +++  A+K    + K +    +E    A ++ K+Q+ ++    +
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNNI 98

Query: 520 LVYEYLPNKSLDFFI--------FDSSRKSLLDWKKRF-----------SIIEGITQGLL 560
           +       K    F+        F+    SL +   R                 I + L 
Sbjct: 99  V-------KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 561 YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           YL K   + + H DLK  NILLD+    K        T         T  
Sbjct: 152 YLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 41.0 bits (96), Expect = 1e-04
 Identities = 20/81 (24%), Positives = 34/81 (41%), Gaps = 8/81 (9%)

Query: 85  PRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNG 144
           P+ +        +        I+  TD NL +L +  +PI  ++    GN  RA L  +G
Sbjct: 14  PQILHATESLEILFGTHVYRFIMQ-TDCNL-VLYDNNNPIWATNTGGLGNGCRAVLQPDG 71

Query: 145 NLVLYEMNSDGLSIRRELWQS 165
            LV+    ++       +WQS
Sbjct: 72  VLVVI--TNEN----VTVWQS 86

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 28/159 (17%), Positives = 59/159 (37%), Gaps = 37/159 (23%)

Query: 464 LGQGGFGPVYKG--KLQDEQEIAIK---RLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER 518
           LG+G FG V +     + + ++A+K    + K      +E      ++ K++  +   + 
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENKF 82

Query: 519 LLVYEYLPNKSLDFFI--------FDSSRKSLLDWKKR-----FSI--IEGITQGLL--- 560
           L V         D+F         F+   K+  ++ K      + +  +  +   L    
Sbjct: 83  LCV------LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136

Query: 561 -YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
            +LH+    ++ H DLK  NIL        + +   +  
Sbjct: 137 RFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.1 bits (97), Expect = 8e-04
 Identities = 30/159 (18%), Positives = 56/159 (35%), Gaps = 37/159 (23%)

Query: 464 LGQGGFGPVYKGK--LQDEQEIAIK---RLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER 518
           LG+G FG V +        + +A+K    + +       E     +++  L  T+     
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPNSTF 77

Query: 519 LLVYEYLPNKSLDFFI--------FDSSRKSLLDWKKR-----FSI--IEGITQGLL--- 560
             V      + L++F         F+    S  D+ K      F +  I  +   +    
Sbjct: 78  RCV------QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 561 -YLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
            +LH     ++ H DLK  NIL  +    +  +  + R 
Sbjct: 132 NFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	614
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.97
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.97
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.97
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.97
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.97
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.96
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.96
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.96
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.96
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.96
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.96
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.95
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.93
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.93
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.93
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.92
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.92
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.92
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.92
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.91
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.91
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.91
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.91
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.91
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.9
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.9
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.9
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.9
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.9
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.9
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.9
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.9
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.9
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.9
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.9
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.9
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.9
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.89
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.89
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.89
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.89
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.89
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.89
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.89
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.89
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.89
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.89
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.89
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.89
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.89
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.89
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.89
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.89
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.89
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.89
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.89
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.89
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.89
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.89
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.89
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.89
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.89
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.89
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.89
3niz_A	311	Rhodanese family protein; structural genomics, str	99.89
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.89
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.89
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.89
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.89
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.88
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.88
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.88
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.88
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.88
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.88
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.88
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.88
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.88
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.88
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.88
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.88
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.88
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.88
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.88
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.88
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.88
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.88
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.88
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.88
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.88
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.88
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.88
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.88
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.88
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.88
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.88
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.88
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.88
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.88
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.88
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.88
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.88
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.88
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.88
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.87
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.87
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.87
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.87
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.87
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.87
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.87
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.87
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.87
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.87
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.87
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.87
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.87
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.87
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.87
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.87
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.87
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.87
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.87
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.87
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.87
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.87
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.87
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.87
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.87
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.87
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.87
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.87
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.87
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.87
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.87
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.87
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.87
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.87
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.87
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.86
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.86
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.86
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.86
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.86
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.86
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.86
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.86
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.86
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.86
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.86
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.86
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.86
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.86
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.86
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.86
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.86
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.86
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.86
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.86
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.86
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.86
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.86
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.86
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.86
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.86
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.86
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.86
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.86
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.86
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.86
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.86
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.86
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.86
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.86
3bhy_A	283	Death-associated protein kinase 3; death associate	99.86
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.86
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.86
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.85
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.85
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.85
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.85
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.85
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.85
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.85
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.85
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.85
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.85
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.85
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.85
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.85
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.85
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.85
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.85
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.85
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.85
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.85
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.85
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.85
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.85
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.85
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.85
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.85
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.85
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.85
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.85
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.85
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.85
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.85
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.85
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.84
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.84
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.84
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.84
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.84
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.84
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.84
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.84
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.84
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.84
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.84
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.84
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.84
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.84
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.84
3uqc_A	286	Probable conserved transmembrane protein; structur	99.84
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.84
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.84
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.84
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.83
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.83
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.83
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.83
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.83
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.83
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.83
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.83
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.82
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.82
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.82
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.82
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.82
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.82
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.81
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.81
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.81
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.81
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.81
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.8
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.8
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.8
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.79
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.79
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.78
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.75
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.7
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.64
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.59
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.59
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.58
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.57
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.54
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.49
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.48
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.33
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.18
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.13
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.06
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.97
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	98.9
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	98.86
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	98.8
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.76
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	98.45
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.35
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.35
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.31
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.22
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.09
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.81
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.8
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.7
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.61
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.4
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.88
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.88
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.66
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.52
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.29
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.21
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.07
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.97
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.78
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.53
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.88
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.32
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.18
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.25

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=7.3e-41  Score=337.06  Aligned_cols=218  Identities=20%  Similarity=0.197  Sum_probs=165.1

Q ss_pred             ccccccccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCC
Q 042853            5 LCYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIK   84 (614)
Q Consensus         5 ~~~~~~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (614)
                      +|.++.|+|++|++|++|++|+|++|.|+||||+++   ++||   |+                              ..
T Consensus         9 ~~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~------------------------------~~   52 (276)
T 3m7h_A            9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD------------------------------NG   52 (276)
T ss_dssp             CCCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE------------------------------TT
T ss_pred             eccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC------------------------------CC
Confidence            566788999999999999999999999999999433   5777   65                              22


Q ss_pred             CCcEEEcCCCCCCCCC---CCeEEEEEcCCCcEEE--EeCCCCcEEEeeeecC-----CcccEEEeccCCCEEEEeecCC
Q 042853           85 PRPVWIANRDTPVLRN---ESATLIIDSTDGNLKI--LRNGKSPIEISSVRRA-----GNTTRATLLKNGNLVLYEMNSD  154 (614)
Q Consensus        85 ~t~VW~ANr~~Pv~~~---~~~~l~l~~~~G~L~l--~~~~g~~vwss~~~~~-----~~~~~a~LldsGNlVl~~~~~~  154 (614)
                      . +||+||||+|+.++   .+++|+|+. +|+|+|  .|++|++||+|+++..     ..+++|+|+|+|||||+|.   
T Consensus        53 ~-vvW~Anr~~p~~~~~~~~~~~l~l~~-~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~~---  127 (276)
T 3m7h_A           53 A-TVWVANEQQPFSSTIPLRNKKAPLAF-YVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDS---  127 (276)
T ss_dssp             E-EEEECSTTSTTEEEEECCCTTCCSEE-EESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEEE---
T ss_pred             C-eEEECCCCCCcCCcccccceEEEEeC-CCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecCC---
Confidence            3 79999999999762   157899998 999999  8888999999997642     2357899999999999971   


Q ss_pred             CCcccceeceecCCCCCCcCCCCeeeeeecCCceEEEEecCCCCC--ccceEEeecCCCCceEEEEeC-CEEEEEeCCCC
Q 042853          155 GLSIRRELWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEV--SYRLGLGTDPNITNKLVIWKD-DKVVWTSTIWL  231 (614)
Q Consensus       155 ~~~~~~~lWQSFD~PTDTlLpg~~l~~~~~tg~~~~L~S~~s~~~--~G~~~l~~~~~~~~~~~~~~~-~~~yw~~g~w~  231 (614)
                           .+||||  ||||||||||||+.++.+|  ..|   ++.+|  +|.|+++++++|.  +++|+. +.+||++|+|+
T Consensus       128 -----~~lWqS--~ptdtlLpg~~~~~~l~~g--~~L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~  193 (276)
T 3m7h_A          128 -----LALWNG--TPAIPLVPGAIDSLLLAPG--SEL---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQG  193 (276)
T ss_dssp             -----EEEEES--CTTSCCCCSCTTCEEECSS--EEE---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTT
T ss_pred             -----ceeeCc--ccccccccccccccccccC--ccc---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCC
Confidence                 689999  9999999999999999998  446   44555  8999999999985  555654 58999999986


Q ss_pred             CCcceeccCCcccccccccceeeEEEEEecCCeEEEEEEecCCCCeeeEEEEecCCcEE
Q 042853          232 NGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLK  290 (614)
Q Consensus       232 ~~~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~  290 (614)
                      +...     .+..      .....+.+.++++. .+.++... ....+|++|+.||+|+
T Consensus       194 ~~~~-----~l~l------~~dGnLvl~d~~~~-~vWsS~t~-~~~~~rl~Ld~dGnLv  239 (276)
T 3m7h_A          194 KGAV-----RAVF------QGDGNLVVYGAGNA-VLWHSHTG-GHASAVLRLQANGSIA  239 (276)
T ss_dssp             TTCC-----EEEE------CTTSCEEEECTTSC-EEEECSCT-TCTTCEEEECTTSCEE
T ss_pred             CccE-----EEEE------cCCCeEEEEeCCCc-EEEEecCC-CCCCEEEEEcCCccEE
Confidence            4321     1111      11122333444332 22222222 2235799999999987

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=3.2e-35  Score=291.01  Aligned_cols=216  Identities=16%  Similarity=0.231  Sum_probs=160.5

Q ss_pred             cccccccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCC
Q 042853            6 CYCQTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKP   85 (614)
Q Consensus         6 ~~~~~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (614)
                      ..++.|+|++|++|++|++|  ++|.|+|||+.+++     +. +|.                        .       .
T Consensus         4 ~~~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~-ly~------------------------~-------~   44 (236)
T 1dlp_A            4 LFGLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LV-LFD------------------------S-------D   44 (236)
T ss_dssp             CBCSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EE-EEE------------------------S-------S
T ss_pred             ceeccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EE-EEE------------------------C-------C
Confidence            34678999999999999999  59999999987664     23 443                        0       2


Q ss_pred             CcEEEcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceecee
Q 042853           86 RPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS  165 (614)
Q Consensus        86 t~VW~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQS  165 (614)
                      |+||+|||+.|   . ++.|+|.+ ||+|||.|++|++||+|++........|+|+|+|||||++         .++|||
T Consensus        45 ~~vW~an~~~~---~-~~~l~l~~-dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~---------~~~W~S  110 (236)
T 1dlp_A           45 VRVWASNTAGA---T-GCRAVLQS-DGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---------PGLWDS  110 (236)
T ss_dssp             SEEECCCCCSC---S-CCBCCBCS-SSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---------SEEEEC
T ss_pred             EEEEECCCCCC---C-CeEEEEcC-CCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEec---------CCEEEC
Confidence            78999999998   2 58899998 9999999999999999997643334689999999999985         379999


Q ss_pred             cCCCCCCc-CCCCeeeeee-cCCc-----eEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCCCCCCcceec
Q 042853          166 FDYPTDTL-LPGMKLGINL-QTGH-----QWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWLNGSLKSG  238 (614)
Q Consensus       166 FD~PTDTl-Lpg~~l~~~~-~tg~-----~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~w~~~~~~~g  238 (614)
                      |||||||+ ||||  +.|. .+|+     +++|++...+. +|.|++.++++|  +++++++..+||++++|++. + .+
T Consensus       111 ~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s~~d~s-~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~-~~  183 (236)
T 1dlp_A          111 GTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHATQSLQ-LSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-T-GC  183 (236)
T ss_dssp             SCCCSSCCCCSSC--CCEECCCC--CCCCCCEECSSCCCB-CSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-S-SC
T ss_pred             CCCCCcccccCCc--cceEEecCCcCCCccceEEcCcEee-cCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-C-ce
Confidence            99999888 6776  5564 5564     56888633222 899999999998  67888888899999999543 4 55


Q ss_pred             cCCcccccccccceeeEEEEEecCCeEEEEEEecCCCCeeeEEEEecCCcEE
Q 042853          239 IPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALTFDSDGRLK  290 (614)
Q Consensus       239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~  290 (614)
                      +|++..+     ...+  .|..+..+.+.++...+  ....|++|+++|+++
T Consensus       184 ~~~L~~~-----Gnl~--ly~~~~~~vw~s~~~~~--~~~~rl~Ld~dG~l~  226 (236)
T 1dlp_A          184 RAVLQPN-----GRMD--VLTNQNIAVWTSGNSRS--AGRYVFVLQPDRNLA  226 (236)
T ss_dssp             EEEEETT-----TEEE--EEETTTEEEEECCCCCS--SSCCEEEECSSSCEE
T ss_pred             EEEECCC-----CcEE--EEeCCCcEEEEeCCCCC--CCCEEEEEcCCCcEE
Confidence            6655321     2112  22223334444443332  246799999999886

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.97  E-value=2.5e-32  Score=279.64  Aligned_cols=156  Identities=29%  Similarity=0.494  Sum_probs=130.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++....+..++|.+|+++|++++||||         .+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45667899999999999999874      467899999987666677889999999999999999         567899


Q ss_pred             EEEecCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 042853          521 VYEYLPNKSLDFFIFDSS----------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI  590 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI  590 (614)
                      |||||++|+|..+|....          ....++|.+++.|+.|||+||.|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999997532          2346899999999999999999999986   999999999999999999999


Q ss_pred             eecCcceeecCCccccCCCceecC
Q 042853          591 SDFGMARTFTMNELEANTNRIVGT  614 (614)
Q Consensus       591 ~DFGla~~~~~~~~~~~~~~~~GT  614 (614)
                      +|||+|+.+...+....+...+||
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt  193 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLP  193 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEEC
T ss_pred             CCcccceecCCCCceeecCceecC
Confidence            999999987655433333334454

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.97  E-value=6e-32  Score=280.54  Aligned_cols=156  Identities=28%  Similarity=0.487  Sum_probs=123.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++....+..++|.+|+++|++++||||         ....+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45666789999999999999874      467899999987666677889999999999999999         467899


Q ss_pred             EEEecCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          521 VYEYLPNKSLDFFIFDSSR------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      |||||++|+|..++.....            ...++|.+++.|+.|||+||.|||+.+   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999975321            246899999999999999999999986   9999999999999999999


Q ss_pred             EEeecCcceeecCCccccCCCceecC
Q 042853          589 KISDFGMARTFTMNELEANTNRIVGT  614 (614)
Q Consensus       589 kI~DFGla~~~~~~~~~~~~~~~~GT  614 (614)
                      ||+|||+|+.+...+....+.+.+||
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt  223 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLP  223 (329)
T ss_dssp             EECCCC----------------CCCC
T ss_pred             EEcccccceeccCCCcceecCccccc
Confidence            99999999987655433333334554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.97  E-value=1.4e-31  Score=275.27  Aligned_cols=154  Identities=32%  Similarity=0.468  Sum_probs=127.1

Q ss_pred             CCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      +...++||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.++++++||||         ....+||
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            344689999999999999873      45789999997543 3445789999999999999999         4678999


Q ss_pred             EEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          522 YEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      ||||++|+|..+|.....             ...++|.++++|+.|||+||.|||+.+   ||||||||+||||++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence            999999999999964321             245899999999999999999999986   9999999999999999999


Q ss_pred             EEeecCcceeecCCccccCCCceecC
Q 042853          589 KISDFGMARTFTMNELEANTNRIVGT  614 (614)
Q Consensus       589 kI~DFGla~~~~~~~~~~~~~~~~GT  614 (614)
                      ||+|||+|+.+...+....+...+||
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt  210 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLP  210 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred             EECCcccceeccCCCceeEecccccC
Confidence            99999999987655433333334554

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=273.89  Aligned_cols=155  Identities=28%  Similarity=0.474  Sum_probs=125.1

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      +..+++...++||+|+||+||+|++.+  .||||.++..  ..+..++|.+|+.++++++||||        .++.+|||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVm  110 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVT  110 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEE
Confidence            344667778999999999999999764  5899998643  33456789999999999999999        56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |||++|+|..+|...  ...++|.+++.|+.|||+||.|||+++   ||||||||+||||++++.+||+|||+|+.+...
T Consensus       111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            999999999999643  345899999999999999999999986   999999999999999999999999999987654


Q ss_pred             ccccCCCceecC
Q 042853          603 ELEANTNRIVGT  614 (614)
Q Consensus       603 ~~~~~~~~~~GT  614 (614)
                      .....+...+||
T Consensus       186 ~~~~~~~~~~GT  197 (307)
T 3omv_A          186 SGSQQVEQPTGS  197 (307)
T ss_dssp             --------CCCC
T ss_pred             CcceeecccccC
Confidence            433333445666

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.97  E-value=9.8e-31  Score=271.70  Aligned_cols=150  Identities=26%  Similarity=0.385  Sum_probs=131.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +.|+..++||+|+||+||+|... +++.||||++........+.+.+|+.+|++++||||         .+..+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888899999999999999986 689999999976555566779999999999999999         57899999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCccc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE  605 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~~  605 (614)
                      ++|+|..++..    ..+++.+...++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..+...
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999998854    34899999999999999999999987   999999999999999999999999999988654432


Q ss_pred             cCCCceecC
Q 042853          606 ANTNRIVGT  614 (614)
Q Consensus       606 ~~~~~~~GT  614 (614)
                        ..+.+||
T Consensus       227 --~~~~~GT  233 (346)
T 4fih_A          227 --RKSLVGT  233 (346)
T ss_dssp             --BCCCCSC
T ss_pred             --ccccccC
Confidence              2336776

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.97  E-value=8.1e-31  Score=268.34  Aligned_cols=153  Identities=31%  Similarity=0.426  Sum_probs=132.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||+||++... +++.||||.+.+.   .....+.+.+|++++++++||||         ....+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46888999999999999999975 6889999999653   22345678999999999999999         56889999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++...   ..+++.+...++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..+
T Consensus       112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999998643   35899999999999999999999987   999999999999999999999999999998765


Q ss_pred             ccccCCCceecC
Q 042853          603 ELEANTNRIVGT  614 (614)
Q Consensus       603 ~~~~~~~~~~GT  614 (614)
                      .....+.+++||
T Consensus       186 ~~~~~~~~~~GT  197 (311)
T 4aw0_A          186 SKQARANSFVGT  197 (311)
T ss_dssp             TTCCCBCCCCSC
T ss_pred             CCcccccCcccC
Confidence            544445557887

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.97  E-value=1.6e-30  Score=270.59  Aligned_cols=143  Identities=24%  Similarity=0.407  Sum_probs=120.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|++.++||+|+||+||++... +++.||||.+.+..  ....++|.+|+.++++++||||         ....+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            67899999999999999999975 68999999997542  3345679999999999999999         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||++|+|.++|.... ...+++.+...++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus       104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            999999999986532 345788899999999999999999987   999999999999999999999999999987543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.97  E-value=4.4e-30  Score=273.33  Aligned_cols=150  Identities=26%  Similarity=0.385  Sum_probs=131.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +.|+..++||+|+||+||+|... +++.||||++........+.+.+|+.+|++++||||         ....+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56888899999999999999986 689999999977665666779999999999999999         57889999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCccc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELE  605 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~~  605 (614)
                      ++|+|..++..    ..+++.+...++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+......
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            99999998853    24899999999999999999999987   999999999999999999999999999988654432


Q ss_pred             cCCCceecC
Q 042853          606 ANTNRIVGT  614 (614)
Q Consensus       606 ~~~~~~~GT  614 (614)
                        ...++||
T Consensus       304 --~~~~~GT  310 (423)
T 4fie_A          304 --RKSLVGT  310 (423)
T ss_dssp             --BCCCEEC
T ss_pred             --ccccccC
Confidence              2336776

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.96  E-value=1.9e-30  Score=271.47  Aligned_cols=166  Identities=24%  Similarity=0.378  Sum_probs=137.4

Q ss_pred             echhhHHhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCC-CCC---
Q 042853          446 FDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQH-TNL---  514 (614)
Q Consensus       446 ~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H-~nl---  514 (614)
                      ++..++++..++|++.+.||+|+||+||+|.+.      .++.||||++..... ...++|.+|+++|.+++| |||   
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            455667788889999999999999999999864      246799999976543 345679999999999965 898   


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD  574 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD  574 (614)
                             ....+||||||++|+|..+|.....             ...++|.+++.++.|||+||.|||+++   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence                   2457999999999999999975321             345899999999999999999999987   99999


Q ss_pred             CCCCCEEEcCCCcEEEeecCcceeecCCccccCCCceecC
Q 042853          575 LKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT  614 (614)
Q Consensus       575 lkp~NILld~~~~~kI~DFGla~~~~~~~~~~~~~~~~GT  614 (614)
                      |||+||||++++.+||+|||+||.+..+.....+...+||
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt  250 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  250 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence            9999999999999999999999988665544333445555

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.96  E-value=4.6e-30  Score=263.91  Aligned_cols=152  Identities=26%  Similarity=0.326  Sum_probs=119.0

Q ss_pred             CCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCC-------------CeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG-------------GERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~-------------~~~~lv~E  523 (614)
                      ++.+.++||+|+||+||+|++ +++.||||+++... .....+..|+..+.+++||||.             .+.+||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            456678999999999999998 57899999996532 1222234566666789999991             25789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY-----SRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ||++|+|..++...    .++|..+.+++.|+|+||+|||++     ..++||||||||+|||||.++.+||+|||+|+.
T Consensus        82 y~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999643    489999999999999999999986     234699999999999999999999999999998


Q ss_pred             ecCCccc--cCCCceecC
Q 042853          599 FTMNELE--ANTNRIVGT  614 (614)
Q Consensus       599 ~~~~~~~--~~~~~~~GT  614 (614)
                      .......  ..+...+||
T Consensus       158 ~~~~~~~~~~~~~~~~GT  175 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGT  175 (303)
T ss_dssp             EETTTTEESCC-----CC
T ss_pred             ccCCCCceeeeccccccc
Confidence            8654322  122335565

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.96  E-value=1.6e-29  Score=259.10  Aligned_cols=144  Identities=27%  Similarity=0.425  Sum_probs=117.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCCCC------------------
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLGG------------------  516 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl~~------------------  516 (614)
                      +|++.+.||+|+||+||+|... +++.||||+++.... ...+.|.+|+.+|++++||||..                  
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5778899999999999999975 688999999975433 34467999999999999999911                  


Q ss_pred             ---eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          517 ---ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       517 ---~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                         ..++|||||++|+|..++.........++.....++.||++||.|||+++   ||||||||+||||+.++.+||+||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence               25899999999999999976554445677778899999999999999987   999999999999999999999999


Q ss_pred             CcceeecCCc
Q 042853          594 GMARTFTMNE  603 (614)
Q Consensus       594 Gla~~~~~~~  603 (614)
                      |+|+.+..++
T Consensus       163 Gla~~~~~~~  172 (299)
T 4g31_A          163 GLVTAMDQDE  172 (299)
T ss_dssp             CCC-------
T ss_pred             ccceecCCCc
Confidence            9999886543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.96  E-value=1.4e-29  Score=257.71  Aligned_cols=148  Identities=30%  Similarity=0.410  Sum_probs=122.1

Q ss_pred             CccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCC-------------CeeEEEE
Q 042853          459 SPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLG-------------GERLLVY  522 (614)
Q Consensus       459 ~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~-------------~~~~lv~  522 (614)
                      ...++||+|+||+||+|... ++..||||.+...  .....+.|.+|++++++++||||.             ...+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            34568999999999999986 6789999999643  233456799999999999999991             2368999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-QMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-~~~~kI~DFGla~~~~~  601 (614)
                      |||++|+|..++...   ..+++.....++.||+.||.|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999643   45899999999999999999999874 46999999999999984 78999999999986543


Q ss_pred             CccccCCCceecC
Q 042853          602 NELEANTNRIVGT  614 (614)
Q Consensus       602 ~~~~~~~~~~~GT  614 (614)
                      ..    +.+.+||
T Consensus       185 ~~----~~~~~GT  193 (290)
T 3fpq_A          185 SF----AKAVIGT  193 (290)
T ss_dssp             TS----BEESCSS
T ss_pred             Cc----cCCcccC
Confidence            22    2235676

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.96  E-value=5.4e-29  Score=251.20  Aligned_cols=140  Identities=29%  Similarity=0.466  Sum_probs=115.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||+||++... +++.||||.+.+..   ......|.+|++++++++||||         ....++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57888999999999999999975 68999999996542   2335679999999999999999         56889999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+ +|+|.+++...   ..+++.+...++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 68998888643   35899999999999999999999987   999999999999999999999999999977543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.96  E-value=5.8e-29  Score=257.58  Aligned_cols=149  Identities=26%  Similarity=0.323  Sum_probs=122.2

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .+.|...++||+|+||+||+|... +++.||||+++...     .+.+|+.++++++||||         ....+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356777889999999999999986 68899999996532     23579999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceeecCCc
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTFTMNE  603 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~~~~~  603 (614)
                      |++|+|..++...   ..+++.+...++.||+.||.|||+++   ||||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus       132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999643   35899999999999999999999987   99999999999999887 59999999999886543


Q ss_pred             ccc---CCCceecC
Q 042853          604 LEA---NTNRIVGT  614 (614)
Q Consensus       604 ~~~---~~~~~~GT  614 (614)
                      ...   ....++||
T Consensus       206 ~~~~~~~~~~~~GT  219 (336)
T 4g3f_A          206 LGKSLLTGDYIPGT  219 (336)
T ss_dssp             --------CCCCCC
T ss_pred             cccceecCCccccC
Confidence            221   22335676

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.96  E-value=9.8e-30  Score=260.14  Aligned_cols=151  Identities=28%  Similarity=0.385  Sum_probs=120.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC----CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      ++|++.+.||+|+||+||+++..    .++.||||.+++..  .+...++.+|++++++++||||         ....++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46888999999999999999863    46789999997542  2334568899999999999999         578899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||||++|+|..++...   ..+++.+...++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999998643   35899999999999999999999987   9999999999999999999999999999765


Q ss_pred             CCccccCCCceecC
Q 042853          601 MNELEANTNRIVGT  614 (614)
Q Consensus       601 ~~~~~~~~~~~~GT  614 (614)
                      .....  ..+.+||
T Consensus       178 ~~~~~--~~~~~GT  189 (304)
T 3ubd_A          178 DHEKK--AYSFCGT  189 (304)
T ss_dssp             ---CC--CCSCCCC
T ss_pred             CCCcc--ccccccC
Confidence            43322  2235676

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.95  E-value=2.4e-27  Score=252.17  Aligned_cols=152  Identities=28%  Similarity=0.433  Sum_probs=125.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------------CCe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------------GGE  517 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------------~~~  517 (614)
                      ++|++.+.||+|+||+||+|... +++.||||++++..  ....+.+.+|+++|++++||||               ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999985 78999999997543  2345678899999999999999               146


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .+||||||+ |+|..++..   ...+++.+...++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            799999996 789888853   346899999999999999999999987   9999999999999999999999999999


Q ss_pred             eecCCcc--ccCCCceecC
Q 042853          598 TFTMNEL--EANTNRIVGT  614 (614)
Q Consensus       598 ~~~~~~~--~~~~~~~~GT  614 (614)
                      .+.....  .......+||
T Consensus       207 ~~~~~~~~~~~~~~~~~GT  225 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVAT  225 (398)
T ss_dssp             CC-------CCCCCSSCCC
T ss_pred             ecccCccccccccccceeC
Confidence            8754321  1122335666

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.93  E-value=4.9e-26  Score=239.31  Aligned_cols=138  Identities=23%  Similarity=0.404  Sum_probs=120.1

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC----CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCee
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGER  518 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~  518 (614)
                      ...+.|++.++||+|+||+||+|+.+    .++.||||.+.+..  ...++.+|++++..+ +|||+         ..+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999753    46789999986542  345688999999998 69999         5688


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEeecCcce
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-MNPKISDFGMAR  597 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-~~~kI~DFGla~  597 (614)
                      ++||||+++|+|..++.      .+++.+...++.||+.||.|||+++   ||||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999882      3788999999999999999999987   9999999999999876 789999999999


Q ss_pred             eecC
Q 042853          598 TFTM  601 (614)
Q Consensus       598 ~~~~  601 (614)
                      ....
T Consensus       167 ~~~~  170 (361)
T 4f9c_A          167 GTHD  170 (361)
T ss_dssp             ECTT
T ss_pred             ccCC
Confidence            7653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.93  E-value=1.7e-26  Score=256.75  Aligned_cols=150  Identities=27%  Similarity=0.381  Sum_probs=124.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhH---HHHHHHHHhcCCCCC---------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEF---KNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f---~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      -++|++.+.||+|+||+||++... +++.+|||.+.+..   .+....+   +.++.+++.++||||         ....
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            367999999999999999999986 68899999996531   1222223   344666777899999         5688


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      +||||||++|+|..+|...   ..+++.....++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            9999999999999999643   35899999999999999999999987   99999999999999999999999999998


Q ss_pred             ecCCccccCCCceecC
Q 042853          599 FTMNELEANTNRIVGT  614 (614)
Q Consensus       599 ~~~~~~~~~~~~~~GT  614 (614)
                      +....    +.+.+||
T Consensus       342 ~~~~~----~~t~~GT  353 (689)
T 3v5w_A          342 FSKKK----PHASVGT  353 (689)
T ss_dssp             CSSCC----CCSCCSC
T ss_pred             cCCCC----CCCccCC
Confidence            86543    2336776

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.93  E-value=7.9e-26  Score=251.86  Aligned_cols=143  Identities=22%  Similarity=0.385  Sum_probs=126.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|++.+.||+|+||+||++... +++.||||.+........+.+.+|+.+|+.++||||         ....+||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57888999999999999999986 688999999977555556778999999999999999         56889999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC--CcEEEeecCcceeecCCc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ--MNPKISDFGMARTFTMNE  603 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~--~~~kI~DFGla~~~~~~~  603 (614)
                      ++|+|..++...  ...+++.+...++.||+.||.|||+++   ||||||||+|||++.+  +.+||+|||+|+.+...+
T Consensus       237 ~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            999999988532  345889999999999999999999987   9999999999999854  789999999999886543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.92  E-value=5.3e-25  Score=228.15  Aligned_cols=162  Identities=43%  Similarity=0.731  Sum_probs=140.2

Q ss_pred             CCcceechhhHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC-----
Q 042853          441 RDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL-----  514 (614)
Q Consensus       441 ~~~~~~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl-----  514 (614)
                      ..++.|++.++..++++|...+.||+|+||.||+|...+++.||||++..... ....+|.+|+.++.+++|+|+     
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            45677899999999999999999999999999999988899999999975432 233478999999999999999     


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                          ....++||||+++|+|..++.... ....+++..+..++.|++.||.|||+.+.++|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence                467799999999999999987543 234589999999999999999999998444599999999999999999999


Q ss_pred             EeecCcceeecCC
Q 042853          590 ISDFGMARTFTMN  602 (614)
Q Consensus       590 I~DFGla~~~~~~  602 (614)
                      |+|||+|+.+...
T Consensus       175 l~Dfg~~~~~~~~  187 (326)
T 3uim_A          175 VGDFGLAKLMDYK  187 (326)
T ss_dssp             ECCCSSCEECCSS
T ss_pred             eccCccccccCcc
Confidence            9999999987543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.92  E-value=5.2e-25  Score=227.90  Aligned_cols=154  Identities=39%  Similarity=0.669  Sum_probs=135.0

Q ss_pred             eechhhHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------C
Q 042853          445 IFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------G  515 (614)
Q Consensus       445 ~~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~  515 (614)
                      .+.+.++..++++|...+.||+|+||.||+|...+++.||||++.....+..++|.+|+.+++.++|||+         .
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            3445566778899999999999999999999988889999999987666677889999999999999999         4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                      ...++||||+++|+|..++..... ...++|.++..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            678999999999999998864332 235899999999999999999999987   9999999999999999999999999


Q ss_pred             cceeecC
Q 042853          595 MARTFTM  601 (614)
Q Consensus       595 la~~~~~  601 (614)
                      +++....
T Consensus       185 ~~~~~~~  191 (321)
T 2qkw_B          185 ISKKGTE  191 (321)
T ss_dssp             TCEECSS
T ss_pred             ccccccc
Confidence            9987653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.92  E-value=2.9e-24  Score=220.48  Aligned_cols=156  Identities=40%  Similarity=0.664  Sum_probs=137.6

Q ss_pred             CcceechhhHHhhcCCCCcc------ceeccCCceeEEEEEeCCccEEEEEEccCCC----cchhHhHHHHHHHHHhcCC
Q 042853          442 DLKIFDFQTIAVATDNFSPA------NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQH  511 (614)
Q Consensus       442 ~~~~~~~~~~~~~t~~f~~~------~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H  511 (614)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.+|||.+....    .+..+.|.+|+.++.+++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45778999999999999877      8999999999999987 57889999986532    2345679999999999999


Q ss_pred             CCC---------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 042853          512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL  582 (614)
Q Consensus       512 ~nl---------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  582 (614)
                      ||+         ....++||||+++++|..++........+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            999         4578999999999999999875544556899999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEeecCcceeecC
Q 042853          583 DEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       583 d~~~~~kI~DFGla~~~~~  601 (614)
                      +.++.+||+|||+++....
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             CTTCCEEECCCTTCEECCS
T ss_pred             cCCCcEEEeeccccccccc
Confidence            9999999999999997754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.92  E-value=5.2e-25  Score=237.55  Aligned_cols=152  Identities=20%  Similarity=0.312  Sum_probs=130.9

Q ss_pred             chhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC--------
Q 042853          447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL--------  514 (614)
Q Consensus       447 ~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl--------  514 (614)
                      .+.++....++|++.++||+|+||+||+++.. +++.+|||++.+..   ......+.+|+.++..++|+|+        
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            45566777889999999999999999999987 46889999996531   2233458999999999999999        


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          515 -GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       515 -~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                       ....+||||||++|+|..++...  ...+++.....++.||+.||.|||+.+   ||||||||+||||+.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence             56789999999999999999642  345899999999999999999999987   999999999999999999999999


Q ss_pred             CcceeecCCc
Q 042853          594 GMARTFTMNE  603 (614)
Q Consensus       594 Gla~~~~~~~  603 (614)
                      |+|+.+....
T Consensus       220 Gla~~~~~~~  229 (437)
T 4aw2_A          220 GSCLKLMEDG  229 (437)
T ss_dssp             TTCEECCTTS
T ss_pred             hhhhhcccCC
Confidence            9998876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.91  E-value=1.5e-24  Score=232.37  Aligned_cols=153  Identities=21%  Similarity=0.301  Sum_probs=131.6

Q ss_pred             echhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC-------
Q 042853          446 FDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL-------  514 (614)
Q Consensus       446 ~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl-------  514 (614)
                      +.++++....++|++.+.||+|+||+||++... +++.||||.+.+..   ......+.+|..++..++|+|+       
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345566677789999999999999999999986 68899999996531   2234568999999999999999       


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEee
Q 042853          515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISD  592 (614)
Q Consensus       515 --~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~D  592 (614)
                        ....++||||+++|+|..++....  ..+++.....++.||+.||.|||+.+   ||||||||+||||+.++.+||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence              467899999999999999986432  35889999999999999999999987   99999999999999999999999


Q ss_pred             cCcceeecCCc
Q 042853          593 FGMARTFTMNE  603 (614)
Q Consensus       593 FGla~~~~~~~  603 (614)
                      ||+|+.+....
T Consensus       206 FGla~~~~~~~  216 (412)
T 2vd5_A          206 FGSCLKLRADG  216 (412)
T ss_dssp             CTTCEECCTTS
T ss_pred             chhheeccCCC
Confidence            99999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.91  E-value=4.8e-24  Score=220.91  Aligned_cols=152  Identities=26%  Similarity=0.384  Sum_probs=131.6

Q ss_pred             ceechhhHHhhcCC----------CCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCC
Q 042853          444 KIFDFQTIAVATDN----------FSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT  512 (614)
Q Consensus       444 ~~~~~~~~~~~t~~----------f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~  512 (614)
                      +.++++++..+++.          |...+.||+|+||.||+|... +++.||||.+.....+..+.+.+|+.++++++|+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34666777666654          566779999999999999987 7899999999766666677899999999999999


Q ss_pred             CC---------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 042853          513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD  583 (614)
Q Consensus       513 nl---------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld  583 (614)
                      |+         ....++||||+++++|..++..    ..+++..+..++.|+++||.|||+.+   |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            99         5678999999999999998842    35899999999999999999999987   99999999999999


Q ss_pred             CCCcEEEeecCcceeecCC
Q 042853          584 EQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       584 ~~~~~kI~DFGla~~~~~~  602 (614)
                      .++.+||+|||+++.+...
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             TTCCEEECCCTTCEECCSS
T ss_pred             CCCcEEEeeeeeeeecccC
Confidence            9999999999999987643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.91  E-value=1.5e-24  Score=232.15  Aligned_cols=149  Identities=23%  Similarity=0.308  Sum_probs=128.4

Q ss_pred             hhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------
Q 042853          448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------  514 (614)
Q Consensus       448 ~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------  514 (614)
                      +.++....++|.+.+.||+|+||+||++... +++.+|||.+.+.   .......+.+|+.++..++|||+         
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455666788999999999999999999986 5788999998652   12234568899999999999999         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                      ....++||||+++|+|..++...    .+++.....++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence            56789999999999999988542    4788899999999999999999987   9999999999999999999999999


Q ss_pred             cceeecCCc
Q 042853          595 MARTFTMNE  603 (614)
Q Consensus       595 la~~~~~~~  603 (614)
                      +|+.+....
T Consensus       214 ~a~~~~~~~  222 (410)
T 3v8s_A          214 TCMKMNKEG  222 (410)
T ss_dssp             TCEECCTTS
T ss_pred             eeEeeccCC
Confidence            999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.91  E-value=8.7e-24  Score=217.45  Aligned_cols=142  Identities=29%  Similarity=0.477  Sum_probs=126.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|...+.||+|+||.||++... +++.+|+|.+........+.|.+|++++.+++|||+         ....++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            46777899999999999999986 678999999877666677889999999999999999         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ++++|..++...  ...+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            999999999653  345899999999999999999999987   999999999999999999999999999987543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.91  E-value=8.8e-24  Score=216.45  Aligned_cols=141  Identities=29%  Similarity=0.434  Sum_probs=125.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|...+.||+|+||+||++... +++.||||.+........+.+.+|+.+++.++|||+         ....++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            57888999999999999999864 688999999876555556778999999999999999         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      ++|+|..++...    .+++.+...++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+....
T Consensus       100 ~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A          100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            999999998543    4789999999999999999999987   9999999999999999999999999999876543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.90  E-value=1e-23  Score=222.86  Aligned_cols=146  Identities=25%  Similarity=0.456  Sum_probs=125.1

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC--------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---------
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ--------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---------  514 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---------  514 (614)
                      ..++|.+.+.||+|+||.||++...        ++..||||.++... ....++|.+|+.++.++ +|||+         
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3467888899999999999999862        35679999997643 33456799999999999 89999         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL  581 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  581 (614)
                      ....++||||+++|+|..++.....             ...+++.++..++.||++||.|||+.+   ||||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            4578999999999999999975431             235789999999999999999999987   999999999999


Q ss_pred             EcCCCcEEEeecCcceeecCC
Q 042853          582 LDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       582 ld~~~~~kI~DFGla~~~~~~  602 (614)
                      ++.++.+||+|||+|+.+...
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~  256 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNI  256 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCC
T ss_pred             ECCCCCEEEccccCCcccCcc
Confidence            999999999999999977543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.90  E-value=3.2e-24  Score=226.22  Aligned_cols=146  Identities=18%  Similarity=0.244  Sum_probs=123.6

Q ss_pred             hhHHhhcCCCCccceeccCCceeEEEEE------eCCccEEEEEEccCCCcchhHhHHHHHHHHHhcC---CCCC-----
Q 042853          449 QTIAVATDNFSPANRLGQGGFGPVYKGK------LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ---HTNL-----  514 (614)
Q Consensus       449 ~~~~~~t~~f~~~~~lG~G~fg~Vy~g~------~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~---H~nl-----  514 (614)
                      .++....++|.+.+.||+|+||.||+|.      ...++.||||.+...   ...++..|++++..++   |+|+     
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            3444566789999999999999999994      346788999999653   3457888888888887   8888     


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC----
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDSS--RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE----  584 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~----  584 (614)
                          ....++||||+++|+|..++....  ....+++..+..++.||++||.|||+.+   ||||||||+||||+.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence                567899999999999999986422  2456899999999999999999999986   999999999999998    


Q ss_pred             -------CCcEEEeecCcceeec
Q 042853          585 -------QMNPKISDFGMARTFT  600 (614)
Q Consensus       585 -------~~~~kI~DFGla~~~~  600 (614)
                             ++.+||+|||+|+.+.
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~  234 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMK  234 (365)
T ss_dssp             C------CTTEEECCCTTCEEGG
T ss_pred             ccccccccCCEEEeeCchhhhhh
Confidence                   8999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.90  E-value=1.3e-23  Score=217.59  Aligned_cols=144  Identities=26%  Similarity=0.410  Sum_probs=124.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCCCC-----------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLGG-----------------  516 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl~~-----------------  516 (614)
                      ++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++|||+..                 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            46778899999999999999987 78899999996533 334567999999999999999921                 


Q ss_pred             -------------------------------------------------eeEEEEEecCCCCHHHHHhhcCCCCCCCHHH
Q 042853          517 -------------------------------------------------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKK  547 (614)
Q Consensus       517 -------------------------------------------------~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~  547 (614)
                                                                       ..++||||+++++|..++.........++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             1789999999999999997765555677888


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          548 RFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       548 ~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            8999999999999999987   999999999999999999999999999987654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.90  E-value=5.2e-24  Score=220.71  Aligned_cols=144  Identities=25%  Similarity=0.428  Sum_probs=121.4

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCC-------------CeeEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG-------------GERLL  520 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~-------------~~~~l  520 (614)
                      ..++|++.+.||+|+||.||+|... ++.||||++... ......+..|+.++.+++||||.             ...++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3467888999999999999999886 688999999653 23344567799999999999991             23689


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY-------SRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                      ||||+++|+|..++...    .+++..+..++.|+++||.|||+.       ...+|+||||||+|||++.++.+||+||
T Consensus       100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999998542    489999999999999999999987       0114999999999999999999999999


Q ss_pred             CcceeecCCc
Q 042853          594 GMARTFTMNE  603 (614)
Q Consensus       594 Gla~~~~~~~  603 (614)
                      |+|+.+....
T Consensus       176 g~a~~~~~~~  185 (322)
T 3soc_A          176 GLALKFEAGK  185 (322)
T ss_dssp             TTCEEECTTS
T ss_pred             Cccccccccc
Confidence            9999876544

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.90  E-value=6.3e-24  Score=221.62  Aligned_cols=139  Identities=26%  Similarity=0.382  Sum_probs=122.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|+..+.||+|+||+||++... +++.+|||.+++.   .......+.+|+.++..++|||+         ....++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56788899999999999999986 6889999999653   22345678899999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++|+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999888543   35789999999999999999999987   9999999999999999999999999998654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.90  E-value=1.1e-23  Score=218.96  Aligned_cols=142  Identities=28%  Similarity=0.477  Sum_probs=124.8

Q ss_pred             cCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .++|.+.+.||+|+||.||++.. .+++.||||++.+.  .....+.+.+|+++++.++|||+         ....++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35788899999999999999998 47889999999653  23345678899999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++...   ..+++.+...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999998653   34889999999999999999999987   999999999999999999999999999876543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.90  E-value=5.3e-24  Score=223.55  Aligned_cols=154  Identities=26%  Similarity=0.446  Sum_probs=130.1

Q ss_pred             echhhHHhhcCCCCccceeccCCceeEEEEEe------CCccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC---
Q 042853          446 FDFQTIAVATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL---  514 (614)
Q Consensus       446 ~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl---  514 (614)
                      ++..++....++|.+.+.||+|+||.||++.+      .+++.||||+++... ....+.|.+|++++.++ +|||+   
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            44566677788999999999999999999974      246789999997643 33456799999999999 79999   


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCC------------------------------------------------
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSR------------------------------------------------  539 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~------------------------------------------------  539 (614)
                             ....++||||+++|+|..++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence                   2348999999999999999975432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          540 ---------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       540 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                                     ...+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+...
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                           122889999999999999999999987   999999999999999999999999999977543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.90  E-value=1.5e-23  Score=217.52  Aligned_cols=141  Identities=30%  Similarity=0.425  Sum_probs=121.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.+++.++|+|+         ....++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57888999999999999999986 78899999986432 2334678999999999999999         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +++++|..++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999988742   335899999999999999999999987   999999999999999999999999999977533

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.90  E-value=6.5e-24  Score=218.76  Aligned_cols=151  Identities=27%  Similarity=0.517  Sum_probs=122.2

Q ss_pred             hhHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCe
Q 042853          449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGE  517 (614)
Q Consensus       449 ~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~  517 (614)
                      .++.+..++|.+.+.||+|+||.||++.. .++.||||.+....  .+..++|.+|++++++++|+|+         ...
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            33445557788899999999999999987 57789999986543  3345679999999999999999         456


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++||||+++|+|..++........+++..+..++.||++||.|||+.+ .+|+||||||+|||++.++.+||+|||+|+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            8999999999999999865433334899999999999999999999874 359999999999999999999999999998


Q ss_pred             eecC
Q 042853          598 TFTM  601 (614)
Q Consensus       598 ~~~~  601 (614)
                      ....
T Consensus       188 ~~~~  191 (309)
T 3p86_A          188 LKAS  191 (309)
T ss_dssp             ----
T ss_pred             cccc
Confidence            6543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.90  E-value=1.2e-23  Score=220.89  Aligned_cols=140  Identities=29%  Similarity=0.438  Sum_probs=121.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~l  520 (614)
                      .++|.+.+.||+|+||+||++... +++.+|||.+++.   .....+.+..|..++..+ +|||+         ....++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            467888999999999999999986 5789999999753   223445678999999988 79999         567899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++|+|..++...   ..+++.....++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+...
T Consensus       102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999998643   34889999999999999999999987   9999999999999999999999999998654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.90  E-value=5.3e-24  Score=231.34  Aligned_cols=147  Identities=27%  Similarity=0.467  Sum_probs=128.4

Q ss_pred             hHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       450 ~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      .+.+..++|.+.+.||+|+||.||+|...++..||||.++... ...++|.+|+.++++++|||+        ....++|
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv  260 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYII  260 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEE
Confidence            3445567788889999999999999999888899999997643 456789999999999999999        4578999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++|+|..++.... ...+++.++..++.||++||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+..
T Consensus       261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999986432 224788999999999999999999987   99999999999999999999999999997754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.90  E-value=2e-23  Score=222.36  Aligned_cols=140  Identities=25%  Similarity=0.381  Sum_probs=120.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhc-CCCCC---------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNL---------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~l  520 (614)
                      .++|.+.+.||+|+||+||+++.. +++.+|||.+++..   .+....+..|..++.++ +||||         ....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            356888899999999999999986 57789999997542   23345688999999887 89999         567899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++|+|..++...   ..+++.....++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+...
T Consensus       131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999888643   35899999999999999999999987   9999999999999999999999999998643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.89  E-value=2.4e-23  Score=217.85  Aligned_cols=142  Identities=30%  Similarity=0.465  Sum_probs=122.5

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhc-CCCCC---------CCee
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNL---------GGER  518 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nl---------~~~~  518 (614)
                      ...++|.+.+.||+|+||.||++... +++.||||.+++..   ......+..|..++..+ +|||+         ....
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578888999999999999999986 67899999996532   23445678899999887 89999         4678


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||+++|+|..++...   ..+++.+...++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999998643   34889999999999999999999987   99999999999999999999999999987


Q ss_pred             ec
Q 042853          599 FT  600 (614)
Q Consensus       599 ~~  600 (614)
                      ..
T Consensus       168 ~~  169 (345)
T 1xjd_A          168 NM  169 (345)
T ss_dssp             CC
T ss_pred             cc
Confidence            54

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.89  E-value=1.3e-23  Score=222.82  Aligned_cols=144  Identities=27%  Similarity=0.457  Sum_probs=125.4

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ...++|.+.+.||+|+||.||+|... +++.||||.+.... .+...+|.+|+.++++++|||+         ....++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34467788899999999999999986 68899999997543 2344679999999999999999         4568999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++|+|..++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+....
T Consensus       191 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            9999999999998643  234889999999999999999999987   99999999999999999999999999987643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.89  E-value=1.4e-23  Score=214.20  Aligned_cols=142  Identities=30%  Similarity=0.519  Sum_probs=122.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-----CCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKL-----QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~  519 (614)
                      ++|++.+.||+|+||.||++.+     .+++.||||++........++|.+|+.++.+++|||+           ....+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5677789999999999999984     2578899999987666667789999999999999999           23478


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++|+|..++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        90 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999986542  34899999999999999999999987   999999999999999999999999999987


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       165 ~~~  167 (295)
T 3ugc_A          165 PQD  167 (295)
T ss_dssp             ---
T ss_pred             cCC
Confidence            543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.89  E-value=1.7e-23  Score=218.20  Aligned_cols=150  Identities=27%  Similarity=0.505  Sum_probs=128.7

Q ss_pred             hhHHhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC-------
Q 042853          449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL-------  514 (614)
Q Consensus       449 ~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl-------  514 (614)
                      ..+....++|.+.+.||+|+||.||++...      +++.||||.++... ....++|.+|+.++.+++|||+       
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344556688999999999999999999874      34789999997643 3345679999999999999999       


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 042853          515 --GGERLLVYEYLPNKSLDFFIFDSSR---------------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI  571 (614)
Q Consensus       515 --~~~~~lv~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii  571 (614)
                        ....++||||+++|+|..++.....                     ...+++.++..++.||++||.|||+.+   |+
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence              4678999999999999999875321                     146899999999999999999999987   99


Q ss_pred             ecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          572 HRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       572 HrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||||||+|||++.++.+||+|||+++.+..
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  226 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYS  226 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCccccc
Confidence            999999999999999999999999987643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.89  E-value=4e-23  Score=213.50  Aligned_cols=145  Identities=26%  Similarity=0.385  Sum_probs=125.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++|||+           ....++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            46778899999999999999986 57899999997533 2345678899999999999999           23678999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEeecCccee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL----DEQMNPKISDFGMART  598 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----d~~~~~kI~DFGla~~  598 (614)
                      ||+++++|..++........+++.++..++.||++||.|||+.+   |+||||||+|||+    +.++.+||+|||+|+.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976554445899999999999999999999987   9999999999999    7888899999999998


Q ss_pred             ecCCc
Q 042853          599 FTMNE  603 (614)
Q Consensus       599 ~~~~~  603 (614)
                      +....
T Consensus       166 ~~~~~  170 (319)
T 4euu_A          166 LEDDE  170 (319)
T ss_dssp             CCTTC
T ss_pred             cCCCC
Confidence            76443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.89  E-value=3.1e-23  Score=215.20  Aligned_cols=143  Identities=29%  Similarity=0.536  Sum_probs=123.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeC----CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      .++|.+.+.||+|+||.||+|...    .+..||||.++.. .....++|.+|+.++.+++||||         ....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356788899999999999999985    3456999999764 33445679999999999999999         457899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++++|..++...  ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999998543  345899999999999999999999987   9999999999999999999999999999875


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       203 ~~  204 (325)
T 3kul_A          203 DD  204 (325)
T ss_dssp             --
T ss_pred             cC
Confidence            43

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.89  E-value=3e-23  Score=212.20  Aligned_cols=140  Identities=27%  Similarity=0.412  Sum_probs=117.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--------------------------chhHhHHHHHHHHHh
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--------------------------QGIVEFKNEAKLIAK  508 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--------------------------~~~~~f~~E~~~l~~  508 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+.....                          ...++|.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57888899999999999999875 678899999865321                          123568999999999


Q ss_pred             cCCCCC-----------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 042853          509 LQHTNL-----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKV  577 (614)
Q Consensus       509 l~H~nl-----------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  577 (614)
                      ++|||+           ....++||||+++++|..++    ....+++.+...++.||++||.|||+.+   |+||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence            999999           24679999999999997754    2346899999999999999999999987   99999999


Q ss_pred             CCEEEcCCCcEEEeecCcceeecCC
Q 042853          578 SNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       578 ~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +|||++.++.+||+|||+|+.+...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~  190 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGS  190 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSS
T ss_pred             HHEEECCCCCEEEecCCCccccccc
Confidence            9999999999999999999987543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.89  E-value=1.6e-23  Score=221.61  Aligned_cols=143  Identities=31%  Similarity=0.554  Sum_probs=117.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC----CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      .++|.+.+.||+|+||.||+|...    .+..||||.++... ....++|.+|+.++++++|||+         ....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357888999999999999999875    46789999997543 3445679999999999999999         457899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++|+|..++...  ...+++.++..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999998643  345899999999999999999999987   9999999999999999999999999999875


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       199 ~~  200 (373)
T 2qol_A          199 DD  200 (373)
T ss_dssp             --
T ss_pred             cC
Confidence            43

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.89  E-value=2e-23  Score=229.34  Aligned_cols=146  Identities=25%  Similarity=0.449  Sum_probs=127.3

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeCC-ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ....++|.+.+.||+|+||.||+|.+.. +..||||.++... ...++|.+|+.++++++||||         ....++|
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            3345667888999999999999999874 7889999997643 346789999999999999999         4578999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||||++|+|..++.... ...+++..++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+..
T Consensus       295 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999997543 345899999999999999999999987   99999999999999999999999999998754


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus       371 ~  371 (495)
T 1opk_A          371 D  371 (495)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.89  E-value=3.2e-23  Score=213.19  Aligned_cols=149  Identities=30%  Similarity=0.462  Sum_probs=126.8

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEe------CCccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------  514 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------  514 (614)
                      +....++|.+.+.||+|+||.||++..      .+++.||||.+.... ....+++.+|+.++.+++|||+         
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            344457788899999999999999986      245789999997543 3445678999999999999999         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSR---------------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR  573 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr  573 (614)
                      ....++||||+++++|..++.....                     ...+++.++..++.||++||.|||+.+   |+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence            4578999999999999999975432                     134789999999999999999999987   9999


Q ss_pred             CCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          574 DLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       574 Dlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||||+|||++.++.+||+|||+++.+...
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~  203 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEE  203 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTT
T ss_pred             ccchheEEEcCCCCEEEcccccccccccc
Confidence            99999999999999999999999987543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.89  E-value=4.8e-23  Score=207.11  Aligned_cols=142  Identities=30%  Similarity=0.450  Sum_probs=125.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .++|.+.+.||+|+||.||++...++..||||.+.... ...+++.+|+.++.+++|||+         ....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            45778889999999999999999888899999997543 345679999999999999999         45789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ++++|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            999999998653  234899999999999999999999987   999999999999999999999999999977544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.89  E-value=2.3e-23  Score=212.95  Aligned_cols=141  Identities=27%  Similarity=0.458  Sum_probs=122.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      .++|.+.+.||+|+||.||++... +++.||+|.+....   .+..+.|.+|+.++.+++|||+         ....++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            357888999999999999999975 67899999985432   2345678999999999999999         4678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++++|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999998643   35899999999999999999999987   99999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.89  E-value=2.9e-23  Score=208.99  Aligned_cols=141  Identities=28%  Similarity=0.479  Sum_probs=124.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .++|...+.||+|+||.||++...+++.||+|++.... ...++|.+|++++.+++|||+         ....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            35677789999999999999999888899999997643 345679999999999999999         45789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999998543  345899999999999999999999987   99999999999999999999999999987654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.89  E-value=7.1e-23  Score=215.65  Aligned_cols=142  Identities=28%  Similarity=0.394  Sum_probs=123.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcc------hhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQ------GIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~------~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      .+.|.+.+.||+|+||.||++... +++.+|||.+.+....      ..+++.+|+.++.+++|||+         ....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            356888999999999999999986 6889999999754321      34678999999999999999         5678


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEeecC
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM----NPKISDFG  594 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~----~~kI~DFG  594 (614)
                      ++||||+++|+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999843   345899999999999999999999987   99999999999998776    79999999


Q ss_pred             cceeecCC
Q 042853          595 MARTFTMN  602 (614)
Q Consensus       595 la~~~~~~  602 (614)
                      +|+.+...
T Consensus       165 ~a~~~~~~  172 (361)
T 2yab_A          165 LAHEIEDG  172 (361)
T ss_dssp             SCEECCTT
T ss_pred             CceEcCCC
Confidence            99987643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.89  E-value=2.9e-23  Score=220.22  Aligned_cols=141  Identities=26%  Similarity=0.397  Sum_probs=123.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.+|+|.+.+..   ......+.+|+.++..++||||         ....++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56778899999999999999976 57889999986432   2345678899999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++..   ...+++.....++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999854   335899999999999999999999987   999999999999999999999999999987543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.89  E-value=4.5e-23  Score=215.90  Aligned_cols=139  Identities=26%  Similarity=0.388  Sum_probs=121.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhc-CCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv  521 (614)
                      ++|...+.||+|+||.||+++.. +++.+|||.+.+..   .+....+.+|+.++.++ +|||+         ....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46777899999999999999986 57889999997542   23445688999999988 89999         4678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||+++|+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999988643   34889999999999999999999987   9999999999999999999999999998653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.89  E-value=5.2e-23  Score=218.44  Aligned_cols=148  Identities=26%  Similarity=0.434  Sum_probs=126.4

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeC--------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC-------
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQ--------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL-------  514 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl-------  514 (614)
                      ....++|.+.+.||+|+||.||++...        .+..||||++.... .+...++.+|++++.++ +||||       
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            445578888999999999999999862        33579999997543 33456799999999999 99999       


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 042853          515 --GGERLLVYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN  579 (614)
Q Consensus       515 --~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N  579 (614)
                        ....++||||+++|+|..++.....             ...+++.++..++.||+.||.|||+.+   ||||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence              4578999999999999999975431             235899999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEeecCcceeecCC
Q 042853          580 ILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       580 ILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||++.++.+||+|||+|+.+...
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~  244 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHI  244 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCC
T ss_pred             EEEcCCCcEEEcccCcccccccc
Confidence            99999999999999999977543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.89  E-value=3.8e-23  Score=213.96  Aligned_cols=140  Identities=26%  Similarity=0.349  Sum_probs=122.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.+|+|.+++..   ....+.+.+|+.++..++|||+         ....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            46778899999999999999986 68899999996531   2345668899999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++|+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+....
T Consensus        86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999998643   34789999999999999999999887   99999999999999999999999999997653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.89  E-value=7.4e-23  Score=209.11  Aligned_cols=137  Identities=28%  Similarity=0.415  Sum_probs=117.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHh--cCCCCCC-------------CeeE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNLG-------------GERL  519 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~nl~-------------~~~~  519 (614)
                      .++|.+.+.||+|+||.||+|.. +++.||||.+..   .....+..|.+++..  ++|||+.             ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            35788899999999999999998 578899999864   234566777777777  7999991             3468


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCCEEEcCCCcEEEe
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH--------KYSRLRVIHRDLKVSNILLDEQMNPKIS  591 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlkp~NILld~~~~~kI~  591 (614)
                      +||||+++|+|..++.    ...+++..+..++.||+.||.|||        +.   +|+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999983    235899999999999999999999        55   49999999999999999999999


Q ss_pred             ecCcceeecCC
Q 042853          592 DFGMARTFTMN  602 (614)
Q Consensus       592 DFGla~~~~~~  602 (614)
                      |||+|+.....
T Consensus       156 Dfg~a~~~~~~  166 (301)
T 3q4u_A          156 DLGLAVMHSQS  166 (301)
T ss_dssp             CCTTCEEEETT
T ss_pred             eCCCeeecccc
Confidence            99999877543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.89  E-value=4e-23  Score=216.91  Aligned_cols=140  Identities=26%  Similarity=0.370  Sum_probs=121.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhc-CCCCC---------CCeeEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNL---------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~l  520 (614)
                      .++|...+.||+|+||.||++... +++.+|||.+++..   ....+.+..|..++..+ +|||+         ....++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467888999999999999999987 47889999996531   23455688999999887 79999         467899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++|+|..++...   ..+++.....++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+...
T Consensus        99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999998643   34889999999999999999999987   9999999999999999999999999998653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=5.9e-23  Score=214.35  Aligned_cols=149  Identities=26%  Similarity=0.436  Sum_probs=124.6

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEe------CCccEEEEEEccCC-CcchhHhHHHHHHHHHhc-CCCCC--------
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNL--------  514 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~------~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nl--------  514 (614)
                      +....++|...+.||+|+||.||++..      ..+..||||.+... .....+.+.+|+.++.++ +|||+        
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            445667889999999999999999986      24568999999754 233456799999999999 89999        


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 042853          515 -GGERLLVYEYLPNKSLDFFIFDSSRK--------------------SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHR  573 (614)
Q Consensus       515 -~~~~~lv~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr  573 (614)
                       ....++||||+++|+|..++......                    ..+++..+..++.||++||.|||+.+   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence             46789999999999999999654321                    24789999999999999999999987   9999


Q ss_pred             CCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          574 DLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       574 Dlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||||+|||++.++.+||+|||+|+.+...
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~  225 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSD  225 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccC
Confidence            99999999999999999999999877543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.89  E-value=2.6e-23  Score=215.04  Aligned_cols=150  Identities=26%  Similarity=0.483  Sum_probs=115.0

Q ss_pred             hHHhhcCCCCccceeccCCceeEEEEEeCCcc----EEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------
Q 042853          450 TIAVATDNFSPANRLGQGGFGPVYKGKLQDEQ----EIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------  514 (614)
Q Consensus       450 ~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~----~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------  514 (614)
                      ++....++|.+.+.||+|+||.||++......    .||||.+...  .....++|.+|++++++++|||+         
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            34455678999999999999999999876432    7999999754  34456789999999999999999         


Q ss_pred             CCe------eEEEEEecCCCCHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 042853          515 GGE------RLLVYEYLPNKSLDFFIFDSSR---KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ  585 (614)
Q Consensus       515 ~~~------~~lv~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~  585 (614)
                      ...      .++||||+++|+|..++.....   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence            112      2899999999999999864321   225899999999999999999999987   9999999999999999


Q ss_pred             CcEEEeecCcceeecCC
Q 042853          586 MNPKISDFGMARTFTMN  602 (614)
Q Consensus       586 ~~~kI~DFGla~~~~~~  602 (614)
                      +.+||+|||+|+.+...
T Consensus       174 ~~~kl~Dfg~a~~~~~~  190 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSG  190 (323)
T ss_dssp             SCEEECCCCC-------
T ss_pred             CCEEEeecccccccccc
Confidence            99999999999876543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.89  E-value=2.1e-23  Score=217.23  Aligned_cols=138  Identities=21%  Similarity=0.275  Sum_probs=115.9

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCC--------cchhHhHHHHHHHHHhcC---------CCCC----
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQ---------HTNL----  514 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~nl----  514 (614)
                      ++|.+.+.||+|+||+||+|.. +++.||||++....        ....+.+.+|+.++++++         |+|+    
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4577789999999999999998 67899999997542        223467899999999986         5554    


Q ss_pred             -----------------------------------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 042853          515 -----------------------------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL  559 (614)
Q Consensus       515 -----------------------------------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL  559 (614)
                                                         ....++||||+++|++...+.    ...+++.....++.||+.||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHHH
Confidence                                               357899999999997655552    24579999999999999999


Q ss_pred             HHHH-hCCCCceEecCCCCCCEEEcCCC--------------------cEEEeecCcceeecC
Q 042853          560 LYLH-KYSRLRVIHRDLKVSNILLDEQM--------------------NPKISDFGMARTFTM  601 (614)
Q Consensus       560 ~yLH-~~~~~~iiHrDlkp~NILld~~~--------------------~~kI~DFGla~~~~~  601 (614)
                      .||| +.+   ||||||||+||||+.++                    .+||+|||+|+.+..
T Consensus       175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~  234 (336)
T 2vuw_A          175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD  234 (336)
T ss_dssp             HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred             HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence            9999 776   99999999999999876                    899999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=1.3e-22  Score=210.08  Aligned_cols=142  Identities=23%  Similarity=0.342  Sum_probs=123.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++..++|||+         ....++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            367888999999999999999986 5788999998653 3445678999999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--CCcEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE--QMNPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~--~~~~kI~DFGla~~~~~~  602 (614)
                      +++++|..++...  ...+++.+...++.||++||.|||+.+   |+||||||+|||++.  ++.+||+|||+|+.+...
T Consensus        83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999988432  335899999999999999999999987   999999999999987  789999999999987544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.89  E-value=3.8e-23  Score=209.56  Aligned_cols=144  Identities=27%  Similarity=0.457  Sum_probs=123.5

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ....++|...+.||+|+||.||++...++..||||.+.... ...++|.+|++++.+++|+|+         ....++||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            34456788889999999999999999888899999997643 345679999999999999999         45789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...  ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999999999998643  235899999999999999999999987   99999999999999999999999999987643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.89  E-value=6e-23  Score=215.34  Aligned_cols=140  Identities=26%  Similarity=0.353  Sum_probs=123.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|...+.||+|+||.||++... +++.||||.+.+..   ....+.+.+|+.++..++|||+         ....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            46777899999999999999986 68899999986532   2345678899999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++|+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999998643   34789999999999999999999987   99999999999999999999999999997754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.89  E-value=3.8e-23  Score=214.70  Aligned_cols=139  Identities=27%  Similarity=0.446  Sum_probs=113.6

Q ss_pred             CCCCccceeccCCceeEEEEEe----CCccEEEEEEccCCC----cchhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKL----QDEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      ++|.+.+.||+|+||.||++..    .+++.+|+|.+++..    ......+.+|+.++++++|||+         ....
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5678889999999999999987    468899999997642    2334568899999999999999         4678


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||+++++|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus        97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           97 YLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            9999999999999988643   34788899999999999999999987   99999999999999999999999999986


Q ss_pred             ec
Q 042853          599 FT  600 (614)
Q Consensus       599 ~~  600 (614)
                      ..
T Consensus       171 ~~  172 (327)
T 3a62_A          171 SI  172 (327)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.89  E-value=1e-22  Score=209.97  Aligned_cols=139  Identities=27%  Similarity=0.445  Sum_probs=119.8

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|.+.+.||+|+||+||++...+++.||+|++....  ......+.+|+.++++++|||+         ....++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            5788889999999999999999889999999996432  2234678999999999999999         4578999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++ +|..++...  ...+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       101 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A          101 MEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             CSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             CCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            985 777777543  345889999999999999999999987   9999999999999999999999999999765

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.89  E-value=5.4e-23  Score=208.00  Aligned_cols=146  Identities=33%  Similarity=0.534  Sum_probs=126.8

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEE
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYE  523 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~E  523 (614)
                      ....++|.+.+.||+|+||.||+|...+++.||||.+.... ...+.|.+|++++.+++|+|+        ....++|||
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e   87 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE   87 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEe
Confidence            34456788899999999999999999888899999997543 345689999999999999999        456789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |+++++|..++.... ...+++.++..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             cCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            999999999985321 125889999999999999999999987   999999999999999999999999999987543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.89  E-value=2.8e-23  Score=219.28  Aligned_cols=143  Identities=32%  Similarity=0.515  Sum_probs=121.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      .++|.+.+.||+|+||.||+|...      +++.||||++... ..+...+|.+|+.++.+++|+||         ....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357888899999999999999853      4568999999654 33455679999999999999999         4567


Q ss_pred             EEEEEecCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEe
Q 042853          519 LLVYEYLPNKSLDFFIFDSS----RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM---NPKIS  591 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~---~~kI~  591 (614)
                      ++||||+++|+|..++....    ....+++.++..++.||++||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997542    2245899999999999999999999987   99999999999999554   59999


Q ss_pred             ecCcceeec
Q 042853          592 DFGMARTFT  600 (614)
Q Consensus       592 DFGla~~~~  600 (614)
                      |||+|+.+.
T Consensus       227 DFG~a~~~~  235 (367)
T 3l9p_A          227 DFGMARDIY  235 (367)
T ss_dssp             CCHHHHHHH
T ss_pred             CCccccccc
Confidence            999998664

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.89  E-value=2.4e-23  Score=226.12  Aligned_cols=145  Identities=30%  Similarity=0.510  Sum_probs=124.0

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEE
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYE  523 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~E  523 (614)
                      .+..++|.+.+.||+|+||.||+|...++..||||.++... ...++|.+|+.++++++|||+        ....++|||
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e  258 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE  258 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEeh
Confidence            34456778889999999999999999888889999997643 345689999999999999999        456799999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+++|+|..++.... ...+++.++..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+..
T Consensus       259 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          259 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             hhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            999999999985421 234889999999999999999999987   99999999999999999999999999997754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.88  E-value=1.6e-22  Score=209.93  Aligned_cols=140  Identities=27%  Similarity=0.430  Sum_probs=122.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc------chhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      +.|.+.+.||+|+||.||++... +++.+|||.+.....      ...+++.+|+.++.+++|||+         ....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45778899999999999999986 678999999865422      135679999999999999999         46789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEeecCc
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM----NPKISDFGM  595 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~----~~kI~DFGl  595 (614)
                      +||||+++++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            99999999999999853   345899999999999999999999987   99999999999999877    799999999


Q ss_pred             ceeecC
Q 042853          596 ARTFTM  601 (614)
Q Consensus       596 a~~~~~  601 (614)
                      |+.+..
T Consensus       165 a~~~~~  170 (326)
T 2y0a_A          165 AHKIDF  170 (326)
T ss_dssp             CEECCT
T ss_pred             CeECCC
Confidence            998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.88  E-value=7.2e-23  Score=226.70  Aligned_cols=146  Identities=28%  Similarity=0.404  Sum_probs=126.6

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      ...++|...+.||+|+||.||++... +++.||||.+.+.   .......+.+|+.++.+++|||+         ....+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            34567888999999999999999986 6889999999653   12344568899999999999999         46789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++|+|..++.... ...+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+
T Consensus       261 lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence            9999999999999886543 234899999999999999999999987   999999999999999999999999999987


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       337 ~~~  339 (576)
T 2acx_A          337 PEG  339 (576)
T ss_dssp             CTT
T ss_pred             ccC
Confidence            644

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.88  E-value=3.1e-23  Score=214.28  Aligned_cols=153  Identities=27%  Similarity=0.470  Sum_probs=129.1

Q ss_pred             chhhHHhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC-----
Q 042853          447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL-----  514 (614)
Q Consensus       447 ~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl-----  514 (614)
                      ..+++....++|.+.+.||+|+||.||+|...      .++.||||.+..... ....+|.+|+.++++++|+|+     
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            33455666788999999999999999999864      367899999975432 345578999999999999999     


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDSS-------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD  583 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld  583 (614)
                          ....++||||+++|+|..++....       ....+++..+..++.||++||.|||+.+   |+||||||+|||++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence                457899999999999999986422       1245789999999999999999999987   99999999999999


Q ss_pred             CCCcEEEeecCcceeecCC
Q 042853          584 EQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       584 ~~~~~kI~DFGla~~~~~~  602 (614)
                      .++.+||+|||+++.+...
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~  191 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYET  191 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGG
T ss_pred             CCCeEEECcCccccccccc
Confidence            9999999999999876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.88  E-value=4.6e-23  Score=214.00  Aligned_cols=143  Identities=27%  Similarity=0.458  Sum_probs=118.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-Ccc----EEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~----~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      ++|...+.||+|+||.||+|... +++    .||+|.+... ..+..++|.+|+.++++++|||+        ....++|
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v   94 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   94 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            45777899999999999999864 333    3688888543 23456789999999999999999        4567899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +||+++|+|..++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        95 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999986543  45899999999999999999999987   99999999999999999999999999998754


Q ss_pred             Cc
Q 042853          602 NE  603 (614)
Q Consensus       602 ~~  603 (614)
                      ..
T Consensus       170 ~~  171 (327)
T 3poz_A          170 EE  171 (327)
T ss_dssp             TC
T ss_pred             Cc
Confidence            43

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.88  E-value=9e-23  Score=221.39  Aligned_cols=141  Identities=26%  Similarity=0.475  Sum_probs=123.7

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVY  522 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~  522 (614)
                      ...++|.+.+.||+|+||.||+|... ++.||||.++...  ..++|.+|+.++++++|||+          ....++||
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            44567788899999999999999986 6789999997543  45789999999999999999          23689999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||++|+|..++.... ...+++..+..++.||++||.|||+.+   ||||||||+|||++.++.+||+|||+|+...
T Consensus       267 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             ECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            9999999999997543 234789999999999999999999987   9999999999999999999999999999654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.88  E-value=1.1e-22  Score=224.36  Aligned_cols=146  Identities=28%  Similarity=0.433  Sum_probs=126.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      .++|...+.||+|+||.||++... +++.||||.+.+..   ......+.+|+.++.+++|||+         ....++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888899999999999999986 68899999996532   2334678999999999999999         4678999


Q ss_pred             EEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDSSR-KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||+++|+|..++..... ...+++.....++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999875432 345899999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCc
Q 042853          601 MNE  603 (614)
Q Consensus       601 ~~~  603 (614)
                      ...
T Consensus       341 ~~~  343 (543)
T 3c4z_A          341 AGQ  343 (543)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.88  E-value=5.6e-23  Score=213.11  Aligned_cols=143  Identities=27%  Similarity=0.423  Sum_probs=121.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccE----EEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQE----IAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~----vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      ++|...+.||+|+||.||+|... +++.    ||+|.+.... .+...++.+|+.++++++|+|+        ....++|
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v   92 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV   92 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence            46777899999999999999875 3433    7888875432 3445678899999999999999        4678899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++|+|..++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            9999999999998643  335788899999999999999999987   99999999999999999999999999998754


Q ss_pred             Cc
Q 042853          602 NE  603 (614)
Q Consensus       602 ~~  603 (614)
                      ..
T Consensus       168 ~~  169 (325)
T 3kex_A          168 DD  169 (325)
T ss_dssp             CT
T ss_pred             cc
Confidence            43

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.88  E-value=1.3e-22  Score=212.90  Aligned_cols=144  Identities=25%  Similarity=0.396  Sum_probs=122.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-----CcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      +.|.+.+.||+|+||.||++... +++.||||.+...     .....+++.+|+.++..++||||         ....++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46788899999999999999875 6889999998532     12245679999999999999999         567899


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEeecCcc
Q 042853          521 VYEYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGMA  596 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~---~kI~DFGla  596 (614)
                      ||||+++++|..++.... ....+++.....++.||++||.|||+.+   |+||||||+|||++.++.   +||+|||+|
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999988775432 2345789999999999999999999987   999999999999986654   999999999


Q ss_pred             eeecCC
Q 042853          597 RTFTMN  602 (614)
Q Consensus       597 ~~~~~~  602 (614)
                      +.+...
T Consensus       181 ~~~~~~  186 (351)
T 3c0i_A          181 IQLGES  186 (351)
T ss_dssp             EECCTT
T ss_pred             eEecCC
Confidence            987653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.88  E-value=1.5e-22  Score=210.66  Aligned_cols=147  Identities=25%  Similarity=0.459  Sum_probs=124.5

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC--------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC--------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ--------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL--------  514 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl--------  514 (614)
                      ...++|.+.+.||+|+||.||++...        ++..||||.+.... .....++.+|+.++.++ +|||+        
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            44577888999999999999999863        45689999997543 33456789999999999 89999        


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 042853          515 -GGERLLVYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNI  580 (614)
Q Consensus       515 -~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI  580 (614)
                       ....++||||+++|+|..++.....             ...+++..+..++.||++||.|||+.+   |+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence             4578999999999999999975432             234889999999999999999999987   99999999999


Q ss_pred             EEcCCCcEEEeecCcceeecCC
Q 042853          581 LLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       581 Lld~~~~~kI~DFGla~~~~~~  602 (614)
                      |++.++.+||+|||+++.+...
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~  210 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNI  210 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTT
T ss_pred             EEcCCCCEEEcccccccccccc
Confidence            9999999999999999987643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.88  E-value=1.7e-22  Score=206.05  Aligned_cols=140  Identities=27%  Similarity=0.466  Sum_probs=119.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|.+.+.||+|+||+||++... +++.||||.+....  ......+.+|+.++.+++|+|+         ....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888899999999999999986 67899999996542  2334678999999999999999         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+++ +|..++...  ...+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            9986 555544332  345899999999999999999999987   99999999999999999999999999997753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.88  E-value=8.3e-23  Score=210.55  Aligned_cols=140  Identities=26%  Similarity=0.315  Sum_probs=117.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~  522 (614)
                      ++|+..++||+|+||+||+|... +++.||||++....  .....++..|+..+.++ +|+|+         ....++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57888999999999999999987 78899999986532  23334556666666555 89999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+ +++|..++....  ..++|..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+..
T Consensus       137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 678888876542  35899999999999999999999987   99999999999999999999999999988754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.88  E-value=1.1e-22  Score=209.19  Aligned_cols=149  Identities=30%  Similarity=0.444  Sum_probs=126.8

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEe------CCccEEEEEEccCCCc-chhHhHHHHHHHHHhc-CCCCC---------
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNL---------  514 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~------~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nl---------  514 (614)
                      ....++|...+.||+|+||.||++..      .+++.||||.+..... ...+.+.+|+.++.++ +|||+         
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34456788899999999999999985      2567899999975433 3456799999999999 99999         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSR---------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSN  579 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N  579 (614)
                      ....++||||+++|+|..++.....               ...+++..+..++.||++||.|||+.+   |+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence            4678999999999999999875432               124899999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEeecCcceeecCCc
Q 042853          580 ILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       580 ILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      ||++.++.+||+|||+++.+....
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~  199 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDS  199 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCT
T ss_pred             EEEcCCCCEEEccccccccccccc
Confidence            999999999999999999876543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.88  E-value=1.9e-22  Score=209.45  Aligned_cols=139  Identities=25%  Similarity=0.345  Sum_probs=120.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|.+.+.||+|+||.||+|... +++.||||.+....  ...++.+|+.++.++ +|+|+         ....++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            57888999999999999999974 78899999986532  235689999999999 99999         4677999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-----EEEeecCcceee
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN-----PKISDFGMARTF  599 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~-----~kI~DFGla~~~  599 (614)
                      + +++|..++...  ...+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.     +||+|||+|+.+
T Consensus        87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            9 99999998653  346899999999999999999999987   999999999999998887     999999999987


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       161 ~~~  163 (330)
T 2izr_A          161 IDP  163 (330)
T ss_dssp             BCT
T ss_pred             ecC
Confidence            543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=6.5e-23  Score=215.52  Aligned_cols=142  Identities=25%  Similarity=0.390  Sum_probs=123.0

Q ss_pred             cCCCCccceeccCCceeEEEEEe----CCccEEEEEEccCCC----cchhHhHHHHHHHHHhc-CCCCC---------CC
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKL----QDEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKL-QHTNL---------GG  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nl---------~~  516 (614)
                      .++|.+.+.||+|+||.||++..    .+++.||||.+++..    ....+.+.+|++++.++ +|+|+         ..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35788899999999999999987    367899999986532    23345688899999999 69999         45


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++||||+++++|..++...   ..+++.+...++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            789999999999999998643   34889999999999999999999987   999999999999999999999999999


Q ss_pred             eeecCC
Q 042853          597 RTFTMN  602 (614)
Q Consensus       597 ~~~~~~  602 (614)
                      +.+...
T Consensus       207 ~~~~~~  212 (355)
T 1vzo_A          207 KEFVAD  212 (355)
T ss_dssp             EECCGG
T ss_pred             eecccC
Confidence            987543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.88  E-value=2.2e-23  Score=225.91  Aligned_cols=140  Identities=27%  Similarity=0.369  Sum_probs=113.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      .++|.+.+.||+|+||.||++... +++.||||.+.+.   .......+.+|+.++..++|||+         ....++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            457888999999999999999975 6789999998643   23345678899999999999999         4678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK-YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||+++|+|..++...   ..+++.....++.||+.||.|||+ .+   ||||||||+||||+.++.+||+|||+|+...
T Consensus       227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999888543   358999999999999999999997 65   9999999999999999999999999998654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.88  E-value=2.2e-22  Score=213.88  Aligned_cols=142  Identities=25%  Similarity=0.348  Sum_probs=124.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|.+.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.++..++|+|+         ....++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            57888999999999999999986 678899999976555556679999999999999999         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--CCcEEEeecCcceeecCC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE--QMNPKISDFGMARTFTMN  602 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~--~~~~kI~DFGla~~~~~~  602 (614)
                      ++|+|..++...  ...+++.+...++.||+.||.|||+.+   |+||||||+|||++.  .+.+||+|||+|+.+...
T Consensus       131 ~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          131 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999888532  235899999999999999999999987   999999999999974  467999999999987644

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.88  E-value=1.8e-22  Score=213.64  Aligned_cols=137  Identities=31%  Similarity=0.415  Sum_probs=115.7

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecCCCCH
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~~gsL  530 (614)
                      .+.||+|+||.||+|... +++.||+|.+........++|.+|+.++.+++|||+         ....+|||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999875 688999999977555566789999999999999999         4678999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE--cCCCcEEEeecCcceeecCC
Q 042853          531 DFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL--DEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       531 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl--d~~~~~kI~DFGla~~~~~~  602 (614)
                      ..++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||+  +.++.+||+|||+|+.+...
T Consensus       174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            8888643  235889999999999999999999987   9999999999999  56788999999999987644

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.88  E-value=3.3e-23  Score=229.63  Aligned_cols=146  Identities=29%  Similarity=0.503  Sum_probs=127.2

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      +.+..++|.+.++||+|+||.||+|.+.++..||||.++... ...++|.+|+++|++++|+||        ....++||
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~  340 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT  340 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEee
Confidence            344556788889999999999999999888889999997643 345689999999999999999        45679999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||++|+|..++.... ...+++.+++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+++.+..
T Consensus       341 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             CCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             ehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            9999999999985421 234889999999999999999999987   99999999999999999999999999987753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.88  E-value=1.3e-22  Score=220.63  Aligned_cols=139  Identities=23%  Similarity=0.387  Sum_probs=112.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC--------------CCe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--------------GGE  517 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl--------------~~~  517 (614)
                      .++|.+.+.||+|+||+||++... +++.||||++.+..  ....+++.+|+.++.+++|+||              ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367889999999999999999876 67899999996532  2345678999999999999999              145


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++||||+. ++|..++..   ...+++.....++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+
T Consensus       132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            799999985 788888743   345899999999999999999999987   9999999999999999999999999999


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      .+.
T Consensus       205 ~~~  207 (458)
T 3rp9_A          205 TVD  207 (458)
T ss_dssp             CTT
T ss_pred             hcc
Confidence            875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.88  E-value=7.9e-23  Score=208.21  Aligned_cols=142  Identities=35%  Similarity=0.576  Sum_probs=116.4

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      +..++|.+.+.||+|+||.||+|....  .+|||.++...  .+..+.|.+|+.++++++|+|+        ....++||
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~   98 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT   98 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEE
Confidence            345678889999999999999998754  59999986542  3445679999999999999999        45679999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...  ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+....
T Consensus        99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            999999999988533  345899999999999999999999987   99999999999999999999999999986653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.88  E-value=2e-22  Score=212.44  Aligned_cols=142  Identities=26%  Similarity=0.420  Sum_probs=122.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+....  ....+.+.+|+.++++++|||+         ....++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357888999999999999999986 67899999996542  2345678999999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM---NPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~---~~kI~DFGla~~~  599 (614)
                      ||+++|+|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.+.   .+||+|||+|+.+
T Consensus       108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999888853   345899999999999999999999987   99999999999998654   5999999999877


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       182 ~~~  184 (362)
T 2bdw_A          182 NDS  184 (362)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            643

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.88  E-value=1.4e-22  Score=216.12  Aligned_cols=145  Identities=26%  Similarity=0.385  Sum_probs=124.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++|+|+           ....++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            46778899999999999999986 58899999997532 2345678899999999999999           23679999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEeecCccee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL----DEQMNPKISDFGMART  598 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----d~~~~~kI~DFGla~~  598 (614)
                      ||+++|+|..++........+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+|+.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999865444444899999999999999999999987   9999999999999    7778899999999998


Q ss_pred             ecCCc
Q 042853          599 FTMNE  603 (614)
Q Consensus       599 ~~~~~  603 (614)
                      +....
T Consensus       166 ~~~~~  170 (396)
T 4eut_A          166 LEDDE  170 (396)
T ss_dssp             CCCGG
T ss_pred             ccCCC
Confidence            76543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.88  E-value=6e-23  Score=211.47  Aligned_cols=140  Identities=27%  Similarity=0.418  Sum_probs=118.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCCC-------------Cee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLG-------------GER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl~-------------~~~  518 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+....   ......|.+|+.++.+++||||.             ...
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            57888999999999999999974 77899999997542   23345789999999999999991             123


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||+++++|..++...   ..+++.+...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus        92 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            8999999999999998643   35899999999999999999999987   99999999999999999999999999987


Q ss_pred             ecC
Q 042853          599 FTM  601 (614)
Q Consensus       599 ~~~  601 (614)
                      +..
T Consensus       166 ~~~  168 (311)
T 3ork_A          166 IAD  168 (311)
T ss_dssp             ---
T ss_pred             ccc
Confidence            754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.88  E-value=9.9e-23  Score=206.93  Aligned_cols=147  Identities=25%  Similarity=0.435  Sum_probs=127.6

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      +....++|...+.||+|+||.||++... ++..||+|.+... ....++|.+|+.++++++|+|+         ....++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            3345567888899999999999999987 4778999999753 3456789999999999999999         467899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++++|..++.... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        87 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999986543 345899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       163 ~~  164 (288)
T 3kfa_A          163 GD  164 (288)
T ss_dssp             SS
T ss_pred             CC
Confidence            43

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.88  E-value=2e-22  Score=219.59  Aligned_cols=141  Identities=30%  Similarity=0.504  Sum_probs=124.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||+|... +++.||||.+.+..   ......+.+|+.+++.++|||+         ....++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56788899999999999999986 78899999996532   2234578999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++..   ...+++.+...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999853   345899999999999999999999987   999999999999999999999999999987643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.88  E-value=1.1e-22  Score=209.26  Aligned_cols=154  Identities=26%  Similarity=0.447  Sum_probs=129.2

Q ss_pred             echhhHHhhcCCCCccceeccCCceeEEEEEe------CCccEEEEEEccCCCc-chhHhHHHHHHHHHhc-CCCCC---
Q 042853          446 FDFQTIAVATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNL---  514 (614)
Q Consensus       446 ~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~------~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nl---  514 (614)
                      ++..++....++|.+.+.||+|+||.||++..      .+++.||||.+..... ...+++.+|+.++.++ +|||+   
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34455666778899999999999999999974      3567899999976433 3456789999999999 79999   


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRD  574 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD  574 (614)
                             ....++||||+++++|..++.....             ...+++..+..++.|+++||.|||+.+   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence                   2358999999999999999965432             123788999999999999999999987   99999


Q ss_pred             CCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          575 LKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       575 lkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |||+|||++.++.+||+|||+++.+...
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~  201 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKD  201 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred             CccceEEECCCCCEEECCCccccccccC
Confidence            9999999999999999999999876543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.88  E-value=4.5e-22  Score=205.63  Aligned_cols=143  Identities=27%  Similarity=0.466  Sum_probs=109.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++|||+         ....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357888899999999999999876 67899999986543 2344678999999999999999         467899999


Q ss_pred             ecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSS---RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |++ ++|..++....   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 69988886432   1235889999999999999999999987   9999999999999999999999999999875


Q ss_pred             C
Q 042853          601 M  601 (614)
Q Consensus       601 ~  601 (614)
                      .
T Consensus       160 ~  160 (317)
T 2pmi_A          160 I  160 (317)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.88  E-value=2.3e-22  Score=228.45  Aligned_cols=142  Identities=26%  Similarity=0.364  Sum_probs=122.4

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhc-CCCCC---------CCeeE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNL---------GGERL  519 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~  519 (614)
                      ..++|.+.+.||+|+||.||++... +++.||||.+++.   .....+.+..|..++..+ +|+++         ....+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3467888999999999999999986 5778999999753   223456688899999887 68888         46789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |||||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999998653   34899999999999999999999987   999999999999999999999999999975


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       493 ~~  494 (674)
T 3pfq_A          493 IW  494 (674)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.88  E-value=1.8e-22  Score=216.90  Aligned_cols=142  Identities=25%  Similarity=0.356  Sum_probs=119.7

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--------cchhHhHHHHHHHHHhcCCCCC--------CC
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQHTNL--------GG  516 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nl--------~~  516 (614)
                      ..++|.+.+.||+|+||.||+|... +++.||||.+.+..        .+....+.+|+.++++++|||+        ..
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3578999999999999999999876 57899999986431        1223468899999999999999        46


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEeec
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDF  593 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~---~~~kI~DF  593 (614)
                      ..++||||+++|+|..++..   ...+++.....++.|+++||.|||+.+   |+||||||+|||++.+   ..+||+||
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             ceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence            78999999999999888743   345899999999999999999999987   9999999999999754   45999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |+|+.+..
T Consensus       287 G~a~~~~~  294 (419)
T 3i6u_A          287 GHSKILGE  294 (419)
T ss_dssp             STTTSCC-
T ss_pred             ccceecCC
Confidence            99997754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.88  E-value=9.6e-23  Score=215.58  Aligned_cols=139  Identities=25%  Similarity=0.385  Sum_probs=112.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHH-HHhcCCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKL-IAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~-l~~l~H~nl---------~~~~~lv  521 (614)
                      ++|...+.||+|+||.||+++.. +++.+|||.+.+..   ......+..|..+ ++.++|||+         ....++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56888999999999999999986 57889999996542   2234456677776 577899999         4678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||+++|+|..++...   ..+++.....++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+...
T Consensus       118 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          118 LDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999988643   34788888899999999999999987   9999999999999999999999999998643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.88  E-value=2.4e-22  Score=208.38  Aligned_cols=142  Identities=28%  Similarity=0.473  Sum_probs=124.7

Q ss_pred             CCCCccceeccCCceeEEEEEe-----CCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKL-----QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~  519 (614)
                      ++|...+.||+|+||.||++.+     .+++.||||++........+.|.+|++++.+++|+|+           ....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4677789999999999999984     3678899999987666666789999999999999999           24578


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++++|..++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            9999999999999986432  34899999999999999999999987   999999999999999999999999999987


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       178 ~~~  180 (327)
T 3lxl_A          178 PLD  180 (327)
T ss_dssp             CTT
T ss_pred             ccC
Confidence            543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.88  E-value=8.1e-23  Score=213.60  Aligned_cols=142  Identities=24%  Similarity=0.335  Sum_probs=119.8

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCC--CCC---------CCeeEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH--TNL---------GGERLL  520 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H--~nl---------~~~~~l  520 (614)
                      ..++|.+.+.||+|+||.||++...+++.||||++...  ..+..++|.+|+.++.+++|  +|+         ....++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            34568889999999999999999988999999998643  23445779999999999987  888         567899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||| +.+++|..++...   ..+++.++..++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||+|+.+.
T Consensus        87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 5688999998653   35889999999999999999999987   99999999999997 5689999999999875


Q ss_pred             CCc
Q 042853          601 MNE  603 (614)
Q Consensus       601 ~~~  603 (614)
                      ...
T Consensus       159 ~~~  161 (343)
T 3dbq_A          159 PDT  161 (343)
T ss_dssp             ---
T ss_pred             ccc
Confidence            443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.88  E-value=2.1e-22  Score=207.05  Aligned_cols=142  Identities=29%  Similarity=0.401  Sum_probs=118.1

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-------CCeeEEEEEecCCC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------GGERLLVYEYLPNK  528 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-------~~~~~lv~Ey~~~g  528 (614)
                      ++|++.+.||+|+||.||++... ++.||||.+...  ...+.|.+|+.++++++|||+       ....++||||++++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~   84 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGG   84 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCC
Confidence            45677899999999999999985 678999999643  345679999999999999999       35578999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-EEEeecCcceeec
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN-PKISDFGMARTFT  600 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~-~kI~DFGla~~~~  600 (614)
                      +|..++........+++...+.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||+|+.+.
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99999976544445788999999999999999999944345999999999999998876 7999999998664

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.88  E-value=2.5e-22  Score=216.70  Aligned_cols=141  Identities=26%  Similarity=0.420  Sum_probs=121.1

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------C-----Ce
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------G-----GE  517 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~-----~~  517 (614)
                      .++|.+.+.||+|+||.||++... +++.||||++.+..  ....+.+.+|+.++++++|+|+         .     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            368888999999999999999976 57889999997542  2345678999999999999999         1     46


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++||||++ ++|..++..   ...+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999987 599988853   345899999999999999999999987   9999999999999999999999999999


Q ss_pred             eecCC
Q 042853          598 TFTMN  602 (614)
Q Consensus       598 ~~~~~  602 (614)
                      .+...
T Consensus       178 ~~~~~  182 (432)
T 3n9x_A          178 TINSE  182 (432)
T ss_dssp             EC---
T ss_pred             ccccc
Confidence            87543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.88  E-value=1.5e-22  Score=206.14  Aligned_cols=139  Identities=27%  Similarity=0.461  Sum_probs=121.1

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|...+.||+|+||.||++...+++.+|||++.....  .....+.+|+.++++++|||+         ....++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46788899999999999999998889999999865432  234678899999999999999         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++ +|..++...  ...+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            985 888887543  245889999999999999999999987   9999999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.87  E-value=1.2e-22  Score=205.98  Aligned_cols=142  Identities=23%  Similarity=0.346  Sum_probs=115.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeCC----ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      .++|.+.+.||+|+||.||+|....    +..||+|.+.... ....+.|.+|+.++++++|||+        ....++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv   93 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII   93 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence            4578888999999999999998753    3569999987543 3345679999999999999999        4577899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++++|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           94 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            9999999999998643  235899999999999999999999987   99999999999999999999999999987754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.87  E-value=4.1e-22  Score=201.27  Aligned_cols=141  Identities=26%  Similarity=0.394  Sum_probs=124.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|.+.+.||+|+||.||++... ++..+|+|++........+.|.+|++++.+++|||+         ....++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            46788899999999999999986 467899999976555567789999999999999999         46789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEeecCcceeecCC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---d~~~~~kI~DFGla~~~~~~  602 (614)
                      ++++|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+|+.+...
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           89 TGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            999998888643   34889999999999999999999987   9999999999999   78889999999999887543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.87  E-value=1.7e-22  Score=210.72  Aligned_cols=140  Identities=26%  Similarity=0.442  Sum_probs=121.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+.+..   .+....+.+|+.+++.++|||+         ....++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57888999999999999999974 77899999986431   2234578999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+ +|+|..++...   ..+++.+...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 68888887543   34899999999999999999999987   999999999999999999999999999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.87  E-value=2.5e-22  Score=217.19  Aligned_cols=142  Identities=25%  Similarity=0.368  Sum_probs=121.1

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+....  ....+.+.+|+.+++.++||||         ....++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            356888899999999999999875 68899999986543  2345578999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld---~~~~~kI~DFGla~~~  599 (614)
                      ||+++|+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+|+.+
T Consensus        90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            999999999888643   35899999999999999999999987   99999999999998   4578999999999877


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       164 ~~~  166 (444)
T 3soa_A          164 EGE  166 (444)
T ss_dssp             CTT
T ss_pred             cCC
Confidence            644

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.87  E-value=2.5e-22  Score=206.69  Aligned_cols=150  Identities=23%  Similarity=0.453  Sum_probs=120.1

Q ss_pred             hhHHhhcCCCCccceeccCCceeEEEEEeC----CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCC-------
Q 042853          449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLG-------  515 (614)
Q Consensus       449 ~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~-------  515 (614)
                      .++....++|.+.+.||+|+||.||+|...    .++.||||.+...  .....++|.+|+.++.+++|||+.       
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            445556678888999999999999999864    3457999998654  233456799999999999999991       


Q ss_pred             -------CeeEEEEEecCCCCHHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 042853          516 -------GERLLVYEYLPNKSLDFFIFDS---SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ  585 (614)
Q Consensus       516 -------~~~~lv~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~  585 (614)
                             ...++||||+++++|..++...   .....+++..+..++.||++||.|||+.+   |+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence                   1358999999999999998543   23356899999999999999999999886   9999999999999999


Q ss_pred             CcEEEeecCcceeecC
Q 042853          586 MNPKISDFGMARTFTM  601 (614)
Q Consensus       586 ~~~kI~DFGla~~~~~  601 (614)
                      +.+||+|||+++.+..
T Consensus       184 ~~~kl~Dfg~~~~~~~  199 (313)
T 3brb_A          184 MTVCVADFGLSKKIYS  199 (313)
T ss_dssp             SCEEECSCSCC-----
T ss_pred             CcEEEeecCcceeccc
Confidence            9999999999987654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.87  E-value=4.5e-22  Score=209.12  Aligned_cols=155  Identities=26%  Similarity=0.318  Sum_probs=132.0

Q ss_pred             CCcceechhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC-----CCCC
Q 042853          441 RDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----HTNL  514 (614)
Q Consensus       441 ~~~~~~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----H~nl  514 (614)
                      .+...+.+++.....++|.+.++||+|+||.||++... +++.||||.+.. .......+..|+.++.+++     |+|+
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            44556677777778899999999999999999999985 678999999964 2344567888999999997     9998


Q ss_pred             ---------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-
Q 042853          515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-  584 (614)
Q Consensus       515 ---------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-  584 (614)
                               ....++||||+ +++|..++.... ...+++.....++.||+.||.|||+.+   ||||||||+|||++. 
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP  173 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence                     46789999999 999999986543 234889999999999999999999987   999999999999985 


Q ss_pred             ------------------------CCcEEEeecCcceeecC
Q 042853          585 ------------------------QMNPKISDFGMARTFTM  601 (614)
Q Consensus       585 ------------------------~~~~kI~DFGla~~~~~  601 (614)
                                              ++.+||+|||+|+....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~  214 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD  214 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence                                    78899999999987543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.87  E-value=4.2e-22  Score=203.76  Aligned_cols=142  Identities=28%  Similarity=0.529  Sum_probs=120.9

Q ss_pred             CCCCccceeccCCceeEEEEEe-----CCccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC-----------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKL-----QDEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL-----------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl-----------~~~~  518 (614)
                      +.|+..+.||+|+||.||++.+     .+++.||||.+.... ......+.+|+.++.+++|+|+           ....
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3467789999999999999984     367899999997532 3445779999999999999999           2457


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||+++++|..++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            89999999999999985432  34899999999999999999999987   99999999999999999999999999998


Q ss_pred             ecCC
Q 042853          599 FTMN  602 (614)
Q Consensus       599 ~~~~  602 (614)
                      +...
T Consensus       176 ~~~~  179 (302)
T 4e5w_A          176 IETD  179 (302)
T ss_dssp             CCTT
T ss_pred             ccCC
Confidence            7644

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.87  E-value=2e-22  Score=202.13  Aligned_cols=141  Identities=28%  Similarity=0.462  Sum_probs=124.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      .++|...+.||+|+||.||++...+++.||+|.+.... ...+++.+|++++.+++|||+         ....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            35677789999999999999999888899999997643 334679999999999999999         45789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++++|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999998643  245789999999999999999999987   99999999999999999999999999987643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.87  E-value=4.7e-22  Score=209.46  Aligned_cols=139  Identities=23%  Similarity=0.345  Sum_probs=119.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .++|.+.+.||+|+||.||++... +++.||||.+.... ...+.+.+|+.+++.++|||+         ....++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467888999999999999999986 67899999997532 334678899999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--EEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN--PKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~--~kI~DFGla~~~~  600 (614)
                      +++|+|..++...   ..+++.....++.|+++||.|||+.+   |+||||||+|||++.++.  +||+|||+|+...
T Consensus        98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            9999999988643   34899999999999999999999987   999999999999987765  9999999998543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.87  E-value=3.3e-22  Score=212.60  Aligned_cols=138  Identities=26%  Similarity=0.512  Sum_probs=112.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcC-CCCC-----------CCeeE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQ-HTNL-----------GGERL  519 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~-H~nl-----------~~~~~  519 (614)
                      .++|.+.+.||+|+||.||++... +++.||||++.+.  .......+.+|+.++..+. |+|+           ....+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            468888999999999999999875 6889999998653  2334566889999999997 9999           23679


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +|||||+ ++|..++..    ..+++..+..++.||++||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+
T Consensus        88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            9999998 689888854    35889999999999999999999987   999999999999999999999999999976


Q ss_pred             c
Q 042853          600 T  600 (614)
Q Consensus       600 ~  600 (614)
                      .
T Consensus       160 ~  160 (388)
T 3oz6_A          160 V  160 (388)
T ss_dssp             S
T ss_pred             c
Confidence            4

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.87  E-value=9.6e-22  Score=200.21  Aligned_cols=142  Identities=27%  Similarity=0.381  Sum_probs=121.7

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      .|.....||+|+||.||+|... +++.||||.+........+.+.+|+.++..++|+|+         ....++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3444578999999999999975 678999999977655566789999999999999999         467899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEeecCcceeecC
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-QMNPKISDFGMARTFTM  601 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-~~~~kI~DFGla~~~~~  601 (614)
                      +++|..++........+++.....++.|+++||.|||+.+   |+||||||+|||++. ++.+||+|||+++.+..
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999976544445678888999999999999999987   999999999999987 88999999999987753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.87  E-value=5.1e-22  Score=211.18  Aligned_cols=142  Identities=16%  Similarity=0.268  Sum_probs=124.1

Q ss_pred             cCCCCccceeccC--CceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          455 TDNFSPANRLGQG--GFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~~lG~G--~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      .++|++.+.||+|  +||.||++... +++.||||++....  .+..+.+.+|+.+++.++||||         ....++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3568888999999  99999999986 68899999996532  3345678899999999999999         567899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||||++|+|..++.... ...+++.....++.||++||.|||+.+   ||||||||+|||++.++.+||+|||++..+.
T Consensus       104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999986542 234899999999999999999999987   9999999999999999999999999987653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.87  E-value=1.5e-22  Score=210.30  Aligned_cols=150  Identities=29%  Similarity=0.448  Sum_probs=126.5

Q ss_pred             hHHhhcCCCCccceeccCCceeEEEEEeCC------ccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC-------
Q 042853          450 TIAVATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL-------  514 (614)
Q Consensus       450 ~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl-------  514 (614)
                      .+....++|...+.||+|+||.||++....      .+.||+|.+.... ....+.+.+|+.++.++ +|||+       
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345556789999999999999999998752      2479999997543 23456799999999999 89999       


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 042853          515 --GGERLLVYEYLPNKSLDFFIFDSSR-----------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL  581 (614)
Q Consensus       515 --~~~~~lv~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  581 (614)
                        ....++||||+++|+|..++.....           ...+++.....++.||+.||.|||+.+   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence              4678999999999999999864321           235789999999999999999999987   999999999999


Q ss_pred             EcCCCcEEEeecCcceeecCC
Q 042853          582 LDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       582 ld~~~~~kI~DFGla~~~~~~  602 (614)
                      ++.++.+||+|||+|+.+...
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~  217 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMND  217 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGC
T ss_pred             ECCCCeEEECccccccccccc
Confidence            999999999999999976543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.87  E-value=3.4e-22  Score=201.09  Aligned_cols=142  Identities=32%  Similarity=0.465  Sum_probs=114.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCC----cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      .++|...+.||+|+||.||++... ++.+|||.+....    .+..+.+.+|+.+++.++|||+         ....++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357788899999999999999985 7889999986532    2335678999999999999999         4567999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--------CCcEEEeec
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE--------QMNPKISDF  593 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~--------~~~~kI~DF  593 (614)
                      |||+++++|..++.    ...+++.....++.|+++||.|||+.+..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999883    335899999999999999999999987666999999999999986        677999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |+++.+..
T Consensus       161 g~~~~~~~  168 (271)
T 3dtc_A          161 GLAREWHR  168 (271)
T ss_dssp             CC------
T ss_pred             Cccccccc
Confidence            99987654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.87  E-value=2e-22  Score=204.79  Aligned_cols=140  Identities=27%  Similarity=0.454  Sum_probs=122.1

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-c-------cEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-E-------QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-~-------~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      ++|...+.||+|+||.||++.... +       ..||+|.+........++|.+|+.++.+++|||+         ....
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            567778999999999999998753 2       4699999976655667789999999999999999         4577


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--------EEE
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN--------PKI  590 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~--------~kI  590 (614)
                      ++||||+++++|..++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.        +||
T Consensus        88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999998653  234889999999999999999999987   999999999999998877        999


Q ss_pred             eecCcceeec
Q 042853          591 SDFGMARTFT  600 (614)
Q Consensus       591 ~DFGla~~~~  600 (614)
                      +|||+++...
T Consensus       163 ~Dfg~~~~~~  172 (289)
T 4fvq_A          163 SDPGISITVL  172 (289)
T ss_dssp             CCCCSCTTTS
T ss_pred             ccCccccccc
Confidence            9999997654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.87  E-value=5.3e-22  Score=205.79  Aligned_cols=142  Identities=30%  Similarity=0.527  Sum_probs=124.6

Q ss_pred             CCCCccceeccCCceeEEEEEe-----CCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKL-----QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~-----~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~  519 (614)
                      ++|.+.+.||+|+||.||++..     .+++.||||.+........++|.+|+.++.+++|+|+           ....+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4577789999999999999984     3678999999987666667789999999999999999           12578


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++++|..++...  ...+++.++..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       121 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            999999999999998653  235899999999999999999999987   999999999999999999999999999987


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       196 ~~~  198 (326)
T 2w1i_A          196 PQD  198 (326)
T ss_dssp             CSS
T ss_pred             ccc
Confidence            544

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.87  E-value=3.7e-22  Score=209.22  Aligned_cols=141  Identities=28%  Similarity=0.417  Sum_probs=111.6

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ...++|.+.+.||+|+||.||++... +++.||||.+....  ..+.+.+|+.++.+++|+|+         ....++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            34567888999999999999999987 57889999997532  34568899999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE---QMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~---~~~~kI~DFGla~~~  599 (614)
                      ||+++++|..++..   ...+++.+...++.||++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++.+
T Consensus       128 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999998853   345899999999999999999999987   999999999999975   889999999999976


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       202 ~~  203 (349)
T 2w4o_A          202 EH  203 (349)
T ss_dssp             --
T ss_pred             Cc
Confidence            54

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.87  E-value=3.2e-22  Score=208.48  Aligned_cols=142  Identities=27%  Similarity=0.377  Sum_probs=122.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--------chhHhHHHHHHHHHhcCCCCC---------CC
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--------QGIVEFKNEAKLIAKLQHTNL---------GG  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--------~~~~~f~~E~~~l~~l~H~nl---------~~  516 (614)
                      .++|.+.+.||+|+||.||++... +++.||||.+.....        .....+.+|+.++.+++|||+         ..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            357888999999999999999875 678899999975421        134568899999999999999         56


Q ss_pred             eeEEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          517 ERLLVYEYLPNK-SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       517 ~~~lv~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      ..++||||+..| +|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence            788999999887 998888533   35899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeecCC
Q 042853          596 ARTFTMN  602 (614)
Q Consensus       596 a~~~~~~  602 (614)
                      |+.+...
T Consensus       177 a~~~~~~  183 (335)
T 3dls_A          177 AAYLERG  183 (335)
T ss_dssp             CEECCTT
T ss_pred             ceECCCC
Confidence            9987644

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.87  E-value=4.7e-22  Score=200.51  Aligned_cols=140  Identities=29%  Similarity=0.419  Sum_probs=122.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.+++.++|+|+         ....++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            46788899999999999999986 68899999986432 3345678999999999999999         4677999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++++|..++..   ...+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        87 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            999999988742   345889999999999999999999987   99999999999999999999999999987643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.87  E-value=6.8e-22  Score=203.18  Aligned_cols=140  Identities=29%  Similarity=0.374  Sum_probs=122.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|.+.+.||+|+||.||++... +++.||||++.....  ...+.+.+|+.++.+++|+|+         ....++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999986 588999999865432  234668899999999999999         467899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+++++|..++..   ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            9999999888743   235899999999999999999999987   99999999999999999999999999988753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.87  E-value=5.4e-22  Score=200.83  Aligned_cols=144  Identities=28%  Similarity=0.381  Sum_probs=123.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+...  ......++.+|+..+..+ +|||+         ....++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            56788899999999999999986 7889999998753  234456789999999999 99999         56789999


Q ss_pred             EecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----------------
Q 042853          523 EYLPNKSLDFFIFDSSR-KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-----------------  584 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-----------------  584 (614)
                      ||+++++|..++..... ...+++.++..++.||++||.|||+.+   |+||||||+|||++.                 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            99999999999865322 245899999999999999999999987   999999999999984                 


Q ss_pred             --CCcEEEeecCcceeecCC
Q 042853          585 --QMNPKISDFGMARTFTMN  602 (614)
Q Consensus       585 --~~~~kI~DFGla~~~~~~  602 (614)
                        ...+||+|||+++.....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~  187 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP  187 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS
T ss_pred             CCceEEEEcccccccccCCc
Confidence              447999999999987643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.87  E-value=3.6e-22  Score=224.75  Aligned_cols=142  Identities=27%  Similarity=0.481  Sum_probs=121.2

Q ss_pred             CCCCccc-eeccCCceeEEEEEeC---CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          456 DNFSPAN-RLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~-~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      +++.+.+ .||+|+||.||+|.+.   ++..||||.++... ....++|.+|+.++++++|+||        ....++||
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~  414 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM  414 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEE
Confidence            4444444 7999999999999874   45679999997643 3456789999999999999999        45689999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++...  ...+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus       415 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            999999999998543  345899999999999999999999987   999999999999999999999999999977543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.87  E-value=4.9e-22  Score=211.52  Aligned_cols=140  Identities=24%  Similarity=0.340  Sum_probs=118.1

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCC--CcchhHhHHHHHHHHHhcC--CCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQ--HTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~--H~nl---------~~~~~lv~  522 (614)
                      +.|.+.+.||+|+||.||++....++.||||.+...  ..+..++|.+|+.++.+++  |+|+         ....++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458889999999999999999888899999998653  2345577999999999997  4888         45789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      | +.+++|..++...   ..+++.++..++.||++||.|||+.+   ||||||||+|||++ ++.+||+|||+|+.+...
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 5788999998653   35788899999999999999999986   99999999999996 478999999999987644


Q ss_pred             c
Q 042853          603 E  603 (614)
Q Consensus       603 ~  603 (614)
                      .
T Consensus       208 ~  208 (390)
T 2zmd_A          208 T  208 (390)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.87  E-value=6.8e-22  Score=203.76  Aligned_cols=145  Identities=26%  Similarity=0.331  Sum_probs=124.1

Q ss_pred             hhcCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCC-------------Cee
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG-------------GER  518 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~-------------~~~  518 (614)
                      ...++|.+.+.||+|+||.||++.. .+++.||||.+........+.+.+|+.++.+++|||+.             ...
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            3446788899999999999999997 47889999998765556677899999999999999991             256


Q ss_pred             EEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          519 LLVYEYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      ++||||+++|+|..++.... ....+++.++..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            79999999999999886522 2356899999999999999999999987   9999999999999999999999999988


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      ...
T Consensus       183 ~~~  185 (317)
T 2buj_A          183 QAC  185 (317)
T ss_dssp             ESC
T ss_pred             hcc
Confidence            653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.87  E-value=4.7e-22  Score=216.43  Aligned_cols=138  Identities=29%  Similarity=0.365  Sum_probs=114.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCCC---------------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLG---------------G  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl~---------------~  516 (614)
                      .++|++.+.||+|+||+||++... +++.||||++.+.  .....+++.+|+.+++.++||||.               .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468888999999999999999875 6788999999754  233456789999999999999991               3


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      +.++|||||+++ |...+.     ..+++.++..++.||++||.|||+.+   ||||||||+|||++.++.+||+|||+|
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999865 555552     23789999999999999999999987   999999999999999999999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +....
T Consensus       212 ~~~~~  216 (464)
T 3ttj_A          212 RTAGT  216 (464)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            97754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.87  E-value=4.2e-22  Score=207.08  Aligned_cols=138  Identities=36%  Similarity=0.599  Sum_probs=113.5

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHH--HHhcCCCCCC--------------CeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKL--IAKLQHTNLG--------------GERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~--l~~l~H~nl~--------------~~~~  519 (614)
                      ++|.+.+.||+|+||.||+|+. +++.||||.+...   ...++..|.++  +..++|+|+.              ...+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            5778889999999999999987 5788999998643   23445555554  4458999992              2457


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS------RLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                      +||||+++|+|..++...    ..++..+..++.||++||.|||+..      ..+||||||||+|||++.++.+||+||
T Consensus        89 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            999999999999998543    3488999999999999999999871      114999999999999999999999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |+|+.+..
T Consensus       165 G~a~~~~~  172 (336)
T 3g2f_A          165 GLSMRLTG  172 (336)
T ss_dssp             TTCEECSS
T ss_pred             cceeeccc
Confidence            99998754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.87  E-value=6.8e-22  Score=201.89  Aligned_cols=142  Identities=29%  Similarity=0.465  Sum_probs=120.3

Q ss_pred             CCCCccceeccCCceeEEEEEeCCc----cEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC----------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDE----QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL----------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~----~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl----------~~~~~l  520 (614)
                      .+|...+.||+|+||.||+|.....    ..+|+|.+.... ....++|.+|+.++++++|||+          ....++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            3466779999999999999987432    358999987543 3345679999999999999999          346789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++|+|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            99999999999998642  345789999999999999999999987   9999999999999999999999999998775


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       180 ~~  181 (298)
T 3f66_A          180 DK  181 (298)
T ss_dssp             CG
T ss_pred             cc
Confidence            43

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.87  E-value=4.6e-22  Score=208.46  Aligned_cols=140  Identities=34%  Similarity=0.462  Sum_probs=120.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      +.|...+.||+|+||.||+|... +++.||||++.....   ...++|.+|+.++.+++|||+         ....++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45788899999999999999974 788999999965422   234578999999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||++ |+|..++...  ...+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 6787776432  245899999999999999999999987   99999999999999999999999999987653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.87  E-value=3.1e-22  Score=211.72  Aligned_cols=140  Identities=29%  Similarity=0.473  Sum_probs=113.4

Q ss_pred             CCCccceeccCCceeEEEEEeC--C--ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC----------CCeeEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ--D--EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL----------GGERLLV  521 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~--~--~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv  521 (614)
                      .|...+.||+|+||.||+|...  +  ...+|||.++... ....++|.+|+.++++++|||+          ....++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556789999999999999874  2  2468999986543 3456789999999999999999          3467899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++|+|..++...  ...+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus       170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999998543  345789999999999999999999987   99999999999999999999999999987643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.87  E-value=8.8e-22  Score=203.63  Aligned_cols=141  Identities=28%  Similarity=0.392  Sum_probs=122.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc------chhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      ++|.+.+.||+|+||.||++... +++.+|||.+.....      ...+++.+|+.++.+++|||+         ....+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46778899999999999999986 678999999865422      135679999999999999999         46789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEeecCc
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM----NPKISDFGM  595 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~----~~kI~DFGl  595 (614)
                      +||||+++++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            99999999999999854   235789999999999999999999987   99999999999999887    799999999


Q ss_pred             ceeecCC
Q 042853          596 ARTFTMN  602 (614)
Q Consensus       596 a~~~~~~  602 (614)
                      ++.+...
T Consensus       166 ~~~~~~~  172 (321)
T 2a2a_A          166 AHEIEDG  172 (321)
T ss_dssp             CEECCTT
T ss_pred             ceecCcc
Confidence            9987543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.87  E-value=1.1e-21  Score=199.33  Aligned_cols=144  Identities=28%  Similarity=0.556  Sum_probs=121.0

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcc-------hhHhHHHHHHHHHhcCCCCC-------CCeeE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQ-------GIVEFKNEAKLIAKLQHTNL-------GGERL  519 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-------~~~~f~~E~~~l~~l~H~nl-------~~~~~  519 (614)
                      .++|...+.||+|+||.||++... +++.||||.+......       ..++|.+|+.++.+++|+|+       ....+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR   97 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence            357888899999999999999985 7789999998643221       12678999999999999999       34457


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-----EEEeecC
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN-----PKISDFG  594 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~-----~kI~DFG  594 (614)
                      +||||+++++|..++...  ...+++..+..++.|++.||.|||+.+ .+|+||||||+|||++.++.     +||+|||
T Consensus        98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             EEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            999999999998888643  346899999999999999999999874 34999999999999987776     9999999


Q ss_pred             cceeecC
Q 042853          595 MARTFTM  601 (614)
Q Consensus       595 la~~~~~  601 (614)
                      +|+....
T Consensus       175 ~~~~~~~  181 (287)
T 4f0f_A          175 LSQQSVH  181 (287)
T ss_dssp             TCBCCSS
T ss_pred             ccccccc
Confidence            9986543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.87  E-value=8e-22  Score=207.33  Aligned_cols=147  Identities=26%  Similarity=0.373  Sum_probs=122.9

Q ss_pred             hhhHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcc-----------hhHhHHHHHHHHHhcCCCCC--
Q 042853          448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ-----------GIVEFKNEAKLIAKLQHTNL--  514 (614)
Q Consensus       448 ~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~nl--  514 (614)
                      ..++....++|.+.+.||+|+||.||++...+++.||||++......           ..+.+.+|+.++.+++|||+  
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            46677888999999999999999999999888999999998543211           13678999999999999999  


Q ss_pred             ------------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 042853          515 ------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL  582 (614)
Q Consensus       515 ------------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  582 (614)
                                  ....++||||++ |+|..++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence                        124689999998 688777753  2345899999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEeecCcceeec
Q 042853          583 DEQMNPKISDFGMARTFT  600 (614)
Q Consensus       583 d~~~~~kI~DFGla~~~~  600 (614)
                      +.++.+||+|||+|+...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~  185 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDT  185 (362)
T ss_dssp             CTTCCEEECCTTC-----
T ss_pred             cCCCCEEEEecCcccccc
Confidence            999999999999998654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.87  E-value=6.8e-22  Score=200.96  Aligned_cols=142  Identities=27%  Similarity=0.487  Sum_probs=122.3

Q ss_pred             CCCCccc-eeccCCceeEEEEEeC---CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          456 DNFSPAN-RLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~-~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      ++|.+.+ .||+|+||.||+|...   ++..||||.+.... ....+++.+|++++.+++|||+        ....++||
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~   88 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM   88 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence            4455555 8999999999999864   56789999997643 3456679999999999999999        45689999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++++|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           89 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             ECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            999999999998532  345899999999999999999999987   999999999999999999999999999987543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.87  E-value=3e-22  Score=208.92  Aligned_cols=148  Identities=26%  Similarity=0.323  Sum_probs=121.3

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-----CcchhHhHHHHHHHHHhcCCCCC---------C
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNL---------G  515 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nl---------~  515 (614)
                      +....++|.+.+.||+|+||.||++... +++.+|+|.+.+.     .....+++.+|+.++.+++|||+         .
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3445578888999999999999999885 6778999998543     23455789999999999999999         5


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSR-------------------------------------KSLLDWKKRFSIIEGITQG  558 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~g  558 (614)
                      ...++||||+++|+|..++.....                                     ...+++.....++.||++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            678999999999999998842100                                     1123566677899999999


Q ss_pred             HHHHHhCCCCceEecCCCCCCEEEcCCC--cEEEeecCcceeecC
Q 042853          559 LLYLHKYSRLRVIHRDLKVSNILLDEQM--NPKISDFGMARTFTM  601 (614)
Q Consensus       559 L~yLH~~~~~~iiHrDlkp~NILld~~~--~~kI~DFGla~~~~~  601 (614)
                      |.|||+.+   |+||||||+|||++.++  .+||+|||+|+.+..
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence            99999987   99999999999998766  899999999997643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.87  E-value=5.7e-22  Score=205.82  Aligned_cols=142  Identities=27%  Similarity=0.453  Sum_probs=117.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-Ccc----EEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~----~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      ++|.+.+.||+|+||.||+|... +++    .||+|.+... .....+++.+|+.++.+++|||+        ....++|
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v   94 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   94 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence            57888899999999999999875 343    3578877543 34456789999999999999999        4567899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +||+++|+|..++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        95 ~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             ECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999986542  35889999999999999999999987   99999999999999999999999999998754


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus       170 ~  170 (327)
T 3lzb_A          170 E  170 (327)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.86  E-value=7.2e-22  Score=199.60  Aligned_cols=140  Identities=31%  Similarity=0.536  Sum_probs=122.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+....   ....+.+.+|+.++.+++|||+         ....++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            46778899999999999999974 78899999986431   2234678999999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||+++++|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             ECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999998643  345899999999999999999999987   9999999999999999999999999998765

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.86  E-value=1.4e-21  Score=201.40  Aligned_cols=139  Identities=24%  Similarity=0.340  Sum_probs=118.8

Q ss_pred             CCCCcc-ceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEE
Q 042853          456 DNFSPA-NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~-~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~E  523 (614)
                      +.|.+. +.||+|+||.||++... +++.||||.+..........+.+|++++.++ +|||+         ....++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            456653 67999999999999865 6889999999766555567899999999985 79999         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~---~kI~DFGla~~~~  600 (614)
                      |+++++|..++...   ..+++.+...++.||++||.|||+.+   |+||||||+|||++.++.   +||+|||+++.+.
T Consensus        92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999998653   35789999999999999999999987   999999999999998766   9999999998764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.86  E-value=2.1e-21  Score=198.86  Aligned_cols=140  Identities=29%  Similarity=0.471  Sum_probs=123.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +.|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++|+|+         ....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46778899999999999999875 67899999986543 3445789999999999999999         4678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +++++|..++..    ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       102 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          102 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999998842    45899999999999999999999987   999999999999999999999999999887543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.86  E-value=6.3e-22  Score=200.46  Aligned_cols=144  Identities=26%  Similarity=0.420  Sum_probs=121.8

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCC----ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLL  520 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~l  520 (614)
                      ..++|.+.+.||+|+||.||+|....    +..||||.+.... ....+.|.+|+.++++++|||+        ....++
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence            34577888999999999999998642    3469999997643 3445679999999999999999        456789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++++|..++...  ...+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999998653  234789999999999999999999987   9999999999999999999999999998765


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       165 ~~  166 (281)
T 3cc6_A          165 DE  166 (281)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.86  E-value=1.7e-21  Score=201.37  Aligned_cols=138  Identities=30%  Similarity=0.456  Sum_probs=120.2

Q ss_pred             CCccceeccCCceeEEEEEeC-----CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC-----------CCeeEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQ-----DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL-----------GGERLL  520 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~-----~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~l  520 (614)
                      |.+.+.||+|+||.||++.+.     +++.||||.+.... .+..+.|.+|++++++++|+|+           ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            367899999999999998753     57889999997643 2445679999999999999999           246789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++++|..++...    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            99999999999998532    3899999999999999999999987   9999999999999999999999999999876


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       186 ~~  187 (318)
T 3lxp_A          186 EG  187 (318)
T ss_dssp             TT
T ss_pred             cc
Confidence            43

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.86  E-value=2.5e-21  Score=197.43  Aligned_cols=140  Identities=22%  Similarity=0.351  Sum_probs=120.5

Q ss_pred             cCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~E  523 (614)
                      .++|.+.+.||+|+||.||+|.. .+++.||||.+...  ....++.+|+.++.++ +|+|+         ....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35788899999999999999997 47889999998643  2345688999999999 78887         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-----EEEeecCccee
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN-----PKISDFGMART  598 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~-----~kI~DFGla~~  598 (614)
                      |+ +++|..++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.     +||+|||+|+.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999998653  235899999999999999999999886   999999999999987766     99999999998


Q ss_pred             ecCC
Q 042853          599 FTMN  602 (614)
Q Consensus       599 ~~~~  602 (614)
                      +...
T Consensus       161 ~~~~  164 (298)
T 1csn_A          161 YRDP  164 (298)
T ss_dssp             SBCT
T ss_pred             cccc
Confidence            7643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.86  E-value=6.9e-22  Score=200.87  Aligned_cols=143  Identities=28%  Similarity=0.374  Sum_probs=120.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|...+.||+|+||.||++... ++..+|+|.+.... ....+++.+|++++++++|||+         ....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            45777899999999999999985 67899999986543 3345779999999999999999         4678999999


Q ss_pred             cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---d~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++.... ....+++..+..++.|+++||.|||+.+   |+||||||+|||+   +.++.+||+|||+|+.+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999998886432 2346899999999999999999999987   9999999999999   456789999999998765


Q ss_pred             C
Q 042853          601 M  601 (614)
Q Consensus       601 ~  601 (614)
                      .
T Consensus       179 ~  179 (285)
T 3is5_A          179 S  179 (285)
T ss_dssp             -
T ss_pred             C
Confidence            4

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.86  E-value=1.5e-21  Score=203.25  Aligned_cols=140  Identities=27%  Similarity=0.368  Sum_probs=122.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.+|+|.+...   .....+.+.+|+.+++.++|+|+         ....++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            56888899999999999999986 5678999998653   22345678999999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...   ..+++.++..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       121 e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          121 ELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             CCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999987543   35889999999999999999999987   99999999999999999999999999998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.86  E-value=1.3e-21  Score=199.53  Aligned_cols=140  Identities=27%  Similarity=0.368  Sum_probs=122.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|...+.||+|+||.||++... +++.+|+|.+...   .....+.+.+|+.++++++|+|+         ....++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            46777899999999999999987 5678999998653   22345678999999999999999         45789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...   ..+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        95 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           95 ELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             ECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999987543   35889999999999999999999987   99999999999999999999999999998753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.86  E-value=1.5e-21  Score=205.99  Aligned_cols=139  Identities=25%  Similarity=0.394  Sum_probs=114.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------C------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------G------G  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~------~  516 (614)
                      .++|...+.||+|+||.||++... +++.||||++....  ....+++.+|+.+++.++|+|+         .      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467888999999999999999985 68899999996532  2335678999999999999999         1      2


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++||||+ +++|..++..    ..+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 7899998854    34789999999999999999999987   999999999999999999999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +....
T Consensus       176 ~~~~~  180 (367)
T 1cm8_A          176 RQADS  180 (367)
T ss_dssp             EECCS
T ss_pred             ccccc
Confidence            98653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.86  E-value=9.4e-22  Score=207.23  Aligned_cols=143  Identities=21%  Similarity=0.314  Sum_probs=116.3

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCC------ccEEEEEEccCCCcch-----------hHhHHHHHHHHHhcCCCCCC-
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSGQG-----------IVEFKNEAKLIAKLQHTNLG-  515 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~------~~~vavK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~nl~-  515 (614)
                      ..++|.+.+.||+|+||.||+|.+..      ++.||||.+.......           ...+..|+..+..++|+|+. 
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            44678889999999999999998864      3689999986543211           11234456667778899991 


Q ss_pred             ------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 042853          516 ------------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD  583 (614)
Q Consensus       516 ------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld  583 (614)
                                  ...++||||+ +++|..++...  ...+++..+..++.||+.||.|||+.+   ||||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence                        3379999999 99999998653  345899999999999999999999987   99999999999999


Q ss_pred             --CCCcEEEeecCcceeecCC
Q 042853          584 --EQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       584 --~~~~~kI~DFGla~~~~~~  602 (614)
                        .++.+||+|||+|+.+...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGG
T ss_pred             cCCCCeEEEEECCcceecccC
Confidence              8899999999999987644

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.86  E-value=2.3e-21  Score=204.54  Aligned_cols=146  Identities=23%  Similarity=0.395  Sum_probs=125.7

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--------chhHhHHHHHHHHHhc-CCCCC------
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--------QGIVEFKNEAKLIAKL-QHTNL------  514 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--------~~~~~f~~E~~~l~~l-~H~nl------  514 (614)
                      .....++|.+.+.||+|+||.||++... +++.||||.+.....        +..+.+.+|+.++.++ +|||+      
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3444567888999999999999999986 689999999865321        1134678999999999 79999      


Q ss_pred             ---CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEe
Q 042853          515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKIS  591 (614)
Q Consensus       515 ---~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~  591 (614)
                         ....++||||+++++|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence               56789999999999999998643   35899999999999999999999987   9999999999999999999999


Q ss_pred             ecCcceeecCC
Q 042853          592 DFGMARTFTMN  602 (614)
Q Consensus       592 DFGla~~~~~~  602 (614)
                      |||+++.+...
T Consensus       243 DfG~~~~~~~~  253 (365)
T 2y7j_A          243 DFGFSCHLEPG  253 (365)
T ss_dssp             CCTTCEECCTT
T ss_pred             ecCcccccCCC
Confidence            99999987643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.86  E-value=1e-21  Score=200.80  Aligned_cols=140  Identities=24%  Similarity=0.441  Sum_probs=121.0

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      .++|++.+.||+|+||.||++... +++.+|+|.+........++|.+|+.++.+++|||+         ....++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            357888999999999999999986 578999999976655667789999999999999999         4578999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +++++|..++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999886432  34899999999999999999999987   999999999999999999999999998643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.86  E-value=1.5e-21  Score=202.48  Aligned_cols=133  Identities=27%  Similarity=0.332  Sum_probs=114.8

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCC---------CCeeEEEEEecCCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL---------GGERLLVYEYLPNKS  529 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl---------~~~~~lv~Ey~~~gs  529 (614)
                      .+.||+|+||.||++... +++.||||.+.+   .....+.+|+.++..++ ||||         ....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999986 678999999964   24467789999999997 9999         567899999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEeecCcceeecCC
Q 042853          530 LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM---NPKISDFGMARTFTMN  602 (614)
Q Consensus       530 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~---~~kI~DFGla~~~~~~  602 (614)
                      |..++...   ..+++.++..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+|+.....
T Consensus        93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99998653   45899999999999999999999987   99999999999997665   7999999999976543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.86  E-value=1.5e-21  Score=203.94  Aligned_cols=137  Identities=27%  Similarity=0.424  Sum_probs=117.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|.+.+.||+|+||.||++... +++.+|||.+.+...    .+.+|++++.++ +|||+         ....++||||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            56888899999999999999986 678999999976432    356788888888 79999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC----CcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ----MNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~----~~~kI~DFGla~~~~  600 (614)
                      +++|+|..++...   ..+++.+...++.||+.||.|||+.+   |+||||||+|||+.++    ..+||+|||+|+.+.
T Consensus        98 ~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           98 MKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999988543   35899999999999999999999987   9999999999998533    349999999999875


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       172 ~~  173 (342)
T 2qr7_A          172 AE  173 (342)
T ss_dssp             CT
T ss_pred             CC
Confidence            43

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.86  E-value=2.2e-21  Score=199.25  Aligned_cols=143  Identities=28%  Similarity=0.484  Sum_probs=116.9

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-----cchhHhHHHHHHHHHhcC---CCCCC---------
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQ---HTNLG---------  515 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~---H~nl~---------  515 (614)
                      ..++|.+.+.||+|+||+||++... +++.||||.+....     ......+.+|+.++.+++   |||+.         
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4578999999999999999999974 67899999986322     122346778888777765   99991         


Q ss_pred             C-----eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 042853          516 G-----ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKI  590 (614)
Q Consensus       516 ~-----~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI  590 (614)
                      .     ..++||||++ ++|..++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            1     4789999997 59999886543 234899999999999999999999987   999999999999999999999


Q ss_pred             eecCcceeecC
Q 042853          591 SDFGMARTFTM  601 (614)
Q Consensus       591 ~DFGla~~~~~  601 (614)
                      +|||+|+.+..
T Consensus       162 ~Dfg~a~~~~~  172 (308)
T 3g33_A          162 ADFGLARIYSY  172 (308)
T ss_dssp             CSCSCTTTSTT
T ss_pred             eeCccccccCC
Confidence            99999987653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.86  E-value=2.1e-21  Score=198.81  Aligned_cols=141  Identities=25%  Similarity=0.364  Sum_probs=120.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC----cchhHhHHHHHHHHHhcCCCCC-----------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNL-----------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~  519 (614)
                      ++|.+.+.||+|+||.||++... +++.+|||.+....    ......+.+|+.++.+++|+|+           ....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            67888999999999999999985 67899999986532    2345679999999999999999           23679


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||++++ |..++.... ...+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence            999999987 666665432 345899999999999999999999987   999999999999999999999999999977


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       160 ~~  161 (305)
T 2wtk_C          160 HP  161 (305)
T ss_dssp             CT
T ss_pred             Cc
Confidence            53

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.86  E-value=9.8e-22  Score=203.37  Aligned_cols=153  Identities=30%  Similarity=0.430  Sum_probs=126.8

Q ss_pred             ceechhhHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC-------
Q 042853          444 KIFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL-------  514 (614)
Q Consensus       444 ~~~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl-------  514 (614)
                      ..+++.++....++|.+.+.||+|+||.||+|... +++.||||.+... .....++.+|+.++.++ +|+|+       
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            34455666677889999999999999999999985 6789999998653 23456789999999999 79999       


Q ss_pred             --------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC
Q 042853          515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM  586 (614)
Q Consensus       515 --------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~  586 (614)
                              ....++||||+++++|..++.... ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence                    135789999999999999986542 345889999999999999999999987   99999999999999999


Q ss_pred             cEEEeecCcceeecC
Q 042853          587 NPKISDFGMARTFTM  601 (614)
Q Consensus       587 ~~kI~DFGla~~~~~  601 (614)
                      .+||+|||+++.+..
T Consensus       167 ~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDR  181 (326)
T ss_dssp             CEEECCCTTTC----
T ss_pred             CEEEeeCcCceecCc
Confidence            999999999987643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.86  E-value=5.6e-22  Score=223.81  Aligned_cols=135  Identities=28%  Similarity=0.455  Sum_probs=117.6

Q ss_pred             ceeccCCceeEEEEEeC---CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~g  528 (614)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....++|.+|++++.+++|+||        ....++|||||++|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG  454 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence            47999999999999653   46789999997542  2345789999999999999999        45678999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      +|..++...   ..+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+..+
T Consensus       455 ~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          455 PLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            999999543   35899999999999999999999987   999999999999999999999999999977543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.86  E-value=5.8e-22  Score=205.55  Aligned_cols=147  Identities=29%  Similarity=0.374  Sum_probs=125.2

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCCC---------------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLG---------------  515 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl~---------------  515 (614)
                      ....+|.+.+.||+|+||.||++... +++.||||++........+.+.+|+.++.++. |+|+.               
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            33457888899999999999999975 67899999987655556678999999999996 99992               


Q ss_pred             --CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          516 --GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       516 --~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                        ...++||||++ |+|..++........+++..+..++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence              12689999996 799888865444456899999999999999999999864 35999999999999999999999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |+++.+..
T Consensus       183 g~~~~~~~  190 (337)
T 3ll6_A          183 GSATTISH  190 (337)
T ss_dssp             TTCBCCSS
T ss_pred             ccceeccc
Confidence            99987754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.86  E-value=2e-22  Score=213.43  Aligned_cols=143  Identities=17%  Similarity=0.213  Sum_probs=116.6

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHH---HHHHhcCCCCCCC----------
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEA---KLIAKLQHTNLGG----------  516 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~---~~l~~l~H~nl~~----------  516 (614)
                      ..++|.+.+.||+|+||.||+|... +++.||||.+...   .....+.|.+|+   +++++++|||+..          
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            3467888899999999999999974 6889999999643   334557789999   5566668999810          


Q ss_pred             -----------------------eeEEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 042853          517 -----------------------ERLLVYEYLPNKSLDFFIFDSSR----KSLLDWKKRFSIIEGITQGLLYLHKYSRLR  569 (614)
Q Consensus       517 -----------------------~~~lv~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  569 (614)
                                             ..++||||+ +|+|..++.....    ...+++..+..++.||++||.|||+.+   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence                                   278999999 6899999865321    122446888899999999999999987   


Q ss_pred             eEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          570 VIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       570 iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||||||+|||++.++.+||+|||+|+...
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~  257 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  257 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence            9999999999999999999999999999644

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.86  E-value=8.5e-22  Score=199.28  Aligned_cols=140  Identities=29%  Similarity=0.428  Sum_probs=120.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      .++|.+.+.||+|+||.||++... +++.+|||.+....   .....++.+|+.++.+++|||+         ....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            456888899999999999999876 56789999985431   2234568999999999999999         4678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||+++++|..++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999988643   34789999999999999999999886   9999999999999999999999999987654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.86  E-value=2.4e-21  Score=204.10  Aligned_cols=140  Identities=26%  Similarity=0.407  Sum_probs=121.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCCC--------------Cee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLG--------------GER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl~--------------~~~  518 (614)
                      .++|.+.+.||+|+||.||++... +++.||||++..... .....+.+|++++.+++|+|+.              ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357888999999999999999876 678899999975432 3346789999999999999991              357


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||++ ++|..++..    ..+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999998 589888853    24899999999999999999999987   99999999999999999999999999998


Q ss_pred             ecCC
Q 042853          599 FTMN  602 (614)
Q Consensus       599 ~~~~  602 (614)
                      ....
T Consensus       178 ~~~~  181 (364)
T 3qyz_A          178 ADPD  181 (364)
T ss_dssp             CCGG
T ss_pred             cCCC
Confidence            7643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.86  E-value=1.3e-21  Score=203.54  Aligned_cols=142  Identities=31%  Similarity=0.556  Sum_probs=118.0

Q ss_pred             cCCCCccceeccCCceeEEEEEeCC-----ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQD-----EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~-----~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      .++|...+.||+|+||.||+|....     +..||||.+.... .....+|.+|+.++.+++|+|+         ....+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567778999999999999998752     2469999997543 3345679999999999999999         46789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++++|..++...  ...+++.++..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            999999999999998643  245899999999999999999999987   999999999999999999999999999977


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       198 ~~  199 (333)
T 1mqb_A          198 ED  199 (333)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.86  E-value=1.9e-21  Score=197.05  Aligned_cols=142  Identities=27%  Similarity=0.420  Sum_probs=122.4

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .++|.+.+.||+|+||.||++... +++.||+|.+...  .....+.+.+|+.++.+++|+|+         ....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467888999999999999999986 5789999998643  23345678899999999999999         46779999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~---~kI~DFGla~~~  599 (614)
                      ||+++++|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||+++..
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999998887543   35889999999999999999999987   999999999999986655   999999999877


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       159 ~~~  161 (284)
T 3kk8_A          159 NDS  161 (284)
T ss_dssp             CSS
T ss_pred             ccC
Confidence            543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.86  E-value=6.1e-22  Score=209.24  Aligned_cols=140  Identities=10%  Similarity=0.125  Sum_probs=109.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHHHHhc--CCCCCC--------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKLIAKL--QHTNLG--------------  515 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l--~H~nl~--------------  515 (614)
                      ..|...+.||+|+||.||+|... +++.||||.+.....   ...+.+.+|+.++..+  +|||+.              
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45777899999999999999976 788999999976432   3345678886655555  599951              


Q ss_pred             -------------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCce
Q 042853          516 -------------------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKR------FSIIEGITQGLLYLHKYSRLRV  570 (614)
Q Consensus       516 -------------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i  570 (614)
                                         ...++||||++ |+|..++.....  .+++..+      ..++.||++||.|||+++   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence                               33799999999 899999975422  2455555      778899999999999987   9


Q ss_pred             EecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          571 IHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       571 iHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||||||+|||++.++.+||+|||+|+....
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~  246 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT  246 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence            9999999999999999999999999997753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.86  E-value=1.7e-21  Score=201.53  Aligned_cols=141  Identities=26%  Similarity=0.371  Sum_probs=118.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--------cchhHhHHHHHHHHHhcCCCCC--------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQHTNL--------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nl--------~~~~  518 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+....        ......|.+|+.++.+++|||+        ....
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   89 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY   89 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence            56888899999999999999886 57889999986532        1223468899999999999999        4568


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEeecCc
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGM  595 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~---~kI~DFGl  595 (614)
                      ++||||+++++|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             EEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            999999999999988843   345889999999999999999999987   999999999999987654   99999999


Q ss_pred             ceeecCC
Q 042853          596 ARTFTMN  602 (614)
Q Consensus       596 a~~~~~~  602 (614)
                      ++.+...
T Consensus       164 ~~~~~~~  170 (322)
T 2ycf_A          164 SKILGET  170 (322)
T ss_dssp             CEECCCC
T ss_pred             ceecccc
Confidence            9987543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.86  E-value=1.2e-21  Score=203.43  Aligned_cols=141  Identities=26%  Similarity=0.437  Sum_probs=116.4

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhc--CCCCC---------C----Cee
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL--QHTNL---------G----GER  518 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l--~H~nl---------~----~~~  518 (614)
                      ..++|.+.+.||+|+||.||+|... ++.||||.+...   ....+..|.+++..+  +|+|+         .    ...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3467888999999999999999986 788999998542   234455566665554  89999         2    568


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS-----RLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                      ++||||+++|+|..++...    .+++..+..++.|++.||.|||+..     +.+||||||||+|||++.++.+||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            9999999999999998542    4889999999999999999999871     124999999999999999999999999


Q ss_pred             CcceeecCC
Q 042853          594 GMARTFTMN  602 (614)
Q Consensus       594 Gla~~~~~~  602 (614)
                      |+|+.+...
T Consensus       187 g~a~~~~~~  195 (337)
T 3mdy_A          187 GLAVKFISD  195 (337)
T ss_dssp             TTCEECC--
T ss_pred             CCceeeccc
Confidence            999877543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.86  E-value=9.6e-22  Score=200.26  Aligned_cols=142  Identities=27%  Similarity=0.432  Sum_probs=120.8

Q ss_pred             cCCCCccc-eeccCCceeEEEEEeC---CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC--------CCeeEE
Q 042853          455 TDNFSPAN-RLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL--------GGERLL  520 (614)
Q Consensus       455 t~~f~~~~-~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl--------~~~~~l  520 (614)
                      .++|.+.+ .||+|+||.||+|...   .++.||||.+....  ....++|.+|+.++..++|||+        ....++
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l   94 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML   94 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence            34566666 8999999999999642   46789999997542  2335679999999999999999        467889


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++++|..++...   ..+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        95 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999998653   34889999999999999999999987   9999999999999999999999999999875


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       169 ~~  170 (291)
T 1xbb_A          169 AD  170 (291)
T ss_dssp             TT
T ss_pred             cC
Confidence            43

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.86  E-value=1.2e-21  Score=204.93  Aligned_cols=141  Identities=32%  Similarity=0.487  Sum_probs=115.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-----chhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-----QGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-----~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      .++|...+.||+|+||.||++... +++.||||.+.....     ...+.+.+|+.++.+++|+|+         ....+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            467888999999999999999986 578999999864321     123468899999999999999         45789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++ +|..++...  ...+++.+...++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        89 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            99999986 888877532  345788889999999999999999987   999999999999999999999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       163 ~~  164 (346)
T 1ua2_A          163 GS  164 (346)
T ss_dssp             TS
T ss_pred             cC
Confidence            43

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.86  E-value=1.2e-21  Score=203.15  Aligned_cols=143  Identities=32%  Similarity=0.511  Sum_probs=118.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~  518 (614)
                      .++|.+.+.||+|+||.||+|...      +++.||||.+... ......+|.+|+.++.+++|||+         ....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            357888999999999999999842      4678999999654 33455679999999999999999         4567


Q ss_pred             EEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEe
Q 042853          519 LLVYEYLPNKSLDFFIFDSSR----KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE---QMNPKIS  591 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~---~~~~kI~  591 (614)
                      ++||||+++++|..++.....    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999976432    245889999999999999999999987   999999999999984   4569999


Q ss_pred             ecCcceeec
Q 042853          592 DFGMARTFT  600 (614)
Q Consensus       592 DFGla~~~~  600 (614)
                      |||+++.+.
T Consensus       186 Dfg~~~~~~  194 (327)
T 2yfx_A          186 DFGMARDIY  194 (327)
T ss_dssp             CCHHHHHHH
T ss_pred             ccccccccc
Confidence            999998654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.86  E-value=3.9e-21  Score=195.67  Aligned_cols=140  Identities=25%  Similarity=0.383  Sum_probs=118.1

Q ss_pred             cCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~E  523 (614)
                      .++|.+.+.||+|+||.||++.. .+++.||||.+....  ...++.+|+.++..++|+++          ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            46788899999999999999997 477899999875432  23468899999999998886          456789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---d~~~~~kI~DFGla~~~~  600 (614)
                      |+ +++|..++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+|+.+.
T Consensus        86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             cc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            99 999999986432  35899999999999999999999987   9999999999999   788999999999999876


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       160 ~~  161 (296)
T 4hgt_A          160 DA  161 (296)
T ss_dssp             CT
T ss_pred             Cc
Confidence            54

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.86  E-value=2.1e-21  Score=196.38  Aligned_cols=139  Identities=32%  Similarity=0.511  Sum_probs=121.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCC------------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG------------------  516 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~------------------  516 (614)
                      ++|...+.||+|+||.||++... +++.||+|.+....    ..+.+|++++.+++|||+..                  
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            46778899999999999999986 78899999996532    46789999999999999921                  


Q ss_pred             -------eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          517 -------ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       517 -------~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                             ..++||||+++++|..++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence                   2689999999999999986532 345899999999999999999999987   99999999999999999999


Q ss_pred             EeecCcceeecCC
Q 042853          590 ISDFGMARTFTMN  602 (614)
Q Consensus       590 I~DFGla~~~~~~  602 (614)
                      |+|||+++.+...
T Consensus       163 l~Dfg~~~~~~~~  175 (284)
T 2a19_B          163 IGDFGLVTSLKND  175 (284)
T ss_dssp             ECCCTTCEESSCC
T ss_pred             ECcchhheecccc
Confidence            9999999987543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.86  E-value=1.8e-21  Score=200.33  Aligned_cols=140  Identities=24%  Similarity=0.328  Sum_probs=119.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+....   ....+++.+|+.++.+++|||+         ....++||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            67888999999999999999986 67889999986542   2234678999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...   ..+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       114 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          114 RLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             ECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999998643   35899999999999999999999987   99999999999999999999999999987654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.86  E-value=2.2e-21  Score=196.39  Aligned_cols=140  Identities=26%  Similarity=0.408  Sum_probs=121.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc------chhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      ++|.+.+.||+|+||.||++... +++.+|+|.+.....      ...++|.+|+.++.+++|||+         ....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45778899999999999999987 688999999865321      135679999999999999999         46789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEeecCc
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM----NPKISDFGM  595 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~----~~kI~DFGl  595 (614)
                      +||||+++++|..++...   ..+++.++..++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999998543   35899999999999999999999987   99999999999998876    799999999


Q ss_pred             ceeecC
Q 042853          596 ARTFTM  601 (614)
Q Consensus       596 a~~~~~  601 (614)
                      ++.+..
T Consensus       159 ~~~~~~  164 (283)
T 3bhy_A          159 AHKIEA  164 (283)
T ss_dssp             CEECC-
T ss_pred             ceeccC
Confidence            987754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.86  E-value=1.6e-21  Score=198.83  Aligned_cols=139  Identities=32%  Similarity=0.474  Sum_probs=117.8

Q ss_pred             CCccceeccCCceeEEEEEeCC----ccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC----------CCeeEEEE
Q 042853          458 FSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL----------GGERLLVY  522 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~  522 (614)
                      |...+.||+|+||.||+|...+    +..+|+|.+..... ...+.|.+|+.++++++|||+          ....++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            4446899999999999998632    23799999975433 445779999999999999999          22348999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus       103 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          103 PYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             ecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999998642  345789999999999999999999987   99999999999999999999999999986643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.86  E-value=9.6e-22  Score=203.78  Aligned_cols=139  Identities=30%  Similarity=0.550  Sum_probs=117.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+..... .....+.+|+.++.+++|+|+         ....++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888899999999999999986 678999999965432 223356789999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ++ |+|..++...  ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            98 5888887653  335889999999999999999999987   9999999999999999999999999998664

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.85  E-value=3.8e-21  Score=199.27  Aligned_cols=135  Identities=22%  Similarity=0.401  Sum_probs=118.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCC-----------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL-----------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl-----------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.++..   ..+.+.+|+.++.+++ |+|+           ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            57888999999999999999874 6789999999643   3467899999999997 9999           34578999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++.      .+++.....++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999998873      3788899999999999999999987   99999999999999776 899999999997754


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus       184 ~  184 (330)
T 3nsz_A          184 G  184 (330)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.85  E-value=4e-21  Score=211.45  Aligned_cols=142  Identities=33%  Similarity=0.460  Sum_probs=120.5

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-------------chhHhHHHHHHHHHhcCCCCC------
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-------------QGIVEFKNEAKLIAKLQHTNL------  514 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-------------~~~~~f~~E~~~l~~l~H~nl------  514 (614)
                      .++|.+.++||+|+||+||++... +++.+|||.+.+...             ...+++.+|+.++++++||||      
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467888999999999999999986 578899999865321             234678999999999999999      


Q ss_pred             ---CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cE
Q 042853          515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM---NP  588 (614)
Q Consensus       515 ---~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~---~~  588 (614)
                         ....++||||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence               56789999999999998888543   34899999999999999999999987   99999999999998765   69


Q ss_pred             EEeecCcceeecCC
Q 042853          589 KISDFGMARTFTMN  602 (614)
Q Consensus       589 kI~DFGla~~~~~~  602 (614)
                      ||+|||+|+.+...
T Consensus       189 kl~Dfg~a~~~~~~  202 (504)
T 3q5i_A          189 KIVDFGLSSFFSKD  202 (504)
T ss_dssp             EECCCTTCEECCTT
T ss_pred             EEEECCCCEEcCCC
Confidence            99999999987644

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.85  E-value=5e-21  Score=195.33  Aligned_cols=142  Identities=27%  Similarity=0.403  Sum_probs=123.1

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---------cchhHhHHHHHHHHHhcC-CCCC---------
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---------GQGIVEFKNEAKLIAKLQ-HTNL---------  514 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---------~~~~~~f~~E~~~l~~l~-H~nl---------  514 (614)
                      .++|.+.+.||+|+||.||++... +++.||||.+....         ....+.+.+|+.++.++. |||+         
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            367888999999999999999986 67899999986532         122356889999999996 9999         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                      ....++||||+++++|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            46789999999999999998643   35889999999999999999999987   9999999999999999999999999


Q ss_pred             cceeecCC
Q 042853          595 MARTFTMN  602 (614)
Q Consensus       595 la~~~~~~  602 (614)
                      +++.+...
T Consensus       170 ~~~~~~~~  177 (298)
T 1phk_A          170 FSCQLDPG  177 (298)
T ss_dssp             TCEECCTT
T ss_pred             chhhcCCC
Confidence            99987543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.85  E-value=4.2e-21  Score=201.05  Aligned_cols=139  Identities=26%  Similarity=0.513  Sum_probs=118.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC-----------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG-----------------  515 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~-----------------  515 (614)
                      ++|.+.+.||+|+||.||++... +++.||||++....  ......+.+|+.++..++|+|+.                 
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            56888899999999999999985 78899999986542  23345788999999999999991                 


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      ...++||||+++ +|...+...  ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            247899999985 676666432  235899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeec
Q 042853          596 ARTFT  600 (614)
Q Consensus       596 a~~~~  600 (614)
                      |+.+.
T Consensus       171 a~~~~  175 (351)
T 3mi9_A          171 ARAFS  175 (351)
T ss_dssp             CEECC
T ss_pred             ccccc
Confidence            99875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.85  E-value=2.7e-21  Score=196.07  Aligned_cols=140  Identities=29%  Similarity=0.437  Sum_probs=121.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+....   ......+.+|+.++.+++|+|+         ....++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46778899999999999999986 56789999985431   2234678999999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...   ..+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999988643   34789999999999999999999886   99999999999999999999999999987653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.85  E-value=2.6e-21  Score=201.42  Aligned_cols=139  Identities=27%  Similarity=0.401  Sum_probs=120.4

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHh--cCCCCC---------C----Ce
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNL---------G----GE  517 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~nl---------~----~~  517 (614)
                      ...++|.+.+.||+|+||.||++.. +++.||||.+..   ....++..|++++..  ++|||+         .    ..
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            3446788899999999999999998 478999999964   334678889999888  799999         1    26


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCCEEEcCCCcEE
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH--------KYSRLRVIHRDLKVSNILLDEQMNPK  589 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlkp~NILld~~~~~k  589 (614)
                      .++||||+++|+|..++...    .+++.++..++.|+++||.|||        +.+   |+||||||+|||++.++.+|
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred             eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence            89999999999999998542    4789999999999999999999        554   99999999999999999999


Q ss_pred             EeecCcceeecCC
Q 042853          590 ISDFGMARTFTMN  602 (614)
Q Consensus       590 I~DFGla~~~~~~  602 (614)
                      |+|||+|+.+...
T Consensus       188 L~Dfg~~~~~~~~  200 (342)
T 1b6c_B          188 IADLGLAVRHDSA  200 (342)
T ss_dssp             ECCCTTCEEEETT
T ss_pred             EEECCCceecccc
Confidence            9999999887644

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.85  E-value=2.5e-21  Score=199.21  Aligned_cols=137  Identities=29%  Similarity=0.469  Sum_probs=115.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCC-------------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG-------------------  515 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~-------------------  515 (614)
                      ++|.+.+.||+|+||.||++... +++.||||++.....+..+++.+|+.++++++|||+.                   
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            57888999999999999999987 4789999999766666677899999999999999991                   


Q ss_pred             ----CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEE
Q 042853          516 ----GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKI  590 (614)
Q Consensus       516 ----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-~~~~~kI  590 (614)
                          ...++||||++ |+|..++.    ...+++.....++.|+++||.|||+.+   |+||||||+|||++ +++.+||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence                35689999998 69998884    235889999999999999999999987   99999999999997 5678999


Q ss_pred             eecCcceeec
Q 042853          591 SDFGMARTFT  600 (614)
Q Consensus       591 ~DFGla~~~~  600 (614)
                      +|||+++.+.
T Consensus       163 ~Dfg~~~~~~  172 (320)
T 2i6l_A          163 GDFGLARIMD  172 (320)
T ss_dssp             CCCTTCBCC-
T ss_pred             ccCccccccC
Confidence            9999999764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.85  E-value=3e-21  Score=211.88  Aligned_cols=141  Identities=29%  Similarity=0.423  Sum_probs=117.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      +.|...+.||+|+||+||++... ++..+|||.+.+..  ......+.+|+.+++.++||||         ....++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46888899999999999999986 67889999987542  3345678999999999999999         467899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~---~~~kI~DFGla~~~~  600 (614)
                      |+++|+|..++...   ..+++.....++.||++||.|||+.+   |+||||||+|||++..   +.+||+|||+|+.+.
T Consensus       117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            99999998887543   34889999999999999999999987   9999999999999764   459999999999876


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       191 ~~  192 (494)
T 3lij_A          191 NQ  192 (494)
T ss_dssp             TT
T ss_pred             CC
Confidence            43

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.85  E-value=2.3e-21  Score=207.07  Aligned_cols=137  Identities=26%  Similarity=0.338  Sum_probs=113.4

Q ss_pred             CCCCcc-ceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHH-hcCCCCC-------------CCeeE
Q 042853          456 DNFSPA-NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIA-KLQHTNL-------------GGERL  519 (614)
Q Consensus       456 ~~f~~~-~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~-~l~H~nl-------------~~~~~  519 (614)
                      ++|.+. +.||+|+||+||++... +++.||||.+..     ...+.+|+.++. ..+|+|+             ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            345554 68999999999999986 678899999863     245678888874 4589998             12468


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEeecCcc
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE---QMNPKISDFGMA  596 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~---~~~~kI~DFGla  596 (614)
                      +||||+++|+|..++.... ...+++.++..++.||+.||.|||+.+   ||||||||+|||++.   ++.+||+|||+|
T Consensus       136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            9999999999999986532 235899999999999999999999987   999999999999997   788999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +....
T Consensus       212 ~~~~~  216 (400)
T 1nxk_A          212 KETTS  216 (400)
T ss_dssp             EECC-
T ss_pred             cccCC
Confidence            97653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.85  E-value=2e-21  Score=201.93  Aligned_cols=140  Identities=29%  Similarity=0.439  Sum_probs=118.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|...+.||+|+||.||++... +++.||||++.....  ...+.+.+|+.++.+++|+|+         ....++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            46778899999999999999986 578999999865432  234568899999999999999         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+++++|..++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999887643   235899999999999999999999987   99999999999999999999999999987653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.85  E-value=1.2e-21  Score=197.94  Aligned_cols=146  Identities=27%  Similarity=0.426  Sum_probs=121.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC-----------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL-----------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv  521 (614)
                      ++|.+.+.||+|+||.||++... +++.+|+|.+....  ....+.|.+|+.++++++|||+           ....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            56788899999999999999986 67899999996532  3345678999999999999999           2467899


Q ss_pred             EEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          522 YEYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYS--RLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      |||+++++|..++.... ....+++..+..++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            99999999999986532 2345899999999999999999999875  23499999999999999999999999999987


Q ss_pred             ecC
Q 042853          599 FTM  601 (614)
Q Consensus       599 ~~~  601 (614)
                      +..
T Consensus       166 ~~~  168 (279)
T 2w5a_A          166 LNH  168 (279)
T ss_dssp             C--
T ss_pred             ecc
Confidence            653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.85  E-value=1.4e-21  Score=199.26  Aligned_cols=139  Identities=32%  Similarity=0.501  Sum_probs=121.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCC-------------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG-------------------  515 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~-------------------  515 (614)
                      ++|++.+.||+|+||.||++... +++.||||.+.. .....+++.+|+.++.+++|||+.                   
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            46788899999999999999975 788999999964 234456789999999999999982                   


Q ss_pred             ---CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEee
Q 042853          516 ---GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISD  592 (614)
Q Consensus       516 ---~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~D  592 (614)
                         ...++||||+++++|..++...  ...+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence               3468999999999999999653  234678889999999999999999987   99999999999999999999999


Q ss_pred             cCcceeec
Q 042853          593 FGMARTFT  600 (614)
Q Consensus       593 FGla~~~~  600 (614)
                      ||+++.+.
T Consensus       160 fg~~~~~~  167 (303)
T 1zy4_A          160 FGLAKNVH  167 (303)
T ss_dssp             CCCCSCTT
T ss_pred             Ccchhhcc
Confidence            99998764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.85  E-value=9.4e-22  Score=204.28  Aligned_cols=139  Identities=30%  Similarity=0.475  Sum_probs=115.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc--chhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .++|.+.+.||+|+||.||++... +++.||||.+.....  .....+.+|+.++++++|+|+         ....++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            357888999999999999999875 678999999965432  234568899999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-----CCCcEEEeecCcce
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-----EQMNPKISDFGMAR  597 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-----~~~~~kI~DFGla~  597 (614)
                      ||++ |+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++     ..+.+||+|||+|+
T Consensus       113 e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             ECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             ecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            9998 5998888543   34889999999999999999999987   99999999999994     55569999999998


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      .+.
T Consensus       186 ~~~  188 (329)
T 3gbz_A          186 AFG  188 (329)
T ss_dssp             HHC
T ss_pred             ccC
Confidence            764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.85  E-value=6.4e-21  Score=194.19  Aligned_cols=140  Identities=24%  Similarity=0.378  Sum_probs=121.0

Q ss_pred             cCCCCccceeccCCceeEEEEEe-CCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~E  523 (614)
                      .++|.+.+.||+|+||.||+|.. .+++.||||.+....  ...++.+|+.++..++|+++          ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            36788899999999999999997 478899999986532  23568999999999999886          456789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---d~~~~~kI~DFGla~~~~  600 (614)
                      |+ +++|..++...  ...+++.++..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+|+.+.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999998643  235899999999999999999999987   9999999999999   488899999999999876


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       160 ~~  161 (296)
T 3uzp_A          160 DA  161 (296)
T ss_dssp             CT
T ss_pred             cc
Confidence            54

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.85  E-value=2.4e-21  Score=195.43  Aligned_cols=140  Identities=28%  Similarity=0.462  Sum_probs=123.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+....   .+..+.+.+|+.+++.++|+|+         ....++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888899999999999999986 68899999986432   2334578999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999998643   34789999999999999999999987   99999999999999999999999999987654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.85  E-value=1.7e-21  Score=203.57  Aligned_cols=142  Identities=27%  Similarity=0.431  Sum_probs=122.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcc---h--------------hHhHHHHHHHHHhcCCCCC---
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQ---G--------------IVEFKNEAKLIAKLQHTNL---  514 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~---~--------------~~~f~~E~~~l~~l~H~nl---  514 (614)
                      .++|.+.+.||+|+||.||++.. +++.||||.+......   .              ...|.+|+.++.+++|||+   
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788899999999999999999 8899999998643111   1              1789999999999999999   


Q ss_pred             ------CCeeEEEEEecCCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEE
Q 042853          515 ------GGERLLVYEYLPNKSLDFF------IFDSSRKSLLDWKKRFSIIEGITQGLLYLHK-YSRLRVIHRDLKVSNIL  581 (614)
Q Consensus       515 ------~~~~~lv~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NIL  581 (614)
                            ....++||||+++++|..+      +.. .....+++..+..++.||+.||.|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence                  4678999999999999988      432 114568999999999999999999998 76   999999999999


Q ss_pred             EcCCCcEEEeecCcceeecC
Q 042853          582 LDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       582 ld~~~~~kI~DFGla~~~~~  601 (614)
                      ++.++.+||+|||+++.+..
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~  204 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVD  204 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBT
T ss_pred             EcCCCcEEEecccccccccc
Confidence            99999999999999998654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.85  E-value=3.1e-21  Score=198.20  Aligned_cols=143  Identities=24%  Similarity=0.410  Sum_probs=116.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+...   ......++.+|+.++.+++|+|+         ....++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            46888899999999999999974 7889999998753   23345678999999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..++.... ....+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999999886422 2345889999999999999999999987   99999999999999999999999999987653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.85  E-value=5.5e-21  Score=208.58  Aligned_cols=140  Identities=26%  Similarity=0.407  Sum_probs=120.1

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYE  523 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~E  523 (614)
                      .++|.+.++||+|+||.||+|... +++.||||.+....  ...++..|++++..++|.+.          ....+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            367888999999999999999974 68899999876432  23468899999999988654          457789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---d~~~~~kI~DFGla~~~~  600 (614)
                      |+ +++|..++....  ..+++..+..|+.||+.||.|||+.+   ||||||||+||||   +.++.+||+|||+|+.+.
T Consensus        84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 999999986432  35899999999999999999999987   9999999999999   688899999999999876


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       158 ~~  159 (483)
T 3sv0_A          158 DT  159 (483)
T ss_dssp             CT
T ss_pred             CC
Confidence            54

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.85  E-value=2.6e-21  Score=200.56  Aligned_cols=141  Identities=33%  Similarity=0.538  Sum_probs=118.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccE--EEEEEccCC-CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQE--IAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~--vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv  521 (614)
                      ++|.+.+.||+|+||.||++... ++..  +|||.+... .....+++.+|++++.++ +|||+         ....++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            46777899999999999999875 4443  599988653 234456789999999999 89999         5678999


Q ss_pred             EEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          522 YEYLPNKSLDFFIFDSS-------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      |||+++++|..++....             ....+++.++..++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999986532             2346899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCcceee
Q 042853          589 KISDFGMARTF  599 (614)
Q Consensus       589 kI~DFGla~~~  599 (614)
                      ||+|||+++..
T Consensus       182 kL~Dfg~~~~~  192 (327)
T 1fvr_A          182 KIADFGLSRGQ  192 (327)
T ss_dssp             EECCTTCEESS
T ss_pred             EEcccCcCccc
Confidence            99999999854

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.85  E-value=3.8e-21  Score=195.62  Aligned_cols=141  Identities=30%  Similarity=0.403  Sum_probs=119.3

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC-------------CCeeEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL-------------GGERLL  520 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl-------------~~~~~l  520 (614)
                      .|...+.||+|+||.||+|... ++..||+|.+...  .....+.|.+|+.++++++|||+             ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3566788999999999999885 5678999998643  23345678999999999999999             134789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEeecCcceee
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTF  599 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-~~~~~kI~DFGla~~~  599 (614)
                      ||||+++++|..++...   ..+++.....++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||+|+..
T Consensus       107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999999999998643   35789999999999999999999874 3599999999999998 7889999999999765


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       183 ~~  184 (290)
T 1t4h_A          183 RA  184 (290)
T ss_dssp             CT
T ss_pred             cc
Confidence            43

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.85  E-value=2.7e-21  Score=198.21  Aligned_cols=139  Identities=27%  Similarity=0.406  Sum_probs=119.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|.+.+.||+|+||.||++... +++.||+|.+..........+.+|+.++.+++|||+         ....++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            46778899999999999999986 688999999976544455678999999999999999         46789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEeecCcceeec
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTFT  600 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---d~~~~~kI~DFGla~~~~  600 (614)
                      ++++|..++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        89 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           89 SGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999888543   34789999999999999999999987   9999999999999   788899999999998654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.85  E-value=7.1e-21  Score=195.83  Aligned_cols=141  Identities=29%  Similarity=0.457  Sum_probs=118.8

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ..++|.+.+.||+|+||.||+|... +++.||||.+...  ....++.+|+.++.+++|+|+         ....++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4467888999999999999999986 5889999999753  235678999999999999999         467899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |+++++|..++...  ...+++.....++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||+++.+..
T Consensus       105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            99999999988532  345899999999999999999999987   99999999999999999999999999987754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.85  E-value=1.9e-21  Score=209.12  Aligned_cols=138  Identities=28%  Similarity=0.442  Sum_probs=112.7

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCC---------------eeEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG---------------ERLL  520 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~---------------~~~l  520 (614)
                      +|...+.||+|+||.||+|... +++.||||++....    ..+.+|++++++++|+||..               ..++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            5777899999999999999986 58899999986532    23457999999999999921               2568


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEeecCccee
Q 042853          521 VYEYLPNKSLDFFIFD-SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-MNPKISDFGMART  598 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-~~~kI~DFGla~~  598 (614)
                      ||||+++ +|...+.. ......+++.....++.||++||.|||+.+   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            9999986 55555432 123456899999999999999999999886   9999999999999955 5689999999998


Q ss_pred             ecCC
Q 042853          599 FTMN  602 (614)
Q Consensus       599 ~~~~  602 (614)
                      +...
T Consensus       207 ~~~~  210 (420)
T 1j1b_A          207 LVRG  210 (420)
T ss_dssp             CCTT
T ss_pred             cccC
Confidence            7543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.85  E-value=2.2e-21  Score=203.90  Aligned_cols=139  Identities=24%  Similarity=0.328  Sum_probs=122.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++.+++|+|+         ....++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56788899999999999999986 67899999987543 3345678999999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY-SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +++++|..++...   ..+++.....++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       113 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          113 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999998653   2478999999999999999999985 5   9999999999999999999999999997653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.85  E-value=1.2e-21  Score=200.20  Aligned_cols=146  Identities=28%  Similarity=0.430  Sum_probs=109.9

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ...++|.+.+.||+|+||.||++... +++.||||.+.... .....++.+|+.++.+++|||+         ....++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            44578888999999999999999875 67899999986532 3345678999999999999999         4678999


Q ss_pred             EEecCCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          522 YEYLPNKSLDFFIFDS-----SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      |||+++++|..++...     .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999988641     12345899999999999999999999987   999999999999999999999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +.+..
T Consensus       169 ~~~~~  173 (303)
T 2vwi_A          169 AFLAT  173 (303)
T ss_dssp             HHCC-
T ss_pred             heecc
Confidence            87643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.85  E-value=1.6e-21  Score=204.45  Aligned_cols=137  Identities=18%  Similarity=0.268  Sum_probs=118.5

Q ss_pred             CCCCccceeccCCceeEEEEEeCC---------ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD---------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------------  514 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~---------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl------------  514 (614)
                      ++|.+.+.||+|+||.||++....         ++.||||.+...     ..+.+|+.++.+++|+|+            
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578889999999999999999864         788999998653     468899999999999886            


Q ss_pred             -------------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 042853          515 -------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL  581 (614)
Q Consensus       515 -------------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  581 (614)
                                   ....++||||+ +++|..++.... ...+++.++..++.||+.||.|||+.+   |+||||||+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence                         24679999999 999999997542 346899999999999999999999987   999999999999


Q ss_pred             EcCCC--cEEEeecCcceeecCC
Q 042853          582 LDEQM--NPKISDFGMARTFTMN  602 (614)
Q Consensus       582 ld~~~--~~kI~DFGla~~~~~~  602 (614)
                      ++.++  .+||+|||+|+.+...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGG
T ss_pred             EcCCCCceEEEecCcceeeccCC
Confidence            99988  8999999999877543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.85  E-value=4e-21  Score=199.36  Aligned_cols=149  Identities=26%  Similarity=0.370  Sum_probs=123.1

Q ss_pred             hhHHhhcCCCCcc-ceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcC-CCCC---------
Q 042853          449 QTIAVATDNFSPA-NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQ-HTNL---------  514 (614)
Q Consensus       449 ~~~~~~t~~f~~~-~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nl---------  514 (614)
                      +......+.|.+. +.||+|+||.||++... +++.||||.+....  .....++.+|+.++.+++ |||+         
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344444566665 78999999999999986 68899999986532  334567899999999995 6998         


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEe
Q 042853          515 GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE---QMNPKIS  591 (614)
Q Consensus       515 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~---~~~~kI~  591 (614)
                      ....++||||+++|+|..++... ....+++.++..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence            56789999999999999887533 2346899999999999999999999987   999999999999997   7899999


Q ss_pred             ecCcceeecC
Q 042853          592 DFGMARTFTM  601 (614)
Q Consensus       592 DFGla~~~~~  601 (614)
                      |||+|+.+..
T Consensus       177 Dfg~a~~~~~  186 (327)
T 3lm5_A          177 DFGMSRKIGH  186 (327)
T ss_dssp             CGGGCEEC--
T ss_pred             eCccccccCC
Confidence            9999998754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.85  E-value=5e-21  Score=200.34  Aligned_cols=139  Identities=27%  Similarity=0.396  Sum_probs=120.9

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCCC--------------Cee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLG--------------GER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl~--------------~~~  518 (614)
                      .++|.+.+.||+|+||.||++... +++.||||.+.... .....++.+|+.++.+++|+|+.              ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467888999999999999999986 67899999996533 23456788999999999999991              467


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||++ ++|..++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999998 689888854    35899999999999999999999987   99999999999999999999999999998


Q ss_pred             ecC
Q 042853          599 FTM  601 (614)
Q Consensus       599 ~~~  601 (614)
                      +..
T Consensus       162 ~~~  164 (353)
T 2b9h_A          162 IDE  164 (353)
T ss_dssp             CC-
T ss_pred             ccc
Confidence            753

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.85  E-value=3.1e-21  Score=196.03  Aligned_cols=142  Identities=27%  Similarity=0.388  Sum_probs=114.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC--Cc--cEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC--------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ--DE--QEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL--------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~--~~--~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~l  520 (614)
                      ++|.+.+.||+|+||.||+|.+.  ++  ..||||.++..   ..+..++|.+|+.++.+++|+|+        ....++
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM   97 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence            56778899999999999999863  23  36899988653   23456789999999999999999        456789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++++|..++...  ...+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        98 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence            99999999999998653  234789999999999999999999987   9999999999999999999999999999875


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       173 ~~  174 (291)
T 1u46_A          173 QN  174 (291)
T ss_dssp             C-
T ss_pred             cc
Confidence            43

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.85  E-value=3.8e-21  Score=217.83  Aligned_cols=148  Identities=22%  Similarity=0.338  Sum_probs=125.9

Q ss_pred             hHHhhcCCCCccceeccCCceeEEEEEeCC----ccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CC
Q 042853          450 TIAVATDNFSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GG  516 (614)
Q Consensus       450 ~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~  516 (614)
                      +.....++|.+.+.||+|+||.||+|....    +..||||.+.... ....++|.+|+.++++++||||        ..
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  463 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN  463 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            344555778889999999999999998742    4579999987543 3344679999999999999999        45


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++||||+++|+|..++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence            689999999999999998643  235899999999999999999999987   999999999999999999999999999


Q ss_pred             eeecCC
Q 042853          597 RTFTMN  602 (614)
Q Consensus       597 ~~~~~~  602 (614)
                      +.+...
T Consensus       539 ~~~~~~  544 (656)
T 2j0j_A          539 RYMEDS  544 (656)
T ss_dssp             CSCCC-
T ss_pred             eecCCC
Confidence            977543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.85  E-value=3.4e-21  Score=201.45  Aligned_cols=140  Identities=19%  Similarity=0.298  Sum_probs=112.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC----CccEEEEEEccCCCcc-----------hhHhHHHHHHHHHhcCCCCC------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSSGQ-----------GIVEFKNEAKLIAKLQHTNL------  514 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~nl------  514 (614)
                      ++|.+.+.||+|+||.||+|...    .+..+|||.+......           ....+.+|+..+..++|+|+      
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57888999999999999999986    5678999998754321           12346778889999999999      


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-
Q 042853          515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-  586 (614)
Q Consensus       515 -------~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-  586 (614)
                             ....++||||+ +++|..++....   .+++.++..++.||+.||.|||+.+   |+||||||+|||++.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence                   24679999999 999999985432   6899999999999999999999987   99999999999999877 


Q ss_pred             -cEEEeecCcceeecCC
Q 042853          587 -NPKISDFGMARTFTMN  602 (614)
Q Consensus       587 -~~kI~DFGla~~~~~~  602 (614)
                       .+||+|||+|+.+...
T Consensus       190 ~~~kL~Dfg~a~~~~~~  206 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPN  206 (345)
T ss_dssp             TSEEECCCTTCEESSGG
T ss_pred             CcEEEEeCCCceecccc
Confidence             9999999999987543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.84  E-value=4.2e-21  Score=203.77  Aligned_cols=143  Identities=21%  Similarity=0.329  Sum_probs=116.4

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCC--------------
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG--------------  516 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~--------------  516 (614)
                      ....++|.+.+.||+|+||.||++... +++.||||++....    ..+.+|+.+++.++|+|+..              
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999874 78899999986532    23357999999999999911              


Q ss_pred             ---------------------------------eeEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 042853          517 ---------------------------------ERLLVYEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYL  562 (614)
Q Consensus       517 ---------------------------------~~~lv~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yL  562 (614)
                                                       ..++||||++ ++|...+... .....+++.....++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                             1679999998 5887776542 2334689999999999999999999


Q ss_pred             HhCCCCceEecCCCCCCEEEc-CCCcEEEeecCcceeecCC
Q 042853          563 HKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       563 H~~~~~~iiHrDlkp~NILld-~~~~~kI~DFGla~~~~~~  602 (614)
                      |+.+   |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  195 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS  195 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence            9887   99999999999998 6889999999999987544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.84  E-value=3e-21  Score=203.79  Aligned_cols=138  Identities=28%  Similarity=0.397  Sum_probs=106.1

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC---------------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG---------------G  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~---------------~  516 (614)
                      .++|...+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.+++.++|+|+.               .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            368888999999999999999875 67899999996532  23456788999999999999991               4


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++|+||+ +++|..++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            569999999 6888888742    35899999999999999999999987   999999999999999999999999999


Q ss_pred             eeec
Q 042853          597 RTFT  600 (614)
Q Consensus       597 ~~~~  600 (614)
                      +...
T Consensus       180 ~~~~  183 (367)
T 2fst_X          180 RHTA  183 (367)
T ss_dssp             ----
T ss_pred             cccc
Confidence            8764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.84  E-value=1.8e-21  Score=196.87  Aligned_cols=140  Identities=26%  Similarity=0.468  Sum_probs=115.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEEe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYEY  524 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~Ey  524 (614)
                      .++|.+.+.||+|+||.||++... ++.||||.+...  ...+.|.+|+.++.+++|+|+          ....++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            356788899999999999999885 778999999753  345679999999999999998          2367999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +++++|..++.... ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            99999999986432 223788899999999999999999987   99999999999999999999999999986643

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.84  E-value=6.2e-21  Score=194.73  Aligned_cols=140  Identities=30%  Similarity=0.506  Sum_probs=119.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|+..+.||+|+||.||++... +++.||||.+....  ......+.+|+.++++++|+|+         ....++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            57888899999999999999986 68899999986532  2334678899999999999999         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |++ ++|..++.... ...+++.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        83 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  154 (299)
T 2r3i_A           83 FLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG  154 (299)
T ss_dssp             CCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             ccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence            998 69998886543 234788999999999999999999987   9999999999999999999999999998764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.84  E-value=2e-21  Score=200.00  Aligned_cols=150  Identities=25%  Similarity=0.354  Sum_probs=123.4

Q ss_pred             eechhhHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCC--CCC------
Q 042853          445 IFDFQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH--TNL------  514 (614)
Q Consensus       445 ~~~~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H--~nl------  514 (614)
                      .+.++++....++|.+.+.||+|+||.||++...+++.+|||.+...  ..+...++.+|+.++.+++|  +|+      
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            34455566667789999999999999999999988899999998643  23455779999999999974  888      


Q ss_pred             ---CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEe
Q 042853          515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKIS  591 (614)
Q Consensus       515 ---~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~  591 (614)
                         ....++||| +.+++|..++...   ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++ +.+||+
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEEC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEe
Confidence               457789999 6788999998643   35789999999999999999999987   999999999999975 789999


Q ss_pred             ecCcceeecCC
Q 042853          592 DFGMARTFTMN  602 (614)
Q Consensus       592 DFGla~~~~~~  602 (614)
                      |||+++.+...
T Consensus       169 Dfg~~~~~~~~  179 (313)
T 3cek_A          169 DFGIANQMQPD  179 (313)
T ss_dssp             CCSSSCC----
T ss_pred             eccccccccCc
Confidence            99999877543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.84  E-value=3.7e-21  Score=205.06  Aligned_cols=140  Identities=26%  Similarity=0.381  Sum_probs=114.7

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCC---------------eeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG---------------ERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~---------------~~~l  520 (614)
                      .+|...+.||+|+||.||++....+..+|+|++....    ....+|+++++.++|+|+..               ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            4577889999999999999999877779999885432    12347999999999999911               2779


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEeecCcceee
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTF  599 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-~~~~~kI~DFGla~~~  599 (614)
                      ||||++++.+............+++.....++.||++||.|||+.+   |+||||||+|||++ .++.+||+|||+|+.+
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999997655444332223456899999999999999999999987   99999999999999 7899999999999987


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       193 ~~~  195 (394)
T 4e7w_A          193 IAG  195 (394)
T ss_dssp             CTT
T ss_pred             cCC
Confidence            543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.84  E-value=3.3e-21  Score=211.05  Aligned_cols=141  Identities=32%  Similarity=0.454  Sum_probs=122.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|...+.||+|+||.||++... +++.||||.+.+..   ......+.+|+.++++++|||+         ....++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56788899999999999999986 78899999986532   3345679999999999999999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---DEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---d~~~~~kI~DFGla~~~  599 (614)
                      ||+++|+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+|+.+
T Consensus       106 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          106 EVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             CCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            999999999888543   35899999999999999999999987   9999999999999   46788999999999876


Q ss_pred             cCC
Q 042853          600 TMN  602 (614)
Q Consensus       600 ~~~  602 (614)
                      ...
T Consensus       180 ~~~  182 (484)
T 3nyv_A          180 EAS  182 (484)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.84  E-value=3.6e-21  Score=193.21  Aligned_cols=141  Identities=19%  Similarity=0.362  Sum_probs=121.2

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------C--CeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------G--GERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~--~~~~lv~  522 (614)
                      ++|...+.||+|+||.||+|... ++.+|||.+....  ....++|.+|+.++.+++|||+         .  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            46777899999999999999985 7889999997542  3445679999999999999999         2  5679999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||+++|+|..++.... ...+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||++...
T Consensus        89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence            9999999999996532 235899999999999999999999864 45999999999999999999999999987654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.84  E-value=4e-21  Score=210.47  Aligned_cols=140  Identities=31%  Similarity=0.485  Sum_probs=121.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|.+.+.||+|+||+||++... +++.||||.+.+.  .......+.+|+.++++++|||+         ....++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            46888899999999999999986 6889999998543  23345678999999999999999         467899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld---~~~~~kI~DFGla~~~~  600 (614)
                      |+++|+|..++...   ..+++.....++.||+.||.|||+.+   ||||||||+|||++   .++.+||+|||+|+.+.
T Consensus       102 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999998888543   35899999999999999999999987   99999999999995   45679999999998765


Q ss_pred             C
Q 042853          601 M  601 (614)
Q Consensus       601 ~  601 (614)
                      .
T Consensus       176 ~  176 (486)
T 3mwu_A          176 Q  176 (486)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.84  E-value=7.3e-21  Score=201.05  Aligned_cols=138  Identities=29%  Similarity=0.373  Sum_probs=114.4

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------C------C
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------G------G  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~------~  516 (614)
                      .++|.+.+.||+|+||.||++... +++.||||++...  .....+++.+|+.+++.++|||+         .      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367888999999999999999875 6788999999653  22345678999999999999999         1      2


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++||||+++ +|..++.     ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999985 6777763     23789999999999999999999987   999999999999999999999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +....
T Consensus       175 ~~~~~  179 (371)
T 2xrw_A          175 RTAGT  179 (371)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.84  E-value=5.2e-21  Score=194.35  Aligned_cols=140  Identities=16%  Similarity=0.167  Sum_probs=113.1

Q ss_pred             hhhHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCc------------------chhHhHHHHHHHHHhc
Q 042853          448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG------------------QGIVEFKNEAKLIAKL  509 (614)
Q Consensus       448 ~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~------------------~~~~~f~~E~~~l~~l  509 (614)
                      +..+......|.+.+.||+|+||.||+|...+++.||||.++....                  .....|.+|+.++.++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3444455566777899999999999999997789999999864321                  1345689999999999


Q ss_pred             CCCCC-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 042853          510 QHTNL-----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE  584 (614)
Q Consensus       510 ~H~nl-----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~  584 (614)
                      +|+++     ....++||||+++++|.. +.       .  .....++.||++||.|||+.+   ||||||||+|||++ 
T Consensus       162 ~~~~v~~~~~~~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-  227 (282)
T 1zar_A          162 QGLAVPKVYAWEGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-  227 (282)
T ss_dssp             TTSSSCCEEEEETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred             cCCCcCeEEeccceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence            87655     345689999999999987 31       1  123469999999999999987   99999999999999 


Q ss_pred             CCcEEEeecCcceeecC
Q 042853          585 QMNPKISDFGMARTFTM  601 (614)
Q Consensus       585 ~~~~kI~DFGla~~~~~  601 (614)
                      ++.+||+|||+|+....
T Consensus       228 ~~~vkl~DFG~a~~~~~  244 (282)
T 1zar_A          228 EEGIWIIDFPQSVEVGE  244 (282)
T ss_dssp             TTEEEECCCTTCEETTS
T ss_pred             CCcEEEEECCCCeECCC
Confidence            99999999999997653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.84  E-value=1.4e-20  Score=202.73  Aligned_cols=140  Identities=26%  Similarity=0.289  Sum_probs=118.2

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC------CCCC---------CCee
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ------HTNL---------GGER  518 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~------H~nl---------~~~~  518 (614)
                      ..+|.+.+.||+|+||.||+|... +++.||||.+... .....++.+|+.++..++      |+|+         ....
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457888999999999999999876 5789999999753 334567888999988884      5576         5678


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--EEEeecCcc
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN--PKISDFGMA  596 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~--~kI~DFGla  596 (614)
                      ++||||++ ++|..++.... ...+++..+..++.||++||.|||+.+   ||||||||+||||+.++.  +||+|||+|
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 68888886543 234899999999999999999999987   999999999999998887  999999999


Q ss_pred             eeec
Q 042853          597 RTFT  600 (614)
Q Consensus       597 ~~~~  600 (614)
                      +...
T Consensus       250 ~~~~  253 (429)
T 3kvw_A          250 CYEH  253 (429)
T ss_dssp             EETT
T ss_pred             eecC
Confidence            8654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.84  E-value=1.6e-20  Score=192.15  Aligned_cols=138  Identities=26%  Similarity=0.340  Sum_probs=116.4

Q ss_pred             CCCCcc-ceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHH-HhcCCCCC-------------CCeeE
Q 042853          456 DNFSPA-NRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLI-AKLQHTNL-------------GGERL  519 (614)
Q Consensus       456 ~~f~~~-~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l-~~l~H~nl-------------~~~~~  519 (614)
                      ++|.+. +.||+|+||.||++... +++.||||.+..     ...+.+|+.++ ..++|+|+             ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            345555 77999999999999985 678999999854     24577888887 66699999             13468


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEeecCcc
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE---QMNPKISDFGMA  596 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~---~~~~kI~DFGla  596 (614)
                      +||||+++|+|..++.... ...+++.....++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+|
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            9999999999999987643 235899999999999999999999987   999999999999997   788999999999


Q ss_pred             eeecCC
Q 042853          597 RTFTMN  602 (614)
Q Consensus       597 ~~~~~~  602 (614)
                      +.....
T Consensus       168 ~~~~~~  173 (299)
T 3m2w_A          168 KETTGE  173 (299)
T ss_dssp             EECTTC
T ss_pred             cccccc
Confidence            887643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.84  E-value=2.5e-21  Score=196.57  Aligned_cols=144  Identities=26%  Similarity=0.336  Sum_probs=110.7

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-ch-hHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QG-IVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~-~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ..++|++.+.||+|+||.||++... +++.||||++..... .. .+.+..+...++.++|||+         ....++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3467888999999999999999985 788999999975422 22 2334555556888999999         4678999


Q ss_pred             EEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          522 YEYLPNKSLDFFIFDS-SRKSLLDWKKRFSIIEGITQGLLYLHKY-SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |||++ |+|..++... .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99998 5887776542 2334689999999999999999999987 6   999999999999999999999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       161 ~~  162 (290)
T 3fme_A          161 VD  162 (290)
T ss_dssp             --
T ss_pred             cc
Confidence            54

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.84  E-value=1.3e-20  Score=191.87  Aligned_cols=133  Identities=9%  Similarity=0.008  Sum_probs=115.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|.+.+.||+|+||.||+|... +++.||||.+....   .+..++|.+|+.++.+++|+|+         .+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            67888999999999999999986 47899999997543   2334679999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ||+++++|..++..    . ....+..+++.|++.||.|||+.+   |+||||||+|||++.++.+||+++|..
T Consensus       111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence            99999999999832    2 345567889999999999999987   999999999999999999999987754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.84  E-value=6.5e-21  Score=203.83  Aligned_cols=135  Identities=32%  Similarity=0.492  Sum_probs=104.0

Q ss_pred             cceeccCCceeEEEEEeC---CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEEEecC
Q 042853          461 ANRLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~Ey~~  526 (614)
                      .++||+|+||.||+|...   +++.||||.+....  ....+.+|+.++++++||||           ....++||||++
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            457999999999999975   46789999997532  23568899999999999999           346789999997


Q ss_pred             CCCHHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEeecCcc
Q 042853          527 NKSLDFFIFDS------SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL----DEQMNPKISDFGMA  596 (614)
Q Consensus       527 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----d~~~~~kI~DFGla  596 (614)
                      + +|..++...      .....+++..+..++.||+.||.|||+.+   ||||||||+||||    +.++.+||+|||+|
T Consensus       104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence            5 777666421      11224899999999999999999999987   9999999999999    67789999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +.+..
T Consensus       180 ~~~~~  184 (405)
T 3rgf_A          180 RLFNS  184 (405)
T ss_dssp             C----
T ss_pred             eecCC
Confidence            97753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.84  E-value=1.9e-21  Score=216.48  Aligned_cols=131  Identities=19%  Similarity=0.226  Sum_probs=99.5

Q ss_pred             eeccCCceeEEEEEe-CCccEEEEEEccCCC----------cchhHhHHHHHHHHHhc-CCCCC---------CCeeEEE
Q 042853          463 RLGQGGFGPVYKGKL-QDEQEIAIKRLSKSS----------GQGIVEFKNEAKLIAKL-QHTNL---------GGERLLV  521 (614)
Q Consensus       463 ~lG~G~fg~Vy~g~~-~~~~~vavK~l~~~~----------~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv  521 (614)
                      ..+.|++|.+..+.. -.++.+|||.+.+..          ....++|.+|+++|+++ .|+|+         ..+.+||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            455666666554432 247789999986541          12345799999999999 69998         5689999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++++|.++|...   ..++..   +|+.||+.||.|||+++   ||||||||+||||++++.+||+|||+|+.+..
T Consensus       321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999643   346654   48899999999999998   99999999999999999999999999998764


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      +
T Consensus       392 ~  392 (569)
T 4azs_A          392 D  392 (569)
T ss_dssp             -
T ss_pred             C
Confidence            4

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.84  E-value=9.3e-21  Score=198.81  Aligned_cols=147  Identities=26%  Similarity=0.297  Sum_probs=109.2

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCC-------------
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG-------------  516 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~-------------  516 (614)
                      .....++|.+.+.||+|+||.||++... +++.||||++... ......+.+|+..+..++|+|+..             
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            4455688999999999999999999985 6789999998653 233446778888999999999921             


Q ss_pred             ---eeEEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecCCCCCCEEEcC-CCcEE
Q 042853          517 ---ERLLVYEYLPNKSLDFFIFD-SSRKSLLDWKKRFSIIEGITQGLLYLH--KYSRLRVIHRDLKVSNILLDE-QMNPK  589 (614)
Q Consensus       517 ---~~~lv~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiHrDlkp~NILld~-~~~~k  589 (614)
                         ..++||||++++ |...+.. ......+++.....++.|++.||.|||  +.+   |+||||||+|||++. ++.+|
T Consensus        97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred             cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence               178999999874 4433332 234456888999999999999999999  665   999999999999996 89999


Q ss_pred             EeecCcceeecCC
Q 042853          590 ISDFGMARTFTMN  602 (614)
Q Consensus       590 I~DFGla~~~~~~  602 (614)
                      |+|||+|+.+...
T Consensus       173 l~Dfg~a~~~~~~  185 (360)
T 3e3p_A          173 LCDFGSAKKLSPS  185 (360)
T ss_dssp             ECCCTTCBCCCTT
T ss_pred             EeeCCCceecCCC
Confidence            9999999987543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.83  E-value=6e-21  Score=217.71  Aligned_cols=137  Identities=23%  Similarity=0.354  Sum_probs=116.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC--CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCe-----e
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ--DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGE-----R  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~--~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~-----~  518 (614)
                      ++|.+.+.||+|+||.||++...  +++.||||.+.... .+....|.+|+.++.+++||||         ...     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67888999999999999999985  57899999986543 3445678999999999999999         112     6


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      +|||||+++++|..++..     .+++.++..++.||+.||.|||+.+   ||||||||+|||++.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999877632     5899999999999999999999987   9999999999999986 899999999998


Q ss_pred             ecC
Q 042853          599 FTM  601 (614)
Q Consensus       599 ~~~  601 (614)
                      +..
T Consensus       231 ~~~  233 (681)
T 2pzi_A          231 INS  233 (681)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            754

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.83  E-value=2.4e-20  Score=159.48  Aligned_cols=104  Identities=18%  Similarity=0.388  Sum_probs=88.5

Q ss_pred             ccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEEE
Q 042853           11 DKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWI   90 (614)
Q Consensus        11 ~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW~   90 (614)
                      |+|.+||.|.+|++|.|  |.|.|.|...++     |.++..                        +        ++||+
T Consensus         2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~------------------------~--------~~vW~   42 (105)
T 4h3o_A            2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH------------------------S--------TSTWA   42 (105)
T ss_dssp             CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET------------------------T--------EEEEE
T ss_pred             CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC------------------------C--------EEEEE
Confidence            68999999999999988  889999976554     566543                        2        67999


Q ss_pred             cCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceecee
Q 042853           91 ANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS  165 (614)
Q Consensus        91 ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQS  165 (614)
                      |||+.|...  .+.|+|.. ||+|||.|+++++||+|++.......+|+|+|+|||||++         +.+|||
T Consensus        43 ant~~~~~~--~~~L~l~~-dGnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~---------~~~W~S  105 (105)
T 4h3o_A           43 SNTEIGGKS--GCSAVLQS-DGNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYG---------SDIWST  105 (105)
T ss_dssp             CCCCCTTCC--SCEEEECT-TSCEEEECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEE---------SEEEEC
T ss_pred             ecCCCCCCc--cEEEEEeC-CccEEEECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEEC---------CcEecC
Confidence            999999874  47899998 9999999999999999998754445689999999999996         469998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.83  E-value=1.6e-20  Score=198.46  Aligned_cols=138  Identities=27%  Similarity=0.418  Sum_probs=115.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CC------
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GG------  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~------  516 (614)
                      .++|...+.||+|+||.||+|... +++.||||++....  ....+++.+|+.+++.++|+|+         ..      
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467888999999999999999876 67899999997542  2335678999999999999999         11      


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ..++||||++ ++|..++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence            2399999998 68877762     23899999999999999999999987   999999999999999999999999999


Q ss_pred             eeecC
Q 042853          597 RTFTM  601 (614)
Q Consensus       597 ~~~~~  601 (614)
                      +....
T Consensus       192 ~~~~~  196 (371)
T 4exu_A          192 RHADA  196 (371)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.83  E-value=1.3e-20  Score=193.87  Aligned_cols=144  Identities=27%  Similarity=0.390  Sum_probs=117.7

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc------chhHhHHHHHHHHHhc----CCCCC-------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG------QGIVEFKNEAKLIAKL----QHTNL-------  514 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l----~H~nl-------  514 (614)
                      ...++|.+.+.||+|+||.||++... +++.||||.+.....      .....+.+|+.++.++    +|+|+       
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34578999999999999999999875 678999999965422      2334577899999999    89999       


Q ss_pred             --CCeeEEEEEe-cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEE
Q 042853          515 --GGERLLVYEY-LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKI  590 (614)
Q Consensus       515 --~~~~~lv~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-~~~~~kI  590 (614)
                        ....++|||| +++++|..++...   ..+++..+..++.||++||.|||+.+   |+||||||+|||++ .++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence              4567899999 7899999998653   34899999999999999999999987   99999999999999 8889999


Q ss_pred             eecCcceeecCC
Q 042853          591 SDFGMARTFTMN  602 (614)
Q Consensus       591 ~DFGla~~~~~~  602 (614)
                      +|||+++.+...
T Consensus       182 ~dfg~~~~~~~~  193 (312)
T 2iwi_A          182 IDFGSGALLHDE  193 (312)
T ss_dssp             CCCSSCEECCSS
T ss_pred             EEcchhhhcccC
Confidence            999999987643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.83  E-value=3.3e-20  Score=192.28  Aligned_cols=140  Identities=24%  Similarity=0.317  Sum_probs=119.2

Q ss_pred             CCCCccceeccCCceeEEEEEe-C-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCC------C---------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKL-Q-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN------L---------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~-~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n------l---------~~~~  518 (614)
                      ++|.+.+.||+|+||.||++.. . +++.||||.++.. ....+.+.+|+.++..++|++      +         ....
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            5788899999999999999987 3 6788999999653 344567899999999998876      3         4578


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--------------
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE--------------  584 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~--------------  584 (614)
                      ++||||+ +++|..++.... ...+++.....++.||++||.|||+.+   |+||||||+|||++.              
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence            9999999 889998886543 235789999999999999999999987   999999999999987              


Q ss_pred             -----CCcEEEeecCcceeecC
Q 042853          585 -----QMNPKISDFGMARTFTM  601 (614)
Q Consensus       585 -----~~~~kI~DFGla~~~~~  601 (614)
                           ++.+||+|||+|+....
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~  189 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE  189 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS
T ss_pred             cccccCCCceEeeCcccccCcc
Confidence                 66799999999987543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.83  E-value=2.2e-20  Score=193.06  Aligned_cols=144  Identities=25%  Similarity=0.420  Sum_probs=119.5

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC--CccEEEEEEccCCC--cchhHhHHHHHHHHHhc---CCCCCC----------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ--DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL---QHTNLG----------  515 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~--~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nl~----------  515 (614)
                      .+.++|.+.+.||+|+||.||++...  +++.||||.+....  ......+.+|+.+++.+   +|||+.          
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34467888999999999999999983  67889999986432  22234677888887776   899991          


Q ss_pred             ----CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEe
Q 042853          516 ----GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKIS  591 (614)
Q Consensus       516 ----~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~  591 (614)
                          ...++||||++ |+|..++.... ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence                34689999998 69999886543 234789999999999999999999987   9999999999999999999999


Q ss_pred             ecCcceeecC
Q 042853          592 DFGMARTFTM  601 (614)
Q Consensus       592 DFGla~~~~~  601 (614)
                      |||+++.+..
T Consensus       163 Dfg~~~~~~~  172 (326)
T 1blx_A          163 DFGLARIYSF  172 (326)
T ss_dssp             SCCSCCCCCG
T ss_pred             cCcccccccC
Confidence            9999987653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.83  E-value=2e-20  Score=196.15  Aligned_cols=136  Identities=27%  Similarity=0.415  Sum_probs=115.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------C------Ce
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------G------GE  517 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~------~~  517 (614)
                      ++|...+.||+|+||.||+|... +++.||||.+....  ....+++.+|+.+++.++|||+         .      ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888899999999999999975 68899999996532  2335678999999999999999         1      13


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++||||++ ++|..++.     ..+++.+...++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence            499999998 68877652     24899999999999999999999987   9999999999999999999999999998


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      ...
T Consensus       175 ~~~  177 (353)
T 3coi_A          175 HAD  177 (353)
T ss_dssp             C--
T ss_pred             CCC
Confidence            754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.83  E-value=2.3e-20  Score=198.23  Aligned_cols=126  Identities=26%  Similarity=0.343  Sum_probs=103.3

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC--------CCCC-----------
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ--------HTNL-----------  514 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~--------H~nl-----------  514 (614)
                      .++|.+.+.||+|+||+||++... +++.||||.+... ....+.+.+|+.++..++        |+|+           
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            367999999999999999999875 6788999999753 344567899999999996        5666           


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCC
Q 042853          515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY-SRLRVIHRDLKVSNILLDEQM  586 (614)
Q Consensus       515 --~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILld~~~  586 (614)
                        ....++||||+ +++|..++.... ...+++.....++.||++||.|||++ +   ||||||||+|||++.++
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence              13678999999 556655554432 24589999999999999999999997 5   99999999999999775

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.82  E-value=2.7e-20  Score=189.15  Aligned_cols=140  Identities=31%  Similarity=0.484  Sum_probs=121.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+...  .......+.+|+.++++++|||+         ....++|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            57888999999999999999986 6789999998643  23345678999999999999999         467899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEeecCcceeec
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ---MNPKISDFGMARTFT  600 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~---~~~kI~DFGla~~~~  600 (614)
                      |+++++|..++...   ..+++.+...++.||+.||.|||+.+   |+||||||+|||++.+   ..+||+|||+++.+.
T Consensus       102 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999998887543   34889999999999999999999987   9999999999999754   469999999998765


Q ss_pred             C
Q 042853          601 M  601 (614)
Q Consensus       601 ~  601 (614)
                      .
T Consensus       176 ~  176 (287)
T 2wei_A          176 Q  176 (287)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.82  E-value=2.4e-20  Score=192.89  Aligned_cols=145  Identities=26%  Similarity=0.346  Sum_probs=122.1

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc------chhHhHHHHHHHHHhcCC--CCC--------
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQH--TNL--------  514 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H--~nl--------  514 (614)
                      ....++|.+.+.||+|+||.||+|... +++.||||.+.....      .....+.+|+.++.+++|  +|+        
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            344578889999999999999999875 678999999865421      123567889999999974  888        


Q ss_pred             -CCeeEEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEe
Q 042853          515 -GGERLLVYEYLPN-KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKIS  591 (614)
Q Consensus       515 -~~~~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-~~~~~kI~  591 (614)
                       ....++||||+.. ++|..++...   ..+++.....++.||++||.|||+.+   |+||||||+|||++ +++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence             4678999999986 8999988643   35789999999999999999999987   99999999999999 78899999


Q ss_pred             ecCcceeecCC
Q 042853          592 DFGMARTFTMN  602 (614)
Q Consensus       592 DFGla~~~~~~  602 (614)
                      |||+++.+...
T Consensus       193 Dfg~~~~~~~~  203 (320)
T 3a99_A          193 DFGSGALLKDT  203 (320)
T ss_dssp             CCTTCEECCSS
T ss_pred             eCccccccccc
Confidence            99999987543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.82  E-value=5.1e-21  Score=197.24  Aligned_cols=144  Identities=26%  Similarity=0.449  Sum_probs=119.3

Q ss_pred             hhHHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC---------CCe
Q 042853          449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---------GGE  517 (614)
Q Consensus       449 ~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl---------~~~  517 (614)
                      +++.+..++|.+.+.||+|+||.||+|....  .+|+|.+...  .....+.|.+|+.++.+++|+|+         ...
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            4445556788889999999999999999854  4999998643  23345678899999999999999         457


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++||||+++++|..++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||+|+
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             eEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            89999999999999998542  335888999999999999999999987   99999999999998 5799999999988


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      ...
T Consensus       178 ~~~  180 (319)
T 2y4i_B          178 ISG  180 (319)
T ss_dssp             ---
T ss_pred             ccc
Confidence            653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.82  E-value=5.6e-20  Score=192.00  Aligned_cols=141  Identities=21%  Similarity=0.321  Sum_probs=116.6

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-Cc-cEEEEEEccCCCcchhHhHHHHHHHHHhcCCCC------C---------CCe
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DE-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN------L---------GGE  517 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~-~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n------l---------~~~  517 (614)
                      .++|.+.+.||+|+||.||++... ++ +.||||.++.. ....+.+.+|+.++.+++|++      +         ...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            367888999999999999999875 33 68999999653 344567889999999998776      3         467


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---------------
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILL---------------  582 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---------------  582 (614)
                      .++||||+ +++|..++.... ...+++.++..++.||+.||.|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            89999999 566666665432 235899999999999999999999886   9999999999999               


Q ss_pred             ----cCCCcEEEeecCcceeecC
Q 042853          583 ----DEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       583 ----d~~~~~kI~DFGla~~~~~  601 (614)
                          +.++.+||+|||+|+....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~  194 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE  194 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS
T ss_pred             cccccCCCcEEEeecCccccccc
Confidence                5678999999999987543

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.82  E-value=5.4e-20  Score=160.98  Aligned_cols=108  Identities=20%  Similarity=0.334  Sum_probs=91.4

Q ss_pred             cccccccCCCccCCCCeEE--eCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCC
Q 042853            8 CQTDKLQQGQVLKDGEELV--SAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKP   85 (614)
Q Consensus         8 ~~~~~i~~g~~l~~~~~l~--S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (614)
                      ++.|+|.+|++|.+|++|+  |++|.|+|+|+++++   .   +||+                              . .
T Consensus         6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn---l---vly~------------------------------~-~   48 (119)
T 1b2p_A            6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN---L---VLYD------------------------------N-N   48 (119)
T ss_dssp             CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC---E---EEEE------------------------------T-T
T ss_pred             ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC---E---EEEE------------------------------C-C
Confidence            5689999999999999999  999999999998775   2   5786                              1 2


Q ss_pred             CcEEEcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceecee
Q 042853           86 RPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS  165 (614)
Q Consensus        86 t~VW~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQS  165 (614)
                      ++||+||++.|-  . ++.|+|.+ +|||||.|.++.++|+|++........++|+|+|||||++         .++|||
T Consensus        49 ~~vW~sn~~~~~--~-~~~l~l~~-dGNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~S  115 (119)
T 1b2p_A           49 NPIWATNTGGLG--N-GCRAVLQP-DGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---------DALWAT  115 (119)
T ss_dssp             EEEEECCCTTSC--S-SCEEEECT-TSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---------SEEEEC
T ss_pred             EEEEeCCCccCC--C-ceEEEEcc-CCEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---------ccEeCC
Confidence            679999998773  2 57899998 9999999999999999987643334679999999999986         378998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.82  E-value=5e-20  Score=195.39  Aligned_cols=146  Identities=25%  Similarity=0.337  Sum_probs=119.4

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCC-----C---------C
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTN-----L---------G  515 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~n-----l---------~  515 (614)
                      ....++|.+.+.||+|+||+||+|... +++.||||.++.. .....++..|+.++..++ |+|     +         .
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            344578999999999999999999876 6788999999753 334567888999999886 554     3         4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCcEEEeec
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD--EQMNPKISDF  593 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld--~~~~~kI~DF  593 (614)
                      ...++||||++ ++|..++.... ...+++..+..++.|++.||.|||.+ ..+||||||||+|||++  .++.+||+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            67899999996 59998886543 23489999999999999999999953 23599999999999994  5778999999


Q ss_pred             CcceeecC
Q 042853          594 GMARTFTM  601 (614)
Q Consensus       594 Gla~~~~~  601 (614)
                      |+|+.+..
T Consensus       206 G~a~~~~~  213 (382)
T 2vx3_A          206 GSSCQLGQ  213 (382)
T ss_dssp             TTCEETTC
T ss_pred             cCceeccc
Confidence            99998753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.81  E-value=1.9e-20  Score=209.62  Aligned_cols=144  Identities=30%  Similarity=0.423  Sum_probs=121.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------------CCee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------------GGER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------------~~~~  518 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+... .....+.|.+|+.++.+++|||+               ....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            57888999999999999999875 6789999998754 33445679999999999999998               2356


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEeecCc
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMN---PKISDFGM  595 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~---~kI~DFGl  595 (614)
                      ++||||+++|+|..++........+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            899999999999999976554446888899999999999999999987   999999999999996654   99999999


Q ss_pred             ceeecCC
Q 042853          596 ARTFTMN  602 (614)
Q Consensus       596 a~~~~~~  602 (614)
                      |+.+...
T Consensus       171 a~~~~~~  177 (676)
T 3qa8_A          171 AKELDQG  177 (676)
T ss_dssp             CCBTTSC
T ss_pred             ccccccc
Confidence            9977543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.81  E-value=3.9e-20  Score=199.66  Aligned_cols=138  Identities=25%  Similarity=0.310  Sum_probs=108.4

Q ss_pred             CCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEEEecCC
Q 042853          458 FSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVYEYLPN  527 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~Ey~~~  527 (614)
                      |...+.||+|+||+||.+...+++.||||++...   ..+.+.+|+.++.++ +||||         ....++||||++ 
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            3446789999999998766667899999998642   345678999999886 89999         467899999996 


Q ss_pred             CCHHHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-------------CcEEE
Q 042853          528 KSLDFFIFDSSRKS----LLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQ-------------MNPKI  590 (614)
Q Consensus       528 gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~-------------~~~kI  590 (614)
                      |+|..++.......    ...+.....++.||+.||.|||+.+   ||||||||+|||++.+             +.+||
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            69999986533211    1123345679999999999999987   9999999999999754             48999


Q ss_pred             eecCcceeecCC
Q 042853          591 SDFGMARTFTMN  602 (614)
Q Consensus       591 ~DFGla~~~~~~  602 (614)
                      +|||+|+.+...
T Consensus       170 ~DFG~a~~~~~~  181 (434)
T 2rio_A          170 SDFGLCKKLDSG  181 (434)
T ss_dssp             CCCTTCEECCC-
T ss_pred             cccccceecCCC
Confidence            999999987654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.81  E-value=6.1e-20  Score=190.10  Aligned_cols=143  Identities=24%  Similarity=0.346  Sum_probs=115.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHH-HHHhcCCCCC---------CCeeEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAK-LIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~-~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .++|...+.||+|+||.||++... +++.||||.+.... .....++..|+. +++.++|||+         ....++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367888899999999999999986 68899999997543 233445666666 7778899999         46788999


Q ss_pred             EecCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          523 EYLPNKSLDFFIFD--SSRKSLLDWKKRFSIIEGITQGLLYLHKY-SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       523 Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||+++ +|..++..  ......+++.....++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++.+
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 77776642  11245689999999999999999999997 6   999999999999999999999999999876


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       177 ~~  178 (327)
T 3aln_A          177 VD  178 (327)
T ss_dssp             --
T ss_pred             cc
Confidence            53

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.81  E-value=1.1e-19  Score=189.30  Aligned_cols=138  Identities=22%  Similarity=0.287  Sum_probs=110.0

Q ss_pred             CCCCccc-eeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-------------CCeeEE
Q 042853          456 DNFSPAN-RLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~-~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-------------~~~~~l  520 (614)
                      ++|.+.+ .||+|+||.||++... +++.||||.+... ..   ........+..++|+|+             ....++
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  103 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI  103 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence            5677644 6999999999999987 6889999998652 11   12223334667799998             123689


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEeecCcce
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE---QMNPKISDFGMAR  597 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~---~~~~kI~DFGla~  597 (614)
                      ||||+++|+|..++.... ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+|+
T Consensus       104 v~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            999999999999986543 245899999999999999999999987   999999999999986   4559999999998


Q ss_pred             eecC
Q 042853          598 TFTM  601 (614)
Q Consensus       598 ~~~~  601 (614)
                      ....
T Consensus       180 ~~~~  183 (336)
T 3fhr_A          180 ETTQ  183 (336)
T ss_dssp             EC--
T ss_pred             eccc
Confidence            7653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.81  E-value=2e-20  Score=201.69  Aligned_cols=141  Identities=25%  Similarity=0.430  Sum_probs=110.9

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLVY  522 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv~  522 (614)
                      ....+|...+.||+|+||+|+.....+++.||||++....   ...+.+|+.++.++ +||||         ....++||
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            3445678889999999999665555578899999996532   34567899999999 79999         45779999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-----CCCcEEEeecCcce
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-----EQMNPKISDFGMAR  597 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-----~~~~~kI~DFGla~  597 (614)
                      ||++ |+|..++.....  .+.+.....++.||++||.|||+.+   ||||||||+|||++     ....+||+|||+|+
T Consensus        98 E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             ECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             ECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            9997 699998864332  2344456789999999999999987   99999999999994     33468899999999


Q ss_pred             eecCC
Q 042853          598 TFTMN  602 (614)
Q Consensus       598 ~~~~~  602 (614)
                      .+...
T Consensus       172 ~~~~~  176 (432)
T 3p23_A          172 KLAVG  176 (432)
T ss_dssp             CC---
T ss_pred             eccCC
Confidence            87543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.80  E-value=1e-19  Score=191.63  Aligned_cols=140  Identities=24%  Similarity=0.361  Sum_probs=117.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC-----------CCCC---------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----------HTNL---------  514 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~nl---------  514 (614)
                      ++|.+.+.||+|+||.||++... +++.||||.+... ......+.+|+.++.+++           |+|+         
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            57888999999999999999974 6789999999652 334567889999999887           7787         


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEc------
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY-SRLRVIHRDLKVSNILLD------  583 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILld------  583 (614)
                          ....++||||+ +++|..++.... ...+++.....++.||+.||.|||+. +   |+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence                11678999999 889999886543 23488999999999999999999997 6   99999999999994      


Q ss_pred             CCCcEEEeecCcceeecC
Q 042853          584 EQMNPKISDFGMARTFTM  601 (614)
Q Consensus       584 ~~~~~kI~DFGla~~~~~  601 (614)
                      ..+.+||+|||+|+.+..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~  190 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE  190 (373)
T ss_dssp             TEEEEEECCCTTCEETTB
T ss_pred             CcceEEEcccccccccCC
Confidence            445799999999987753

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.80  E-value=2.1e-19  Score=155.26  Aligned_cols=109  Identities=21%  Similarity=0.353  Sum_probs=91.6

Q ss_pred             cccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEE
Q 042853           10 TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVW   89 (614)
Q Consensus        10 ~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW   89 (614)
                      +|+|.+|+.|.+|++|+ ++|.|+|+|+..++     | |+|+                        .       .++||
T Consensus         1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~------------------------~-------~~~vW   42 (110)
T 3a0c_A            1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD------------------------S-------GKPVW   42 (110)
T ss_dssp             CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE------------------------T-------TEEEE
T ss_pred             CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE------------------------C-------CEEEE
Confidence            48899999999999999 99999999988775     2 6665                        1       26799


Q ss_pred             EcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCC
Q 042853           90 IANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYP  169 (614)
Q Consensus        90 ~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~P  169 (614)
                      +||++.|.  . .+.++|.+ +|||||.|.++.++|+|++........++|+|+|||||++         ..+||||+||
T Consensus        43 ~sn~~~~~--~-~~~l~l~~-dGNLVl~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~---------~~~W~S~~~~  109 (110)
T 3a0c_A           43 ASNTGGLG--S-GCRLTLHN-NGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYG---------PVVWATGSGP  109 (110)
T ss_dssp             ECCCTTSC--S-SCEEEECT-TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---------SEEEECSCCC
T ss_pred             ECCCCCCC--C-cEEEEEeC-CCCEEEECCCCcEEEecCCCCCCCCEEEEEeCCccEEEEC---------CCEecCCCcC
Confidence            99998774  2 47899998 9999999999999999997643334589999999999986         2699999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.80  E-value=1.1e-19  Score=201.13  Aligned_cols=127  Identities=24%  Similarity=0.340  Sum_probs=99.5

Q ss_pred             CccceeccCCceeEEEEEeCCccEEEEEEccCCCc--c------hhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          459 SPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG--Q------GIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       459 ~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~--~------~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ...+.||+|+||.||++.. .++.+++|+......  .      ..++|.+|++++++++|||+         ..+.+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999955 467788887643211  1      13458999999999999999         3467999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||+++++|.+++..           +..++.|+++||.|||+++   ||||||||+|||++.  .+||+|||+|+.+..
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999998843           4578999999999999987   999999999999999  999999999998865


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus       482 ~  482 (540)
T 3en9_A          482 D  482 (540)
T ss_dssp             H
T ss_pred             c
Confidence            4

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.79  E-value=8.2e-20  Score=195.84  Aligned_cols=144  Identities=19%  Similarity=0.185  Sum_probs=113.2

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCC-CC-------------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHT-NL-------------  514 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~-nl-------------  514 (614)
                      ..+..|...+.||+|+||.||+|... +++.||||.+....   ....+.|.+|+.++..++|. |.             
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34445677789999999999999965 68899999987432   23367799999999999872 21             


Q ss_pred             ----------------------CCeeEEEEEecCCCCHHHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 042853          515 ----------------------GGERLLVYEYLPNKSLDFFIFD----SSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL  568 (614)
Q Consensus       515 ----------------------~~~~~lv~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  568 (614)
                                            ....+++|+++ .++|..++..    ......+++..++.++.||++||.|||+.+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  231 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  231 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence                                  11345566654 6889888742    122345788899999999999999999987  


Q ss_pred             ceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       569 ~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                       ||||||||+||||+.++.+||+|||+|+...
T Consensus       232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~  262 (413)
T 3dzo_A          232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  262 (413)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             -cccCCcccceEEEecCCeEEEEeccceeecC
Confidence             9999999999999999999999999998764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.79  E-value=2e-19  Score=185.11  Aligned_cols=141  Identities=22%  Similarity=0.350  Sum_probs=104.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-ch-hHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QG-IVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~-~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      .++|...+.||+|+||.||++... +++.||||.+..... .. .+.+..+..++..++|+|+         ....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457788899999999999999986 688999999975432 22 2334555567888899999         46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY-SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+ ++.+..+....  ...+++.....++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 44554444321  24588999999999999999999984 6   99999999999999999999999999987653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=3.1e-19  Score=178.88  Aligned_cols=133  Identities=16%  Similarity=0.178  Sum_probs=103.6

Q ss_pred             CCccceeccCCceeEEEEEe-CCccE--EEEEEccCCCcc------------------------hhHhHHHHHHHHHhcC
Q 042853          458 FSPANRLGQGGFGPVYKGKL-QDEQE--IAIKRLSKSSGQ------------------------GIVEFKNEAKLIAKLQ  510 (614)
Q Consensus       458 f~~~~~lG~G~fg~Vy~g~~-~~~~~--vavK~l~~~~~~------------------------~~~~f~~E~~~l~~l~  510 (614)
                      |.+.+.||+|+||.||+|.. .+++.  ||||.++.....                        ....+.+|+..+.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999998 67888  999986532110                        1135789999999999


Q ss_pred             CCCC-------CCeeEEEEEecCC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCC
Q 042853          511 HTNL-------GGERLLVYEYLPN-K----SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH-KYSRLRVIHRDLKV  577 (614)
Q Consensus       511 H~nl-------~~~~~lv~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDlkp  577 (614)
                      |+++       ....+|||||+.. |    +|..+...      .++.....++.|++.||.||| +.+   ||||||||
T Consensus       129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp  199 (258)
T 1zth_A          129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSE  199 (258)
T ss_dssp             HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCST
T ss_pred             hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence            8876       2345799999952 4    66655422      123345678999999999999 776   99999999


Q ss_pred             CCEEEcCCCcEEEeecCcceeecC
Q 042853          578 SNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       578 ~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +|||++.  .+||+|||+|+....
T Consensus       200 ~NILl~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEETTS
T ss_pred             HHEEEcC--cEEEEECcccccCCC
Confidence            9999998  999999999987643

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.78  E-value=9.5e-19  Score=152.46  Aligned_cols=110  Identities=25%  Similarity=0.351  Sum_probs=90.5

Q ss_pred             cccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEE
Q 042853           10 TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVW   89 (614)
Q Consensus        10 ~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW   89 (614)
                      .|+|.+||+|.+|++|+  +|.|+|+|++.++   ..   +|.                        .       .++||
T Consensus         2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn---lv---ly~------------------------~-------~~~vW   42 (115)
T 2dpf_A            2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN---LV---KYQ------------------------N-------GRQIW   42 (115)
T ss_dssp             CCEEETTCEEETTEEEE--ETTEEEEECTTSC---EE---EEE------------------------T-------TEEEE
T ss_pred             CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc---EE---EEe------------------------C-------CEEEE
Confidence            48999999999999998  7999999987664   22   354                        0       16799


Q ss_pred             EcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCC
Q 042853           90 IANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYP  169 (614)
Q Consensus        90 ~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~P  169 (614)
                      +||++.|.  . ++.|+|.+ +|+|||.|.++.++|+|+........+|+|+|+|||||++         .++||||.++
T Consensus        43 ~sn~~~~~--~-~~~l~l~~-~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~---------~~~W~S~~~~  109 (115)
T 2dpf_A           43 ASNTDRRG--S-GCRLTLLS-DGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYG---------PVLWSLGPNG  109 (115)
T ss_dssp             ECSCTTSC--S-SCEEEECT-TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---------SEEECSSTTC
T ss_pred             eCCCCCCC--C-ceEEEECC-CCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEEC---------CCEEECCCCC
Confidence            99999884  2 57899998 9999999998999999987643334689999999999985         3699999987


Q ss_pred             CC
Q 042853          170 TD  171 (614)
Q Consensus       170 TD  171 (614)
                      +.
T Consensus       110 ~~  111 (115)
T 2dpf_A          110 CR  111 (115)
T ss_dssp             BC
T ss_pred             Cc
Confidence            64

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.75  E-value=5.4e-18  Score=146.99  Aligned_cols=110  Identities=25%  Similarity=0.447  Sum_probs=89.5

Q ss_pred             cccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEE
Q 042853           10 TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVW   89 (614)
Q Consensus        10 ~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW   89 (614)
                      +|+|.+||.|.+|++|  ++|.|+|+|+++++   .   +||.                              . .++||
T Consensus         1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn---l---vl~~------------------------------~-~~~vW   41 (112)
T 1xd5_A            1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN---L---VLYD------------------------------N-NRAVW   41 (112)
T ss_dssp             CCEEETTEEECTTCEE--EETTEEEEECTTSC---E---EEEE------------------------------T-TEEEE
T ss_pred             CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc---E---EEEE------------------------------C-CEEEE
Confidence            5899999999999999  58999999998875   1   3565                              1 25799


Q ss_pred             EcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCC
Q 042853           90 IANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYP  169 (614)
Q Consensus        90 ~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~P  169 (614)
                      +||++.+  .. ++.|+|.+ +|||||.| ++.++|+|++........++|+++|||||++.   ++   .++||||+|.
T Consensus        42 ~sn~~~~--~~-~~~l~l~~-~GNLvl~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~---~~---~~~W~S~~~~  110 (112)
T 1xd5_A           42 ASGTNGK--AS-GCVLKMQN-DGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN---SN---NAIWATHTNV  110 (112)
T ss_dssp             ECCCTTS--CS-SEEEEECT-TSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECT---TS---CEEEECCCCC
T ss_pred             eCCCcCC--CC-CEEEEEeC-CCCEEEEc-CCEEEEECCccCCCCCEEEEEeCCCcEEEECC---CC---ceEEECCCcc
Confidence            9999764  23 57899998 99999999 88899999875433346799999999999873   22   6899999985

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.70  E-value=5e-17  Score=140.05  Aligned_cols=103  Identities=26%  Similarity=0.442  Sum_probs=84.4

Q ss_pred             ccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEEE
Q 042853           11 DKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWI   90 (614)
Q Consensus        11 ~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW~   90 (614)
                      .+|.+||.|.+|++|+  +|.|+|.|+..++   .+|   |.                              . .++||+
T Consensus         2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn---Lvl---y~------------------------------~-~~~vW~   42 (109)
T 3dzw_A            2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN---LVL---YD------------------------------V-DKPIWA   42 (109)
T ss_dssp             CEEETTEEECTTCEEE--ETTEEEEECTTSC---EEE---EE------------------------------T-TEEEEE
T ss_pred             CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc---EEE---Ee------------------------------C-CEEEEE
Confidence            5799999999999996  7999999987765   332   54                              1 257999


Q ss_pred             cCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceecee
Q 042853           91 ANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS  165 (614)
Q Consensus        91 ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQS  165 (614)
                      ||++.+-  . +..|.|.+ +|||||.|.++.++|+|++.......+|+|+|+|||||++         ..+|||
T Consensus        43 snt~~~~--~-~~~l~l~~-dGNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~---------~~~W~s  104 (109)
T 3dzw_A           43 TNTGGLD--R-RCHLSMQS-DGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYG---------TARWAT  104 (109)
T ss_dssp             CCCTTSS--S-SCEEEECT-TSCEEEECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEE---------SCCCCC
T ss_pred             CCcccCC--C-CEEEEEeC-CCCEEEECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEEC---------CCEEeC
Confidence            9998762  2 57899998 9999999999999999997654334689999999999997         368998

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.64  E-value=7.1e-16  Score=132.87  Aligned_cols=104  Identities=21%  Similarity=0.267  Sum_probs=81.8

Q ss_pred             ccccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcE
Q 042853            9 QTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPV   88 (614)
Q Consensus         9 ~~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~V   88 (614)
                      ++|+|.+||.|..|++|+|  |.|+|-|-..++     |.+ |.                        .        ++|
T Consensus         5 ~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~------------------------~--------~~v   44 (110)
T 3r0e_B            5 TNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YG------------------------G--------KYG   44 (110)
T ss_dssp             BTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-EC------------------------S--------SSC
T ss_pred             ccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-EC------------------------C--------eEE
Confidence            4689999999999999998  458886543332     444 54                        1        369


Q ss_pred             EEcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceecee
Q 042853           89 WIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS  165 (614)
Q Consensus        89 W~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQS  165 (614)
                      |++|++..  .. +..|.|.+ +|+|||.|.++.++|+|++.......+|+|+|+|||||++         ..+|+|
T Consensus        45 W~snt~~~--~~-~~~l~l~~-dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---------~~~W~t  108 (110)
T 3r0e_B           45 WQSNTHGN--GE-HCFLRLNH-KGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---------PAIFET  108 (110)
T ss_dssp             EECCCTTS--SS-SCEEEECT-TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred             EECCCcCC--Cc-CEEEEEeC-CCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---------CCEecC
Confidence            99999863  22 46899998 9999999999999999998643334689999999999996         368987

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.59  E-value=6.8e-15  Score=127.39  Aligned_cols=107  Identities=20%  Similarity=0.299  Sum_probs=85.0

Q ss_pred             ccccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcE
Q 042853            9 QTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPV   88 (614)
Q Consensus         9 ~~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~V   88 (614)
                      +.|+|.+||.|.+|+.|.+  |.|.|-|...++     |.++ .                        .     ...++|
T Consensus         5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~-~------------------------~-----~~~~~v   47 (113)
T 3mez_B            5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLT-K------------------------G-----SKTNIV   47 (113)
T ss_dssp             CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEE-E------------------------T-----TTTEEE
T ss_pred             cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEE-E------------------------C-----CCCEEE
Confidence            3689999999999999974  889999865553     5554 3                        1     112689


Q ss_pred             EEcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceecee
Q 042853           89 WIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS  165 (614)
Q Consensus        89 W~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQS  165 (614)
                      |.+|++.+-  . ...|.|.+ +|||||.|.+++++|+|++.......+|+|+|+|||||++         ..+|+|
T Consensus        48 Wssnt~~~~--~-~~~l~l~~-dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---------~~~W~s  111 (113)
T 3mez_B           48 WESGTSGRG--Q-HCFMRLGH-SGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---------PAVWST  111 (113)
T ss_dssp             EECCCTTSC--S-SCEEEECT-TSCEEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred             EECCcccCC--c-CEEEEEeC-CCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---------CCEecC
Confidence            999998763  2 46899998 9999999999999999998643334689999999999996         478987

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.59  E-value=5e-15  Score=128.21  Aligned_cols=97  Identities=21%  Similarity=0.357  Sum_probs=77.0

Q ss_pred             CCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcC
Q 042853           95 TPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLL  174 (614)
Q Consensus        95 ~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlL  174 (614)
                      .|+.+. ..+|.|.. ||+|+|.+. +++||++++........|+|+|+|||||++    ++   .++||||+.|.    
T Consensus        14 ~~L~~~-~~~L~~~~-dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d----~~---~~~W~S~~~~~----   79 (112)
T 1xd5_A           14 GSLAEG-GYLFIIQN-DCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS----GS---RAIWASNTNRQ----   79 (112)
T ss_dssp             CEEEET-TEEEEECT-TSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE----TT---EEEEECCCCCS----
T ss_pred             CEEeCC-CEEEEEcC-CCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc----CC---EEEEECCccCC----
Confidence            344333 68999998 999999987 889999997643345789999999999997    12   68999996541    


Q ss_pred             CCCeeeeeecCCceEEEEecCCCCCccceEEeecCCCCceEEEEe-CCEEEEEeCCCCC
Q 042853          175 PGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWK-DDKVVWTSTIWLN  232 (614)
Q Consensus       175 pg~~l~~~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~-~~~~yw~~g~w~~  232 (614)
                                               +|.|++.++++|.  +++|+ ...+||++++|+|
T Consensus        80 -------------------------~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           80 -------------------------NGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             -------------------------CCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred             -------------------------CCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence                                     4678999999997  56665 4679999999975

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.58  E-value=1.3e-15  Score=159.50  Aligned_cols=137  Identities=18%  Similarity=0.175  Sum_probs=100.2

Q ss_pred             HHhhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCc--------------chhHh--------HHHHHHHHHh
Q 042853          451 IAVATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG--------------QGIVE--------FKNEAKLIAK  508 (614)
Q Consensus       451 ~~~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~--------------~~~~~--------f~~E~~~l~~  508 (614)
                      +.....-|.+.+.||+|+||.||+|...+|+.||||.++....              .....        ...|...|.+
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            3333334788999999999999999999999999998753210              00011        1346667777


Q ss_pred             cCCCCC-C------CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 042853          509 LQHTNL-G------GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNIL  581 (614)
Q Consensus       509 l~H~nl-~------~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  581 (614)
                      +.+..+ .      ...+|||||++++.|..+..       .  .....++.|++.+|.|||+.+   ||||||||.|||
T Consensus       170 L~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL  237 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL  237 (397)
T ss_dssp             HHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             HHhcCCCCCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence            766655 1      12369999999988765431       1  122457889999999999987   999999999999


Q ss_pred             EcCCC----------cEEEeecCcceee
Q 042853          582 LDEQM----------NPKISDFGMARTF  599 (614)
Q Consensus       582 ld~~~----------~~kI~DFGla~~~  599 (614)
                      +++++          .+.|+||+-+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98776          3899999987754

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.57  E-value=1.1e-14  Score=125.18  Aligned_cols=108  Identities=23%  Similarity=0.354  Sum_probs=86.0

Q ss_pred             ccccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcE
Q 042853            9 QTDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPV   88 (614)
Q Consensus         9 ~~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~V   88 (614)
                      +.|||.+||.|..|+.|  .+|.|.|.|...++     |- .|.                        .          +
T Consensus         2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lv-l~~------------------------~----------~   39 (109)
T 3r0e_A            2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LV-LYN------------------------G----------N   39 (109)
T ss_dssp             CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EE-EET------------------------T----------T
T ss_pred             ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EE-EEe------------------------C----------e
Confidence            46899999999999999  57999999976554     22 243                        2          7


Q ss_pred             EEcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCC
Q 042853           89 WIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDY  168 (614)
Q Consensus        89 W~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~  168 (614)
                      |.+|+..+-  . ...|+|.+ +|+|||.|.+++++|+|++.......+|+|+|+|||||++         ..+|+|   
T Consensus        40 Wssnt~~~~--~-~~~l~l~~-dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---------~~~W~s---  103 (109)
T 3r0e_A           40 WQSNTANNG--R-DCKLTLTD-YGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---------PSVFKI---  103 (109)
T ss_dssp             EECCCTTSC--S-SCEEEECT-TSCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---------SEEEEE---
T ss_pred             EEcCCCCCC--C-cEEEEEcC-CCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---------cCEECC---
Confidence            999987652  2 57899998 9999999999999999987643334689999999999986         478997   


Q ss_pred             CCCCcCCC
Q 042853          169 PTDTLLPG  176 (614)
Q Consensus       169 PTDTlLpg  176 (614)
                        .|.+||
T Consensus       104 --~t~~~~  109 (109)
T 3r0e_A          104 --DPWVRG  109 (109)
T ss_dssp             --CTTSCC
T ss_pred             --CCccCC
Confidence              666654

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.54  E-value=2.9e-14  Score=122.83  Aligned_cols=88  Identities=30%  Similarity=0.427  Sum_probs=71.6

Q ss_pred             CeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeee
Q 042853          102 SATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGI  181 (614)
Q Consensus       102 ~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~  181 (614)
                      ..+|.+.. ||+|+|.+ .+++||++|+...+....|+|+|+|||||++.   ++   .++||||..|.           
T Consensus        21 ~~~l~~~~-dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~---~~---~~~W~S~t~~~-----------   81 (110)
T 3a0c_A           21 SYRLIMQG-DCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ---SN---RVIWQTKTNGK-----------   81 (110)
T ss_dssp             TEEEEECT-TSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT---TC---CEEEECCCCCS-----------
T ss_pred             CEEEEEcC-CCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC---CC---cEEEecCCCCC-----------
Confidence            58899988 99999998 58999999986544457899999999999984   32   68999995331           


Q ss_pred             eecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCCC
Q 042853          182 NLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIW  230 (614)
Q Consensus       182 ~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~w  230 (614)
                                        +|.|++.++++|.  +++|++  +||+++++
T Consensus        82 ------------------~g~~~l~l~~dGn--lvl~~~--~~W~S~~~  108 (110)
T 3a0c_A           82 ------------------EDHYVLVLQQDRN--VVIYGP--VVWATGSG  108 (110)
T ss_dssp             ------------------SSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred             ------------------CCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence                              5789999999997  566765  89999875

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.49  E-value=1.3e-13  Score=120.35  Aligned_cols=87  Identities=26%  Similarity=0.377  Sum_probs=70.3

Q ss_pred             CeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeee
Q 042853          102 SATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGI  181 (614)
Q Consensus       102 ~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~  181 (614)
                      ...|.+.. ||+|+|.+. +++||++|+...+....|+|+|+|||||+|.   ++   .++||||..|.           
T Consensus        31 ~~~L~~~~-dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~---~~---~~lW~S~~~~~-----------   91 (119)
T 1b2p_A           31 VYRFIMQT-DCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN---EN---VTVWQSPVAGK-----------   91 (119)
T ss_dssp             EEEEEECT-TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT---TC---CEEEECSCCCC-----------
T ss_pred             CEEEEEec-CCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC---CC---cEEEcCCCCCC-----------
Confidence            35788888 999999987 8999999986544457899999999999983   32   69999995441           


Q ss_pred             eecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCC
Q 042853          182 NLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTI  229 (614)
Q Consensus       182 ~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~  229 (614)
                                        +|.|++.++++|.  +++++  .+||++|+
T Consensus        92 ------------------~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~  117 (119)
T 1b2p_A           92 ------------------AGHYVLVLQPDRN--VVIYG--DALWATQT  117 (119)
T ss_dssp             ------------------SSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred             ------------------CCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence                              5789999999997  56666  38999986

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.48  E-value=1.4e-13  Score=119.68  Aligned_cols=89  Identities=28%  Similarity=0.383  Sum_probs=73.0

Q ss_pred             CeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeee
Q 042853          102 SATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGI  181 (614)
Q Consensus       102 ~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~  181 (614)
                      ...|.+.. ||+|+|.+ .+++||++|+..+..+..++|+|+|||||+|.   +.   .++|||||+|.           
T Consensus        21 ~~~L~~~~-dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~---~~---~~vW~S~~~~~-----------   81 (115)
T 2dpf_A           21 AYTLTIQN-KCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH---NN---NDVWGSACWGD-----------   81 (115)
T ss_dssp             TEEEEECT-TSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT---TC---CEEEECCCCCS-----------
T ss_pred             CEEEEEcC-CCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC---Cc---eEEEEcCCCCC-----------
Confidence            57899987 99999998 58899999976544457899999999999984   22   68999999841           


Q ss_pred             eecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCCCC
Q 042853          182 NLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIWL  231 (614)
Q Consensus       182 ~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~w~  231 (614)
                                        +|.|++.++++|.  +++|+.  +||++++|.
T Consensus        82 ------------------~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~  109 (115)
T 2dpf_A           82 ------------------NGKYALVLQKDGR--FVIYGP--VLWSLGPNG  109 (115)
T ss_dssp             ------------------SSCCEEEECTTSC--EEEECS--EEECSSTTC
T ss_pred             ------------------CCCEEEEEeCCCe--EEEECC--CEEECCCCC
Confidence                              4678899999997  566755  899999996

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.33  E-value=5.4e-12  Score=108.65  Aligned_cols=103  Identities=17%  Similarity=0.316  Sum_probs=79.8

Q ss_pred             cccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEE
Q 042853           10 TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVW   89 (614)
Q Consensus        10 ~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW   89 (614)
                      .|+|.+||.|.+|+.|  .+|.|.|-|...++   .  .+ |.                        .      . . ||
T Consensus         2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn---L--vl-~~------------------------~------~-~-vW   41 (111)
T 3mez_A            2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN---L--VL-YN------------------------E------A-G-GF   41 (111)
T ss_dssp             TTEEETTCEECTTCEE--EETTEEEEECTTSC---E--EE-EC------------------------S------S-C-CE
T ss_pred             cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe---E--EE-EC------------------------C------C-C-EE
Confidence            5789999999999999  47899999965553   2  22 43                        1      1 4 99


Q ss_pred             EcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCC-cEEEeeeec--CCcccEEEeccCCCEEEEeecCCCCcccceecee
Q 042853           90 IANRDTPVLRNESATLIIDSTDGNLKILRNGKS-PIEISSVRR--AGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS  165 (614)
Q Consensus        90 ~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~-~vwss~~~~--~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQS  165 (614)
                      .+|+..+-  . ...|.|.+ +|||||.|.++. ++|+|++..  .....++.|+|+|||||++         ..+|+|
T Consensus        42 ~snt~~~~--~-~~~l~l~~-dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s  107 (111)
T 3mez_A           42 QSNTHGRG--V-DCTLRLNN-RGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---------PAIWST  107 (111)
T ss_dssp             ECCCTTSC--S-SCEEEECT-TSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---------SEEEEC
T ss_pred             ECCcccCC--c-CEEEEEcC-CCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---------cCEEcc
Confidence            99998763  2 47899998 999999998876 599998632  2224689999999999986         478987

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.18  E-value=5.7e-11  Score=119.11  Aligned_cols=112  Identities=21%  Similarity=0.338  Sum_probs=86.8

Q ss_pred             ccccccCCCc----cCCCCeEEeCCCeEEEEeeCCC--CCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCC
Q 042853            9 QTDKLQQGQV----LKDGEELVSAYGNFRLGFFSPS--GRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQA   82 (614)
Q Consensus         9 ~~~~i~~g~~----l~~~~~l~S~~g~F~lGFf~~~--~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (614)
                      .+||+.||+.    |..|+.|.| ...++.|+|+..  ...+.+  + |.                              
T Consensus       135 ptdtlLpg~~~~~~l~~g~~L~S-~~dps~G~fsl~l~~dGnlv--L-y~------------------------------  180 (276)
T 3m7h_A          135 PAIPLVPGAIDSLLLAPGSELVQ-GVVYGAGASKLVFQGDGNLV--A-YG------------------------------  180 (276)
T ss_dssp             TTSCCCCSCTTCEEECSSEEECT-TCEEEETTEEEEECTTSCEE--E-EC------------------------------
T ss_pred             cccccccccccccccccCccccc-CCCCCCceEEEeecCCceEE--E-Ee------------------------------
Confidence            4799999999    888999865 468888888642  222333  3 33                              


Q ss_pred             CCCCcEEEcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCccccee
Q 042853           83 IKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRREL  162 (614)
Q Consensus        83 ~~~t~VW~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~l  162 (614)
                      ...+++|.+++..+-    ...|.+.. +|+|++.|.++.++|++++... ...+|+|+++|||||++.        +.+
T Consensus       181 ~~~~~yW~Sgt~~~~----~~~l~l~~-dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~--------~~~  246 (276)
T 3m7h_A          181 PNGAATWNAGTQGKG----AVRAVFQG-DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE--------KPV  246 (276)
T ss_dssp             TTSSEEEECCCTTTT----CCEEEECT-TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE--------EEE
T ss_pred             CCCeEEEECCCCCCc----cEEEEEcC-CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC--------CCe
Confidence            112679999998762    26899988 9999999998899999997643 347899999999999973        479


Q ss_pred             ceecCC
Q 042853          163 WQSFDY  168 (614)
Q Consensus       163 WQSFD~  168 (614)
                      ||||||
T Consensus       247 Wqsf~~  252 (276)
T 3m7h_A          247 WARFGF  252 (276)
T ss_dssp             EESSSC
T ss_pred             EEccCc
Confidence            999997

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.13  E-value=1.6e-10  Score=99.78  Aligned_cols=96  Identities=16%  Similarity=0.162  Sum_probs=71.7

Q ss_pred             CCCCCCCCCCeEEEEEcCCCcEEEEeC-CCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCC
Q 042853           93 RDTPVLRNESATLIIDSTDGNLKILRN-GKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTD  171 (614)
Q Consensus        93 r~~Pv~~~~~~~l~l~~~~G~L~l~~~-~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTD  171 (614)
                      .+.|+.+. ..+|.+.. ||+|||.+. .++++|++++.....+..++|+|+|||||++.   ++   .++|||=.+-  
T Consensus        17 ~g~~L~~g-~~~L~~q~-dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~---~~---~~iW~S~t~~--   86 (113)
T 3mez_B           17 DNAQLATR-DYSLVMRD-DCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD---RL---NTVFVSNTVG--   86 (113)
T ss_dssp             TTCEEEET-TEEEEECT-TSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT---TS---CEEEECSCCC--
T ss_pred             CCCEeEcC-CEEEEEcC-CCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC---CC---CEEEECCCcC--
Confidence            35666654 68999998 999999998 58999999986543456899999999999984   32   5899973310  


Q ss_pred             CcCCCCeeeeeecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCC
Q 042853          172 TLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTI  229 (614)
Q Consensus       172 TlLpg~~l~~~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~  229 (614)
                                                 ..|.|.+.++.+|...+  |+  .+.|.+++
T Consensus        87 ---------------------------~~~~~~~~L~~dGnlvl--y~--~~~W~s~~  113 (113)
T 3mez_B           87 ---------------------------QEGDYVLILQINGQAVV--YG--PAVWSTAA  113 (113)
T ss_dssp             ---------------------------SSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred             ---------------------------CCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence                                       03457888999997554  44  58898874

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.06  E-value=7.1e-10  Score=110.44  Aligned_cols=135  Identities=16%  Similarity=0.103  Sum_probs=100.6

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCC-CCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH-TNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H-~nl---------~~~~~lv~Ey~  525 (614)
                      ..|.....++.|+.+.||+.... ++.+++|............+.+|++++..+.+ ..+         .+..++||||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            46766777888888999998764 57899998864322233468999999998853 333         34678999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY----------------------------------------  565 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  565 (614)
                      ++.+|...+.        +......++.+++++|..||+.                                        
T Consensus        93 ~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           93 DGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             SSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             CCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            9999876531        1112346788999999999981                                        


Q ss_pred             ----------------CCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          566 ----------------SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       566 ----------------~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                                      .+..++|+|++|.|||++++..+.|+||+.|..-
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                            1145999999999999987656789999988654

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.06  E-value=3.5e-10  Score=97.24  Aligned_cols=95  Identities=15%  Similarity=0.210  Sum_probs=69.4

Q ss_pred             CCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcC
Q 042853           95 TPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLL  174 (614)
Q Consensus        95 ~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlL  174 (614)
                      .++... ...|.+.. ||+|||.+.++  +|++++...+....++|+|+|||||++.   ++.  .++|||.-+      
T Consensus        15 ~~L~~g-~~~L~~q~-dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~---~~~--~~vW~S~t~------   79 (111)
T 3mez_A           15 NQLSYE-SAAFVMQG-DCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSA---NSN--TPVWVYPRS------   79 (111)
T ss_dssp             CEEEET-TEEEEECT-TSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECS---SCS--SCSEEESSS------
T ss_pred             CEEecC-CEEEEEcc-CCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeC---CCC--EEEEEeccc------
Confidence            344433 57899988 99999998876  9999986543457899999999999984   222  359999731      


Q ss_pred             CCCeeeeeecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCC
Q 042853          175 PGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTI  229 (614)
Q Consensus       175 pg~~l~~~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~  229 (614)
                           .                ....|.|.+.++.+|...+  |.  .++|.+++
T Consensus        80 -----~----------------~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t  109 (111)
T 3mez_A           80 -----V----------------NTVRGNYAATLGPDQHVTI--YG--PAIWSTPA  109 (111)
T ss_dssp             -----C----------------CCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred             -----c----------------CCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence                 0                0014678999999997555  44  68999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.97  E-value=1e-09  Score=108.61  Aligned_cols=125  Identities=18%  Similarity=0.206  Sum_probs=91.9

Q ss_pred             ceec-cCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEEEecCCCC
Q 042853          462 NRLG-QGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVYEYLPNKS  529 (614)
Q Consensus       462 ~~lG-~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~Ey~~~gs  529 (614)
                      ..++ .|..+.||+....++..+++|.....   ....+..|+.++..+.+.++           .+..++||||+++.+
T Consensus        25 ~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~  101 (264)
T 1nd4_A           25 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD  101 (264)
T ss_dssp             EECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence            3454 55569999998777788999987543   33567899999999875554           235689999999988


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 042853          530 LDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS-------------------------------------------  566 (614)
Q Consensus       530 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------  566 (614)
                      |.  . .     ..+   ...++.++++.|..||...                                           
T Consensus       102 l~--~-~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          102 LL--S-S-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             TT--T-S-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cC--c-C-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            74  2 1     112   2256777888888888643                                           


Q ss_pred             ------------CCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          567 ------------RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       567 ------------~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                                  +..++|+|++|.|||++++..++|.||+.|....
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~  216 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD  216 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence                        1239999999999999887667899999987653

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=98.90  E-value=4.6e-09  Score=89.96  Aligned_cols=86  Identities=16%  Similarity=0.240  Sum_probs=64.0

Q ss_pred             CeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeee
Q 042853          102 SATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGI  181 (614)
Q Consensus       102 ~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~  181 (614)
                      ...|.+.. ||+|+|.+. ++++|++++........++|+|+|||||++.   ++   .++|||.....           
T Consensus        20 ~~~L~~q~-dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~---~~---~~~W~S~t~~~-----------   80 (109)
T 3dzw_A           20 RYVFIMQE-DCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP---RN---NPIWASNTGGE-----------   80 (109)
T ss_dssp             TEEEEECT-TSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT---TS---CEEEECCCCCS-----------
T ss_pred             CEEEEEcC-CCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC---CC---CEEEECCCCCC-----------
Confidence            47899988 999999987 7899999986543356899999999999984   22   68999864220           


Q ss_pred             eecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeC
Q 042853          182 NLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTST  228 (614)
Q Consensus       182 ~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g  228 (614)
                                        .+.|.+.++.+|...+  ++.  +.|.++
T Consensus        81 ------------------~~~~~~~L~ddGNlvl--y~~--~~W~s~  105 (109)
T 3dzw_A           81 ------------------NGNYVCVLQKDRNVVI--YGT--ARWATG  105 (109)
T ss_dssp             ------------------SSCEEEEECTTSCEEE--EES--CCCCCC
T ss_pred             ------------------CCCEEEEEeCCCEEEE--ECC--CEEeCC
Confidence                              2457788899987544  443  566655

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.86  E-value=5.3e-09  Score=89.66  Aligned_cols=86  Identities=14%  Similarity=0.186  Sum_probs=64.2

Q ss_pred             CeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeee
Q 042853          102 SATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGI  181 (614)
Q Consensus       102 ~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~  181 (614)
                      ...|.+.. ||+|+|.+.  +++|++++...+....++|+|+|||||++.   ++   .++|||-.+-            
T Consensus        25 ~~~L~~q~-dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~---~~---~~iW~S~t~~------------   83 (110)
T 3r0e_B           25 NHQLVMQG-DCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD---DF---KTIWSSRSSS------------   83 (110)
T ss_dssp             SCEEEECT-TSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT---TC---CEEEECCCCC------------
T ss_pred             CEEEEEcC-CCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC---CC---CEEEEcCCcC------------
Confidence            46899988 999999876  699999986543346899999999999984   22   6899986421            


Q ss_pred             eecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCC
Q 042853          182 NLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTI  229 (614)
Q Consensus       182 ~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~  229 (614)
                                       ..|.|.+.++.+|...+  |+  .+.|.+|+
T Consensus        84 -----------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~~  110 (110)
T 3r0e_B           84 -----------------KQGEYVLILQDDGFGVI--YG--PAIFETSS  110 (110)
T ss_dssp             -----------------SSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred             -----------------CCCCEEEEEcCCccEEE--ec--CCEecCCC
Confidence                             03457788899997554  44  37888763

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.80  E-value=9.7e-09  Score=87.86  Aligned_cols=92  Identities=18%  Similarity=0.239  Sum_probs=67.2

Q ss_pred             CCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCc
Q 042853           94 DTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTL  173 (614)
Q Consensus        94 ~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTl  173 (614)
                      ..|+.+. ...|.+.. ||||||.++    +|+|++...+....++|+++|||||+|.   +.   .++|+|-.+     
T Consensus        15 g~~L~~g-~~~L~~q~-dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~---~~---~~vWss~t~-----   77 (109)
T 3r0e_A           15 EGHLKNG-DFDLVMQD-DCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG---DG---STVWKSGAQ-----   77 (109)
T ss_dssp             TCEEEET-TEEEEECT-TSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT---TS---CEEEECCCC-----
T ss_pred             CCEeECC-CEEEEEec-CCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC---CC---CEEEcCCCc-----
Confidence            3445433 67899988 999999874    7999987543456899999999999974   22   589975210     


Q ss_pred             CCCCeeeeeecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCCC
Q 042853          174 LPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIW  230 (614)
Q Consensus       174 Lpg~~l~~~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~w  230 (614)
                        +                      ..+.|.+.++++|...+  +.  .+.|.+++|
T Consensus        78 --~----------------------~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~  106 (109)
T 3r0e_A           78 --S----------------------VKGNYAAVVHPDGRLVV--FG--PSVFKIDPW  106 (109)
T ss_dssp             --C----------------------SSSCCEEEEETTTEEEE--EC--SEEEEECTT
T ss_pred             --C----------------------CCcCEEEEEcCCCeEEE--Ee--cCEECCCCc
Confidence              0                      13567888999997554  44  689999987

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.76  E-value=3.4e-08  Score=103.10  Aligned_cols=133  Identities=14%  Similarity=0.216  Sum_probs=97.2

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEcc--CCC-cchhHhHHHHHHHHHhcCCCCC--------------CCeeEEEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLS--KSS-GQGIVEFKNEAKLIAKLQHTNL--------------GGERLLVYE  523 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~--~~~-~~~~~~f~~E~~~l~~l~H~nl--------------~~~~~lv~E  523 (614)
                      .+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.++..+.+..+              .+..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            5789999999999988765 567788765  321 1223568889999999975444              134789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS-------------------------------------  566 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  566 (614)
                      |+++..+....     ...++..++..++.++++.|..||...                                     
T Consensus       122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99988764311     123677888889999999999999731                                     


Q ss_pred             ------------------CCceEecCCCCCCEEEcCCCc--EEEeecCcceee
Q 042853          567 ------------------RLRVIHRDLKVSNILLDEQMN--PKISDFGMARTF  599 (614)
Q Consensus       567 ------------------~~~iiHrDlkp~NILld~~~~--~kI~DFGla~~~  599 (614)
                                        +..++|+|+++.|||++.++.  +.|.||++|..-
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              356999999999999997653  699999998753

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=98.45  E-value=7.4e-07  Score=75.48  Aligned_cols=84  Identities=23%  Similarity=0.334  Sum_probs=60.5

Q ss_pred             eEEEEEcCCCcEEEEeCCCCcEEEeeeecCCc-ccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeee
Q 042853          103 ATLIIDSTDGNLKILRNGKSPIEISSVRRAGN-TTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGI  181 (614)
Q Consensus       103 ~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~-~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~  181 (614)
                      -+|.+.. ||||||.+. +++||++|+..+.. ...+.|.++|||||.|.   +.   .++|+|=.+             
T Consensus        21 y~l~~q~-DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~---~~---~~vWss~t~-------------   79 (105)
T 4h3o_A           21 YHFIMQD-DCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS---SG---RSLWASHST-------------   79 (105)
T ss_dssp             EEEEECT-TSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT---TC---CEEEECCCC-------------
T ss_pred             EEEEECC-CCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC---Cc---EEEEEecCC-------------
Confidence            5788888 999999875 68999999865432 46789999999999984   32   689986210             


Q ss_pred             eecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEe
Q 042853          182 NLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTS  227 (614)
Q Consensus       182 ~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~  227 (614)
                                      ...+.+.+.++.+|...+  ++.  ..|.|
T Consensus        80 ----------------~~~~~~~l~L~ddGNlVl--y~~--~~W~S  105 (105)
T 4h3o_A           80 ----------------RGSGNYILILQDDGNVII--YGS--DIWST  105 (105)
T ss_dssp             ----------------CCSSCEEEEECTTSCEEE--EES--EEEEC
T ss_pred             ----------------CCCCCEEEEEeCCCeEEE--ECC--cEecC
Confidence                            014567888999987544  432  46653

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.35  E-value=6.2e-07  Score=87.84  Aligned_cols=93  Identities=18%  Similarity=0.249  Sum_probs=67.6

Q ss_pred             CCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCC
Q 042853           93 RDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDT  172 (614)
Q Consensus        93 r~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDT  172 (614)
                      .++|.++  .-+|.+.. +|+|+|.+.+ .++|++++.......+++|.++||||+++.   +.   ..+||||.+.   
T Consensus       144 ~~d~s~G--~~~l~l~~-dG~LvL~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~---~~---~~vw~s~~~~---  210 (236)
T 1dlp_A          144 TQSLQLS--PYRLSMET-DCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTN---QN---IAVWTSGNSR---  210 (236)
T ss_dssp             SCCCBCS--SCEEEEET-TTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEET---TT---EEEEECCCCC---
T ss_pred             CcEeecC--cEEEEECC-CCcEEEEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeC---CC---cEEEEeCCCC---
Confidence            3455543  36899998 9999998764 689998875432346789999999999973   32   6899999531   


Q ss_pred             cCCCCeeeeeecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeC
Q 042853          173 LLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTST  228 (614)
Q Consensus       173 lLpg~~l~~~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g  228 (614)
                                                .+|.|++.+|++|.++++  .  ..||.+|
T Consensus       211 --------------------------~~~~~rl~Ld~dG~l~ly--~--~~~W~sg  236 (236)
T 1dlp_A          211 --------------------------SAGRYVFVLQPDRNLAIY--G--GALWTTG  236 (236)
T ss_dssp             --------------------------SSSCCEEEECSSSCEEEE--C--CCCCBC-
T ss_pred             --------------------------CCCCEEEEEcCCCcEEEe--C--CCCccCC
Confidence                                      145688999999986665  3  2688764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.35  E-value=1.2e-06  Score=89.13  Aligned_cols=129  Identities=19%  Similarity=0.219  Sum_probs=93.5

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCC----------C----CeeEEEEEec
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL----------G----GERLLVYEYL  525 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl----------~----~~~~lv~Ey~  525 (614)
                      .+.++.|....||+..    ..+++|....  ......+..|++++..+ .+..+          .    ...++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568999999999853    4578887543  23456789999999888 44444          1    1347889999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY----------------------------------------  565 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  565 (614)
                      ++..|.....     ..++..++..++.++++.|..||..                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988765332     1256667777888888888888851                                        


Q ss_pred             ---------------CCCceEecCCCCCCEEEcC--CCcEEEeecCcceeec
Q 042853          566 ---------------SRLRVIHRDLKVSNILLDE--QMNPKISDFGMARTFT  600 (614)
Q Consensus       566 ---------------~~~~iiHrDlkp~NILld~--~~~~kI~DFGla~~~~  600 (614)
                                     .++.++|+|++|.|||+++  ...+.|.||+.+..-.
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~  225 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD  225 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence                           1245899999999999998  4567999999987653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.09  E-value=2.8e-05  Score=79.09  Aligned_cols=129  Identities=21%  Similarity=0.200  Sum_probs=85.4

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCC-CC------------CCeeEEEEEecCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT-NL------------GGERLLVYEYLPN  527 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~-nl------------~~~~~lv~Ey~~~  527 (614)
                      .+.++.|....||+.    +..+++|.-.  .......+..|++++..+.+. .+            .+..++||||+++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888899987    4567778742  223456789999999999753 22            1236899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY------------------------------------------  565 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------  565 (614)
                      ..|......     .++..++..++.++++.|..||..                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            887653211     123333334444444444444421                                          


Q ss_pred             ---------------CCCceEecCCCCCCEEEcC---CCc-EEEeecCcceeec
Q 042853          566 ---------------SRLRVIHRDLKVSNILLDE---QMN-PKISDFGMARTFT  600 (614)
Q Consensus       566 ---------------~~~~iiHrDlkp~NILld~---~~~-~kI~DFGla~~~~  600 (614)
                                     .++.++|+|++|.|||++.   ++. +.|.||+.+..-.
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                           3345799999999999987   455 5899999987643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.81  E-value=6.2e-05  Score=77.98  Aligned_cols=71  Identities=7%  Similarity=0.093  Sum_probs=46.4

Q ss_pred             ccee-ccCCceeEEEEEeC-------CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCC-CC----------C---
Q 042853          461 ANRL-GQGGFGPVYKGKLQ-------DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHT-NL----------G---  515 (614)
Q Consensus       461 ~~~l-G~G~fg~Vy~g~~~-------~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~-nl----------~---  515 (614)
                      .+.| +.|....+|+....       ++..+++|.-....   ......+..|+.++..+... .+          .   
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88888999988764       25677888764322   11124678888888877532 33          1   


Q ss_pred             -CeeEEEEEecCCCCHH
Q 042853          516 -GERLLVYEYLPNKSLD  531 (614)
Q Consensus       516 -~~~~lv~Ey~~~gsL~  531 (614)
                       +..++||||+++..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             2357999999886653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.70  E-value=0.00017  Score=71.40  Aligned_cols=127  Identities=18%  Similarity=0.168  Sum_probs=83.2

Q ss_pred             ceeccCCce-eEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFG-PVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg-~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~Ey~~~g  528 (614)
                      +.+..|..+ .||+.... ++..+.+|+-..   ....++..|...|+.+.. .+           .+..++|||++++.
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~-~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTA-FMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTT-TSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhcc-CCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            345555555 58987765 456788887543   234568889999988853 34           45678999999998


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY-------------------------------------------  565 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------  565 (614)
                      ++.......       ...+..++.++++.|.-||..                                           
T Consensus       106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            776543211       011223344444444444421                                           


Q ss_pred             ------------CCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          566 ------------SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       566 ------------~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                                  .++.++|+|+.+.|||++++..+-|.||+.|..-
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                        1123899999999999998877789999998754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.61  E-value=0.00045  Score=70.63  Aligned_cols=132  Identities=15%  Similarity=0.194  Sum_probs=76.6

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcC-----CCCC------------CCeeEEEEEe
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----HTNL------------GGERLLVYEY  524 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----H~nl------------~~~~~lv~Ey  524 (614)
                      +.|+.|..+.||+....++. +++|.....    ..++..|..++..|.     .|.+            .+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTEE-EEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCCC-EEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            45666778999998876554 888888642    123334555554442     2333            2356899999


Q ss_pred             cCCCCHH-----------H---HHhhc-C----C------CCCCCHHHHHH-----------------------------
Q 042853          525 LPNKSLD-----------F---FIFDS-S----R------KSLLDWKKRFS-----------------------------  550 (614)
Q Consensus       525 ~~~gsL~-----------~---~l~~~-~----~------~~~l~~~~~~~-----------------------------  550 (614)
                      +++..+.           .   .++.. .    .      .....|...+.                             
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542           0   01110 0    0      01124432110                             


Q ss_pred             --HHHHHHHHHHHHHh----------CCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          551 --IIEGITQGLLYLHK----------YSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       551 --i~~~ia~gL~yLH~----------~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                        +...+.+++.+|++          ..+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence              11223446667763          1245699999999999998778899999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.53  E-value=0.00048  Score=72.43  Aligned_cols=68  Identities=18%  Similarity=0.204  Sum_probs=45.3

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCCCc-------chhHhHHHHHHHHHhcCC--CCC--------CCeeEEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-------QGIVEFKNEAKLIAKLQH--TNL--------GGERLLVY  522 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~f~~E~~~l~~l~H--~nl--------~~~~~lv~  522 (614)
                      .+.||.|.++.||++... +++.++||.......       .....+..|.+++..+.+  +..        ....++||
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm  114 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM  114 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence            468999999999999765 467899997643211       123456788888887743  222        34567999


Q ss_pred             EecCCC
Q 042853          523 EYLPNK  528 (614)
Q Consensus       523 Ey~~~g  528 (614)
                      ||+++.
T Consensus       115 E~l~g~  120 (397)
T 2olc_A          115 EDLSHL  120 (397)
T ss_dssp             CCCTTS
T ss_pred             EeCCCc
Confidence            999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.40  E-value=0.00067  Score=67.94  Aligned_cols=71  Identities=18%  Similarity=0.184  Sum_probs=53.8

Q ss_pred             ccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCC-CC-------CCeeEEEEEecCCCCH
Q 042853          460 PANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT-NL-------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       460 ~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~-nl-------~~~~~lv~Ey~~~gsL  530 (614)
                      ..+.+|.|..+.||+..+.+|+.+.+|+-..........|..|+..|+.|... .+       .+..++||||++.+..
T Consensus        19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVDERPP   97 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCCCCCC
T ss_pred             EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeecccCC
Confidence            35789999999999999999999999987554444445688999999988532 23       2345789999987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.88  E-value=0.0063  Score=61.63  Aligned_cols=135  Identities=19%  Similarity=0.193  Sum_probs=77.9

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------------CCeeEEEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------------GGERLLVYE  523 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------------~~~~~lv~E  523 (614)
                      .+.|+.|....+|+....++ .+++|.....  ....++..|+.++..+....+                 .+..++++|
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            35677788899999887655 5778877542  122345667777776643222                 134578999


Q ss_pred             ecCCCCHHH----H----------HhhcC----CC-----CCCCHHHHHH------------HHHHHHHHHHHHHhC---
Q 042853          524 YLPNKSLDF----F----------IFDSS----RK-----SLLDWKKRFS------------IIEGITQGLLYLHKY---  565 (614)
Q Consensus       524 y~~~gsL~~----~----------l~~~~----~~-----~~l~~~~~~~------------i~~~ia~gL~yLH~~---  565 (614)
                      |+++..+..    .          ++...    ..     ....|...+.            +...+.+.+.++++.   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            999865311    0          11110    00     0112433211            011244556666532   


Q ss_pred             -CCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          566 -SRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       566 -~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                       .+..++|+|+.+.|||++.+..+.|.||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence             234699999999999999875568999998864

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.88  E-value=0.0052  Score=65.04  Aligned_cols=32  Identities=16%  Similarity=0.240  Sum_probs=27.9

Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       567 ~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +..++|+|++|.|||++.+. ++|.||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            45699999999999998776 999999988753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.66  E-value=0.0086  Score=60.70  Aligned_cols=129  Identities=21%  Similarity=0.223  Sum_probs=81.4

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCC-CC-----------CCeeEEEEEecCCC
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT-NL-----------GGERLLVYEYLPNK  528 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~-nl-----------~~~~~lv~Ey~~~g  528 (614)
                      .+.|+.|....+|+... ++..+++|.-...   ....|..|.+.|+.|... .+           .+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46789999999999876 4567888876432   345688899988888532 22           24578999999987


Q ss_pred             CHHH-----------HHhhcCC-C------------------CCCCHHHHHH---HH----------------HHHHHHH
Q 042853          529 SLDF-----------FIFDSSR-K------------------SLLDWKKRFS---II----------------EGITQGL  559 (614)
Q Consensus       529 sL~~-----------~l~~~~~-~------------------~~l~~~~~~~---i~----------------~~ia~gL  559 (614)
                      .+..           -|+.... .                  -.-+|...+.   +.                ..+...+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6421           1121111 0                  0125654321   11                1111111


Q ss_pred             -HHHHh-CCCCceEecCCCCCCEEEcCCCcEEEeecC
Q 042853          560 -LYLHK-YSRLRVIHRDLKVSNILLDEQMNPKISDFG  594 (614)
Q Consensus       560 -~yLH~-~~~~~iiHrDlkp~NILld~~~~~kI~DFG  594 (614)
                       ..|.. ..++.+||+|+.+.|++++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             23422 2356799999999999999887 8999984

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.52  E-value=0.012  Score=59.07  Aligned_cols=132  Identities=14%  Similarity=0.111  Sum_probs=71.5

Q ss_pred             cceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEec-CCCCHH
Q 042853          461 ANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYL-PNKSLD  531 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~-~~gsL~  531 (614)
                      .+.|+.|....+|+.     ..+++|.-..... .......|+.++..+....+        ...-++++||+ ++..|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l~   96 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTMS   96 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEECC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccCC
Confidence            477888999999998     4577777654221 12233568877777654333        22356899999 554442


Q ss_pred             HH------------------HhhcCC--CCCCCHHHHH-HHHH--------------HHHHHHH----HHHh-CCCCceE
Q 042853          532 FF------------------IFDSSR--KSLLDWKKRF-SIIE--------------GITQGLL----YLHK-YSRLRVI  571 (614)
Q Consensus       532 ~~------------------l~~~~~--~~~l~~~~~~-~i~~--------------~ia~gL~----yLH~-~~~~~ii  571 (614)
                      ..                  ++....  ....+...++ .+..              .+.+.+.    .|.. ..+..++
T Consensus        97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~  176 (301)
T 3dxq_A           97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC  176 (301)
T ss_dssp             HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred             HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence            10                  011100  0001111111 1100              1111111    1211 2334589


Q ss_pred             ecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          572 HRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       572 HrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      |+|+.+.||| ..++.+.|+||..|..-
T Consensus       177 HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          177 HCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             ccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            9999999999 55667899999988753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.29  E-value=0.015  Score=59.19  Aligned_cols=33  Identities=24%  Similarity=0.339  Sum_probs=28.3

Q ss_pred             CCceEecCCCCCCEEEcCC----CcEEEeecCcceee
Q 042853          567 RLRVIHRDLKVSNILLDEQ----MNPKISDFGMARTF  599 (614)
Q Consensus       567 ~~~iiHrDlkp~NILld~~----~~~kI~DFGla~~~  599 (614)
                      +..++|+|+.+.|||++.+    ..+.|.||+.|..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4569999999999999874    67999999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.21  E-value=0.036  Score=56.05  Aligned_cols=134  Identities=13%  Similarity=0.179  Sum_probs=76.7

Q ss_pred             ceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------------CCeeEEEEEec
Q 042853          462 NRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------------GGERLLVYEYL  525 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------------~~~~~lv~Ey~  525 (614)
                      ..|+ |....||+....+++.+++|...... ....++..|..++..+....+                .+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 77788998877667778899875321 123456677777777643222                12346799999


Q ss_pred             CCCCHH-----HH---------Hhh--cC----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 042853          526 PNKSLD-----FF---------IFD--SS----RKSLLDWKKR----FSI---------------IEGITQGLLYLHK--  564 (614)
Q Consensus       526 ~~gsL~-----~~---------l~~--~~----~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~--  564 (614)
                      ++..+.     ..         ++.  ..    .....++...    ..+               ...+.+.+..+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875432     10         111  00    0112232211    001               1111122333332  


Q ss_pred             --CCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          565 --YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       565 --~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                        ..+..++|+|+++.|||++ + .+.|.||+.+..-
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence              1244589999999999999 4 8999999887654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.07  E-value=0.054  Score=57.86  Aligned_cols=69  Identities=16%  Similarity=0.151  Sum_probs=43.6

Q ss_pred             cceeccCCceeEEEEEeCC-ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCCee------EEEEEecCCCCH
Q 042853          461 ANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER------LLVYEYLPNKSL  530 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~~~------~lv~Ey~~~gsL  530 (614)
                      .+.|+.|-...+|+....+ +..+.+|...... .....-..|..++..|...++....      .+||||+++..|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~G~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFTNGRIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEETTEEEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCCeEEEEeeCCccC
Confidence            3678888889999998865 4667777664322 1111225899999988766663222      359999987443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.97  E-value=0.017  Score=61.26  Aligned_cols=67  Identities=15%  Similarity=0.280  Sum_probs=44.9

Q ss_pred             cceeccCCceeEEEEEeCC--------ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCCee------EEEEEecC
Q 042853          461 ANRLGQGGFGPVYKGKLQD--------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER------LLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~~~------~lv~Ey~~  526 (614)
                      .+.|+.|....+|+...++        +..+.+|+....  .....+..|..++..+...++....      .+|+||++
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~g~v~e~l~  155 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEYIP  155 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECCCC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCCCEEEEEeC
Confidence            4678888889999998753        467888876331  1114566899988888655552221      36899998


Q ss_pred             CCC
Q 042853          527 NKS  529 (614)
Q Consensus       527 ~gs  529 (614)
                      +..
T Consensus       156 G~~  158 (429)
T 1nw1_A          156 SRP  158 (429)
T ss_dssp             EEE
T ss_pred             Ccc
Confidence            633

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.78  E-value=0.042  Score=57.16  Aligned_cols=137  Identities=18%  Similarity=0.214  Sum_probs=77.6

Q ss_pred             cceeccCCceeEEEEEeCC--------ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCCee------EEEEEecC
Q 042853          461 ANRLGQGGFGPVYKGKLQD--------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER------LLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~~~------~lv~Ey~~  526 (614)
                      .+.|..|-...+|+....+        ++.+.+|+--. .......+.+|.++++.+.-..+....      .+||||++
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g~v~e~i~  133 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEGRLEQYIP  133 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTEEEEECCS
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCccEEEEec
Confidence            3567777788899988752        36788887532 222345567899998888654552211      28999999


Q ss_pred             CCCHHHH-----------------HhhcC--CCCCCC--HHHHHHHHHHHH-------------------HHHHHHH---
Q 042853          527 NKSLDFF-----------------IFDSS--RKSLLD--WKKRFSIIEGIT-------------------QGLLYLH---  563 (614)
Q Consensus       527 ~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia-------------------~gL~yLH---  563 (614)
                      +..|..-                 |+...  -.....  |.+..++..++.                   +.+..|.   
T Consensus       134 G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L  213 (379)
T 3feg_A          134 SRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLL  213 (379)
T ss_dssp             EEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHH
T ss_pred             CccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHH
Confidence            7554210                 11110  011122  333333333321                   2233332   


Q ss_pred             -h-CCCCceEecCCCCCCEEEcCC----CcEEEeecCccee
Q 042853          564 -K-YSRLRVIHRDLKVSNILLDEQ----MNPKISDFGMART  598 (614)
Q Consensus       564 -~-~~~~~iiHrDlkp~NILld~~----~~~kI~DFGla~~  598 (614)
                       . ..+..++|+|+.+.|||++.+    ..+.|+||..|..
T Consensus       214 ~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          214 ESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence             2 223469999999999999876    6899999998874

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.53  E-value=0.032  Score=57.68  Aligned_cols=68  Identities=10%  Similarity=0.135  Sum_probs=39.8

Q ss_pred             cceeccCCceeEEEEEeCCc---------cEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCC------CeeEEEEEec
Q 042853          461 ANRLGQGGFGPVYKGKLQDE---------QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG------GERLLVYEYL  525 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~---------~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~------~~~~lv~Ey~  525 (614)
                      ...|+.|....+|+....++         ..+++|..... .........|..++..+....+.      ..-.+||||+
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~~~~v~e~i  116 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-VDELYNTISEFEVYKTMSKYKIAPQLLNTFNGGRIEEWL  116 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-GGGTSCHHHHHHHHHHHHHTTSSCCEEEEETTEEEEECC
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-ccceecHHHHHHHHHHHHhcCCCCceEEecCCcEEEEEe
Confidence            35677788889999887542         56777765432 22222346788888777543431      1236899999


Q ss_pred             CCCC
Q 042853          526 PNKS  529 (614)
Q Consensus       526 ~~gs  529 (614)
                      ++..
T Consensus       117 ~G~~  120 (369)
T 3c5i_A          117 YGDP  120 (369)
T ss_dssp             CSEE
T ss_pred             cCCc
Confidence            8754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.88  E-value=0.17  Score=51.63  Aligned_cols=34  Identities=18%  Similarity=0.287  Sum_probs=29.2

Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       567 ~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      +..++|+|+.+.|||++.++.+.|.||+.+..-.
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            3569999999999999987789999999887543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.32  E-value=0.8  Score=48.15  Aligned_cols=69  Identities=13%  Similarity=0.173  Sum_probs=44.5

Q ss_pred             cceeccCCceeEEEEEeCC--------ccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCC------eeEEEEEecC
Q 042853          461 ANRLGQGGFGPVYKGKLQD--------EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGG------ERLLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~------~~~lv~Ey~~  526 (614)
                      .+.|..|-...+|+....+        ++.+.+|+-.... +....-.+|..++..+....+..      .-.+||||++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~~~~I~efI~  153 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFPEGRIEEFID  153 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEETTEEEEECCC
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcCCCEEEEEeC
Confidence            4567777788899988763        4678888753322 22223467888888876444522      2268999999


Q ss_pred             CCCH
Q 042853          527 NKSL  530 (614)
Q Consensus       527 ~gsL  530 (614)
                      +..|
T Consensus       154 G~~l  157 (424)
T 3mes_A          154 GEPL  157 (424)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            8653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.25  E-value=0.78  Score=47.83  Aligned_cols=30  Identities=30%  Similarity=0.387  Sum_probs=25.2

Q ss_pred             ceEecCCCCCCEEE------cCCCcEEEeecCccee
Q 042853          569 RVIHRDLKVSNILL------DEQMNPKISDFGMART  598 (614)
Q Consensus       569 ~iiHrDlkp~NILl------d~~~~~kI~DFGla~~  598 (614)
                      .++|+|+.+.|||+      +++..++++||-+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4566799999998874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	614
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-41
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-37
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-36
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-35
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-34
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-34
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-33
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-33
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-32
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-31
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-31
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-30
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-30
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-30
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-30
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-29
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-29
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-28
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-28
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-28
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-28
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-26
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-25
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-25
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-24
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-24
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-24
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-24
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-23
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-23
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-22
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-21
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-21
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-21
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-21
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-20
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-20
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-19
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-19
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-19
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-18
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-17
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-17
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	5e-13
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-13
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	4e-08
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	2e-07
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	2e-06
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	2e-04
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	0.002
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 9e-41
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 13/167 (7%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
              +   R+G G FG VYKGK   +  + +  ++  + Q +  FKNE  ++ K +H N+ 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
                    +  +V ++    SL   +     ++  +  K   I     QG+ YLH    
Sbjct: 68  LFMGYSTAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH---A 122

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             +IHRDLK +NI L E +  KI DFG+A   +         ++ G+
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-37
 Identities = 39/175 (22%), Positives = 74/175 (42%), Gaps = 20/175 (11%)

Query: 451 IAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           + +  D+F   + LG G  G V+K         +A K +       I      E +++ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 509 LQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                +          GE  +  E++   SLD  +  + R   +  +    +   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            YL    + +++HRD+K SNIL++ +   K+ DFG++        ++  N  VGT
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGT 166

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-36
 Identities = 49/162 (30%), Positives = 75/162 (46%), Gaps = 13/162 (8%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
           +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  L 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
                       ++ EY+ N SL  F+   S    L   K   +   I +G+ ++ +   
Sbjct: 72  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE--- 127

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
              IHRDL+ +NIL+ + ++ KI+DFG+AR    NE  A   
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-35
 Identities = 38/164 (23%), Positives = 70/164 (42%), Gaps = 15/164 (9%)

Query: 455 TDNFSPANRLGQGGFGPVYKGKLQDEQEI-AIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 513
            D +     LG G FG VYK + ++   + A K +   S + + ++  E  ++A   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +              ++ E+    ++D  + +  R   L   +   + +     L YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH- 127

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
               ++IHRDLK  NIL     + K++DFG++   T      ++
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (334), Expect = 4e-35
 Identities = 52/173 (30%), Positives = 72/173 (41%), Gaps = 25/173 (14%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 510
              FS    +G G FG VY  + +++ + +AIK++S S  Q      +   E + + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H N               LV EY    + D        K  L   +  ++  G  QGL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +IHRD+K  NILL E    K+ DFG A            N  VGT
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGT 174

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (330), Expect = 9e-35
 Identities = 46/191 (24%), Positives = 81/191 (42%), Gaps = 28/191 (14%)

Query: 446 FDFQTIAVATDNFSPA---------NRLGQGGFGPVYKGKL----QDEQEIAIKRLSKS- 491
           F F+    A   F+             +G G FG V  G L    + E  +AIK L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 492 SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSL 542
           + +   +F +EA ++ +  H N+             +++ E++ N SLD F+  +  +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 543 LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
               +   ++ GI  G+ YL        +HRDL   NIL++  +  K+SDFG++R    +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 603 ELEANTNRIVG 613
             +      +G
Sbjct: 182 TSDPTYTSALG 192

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-34
 Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 17/170 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHT 512
           +++     +G G +G   K +   D + +  K L   S          +E  L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 513 NL-----------GGERLLVYEYLPNKSLDFFIFDSSR-KSLLDWKKRFSIIEGITQGLL 560
           N+                +V EY     L   I   ++ +  LD +    ++  +T  L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 561 YLHKYSR--LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
             H+ S     V+HRDLK +N+ LD + N K+ DFG+AR    +   A  
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (328), Expect = 2e-34
 Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 40/205 (19%)

Query: 447 DFQTIAVATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIV-EF 499
              ++    +N      +G+G FG V++ +       +    +A+K L + +   +  +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 500 KNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSL-------- 542
           + EA L+A+  + N+         G    L++EY+    L+ F+   S  ++        
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 543 -------------LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPK 589
                        L   ++  I   +  G+ YL +    + +HRDL   N L+ E M  K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180

Query: 590 ISDFGMARTFTMNELEANTNRIVGT 614
           I+DFG++R     +           
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIP 205

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-34
 Identities = 47/170 (27%), Positives = 71/170 (41%), Gaps = 17/170 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 513
           +++     LG+G +G V        E+ +A+K +         E  K E  +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +         G  + L  EY     L   I        +           +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH- 120

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
              + + HRD+K  N+LLDE+ N KISDFG+A  F  N  E   N++ GT
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 7e-34
 Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 13/165 (7%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
           ++     +LGQG FG V+ G       +AIK L   +      F  EA+++ KL+H  L 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 515 -------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
                       +V EY+   SL  F+   + K L    +   +   I  G+ Y+ +   
Sbjct: 76  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM-- 132

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
              +HRDL+ +NIL+ E +  K++DFG+AR    NE  A      
Sbjct: 133 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 3e-33
 Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 16/168 (9%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
            + +    LG G FG V  GK + + ++AIK + + S     EF  EAK++  L H  L 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                        ++ EY+ N  L  ++ +   +     ++   + + + + + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE--- 117

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             + +HRDL   N L+++Q   K+SDFG++R    +E  ++       
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFP 164

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-33
 Identities = 39/176 (22%), Positives = 74/176 (42%), Gaps = 19/176 (10%)

Query: 453 VATDNFSPANR-LGQGGFGPVYKGKLQ---DEQEIAIKRLSKSSGQGIVE-FKNEAKLIA 507
           +  DN   A+  LG G FG V +G  +    + ++AIK L + + +   E    EA+++ 
Sbjct: 5   LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 64

Query: 508 KLQHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           +L +  +            +LV E      L  F+    ++  +       ++  ++ G+
Sbjct: 65  QLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEAN-TNRIVGT 614
            YL        +HRDL   N+LL  +   KISDFG+++    ++      +     
Sbjct: 123 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  125 bits (315), Expect = 7e-33
 Identities = 38/164 (23%), Positives = 78/164 (47%), Gaps = 15/164 (9%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 514
            + +  ++LG G +G VY+G  +     +A+K L + + + + EF  EA ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                         ++ E++   +L  ++ + +R+  +       +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN 609
            +   IHRDL   N L+ E    K++DFG++R  T +   A+  
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-32
 Identities = 40/168 (23%), Positives = 75/168 (44%), Gaps = 16/168 (9%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
              +    +G G FG V+ G   ++ ++AIK + + +     +F  EA+++ KL H  L 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                        LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
              VIHRDL   N L+ E    K+SDFGM R    ++   ++      
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-31
 Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 17/158 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL- 514
                   +G+G FG V  G  +   ++A+K +   +      F  EA ++ +L+H+NL 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLV 63

Query: 515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                     G   +V EY+   SL  ++  S  +S+L           + + + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
                +HRDL   N+L+ E    K+SDFG+ +  +  +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 6e-31
 Identities = 40/172 (23%), Positives = 71/172 (41%), Gaps = 26/172 (15%)

Query: 463 RLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-------- 514
            +G+G FG V++GK +  +E+A+K  S    +     + E      L+H N+        
Sbjct: 10  SIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67

Query: 515 -----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK----- 564
                  +  LV +Y  + SL  ++     +  +  +    +      GL +LH      
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF--TMNELEANTNRIVGT 614
             +  + HRDLK  NIL+ +     I+D G+A       + ++   N  VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 8e-31
 Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 21/190 (11%)

Query: 435 SDQTVKRDLKIFDFQTIAVATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSG 493
           SD+ +   L+     ++      ++   ++GQG  G VY    +   QE+AI++++    
Sbjct: 1   SDEEILEKLR--SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 494 QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLD 544
                  NE  ++ + ++ N+         G E  +V EYL   SL   + ++      D
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----D 114

Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
             +  ++     Q L +LH     +VIHRD+K  NILL    + K++DFG     T    
Sbjct: 115 EGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169

Query: 605 EANTNRIVGT 614
           ++  + +VGT
Sbjct: 170 QSKRSTMVGT 179

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-30
 Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 23/172 (13%)

Query: 456 DNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G FG VY  +  Q +  +A+K L K+         + + E ++ + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL 562
            N+              L+ EY P  ++   +   S+    D ++  + I  +   L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           H     RVIHRD+K  N+LL      KI+DFG +     +        + GT
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-30
 Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 19/173 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKL 509
             F     LG G FG VYKG    E E     +AIK L ++ S +   E  +EA ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 510 QHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            + ++             L+ + +P   L  ++ +   K  +  +   +    I +G+ Y
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 126

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           L      R++HRDL   N+L+    + KI+DFG+A+     E E +       
Sbjct: 127 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-30
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 22/169 (13%)

Query: 457 NFSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQH 511
           +F+    +G+G FG VY G L D    +   A+K L++ +  G V  F  E  ++    H
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 512 TNL----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            N+           G  L+V  Y+ +  L  FI + +    +     F +          
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK-----G 142

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR 610
           +   +  + +HRDL   N +LDE+   K++DFG+AR     E ++  N+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 4e-30
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 20/180 (11%)

Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKL----QDEQEIAIKRLSK---SSGQGIVEFKNE 502
           T  +   +     +LG G FG V +G+          +A+K L     S  + + +F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 503 AKLIAKLQHTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG 554
              +  L H NL             +V E  P  SL   +       LL    R+++   
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--Q 119

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           + +G+ YL      R IHRDL   N+LL  +   KI DFG+ R    N+           
Sbjct: 120 VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 5e-30
 Identities = 39/167 (23%), Positives = 67/167 (40%), Gaps = 20/167 (11%)

Query: 462 NRLGQGGFGPVYKGKLQDE---QEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTNL-- 514
             LG G FG V KG  Q +   + +A+K L   +    +  E   EA ++ +L +  +  
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                     +LV E      L+ ++  +     +  K    ++  ++ G+ YL      
Sbjct: 73  MIGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ES 126

Query: 569 RVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTN-RIVGT 614
             +HRDL   N+LL  Q   KISDFG+++    +E            
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 6e-30
 Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 33/186 (17%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQD---EQEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-Q 510
           ++    + +G+G FG V K +++      + AIKR+ + +S     +F  E +++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFI-------------FDSSRKSLLDWKKR 548
           H N+          G   L  EY P+ +L  F+               +S  S L  ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 549 FSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
                 + +G+ YL +    + IHRDL   NIL+ E    KI+DFG++R   +       
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 609 NRIVGT 614
                 
Sbjct: 184 TMGRLP 189

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 9e-30
 Identities = 45/191 (23%), Positives = 66/191 (34%), Gaps = 35/191 (18%)

Query: 456 DNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           +  S    LG G FG V +              +A+K L  S+     E   +E K+++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 509 L-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSL---------------L 543
           L  H N+         GG  L++ EY     L  F+       +               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 544 DWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
           D +   S    + +G+ +L        IHRDL   NILL      KI DFG+AR    + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 604 LEANTNRIVGT 614
                      
Sbjct: 200 NYVVKGNARLP 210

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 3e-29
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 20/174 (11%)

Query: 450 TIAVATDNFSPANRLGQGGFGPVYKGKLQD-----EQEIAIKRLSKSSGQG-IVEFKNEA 503
           T  +     +    +G G FG VYKG L+      E  +AIK L     +   V+F  EA
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 504 KLIAKLQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEG 554
            ++ +  H N+             +++ EY+ N +LD F+ +  +       +   ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRG 118

Query: 555 ITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
           I  G+ YL     +  +HRDL   NIL++  +  K+SDFG++R    +     T
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 3e-29
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 25/170 (14%)

Query: 462 NRLGQGGFGPVYKGKL-QDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL---- 514
             +G+G F  VYKG   +   E+A   L     +      FK EA+++  LQH N+    
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                        +LV E + + +L  ++    R  ++  K   S    I +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 566 SRLRVIHRDLKVSNILL-DEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           +   +IHRDLK  NI +     + KI D G+A     +        ++GT
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 7e-29
 Identities = 38/196 (19%), Positives = 66/196 (33%), Gaps = 40/196 (20%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 508
           +N      LG G FG V               ++A+K L + +     E   +E K++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 509 L-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRK------------------ 540
           L  H N+          G   L++EY     L  ++     K                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 541 --SLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART 598
             ++L ++        + +G+ +L        +HRDL   N+L+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 599 FTMNELEANTNRIVGT 614
              +            
Sbjct: 214 IMSDSNYVVRGNARLP 229

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (285), Expect = 8e-29
 Identities = 43/171 (25%), Positives = 65/171 (38%), Gaps = 19/171 (11%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           ++F     LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL 562
                         +      Y  N  L  +I         D            + +  L
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETC---TRFYTAEIVSAL 121

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVG 613
                  +IHRDLK  NILL+E M+ +I+DFG A+  +    +A  N  VG
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-28
 Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 26/182 (14%)

Query: 456 DNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKS-SGQGIVEFKNEAKLIAK 508
           +  + +  LGQG FG VY+G        + E  +AIK ++++ S +  +EF NEA ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 509 LQHTNL---------GGERLLVYEYLPNKSLDFFIF-------DSSRKSLLDWKKRFSII 552
               ++         G   L++ E +    L  ++        ++   +     K   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
             I  G+ YL+     + +HRDL   N ++ E    KI DFGM R     +      + +
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 613 GT 614
             
Sbjct: 197 LP 198

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  115 bits (288), Expect = 1e-28
 Identities = 32/157 (20%), Positives = 62/157 (39%), Gaps = 17/157 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 514
           D++     LG G FG V++          A K +           + E + ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                      E +++YE++    L   + D   K  +   +    +  + +GL ++H+ 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE- 142

Query: 566 SRLRVIHRDLKVSNILLDEQMNP--KISDFGMARTFT 600
                +H DLK  NI+   + +   K+ DFG+     
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 33/172 (19%), Positives = 61/172 (35%), Gaps = 19/172 (11%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQ 510
           +       +G+G FG V++G     +     +AIK     +   + E F  EA  + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 511 HTNL--------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL 562
           H ++             ++ E      L  F+        LD          ++  L YL
Sbjct: 67  HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYL 124

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                 R +HRD+   N+L+      K+ DFG++R    +      ++    
Sbjct: 125 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLP 172

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  113 bits (284), Expect = 5e-28
 Identities = 35/161 (21%), Positives = 65/161 (40%), Gaps = 17/161 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 514
           D +     LG G FG V++       +    K ++          KNE  ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                      E +L+ E+L    L   I  ++    +   +  + +    +GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 566 SRLRVIHRDLKVSNILLDEQMNP--KISDFGMARTFTMNEL 604
               ++H D+K  NI+ + +     KI DFG+A     +E+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  113 bits (284), Expect = 5e-28
 Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 22/165 (13%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNE---AKLIAK 508
           ++FS    +G+GGFG VY  +     +  A+K L K      QG     NE     L++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 509 LQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                +           +   + + +    L + +   S+  +            I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
            ++H      V++RDLK +NILLDE  + +ISD G+A  F+  + 
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 9e-28
 Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 14/160 (8%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 512
              ++  + +G+G +G V       ++  +AIK++S    Q   +    E K++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+              +   YL    +   ++   +   L        +  I +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
                 V+HRDLK SN+LL+   + KI DFG+AR    + 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-27
 Identities = 39/190 (20%), Positives = 67/190 (35%), Gaps = 34/190 (17%)

Query: 456 DNFSPANRLGQGGFGPVYKG------KLQDEQEIAIKRLSKSSGQG-IVEFKNEAKLIAK 508
           D       LG+G FG V +       K    + +A+K L + +         +E K++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 509 LQHTNL-----------GGERLLVYEYLPNKSLDFFIF-------------DSSRKSLLD 544
           + H              GG  +++ E+    +L  ++              +   K  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 545 WKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL 604
            +        + +G+ +L      + IHRDL   NILL E+   KI DFG+AR    +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 605 EANTNRIVGT 614
                     
Sbjct: 190 YVRKGDARLP 199

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (265), Expect = 7e-26
 Identities = 36/160 (22%), Positives = 64/160 (40%), Gaps = 19/160 (11%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
            +F     LG G FG V+  +   + +  A+K L K      + +    +E  +++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 512 TNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYL 562
             +           +  ++ +Y+    L   +  S R      K   + +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 563 HKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
                  +I+RDLK  NILLD+  + KI+DFG A+     
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  105 bits (262), Expect = 9e-26
 Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 29/179 (16%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE---------FKNEAKL 505
           +N+ P   LG+G    V +       +E A+K +  + G                 E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 506 IAKLQ-HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGI 555
           + K+  H N+              LV++ +    L  ++   + K  L  K+   I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
            + +  LH   +L ++HRDLK  NILLD+ MN K++DFG +      E       + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 5e-25
 Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 35/191 (18%)

Query: 456 DNFSPANRLGQGGFGPVYKGKL--------QDEQEIAIKRLSK-SSGQGIVEFKNEAKLI 506
           D       LG+G FG V   +             ++A+K L   ++ + + +  +E +++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 507 AKL-QHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSL-------------L 543
             + +H N+          G   ++ EY    +L  ++       L             L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 544 DWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
             K   S    + +G+ YL      + IHRDL   N+L+ E    KI+DFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 604 LEANTNRIVGT 614
               T      
Sbjct: 190 YYKKTTNGRLP 200

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  103 bits (258), Expect = 6e-25
 Identities = 36/171 (21%), Positives = 68/171 (39%), Gaps = 17/171 (9%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 512
            D +   + LG G F  V   +  + ++ +AIK ++K + +G     +NE  ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+         GG   L+ + +    L   I     K     +    +I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
               +    +   +    LDE     ISDFG+++      +    +   GT
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  102 bits (254), Expect = 1e-24
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 17/164 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN 513
           + +    ++G+G +G VYK +    +  A+K  RL K           E  ++ +L+H+N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +             +LV+E+L              +  L+     S +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 565 YSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANT 608
               RV+HRDLK  N+L++ +   KI+DFG+AR F +   +   
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-24
 Identities = 33/160 (20%), Positives = 69/160 (43%), Gaps = 18/160 (11%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 514
           + +  A  LG+G FG V++      ++    K + K  G   V  K E  ++   +H N+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63

Query: 515 ---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
                      E ++++E++    +   I  ++    L+ ++  S +  + + L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLH-- 119

Query: 566 SRLRVIHRDLKVSNILLDEQMNP--KISDFGMARTFTMNE 603
               + H D++  NI+   + +   KI +FG AR     +
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  100 bits (250), Expect = 3e-24
 Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 24/178 (13%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 510
           +D +     LG GG   V+  + L+  +++A+K L     +     + F+ EA+  A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 511 HTNL-------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           H  +             G    +V EY+   +L   +        +  K+   +I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN-ELEANTNRIVGT 614
            L + H   +  +IHRD+K +NI++      K+ DFG+AR    +      T  ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 4e-24
 Identities = 42/165 (25%), Positives = 69/165 (41%), Gaps = 24/165 (14%)

Query: 456 DNFSPANRLGQGGFGPVYKGKL-QDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 514
            +++    +G G FG VY+ KL    + +AIK++ +           E +++ KL H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75

Query: 515 ---------GGER------LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
                     GE+       LV +Y+P          S  K  L        +  + + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 560 LYLHKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTFTMNE 603
            Y+H      + HRD+K  N+LLD +    K+ DFG A+     E
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =   99 bits (248), Expect = 1e-23
 Identities = 38/181 (20%), Positives = 80/181 (44%), Gaps = 28/181 (15%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHT 512
             +    ++GQG FG V+K +  +  Q++A+K++   + +    +    E K++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 513 NL-----------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGI 555
           N+                  G   LV+++  +           + +L + K+   ++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126

Query: 556 TQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNR--IVG 613
              L  L+   R +++HRD+K +N+L+      K++DFG+AR F++ +          V 
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 614 T 614
           T
Sbjct: 184 T 184

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 1e-23
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 17/160 (10%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 512
           +NF    ++G+G +G VYK +     + +A+K++     +         E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+L      F   D+S  + +      S +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
            +   RV+HRDLK  N+L++ +   K++DFG+AR F +  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 4e-23
 Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 21/156 (13%)

Query: 462 NRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQHTNL- 514
           + LG+G F  VYK +     Q +AIK++         +        E KL+ +L H N+ 
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 515 --------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYS 566
                        LV++++                +L      + +    QGL YLH++ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
              ++HRDLK +N+LLDE    K++DFG+A++F   
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 8e-23
 Identities = 38/175 (21%), Positives = 70/175 (40%), Gaps = 21/175 (12%)

Query: 453 VATDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAK 508
           V  ++F     LG+G FG V   +     +  A+K L K    +   +     E++++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 509 LQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
            +H  L               V EY     L F +   SR+ +   ++         + +
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIV 115

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
             L       V++RD+K+ N++LD+  + KI+DFG+ +    +   A      GT
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 22/173 (12%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSG---QGIVEFKNEAKLIAK-LQ 510
           ++F     LG+G FG V+  +  +  Q  AIK L K        +     E ++++   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 511 HTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
           H  L               V EYL    L + I    +    D  +       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
           LH      +++RDLK+ NILLD+  + KI+DFGM +   +   +A TN   GT
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGT 166

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 92.9 bits (230), Expect = 4e-21
 Identities = 37/157 (23%), Positives = 57/157 (36%), Gaps = 13/157 (8%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 511
           D F     LG G FG V   K  +     A+K L K      + I    NE +++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 512 TNL------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY 565
             L        +   +Y  +   +         R               I     YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 159

Query: 566 SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
             L +I+RDLK  N+L+D+Q   +++DFG A+     
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.5 bits (229), Expect = 4e-21
 Identities = 35/158 (22%), Positives = 65/158 (41%), Gaps = 27/158 (17%)

Query: 464 LGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL------- 514
           LG G  G V +    + +++ A+K L         + + E +L  +  Q  ++       
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 74

Query: 515 ------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRL 568
                     L+V E L    L   I D   ++    ++   I++ I + + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---I 130

Query: 569 RVIHRDLKVSNILLDEQMNP---KISDFGMARTFTMNE 603
            + HRD+K  N+L   +      K++DFG A+  T + 
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 5e-21
 Identities = 39/188 (20%), Positives = 80/188 (42%), Gaps = 26/188 (13%)

Query: 438 TVKRDLKIFDF--QTIAVATDNFSPANRLGQGGFGPVYKGKL----QDEQEIAIKRLSKS 491
           TVK +L+  +       V  +NF     LG G +G V+  +        +  A+K L K+
Sbjct: 4   TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 63

Query: 492 S----GQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYEYLPNKSLDFFIFDS 537
           +     +     + E +++  ++ +              +  L+ +Y+    L   +   
Sbjct: 64  TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123

Query: 538 SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR 597
            R +  + +          + +L L    +L +I+RD+K+ NILLD   +  ++DFG+++
Sbjct: 124 ERFTEHEVQIYVG------EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177

Query: 598 TFTMNELE 605
            F  +E E
Sbjct: 178 EFVADETE 185

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.9 bits (227), Expect = 5e-21
 Identities = 40/182 (21%), Positives = 78/182 (42%), Gaps = 29/182 (15%)

Query: 454 ATDNFSPANRLGQGGFGPVYKGK--LQDEQEIAIKRLSKSSGQG--IVEFKNEAKLIAKL 509
           A   +     +G+G +G V+K +      + +A+KR+   +G+    +    E  ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 510 ---QHTNL--------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSII 552
              +H N+                +  LV+E++      +   D   +  +  +    ++
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMM 122

Query: 553 EGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
             + +GL +LH     RV+HRDLK  NIL+      K++DFG+AR ++          +V
Sbjct: 123 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVV 176

Query: 613 GT 614
            T
Sbjct: 177 VT 178

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 91.0 bits (225), Expect = 7e-21
 Identities = 31/173 (17%), Positives = 62/173 (35%), Gaps = 29/173 (16%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           R+G+G FG +++G  L + Q++AIK   + S     + ++E +    L            
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 515 ---GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVI 571
              G   +LV + L                    K      + +   +  +H      ++
Sbjct: 70  GQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123

Query: 572 HRDLKVSNILLDEQMNP-----KISDFGMARTFTMNELEAN-----TNRIVGT 614
           +RD+K  N L+    +       + DFGM + +     + +        + GT
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.4 bits (223), Expect = 1e-20
 Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 18/160 (11%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 512
             +    ++G+G +G V+K K  +  + +A+KR+               E  L+ +L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 513 NL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLH 563
           N+           +  LV+E+       +F   +        K        + Q L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS------FLFQLLKGLG 115

Query: 564 KYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE 603
                 V+HRDLK  N+L++     K+++FG+AR F +  
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 88.0 bits (217), Expect = 8e-20
 Identities = 36/173 (20%), Positives = 63/173 (36%), Gaps = 22/173 (12%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 514
           + +    ++G G FG +Y G  +   +E+AIK     +     +   E+K+   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVG 64

Query: 515 ----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
                     G   ++V E L     D F F S +      K    + + +   + Y+H 
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH- 120

Query: 565 YSRLRVIHRDLKVSNIL---LDEQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                 IHRD+K  N L     +     I DFG+A+ +       +       
Sbjct: 121 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.7 bits (214), Expect = 2e-19
 Identities = 39/171 (22%), Positives = 60/171 (35%), Gaps = 28/171 (16%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVE------FKNEAKLIAKLQ--HTN 513
            LG GGFG VY G  + D   +AIK + K       E         E  L+ K+    + 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 514 L---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHK 564
           +             +L+ E        F     + +  L  +   S    + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 565 YSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTFTMNELEANTNRIVGT 614
                V+HRD+K  NIL+D  +   K+ DFG                  GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 86.8 bits (214), Expect = 4e-19
 Identities = 42/204 (20%), Positives = 91/204 (44%), Gaps = 34/204 (16%)

Query: 430 KTQAR--SDQTVKRDLKIFDFQTIAVAT---DNFSPANRLGQGGFGPVYKGK-LQDEQEI 483
            ++AR  +D    R  + +D+++  V     D++    +LG+G +  V++   + + +++
Sbjct: 4   PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63

Query: 484 AIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL-----------GGERLLVYEYLPNKSLD 531
            +K L     +   + K E K++  L+   N+                LV+E++ N    
Sbjct: 64  VVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK 120

Query: 532 FFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKI 590
                   ++L D+  RF  +  I + L Y H    + ++HRD+K  N+++D E    ++
Sbjct: 121 QLY-----QTLTDYDIRF-YMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRL 171

Query: 591 SDFGMARTFTMNELEANTNRIVGT 614
            D+G+A  +   +     N  V +
Sbjct: 172 IDWGLAEFYHPGQ---EYNVRVAS 192

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.8 bits (214), Expect = 4e-19
 Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 26/162 (16%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 512
             +     +G G +G V      +   ++AIK+L +   S         E +L+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 513 NL---------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
           N+                 +  LV  ++             +   L   +   ++  + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF 599
           GL Y+H      +IHRDLK  N+ ++E    KI DFG+AR  
Sbjct: 133 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.2 bits (210), Expect = 7e-19
 Identities = 41/179 (22%), Positives = 69/179 (38%), Gaps = 29/179 (16%)

Query: 456 DNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKSS------GQGIVEFKNEAKLIAK 508
           D +     LG G F  V K +      + A K + K        G    + + E  ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 509 LQHTNL---------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGL 559
           +QH N+           + +L+ E +    L  F+     K  L  ++    ++ I   L
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQI---L 123

Query: 560 LYLHKYSRLRVIHRDLKVSNILLDEQMNP----KISDFGMARTFTMNELEANTNRIVGT 614
             ++    L++ H DLK  NI+L ++  P    KI DFG+A              I GT
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 2e-18
 Identities = 29/165 (17%), Positives = 54/165 (32%), Gaps = 19/165 (11%)

Query: 462 NRLGQGGFGPVYKGKLQDEQEIAIK--RLSKSSGQ--------GIVEFKNEAKLIAKLQH 511
             +G+G    V+    +   E  +K  ++  +S +        G + F   A   A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 512 TNL----GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSR 567
             L    G     VY +  N  L   I       +        +++ I + +   +    
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYHR-- 122

Query: 568 LRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNELEANTNRIV 612
             ++H DL   N+L+ E     I DF  +             R V
Sbjct: 123 -GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDV 165

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.9 bits (201), Expect = 2e-17
 Identities = 43/192 (22%), Positives = 72/192 (37%), Gaps = 36/192 (18%)

Query: 447 DFQTIAVATDNFSPANR------LGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIV 497
            F ++ V    F+   R      +G G  G V        ++ +AIK+LS+   +     
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 498 EFKNEAKLIAKLQHTNL---------------GGERLLVYEYLPNKSLDFFIFDSSRKSL 542
               E  L+  + H N+                 +  LV E +          +      
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----- 116

Query: 543 LDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
            D ++   ++  +  G+ +LH      +IHRDLK SNI++      KI DFG+ART   +
Sbjct: 117 -DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 603 ELEANTNRIVGT 614
            +       V T
Sbjct: 173 FM---MTPYVVT 181

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.9 bits (196), Expect = 9e-17
 Identities = 38/161 (23%), Positives = 65/161 (40%), Gaps = 16/161 (9%)

Query: 455 TDNFSPANRLGQGGFGPVYKGK-LQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 511
            + +   + +G G +G V      +    +A+K+LS+   S         E +L+  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 512 TNL----------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLY 561
            N+                   YL    +   + +  +   L       +I  I +GL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 562 LHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN 602
           +H      +IHRDLK SN+ ++E    KI DFG+AR     
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 63.4 bits (154), Expect = 5e-13
 Identities = 23/158 (14%), Positives = 41/158 (25%), Gaps = 51/158 (32%)

Query: 11  DKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYP 70
           + L  G+ L  G+ L      +              L +Y                    
Sbjct: 2   NLLTNGEGLYAGQSLDV--EPYHFIMQED-----CNLVLYDHS----------------- 37

Query: 71  TGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVR 130
                            VW +N        +    ++ S DGN  +       +  S   
Sbjct: 38  ---------------TSVWASNTGILG--KKGCKAVLQS-DGNFVVYDAEGRSLWASHSV 79

Query: 131 RAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDY 168
           R        L ++GN+V+Y           ++W +  Y
Sbjct: 80  RGNGNYVLVLQEDGNVVIYG---------SDIWSTGTY 108

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 68.1 bits (165), Expect = 6e-13
 Identities = 38/179 (21%), Positives = 70/179 (39%), Gaps = 36/179 (20%)

Query: 463 RLGQGGFGPVYKGK-LQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL------- 514
           +LG G F  V+  K + +   +A+K +           ++E KL+ ++   +        
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78

Query: 515 -----------------GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQ 557
                            G   ++V+E L    L        R   L + K+  I + +  
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQLLL 136

Query: 558 GLLYLHKYSRLRVIHRDLKVSNILLDEQMNP------KISDFGMARTFTMNELEANTNR 610
           GL Y+H+  R  +IH D+K  N+L++   +P      KI+D G A  +  +   +   R
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 49.5 bits (118), Expect = 4e-08
 Identities = 18/111 (16%), Positives = 35/111 (31%), Gaps = 17/111 (15%)

Query: 72  GDVSMQS------YNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIE 125
           G V + +      Y+           +     L+     L +  TD NL +L +    + 
Sbjct: 1   GSVVVANNGNSILYSTQGNDNHPQTLHATQS-LQLSPYRLSM-ETDCNL-VLFDRDDRVW 57

Query: 126 ISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFD--YPTDTLL 174
            ++    G   RA L  NG + +    +        +W S +       + 
Sbjct: 58  STNTAGKGTGCRAVLQPNGRMDVLTNQN------IAVWTSGNSRSAGRYVF 102

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 47.9 bits (113), Expect = 2e-07
 Identities = 25/162 (15%), Positives = 49/162 (30%), Gaps = 50/162 (30%)

Query: 10  TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGY 69
           +D+L  G  L  G  L    G +     +        L +Y                   
Sbjct: 1   SDRLNSGHQLDTGGSLAE--GGYLFIIQNDC-----NLVLYDNNR--------------- 38

Query: 70  PTGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSV 129
                             VW +  +          L + + DGNL I    ++    ++ 
Sbjct: 39  -----------------AVWASGTNGK---ASGCVLKMQN-DGNLVIYSGSRAIWASNTN 77

Query: 130 RRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTD 171
           R+ GN     L ++ N+V+Y+ ++        +W +     +
Sbjct: 78  RQNGNY-YLILQRDRNVVIYDNSN------NAIWATHTNVGN 112

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 44.6 bits (105), Expect = 2e-06
 Identities = 26/158 (16%), Positives = 43/158 (27%), Gaps = 52/158 (32%)

Query: 11  DKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYP 70
           + L  G+ L  GE L    G+F              L +Y                    
Sbjct: 2   NILYSGETLSTGEFLNY--GSFVFIMQEDC-----NLVLYDVD----------------- 37

Query: 71  TGDVSMQSYNQAIKPRPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVR 130
                          +P+W  N       + S  L + +   NL +      PI  S+  
Sbjct: 38  ---------------KPIWATNTGGL---SRSCFLSMQTDG-NLVVYNPSNKPIWASNTG 78

Query: 131 RAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDY 168
                    L K+ N+V+Y           + W +  +
Sbjct: 79  GQNGNYVCILQKDRNVVIYG---------TDRWATGTH 107

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 39.2 bits (91), Expect = 2e-04
 Identities = 15/78 (19%), Positives = 25/78 (32%), Gaps = 10/78 (12%)

Query: 89  WIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVL 148
              +     L   S    +  +D NL +L +    +  +S        RA L  +G LV+
Sbjct: 15  QTLHAAQS-LELSSFRFTM-QSDCNL-VLFDSDVRV-WASNTAGATGCRAVLQSDGLLVI 70

Query: 149 YEMNSDGLSIRRELWQSF 166
               +         W S 
Sbjct: 71  LTAQN------TIRWSSG 82

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 36.5 bits (84), Expect = 0.002
 Identities = 15/83 (18%), Positives = 25/83 (30%), Gaps = 13/83 (15%)

Query: 86  RPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGN 145
            P+W  N             ++   DG L ++ N    +  S V          L  + N
Sbjct: 49  NPIWATNTGGL---GNGCRAVLQP-DGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104

Query: 146 LVLYEMNSDGLSIRRELWQSFDY 168
           +V+Y            LW +   
Sbjct: 105 VVIYG---------DALWATQTV 118

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 35.8 bits (82), Expect = 0.003
 Identities = 18/127 (14%), Positives = 30/127 (23%), Gaps = 28/127 (22%)

Query: 163 WQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDK 222
            Q  D     L     L I   T               YR  + TD N    LV++ ++ 
Sbjct: 7   KQPDDNHPQILHATESLEILFGTH-------------VYRFIMQTDCN----LVLYDNNN 49

Query: 223 VVWTSTIWLNGSLKSGIPGSVDDVYNFYHQFYNFSYTSNEQERYLTYSVNEDVTSFPALT 282
            +W +               + +      Q          +   +  S          L 
Sbjct: 50  PIWATNTG-----------GLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLV 98

Query: 283 FDSDGRL 289
              D  +
Sbjct: 99  LQPDRNV 105

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	614
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.96
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.96
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.96
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.96
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.96
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.96
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.95
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.95
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.95
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.95
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.95
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.95
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.95
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.95
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.95
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.95
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.95
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.95
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.95
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.95
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.94
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.94
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.94
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.94
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.94
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.94
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.94
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.94
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.94
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.94
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.93
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.93
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.93
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.93
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.93
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.93
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.93
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.93
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.93
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.93
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.93
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.93
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.93
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.93
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.93
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.92
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.92
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.92
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.91
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.91
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.91
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.91
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.91
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.9
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.9
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.9
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.9
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.9
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.82
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.81
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.8
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.8
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.56
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.48
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.41
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.17
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	98.88
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.62
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.59
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.56
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.33
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.9
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.39
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.45
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.31
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.99
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.54

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-30  Score=261.52  Aligned_cols=146  Identities=34%  Similarity=0.542  Sum_probs=127.8

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEe
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEY  524 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey  524 (614)
                      +..++|++.+.||+|+||.||+|.+++++.||||+++... ...++|.+|+.++++++||||        .+..++||||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey   88 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY   88 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEe
Confidence            3446778889999999999999999888899999997643 345689999999999999999        4667999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      +++|+|..++.... ...++|.+++.|+.|||+||.|||+.+   ||||||||+||||++++.+||+|||+|+.+....
T Consensus        89 ~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence            99999998775332 234899999999999999999999986   9999999999999999999999999999886544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-30  Score=261.85  Aligned_cols=155  Identities=32%  Similarity=0.520  Sum_probs=125.1

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCCccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      +..++|.+.+.||+|+||+||+|+...  .||||.++..  ..+..++|.+|+.++.+++||||        ..+.++||
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~   82 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT   82 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEE
Confidence            345678889999999999999998753  5999999643  34556789999999999999999        46789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++...  ...+++.+++.++.|||+||+|||+++   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus        83 Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            999999999998643  345899999999999999999999986   999999999999999999999999999987654


Q ss_pred             ccccCCCceecC
Q 042853          603 ELEANTNRIVGT  614 (614)
Q Consensus       603 ~~~~~~~~~~GT  614 (614)
                      .......+..||
T Consensus       158 ~~~~~~~~~~gt  169 (276)
T d1uwha_         158 SGSHQFEQLSGS  169 (276)
T ss_dssp             --------CCCC
T ss_pred             CCcccccccccC
Confidence            433223334554

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=1.6e-30  Score=262.94  Aligned_cols=149  Identities=25%  Similarity=0.429  Sum_probs=129.8

Q ss_pred             hHHhhcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          450 TIAVATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       450 ~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      ++++..++|...++||+|+||+||+|.+. +++.||||+++.. ....++|.+|+.++++++||||         ....+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            34455567888899999999999999986 5788999999764 3346789999999999999999         56789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++|+|..++.... ...+++..+..++.|||+||.|||+++   ||||||||+||||++++.+||+|||+|+.+
T Consensus        90 iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999986543 346899999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCc
Q 042853          600 TMNE  603 (614)
Q Consensus       600 ~~~~  603 (614)
                      ..+.
T Consensus       166 ~~~~  169 (287)
T d1opja_         166 TGDT  169 (287)
T ss_dssp             CSSS
T ss_pred             CCCC
Confidence            6543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.7e-30  Score=257.75  Aligned_cols=153  Identities=30%  Similarity=0.426  Sum_probs=128.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|++.+.||+|+||+||+|... +++.||||.+.... .+..++|.+|++++++++||||         ....++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            56888899999999999999985 68899999996543 3345679999999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCcc
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNEL  604 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~~  604 (614)
                      +++|+|.+++..   ...+++.+...++.||++||.|||+.+   ||||||||+|||+++++.+||+|||+|+.+.....
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999998843   346899999999999999999999987   99999999999999999999999999998865543


Q ss_pred             ccCCCceecC
Q 042853          605 EANTNRIVGT  614 (614)
Q Consensus       605 ~~~~~~~~GT  614 (614)
                      .......+||
T Consensus       159 ~~~~~~~~GT  168 (271)
T d1nvra_         159 ERLLNKMCGT  168 (271)
T ss_dssp             ECCBCCCCSC
T ss_pred             cccccceeeC
Confidence            3333346676

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.7e-30  Score=254.63  Aligned_cols=142  Identities=28%  Similarity=0.483  Sum_probs=120.2

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      ++|+..+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++||||         ....++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            467778999999999999999988889999999763 3445789999999999999999         567899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      +|+|..++...  ...++|..++.++.|||+||.|||+.+   ||||||||+|||+|+++.+||+|||+|+.+....
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence            99999988543  346899999999999999999999987   9999999999999999999999999999876443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.6e-29  Score=253.28  Aligned_cols=141  Identities=29%  Similarity=0.434  Sum_probs=125.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|+..++||+|+||+||+|... +++.||||.+........+.+.+|++++++++||||         ....++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            46888999999999999999975 688999999976554556779999999999999999         57889999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      ++|+|..++..    ..+++.+...++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+.+..+.
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            99999988753    24899999999999999999999987   9999999999999999999999999999886543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.1e-29  Score=253.33  Aligned_cols=141  Identities=26%  Similarity=0.421  Sum_probs=126.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +.|++.+.||+|+||+||+|... +++.||||.++....+..++|.+|++++++++||||         .+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45777899999999999999985 678999999987666777889999999999999999         57889999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ++|+|..++.+.  ...+++.+...++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+.+..
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999987543  235899999999999999999999987   99999999999999999999999999987754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.95  E-value=3.3e-29  Score=254.59  Aligned_cols=143  Identities=28%  Similarity=0.508  Sum_probs=115.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-Cc---cEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DE---QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~---~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv  521 (614)
                      ++|.+.+.||+|+||+||+|.+. ++   ..||||.+... ..+..++|.+|++++++++||||         ....++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45666789999999999999985 22   25899998654 33455689999999999999999         5688999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||||++|+|..++...  ...++|.+++.++.|||+||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus       106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999988543  345899999999999999999999986   99999999999999999999999999998765


Q ss_pred             Cc
Q 042853          602 NE  603 (614)
Q Consensus       602 ~~  603 (614)
                      ..
T Consensus       181 ~~  182 (299)
T d1jpaa_         181 DT  182 (299)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.5e-29  Score=253.53  Aligned_cols=143  Identities=31%  Similarity=0.521  Sum_probs=123.1

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPN  527 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~  527 (614)
                      ++|.+.+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|+.++++++|+||        .++.++||||+++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~   95 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK   95 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence            567888999999999999999988888999999754 3445789999999999999999        5678999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          528 KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       528 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      |+|..++.... ...++|.+++.++.|||+||+|||+++   |+||||||+|||||.++.+||+|||+|+.+....
T Consensus        96 g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          96 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             Cchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99998886432 235899999999999999999999987   9999999999999999999999999999875443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.4e-29  Score=249.72  Aligned_cols=143  Identities=27%  Similarity=0.490  Sum_probs=122.9

Q ss_pred             CCCCccc-eeccCCceeEEEEEeC---CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC--------CCeeEEEE
Q 042853          456 DNFSPAN-RLGQGGFGPVYKGKLQ---DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL--------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~-~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~  522 (614)
                      ++|...+ +||+|+||+||+|.+.   ++..||||.++... ....++|.+|++++++++||||        .+..++||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm   87 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM   87 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence            4555566 4999999999999874   34579999997643 3345789999999999999999        56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |||++|+|..++...  ...+++..+..++.|||+||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus        88 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          88 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             ECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence            999999999987432  345899999999999999999999986   999999999999999999999999999988654


Q ss_pred             c
Q 042853          603 E  603 (614)
Q Consensus       603 ~  603 (614)
                      .
T Consensus       163 ~  163 (285)
T d1u59a_         163 D  163 (285)
T ss_dssp             S
T ss_pred             c
Confidence            3

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.8e-28  Score=243.75  Aligned_cols=142  Identities=28%  Similarity=0.470  Sum_probs=126.7

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEecC
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYLP  526 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~~  526 (614)
                      ++|+..++||+|+||+||+|+.++++.||||.+++.. ...++|.+|+.++++++||||         ....++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            5788889999999999999999888899999997643 345789999999999999999         568899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          527 NKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       527 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      +|+|..++...  ...+++..+.+++.|||+||.|||+.+   |+||||||+|||+++++.+||+|||+|+.+...+
T Consensus        83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            99999887543  345789999999999999999999986   9999999999999999999999999999876544

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=7.6e-29  Score=252.35  Aligned_cols=153  Identities=27%  Similarity=0.504  Sum_probs=130.3

Q ss_pred             hhhHHhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC------
Q 042853          448 FQTIAVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL------  514 (614)
Q Consensus       448 ~~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl------  514 (614)
                      +.+++.+.++|++.+.||+|+||+||+|+..      +++.||||+++.... +..++|.+|++++++++|||+      
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            3455667788999999999999999999864      457899999975433 345679999999999999999      


Q ss_pred             ---CCeeEEEEEecCCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 042853          515 ---GGERLLVYEYLPNKSLDFFIFDSS---------------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRV  570 (614)
Q Consensus       515 ---~~~~~lv~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  570 (614)
                         ....+++|||+++|+|..++....                     ....+++..++.|+.|||.||+|||+.+   |
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence               567899999999999999986422                     1234889999999999999999999987   9


Q ss_pred             EecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          571 IHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       571 iHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      |||||||+|||||.++.+||+|||+|+.+....
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~  194 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD  194 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCc
Confidence            999999999999999999999999999875544

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.7e-29  Score=249.52  Aligned_cols=153  Identities=31%  Similarity=0.426  Sum_probs=125.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||+||+|... +++.||||.+.+.   .....+.+.+|++++++++|||+         ....++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            45788899999999999999985 6889999998643   22345678999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++...   ..+++.+...++.|++.||.|||+.+   ||||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999887543   35899999999999999999999987   999999999999999999999999999988654


Q ss_pred             ccccCCCceecC
Q 042853          603 ELEANTNRIVGT  614 (614)
Q Consensus       603 ~~~~~~~~~~GT  614 (614)
                      .........+||
T Consensus       162 ~~~~~~~~~~GT  173 (288)
T d1uu3a_         162 SKQARANSFVGT  173 (288)
T ss_dssp             --------CCCC
T ss_pred             CcccccccccCC
Confidence            433333335665

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.6e-29  Score=257.17  Aligned_cols=142  Identities=23%  Similarity=0.313  Sum_probs=125.1

Q ss_pred             hcCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ..++|++.++||+|+||+||+|... +++.||||.++... .....++.+|+.++++++||||         ..+.++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3568888999999999999999975 67899999997543 3345678999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY-SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||++|+|..++...   ..+++.....++.|+++||.|||+. +   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999998643   3589999999999999999999974 5   99999999999999999999999999997653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.1e-29  Score=249.27  Aligned_cols=148  Identities=27%  Similarity=0.425  Sum_probs=117.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC-----------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL-----------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv  521 (614)
                      ++|++.+.||+|+||+||+|... +++.||||.+....  ....+.|.+|++++++++|||+           ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56888899999999999999875 68899999997542  3345678999999999999999           2347899


Q ss_pred             EEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          522 YEYLPNKSLDFFIFDSS-RKSLLDWKKRFSIIEGITQGLLYLHKYS--RLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      |||+++|+|..++.... ....+++.....++.||+.||.|||+.+  ..+||||||||+||||+.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999886432 2446899999999999999999999864  23599999999999999999999999999998


Q ss_pred             ecCCc
Q 042853          599 FTMNE  603 (614)
Q Consensus       599 ~~~~~  603 (614)
                      +..+.
T Consensus       164 ~~~~~  168 (269)
T d2java1         164 LNHDT  168 (269)
T ss_dssp             C----
T ss_pred             cccCC
Confidence            76443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.8e-28  Score=244.42  Aligned_cols=141  Identities=28%  Similarity=0.426  Sum_probs=123.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||+||+|... +++.||||.+.+.   .....+++.+|+.++++++||||         ....++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46788899999999999999986 6789999998643   22345678999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ||+++|+|..++...   ..+++.+...++.||++||.|||+++   ||||||||+||||+.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999998643   35899999999999999999999987   999999999999999999999999999877543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.1e-28  Score=248.77  Aligned_cols=163  Identities=24%  Similarity=0.374  Sum_probs=122.4

Q ss_pred             hhHHhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhc-CCCCC------
Q 042853          449 QTIAVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNL------  514 (614)
Q Consensus       449 ~~~~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nl------  514 (614)
                      .++++..++|++.++||+|+||.||+|...      +++.||||+++... ....++|..|+.++.++ +|+|+      
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            444455678888999999999999999863      34689999997543 33456788888888887 57787      


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 042853          515 ----GGERLLVYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKV  577 (614)
Q Consensus       515 ----~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  577 (614)
                          ....++|||||++|+|..++.....             ...+++.++..++.||++||.|||+++   ||||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence                3467999999999999999965321             235889999999999999999999987   99999999


Q ss_pred             CCEEEcCCCcEEEeecCcceeecCCccccCCCceecC
Q 042853          578 SNILLDEQMNPKISDFGMARTFTMNELEANTNRIVGT  614 (614)
Q Consensus       578 ~NILld~~~~~kI~DFGla~~~~~~~~~~~~~~~~GT  614 (614)
                      +||||++++.+||+|||+|+..............+||
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  199 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  199 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeC
Confidence            9999999999999999999987655443333334554

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.6e-28  Score=250.00  Aligned_cols=148  Identities=25%  Similarity=0.436  Sum_probs=122.8

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeCC------ccEEEEEEccCC-CcchhHhHHHHHHHHHhc-CCCCC---------C
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQD------EQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNL---------G  515 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nl---------~  515 (614)
                      +..++|++.+.||+|+||+||+|....      ...||||.+... .......|.+|+.++.++ +||||         .
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            455778889999999999999998742      236999998653 334456799999999998 89999         5


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSR--------------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDL  575 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl  575 (614)
                      ...++|||||++|+|..++.....                    ...+++..++.++.||++||.|||+++   ||||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence            678999999999999999965321                    235899999999999999999999986   999999


Q ss_pred             CCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          576 KVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       576 kp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      ||+|||++.++.+||+|||+|+......
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~  218 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDS  218 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred             chhccccccCCeEEEeeccccccccCCC
Confidence            9999999999999999999999876544

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.2e-28  Score=243.67  Aligned_cols=136  Identities=29%  Similarity=0.459  Sum_probs=117.7

Q ss_pred             ceeccCCceeEEEEEeC---CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC--------CCeeEEEEEecCCC
Q 042853          462 NRLGQGGFGPVYKGKLQ---DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL--------GGERLLVYEYLPNK  528 (614)
Q Consensus       462 ~~lG~G~fg~Vy~g~~~---~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv~Ey~~~g  528 (614)
                      ++||+|+||+||+|.+.   .++.||||+++..  .....++|.+|+.++++++||||        .+..+|||||+++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            47999999999999864   3468999999653  23345679999999999999999        46789999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          529 SLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       529 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      +|..++...   ..+++..++.++.|||+||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+....
T Consensus        93 ~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          93 PLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             cHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            999998643   35899999999999999999999986   9999999999999999999999999999876543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.9e-28  Score=243.50  Aligned_cols=142  Identities=30%  Similarity=0.552  Sum_probs=117.5

Q ss_pred             CCCCccceeccCCceeEEEEEeCCc-----cEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDE-----QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~-----~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~l  520 (614)
                      +.|+..+.||+|+||+||+|.+...     ..||||++.... .....+|.+|+.++++++||||         ....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577789999999999999987532     469999996543 3345679999999999999999         567899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      |||||+++++..++...  ...++|.++..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+.
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999998887543  345899999999999999999999986   9999999999999999999999999999876


Q ss_pred             CC
Q 042853          601 MN  602 (614)
Q Consensus       601 ~~  602 (614)
                      ..
T Consensus       162 ~~  163 (283)
T d1mqba_         162 DD  163 (283)
T ss_dssp             --
T ss_pred             CC
Confidence            44

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.6e-28  Score=241.68  Aligned_cols=138  Identities=30%  Similarity=0.414  Sum_probs=117.4

Q ss_pred             ccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC-------------CCeeEEEEE
Q 042853          460 PANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL-------------GGERLLVYE  523 (614)
Q Consensus       460 ~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl-------------~~~~~lv~E  523 (614)
                      ..++||+|+||+||+|... +++.||+|.+...  .....+.|.+|++++++++||||             ....++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            3568999999999999986 6789999998643  23345679999999999999999             124689999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD-EQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld-~~~~~kI~DFGla~~~~~  601 (614)
                      |+++|+|..++...   ..+++.....++.||++||.|||+++ ++||||||||+||||+ +++.+||+|||+|+....
T Consensus        93 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          93 LMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             CCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999998643   35899999999999999999999874 4699999999999996 578999999999986543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.95  E-value=1.4e-27  Score=247.69  Aligned_cols=143  Identities=22%  Similarity=0.384  Sum_probs=126.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|.+.+.||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||         ....++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57888999999999999999975 688999999977655556789999999999999999         57899999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCcEEEeecCcceeecCCc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD--EQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld--~~~~~kI~DFGla~~~~~~~  603 (614)
                      ++|+|..++...  ...+++.+...++.||+.||.|||+++   ||||||||+|||++  .++.+||+|||+|+.+....
T Consensus       106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999988533  345899999999999999999999987   99999999999996  45789999999999886543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.3e-28  Score=248.80  Aligned_cols=151  Identities=25%  Similarity=0.371  Sum_probs=128.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||+||+++.. +++.||||.+++.   .....+.+.+|+.+|++++||||         ....++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            56888999999999999999975 7899999999753   22345678999999999999999         56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |||++|+|..++...   ..+++.....++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999988643   35788888899999999999999987   999999999999999999999999999977543


Q ss_pred             ccccCCCceecC
Q 042853          603 ELEANTNRIVGT  614 (614)
Q Consensus       603 ~~~~~~~~~~GT  614 (614)
                      ...  ....+||
T Consensus       159 ~~~--~~~~~GT  168 (337)
T d1o6la_         159 GAT--MKTFCGT  168 (337)
T ss_dssp             TCC--BCCCEEC
T ss_pred             Ccc--cccceeC
Confidence            322  2235665

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.94  E-value=2e-27  Score=246.59  Aligned_cols=143  Identities=25%  Similarity=0.358  Sum_probs=125.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|++.+.||+|+||+||+|... +++.||||.++.........+.+|+.++++++||||         ....++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46888999999999999999975 789999999977555556678999999999999999         56889999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCcEEEeecCcceeecCCc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD--EQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld--~~~~~kI~DFGla~~~~~~~  603 (614)
                      ++|+|..++..  ....+++.+...++.||+.||.|||+.+   ||||||||+||||+  .++.+||+|||+|+.+..+.
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999887643  2345899999999999999999999987   99999999999998  56899999999999886543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=7.4e-28  Score=245.47  Aligned_cols=139  Identities=34%  Similarity=0.494  Sum_probs=121.8

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc---chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      .|+..++||+|+||+||+|... +++.||||.+.....   +..++|.+|+.++++++||||         ....++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4777899999999999999875 678899999975432   334578999999999999999         568899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||++|+|..++..   ...+++.++..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+....
T Consensus        96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999999776643   245899999999999999999999987   99999999999999999999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.94  E-value=4.7e-27  Score=235.78  Aligned_cols=141  Identities=28%  Similarity=0.428  Sum_probs=124.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc---------chhHhHHHHHHHHHhcC-CCCC---------C
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG---------QGIVEFKNEAKLIAKLQ-HTNL---------G  515 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---------~~~~~f~~E~~~l~~l~-H~nl---------~  515 (614)
                      ++|++.+.||+|+||+||+++.. +++.+|||++.+...         ...+.+.+|+.++++++ |||+         .
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57888999999999999999975 788999999965421         12235889999999997 9999         5


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      ...+||||||++|+|.+++...   ..+++.+...++.||++||+|||+++   ||||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            7889999999999999999643   35899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeecCC
Q 042853          596 ARTFTMN  602 (614)
Q Consensus       596 a~~~~~~  602 (614)
                      |+.+...
T Consensus       157 a~~~~~~  163 (277)
T d1phka_         157 SCQLDPG  163 (277)
T ss_dssp             CEECCTT
T ss_pred             eeEccCC
Confidence            9988654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-27  Score=244.40  Aligned_cols=149  Identities=28%  Similarity=0.498  Sum_probs=126.5

Q ss_pred             HhhcCCCCccceeccCCceeEEEEEeC------CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------C
Q 042853          452 AVATDNFSPANRLGQGGFGPVYKGKLQ------DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------G  515 (614)
Q Consensus       452 ~~~t~~f~~~~~lG~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~  515 (614)
                      ++..++|.+.+.||+|+||+||+|.+.      +++.||||++++.. .+....|.+|+.++++++|||+         .
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            344467788899999999999999874      35789999997543 3344569999999999999999         5


Q ss_pred             CeeEEEEEecCCCCHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          516 GERLLVYEYLPNKSLDFFIFDS-------SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      ...++|||||++|+|..++...       .....+++..+.+++.|+|+||.|||+.+   ||||||||+|||||+++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence            6789999999999999988642       22345789999999999999999999986   9999999999999999999


Q ss_pred             EEeecCcceeecCCc
Q 042853          589 KISDFGMARTFTMNE  603 (614)
Q Consensus       589 kI~DFGla~~~~~~~  603 (614)
                      ||+|||+|+.+....
T Consensus       173 Kl~DFGla~~~~~~~  187 (308)
T d1p4oa_         173 KIGDFGMTRDIYETD  187 (308)
T ss_dssp             EECCTTCCCGGGGGG
T ss_pred             EEeecccceeccCCc
Confidence            999999999876544

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.94  E-value=2.2e-27  Score=242.81  Aligned_cols=140  Identities=26%  Similarity=0.353  Sum_probs=122.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||+||++... +++.||||++++.   .....+.+.+|+.++++++||||         ....++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46788899999999999999985 6899999999643   23345678999999999999999         57889999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      |||++|+|..++...   ..+++.....++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus        84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999998887543   34678888889999999999999887   99999999999999999999999999998754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.5e-27  Score=242.76  Aligned_cols=154  Identities=27%  Similarity=0.414  Sum_probs=123.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC-Ccc----EEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC--------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL--------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~----~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~lv  521 (614)
                      ++|++.+.||+|+||+||+|.+. +++    .||||+++.. ..+..++|.+|+.++++++||||        ....+++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v   88 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   88 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence            35888899999999999999875 333    5899998653 34556789999999999999999        5677899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +||+++|+|..++...  ...+++..++.++.|||+||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus        89 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          89 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            9999999998887653  346899999999999999999999986   99999999999999999999999999998865


Q ss_pred             CccccCCCceecC
Q 042853          602 NELEANTNRIVGT  614 (614)
Q Consensus       602 ~~~~~~~~~~~GT  614 (614)
                      .+....+...+||
T Consensus       164 ~~~~~~~~~~~gt  176 (317)
T d1xkka_         164 EEKEYHAEGGKVP  176 (317)
T ss_dssp             TCC--------CC
T ss_pred             ccccccccccccC
Confidence            5443333333443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=1.3e-27  Score=243.44  Aligned_cols=141  Identities=27%  Similarity=0.416  Sum_probs=112.0

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC-cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      +.|++.+.||+|+||+||+|... +++.||||.+.+.. ......|.+|+.++++++||||         ....++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56888999999999999999986 67899999997543 2334568899999999999999         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld---~~~~~kI~DFGla~~~~~  601 (614)
                      |++|+|.+++..   ...+++.+...++.||+.||.|||+.+   ||||||||+|||+.   +++.+||+|||+|+....
T Consensus        89 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          89 VSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             cCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            999999999854   345899999999999999999999987   99999999999994   578899999999997754


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus       163 ~  163 (307)
T d1a06a_         163 G  163 (307)
T ss_dssp             -
T ss_pred             C
Confidence            3

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2e-27  Score=238.32  Aligned_cols=145  Identities=22%  Similarity=0.341  Sum_probs=116.3

Q ss_pred             hcCCCCccceeccCCceeEEEEEeCC----ccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCC--------CCeeEE
Q 042853          454 ATDNFSPANRLGQGGFGPVYKGKLQD----EQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL--------GGERLL  520 (614)
Q Consensus       454 ~t~~f~~~~~lG~G~fg~Vy~g~~~~----~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl--------~~~~~l  520 (614)
                      ..++|++.+.||+|+||.||+|.+..    +..||||.++.... ...++|.+|+.++++++||||        .+..++
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~i   84 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI   84 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEE
Confidence            34678889999999999999998753    34689999865433 345679999999999999999        567899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++|+|..++...  ...+++..+..++.||++||.|||+.+   ||||||||+|||+++++.+||+|||+|+.+.
T Consensus        85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            99999999999887543  345899999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCc
Q 042853          601 MNE  603 (614)
Q Consensus       601 ~~~  603 (614)
                      ...
T Consensus       160 ~~~  162 (273)
T d1mp8a_         160 DST  162 (273)
T ss_dssp             ---
T ss_pred             CCc
Confidence            443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.4e-26  Score=234.51  Aligned_cols=142  Identities=27%  Similarity=0.438  Sum_probs=123.9

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC------cchhHhHHHHHHHHHhcCCCCC---------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~f~~E~~~l~~l~H~nl---------~~~~~  519 (614)
                      +.|++.+.||+|+||+||+|... +++.||||.+++..      ....++|.+|+.++++++||||         ....+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57888999999999999999985 68899999986532      1235679999999999999999         56889


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEeecCc
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM----NPKISDFGM  595 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~----~~kI~DFGl  595 (614)
                      +|||||++|+|..++...   ..+++.....++.||+.||.|||+.+   ||||||||+|||++.++    .+||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence            999999999999998643   35899999999999999999999987   99999999999998776    499999999


Q ss_pred             ceeecCCc
Q 042853          596 ARTFTMNE  603 (614)
Q Consensus       596 a~~~~~~~  603 (614)
                      |+.+....
T Consensus       164 a~~~~~~~  171 (293)
T d1jksa_         164 AHKIDFGN  171 (293)
T ss_dssp             CEECTTSC
T ss_pred             hhhcCCCc
Confidence            99886443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.4e-27  Score=234.43  Aligned_cols=143  Identities=27%  Similarity=0.393  Sum_probs=115.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC--C--ccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC--------CCeeEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ--D--EQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL--------GGERLL  520 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~--~--~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl--------~~~~~l  520 (614)
                      ++|++.+.||+|+||.||+|++.  +  ...||||++++.   ..+..++|.+|+.++++++||||        ....++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l   87 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM   87 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence            45777899999999999999864  2  237899998654   23446789999999999999999        456789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeec
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFT  600 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~  600 (614)
                      ||||+++|+|..++...  ...+++..+..++.|||+||.|||+++   |+||||||+||||+.++.+||+|||+|+.+.
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence            99999999998877543  335899999999999999999999986   9999999999999999999999999999886


Q ss_pred             CCc
Q 042853          601 MNE  603 (614)
Q Consensus       601 ~~~  603 (614)
                      ...
T Consensus       163 ~~~  165 (273)
T d1u46a_         163 QND  165 (273)
T ss_dssp             C-C
T ss_pred             cCC
Confidence            543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.8e-26  Score=235.08  Aligned_cols=142  Identities=23%  Similarity=0.338  Sum_probs=123.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      ++|.+.+.||+|+||+||+|... +++.||||.++... .....+.+|+++|+.++||||         ..+.++|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            57888999999999999999986 67889999997643 334568899999999999999         67889999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--CCcEEEeecCcceeecCCc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE--QMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~--~~~~kI~DFGla~~~~~~~  603 (614)
                      ++|+|..++...  ...+++.+...++.||++||.|||+.+   ||||||||+|||++.  ...+||+|||+|+......
T Consensus        84 ~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          84 SGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            999999998532  335899999999999999999999987   999999999999984  4579999999999876443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.93  E-value=1.2e-26  Score=240.52  Aligned_cols=140  Identities=26%  Similarity=0.353  Sum_probs=123.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHHhcCCCCC---------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNL---------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~  522 (614)
                      ++|++.+.||+|+||.||++... +++.||||.+.+.   .....+.+.+|+.+++.++||||         ....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46888999999999999999985 6899999998643   22345678999999999999999         56778999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||+++|+|..++...   ..+++.+...++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            999999999988643   35899999999999999999999987   99999999999999999999999999998754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=1.1e-26  Score=242.13  Aligned_cols=142  Identities=28%  Similarity=0.395  Sum_probs=119.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHH---HHHHHhcCCCCC---------CCeeE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNE---AKLIAKLQHTNL---------GGERL  519 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E---~~~l~~l~H~nl---------~~~~~  519 (614)
                      ++|++.+.||+|+||.||+|... +++.||||.+.+..   .+....+.+|   +.+++.++||||         ....+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57888999999999999999986 68999999986421   1222334444   666777789999         56789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +||||+++|+|..++...   ..+++.+...++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999998643   35788999999999999999999987   999999999999999999999999999988


Q ss_pred             cCCc
Q 042853          600 TMNE  603 (614)
Q Consensus       600 ~~~~  603 (614)
                      ....
T Consensus       158 ~~~~  161 (364)
T d1omwa3         158 SKKK  161 (364)
T ss_dssp             SSSC
T ss_pred             CCCc
Confidence            6543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.4e-26  Score=236.55  Aligned_cols=149  Identities=30%  Similarity=0.438  Sum_probs=126.3

Q ss_pred             hhcCCCCccceeccCCceeEEEEEe------CCccEEEEEEccCCCc-chhHhHHHHHHHHHhc-CCCCC---------C
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKL------QDEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNL---------G  515 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~------~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nl---------~  515 (614)
                      +..++|++.+.||+|+||.||+|++      ..++.||||+++.... ....+|.+|+.++.++ +||||         .
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            4446788889999999999999986      2457899999976433 3455799999999999 69999         4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSS---------------RKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNI  580 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI  580 (614)
                      ...++|||||++|+|..++....               ....+++..+..++.||++||+|||+++   ||||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence            57899999999999999987532               2235899999999999999999999987   99999999999


Q ss_pred             EEcCCCcEEEeecCcceeecCCcc
Q 042853          581 LLDEQMNPKISDFGMARTFTMNEL  604 (614)
Q Consensus       581 Lld~~~~~kI~DFGla~~~~~~~~  604 (614)
                      |++.++.+||+|||+|+.+.....
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~  200 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSN  200 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTT
T ss_pred             cccccCcccccccchheeccCCCc
Confidence            999999999999999998765443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.3e-26  Score=233.50  Aligned_cols=138  Identities=30%  Similarity=0.504  Sum_probs=118.8

Q ss_pred             cceeccCCceeEEEEEeCCc----cEEEEEEccCC-CcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEEec
Q 042853          461 ANRLGQGGFGPVYKGKLQDE----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYEYL  525 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~----~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~Ey~  525 (614)
                      .++||+|+||+||+|.+...    ..||||++++. .....++|.+|++++++++|||+          ....++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            47899999999999998532    35899999754 34455789999999999999999          35789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      ++|+|..++...  ...+++..+++++.|+|.||.|||+.+   |+||||||+||||++++.+||+|||+++.+....
T Consensus       112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999988643  345788999999999999999999986   9999999999999999999999999999876543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.6e-26  Score=235.06  Aligned_cols=139  Identities=26%  Similarity=0.345  Sum_probs=114.9

Q ss_pred             CCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHH--HHHHHHHhcCCCCC-------------CCeeEEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNL-------------GGERLLV  521 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~--~E~~~l~~l~H~nl-------------~~~~~lv  521 (614)
                      .|...+.||+|+||.||+|++ +++.||||+++..   ..+++.  .|+..+..++||||             ....++|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            455678999999999999997 5788999999643   223344  45555567899999             1257899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY-----SRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      ||||++|+|..++...    .++|..+++++.|+|.||.|||+.     ...+||||||||+||||+.++.+||+|||+|
T Consensus        80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999643    489999999999999999999974     1346999999999999999999999999999


Q ss_pred             eeecCCc
Q 042853          597 RTFTMNE  603 (614)
Q Consensus       597 ~~~~~~~  603 (614)
                      +.+....
T Consensus       156 ~~~~~~~  162 (303)
T d1vjya_         156 VRHDSAT  162 (303)
T ss_dssp             EEEETTT
T ss_pred             ccccCCC
Confidence            9886543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2e-26  Score=234.01  Aligned_cols=142  Identities=29%  Similarity=0.483  Sum_probs=119.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|++.+.||+|+||+||+|... +++.||||+++...  ....+++.+|++++++++|||+         ..+.++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57888999999999999999975 68899999996532  2345689999999999999999         578899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      |+.++.+. ++... ....+++.+...++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhh-hhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence            99765444 43322 2345899999999999999999999987   999999999999999999999999999877543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.3e-26  Score=233.55  Aligned_cols=142  Identities=30%  Similarity=0.481  Sum_probs=121.7

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC---CcchhHhHHHHHHHHH-hcCCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS---SGQGIVEFKNEAKLIA-KLQHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~-~l~H~nl---------~~~~~lv  521 (614)
                      ++|.+.+.||+|+||+||+|+.. +++.||||.+++.   .....+.+..|+.++. .++||||         ....++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            56888999999999999999986 6889999999653   2234456777777765 6899999         5678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          522 YEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      ||||++|+|..++...   ..+++.+...++.||+.||.|||+++   ||||||||+|||+++++.+||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            9999999999998643   34788899999999999999999987   99999999999999999999999999997654


Q ss_pred             Cc
Q 042853          602 NE  603 (614)
Q Consensus       602 ~~  603 (614)
                      ..
T Consensus       156 ~~  157 (320)
T d1xjda_         156 GD  157 (320)
T ss_dssp             TT
T ss_pred             cc
Confidence            33

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.4e-26  Score=233.42  Aligned_cols=142  Identities=32%  Similarity=0.535  Sum_probs=120.0

Q ss_pred             CCCCccceeccCCceeEEEEEeCC-cc--EEEEEEccCC-CcchhHhHHHHHHHHHhc-CCCCC---------CCeeEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQD-EQ--EIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNL---------GGERLLV  521 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nl---------~~~~~lv  521 (614)
                      ++|++.++||+|+||+||+|.+.+ +.  .||||+++.. ..+..++|.+|++++.++ +||||         ....++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            456678999999999999999863 33  5789988643 344567899999999998 79999         5678999


Q ss_pred             EEecCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 042853          522 YEYLPNKSLDFFIFDS-------------SRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNP  588 (614)
Q Consensus       522 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~  588 (614)
                      |||+++|+|.+++...             .....++|..+.+++.|||+||.|||+.+   ||||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643             23456899999999999999999999986   9999999999999999999


Q ss_pred             EEeecCcceeec
Q 042853          589 KISDFGMARTFT  600 (614)
Q Consensus       589 kI~DFGla~~~~  600 (614)
                      ||+|||+|+...
T Consensus       167 kl~DfG~a~~~~  178 (309)
T d1fvra_         167 KIADFGLSRGQE  178 (309)
T ss_dssp             EECCTTCEESSC
T ss_pred             EEcccccccccc
Confidence            999999998654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.93  E-value=5.4e-26  Score=228.27  Aligned_cols=141  Identities=26%  Similarity=0.397  Sum_probs=122.1

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC---cchhHhHHHHHHHHHhcCCCCCC-------------Cee
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLG-------------GER  518 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nl~-------------~~~  518 (614)
                      ++|++.+.||+|+||+||+|... +++.||||.+++..   .+..+.|.+|+++++.++|||+.             ...
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57888999999999999999975 78899999997543   23345799999999999999991             237


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          519 LLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       519 ~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ++||||+++++|..++...   ..+++.+...++.||+.||.|||+++   ||||||||+||||+.++.++|+|||+++.
T Consensus        87 ~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence            8999999999999887543   35899999999999999999999987   99999999999999999999999999987


Q ss_pred             ecCC
Q 042853          599 FTMN  602 (614)
Q Consensus       599 ~~~~  602 (614)
                      ....
T Consensus       161 ~~~~  164 (277)
T d1o6ya_         161 IADS  164 (277)
T ss_dssp             CC--
T ss_pred             hccc
Confidence            6543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.93  E-value=2.9e-26  Score=231.30  Aligned_cols=140  Identities=26%  Similarity=0.454  Sum_probs=123.2

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey  524 (614)
                      ++|.+.++||+|+||+||+|...+++.||||.+....  ....+.|.+|+.++++++||||         ..+.++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788899999999999999999989999999996543  2335679999999999999999         5788999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~  601 (614)
                      +.++.+..+..   ....+++.....++.||++||+|||+.+   ||||||||+|||++.++.+||+|||+|+.+..
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            98877766653   3356899999999999999999999987   99999999999999999999999999987754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.7e-26  Score=233.10  Aligned_cols=137  Identities=31%  Similarity=0.423  Sum_probs=114.4

Q ss_pred             cceeccCCceeEEEEEeC-CccEEEEEEccCCCc-----chhHhHHHHHHHHHhcCCCCC---------CCeeEEEEEec
Q 042853          461 ANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-----QGIVEFKNEAKLIAKLQHTNL---------GGERLLVYEYL  525 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-----~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~Ey~  525 (614)
                      +++||+|+||+||+|... +++.||||+++....     ...+.+.+|+.++++++|||+         ....++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            588999999999999975 688999999965321     123568999999999999999         56789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCCc
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~~  603 (614)
                      +++++..+..   ....+++.+...++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+.+....
T Consensus        83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9887765542   3345788888999999999999999987   9999999999999999999999999998776543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.1e-26  Score=231.25  Aligned_cols=140  Identities=26%  Similarity=0.471  Sum_probs=115.8

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~Ey~  525 (614)
                      ++|+..+.||+|+||.||+|.+. +..||||++++.  ...++|.+|++++++++||||          ....++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            45666899999999999999995 678999999753  345779999999999999999          23578999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ++|+|.+++.... ...++|..+++++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999986532 234899999999999999999999976   999999999999999999999999999976543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.4e-26  Score=231.50  Aligned_cols=148  Identities=26%  Similarity=0.439  Sum_probs=120.9

Q ss_pred             hhcCCCCccceeccCCceeEEEEEeC--------CccEEEEEEccCCCc-chhHhHHHHHHHHHhc-CCCCC--------
Q 042853          453 VATDNFSPANRLGQGGFGPVYKGKLQ--------DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNL--------  514 (614)
Q Consensus       453 ~~t~~f~~~~~lG~G~fg~Vy~g~~~--------~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nl--------  514 (614)
                      +..++|.+.+.||+|+||.||+|+..        ++..||||++++... +...+|.+|+..+.++ +||||        
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            34467888899999999999999863        234799999976543 4457899999999998 89999        


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 042853          515 -GGERLLVYEYLPNKSLDFFIFDSSR-------------KSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNI  580 (614)
Q Consensus       515 -~~~~~lv~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI  580 (614)
                       ....++||||+++|+|..++.....             ...+++.+++.++.||+.||.|||+.+   ||||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence             5678999999999999999965421             245899999999999999999999987   99999999999


Q ss_pred             EEcCCCcEEEeecCcceeecCCc
Q 042853          581 LLDEQMNPKISDFGMARTFTMNE  603 (614)
Q Consensus       581 Lld~~~~~kI~DFGla~~~~~~~  603 (614)
                      |++.++.+||+|||+++......
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~  189 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHID  189 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCC
T ss_pred             eecCCCCeEeccchhhccccccc
Confidence            99999999999999999886544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.5e-25  Score=232.12  Aligned_cols=142  Identities=26%  Similarity=0.379  Sum_probs=118.1

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc-chhHhHHHHHHHHHhcCCCCCC-------------CeeE
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLG-------------GERL  519 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl~-------------~~~~  519 (614)
                      +++|.+.++||+|+||+||+|... +++.||||++.+... ...+++.+|+++|++++|||+.             ...+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            357888999999999999999874 789999999975432 3456789999999999999981             1235


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      +++||+.+|+|..++..    ..+++.....++.||++||+|||+++   ||||||||+||||+.++.+||+|||+|+..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            56677889999999853    24899999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCc
Q 042853          600 TMNE  603 (614)
Q Consensus       600 ~~~~  603 (614)
                      ....
T Consensus       160 ~~~~  163 (345)
T d1pmea_         160 DPDH  163 (345)
T ss_dssp             CGGG
T ss_pred             cCCC
Confidence            5543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.4e-25  Score=228.23  Aligned_cols=139  Identities=26%  Similarity=0.342  Sum_probs=116.6

Q ss_pred             CCCCccc-eeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhc-CCCCCC-------------CeeE
Q 042853          456 DNFSPAN-RLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLG-------------GERL  519 (614)
Q Consensus       456 ~~f~~~~-~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nl~-------------~~~~  519 (614)
                      ++|.+.+ .||+|+||+||+|... +++.||||.+++     ...+.+|+.++.++ +|||+.             ...+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            4677665 5999999999999874 688999999964     24577899887655 899981             3479


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEeecCcc
Q 042853          520 LVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE---QMNPKISDFGMA  596 (614)
Q Consensus       520 lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~---~~~~kI~DFGla  596 (614)
                      +|||||++|+|..++.... ...+++.+...++.||+.||+|||+.+   ||||||||+|||++.   .+.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            9999999999999996432 245899999999999999999999987   999999999999985   457999999999


Q ss_pred             eeecCCc
Q 042853          597 RTFTMNE  603 (614)
Q Consensus       597 ~~~~~~~  603 (614)
                      +.+....
T Consensus       162 ~~~~~~~  168 (335)
T d2ozaa1         162 KETTSHN  168 (335)
T ss_dssp             EECCCCC
T ss_pred             eeccCCC
Confidence            9876543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.9e-25  Score=230.50  Aligned_cols=140  Identities=29%  Similarity=0.433  Sum_probs=114.6

Q ss_pred             CCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCC---------------CeeEE
Q 042853          457 NFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLG---------------GERLL  520 (614)
Q Consensus       457 ~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~---------------~~~~l  520 (614)
                      .|...++||+|+||+||+|+.. +++.||||++.+..    ..+.+|+++|++++|+|+.               ...+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            3555789999999999999986 68899999996543    2345799999999999991               23689


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceee
Q 042853          521 VYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTF  599 (614)
Q Consensus       521 v~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~  599 (614)
                      |||||+++.+..+.........+++.++..++.||++||+|||+++   ||||||||+||||+.++ .+||+|||+|+.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987655444332234456899999999999999999999887   99999999999999765 8999999999987


Q ss_pred             cCCc
Q 042853          600 TMNE  603 (614)
Q Consensus       600 ~~~~  603 (614)
                      ...+
T Consensus       174 ~~~~  177 (350)
T d1q5ka_         174 VRGE  177 (350)
T ss_dssp             CTTS
T ss_pred             cCCc
Confidence            6544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.6e-25  Score=222.68  Aligned_cols=140  Identities=27%  Similarity=0.356  Sum_probs=117.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCc------chhHhHHHHHHHHHhcC--CCCC---------CCe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQ--HTNL---------GGE  517 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~--H~nl---------~~~  517 (614)
                      ++|.+.+.||+|+||+||+|... +++.||||.+.+...      ....++.+|+.++++++  |||+         ...
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57888999999999999999975 688999999865321      12345789999999997  8998         568


Q ss_pred             eEEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEeecCc
Q 042853          518 RLLVYEYLPN-KSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-QMNPKISDFGM  595 (614)
Q Consensus       518 ~~lv~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-~~~~kI~DFGl  595 (614)
                      .++||||+.+ +++..++...   ..+++.+...++.||++||.|||+.+   ||||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            8999999976 5777776432   35899999999999999999999987   999999999999985 47899999999


Q ss_pred             ceeecC
Q 042853          596 ARTFTM  601 (614)
Q Consensus       596 a~~~~~  601 (614)
                      |+....
T Consensus       158 a~~~~~  163 (273)
T d1xwsa_         158 GALLKD  163 (273)
T ss_dssp             CEECCS
T ss_pred             ceeccc
Confidence            997654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=8.1e-25  Score=221.02  Aligned_cols=141  Identities=27%  Similarity=0.449  Sum_probs=123.3

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------CCeeEEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------GGERLLVYE  523 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------~~~~~lv~E  523 (614)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...  .....++.+|+.+++.++|+|+         ....++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57888999999999999999975 77899999986432  3346789999999999999998         567899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcceeecCC
Q 042853          524 YLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMARTFTMN  602 (614)
Q Consensus       524 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~~~~  602 (614)
                      ++.+++|..++..   ...+++..+..++.|+++||+|||+++   ||||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999998877643   345788999999999999999999987   999999999999999999999999999987644

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.91  E-value=9.4e-25  Score=224.55  Aligned_cols=136  Identities=22%  Similarity=0.409  Sum_probs=117.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcC-CCCC-----------CCeeEEEE
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNL-----------GGERLLVY  522 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nl-----------~~~~~lv~  522 (614)
                      ++|++.++||+|+||+||+|+.. +++.||||+++..   ..+++.+|+.+|.+++ |||+           ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57889999999999999999985 6889999999653   3467889999999995 9999           24588999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEeecCcceeecC
Q 042853          523 EYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM-NPKISDFGMARTFTM  601 (614)
Q Consensus       523 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~-~~kI~DFGla~~~~~  601 (614)
                      ||+++++|..+.      ..+++.+...++.||+.||.|||+++   ||||||||+|||++.++ .+||+|||+|+.+..
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999987653      24889999999999999999999987   99999999999998655 589999999998765


Q ss_pred             Cc
Q 042853          602 NE  603 (614)
Q Consensus       602 ~~  603 (614)
                      ..
T Consensus       183 ~~  184 (328)
T d3bqca1         183 GQ  184 (328)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.1e-24  Score=223.14  Aligned_cols=141  Identities=25%  Similarity=0.506  Sum_probs=117.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCC--CcchhHhHHHHHHHHHhcCCCCC-----------------C
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL-----------------G  515 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nl-----------------~  515 (614)
                      ++|++.++||+|+||+||+|... +++.||||++...  ......++.+|+.+|++++|+|+                 .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67888999999999999999975 7899999998643  23345678999999999999999                 1


Q ss_pred             CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          516 GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       516 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                      .+.++||||++.+.+..+.   .....++......++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            3478999999988776543   22345778888899999999999999987   99999999999999999999999999


Q ss_pred             ceeecCC
Q 042853          596 ARTFTMN  602 (614)
Q Consensus       596 a~~~~~~  602 (614)
                      |+.+...
T Consensus       164 ~~~~~~~  170 (318)
T d3blha1         164 ARAFSLA  170 (318)
T ss_dssp             CEECCC-
T ss_pred             eeecccc
Confidence            9877643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.6e-24  Score=222.87  Aligned_cols=140  Identities=25%  Similarity=0.381  Sum_probs=113.7

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------------CC
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------------GG  516 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------------~~  516 (614)
                      .++|++.++||+|+||+||+|... +++.||||++++..  ....+.+.+|+++|+.++|||+               ..
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            367888999999999999999975 68899999997542  2345678999999999999998               12


Q ss_pred             eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcc
Q 042853          517 ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMA  596 (614)
Q Consensus       517 ~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla  596 (614)
                      +.++||||+ +.+|..++..    ..+++.....++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 4567666532    34899999999999999999999987   999999999999999999999999999


Q ss_pred             eeecCC
Q 042853          597 RTFTMN  602 (614)
Q Consensus       597 ~~~~~~  602 (614)
                      +.....
T Consensus       169 ~~~~~~  174 (346)
T d1cm8a_         169 RQADSE  174 (346)
T ss_dssp             EECCSS
T ss_pred             eccCCc
Confidence            987543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.5e-24  Score=222.11  Aligned_cols=142  Identities=25%  Similarity=0.394  Sum_probs=121.2

Q ss_pred             CCCCccceeccCCceeEEEEEeC----CccEEEEEEccCCC----cchhHhHHHHHHHHHhcCC-CCC---------CCe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ----DEQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQH-TNL---------GGE  517 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~----~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H-~nl---------~~~  517 (614)
                      ++|++.+.||+|+||+||+|...    +++.||||.+++..    ....+.+.+|++++.+++| ||+         ...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56888999999999999999862    47899999986532    2345678899999999977 788         567


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .+++|||+++|+|..++....   .+.......++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            899999999999999986543   3567788889999999999999987   9999999999999999999999999999


Q ss_pred             eecCCc
Q 042853          598 TFTMNE  603 (614)
Q Consensus       598 ~~~~~~  603 (614)
                      .+....
T Consensus       178 ~~~~~~  183 (322)
T d1vzoa_         178 EFVADE  183 (322)
T ss_dssp             ECCGGG
T ss_pred             hhcccc
Confidence            875443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.90  E-value=1.2e-23  Score=212.80  Aligned_cols=138  Identities=23%  Similarity=0.363  Sum_probs=116.8

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCC-CCC---------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH-TNL---------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H-~nl---------~~~~~lv~Ey  524 (614)
                      ++|.+.++||+|+||+||+|... +++.||||.++...  ...++.+|++++..++| +|+         ....++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57888999999999999999975 68899999886532  23467889999999976 666         5678999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----CCcEEEeecCcceee
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDE-----QMNPKISDFGMARTF  599 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~-----~~~~kI~DFGla~~~  599 (614)
                      + +++|..++....  ..+++.....++.|++.||+|||+.+   ||||||||+|||++.     ++.+||+|||+|+.+
T Consensus        83 ~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          83 L-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            8 689988875433  35899999999999999999999987   999999999999974     567999999999987


Q ss_pred             cC
Q 042853          600 TM  601 (614)
Q Consensus       600 ~~  601 (614)
                      ..
T Consensus       157 ~~  158 (293)
T d1csna_         157 RD  158 (293)
T ss_dssp             BC
T ss_pred             cc
Confidence            54

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.90  E-value=7.7e-24  Score=214.75  Aligned_cols=139  Identities=24%  Similarity=0.373  Sum_probs=115.4

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------CCeeEEEEEe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------GGERLLVYEY  524 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------~~~~~lv~Ey  524 (614)
                      ++|++.+.||+|+||.||+|... +++.||||.+....  ...++..|+++++.++|+|+          ....++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46888999999999999999875 68899999886532  33568899999999988776          5678899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCcEEEeecCcceeecC
Q 042853          525 LPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLD---EQMNPKISDFGMARTFTM  601 (614)
Q Consensus       525 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld---~~~~~kI~DFGla~~~~~  601 (614)
                      +. ++|...+...  ...+++.....++.|++.||+|||+++   ||||||||+|||++   .+..+||+|||+|+.+..
T Consensus        85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            95 5555555332  345899999999999999999999987   99999999999986   455799999999998864


Q ss_pred             C
Q 042853          602 N  602 (614)
Q Consensus       602 ~  602 (614)
                      .
T Consensus       159 ~  159 (299)
T d1ckia_         159 A  159 (299)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=4.4e-24  Score=217.16  Aligned_cols=143  Identities=24%  Similarity=0.402  Sum_probs=116.4

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-C-ccEEEEEEccCCC--cchhHhHHHHHHHHHhc---CCCCCC------------
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-D-EQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL---QHTNLG------------  515 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~-~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nl~------------  515 (614)
                      .++|++.++||+|+||+||+|... + ++.||||+++...  .....++.+|+.+++.+   +|||+.            
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468899999999999999999974 4 5679999986432  22334567888877766   799981            


Q ss_pred             --CeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeec
Q 042853          516 --GERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDF  593 (614)
Q Consensus       516 --~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DF  593 (614)
                        ...+++|||++++.+.....  .....+++.....++.||+.||+|||+++   ||||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence              35689999999887755443  23345789999999999999999999987   999999999999999999999999


Q ss_pred             CcceeecCC
Q 042853          594 GMARTFTMN  602 (614)
Q Consensus       594 Gla~~~~~~  602 (614)
                      |+++.....
T Consensus       161 g~~~~~~~~  169 (305)
T d1blxa_         161 GLARIYSFQ  169 (305)
T ss_dssp             CSCCCCCGG
T ss_pred             hhhhhhccc
Confidence            999976543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=6.2e-24  Score=220.13  Aligned_cols=139  Identities=27%  Similarity=0.362  Sum_probs=116.8

Q ss_pred             cCCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCCC--------------Ce
Q 042853          455 TDNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLG--------------GE  517 (614)
Q Consensus       455 t~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl~--------------~~  517 (614)
                      .++|++.++||+|+||+||+|... +++.||||++++..  ....+++.+|+.+++.++|+|+.              ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999975 78999999997543  23445789999999999999981              23


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++++||+.+|+|..++..    ..+++.+...++.||+.||+|||+++   ||||||||+|||++.++.+|++|||+|.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            4677888999999998842    35899999999999999999999987   9999999999999999999999999998


Q ss_pred             eec
Q 042853          598 TFT  600 (614)
Q Consensus       598 ~~~  600 (614)
                      ...
T Consensus       170 ~~~  172 (348)
T d2gfsa1         170 HTD  172 (348)
T ss_dssp             CCT
T ss_pred             ccC
Confidence            764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=5.9e-23  Score=213.34  Aligned_cols=137  Identities=28%  Similarity=0.358  Sum_probs=111.5

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCC--cchhHhHHHHHHHHHhcCCCCC---------------CCe
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNL---------------GGE  517 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nl---------------~~~  517 (614)
                      ++|.+.++||+|+||+||+|... +++.||||++.+..  .....++.+|+.++++++|||+               ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67888999999999999999976 68999999997542  3345578999999999999998               147


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCcce
Q 042853          518 RLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGMAR  597 (614)
Q Consensus       518 ~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGla~  597 (614)
                      .++||||+.++.+. .+.     ..+++.....++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            79999999766554 432     24788999999999999999999987   9999999999999999999999999998


Q ss_pred             eecC
Q 042853          598 TFTM  601 (614)
Q Consensus       598 ~~~~  601 (614)
                      ....
T Consensus       168 ~~~~  171 (355)
T d2b1pa1         168 TAGT  171 (355)
T ss_dssp             ----
T ss_pred             cccc
Confidence            7654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=7.5e-21  Score=179.45  Aligned_cols=129  Identities=19%  Similarity=0.200  Sum_probs=100.4

Q ss_pred             CccceeccCCceeEEEEEeCCccEEEEEEccCCCc------------------chhHhHHHHHHHHHhcCCCCCCC----
Q 042853          459 SPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSG------------------QGIVEFKNEAKLIAKLQHTNLGG----  516 (614)
Q Consensus       459 ~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~nl~~----  516 (614)
                      .+.++||+|+||+||+|...++++||||.++....                  .....+..|...+.++.|.++..    
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            34689999999999999998899999998643210                  01123456888899999998832    


Q ss_pred             -eeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEeecCc
Q 042853          517 -ERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQMNPKISDFGM  595 (614)
Q Consensus       517 -~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~~~kI~DFGl  595 (614)
                       ..+++|||+++..+..          ++......++.|++++|.|||+.+   |+||||||+|||++++ .++|+|||+
T Consensus        83 ~~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          83 EGNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             ETTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             cCCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCC
Confidence             3479999999866532          222334578999999999999987   9999999999999965 589999999


Q ss_pred             ceeecC
Q 042853          596 ARTFTM  601 (614)
Q Consensus       596 a~~~~~  601 (614)
                      |+....
T Consensus       149 a~~~~~  154 (191)
T d1zara2         149 SVEVGE  154 (191)
T ss_dssp             CEETTS
T ss_pred             cccCCC
Confidence            988753

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.82  E-value=3.9e-20  Score=158.34  Aligned_cols=112  Identities=23%  Similarity=0.442  Sum_probs=92.6

Q ss_pred             cccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEE
Q 042853           10 TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVW   89 (614)
Q Consensus        10 ~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW   89 (614)
                      +|+|.+||.|.+|++|+|  |.|+|.|...++     |.+++.                        .        ++||
T Consensus         1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~~------------------------~--------~~vW   41 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN------------------------N--------RAVW   41 (112)
T ss_dssp             CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET------------------------T--------EEEE
T ss_pred             CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEcC------------------------C--------cEEE
Confidence            589999999999999975  999999987775     556543                        2        6799


Q ss_pred             EcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCC
Q 042853           90 IANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYP  169 (614)
Q Consensus        90 ~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~P  169 (614)
                      .||++.|..   ...|.|.. ||+|+|.|. +.++|++++.......+|+|+|+|||||++.   ++   .++|||+.+|
T Consensus        42 ~s~~~~~~~---~~~l~l~~-dGnLvl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~---~~---~~~W~S~t~~  110 (112)
T d1xd5a_          42 ASGTNGKAS---GCVLKMQN-DGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDN---SN---NAIWATHTNV  110 (112)
T ss_dssp             ECCCTTSCS---SEEEEECT-TSCEEEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEECT---TS---CEEEECCCCC
T ss_pred             EccCccCCC---CcEEEEec-cccEEEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEECC---CC---cEEecCCCcc
Confidence            999998863   46899998 999999986 5678888876544456899999999999984   33   6899999999


Q ss_pred             CC
Q 042853          170 TD  171 (614)
Q Consensus       170 TD  171 (614)
                      +|
T Consensus       111 ~n  112 (112)
T d1xd5a_         111 GN  112 (112)
T ss_dssp             CC
T ss_pred             CC
Confidence            86

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.81  E-value=9e-20  Score=154.72  Aligned_cols=108  Identities=21%  Similarity=0.394  Sum_probs=89.6

Q ss_pred             cccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEE
Q 042853           10 TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVW   89 (614)
Q Consensus        10 ~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW   89 (614)
                      .|+|.+||.|.+|++|.  +|.|.|+|...++     |.++..                        .        ++||
T Consensus         1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~~------------------------~--------~~vW   41 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYDH------------------------S--------TSVW   41 (109)
T ss_dssp             CCEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEET------------------------T--------EEEE
T ss_pred             CCCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEeC------------------------C--------EEEE
Confidence            37899999999999996  4889999976554     455432                        2        5799


Q ss_pred             EcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCC
Q 042853           90 IANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDY  168 (614)
Q Consensus        90 ~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~  168 (614)
                      +||++.|...  .+.|.|.+ ||+|+|.|++|++||+|+++......+|.|+|+|||||++         ..+|||+-|
T Consensus        42 ~ant~~~~~~--~~~l~l~~-dGnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~---------~~~W~S~t~  108 (109)
T d1kj1a_          42 ASNTGILGKK--GCKAVLQS-DGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG---------SDIWSTGTY  108 (109)
T ss_dssp             ECCCCCTTCC--CCEEEECT-TSCEEEECSSSCEEEECCCCCCSSCCEEEECTTSCEEEEC---------CEEEECCCC
T ss_pred             EeCCCCCCce--eEEEEEcC-CceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEEC---------CCEecCCCc
Confidence            9999999874  47899998 9999999999999999997654445689999999999986         369999865

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.80  E-value=6e-20  Score=190.68  Aligned_cols=143  Identities=20%  Similarity=0.243  Sum_probs=111.6

Q ss_pred             CCCCccceeccCCceeEEEEEeC-CccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC--------------------
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQ-DEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL--------------------  514 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl--------------------  514 (614)
                      ++|.+.++||+|+||+||+|+.. +++.||||++++. ....+.+.+|+.++++++|+|+                    
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35888999999999999999975 7899999999753 2234678899999999987653                    


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC------
Q 042853          515 --GGERLLVYEYLPNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKYSRLRVIHRDLKVSNILLDEQM------  586 (614)
Q Consensus       515 --~~~~~lv~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILld~~~------  586 (614)
                        ....+++|+++..+..............+++.....++.||+.||+|||+..  +|+||||||+||||+.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence              1344677777766554444333344556788889999999999999999722  499999999999998654      


Q ss_pred             cEEEeecCcceeecC
Q 042853          587 NPKISDFGMARTFTM  601 (614)
Q Consensus       587 ~~kI~DFGla~~~~~  601 (614)
                      .+||+|||.|+....
T Consensus       170 ~~kl~dfg~s~~~~~  184 (362)
T d1q8ya_         170 QIKIADLGNACWYDE  184 (362)
T ss_dssp             EEEECCCTTCEETTB
T ss_pred             eeeEeeccccccccc
Confidence            389999999987653

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.80  E-value=7.8e-20  Score=155.05  Aligned_cols=107  Identities=27%  Similarity=0.447  Sum_probs=90.2

Q ss_pred             cccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEE
Q 042853           10 TDKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVW   89 (614)
Q Consensus        10 ~~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW   89 (614)
                      .|+|.+||.|.+|+.|.  +|.|+|.|...|+     |.||..                        .        ++||
T Consensus         1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~------------------------~--------~~vW   41 (108)
T d1jpca_           1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV------------------------D--------KPIW   41 (108)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET------------------------T--------EEEE
T ss_pred             CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC------------------------C--------ceee
Confidence            37899999999999995  6999999998775     567653                        2        5799


Q ss_pred             EcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCC
Q 042853           90 IANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDY  168 (614)
Q Consensus        90 ~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~  168 (614)
                      .||++.|-.   ...|.+.. +|+|+|.|++|.+||+|++.......+|+|+|+|||||++         ..+||||+|
T Consensus        42 ~s~~~~~~~---~~~l~l~~-~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~---------~~~W~S~t~  107 (108)
T d1jpca_          42 ATNTGGLSR---SCFLSMQT-DGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYG---------TDRWATGTH  107 (108)
T ss_dssp             ECCCTTSCS---SCEEEECT-TSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEE---------CCCCCCCCC
T ss_pred             EeCCCCCCC---ccEEEEec-cceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEeC---------CCcccCCCC
Confidence            999998853   46799998 9999999999999999987654445678999999999996         358999998

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.56  E-value=1.5e-15  Score=130.52  Aligned_cols=96  Identities=15%  Similarity=0.143  Sum_probs=76.9

Q ss_pred             CCC-CcEEEcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccce
Q 042853           83 IKP-RPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRE  161 (614)
Q Consensus        83 ~~~-t~VW~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~  161 (614)
                      ++. +++|++|++.|+... ..+|.+.. ||||+|.+. +.++|++++...+....|.|+|+|||||++.   +.   .+
T Consensus        17 ~~~~~~~~~l~~~q~l~~g-~y~L~~q~-DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~---~~---~~   87 (120)
T d1dlpa2          17 QGNDNHPQTLHATQSLQLS-PYRLSMET-DCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN---QN---IA   87 (120)
T ss_dssp             --CCCCCCEECSSCCCBCS-SCEEEEET-TTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET---TT---EE
T ss_pred             CCCCCcccEEcCCCeeEcC-CEEEEEcC-CCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC---CC---CE
Confidence            555 889999999999865 67899998 999999876 6789999987655567899999999999984   32   68


Q ss_pred             eceecCCCCCCcCCCCeeeeeecCCceEEEEecCCCCCccceEEeecCCCCceEE
Q 042853          162 LWQSFDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLV  216 (614)
Q Consensus       162 lWQSFD~PTDTlLpg~~l~~~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~  216 (614)
                      +||||..                             ..+|.|.+.++++|...++
T Consensus        88 lW~S~t~-----------------------------~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          88 VWTSGNS-----------------------------RSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             EEECCCC-----------------------------CSSSCCEEEECSSSCEEEE
T ss_pred             EEEeCCC-----------------------------CCCCcEEEEECCCCcEEEe
Confidence            9999841                             1167788999999985543

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.48  E-value=1.3e-13  Score=117.88  Aligned_cols=103  Identities=20%  Similarity=0.361  Sum_probs=80.4

Q ss_pred             ccccCCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEEE
Q 042853           11 DKLQQGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWI   90 (614)
Q Consensus        11 ~~i~~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW~   90 (614)
                      ++|.++|+|    ...+..|.|.|.|...|+     |.+ |.                               ..++||.
T Consensus        15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~-------------------------------~~~~vWs   53 (119)
T d1b2pa_          15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD-------------------------------NNNPIWA   53 (119)
T ss_dssp             CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE-------------------------------TTEEEEE
T ss_pred             CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE-------------------------------CCeEEEE
Confidence            456666665    346789999999988776     344 33                               1257999


Q ss_pred             cCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecC
Q 042853           91 ANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFD  167 (614)
Q Consensus        91 ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD  167 (614)
                      ||+..|..   ...|.+.. +|+|+|.|++|.+||++++.......+|+|+|+|||||++         ..+|||-.
T Consensus        54 snt~~~~~---~~~l~l~~-dGnLvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T  117 (119)
T d1b2pa_          54 TNTGGLGN---GCRAVLQP-DGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---------DALWATQT  117 (119)
T ss_dssp             CCCTTSCS---SCEEEECT-TSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred             ecCCCCCc---ceEEEEEe-CCCEEEECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---------CCEeccCC
Confidence            99987753   46899998 9999999999999999987654444678999999999985         47999964

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.41  E-value=7e-14  Score=118.66  Aligned_cols=101  Identities=21%  Similarity=0.179  Sum_probs=81.2

Q ss_pred             CcEEEcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceecee
Q 042853           86 RPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS  165 (614)
Q Consensus        86 t~VW~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQS  165 (614)
                      +..|+.+.+.++.+. ..+|.+.. ||||||.++ +.++|++++... .+..|.|+|+|||||++.   .+   .++|||
T Consensus        12 ~~~~tl~~~~~l~~g-~~~l~~q~-DGNLvL~~~-~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d~---~~---~~vWsS   81 (115)
T d1dlpa1          12 SHPQTLHAAQSLELS-SFRFTMQS-DCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTA---QN---TIRWSS   81 (115)
T ss_dssp             CSCSCCCTTCEECST-TEEEEECT-TSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCT---TT---CCSCCC
T ss_pred             CCcceecCCCcEEcC-CEEEEECC-CCeEEEEcC-CeeEEEcccCCC-CceEEEEeccCCEEEEcc---CC---CEEEEc
Confidence            667999999999865 77999998 999999874 789999997643 457899999999999974   32   689999


Q ss_pred             cCCCCCCcCCCCeeeeeecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCC
Q 042853          166 FDYPTDTLLPGMKLGINLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTI  229 (614)
Q Consensus       166 FD~PTDTlLpg~~l~~~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~  229 (614)
                      +..+                             ..|.|.+.++++|...  +|  +.++|.+|.
T Consensus        82 ~t~~-----------------------------~~g~y~l~Lq~DGNlv--lY--~~~~Wssgt  112 (115)
T d1dlpa1          82 GTKG-----------------------------SIGNYVLVLQPDRTVT--IY--GPGLWDSGT  112 (115)
T ss_dssp             CCCC-----------------------------CSSCCEEEECSSSCEE--EE--CSEEEECSC
T ss_pred             CCCC-----------------------------CCCCEEEEECCCCcEE--Ee--CCCeecCCC
Confidence            7421                             1688999999999854  45  348999875

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.17  E-value=1.3e-11  Score=104.39  Aligned_cols=100  Identities=22%  Similarity=0.330  Sum_probs=75.2

Q ss_pred             CCCccCCCCeEEeCCCeEEEEeeCCCCCCCcEEEEEEecCCcccchhhhcccCCCCCCCcccccccCCCCCCcEEEcCCC
Q 042853           15 QGQVLKDGEELVSAYGNFRLGFFSPSGRRNRYLAIYYKKPRDRILDVAFNCLMGYPTGDVSMQSYNQAIKPRPVWIANRD   94 (614)
Q Consensus        15 ~g~~l~~~~~l~S~~g~F~lGFf~~~~~~~~~l~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~VW~ANr~   94 (614)
                      ..|.|.+++.|  .+|.|.|.|...|+     |.++..                        +        .+||.+|..
T Consensus        13 ~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~~------------------------~--------~~vW~s~t~   53 (115)
T d1dlpa1          13 HPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS------------------------D--------VRVWASNTA   53 (115)
T ss_dssp             SCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEES------------------------S--------SEEECCCCC
T ss_pred             CcceecCCCcE--EcCCEEEEECCCCe-----EEEEcC------------------------C--------eeEEEcccC
Confidence            33555555555  46779999988775     566533                        2        579999975


Q ss_pred             CCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecC
Q 042853           95 TPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFD  167 (614)
Q Consensus        95 ~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD  167 (614)
                      .+-    .+.+.|.+ +|+|||.|.++.+||++.+.......+++|+++|||||++         ..+|+|-.
T Consensus        54 ~~~----~~~l~l~~-dGNLvl~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssgt  112 (115)
T d1dlpa1          54 GAT----GCRAVLQS-DGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---------PGLWDSGT  112 (115)
T ss_dssp             SCS----CCBCCBCS-SSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---------SEEEECSC
T ss_pred             CCC----ceEEEEec-cCCEEEEccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---------CCeecCCC
Confidence            422    46788988 9999999999999999987654445679999999999985         46899853

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.88  E-value=2.6e-09  Score=90.79  Aligned_cols=67  Identities=21%  Similarity=0.393  Sum_probs=52.7

Q ss_pred             CcEEEcCCCCCCCCCCCeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceecee
Q 042853           86 RPVWIANRDTPVLRNESATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQS  165 (614)
Q Consensus        86 t~VW~ANr~~Pv~~~~~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQS  165 (614)
                      .+||.+|-.  .... ...+.|.+ +|+|||.|.++.++|+|++.......++.|.++|||||++         ..+|.|
T Consensus        54 ~~vW~s~t~--~~~~-~~~~~l~~-~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~---------~~~W~t  120 (120)
T d1dlpa2          54 DRVWSTNTA--GKGT-GCRAVLQP-NGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG---------GALWTT  120 (120)
T ss_dssp             BCCSCCCCC--SSCS-SCEEEEET-TTEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC---------CCCCBC
T ss_pred             cEEEEEccc--cCCC-cEEEEEeC-CeeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEeC---------CCcccC
Confidence            458988743  3323 46799998 9999999999999999998654445678999999999985         457875

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.62  E-value=8.2e-08  Score=81.11  Aligned_cols=85  Identities=26%  Similarity=0.372  Sum_probs=63.9

Q ss_pred             EEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeeeee
Q 042853          104 TLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGINL  183 (614)
Q Consensus       104 ~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~~~  183 (614)
                      +|.+-. ||||||.++ +.++|++++.....+..+.|.++|||||.+.   ++   .++|+|.-                
T Consensus        33 ~l~mQ~-DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~---~g---~~vWsS~t----------------   88 (119)
T d1b2pa_          33 RFIMQT-DCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN---EN---VTVWQSPV----------------   88 (119)
T ss_dssp             EEEECT-TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT---TC---CEEEECSC----------------
T ss_pred             EEEECC-CCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC---CC---cEEEECCC----------------
Confidence            577777 999999875 6689999987655567899999999999984   33   68897631                


Q ss_pred             cCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCC
Q 042853          184 QTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTI  229 (614)
Q Consensus       184 ~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~  229 (614)
                                   ....|.|.+.++++|...+  |.  .+.|.++.
T Consensus        89 -------------~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T  117 (119)
T d1b2pa_          89 -------------AGKAGHYVLVLQPDRNVVI--YG--DALWATQT  117 (119)
T ss_dssp             -------------CCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred             -------------cCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence                         0115678899999997555  43  47898864

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.59  E-value=4.7e-08  Score=81.31  Aligned_cols=86  Identities=19%  Similarity=0.269  Sum_probs=62.5

Q ss_pred             CeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeee
Q 042853          102 SATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGI  181 (614)
Q Consensus       102 ~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~  181 (614)
                      .-+|.+.. ||||||.+. +.+||++++..++..+.+.|.++|||||++.   ++   .++|+|     +|-        
T Consensus        20 ~~~l~~q~-DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~---~g---~~vWsS-----~t~--------   78 (108)
T d1jpca_          20 SFVFIMQE-DCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNP---SN---KPIWAS-----NTG--------   78 (108)
T ss_dssp             TEEEEECT-TSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT---TC---CEEEEC-----CCC--------
T ss_pred             CEEEEECC-CCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECC---Cc---cceEEc-----ccc--------
Confidence            35788888 999999874 6799999987655567899999999999974   33   689986     110        


Q ss_pred             eecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeC
Q 042853          182 NLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTST  228 (614)
Q Consensus       182 ~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g  228 (614)
                                      ...+.|.+.++.+|.+.+  +..  +.|.++
T Consensus        79 ----------------~~~~~~~l~L~ddGNlVl--y~~--~~W~S~  105 (108)
T d1jpca_          79 ----------------GQNGNYVCILQKDRNVVI--YGT--DRWATG  105 (108)
T ss_dssp             ----------------CSCSCEEEEECTTSCEEE--EEC--CCCCCC
T ss_pred             ----------------CCCCcEEEEEcCCCCEEE--eCC--CcccCC
Confidence                            114677888999997544  432  356554

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.56  E-value=1.8e-07  Score=77.73  Aligned_cols=88  Identities=20%  Similarity=0.347  Sum_probs=63.9

Q ss_pred             CeEEEEEcCCCcEEEEeCCCCcEEEeeeecCC-cccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeee
Q 042853          102 SATLIIDSTDGNLKILRNGKSPIEISSVRRAG-NTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLG  180 (614)
Q Consensus       102 ~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~-~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~  180 (614)
                      .-.|.+-. ||||+|.+ .+.+||++|+..+. ....+.|.++|||||++.   ++   .++|+|=     |        
T Consensus        20 ~~~l~~q~-dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~---~g---~~vW~s~-----t--------   78 (109)
T d1kj1a_          20 PYHFIMQE-DCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA---EG---RSLWASH-----S--------   78 (109)
T ss_dssp             TEEEEECT-TSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS---SS---CEEEECC-----C--------
T ss_pred             CEEEEecC-CCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC---CC---cEEEEEe-----e--------
Confidence            35788888 99999976 56899999976432 246799999999999984   33   6899871     1        


Q ss_pred             eeecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeCCEEEEEeCCC
Q 042853          181 INLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKDDKVVWTSTIW  230 (614)
Q Consensus       181 ~~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~~~~yw~~g~w  230 (614)
                                      ....|.|.+.++++|...+  ++  .+.|.++.+
T Consensus        79 ----------------~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t~  108 (109)
T d1kj1a_          79 ----------------VRGNGNYVLVLQEDGNVVI--YG--SDIWSTGTY  108 (109)
T ss_dssp             ----------------CCCSSCCEEEECTTSCEEE--EC--CEEEECCCC
T ss_pred             ----------------ECCCCCEEEEEeCCCcEEE--EC--CCEecCCCc
Confidence                            0014678889999997544  43  468887654

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.33  E-value=1.6e-06  Score=72.39  Aligned_cols=88  Identities=20%  Similarity=0.367  Sum_probs=63.9

Q ss_pred             CeEEEEEcCCCcEEEEeCCCCcEEEeeeecCCcccEEEeccCCCEEEEeecCCCCcccceeceecCCCCCCcCCCCeeee
Q 042853          102 SATLIIDSTDGNLKILRNGKSPIEISSVRRAGNTTRATLLKNGNLVLYEMNSDGLSIRRELWQSFDYPTDTLLPGMKLGI  181 (614)
Q Consensus       102 ~~~l~l~~~~G~L~l~~~~g~~vwss~~~~~~~~~~a~LldsGNlVl~~~~~~~~~~~~~lWQSFD~PTDTlLpg~~l~~  181 (614)
                      .-.|.+.. ||||||.+ .+.+||+++......++.+.|..+|||||++.   +    ..+|-|                
T Consensus        20 ~~~l~~q~-DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~---~----~~~w~s----------------   74 (112)
T d1xd5a_          20 GYLFIIQN-DCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG---S----RAIWAS----------------   74 (112)
T ss_dssp             TEEEEECT-TSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET---T----EEEEEC----------------
T ss_pred             CEEEEEcC-CCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec---C----CeEEEE----------------
Confidence            36788888 99999986 57899999977554567899999999999973   2    355543                


Q ss_pred             eecCCceEEEEecCCCCCccceEEeecCCCCceEEEEeC-CEEEEEeCC
Q 042853          182 NLQTGHQWFLRSSRSAEVSYRLGLGTDPNITNKLVIWKD-DKVVWTSTI  229 (614)
Q Consensus       182 ~~~tg~~~~L~S~~s~~~~G~~~l~~~~~~~~~~~~~~~-~~~yw~~g~  229 (614)
                                   .+....+.+.+.++.+|..  ++++. ..+.|.++.
T Consensus        75 -------------~t~~~~~~~~l~L~ddGNl--vly~~~~~~~W~S~t  108 (112)
T d1xd5a_          75 -------------NTNRQNGNYYLILQRDRNV--VIYDNSNNAIWATHT  108 (112)
T ss_dssp             -------------CCCCSCCCCEEEECTTSCE--EEECTTSCEEEECCC
T ss_pred             -------------eeccCCCceEEEEcCCCCE--EEECCCCcEEecCCC
Confidence                         0111156788899999974  44554 467898864

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.90  E-value=4e-05  Score=73.24  Aligned_cols=135  Identities=16%  Similarity=0.123  Sum_probs=83.3

Q ss_pred             CCCCccceeccCCceeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcC-C---CCC------CCeeEEEEEec
Q 042853          456 DNFSPANRLGQGGFGPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-H---TNL------GGERLLVYEYL  525 (614)
Q Consensus       456 ~~f~~~~~lG~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H---~nl------~~~~~lv~Ey~  525 (614)
                      ..|......+-++...||+... +++.+.+|+...........+.+|+..+..+. +   |-+      .+..++|||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            3444333322233468998765 45567788876544444456788888887764 1   222      45678999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 042853          526 PNKSLDFFIFDSSRKSLLDWKKRFSIIEGITQGLLYLHKY----------------------------------------  565 (614)
Q Consensus       526 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  565 (614)
                      ++..+.......     ..   ...++.++++.|..||+.                                        
T Consensus        93 ~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          93 DGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             SSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             cccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            998775443111     01   122334444444444421                                        


Q ss_pred             ----------------CCCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          566 ----------------SRLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       566 ----------------~~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                                      .+..++|+|+.|.|||++++..+-|.||+.+..-
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                            1123799999999999998766789999988754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.39  E-value=0.0002  Score=67.79  Aligned_cols=134  Identities=18%  Similarity=0.171  Sum_probs=78.7

Q ss_pred             eeccCCc-eeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC-----------CCeeEEEEEecCCCCH
Q 042853          463 RLGQGGF-GPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-----------GGERLLVYEYLPNKSL  530 (614)
Q Consensus       463 ~lG~G~f-g~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----------~~~~~lv~Ey~~~gsL  530 (614)
                      .+..|.. ..||+....++..+.+|.-...   ...++..|+..+..+....+           .+..++|||++++..+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555543 6789998877777888876432   23457788888887755444           3467899999987654


Q ss_pred             HHH--------------Hhh-cC---CCCCC--CHHHHHHHH--------------------HHHHHHHHHHHhC----C
Q 042853          531 DFF--------------IFD-SS---RKSLL--DWKKRFSII--------------------EGITQGLLYLHKY----S  566 (614)
Q Consensus       531 ~~~--------------l~~-~~---~~~~l--~~~~~~~i~--------------------~~ia~gL~yLH~~----~  566 (614)
                      ...              +.. +.   .....  .+.....-.                    ......+..+.+.    .
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            221              000 00   00000  111110000                    0112233333332    1


Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          567 RLRVIHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       567 ~~~iiHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ++.++|+|+.|.|||++++..+-|.||+.+..-
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g  206 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  206 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence            233899999999999998766789999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.45  E-value=0.0075  Score=60.73  Aligned_cols=69  Identities=19%  Similarity=0.216  Sum_probs=42.4

Q ss_pred             cceeccCCceeEEEEEeCC-ccEEEEEEccCC-------CcchhHhHHHHHHHHHhcC-CC-CC--------CCeeEEEE
Q 042853          461 ANRLGQGGFGPVYKGKLQD-EQEIAIKRLSKS-------SGQGIVEFKNEAKLIAKLQ-HT-NL--------GGERLLVY  522 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~-~~~vavK~l~~~-------~~~~~~~f~~E~~~l~~l~-H~-nl--------~~~~~lv~  522 (614)
                      .+.||.|....||+....+ ++.+.||.-...       ......+...|.+.+..+. +. ..        ....++||
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvm  110 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM  110 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEE
Confidence            4679999999999998764 567888864321       1112234456777776653 21 11        33457899


Q ss_pred             EecCCCC
Q 042853          523 EYLPNKS  529 (614)
Q Consensus       523 Ey~~~gs  529 (614)
                      |++++..
T Consensus       111 E~L~~~~  117 (392)
T d2pula1         111 EDLSHLK  117 (392)
T ss_dssp             CCCTTSE
T ss_pred             eccCCcc
Confidence            9998644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.31  E-value=0.0057  Score=59.87  Aligned_cols=127  Identities=13%  Similarity=0.190  Sum_probs=76.3

Q ss_pred             eeEEEEEeCCccEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCC----------------CCeeEEEEEecCCCCHH--
Q 042853          470 GPVYKGKLQDEQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL----------------GGERLLVYEYLPNKSLD--  531 (614)
Q Consensus       470 g~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl----------------~~~~~lv~Ey~~~gsL~--  531 (614)
                      -.||+...++|..+++|.-... ....+++..|...+..|....+                ....+.+++++++..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            5799999999999999987542 2244667888888888765444                34578889998763321  


Q ss_pred             ---HH------H---hh------cCCCCCCCHHHH-------------------HHHHHHHHHHHHHHH----hCCCCce
Q 042853          532 ---FF------I---FD------SSRKSLLDWKKR-------------------FSIIEGITQGLLYLH----KYSRLRV  570 (614)
Q Consensus       532 ---~~------l---~~------~~~~~~l~~~~~-------------------~~i~~~ia~gL~yLH----~~~~~~i  570 (614)
                         .+      +   +.      ......+++...                   -.+...+.+.+..+.    +..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               11      0   00      011112222111                   111122223333332    2234468


Q ss_pred             EecCCCCCCEEEcCCCcEEEeecCcceee
Q 042853          571 IHRDLKVSNILLDEQMNPKISDFGMARTF  599 (614)
Q Consensus       571 iHrDlkp~NILld~~~~~kI~DFGla~~~  599 (614)
                      ||+|+.+.|||++++  ..+.||+-+..-
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhcccC
Confidence            999999999999754  568999988753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.99  E-value=0.064  Score=51.51  Aligned_cols=31  Identities=29%  Similarity=0.295  Sum_probs=27.3

Q ss_pred             CceEecCCCCCCEEEcCCCcEEEeecCccee
Q 042853          568 LRVIHRDLKVSNILLDEQMNPKISDFGMART  598 (614)
Q Consensus       568 ~~iiHrDlkp~NILld~~~~~kI~DFGla~~  598 (614)
                      ..+||+|+.+.||+++.+...-|.||+.|..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            4599999999999999887778999998863

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.54  E-value=0.034  Score=55.65  Aligned_cols=68  Identities=16%  Similarity=0.279  Sum_probs=42.8

Q ss_pred             cceeccCCceeEEEEEeCCc--------cEEEEEEccCCCcchhHhHHHHHHHHHhcCCCCCCCee------EEEEEecC
Q 042853          461 ANRLGQGGFGPVYKGKLQDE--------QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLGGER------LLVYEYLP  526 (614)
Q Consensus       461 ~~~lG~G~fg~Vy~g~~~~~--------~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nl~~~~------~lv~Ey~~  526 (614)
                      .+.|+-|-.-.+|+...+++        +.+.++..- . ........+|..+++.+.-.++....      .+|+||++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~g~I~efi~  124 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEYIP  124 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECCCC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCCceEEEEec
Confidence            36788888899999887532        345554443 2 22333456788888887655663322      46899998


Q ss_pred             CCCH
Q 042853          527 NKSL  530 (614)
Q Consensus       527 ~gsL  530 (614)
                      +..|
T Consensus       125 g~~l  128 (395)
T d1nw1a_         125 SRPL  128 (395)
T ss_dssp             EEEC
T ss_pred             cccC
Confidence            6443